Citrus Sinensis ID: 015019
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LUC3 | 598 | Mitogen-activated protein | yes | no | 0.997 | 0.690 | 0.893 | 0.0 | |
| Q9C5C0 | 615 | Mitogen-activated protein | no | no | 1.0 | 0.673 | 0.879 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | yes | no | 0.968 | 0.704 | 0.835 | 0.0 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 1.0 | 0.683 | 0.835 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | no | no | 0.997 | 0.675 | 0.852 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.961 | 0.699 | 0.832 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.968 | 0.739 | 0.800 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.968 | 0.805 | 0.790 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 1.0 | 0.730 | 0.775 | 0.0 | |
| Q6L5D4 | 700 | Mitogen-activated protein | no | no | 0.968 | 0.572 | 0.820 | 0.0 |
| >sp|Q9LUC3|MPK19_ARATH Mitogen-activated protein kinase 19 OS=Arabidopsis thaliana GN=MPK19 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/414 (89%), Positives = 390/414 (94%), Gaps = 1/414 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY+N +EG++FLYPSAIG RKQFAYLEEN G+SGPVIPP+RKH SLPR
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPR 413
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q9C5C0|MPK18_ARATH Mitogen-activated protein kinase 18 OS=Arabidopsis thaliana GN=MPK18 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/414 (87%), Positives = 387/414 (93%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY++G+EG+NF+YPSAIG R+QF YLEEN R+GPVIP ERKH SLPR
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPR 414
|
Mitogen-activated protein kinase (MAPK) that is specifically regulated by PHS1 and mediates signaling that regulates cortical microtubule functions, maybe through regulation of microtubule dynamic instability. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 733 bits (1892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/401 (83%), Positives = 378/401 (94%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGDANRYKI EVIGKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T+ +RNEKAR+YL+ MRKK PVP ++FP DP AL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK EREPSCQPI+K+EFEFERR+VTK+D++ELI+REILEYHPQLLKDY+NGTE
Sbjct: 302 PYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTEK 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
TNFLYPSA+ FR+QFA LEENGG++G +P +RKHVSLPR
Sbjct: 362 TNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRKHVSLPR 402
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/414 (83%), Positives = 387/414 (93%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKD++NG + +FLYPSA+ QFR+QFA+LEEN G++GPV P ERKH SLPR
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPR 414
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/414 (85%), Positives = 388/414 (93%), Gaps = 1/414 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK + DFFTEYGDA+RYKI EVIGKGSYGVVC+AID HTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT+EH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRN+KAR+YL+ MRKK P+ QKFP+ DPLAL LLQ+L+AFD
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALA PYFKGLAK+EREPSCQPI+K+EFEFERRRVTK+DIRELI+REILEYH
Sbjct: 301 PKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDYINGTE T FLYPSA+ QFRKQFA+LEENGG +GPVIP +RKH SLPR
Sbjct: 361 PQLLKDYINGTERTTFLYPSAVDQFRKQFAHLEENGG-NGPVIPMDRKHTSLPR 413
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 707 bits (1826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/401 (83%), Positives = 380/401 (94%), Gaps = 3/401 (0%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGD++RYKI E++GKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RN+KAR+YL+ MR+K PVP +KFPNVDPLAL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 AISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK+EREPSCQPISK+EFEFERR+VTKDDI+ELI+REILEYHPQLLKDY+NG+E
Sbjct: 302 PYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSEN 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
T+FLYPSA+ FR+QFA LEENGG+SG + +RKHVSLPR
Sbjct: 362 TSFLYPSAVDNFRRQFAILEENGGKSGAL---DRKHVSLPR 399
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 706 bits (1822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/401 (80%), Positives = 370/401 (92%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTG+KVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPSPE
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ +RNEKAR+YL MR+K P+P QKFPN DPLA+RLL+R++AFDPKDRP+AEEALAD
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFK +A ++REPS QPI+KLEFEFERRR+TK+DIRELIYREILEYHP++L++++ GTE
Sbjct: 302 PYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTES 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
T F+YPSA+ F+KQFAYLEE+ + PPER+H SLPR
Sbjct: 362 TGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPR 402
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/401 (79%), Positives = 366/401 (91%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTGEKVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RNEKAR+YL+ MR+K P+P QKFPN DPLALRLL+R+++F+PKDRP AEEALAD
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYF+ +A ++REPS QP++KLEFEFERRR+TK+DIRELIYR+ILEYHP +L++Y+ GTE
Sbjct: 302 PYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTES 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
F+YPSA+ F+KQFAYLEE+ + PPER+H SLPR
Sbjct: 362 AGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPR 402
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 694 bits (1790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/415 (77%), Positives = 373/415 (89%), Gaps = 1/415 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPER-KHVSLPR 414
P++LK+Y++G+E TNF+YPSA+ F+KQFAYLEE+ PPER +H SLPR
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPR 415
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5D4|MPK9_ORYSJ Mitogen-activated protein kinase 9 OS=Oryza sativa subsp. japonica GN=MPK9 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/402 (82%), Positives = 373/402 (92%), Gaps = 1/402 (0%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
++FFTEYGDANRY+I EVIGKGSYGVVC+AID HT +KVAIKK+H++FEH+SDA RILRE
Sbjct: 95 EEFFTEYGDANRYRIQEVIGKGSYGVVCSAIDLHTRQKVAIKKVHNIFEHVSDAARILRE 154
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLT+EH+QFFL
Sbjct: 155 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEHYQFFL 214
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+LRALKY+HTA+VYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DTP TVFWTDYVAT
Sbjct: 215 YQLLRALKYIHTASVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTVFWTDYVAT 274
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDL+TDLLGTPS
Sbjct: 275 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSM 334
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+TI+ VRNEKAR+YL+ MRKK PVP QKFPN DPLAL+LLQRL+AFDPKDRPTAEEAL
Sbjct: 335 DTISRVRNEKARRYLSSMRKKDPVPFSQKFPNADPLALKLLQRLLAFDPKDRPTAEEALT 394
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
DPYFKGL+KI+REPSCQPI KLEFEFE+++++K+DIRELI++EILEYHPQL K+Y NG E
Sbjct: 395 DPYFKGLSKIDREPSCQPIRKLEFEFEQKKLSKEDIRELIFQEILEYHPQLQKNYRNGRE 454
Query: 373 GTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
FLYPSA+ QF+KQF+ LEE+ G SG IP ERKH SLPR
Sbjct: 455 RATFLYPSAVDQFKKQFSNLEESNG-SGSAIPMERKHASLPR 495
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| 224056591 | 610 | predicted protein [Populus trichocarpa] | 1.0 | 0.678 | 0.934 | 0.0 | |
| 255575145 | 606 | big map kinase/bmk, putative [Ricinus co | 0.983 | 0.671 | 0.938 | 0.0 | |
| 356556856 | 607 | PREDICTED: mitogen-activated protein kin | 1.0 | 0.682 | 0.917 | 0.0 | |
| 224119110 | 596 | predicted protein [Populus trichocarpa] | 0.968 | 0.672 | 0.922 | 0.0 | |
| 356549594 | 588 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 1.0 | 0.704 | 0.910 | 0.0 | |
| 358348772 | 608 | Mitogen-activated protein kinase [Medica | 1.0 | 0.680 | 0.900 | 0.0 | |
| 4732123 | 608 | mitogen-activated protein kinase homolog | 1.0 | 0.680 | 0.898 | 0.0 | |
| 224062744 | 621 | predicted protein [Populus trichocarpa] | 1.0 | 0.666 | 0.876 | 0.0 | |
| 225461820 | 598 | PREDICTED: mitogen-activated protein kin | 1.0 | 0.692 | 0.888 | 0.0 | |
| 186510066 | 598 | mitogen-activated protein kinase 19 [Ara | 0.997 | 0.690 | 0.893 | 0.0 |
| >gi|224056591|ref|XP_002298926.1| predicted protein [Populus trichocarpa] gi|222846184|gb|EEE83731.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/414 (93%), Positives = 400/414 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK+LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTG+KVAIKKI+DVF
Sbjct: 1 MQQDHPKKDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGDKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPS ETI+ VRN+KARKYLTEMRKK PVP QKF NVDPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSSETISGVRNDKARKYLTEMRKKQPVPFAQKFLNVDPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR TAEEALADPYFKGLAK+EREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYH
Sbjct: 301 PKDRLTAEEALADPYFKGLAKVEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY+NG E TNFLYPSAIGQFRKQFAYLEEN GRSGPVIPPERKHVSLPR
Sbjct: 361 PQLLKDYMNGNENTNFLYPSAIGQFRKQFAYLEENSGRSGPVIPPERKHVSLPR 414
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575145|ref|XP_002528477.1| big map kinase/bmk, putative [Ricinus communis] gi|223532086|gb|EEF33894.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2017), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/407 (93%), Positives = 396/407 (97%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
++LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI
Sbjct: 3 QDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREH 127
RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREH
Sbjct: 63 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREH 122
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWT
Sbjct: 123 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWT 182
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
DYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVL+GKPLFPGKSVVHQLDLITDLL
Sbjct: 183 DYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLSGKPLFPGKSVVHQLDLITDLL 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
GTPSPET++ VRN+KARKYLTEMRKK PV QKFPN DPLALRLLQRL+AFDPKDRPTA
Sbjct: 243 GTPSPETVSGVRNDKARKYLTEMRKKHPVSFTQKFPNADPLALRLLQRLLAFDPKDRPTA 302
Query: 308 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDY 367
EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY
Sbjct: 303 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDY 362
Query: 368 INGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
+NG EGTNFLYPSAIG FRKQFAYLEENGGRSGPVIP ERKHVSLPR
Sbjct: 363 LNGNEGTNFLYPSAIGHFRKQFAYLEENGGRSGPVIPLERKHVSLPR 409
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556856|ref|XP_003546736.1| PREDICTED: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/414 (91%), Positives = 398/414 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDMKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRA+KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHHQFFLYQMLRAMKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PETIA VRN+KARKYL EMRKK PVP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPETIAGVRNDKARKYLMEMRKKSPVPFEQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAK+EREPSCQPIS+LEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKVEREPSCQPISRLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY+NGTEGT+FLYPSAI QFRK FAYLEEN G+SGPVIPPERKHVSLPR
Sbjct: 361 PQLLKDYMNGTEGTHFLYPSAIDQFRKHFAYLEENHGKSGPVIPPERKHVSLPR 414
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119110|ref|XP_002331327.1| predicted protein [Populus trichocarpa] gi|222873910|gb|EEF11041.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/401 (92%), Positives = 384/401 (95%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
+FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI++VFEHISDA RILREV
Sbjct: 2 EFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKINNVFEHISDAFRILREV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKYMHTAN+YHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWTDYVATR
Sbjct: 122 QMLRALKYMHTANMYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYT AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTRAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSLE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ VRN+KARKYLTEMRKK PVP QKFPN DP A RLLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TISRVRNDKARKYLTEMRKKQPVPFAQKFPNADPSAHRLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK+EREPSCQPI+KLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY+NG E
Sbjct: 302 PYFKGLAKVEREPSCQPITKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDYMNGNES 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
TNFLYPSAIG FRKQFAYLEEN GRS PVIP ERKHVSLPR
Sbjct: 362 TNFLYPSAIGHFRKQFAYLEENSGRSAPVIPLERKHVSLPR 402
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549594|ref|XP_003543177.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/414 (91%), Positives = 398/414 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDIKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRI+LPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIVLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHYQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPSPETIA VRN+KARKYL EMRKK PVP QKF N DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSPETIAGVRNDKARKYLMEMRKKSPVPFEQKFQNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGL+K+EREPSCQPISKLEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLSKVEREPSCQPISKLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY+NGTEGT+FLYPSA+ QFRK FAYLEEN G+SGPVIPPERKHVSLPR
Sbjct: 361 PQLLKDYMNGTEGTHFLYPSAVDQFRKHFAYLEENHGKSGPVIPPERKHVSLPR 414
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358348772|ref|XP_003638417.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355504352|gb|AES85555.1| Mitogen-activated protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/414 (90%), Positives = 394/414 (95%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS Q IS++EFEFERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQSISRMEFEFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDYINGTEGTNF+YPSAI QFRKQFAYLEEN G+ GPVIPPERKHVSLPR
Sbjct: 361 PQLLKDYINGTEGTNFMYPSAIDQFRKQFAYLEENNGKCGPVIPPERKHVSLPR 414
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4732123|gb|AAD28617.1|AF129087_1 mitogen-activated protein kinase homologue [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/414 (89%), Positives = 395/414 (95%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS QPIS++EF+FERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQPISRMEFDFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDYI+GTEGTNF+YPSAI QFRKQFAYLEEN G+ GPVIPPERKHVSLPR
Sbjct: 361 PQLLKDYISGTEGTNFMYPSAIDQFRKQFAYLEENNGKCGPVIPPERKHVSLPR 414
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224062744|ref|XP_002300882.1| predicted protein [Populus trichocarpa] gi|222842608|gb|EEE80155.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/414 (87%), Positives = 396/414 (95%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK + DFF+EYGDANRYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PSTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI++VRN+KAR+YLT MRKK PVPL QKFPN DPLALRLL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISLVRNDKARRYLTSMRKKQPVPLAQKFPNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLA++EREPSCQPI+K+EFEFERRRVTK+D+RELI+REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLARVEREPSCQPITKMEFEFERRRVTKEDVRELIFREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY+NGTE TNFLYPSA+ QFRKQFA+LEENGG+SGPVIP ERKH SLPR
Sbjct: 361 PQLLKDYLNGTERTNFLYPSAVDQFRKQFAHLEENGGKSGPVIPLERKHASLPR 414
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461820|ref|XP_002285641.1| PREDICTED: mitogen-activated protein kinase 19 [Vitis vinifera] gi|302142803|emb|CBI20098.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1956), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/414 (88%), Positives = 393/414 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+D KK LK+KDFFT YG+ANRYKILEV+GKGSYGVVC+AIDTHTGEKVAIKKI+D+F
Sbjct: 1 MQKDLPKKGLKEKDFFTGYGEANRYKILEVVGKGSYGVVCSAIDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILRE+KLLRLLRHPDIVEIKRIMLPPS REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREIKLLRLLRHPDIVEIKRIMLPPSSREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQ+LRALKYMHTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQLLRALKYMHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS + I+ VRN+KARKYLTEMRKK PVP QKFPN DPLALRLL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDAISKVRNDKARKYLTEMRKKHPVPFSQKFPNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
P DRPTAEEALADPYFKGLAK+EREPSCQ ISKLEF+FERRRVTK+D++ELI+REILEYH
Sbjct: 301 PMDRPTAEEALADPYFKGLAKVEREPSCQSISKLEFDFERRRVTKEDVKELIFREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDYIN TE TN LYPSAIGQFRK FA+ EENGGRSGPVIPPERKHVSLPR
Sbjct: 361 PQLLKDYINRTEETNVLYPSAIGQFRKHFAHFEENGGRSGPVIPPERKHVSLPR 414
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186510066|ref|NP_188090.2| mitogen-activated protein kinase 19 [Arabidopsis thaliana] gi|209572650|sp|Q9LUC3.2|MPK19_ARATH RecName: Full=Mitogen-activated protein kinase 19; Short=AtMPK19; Short=MAP kinase 19 gi|332642038|gb|AEE75559.1| mitogen-activated protein kinase 19 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/414 (89%), Positives = 390/414 (94%), Gaps = 1/414 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY+N +EG++FLYPSAIG RKQFAYLEEN G+SGPVIPP+RKH SLPR
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPR 413
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.997 | 0.690 | 0.893 | 1e-201 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 1.0 | 0.673 | 0.879 | 4.7e-199 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 1.0 | 0.683 | 0.835 | 1.3e-194 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 1.0 | 0.730 | 0.775 | 1.4e-181 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.992 | 0.805 | 0.768 | 5e-179 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.985 | 0.708 | 0.757 | 2.9e-174 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.995 | 0.699 | 0.727 | 8e-172 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.973 | 0.829 | 0.734 | 1.1e-167 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.806 | 0.631 | 0.516 | 4.5e-91 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.792 | 0.872 | 0.504 | 1.9e-90 |
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1952 (692.2 bits), Expect = 1.0e-201, P = 1.0e-201
Identities = 370/414 (89%), Positives = 390/414 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY+N +EG++FLYPSAIG RKQFAYLEEN G+SGPVIPP+RKH SLPR
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPR 413
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1927 (683.4 bits), Expect = 4.7e-199, P = 4.7e-199
Identities = 364/414 (87%), Positives = 387/414 (93%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKDY++G+EG+NF+YPSAIG R+QF YLEEN R+GPVIP ERKH SLPR
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPR 414
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1885 (668.6 bits), Expect = 1.3e-194, P = 1.3e-194
Identities = 346/414 (83%), Positives = 387/414 (93%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
PQLLKD++NG + +FLYPSA+ QFR+QFA+LEEN G++GPV P ERKH SLPR
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPR 414
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1762 (625.3 bits), Expect = 1.4e-181, P = 1.4e-181
Identities = 322/415 (77%), Positives = 373/415 (89%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERK-HVSLPR 414
P++LK+Y++G+E TNF+YPSA+ F+KQFAYLEE+ PPER+ H SLPR
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPR 415
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1738 (616.9 bits), Expect = 5.0e-179, P = 5.0e-179
Identities = 316/411 (76%), Positives = 370/411 (90%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D KK + +FFTEYG+A+RY+I EVIGKGSYGVV +AIDTH+GEKVAIKKI+DVFEH+
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDL 123
SDA RILRE+KLLRLLRHPDIVEIK +MLPPS+REF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
T EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILAN++CKLK+CDFGLARV+F+D P
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD++
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
TDLLGTP PE IA +RNEKAR+YL MR+KPPVP KFP+VDPLALRLL RL+AFDPKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
RP+AEEALADPYF GLA ++REPS QPI KLEFEFERR++TK+D+RELIYREILEYHPQ+
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
L++Y+ G E T+F+YPS + +F++QFA+LEEN G+ P +R+H SLPR
Sbjct: 362 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPR 412
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1693 (601.0 bits), Expect = 2.9e-174, P = 2.9e-174
Identities = 309/408 (75%), Positives = 360/408 (88%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
KK + + +FFTEYG+ANRY+I EV+GKGSYGVV +AIDTHTGE+VAIKKI+DVF+HISDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
RILRE+KLLRLL HPD+VEIK IMLPPS+REF+D+YVVFELMESDLHQVIKANDDLT E
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
HHQFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D P +FW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQLD++TD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTP PE I+ +RN+KAR+YL MRKK PVP +KFP DP ALRLL+RLIAFDPKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366
AEEALADPYF GL+ REPS QPISKLEFEFER+++TKDDIRELIYREILEYHPQ+L++
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 YINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR 414
Y+ G +F+YPS + +FR+QFA+LEEN G G +R+H SLPR
Sbjct: 432 YLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPR 479
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1670 (592.9 bits), Expect = 8.0e-172, P = 8.0e-172
Identities = 305/419 (72%), Positives = 363/419 (86%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ D KK + +FFTEYG+ANRY+I EV+GKGSYGVV +A+D+HTGE+VAIKKI+DVF
Sbjct: 82 LPMDPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVF 139
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPD+VEIK IMLPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 140 EHVSDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKAN 199
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D
Sbjct: 200 DDLTPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 259
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQL
Sbjct: 260 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQL 319
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD LGTP PE+I+ +RNEKAR+YL+ MRKK PVP KFP DPLALRLL+RL+AFD
Sbjct: 320 DLMTDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFD 379
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR +AE+ALADPYF GL+ EREP+ QPISKLEF+FER+++ KDD+RELIYREILEYH
Sbjct: 380 PKDRASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYH 439
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPV-----IPPERKHVSLPR 414
PQ+L++Y+ G + +F+YPS + +F++QFA+LEEN G+ G R H SLPR
Sbjct: 440 PQMLEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPR 498
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1631 (579.2 bits), Expect = 1.1e-167, P = 1.1e-167
Identities = 299/407 (73%), Positives = 359/407 (88%)
Query: 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR 71
+K+FFTEYG+A++Y+I EV+GKGSYGVV +A HTG KVAIKK+ +VFEH+SDAIRILR
Sbjct: 3 EKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILR 62
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
E+KLLRLLRHPDIVEIK IMLPP ++EFKDIYVVFELMESDLH V+K NDDLT +HHQFF
Sbjct: 63 EIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFF 122
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
LYQ+LR LK+MH+A+V+HRDLKPKNILANA+CK+K+CD GLARV+F+D+P VFWTDYVA
Sbjct: 123 LYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVA 182
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
TRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGK+VVHQL+L+TDLLGTPS
Sbjct: 183 TRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPS 242
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
P T++ +RNEKARKYL MR+K PVP KFPN+DP+AL+LLQRLIAFDPKDRP+AEEAL
Sbjct: 243 PITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEAL 302
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGT 371
ADPYF+GLA ++ EPS QPISKLEFEFERR++T+DD+REL+YREILEYHPQ+L++Y+ G
Sbjct: 303 ADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGE 362
Query: 372 EGTN--FLYPSAIGQFRKQFAYLEE-NGGRSGPVIPP-ERKHVSLPR 414
E N FLYPS + QF+++FA LEE N PP +RK+ SLPR
Sbjct: 363 ENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPR 409
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
Identities = 175/339 (51%), Positives = 236/339 (69%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY I++ IG G+YGVVC+A D TGEKVAIKKI F+++ D R LRE+ LLR +H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK I+ P SK +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQMLR LK++H
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N +C LK+CD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYRAPEVILS 325
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ +KYT AIDIWS+GCIFAE+L KPLF GK +HQ+ LI + +G+PS E I + NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+++ M +P V FP +P A+ LL+R++ FDP R T EEALA PYF+ L
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPS 444
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
EP C + K FE + +D ++ELIY E+L YHP+
Sbjct: 445 DEPIC--LHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
Identities = 169/335 (50%), Positives = 242/335 (72%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L IG+G+YG+VCAA ++ TGE+VAIKKI + F++I DA R LRE+KLL+ + H +++ +
Sbjct: 46 LRPIGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAV 105
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K I+ PP + F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQ+LR LKY+H+ANV
Sbjct: 106 KDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANV 165
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP N+L NANC LK+ DFGLAR S+T F T+YV TRWYRAPEL + S+
Sbjct: 166 LHRDLKPSNLLLNANCDLKLGDFGLARTK-SETD---FMTEYVVTRWYRAPELLLNC-SE 220
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267
YT AIDIWS+GCI E +T +PLFPGK VHQL LIT+L+G+P ++ +R++ AR+Y+
Sbjct: 221 YTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYV 280
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
++ + P +FPN+ A+ LL++++ FDP R T +EAL PY L I EP
Sbjct: 281 RQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPV 340
Query: 328 CQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
C + F+FE+ +T+++I+ELIYRE ++++PQ
Sbjct: 341 C--VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5SN53 | MPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8354 | 0.9685 | 0.7047 | yes | no |
| Q9LV37 | MPK9_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7688 | 0.9927 | 0.8058 | no | no |
| Q9LUC3 | MPK19_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8937 | 0.9975 | 0.6906 | yes | no |
| Q5VP69 | MPK16_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7481 | 0.9879 | 0.8163 | no | no |
| Q53N72 | MPK15_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7905 | 0.9685 | 0.8052 | no | no |
| P42525 | ERK1_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5162 | 0.8067 | 0.6313 | yes | no |
| Q84M93 | MPK17_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7297 | 0.9734 | 0.8292 | no | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7556 | 0.9685 | 0.7924 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.991 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 414 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-159 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-144 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-138 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-126 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-117 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-116 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-105 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-104 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-103 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-98 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-90 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-89 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-88 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-88 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-88 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-87 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-86 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-84 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-82 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-78 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-77 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-76 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-75 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-73 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-70 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-69 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-68 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-68 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-67 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-63 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-63 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-62 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-61 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-61 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-61 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-60 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-60 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-59 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-55 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-55 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-54 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-52 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-47 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-40 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-39 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-18 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-04 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 723 bits (1867), Expect = 0.0
Identities = 302/338 (89%), Positives = 325/338 (96%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKI+DVFEH+SDA RILRE+KLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT EHHQFFLYQ+LRALKY+H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
TANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DTP +FWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDLITDLLGTPSPETI+ VRNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+YL+ MRKK PVP QKFPN DPLALRLL+RL+AFDPKDRPTAEEALADPYFKGLAK+E
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
REPS QPI+KLEFEFERRR+TK+D+RELIYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 525 bits (1354), Expect = 0.0
Identities = 186/332 (56%), Positives = 242/332 (72%), Gaps = 2/332 (0%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY++L+ IG G+YGVVC+A+D TG KVAIKKI +VF+ + DA RILRE+KLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ + I+ PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LR LKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N+NC LK+CDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AIDIWS+GCIFAE+LT KPLFPG+ + QL+LI ++LGTPS E + + +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R YL + KKP PL + FP P A+ LL++++ FDPK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
EP +P +F F+ +T+++++ELIY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 451 bits (1163), Expect = e-159
Identities = 182/338 (53%), Positives = 245/338 (72%), Gaps = 6/338 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+G+YG+VC+A ++ T EKVAIKKI + F++ DA R LRE+KLLR L H +
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK IM PP + F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQ+LR LKY+H
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L NANC LK+CDFGLAR S+ F T+YV TRWYRAPEL +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGD--FMTEYVVTRWYRAPELLLN 182
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AID+WS+GCIFAE+L KPLFPGK VHQL LIT+LLG+PS E + +RNEKA
Sbjct: 183 -CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+Y+ + P + FP+ +PLA+ LL++++ FDP R T EEALA PY L
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
EP CQ + F+FE +T++DI+ELIY E+L YHP
Sbjct: 302 DEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 414 bits (1065), Expect = e-144
Identities = 168/334 (50%), Positives = 226/334 (67%), Gaps = 4/334 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L IG+G+YG+VC+A TG KVAIKKI FEH + R LRE+K+LR +H +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKHEN 64
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LR LKY+H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKYIH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N NC LK+CDFGLAR+A + T F T+YVATRWYRAPE+ +
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
YT AIDIWS+GCI AE+L+ +PLFPGK +HQL+LI +LGTPS E + + + +A
Sbjct: 184 S-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R Y+ + KP VP + FPN DP AL LL +++ F+P R T EEALA PY +
Sbjct: 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
EP + +FE + K+ ++ELI+ EI+
Sbjct: 303 DEPVAEEPFPFDFEL-FDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 397 bits (1022), Expect = e-138
Identities = 166/333 (49%), Positives = 235/333 (70%), Gaps = 5/333 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYK +E IG G+YGVVC+AIDT +G+KVAIKKI F+ + A R LRE+K+LR +H +
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I+ I+ PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQ+LR LKY+H
Sbjct: 66 IIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ANV HRDLKP N+L N +C+L++ DFG+AR ++ S T F T+YVATRWYRAPEL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S +YT AID+WS+GCIFAE+L + LFPGK+ VHQL LI +LG+PS E + + +++
Sbjct: 185 SL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
RKY+ + +K PVP + FP P AL LL +++ FDP++R T E+AL P+
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
+ EP+C P +F+FE ++++ ++E I +E
Sbjct: 304 DDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 368 bits (946), Expect = e-126
Identities = 149/337 (44%), Positives = 214/337 (63%), Gaps = 11/337 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y+IL+ +GKG+YG+V AID T E VA+KKI D F + +DA R RE+ L+ L HP
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV++ ++ ++ + KDIY+VFE ME+DLH VI+AN L H ++ +YQ+L+ALKY+
Sbjct: 68 NIVKLLNVI--KAEND-KDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKYI 123
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPMTVFWTDYVATRWYRAPE- 199
H+ NV HRDLKP NIL N++C++K+ DFGLAR + P TDYVATRWYRAPE
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS ++YT +D+WS+GCI E+L GKPLFPG S ++QL+ I +++G PS E I ++
Sbjct: 184 LLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
+ A L + +P PL + P AL LL++L+ F+P R TAEEAL PY
Sbjct: 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
EP + + + +++ + R +Y EI
Sbjct: 302 HNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 344 bits (884), Expect = e-117
Identities = 160/339 (47%), Positives = 220/339 (64%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR- 80
RY++++ +G+G+YG+VC+A + T E VAIKKI +VF A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + + P F ++Y+ ELME+DLHQ+I++ LT H Q F+YQ+L L
Sbjct: 61 HKNITCLYDMDIVFPGN--FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV--FWTDYVATRWYRA 197
KY+H+ANV HRDLKP N+L NA+C+LK+CDFGLAR FS+ P F T+YVATRWYRA
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ SF YT AID+WS+GCI AE+L KP+F GK V QL+ I +LGTP ET++
Sbjct: 178 PEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KA+ Y+ + P P FPN +PLAL LL++L+AFDP R + EEAL PY
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+ EP CQ FE E + +++R++I E+
Sbjct: 297 IWHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 341 bits (877), Expect = e-116
Identities = 149/346 (43%), Positives = 213/346 (61%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + +RY+ L +G G+YG VC+A DT TG KVAIKK+ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A + HRDLKP NI N +C+LK+ DFGLAR D MT YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMT----GYVATRWY 181
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ ++ Y +DIWS+GCI AE+LTGK LFPG + QL I +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ DP R TA EALA PY
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP P + FE R +T D+ +EL+Y+EI+ + P
Sbjct: 301 LAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 128/296 (43%), Positives = 179/296 (60%), Gaps = 18/296 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ LE +G+G+YGVV A D TGE VA+KKI ++ + I LRE+ LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
+IV++ ++ K +Y+VFE + DL + + L+ + +YQ+LR L Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H+ + HRDLKP+NIL N + LK+ DFGLAR AF P+ + T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFG-IPLRTY-THEVVTLWYRAPEIL 170
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
GS Y+ A+DIWS+GCIFAE++TGKPLFPG S + QL I +LGTP+ E+ V
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K Y K PP L + P +DP + LL +++ ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (796), Expect = e-104
Identities = 135/294 (45%), Positives = 178/294 (60%), Gaps = 13/294 (4%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ L IG+G+YGVV A D TGE VAIKKI FE LRE+KLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
+++ + D+Y+VFE M++DL+++IK E + +LYQ+L+ L + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N LK+ DFGLAR S +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---YTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ +DIWS+GCIFAE+L+ +PLFPGKS + QL I LGTP PE +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
AR Y KK +PL + FPN P AL LL +++ +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-103
Identities = 154/343 (44%), Positives = 220/343 (64%), Gaps = 18/343 (5%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
F T + NRY L+ +G G++G+VC+A D TG+ VAIKKI F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQ 134
LL+ LRH +I+ + I + P +DIY V EL+ +DLH+++ + L ++ Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR LKY+H+A V HRDLKP NIL N NC LK+CDFGLAR+ D MT YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMT----GYVSTRY 170
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ ++ KY +DIWS GCIFAE+L GKPLFPGK V+Q +ITDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +E +++ + K+ PVP +KF N DP A+ LL++++ FDP+ R +A EALA P
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 315 YFKGLAKIEREPSCQPISKLEFE--FERRRVTKDDIRELIYRE 355
Y +P+ +P+++ +F+ F + D + ++Y E
Sbjct: 290 YLAPY----HDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 297 bits (763), Expect = 3e-98
Identities = 143/353 (40%), Positives = 208/353 (58%), Gaps = 30/353 (8%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG G++GVV + D G++VA+KK+ +VF+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LR LKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N+NC LK+CDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE 269
A+DIWS+GCIFAE+L + LF +S + QLDLITDLLGTPS E + E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 270 MRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG--------- 318
KPP L+ A+ LL R++ FDP R +A +ALA PY
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCM 302
Query: 319 -----------LAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
+ + EPS P + E+E+ + ++E +++ ILE
Sbjct: 303 CKCCYTTSGGRVYTSDFEPSANP--PFDDEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 276 bits (706), Expect = 3e-90
Identities = 142/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKY+
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N +C+LK+ DFGLAR +D MT YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT----GYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E + + +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ EP P + FE R + D+ + L Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 272 bits (698), Expect = 5e-89
Identities = 134/339 (39%), Positives = 197/339 (58%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY L+ +G G+YG VC+AID TGEKVAIKK+ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQML LKY+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+LK+ DFGLAR A D MT YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMT----GYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P PE + + ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ + K P FP P A+ LL++++ D R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ E QP E +++ D+ ++ IY+E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (695), Expect = 2e-88
Identities = 140/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VC+A DT +KVA+KK+ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQ+LR LKY+
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+L++ DFGLAR A D MT YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMT----GYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+L GK LFPG + QL I +++GTPSPE + + +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
ARKY+ + P L + F +PLA+ LL++++ D R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP +P + E + T ++ +EL Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 3e-88
Identities = 126/300 (42%), Positives = 167/300 (55%), Gaps = 20/300 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLLR 80
RY+ + +G+G+Y VV A D TG VAIKKI + D I LRE+KLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRAL 139
HP+I+ + + K +I +VFE ME+DL +VIK LT + ++ LR L
Sbjct: 61 HPNIIGLLDVF--GHK---SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H+ + HRDLKP N+L ++ LK+ DFGLAR +F P T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 200 LCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L F Y +D+WS+GCIFAE+L P PG S + QL I + LGTP+ E
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
V + E + PP PL Q FP AL LLQRL+ +P R TA +AL PYF
Sbjct: 230 V---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 268 bits (688), Expect = 3e-88
Identities = 121/302 (40%), Positives = 176/302 (58%), Gaps = 29/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPD 83
YK+++ +G G++G V A + TGE VAIKK+ F + + LREVK L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEVF-----RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL- 200
+H +HRDLKP+N+L + +K+ DFGLAR S P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PET 254
S Y+ +DIW++GCI AE+ T +PLFPG S + QL I +LGTP+ PE
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ A K + P L Q PN P A+ L++ ++ +DPK RPTA +AL P
Sbjct: 227 YKL-----ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 315 YF 316
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 1e-87
Identities = 135/339 (39%), Positives = 206/339 (60%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ ++H +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQML+ LKY+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H A + HRDLKP N+ N +C+LK+ DFGLAR D+ MT YV TRWYRAPE+
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT--DSEMT----GYVVTRWYRAPEVIL 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ YT +DIWS+GCI AE+LTGKPLF G + QL I + GTPS E + +++E
Sbjct: 189 NWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ ++ + PN +PLA+ +L++++ D + R TA EALA PYF+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E P + F+ + ++ + L + EIL + P
Sbjct: 308 EDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 265 bits (681), Expect = 2e-87
Identities = 108/293 (36%), Positives = 154/293 (52%), Gaps = 40/293 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ILE +G+GS+G V A D TG+ VAIK I D RILRE+K+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +K+ DFGLAR + T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+DIWS+G I E+LTGKP FPG QL + +G
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIG--------------- 210
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
KP P ++ P A L+++L+ DP+ R TAEEAL P+F
Sbjct: 211 ---------KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 6e-86
Identities = 115/297 (38%), Positives = 171/297 (57%), Gaps = 15/297 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ + IG+G+YG V A + TGE VA+KKI E I +RE+KLL+ LRHP+I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMH 143
V +K I+ K IY+VFE M+ DL ++ T + ++ Q+L L+Y+H
Sbjct: 61 VRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRD+K NIL N + LK+ DFGLAR ++ + T+ V T WYR PE L G
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELLLG 175
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ ++Y P +D+WS+GCI AE+ GKP+F G + + QL+ I +L G+P+ E V
Sbjct: 176 A--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK-- 231
Query: 263 ARKYLTEMRKKPPVP--LFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ ++ K P L + F ++ DP AL LL +L+ DPK R +A++AL YF
Sbjct: 232 -LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 1e-84
Identities = 119/301 (39%), Positives = 176/301 (58%), Gaps = 24/301 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
RYKIL IG+G++G+V A D TGE VA+KK+ + I + LRE+K L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
P +V++ + S +V E M SDL +V++ + L + ++ +L+ +
Sbjct: 59 PYVVKLLDVFPHGS-----GFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
YMH + HRDLKP N+L +A+ LK+ DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 201 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
G+ KY P +D+W++GCIFAE+L G PLFPG++ + QL ++ LGTP+ ET +
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 260 N----EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + P+PL + FP+ P AL LL+ L+ +DP R +A EAL PY
Sbjct: 230 SLPDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 316 F 316
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 3e-82
Identities = 118/299 (39%), Positives = 176/299 (58%), Gaps = 16/299 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
N+Y++L V+G+G+YGVV + TGE VAIKK + + + ++ LREVK+LR LR
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRAL 139
H +IV +K +R+ + +Y+VFE +E L ++++A+ L + + +++Q+L+A+
Sbjct: 59 HENIVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ N+ HRD+KP+NIL + + LK+CDFG AR TDYVATRWYRAPE
Sbjct: 114 AYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPE 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G + Y +D+W+IGCI AE+L G+PLFPG S + QL LI LG P +
Sbjct: 172 LLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + P L +++P V AL L+ + DPK+R T +E L PYF
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 7e-82
Identities = 129/348 (37%), Positives = 195/348 (56%), Gaps = 24/348 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA DT TG+ VAIKK+ F++++ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P EF+D+Y+V ELM+++L QVI DL E + LYQML +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + I + LGTPS E ++ +
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-------DPLALR------LLQRLIAFDPKDRPTAE 308
R Y+ K + FP+V L+ LL +++ DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+AL PY E P + + + R T ++ +ELIY+E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 2e-78
Identities = 94/294 (31%), Positives = 143/294 (48%), Gaps = 36/294 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++L +G GS+G V A TG+ VA+K + E RE+++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + N +K+ DFGLA+ + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y P +D+WS+G I E+LTGKP F G++++ QL
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL----------------------- 208
Query: 264 RKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L PP+ K+ + A L+++ + DP RPTAEE L P+F
Sbjct: 209 --QLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 1e-77
Identities = 130/361 (36%), Positives = 194/361 (53%), Gaps = 44/361 (12%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKL 75
+ +RY L +G GS G+V +A+D+ ++VA+KKI ++D + LRE+K+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTRE 126
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVF 185
H + F+YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + Q+ LI +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 246 LLGTPSPETIAVVRNE-----------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
++ VVR E R E R+ PL P V+P AL L+
Sbjct: 234 --------SVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 295 RLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYR 354
+++ F+P DR TAEEAL PY + EP +E E + + +I +IY
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD-DILLMTEIHSIIYN 340
Query: 355 E 355
Sbjct: 341 W 341
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 1e-76
Identities = 120/298 (40%), Positives = 168/298 (56%), Gaps = 17/298 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ L I +G+YGVV A D TGE VA+KK+ E + I LRE+ +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IV +K +++ IY+V E +E DL +++ + + + Q+L + +
Sbjct: 65 NIVTVKEVVV---GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LK+CDFGLAR + P+ + T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGS-PLKPY-TQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGKS + QL+ I LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K T K P L +KFP + LL RL+ +DP R +AE+AL PYF
Sbjct: 237 LPGAKKKT-FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 2e-75
Identities = 134/321 (41%), Positives = 179/321 (55%), Gaps = 32/321 (9%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVK 74
TE+ NR IG+G+YG+V A DT +GE VA+KK+ ++ D I I LRE+
Sbjct: 7 TEFEKLNR------IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREIT 58
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLY 133
LL LRHP+IVE+K +++ + I++V E E DL ++ + + +
Sbjct: 59 LLLNLRHPNIVELKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVAT 192
Q+LR L+Y+H + HRDLK N+L LK+ DFGLAR PMT V T
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT----PKVVT 171
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WYRAPE L G + YT AID+W++GCI AE+L KPL PGKS + QLDLI LLGTP+
Sbjct: 172 LWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229
Query: 252 PETI--AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E+I K+ + K+P L KFP + LRLL L+ +DPK R TAEE
Sbjct: 230 -ESIWPGFSDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286
Query: 310 ALADPYFKGLAKIEREPSCQP 330
AL YFK E+ C+P
Sbjct: 287 ALESSYFK-----EKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 1e-73
Identities = 115/313 (36%), Positives = 166/313 (53%), Gaps = 28/313 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+IL +G+G++G V A TG VA+KKI E I LRE+K+L+ L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 83 DIVEIKRIML---PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLR 137
++V + + + SKR+ +Y+V M+ DL +++ N + Q ++ Q+L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLE 126
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--------TVFWTDY 189
+ Y+H ++ HRD+K NIL + LK+ DFGLAR P T +T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 190 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GKS + QL LI L G
Sbjct: 187 VVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 249 TPSPETIAVVRNEKARKYL---TEMRKKPPVP--LFQKFPNVDPLALRLLQRLIAFDPKD 303
TP+ ET R L + P L ++F + P L LL +L++ DP
Sbjct: 245 TPTEETWPGWR------SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 304 RPTAEEALADPYF 316
R TA +AL PYF
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 2e-70
Identities = 119/297 (40%), Positives = 167/297 (56%), Gaps = 19/297 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI--RILREVKLLRLLRHP 82
Y+ +E IG+G+YGVV A D TGE VA+KKI E + + +RE+ LL+ L HP
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALK 140
+IV + ++ +K +Y+VFE ++ DL + + L + +LYQ+L+ +
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG S + QL I LGTP + V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K L + PN+D L LL +++ +DP R +A+ AL PYF
Sbjct: 228 -TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 4e-69
Identities = 108/306 (35%), Positives = 163/306 (53%), Gaps = 33/306 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLR- 80
Y+ L IG+G+YG V A D +TG VA+KK+ +S+ + LRE+ LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 81 --HPDIVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQM 135
HP+IV + + P + RE + +VFE ++ DL + L E + + Q+
Sbjct: 58 FEHPNIVRLLDVCHGPRTDREL-KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR + ++H+ + HRDLKP+NIL ++ ++K+ DFGLAR+ + +T V T WY
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT----SVVVTLWY 172
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS--- 251
RAPE L S Y +D+WS+GCIFAE+ +PLF G S QLD I D++G PS
Sbjct: 173 RAPEVLLQS---SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 252 -PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +++ R + P P + L LL++++ F+P R +A EA
Sbjct: 230 WPRNVSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 311 LADPYF 316
L PYF
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 3e-68
Identities = 117/299 (39%), Positives = 172/299 (57%), Gaps = 20/299 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI----LREVKLLRLL 79
+Y+ L IG+GSYGVV + TG+ VAIKK F D I LRE+++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+HP++V + + R + +++VFE + + L+++ K + + ++Q L+A
Sbjct: 58 KHPNLVNLIEVF-----RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 199 EL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G ++Y P +D+W+IGC+FAE+LTG+PL+PGKS V QL LI LG P +
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ K L+ + PL KFPN+ AL L+ + DP +R + EE L PYF
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 6e-68
Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 21/298 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHI-SDAIRILREVKLLRLLRHP 82
+K LE +G+G+Y V + TGE VA+K+IH D E S AIR E+ L++ L+H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHE 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
+IV + ++ +K + +VFE M+ DL + + + L + F YQ+L+ +
Sbjct: 59 NIVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H V HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T WYRAP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +IDIWS+GCI AE++TG+PLFPG + QL I ++GTP+ T +
Sbjct: 171 VLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+Y + PP L Q FP+ DPL + LL RL+ +P+ R +A +AL P+F
Sbjct: 229 SQ--LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 2e-67
Identities = 126/348 (36%), Positives = 195/348 (56%), Gaps = 23/348 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ IG G+ G+VCAA DT G VA+KK+ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + P S EF+D+Y+V ELM+++L QVI +L E + LYQML +K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ ++C LK+ DFGLAR A ++ M T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM----TPYVVTRYYRAPEVIL 195
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +DIWS+GCI E++ G +F G + Q + + + LGTPS E + ++
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 263 ARKYLTEMRKKPPVPLFQKFPN--------VDPL----ALRLLQRLIAFDPKDRPTAEEA 310
R Y+ + P + + FP+ D L A LL +++ DP R + +EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
L PY + E P + + E R ++ +ELIY+E+++
Sbjct: 313 LRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 4e-67
Identities = 111/302 (36%), Positives = 173/302 (57%), Gaps = 30/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPD 83
YKIL IG+G++ V A TG+ AIK + F+ + LRE++ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH------QFFLYQML 136
I+ + ++ + R + +VFELM+ +L+++IK R+ + ++YQ+L
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQLL 110
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
++L +MH ++HRD+KP+NIL + LK+ DFG R +S P +T+Y++TRWYR
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 197 APE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE L + Y P +DIW++GC+F E+L+ PLFPG + + Q+ I D+LGTP E
Sbjct: 166 APECLLTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ R + Y K L + PN L LL++L+A+DP +R TA++AL P
Sbjct: 223 LKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 315 YF 316
YF
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 2e-63
Identities = 133/369 (36%), Positives = 205/369 (55%), Gaps = 31/369 (8%)
Query: 11 KDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
+D +F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDL 123
A R RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L
Sbjct: 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--EL 123
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 182
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + Q + +
Sbjct: 183 ---TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-FPNV------------DPLAL 290
+ LGTP PE + ++ R Y+ E R K F+K FP+V A
Sbjct: 238 IEQLGTPCPEFMKKLQ-PTVRTYV-ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 295
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
LL +++ D R + +EAL PY + E P + + + R T ++ +E
Sbjct: 296 DLLSKMLVIDASKRISVDEALQHPYIN-VWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 354
Query: 351 LIYREILEY 359
LIY+E+++
Sbjct: 355 LIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 120/302 (39%), Positives = 174/302 (57%), Gaps = 16/302 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ +E IG+G+YGVV A D T E +A+KKI E +RE+ LL+ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH--QFFLYQMLRALK 140
+IV ++ ++ K +Y+VFE ++ DL + + ++ D + + +LYQ+LR +
Sbjct: 62 NIVRLQDVV-----HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 141 YMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ F T V T WYRAPE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPE 173
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +DIWS+GCIFAE++ KPLFPG S + +L I +LGTP+ ET V
Sbjct: 174 ILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ Y + K PP L P ++P + LL +++ DP R TA AL YFK
Sbjct: 232 TS--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 319 LA 320
L
Sbjct: 290 LG 291
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 2e-63
Identities = 117/306 (38%), Positives = 173/306 (56%), Gaps = 35/306 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHI-SDAIRILREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ D E + S A LRE+ LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N D+ E + F++Q+L+ L
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ DFGLAR AF P+ + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP------- 220
Query: 258 VRNEKARKYLTEMRKKPPVPLF-------QKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
E++ ++++ P P++ P ++ LLQ L+ +P R +AEEA
Sbjct: 221 --TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 311 LADPYF 316
L PYF
Sbjct: 279 LQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 4e-62
Identities = 130/364 (35%), Positives = 200/364 (54%), Gaps = 34/364 (9%)
Query: 15 FFTEYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 70 LREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERM 121
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TP 177
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LG
Sbjct: 178 YVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRL 296
TP PE + ++ R Y+ K + + FP+ A LL ++
Sbjct: 236 TPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 297 IAFDPKDRPTAEEALADPYFK---GLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIY 353
+ DP R + +EAL PY A++E P Q K + + R T ++ +ELIY
Sbjct: 295 LVIDPAKRISVDEALQHPYINVWYDPAEVEAPPP-QIYDK---QLDEREHTIEEWKELIY 350
Query: 354 REIL 357
+E++
Sbjct: 351 KEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 5e-62
Identities = 110/304 (36%), Positives = 174/304 (57%), Gaps = 28/304 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+Y+ L ++G+GSYG+V TG+ VAIKK + + ++ +RE+++L+ LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-------QFFLY 133
H ++V + + R K +Y+VFE ++ H V+ DDL + + + +L+
Sbjct: 59 HENLVNLIEVF-----RRKKRLYLVFEFVD---HTVL---DDLEKYPNGLDESRVRKYLF 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR +++ H+ N+ HRD+KP+NIL + + +K+CDFG AR P V+ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG S + QL I LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + + K PL ++FP + L L L ++ + DP DRP++ + L
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
Query: 313 DPYF 316
+F
Sbjct: 283 HEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 1e-61
Identities = 114/300 (38%), Positives = 167/300 (55%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PD 83
Y+ LE IG+G+YG V A D +TG+ VA+KK + LRE+ LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRA 138
IV + + K +Y+VFE ++SDL + + +N L + + F+YQ+L+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LK+ D GL R AFS P+ + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG S + QL I LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V + E + P L + P++ P L LLQ+++ +DP R +A+ AL PYF
Sbjct: 238 GVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 117/305 (38%), Positives = 169/305 (55%), Gaps = 21/305 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G YK L+ +G+GSY V TG+ VA+K+I EH A +RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE +++DL Q + H+ + FL+Q+L
Sbjct: 59 DLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L + +LK+ DFGLAR A S T +++ V T WYR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKT--YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPET 254
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG V QL I +LGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 255 I-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEAL 311
V N + + Y PP PL P +D P L + + ++PK R +A EA+
Sbjct: 229 WPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 312 ADPYF 316
PYF
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 5e-61
Identities = 113/296 (38%), Positives = 168/296 (56%), Gaps = 16/296 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y +E IG+G+YGVV + TG+ VA+KKI E +RE+ LL+ L+HP+I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQ---VIKANDDLTREHHQFFLYQMLRALKY 141
V ++ +++ S+ +Y++FE + DL + + + E + +LYQ+L+ + +
Sbjct: 62 VCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H+ V HRDLKP+N+L + +K+ DFGLAR AF P+ V+ T V T WYRAPE L
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
GS +Y+ +DIWSIG IFAE+ T KPLF G S + QL I +LGTP+ + V
Sbjct: 174 LGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV-- 229
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K L N+D L LL++++ +DP R +A++AL PYF
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 112/292 (38%), Positives = 164/292 (56%), Gaps = 15/292 (5%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+IV++
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA 145
++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L + H+
Sbjct: 65 LDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSF 204
V HRDLKP+N+L N +K+ DFGLAR AF P+ + T V T WYRAPE L G
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCK 176
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP V +
Sbjct: 177 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP-- 232
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K + P +D LL +++ +DP R +A+ ALA P+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-60
Identities = 117/315 (37%), Positives = 165/315 (52%), Gaps = 42/315 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-------------ILREVKLLR 77
+G+G+YG V A DT TG+ VAIKK+ + E +D + LRE+K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR 137
++H +I+ + + + + +F I +V ++M SDL +V+ LT + L Q+L
Sbjct: 76 EIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----------TVFW 186
L +H HRDL P NI N+ K+ DFGLAR
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 187 TDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG++ + QL I +
Sbjct: 191 TSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 246 LLGTPSPETIAVVRNEKARKYL---TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
LLGTP+ + N K L TE + P L FPN A+ LLQ L+ +P
Sbjct: 249 LLGTPNED------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 303 DRPTAEEALADPYFK 317
+R +A+EAL YFK
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 3e-60
Identities = 115/300 (38%), Positives = 164/300 (54%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ I+ IG+G+YG V A D TGE VA+KK+ E I +RE+K+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 85 VEIKRIMLPPS-----KREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRA 138
V +K I+ K++ Y+VFE M+ DL ++++ + +H + F+ Q+L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y H N HRD+K NIL N ++K+ DFGLAR+ S+ +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYRPP 186
Query: 199 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G +Y PAID+WS GCI E+ T KP+F + QL+LI+ L G+P P AV
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP---AV 241
Query: 258 VRNEKARKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y M+ K L ++F + AL LL ++ DP R TAEEAL P+
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 1e-59
Identities = 114/324 (35%), Positives = 164/324 (50%), Gaps = 39/324 (12%)
Query: 24 RYKILEVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRL 78
+Y+I IG+G+YG V A + G++ AIKK E IS + RE+ LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF-----LY 133
L+H ++V + + L + + +Y++F+ E DL Q+IK + R L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTD- 188
Q+L + Y+H+ V HRDLKP NIL +K+ D GLAR+ F+ + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-----KSVV----H 238
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G K
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP------VPLFQKFPNVDPLALRL 292
QL+ I ++LGTP+ + ++ L + K +K D L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 293 LQRLIAFDPKDRPTAEEALADPYF 316
L++L+ +DP R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-57
Identities = 111/304 (36%), Positives = 155/304 (50%), Gaps = 11/304 (3%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++Y+ L IG+G++G V A T + VA+KK+ E I LRE+K+L+LL+
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK 69
Query: 81 HPDIV---EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK-ANDDLTREHHQFFLYQML 136
H ++V EI R P R Y+VFE E DL ++ N T + + +L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DTPMTVFWTDYVATRW 194
L Y+H + HRD+K NIL + LK+ DFGLAR AFS +T+ V T W
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVVTLW 188
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
YR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 189 YRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
Query: 254 TI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
V + E +K +K V K DP AL L+ +L+ DP R A+ AL
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306
Query: 313 DPYF 316
+F
Sbjct: 307 HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 1e-55
Identities = 117/306 (38%), Positives = 172/306 (56%), Gaps = 18/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y LE +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + ++ H+ + FLYQ+L
Sbjct: 60 DLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG +V +L LI LLGTP+ ET
Sbjct: 172 PPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ N++ + Y K P PL P +D + LL + + ++ K R +AEEA+
Sbjct: 230 PGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 315 YFKGLA 320
YF+ L
Sbjct: 288 YFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-55
Identities = 115/307 (37%), Positives = 169/307 (55%), Gaps = 18/307 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + + H+ + FL+Q+L
Sbjct: 60 DLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET
Sbjct: 172 PPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
++ NE+ + Y K L P +D LL +L+ F+ + R +AEEA+ P
Sbjct: 230 PGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 315 YFKGLAK 321
YF L +
Sbjct: 288 YFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-54
Identities = 113/302 (37%), Positives = 169/302 (55%), Gaps = 18/302 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ + + +VFE ++SDL Q + +L H+ + F++Q+L
Sbjct: 59 NLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H + HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG +V +L LI LLGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ NE+ R YL + PL P +D + LL L+ ++ K R +AE AL
Sbjct: 229 PGITSNEEFRSYLFPQYR--AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286
Query: 315 YF 316
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-52
Identities = 103/296 (34%), Positives = 168/296 (56%), Gaps = 11/296 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N++++L V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IVE+K R +Y+VFE +E ++ ++++ + + E + ++YQ+++A+ +
Sbjct: 61 NIVELKEAF-----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + N LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D+WS+GCI E+ G+PLFPG+S + QL I +LG E + + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L P L +++ + + L L++ L+ +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-49
Identities = 108/304 (35%), Positives = 157/304 (51%), Gaps = 19/304 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A Y LE +G+GSY V I G+ VA+K I E +RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLR 137
L+H +IV + I+ F VFE M +DL Q + + ++ + F++Q+LR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H ++ HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETI 255
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG S V QL+ I +LG P+ +T
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN---VDPLALRLLQRLIAFDPKDRPTAEEALA 312
V K Y E + P A L +++ PKDR +A++AL
Sbjct: 230 PGV--SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287
Query: 313 DPYF 316
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ E++G+GS+G V A+D TGE +A+K + + + + RE+++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV E + + E + L ++K L + + Q+L L Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL +++ +K+ DFG A+ D T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+Y A DIWS+GC E+ TGKP + + + + + + P
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEP---------- 222
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
P +P ++ A L++ + DPK RPTA+E L P+
Sbjct: 223 -----------PEIP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 3e-47
Identities = 104/304 (34%), Positives = 162/304 (53%), Gaps = 26/304 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLR-- 80
+Y+ + IG+G+YG V A D G + VA+K++ + +REV +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKRI-MLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + + RE K + +VFE ++ DL + + + E + ++Q+L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ +T V T WYR
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE--- 253
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 177 APEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 254 -TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+A+ R K P+ + ++D L LL + + F+P R +A AL+
Sbjct: 235 RDVALPRQAFH--------SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286
Query: 313 DPYF 316
PYF
Sbjct: 287 HPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-47
Identities = 113/337 (33%), Positives = 179/337 (53%), Gaps = 29/337 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
YK+ +IG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKRIMLPPS-KREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLR 137
+ +K K+ K+I+ VV E + +H+ +K N L + + YQ+ R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ + HRDLKP+N+L + N LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G+S V QL I +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAFDPKDRPTAEEALADP 314
+ A +++ K L + FP P A+ + + + ++P R EALADP
Sbjct: 296 KEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+F L R+P + ++ + +I+E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 7e-47
Identities = 89/355 (25%), Positives = 147/355 (41%), Gaps = 35/355 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHPD 83
Y+IL +G+GS+G V A D + VA+K + E S + R LRE+++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
IV++ V+ + L ++K L+ F L Q+L AL
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA---FSDTPMTVFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + + +K+ DFGLA++ S + + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE+ G + + + DIWS+G E+LTG P F G+ +T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ ++ + + P + A LL++L+A DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYIN 369
L E + S + + L D N
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 70/196 (35%), Positives = 107/196 (54%), Gaps = 13/196 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+G+G +G V A D TG+KVAIK I S +LRE+++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 MLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVY 148
+ +Y+V E E L ++K N+ L+ + L Q+L L+Y+H+ +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + N K+K+ DFGL+++ SD + V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAE 223
Y+ DIWS+G I E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 103/303 (33%), Positives = 150/303 (49%), Gaps = 25/303 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y+ + IG G+YG V A D H+G VA+K + + +REV LL+ L D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 84 IVEIKRIM----LPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLR 137
I R+M + RE K + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ +T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT----PVVVTLWYRA 175
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PE 253
PE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P P
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ + R + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 234 DVTLPRG--------AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285
Query: 314 PYF 316
P+F
Sbjct: 286 PFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 88/303 (29%), Positives = 142/303 (46%), Gaps = 55/303 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y+I++ IGKGS+G V G+ +K+I + L EVK+L+ L HP+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------LYQ 134
I++ S E + +V E + DL Q IK ++ + F Q
Sbjct: 61 IIKYYE-----SFEEKGKLCIVMEYADGGDLSQKIKK----QKKEGKPFPEEQILDWFVQ 111
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ALKY+H+ + HRD+KP+NI +N +K+ DFG+++V S + V T +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPY 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL-GTPSPE 253
Y +PELC + Y DIWS+GC+ E+ T K F G++ L+L +L G P
Sbjct: 169 YLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPP- 222
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ + +Y +E+R L LLQ+ DP++RP+ + L
Sbjct: 223 ----IPS----QYSSELRN---------------LVSSLLQK----DPEERPSIAQILQS 255
Query: 314 PYF 316
P+
Sbjct: 256 PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-41
Identities = 81/302 (26%), Positives = 134/302 (44%), Gaps = 61/302 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++ILE IGKG +G V A TG++VAIK I + + +I+ E+++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE--KIINEIQILKKCKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
V+ L + +++V E L ++K+ + LT + ++L+ L+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++ ++K+ DFGL+ SDT V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIWS+G E+ GKP +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY---------------------------SELP 201
Query: 263 ARKYLTEMRKKPPVPL---------FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
K L ++ P L F+ F + LQ +P+ RPTAE+ L
Sbjct: 202 PMKALFKIATNGPPGLRNPEKWSDEFKDFLK------KCLQ----KNPEKRPTAEQLLKH 251
Query: 314 PY 315
P+
Sbjct: 252 PF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 5e-41
Identities = 87/308 (28%), Positives = 140/308 (45%), Gaps = 62/308 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y++LE IGKGS+G V G+ + K+I + ++++ + ++ EV +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------L 132
+IV RI+ ++ +Y+V E E DL Q+I+ ++ ++ L
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQK----CKKERKYIEEEFIWRIL 111
Query: 133 YQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+L AL H + V HRDLKP NI +AN +K+ DFGLA++ D+
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---K 168
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
YV T +Y +PE Y DIWS+GC+ E+ P F ++ QL L + +
Sbjct: 169 TYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI- 222
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
K K+ +P L +++ ++ DP RP+
Sbjct: 223 --------------KEGKF-------RRIPYRYS----SELN-EVIKSMLNVDPDKRPST 256
Query: 308 EEALADPY 315
EE L P
Sbjct: 257 EELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 41/294 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ ++IG+G++GVV ++ TG+ VAIK+I I++E+ LL+ L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K I + Y++ E E+ L Q+IK ++YQ+L+ L Y+
Sbjct: 61 IV--KYIGSIETSDSL---YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V HRD+K NIL + +K+ DFG+A + V T ++ APE+
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD---ASVVGTPYWMAPEVIE 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S + A DIWS+GC E+LTG P + DL P +V+++
Sbjct: 173 --MSGASTASDIWSLGCTVIELLTGNPPY--------YDL------NPMAALFRIVQDD- 215
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
PP+P + P L + DP RPTA++ L P+
Sbjct: 216 ----------HPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 7e-40
Identities = 107/306 (34%), Positives = 164/306 (53%), Gaps = 17/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A+ Y+ LE +G+GSY V G+ VA+K I + E +RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L E+ + FL+Q+LR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K + QL+ I +LGTP+ +T
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 256 AVVRNEKARK--YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K T K + K V+ A L +L+ PK+R +A+ AL+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH-AEDLASKLLQCFPKNRLSAQAALSH 288
Query: 314 PYFKGL 319
YF L
Sbjct: 289 EYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 114/330 (34%), Positives = 163/330 (49%), Gaps = 65/330 (19%)
Query: 31 IGKGSYGVVCAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D ++ A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L S R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK------FPNV-------------D 286
++G P A K ++RK P P QK + N D
Sbjct: 240 VMGFP------------ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYF 316
LLQ+L+ DP R T+E+AL DPYF
Sbjct: 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 110/329 (33%), Positives = 166/329 (50%), Gaps = 63/329 (19%)
Query: 31 IGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L + R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I +
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 246 LLGTPS----------PETIAVVRNEKAR--------KYLTEMRKKPPVPLFQKFPNVDP 287
++G P+ PE ++++ + KY+ + + KP D
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP-----------DS 288
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYF 316
A LLQ+L+ DP R T+E+A+ DPYF
Sbjct: 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 91/323 (28%), Positives = 143/323 (44%), Gaps = 59/323 (18%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DV 59
++ K LKD GD YK LE IG+G+ G V A D TG++VAIKK+
Sbjct: 2 EELKAALKD---IVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
E I+ E+ +++ +HP+IV+ S +++VV E M+ L +I
Sbjct: 59 KE------LIINEILIMKDCKHPNIVDYYD------SYLVGDELWVVMEYMDGGSLTDII 106
Query: 118 KAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
N + + ++L+ L+Y+H+ NV HRD+K NIL + + +K+ DFG A
Sbjct: 107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 177 FSDTPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ +V V T ++ APE+ Y P +DIWS+G + E+ G+P + +
Sbjct: 167 TKEKSKRNSV-----VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
+ L LIT G P + P L
Sbjct: 220 PPLRALFLITT-KGIPPLKNPE---------------------------KWSPEFKDFLN 251
Query: 295 RLIAFDPKDRPTAEEALADPYFK 317
+ + DP+ RP+AEE L P+ K
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R++ IG G++G V A++ TGE +A+K+I I E+K+L LL+HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + + RE +Y+ E L ++++ L + + Q+L L Y+
Sbjct: 61 LVKYYGVEV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRAPEL- 200
H+ + HRD+KP NI + N +K+ DFG A ++ + T M T Y APE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G + A DIWS+GC+ E+ TGK + +LD N
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD------------------N 211
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E + KPP+P + + P L R + DPK RPTA E L P+
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 58/297 (19%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+GKGS+G V TG+ A+K + + I + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK--KKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 88 KRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
F+ +Y+V E +L + + E +F+ +++ AL+Y+H
Sbjct: 59 HY--------AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL +A+ +K+ DFGLA+ S+ T + T Y APE+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG 167
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+D WS+G + E+LTGKP F +
Sbjct: 168 --KGYGKAVDWWSLGVLLYEMLTGKPPFYAED---------------------------- 197
Query: 264 RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPT---AEEALADPYF 316
RK + E K P+ +FP + P A L+ L+ DP R AEE A P+F
Sbjct: 198 RKEIYEKILKDPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 53/294 (18%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP++V++ + + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 60 HPNVVKLLGVCTEE-----EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + N HRDL +N L N +K+ DFGL+R + D + RW AP
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK-LPIRWM-AP 172
Query: 199 ELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
E S K+T D+WS G + E+ T G+ +PG S
Sbjct: 173 E---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS--------------------- 208
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
NE+ +YL + P P P L L+ + A DP+DRPT E
Sbjct: 209 ---NEEVLEYLKNGYRLPQ-------PPNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 7e-34
Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
HP+IV++ + + +V E M DL ++ N L+ F Q+ R
Sbjct: 60 HPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N L N +K+ DFGL+R + D + RW A
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWM-A 172
Query: 198 PELCGSFF-SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255
PE S K+T D+WS G + E+ T G+ +PG S
Sbjct: 173 PE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-------------------- 209
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N + +YL + + P P P L +L+ + A DP+DRPT E
Sbjct: 210 ----NAEVLEYLKKGYRLPK-------PPNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 93/330 (28%), Positives = 144/330 (43%), Gaps = 86/330 (26%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLL 79
+ +K ++IG+GS+ V A + T ++ AIK K + E ++I +EV L RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 80 RHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
HP I IK F+D +Y V E + +L Q I+ L + +F+ ++
Sbjct: 60 GHPGI--IKLYY------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI 111
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-----------------AFS 178
L AL+Y+H+ + HRDLKP+NIL + + +K+ DFG A+V
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238
+ +V T Y +PEL + D+W++GCI ++LTGKP F G +
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN--- 226
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-------FP-NVDPLAL 290
+YLT FQK FP N P A
Sbjct: 227 --------------------------EYLT----------FQKILKLEYSFPPNFPPDAK 250
Query: 291 RLLQRLIAFDPKDRPTA----EEALADPYF 316
L+++L+ DP+DR +E A P+F
Sbjct: 251 DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ ++V+G+GS GVV TG+ A+KKIH V ++LRE+K LR P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ +I +V E M+ L ++K + + Q+L+ L Y+HT
Sbjct: 63 KCYGAFYKEG-----EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 145 -ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
++ HRD+KP N+L N+ ++K+ DFG+++V + + T +V T Y +PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ A DIWS+G E GK P P +L+ + P P A + +
Sbjct: 175 --ESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAICDGPPPSLPAEEFSPE 231
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R +++ LQ+ DPK RP+A E L P+ K
Sbjct: 232 FRDFIS----------------------ACLQK----DPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRAL 139
P+IV + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+ + N HRDL +N L N +K+ DFGL+R + D + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
K+T D+WS G + E+ T G+ +PG S
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----------------------- 209
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
NE+ + L + + P P P L L+ + A+DP+DRPT E
Sbjct: 210 -NEEVLELLEDGYRLPR-------PENCPDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 89/314 (28%), Positives = 137/314 (43%), Gaps = 76/314 (24%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI---------HDVFEHISDAIRILR-EVKLLRL 78
E+IGKG+YG V A++ TGE +A+K++ HD D ++ LR E++ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--SRQKDMVKALRSEIETLKD 64
Query: 79 LRHPDIV---------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ 129
L H +IV E I L YV + S L + + L R
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGRFEEQLVR---- 111
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA------FSDTPM- 182
FF Q+L L Y+H+ + HRDLK N+L +A+ K+ DFG+++ + + M
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 183 -TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
+VFW APE+ S+ Y+ +DIWS+GC+ E+ G+ + + +
Sbjct: 172 GSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---- 218
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
A L R PP+P N+ P+AL L +P
Sbjct: 219 --------------------AAMFKLGNKRSAPPIPP-DVSMNLSPVALDFLNACFTINP 257
Query: 302 KDRPTAEEALADPY 315
+RPTA E L P+
Sbjct: 258 DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 92/305 (30%), Positives = 144/305 (47%), Gaps = 61/305 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRIL-REVKLLRLLR 80
R++ E++G GS+G V ++ G+ A+K + D + +A++ L +E+ LL L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV+ ++RE ++Y+ EL+ L +++K + + Q+L L
Sbjct: 61 HPNIVQYL-----GTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRA 197
+Y+H N HRD+K NIL + N +K+ DFG+A+ V FS F + + ++ A
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS------FAKSFKGSPYWMA 169
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y A DIWS+GC E+ TGKP + QL E +A
Sbjct: 170 PEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQL------------EGVAA 210
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA-------LRLLQRLIAFDPKDRPTAEEA 310
V K L PP+P D L+ L+ LQR DP RPTA E
Sbjct: 211 VFKIGRSKEL------PPIP--------DHLSDEAKDFILKCLQR----DPSLRPTAAEL 252
Query: 311 LADPY 315
L P+
Sbjct: 253 LEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 84/301 (27%), Positives = 139/301 (46%), Gaps = 50/301 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I + ++ D ++L E +L + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVK- 57
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L S + K++Y+V E + DL +++ L + + ++ +++ AL+Y+H+
Sbjct: 58 ----LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL ++N LK+ DFGL++V + + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D WS+GCI E L G P F G++ E + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKG 318
K + + V A+ L+ +L+ DP+ R A EE P+FKG
Sbjct: 217 KIE--------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 319 L 319
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 70/220 (31%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +LE IGKGS+G V AID T + VAIK I D+ E + I +E++ L R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRA 138
I + L SK ++++ E DL + K L + F L ++L
Sbjct: 60 YITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLG 110
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFWTDY 189
L+Y+H HRD+K NIL + +K+ DFG++ R F TP FW
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP---FWM-- 165
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ S Y DIWS+G E+ G+P
Sbjct: 166 -------APEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIR-ILREVKLLRLLRHP 82
+++L VIGKG++G VC T + A+K ++ + + ++R +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+V + F+D +Y+V +L+ DL + + E +F++ +++ A
Sbjct: 61 FLVNLWY--------SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+Y+H+ + HRD+KP NIL + + + DF +A + +T T T Y AP
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLT---TSTSGTPGYMAP 168
Query: 199 ELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
E+ + Y+ A+D WS+G E L GK + G S
Sbjct: 169 EV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A D TG +VA+KK+ D+ + + + EV ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHPNIVEMYSS 84
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL ++H V HR
Sbjct: 85 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LPYGT 194
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLQAMKRI 227
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
R P P + V P L R++ DP R TA E L P+
Sbjct: 228 RDNLP-PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 63/304 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRH 81
Y + V+GKG++G T V K+++ +S+ R L E+ +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--LTRLSEKERRDALNEIVILSLLQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ--FFLYQM 135
P+I+ F D + ME L+ I E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--TVFWTDYVATR 193
+ A+ Y+H A + HRD+K NI +K+ DFG++++ S+ M TV V T
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-----VGTP 165
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG---TP 250
+Y +PELC KY DIW++GC+ E+LT K F + L+L+ ++ TP
Sbjct: 166 YYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTP 220
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
Y +E+ L+ L+ DP+ RPTA+E
Sbjct: 221 VVS-----------VYSSELIS-------------------LVHSLLQQDPEKRPTADEV 250
Query: 311 LADP 314
L P
Sbjct: 251 LDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+KI + IGKG + VV AI G VA+KK+ +FE + R L+E+ LL+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLD 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK--ANDDLTREHHQF--FLYQM 135
HP++ I S E ++ +V EL ++ DL ++IK + Q+
Sbjct: 61 HPNV-----IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL++MH+ + HRD+KP N+ A +K+ D GL R FS V T +Y
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYY 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAE 223
+PE + Y DIWS+GC+ E
Sbjct: 173 MSPERIHE--NGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + H+G +VA+K + D+ + + + EV ++R +H ++VE+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM-DLRKQQRREL-LFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L ++++V+ E ++ I + L E +L+AL Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + S V + +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQA---------------------------MKRL 229
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R PP P + + P+ L+R++ +P++R TA+E L P+
Sbjct: 230 RDSPP-PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y+++EVIG G+ VV AAI EKVAIK+I D+ + + + +EV+ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK---ANDDLTREHHQFFLYQMLRA 138
++V+ S ++++V + L ++K L L ++L+
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRA 197
L+Y+H+ HRD+K NIL + +K+ DFG++ T +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKSVVHQLDLITDLLGTPSPE 253
PE+ Y DIWS G E+ TG P K ++ L P
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-------TLQNDPP- 225
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T K F+K ++L L + DP RPTAEE L
Sbjct: 226 -----------SLETGADYKKYSKSFRKM-----ISLCLQK-----DPSKRPTAEELLKH 264
Query: 314 PYF 316
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 71/300 (23%), Positives = 132/300 (44%), Gaps = 44/300 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILR-EVKLLR 77
++ +++G+G++G V D TG ++A+K++ F+ + L E++LL+
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L+H IV+ + R+ + + + E M + +KA LT + + Q+L
Sbjct: 60 NLQHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++
Sbjct: 115 EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
+PE+ Y D+WS+GC E+LT KP + + E +A
Sbjct: 175 SPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPW------------AEF------EAMA 214
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + +P P Q +V P A L+R + K RP+AEE L +
Sbjct: 215 AIFK---------IATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 58/301 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE +G+GSYG V AI TG+ VAIK + V E + + I++E+ +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
V+ S + D+++V E SD+ ++ N LT E LYQ L+ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLE 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-----RVAFSDTPMTVFWTDYVATRWY 195
Y+H+ HRD+K NIL N + K+ DFG++ +A +T + T ++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--------VIGTPFW 165
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y DIWS+G E+ GKP +
Sbjct: 166 MAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPY------------------------ 199
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + + KPP P P +++ + DP++RP+A + L P+
Sbjct: 200 ---SDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255
Query: 316 F 316
Sbjct: 256 I 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-R 80
++++EVIG+G+YG V A TG+ VAIK + + + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSN 61
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELME----SDLHQVIKANDDLTREHH-QFFLYQ 134
HP+I + + D +++V EL +DL + ++ +E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L Y+H V HRD+K +NIL N ++K+ DFG++ A D+ + T ++ T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNT-FIGTPY 178
Query: 195 YRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ APE C + Y D+WS+G E+ GKP
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI--HDVF-----EHISDAIRILREVKLLRLLRHPD 83
+G G +G V A+K + + EHI E ++L HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI------FSEKEILEECNHPF 54
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV ++ R FKD ++ LME +L +++ +F++ ++ A
Sbjct: 55 IV---KLY-----RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H + +RDLKP+N+L ++N +K+ DFG A+ S WT + T Y APE
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPE 162
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ +K Y ++D WS+G + E+LTG+P F
Sbjct: 163 II---LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 60/312 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
Y+ LE+IG+G+YG V TG VA+K I+ + +SD I REV LL LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQLRQ 58
Query: 82 PDIVEIKR----IMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
I + + P ++++ E E + ++KA + ++ + ++L
Sbjct: 59 SQPPNITKYYGSYLKGPR------LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
ALKY+H V HRD+K NIL +K+CDFG VA + + +V T ++
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWM 168
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ Y DIWS+G E+ TG P + + LI
Sbjct: 169 APEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP------------ 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALA 312
+ KPP + D +LL+ +A +PK+R +AEE L
Sbjct: 216 --------------KSKPP-----RLE--DNGYSKLLREFVAACLDEEPKERLSAEELLK 254
Query: 313 DPYFKGLAKIER 324
+ K +K
Sbjct: 255 SKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-23
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + HTG++VA+KK+ D+ + + + EV ++R H ++V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRREL-LFNEVVIMRDYHHENVVDMYNS 87
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +LRAL Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------------------FNEPPLQAMRRI 230
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328
R P P + V + L ++ +P R TA+E L P+ K+ PSC
Sbjct: 231 RDNLP-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL----KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-23
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
V+GKG+YG+V AA D T ++AIK+I + + E+ L L+H +IV +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV---Q 69
Query: 90 IMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQ---FFLYQMLRALKYM 142
+ S+ F I+ ME L ++++ +++ Q F+ Q+L LKY+
Sbjct: 70 YLGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 143 HTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H + HRD+K N+L N + +K+ DFG ++ P T +T T Y APE+
Sbjct: 125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y DIWS+GC E+ TGKP F + LG P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP----------- 217
Query: 262 KARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+A + M K P +P ++ A + R DP R +A + L DP+
Sbjct: 218 QAAMFKVGMFKIHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + TG+ +A+K I I++AI+ ILRE+ +L P IV
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
DI + E M+ L +++K E +L+ L Y+H
Sbjct: 63 GFYGAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 144 TA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ HRD+KP NIL N+ ++K+CDFG++ + T +V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQ 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ DIWS+G E+ TG+ FP D I +LL +V NE
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFELLQ-------YIV-NEP 220
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + FQ F N L + DP++RP+ +E L P+ K
Sbjct: 221 PPRLPSGKFSPD----FQDFVN------LCLIK----DPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 55/300 (18%)
Query: 24 RYKILEVIGKGSYGVV--CAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLL 79
+Y+ + V+G+G++G+V C + V IK+I E ++ R E ++L+LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIP--VEQMTKDERLAAQNECQVLKLL 56
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--KANDDLTREHHQFFLYQML 136
HP+I+E L E K + +V E L + I + N L + F Q+L
Sbjct: 57 SHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRW 194
AL ++HT + HRDLK +NIL + + +K+ DFG++++ S + TV V T
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPC 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y +PELC Y DIW++GC+ E+ + K F ++ + I GT +P
Sbjct: 167 YISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GTFAP-- 220
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ +Y ++R +L+ ++ DP RP + +A P
Sbjct: 221 -------ISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-23
Identities = 85/304 (27%), Positives = 130/304 (42%), Gaps = 62/304 (20%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH---------DVFEHISDAIRILREVKLLRLLR 80
+IG GS+G V ++ +GE +A+K++ D + DA+ RE+ LL+ L+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQ 64
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +IV+ L YV + + L+ + L R F+ Q+L+ L
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLN 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H + HRD+K NIL + +K+ DFG+++ +++ T T R P L
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST-------KTNGAR-PSL 172
Query: 201 CGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
GS F + YT DIWS+GC+ E+LTGK FP QL I + S
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFKIGENAS 229
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE P N+ A+ L++ D RPTA E L
Sbjct: 230 PE--------------------IP-------SNISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 312 ADPY 315
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-23
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A +G+ VA+KK+ D+ + + + EV ++R +H ++VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHENVVEMYNS 85
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE K + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLKAMKMI 228
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R P P + V P L RL+ DP R TA E L P+
Sbjct: 229 RDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G+G++G V K VA+K + + + + + L+E ++++ L HP++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE--DASEEERKDFLKEARVMKKLGHPNV 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN---------DDLTREHHQFFLYQ 134
V + + +Y+V E ME DL ++ + L+ + F Q
Sbjct: 59 VRLLGVCTEEEP-----LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + ++Y+ + HRDL +N L + +K+ DFGL+R + D + RW
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 195 YRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
APE S +T D+WS G + E+ T L TP P
Sbjct: 174 M-APE---SLKDGIFTSKSDVWSFGVLLWEIFT-------------------LGATPYPG 210
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ NE+ +YL + + P P L+ DP+DRPT E
Sbjct: 211 ----LSNEEVLEYLRK-GYRLPKP-----EYCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-22
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 43/293 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL IGKGS+GVV + A+K+I + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
+ L K + +V E E+ DLH+++K L + F Q+L L +
Sbjct: 62 IRYYESFLDKGK-----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +K+ D G+A++ + T F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y D+W++G + E TGK F + A++
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQG------------------ALILKI 213
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ PPV Q + +L+ + + D + RP + L +P
Sbjct: 214 IRGVF-------PPVS--QMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 61/303 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRH 81
+K+L+ +GKGSYG V + A+K++ +S R + E+++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR-----EHHQFFLYQM 135
P+I+ K L +K + +V E DL + I + E + F+ Q+
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR L+ +H + HRDLK NIL AN +K+ D G+++V + T + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y+ DIWS+GC+ E+ T P F +S
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------------------- 205
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEAL 311
+ ++R K K+P + P+ + LQ I PK RP ++ L
Sbjct: 206 -----------MQDLRYK---VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
Query: 312 ADP 314
A P
Sbjct: 252 ASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-22
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y +L V+G+GS+G ++ +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
IV K S +Y+V E + DL Q IK + + QM ++
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H V HRD+K KNI N K+K+ DFG AR+ S P + YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPEI 171
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
+ Y DIWS+GCI E+ T K F S
Sbjct: 172 WENM--PYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 85/318 (26%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++++ IG G+YG V A D TGE VAIK I D FE I I +L+E
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC------ 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQM 135
RHP+IV R K +++V E D++QV L+ + +
Sbjct: 58 RHPNIVA----YFGSYLRRDK-LWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRET 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFW 186
L+ L Y+H HRD+K NIL + +K+ DFG++ R +F TP +W
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP---YW 167
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
APE Y DIW++G E+ +P P +H +
Sbjct: 168 M---------APEVAAVERKGGYDGKCDIWALGITAIELAELQP--P-MFDLHPM----- 210
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPV--------PLFQKFPNVDPLALRLLQRLI 297
+A +++ PP P+F F +++ +
Sbjct: 211 ----------------RALFLISKSNFPPPKLKDKEKWSPVFHDF----------IKKCL 244
Query: 298 AFDPKDRPTAEEALADPY 315
DPK RPTA + L P+
Sbjct: 245 TKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-22
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 15/223 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+I++ IG+GS+G + A E IK+I + + +EV LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY--QMLRALK 140
IV S +E +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
++H + HRD+K +NI + N + K+ DFG+AR +D+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDS--MELAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
+C + Y DIWS+GC+ E+ T K F G + +HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 29/216 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
++ ++ +G GS+G V +G+ A+K + EH+ + RIL+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
RHP +V L S ++ ++Y+V E + +L ++ + +F+ Q++
Sbjct: 59 --RHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ ++ +RDLKP+N+L +++ +K+ DFG A+ T +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTPEYL 165
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
APE+ SK Y A+D W++G + E+L G P F
Sbjct: 166 APEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 46/227 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
D + I +VIG G +G VC G+K VAIK + SD R+ L E +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF---- 131
+ HP+I+ ++ ++ +K + + ++ E ME+ + D RE+ F
Sbjct: 59 MGQFDHPNIIRLEGVV---TKS--RPVMIITEYMENG------SLDKFLRENDGKFTVGQ 107
Query: 132 LYQMLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV--AFSDTPMT-- 183
L MLR +KY+ N HRDL +NIL N+N KV DFGL+R T T
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 184 ----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ WT APE + K+T A D+WS G + EV++
Sbjct: 168 GKIPIRWT---------APEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 50/301 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----ILREVKLLRLLRHPDI 84
+ +G G++ A D TG +A+K++ V S+ + +E++L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R++ + +++V E M L + + + + Q+LR L
Sbjct: 66 I---RMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCK-LKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRA 197
Y+H + HRD+K N+L ++ + L++ DFG A R+A T F + T + A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L G +Y + D+WS+GC+ E+ T KP + + + L LI + +
Sbjct: 177 PEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---- 229
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
P +P P + + LR L+ P+DRP + E L P F
Sbjct: 230 -----------------PSIPEHLS-PGLRDVTLRCLEL----QPEDRPPSRELLKHPVF 267
Query: 317 K 317
+
Sbjct: 268 R 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRH 81
++IL +G+G YG V A TGE VA+K++ + +R +L E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLR 137
+V++ F+D ++ ME D ++ L+ +H +F++ +M
Sbjct: 61 EWLVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+ +H HRDLKP+N L +A+ +K+ DFGL++ + V DY+ A
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------A 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y +D WS+GC+ E L G P F G + ET
Sbjct: 167 PEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---------------NETWEN 209
Query: 258 VRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALADPY 315
++ K E ++ P++ N+ A L+ +LI DP R + E+ P+
Sbjct: 210 LKYWK------ETLQR---PVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPF 259
Query: 316 FKGL 319
FK +
Sbjct: 260 FKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 93/296 (31%), Positives = 130/296 (43%), Gaps = 56/296 (18%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I HI S+ L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
K P K +Y+V + E H + DL+R +F+ ++L AL+ +H
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLKP+NIL + + +CDFGL ++ D T + T Y APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH 168
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
YT A+D W++G + E+LTG P F ++V NE R
Sbjct: 169 --GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYR 203
Query: 265 KYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR---PTAEEALADPYF 316
K L E PL +FP D A LL L++ DP R A+E P+F
Sbjct: 204 KILQE-------PL--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+GS+G G++ IK+I+ + +EV +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALK 140
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ ALK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H + HRD+K +NI + +K+ DFG+ARV S + + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
C + Y DIW++GC+ E+ T K F G + ++R
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEA--------------GNMKNLVLKIIRG 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
PPV ++ L +L +R +P+DRP+ L +
Sbjct: 217 S-----------YPPVSS-HYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 48/297 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y + V+GKGSYG V G++ IKK++ + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRAL 139
+IV + + E +Y+V E DL+ +K +Q + Q+ AL
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H ++ HRDLK +N+ +KV D G+ARV + M + + T +Y +PE
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYMSPE 172
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L F +K Y D+W++GC E+ T K F K +
Sbjct: 173 L---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---------------------- 207
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y K PP+P + P L+ +++ P+ RP+ + L PY
Sbjct: 208 ---NSLVYRIIEGKLPPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 69/250 (27%), Positives = 119/250 (47%), Gaps = 33/250 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIH--------DVFEHISDAIRILREVKL 75
Y +LE +G G++G V + G+ +A+K+I+ D E I+ EV +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--- 130
++ LRHP+IV + L E +Y+V +L+E + L + + L + +F
Sbjct: 62 IKEQLRHPNIVRYYKTFL-----ENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEE 113
Query: 131 ----FLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
QM+ AL+Y+H + HRDL P NI+ + K+ + DFGLA+ ++ +
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--- 170
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T Y PE+ + Y D+W+ GCI ++ T +P F +++ I +
Sbjct: 171 -TSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 246 LLGTPSPETI 255
+ P PE +
Sbjct: 228 AVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 90/330 (27%), Positives = 142/330 (43%), Gaps = 72/330 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++++VIG+G++G V D TG+ A+K + SD I+ ++ +R R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK-----SDMIK-RNQIAHVRAER-- 52
Query: 83 DI-VEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
DI + + F+D +Y+V E M DL ++ D E +F++ +++
Sbjct: 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSDTP 181
AL +H HRD+KP NIL +A+ +K+ DFGL
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 182 MTVFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
+ V D+ V T Y APE L G + Y D WS+G I E+L G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPP 229
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F ++ ET + N K + L F P V P A+
Sbjct: 230 FYSDTLQ---------------ETYNKIINWK--ESLR----------FPPDPPVSPEAI 262
Query: 291 RLLQRLIAFDPKDR-PTAEEALADPYFKGL 319
L+ RL+ DP+DR + EE + P+FKG+
Sbjct: 263 DLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 6e-20
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
DA+ KI +VIG G +G VC+ G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQ 134
+ HP+I+ ++ ++ + K + +V E ME+ + D R+H QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENG------SLDAFLRKHDGQFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
MLR +KY+ HRDL +NIL N+N KV DFGL+RV D P + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 83/302 (27%), Positives = 141/302 (46%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+I+ + I+ E+ +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
V HRD+K N+L + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS--- 242
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
P+F+ F L R + D + R +A+E L P+ K L
Sbjct: 243 -----------------PIFRDF----------LNRCLEMDVEKRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
+ ++ +G G++G V D + A+K I +V +H+ + R+L+EV
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
HP I+ L ++ + + +Y++ E + +L ++ + + F+ +++
Sbjct: 59 --SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ + +RDLKP+NIL + +K+ DFG A+ T WT T Y
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPEYL 165
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
APE+ S + A+D W++G + E+L G P F +
Sbjct: 166 APEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 2e-19
Identities = 83/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ V
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAV- 244
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
F+ F L R + D R +A+E L P+ K L
Sbjct: 245 -------------------FRDF----------LNRCLEMDVDRRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 56/310 (18%)
Query: 20 GDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
GD + Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRE 72
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQF--FLYQM 135
+HP+IV L +++VV E L L V+ + + Q +
Sbjct: 73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCREC 124
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRW 194
L+AL+++H+ V HRD+K NIL + +K+ DFG A++ TP + V T +
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPY 180
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---S 251
+ APE+ Y P +DIWS+G + E++ G+P + ++ + L LI GTP +
Sbjct: 181 WMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQN 237
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE ++ +F+ F L R + D + R +A+E L
Sbjct: 238 PEKLS--------------------AIFRDF----------LNRCLEMDVEKRGSAKELL 267
Query: 312 ADPYFKGLAK 321
P+ K +AK
Sbjct: 268 QHPFLK-IAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 72/230 (31%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRI 69
+ F++ + L IG GS+G V A D T E VAIKK+ E D I
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---I 62
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDL 123
++EV+ L+ LRHP+ +E K L RE + + +ME SD+ +V K L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPL 112
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
+ L+ L Y+H+ HRD+K NIL +K+ DFG A + +P
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPAN 169
Query: 184 VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLF 231
F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 170 SF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 4e-19
Identities = 66/239 (27%), Positives = 120/239 (50%), Gaps = 18/239 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVV 258
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ +
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+VIG G +G V I G K VAIK + + L E ++ H +I+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNII 69
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRA----LK 140
++ ++ +FK ++ E ME+ L + ++ +D E + L MLR +K
Sbjct: 70 RLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMK 121
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ N HRDL +NIL N+N + KV DFGL+RV D P + T + RW AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAP 179
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
E + K+T A D+WS G + EV++
Sbjct: 180 EAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 8e-19
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
D + KI EVIG G +G VC G++ VAIK + + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
+ HP+I+ ++ ++ + + + ++ E ME+ L ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTV 184
MLR +KY+ N HRDL +NIL N+N KV DFGL+R SD T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
D + L+ +G G +GVV H G+ VAIK I + D I E K+
Sbjct: 2 DPSELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ L HP++V++ + + + I++V E M + + + RE +
Sbjct: 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMA---NGCLL---NYLRERKGKLGTEW 101
Query: 136 L--------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
L A++Y+ + HRDL +N L + +KV DFGLAR D + T
Sbjct: 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ +W PE+ +S+++ D+WS G + EV + GK + S
Sbjct: 162 KF-PVKW-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 86/307 (28%), Positives = 142/307 (46%), Gaps = 40/307 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
K+ + D F + + L IG GS+G V A ++HT E VA+KK+ + ++
Sbjct: 6 KDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW 65
Query: 68 R-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKAN 120
+ I++EVK L+ L+HP+ +E K L K+ + + +ME SDL +V K
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYL-------KE-HTAWLVMEYCLGSASDLLEVHK-- 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A + +
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---S 172
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ KP LF
Sbjct: 173 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 221
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L ++ + NE T+ + QK P P + LL+
Sbjct: 222 NMNAMSALYHIAQNDSPTLQSNE-----WTDSFRGFVDYCLQKIPQERPASAELLRH--D 274
Query: 299 FDPKDRP 305
F +DRP
Sbjct: 275 FVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 80/306 (26%), Positives = 124/306 (40%), Gaps = 67/306 (21%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L+ I KG++G V A TG+ AIK + SD I +V ++ R
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKK-----SDMIA-KNQVTNVKAER------- 47
Query: 88 KRIMLPPSKREF----------KD-IYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQM 135
IM+ + + KD +Y+V E L D +IK L + + ++ ++
Sbjct: 48 -AIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV 106
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ ++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDY 159
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + G D WS+GC+ E L G P F TP
Sbjct: 160 LAPETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPD--- 199
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEAL 311
AV N +R+ P A+ L+ RL+ DP R A +E
Sbjct: 200 -AVFDNILSRRINWPEE---------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249
Query: 312 ADPYFK 317
+ P+FK
Sbjct: 250 SHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L +G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 88 KRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQ-MLRALKYM 142
L S I + E E +++ +K E + + +L+ L Y+
Sbjct: 65 YGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ + HRD+KP NIL ++K+CDFG++ + T + T +Y APE +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQ 176
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
G Y+ D+WS+G EV + FP + G P I ++
Sbjct: 177 GK---PYSITSDVWSLGLTLLEVAQNRFPFPPE-------------GEPPLGPIELL--- 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALADPYFK 317
Y+ M P P + P + I DP RPT + L P+ K
Sbjct: 218 ---SYIVNM----PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
Query: 318 GLAKIE 323
K +
Sbjct: 271 AQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 7e-18
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-------DAIRILREVKLL 76
RY + + +GKGS+G V D + +K V + I + ++ +E +LL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLK----VLKEIPVGELNPNETVQANQEAQLL 56
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-----DLHQVIKANDDLTREHHQFF 131
L HP IV+ L E ++ E E L ++ L+ +
Sbjct: 57 SKLDHPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+L + YMH + HRDLK KNI N LK+ DFG++R+ + T +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTG 167
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GCI E+ F G++ L ++ ++ P+
Sbjct: 168 TPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT 222
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEA 310
P P L ++Q ++ DP RP+A E
Sbjct: 223 PS----------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254
Query: 311 LADPY 315
L +P+
Sbjct: 255 LRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 9e-18
Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 53/328 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R+KIL ++G+G++G V A D E A+K + +V ++ DA +I E++ + +R D
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI--EIQFMEKVRQAD 186
Query: 84 IVEIKRIMLPPSKREFKD----IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R L +R F++ + +V L I + + H ++Q AL
Sbjct: 187 PAD--RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244
Query: 140 KYMHTA-NVYHRDLKPKNILANAN----------------CKLKVCDFGLARVAFSDTPM 182
Y HT ++ H DLKP+NIL + C++++CD G D
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----GCCDERH 300
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
+ T V+TR YR+PE+ Y+ D+WS+GCI E+ TGK L+ + L L
Sbjct: 301 SR--TAIVSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356
Query: 243 ITDLLGTPSPETIAVVRNEKAR---------------KYLTEMRKKPPVPLFQKFPNVDP 287
+ LG E E+AR K+L + + PV + D
Sbjct: 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR----DD 412
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPY 315
L L+ L+ +D + R A + PY
Sbjct: 413 LLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 26/222 (11%)
Query: 31 IGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G G +GVV H G+ KVAIK I++ D I E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ + + K +Y+V E ME+ L+ + + L+++ + ++Y+
Sbjct: 63 QLYGVCT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N L ++ +KV DFG+ R D + + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
FSKY+ D+WS G + EV T GK F KS +++I+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A + VA+KK+ +FE + R ++E+ LL+ L HP
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL Q+I K L E + + Q+
Sbjct: 63 NVIKYLDSFI-----EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEV 224
PE + Y DIWS+GC+ E+
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRILREVKLLRLLRHPDI 84
EV+GKG+YG V + T+ G+ +A+K++ +V + ++ EV LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V+ L + I + E + + ++ L + Q+L + Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTPMTVFWTDYVATRWY 195
V HRD+K N++ N +K+ DFG AR S+ ++ T Y +
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY-----W 174
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ S Y DIWSIGC E+ TGKP
Sbjct: 175 MAPEVINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 66/200 (33%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 47 TGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105
TG +VAIK + D E R RE L L HP+IV +L + ++ V
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVA----LLDSGEAPPGLLFAV 57
Query: 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANA 161
FE + L +V+ A+ L + Q+L AL H + HRDLKP+NI+
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 162 NCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWS 216
KV DFG+ V +D T+ + T Y APE L G TP D+++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDLYA 174
Query: 217 IGCIFAEVLTGKPLFPGKSV 236
G IF E LTG+ + G SV
Sbjct: 175 WGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ + E + + E++LL+ L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
IV+ + P +R + E M + +K+ LT + + Q+L +
Sbjct: 64 ERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYR 196
Y+H+ + HRD+K NIL ++ +K+ DFG ++ + S T M T ++
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM----KSVTGTPYWM 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+PE+ Y DIWS+GC E+LT KP
Sbjct: 177 SPEVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 18/241 (7%)
Query: 28 LEVIGKGSYG---VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
L+V+G+GS+G +V G+ A+K + + D +R E +L + HP I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V++ K +Y++ + + DL + T E +F+L ++ AL ++H
Sbjct: 61 VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL + +K+ DFGL++ + + T Y APE+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR 172
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL-LGTP---SPETIAVVR 259
+T + D WS G + E+LTG F GK + +I LG P SPE +++R
Sbjct: 173 --RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230
Query: 260 N 260
Sbjct: 231 A 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 26 KILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HD-VFEHISDAIRILREVKLLRLL 79
K ++ +G+G +G V + +TGE+VA+K + H +H SD RE+++LR L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTL 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQM 135
H +IV+ K + P R + ++ E + S D Q + +L R F Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKRL--LLFSSQI 118
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVATRW 194
+ + Y+ + HRDL +NIL + +K+ DFGLA+V V W
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
Y APE C SK++ A D+WS G E+ T
Sbjct: 179 Y-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ D E + + E++LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV+ + P +++ I+V + + + +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRA 197
+H+ + HRD+K NIL ++ +K+ DFG ++ + S T + T ++ +
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI----KSVTGTPYWMS 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
PE+ Y D+WS+ C E+LT KP
Sbjct: 178 PEVISG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-17
Identities = 105/353 (29%), Positives = 161/353 (45%), Gaps = 69/353 (19%)
Query: 10 LKDKD----FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
LKD + FF E D + + L IG GS+G V A D T E VAIKK+ + +
Sbjct: 9 LKDPEIAELFFKE--DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 65 DAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKAN 120
+ + I++EVK L+ ++HP+ +E K L RE ++V E SDL +V K
Sbjct: 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK-- 119
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A +A +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---S 176
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 177 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 225
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L E+ + NE + F+ F VD LQ++
Sbjct: 226 NMNAMSALYHIAQNESPTLQSNEWS-------------DYFRNF--VD----SCLQKI-- 264
Query: 299 FDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
P+DRPT+EE L K + + P I ++ TKD +REL
Sbjct: 265 --PQDRPTSEELL-----KHMFVLRERPETVLIDLIQ-------RTKDAVREL 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 16 FTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILR 71
F + D ++ ++I+E IGKG+YG V ++ G K A+K IHD+ E I IL+
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ-VIKANDDLTRE 126
L HP++V+ + + +++V EL +DL + +K + +
Sbjct: 70 A-----LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ L++ L L+++H HRD+K NIL +K+ DFG V+ T +
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRR 181
Query: 187 TDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
V T ++ APE+ S Y D+WS+G E+ G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L HP
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL ++I K L E + + Q+
Sbjct: 63 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
AL++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
PE + Y DIWS+GC+ E+ + F G
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + +G +A K IH E I AIR I+RE+K+L P IV
Sbjct: 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+I + E M+ L QV+K + +LR L Y+
Sbjct: 63 GFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ HRD+KP NIL N+ ++K+CDFG+ S + +V TR Y +PE L G
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ YT DIWS+G E+ G+ +P
Sbjct: 173 ---THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 49/296 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRHPDIV 85
+++G+G++G V D TG ++A K++ + E + + E++LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ + R K + + E M + +KA LT + + Q+L + Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFG----LARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ HRD+K NIL ++ +K+ DFG L + S T + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI----RSVTGTPYWMSPEV 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETIAVVR 259
Y D+WS+GC E+LT KP + +++ + T P I+
Sbjct: 181 ISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS--- 235
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E AR +L I + + RP+AEE L P+
Sbjct: 236 -EHARDFL---------------------------GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 26 KILEVIGKGSYGVV--CA--AIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K ++ +GKG++G V C + +TGE VA+KK+ H EH+ D RE+++L+ L+
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLY--QMLR 137
H +IV+ K + +R + +V E L L ++ + + +H + LY Q+ +
Sbjct: 64 HDNIVKYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICK 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR---- 193
++Y+ + HRDL +NIL + ++K+ DFGL +V D +Y R
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGE 172
Query: 194 ----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 173 SPIFWY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 31/239 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPD 83
+ + +G G +G V + +VAIK + D D +EV+ L+ LRH
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
++ + + + +Y++ ELME L +++ + L Q+ +
Sbjct: 64 LISLFAVC-----SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARV------AFSDTPMTVFWTDYVATRW 194
Y+ N HRDL +NIL + KV DFGLAR+ SD + WT
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT------- 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252
APE ++ D+WS G + E+ T G+ +PG + D IT P P
Sbjct: 172 --APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
L IG GS+G V A D E VAIKK+ + ++ + I++EV+ L+ LRHP+ ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 87 IKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ L RE + + +ME SDL +V K L + L+ L
Sbjct: 80 YRGCYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ N+ HRD+K NIL + +K+ DFG A + P F V T ++ APE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF----VGTPYWMAPEV 182
Query: 201 CGSF-FSKYTPAIDIWSIGCIFAEVLTGKP 229
+ +Y +D+WS+G E+ KP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKL 75
+ +++ IG G +G+V G KVAIK I + D I E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKAND-DLTREHHQFFLY 133
+ L HP +V++ + E I +VFE ME L ++A ++E
Sbjct: 53 MMKLSHPKLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ + Y+ ++NV HRDL +N L N +KV DFG+ R D + T + +
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
W +PE+ FSKY+ D+WS G + EV +
Sbjct: 167 W-SSPEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 83/312 (26%), Positives = 126/312 (40%), Gaps = 40/312 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE G+ G A ID T E V IK E +LR + HP I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+++K ++ ++DL+ + A ++ +LRA++Y+H
Sbjct: 146 IQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGS 203
+ HRD+K +NI N + + DFG A + W +AT APEL
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPELLAR 257
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV------VHQLDLITDLLGT-PSPETI 255
Y PA+DIWS G + E+ T LF + Q+ LI GT P+ I
Sbjct: 258 --DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 256 ---AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAE--- 308
A + RK PL+ + P+ L L+ +++AFD RP+AE
Sbjct: 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL-PIDLEYLICKMLAFDAHHRPSAEALL 374
Query: 309 -----EALADPY 315
+ + DPY
Sbjct: 375 DFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 26 KILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ +G G +G V + T KVA+K + L+E ++++ LRH +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
V++ + S+ E IY+V E M L +K+ + L Q+ + Y
Sbjct: 64 VQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARV-------AFSDTPMTVFWTDYVATRW 194
+ + N HRDL +NIL N K+ DFGLAR+ A + WT
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT------- 171
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLDL 242
APE G F K D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 172 --APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 55/311 (17%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREV 73
+++L+V+G G+YG +V TG +K A+ + EH +L V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+ + P +V + +K YV M + L+Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL+++H + +RD+K +NIL ++ + + DFGL++ S+ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGA----------------------SPF 207
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAE 308
T+ RN ++ ++ PP P + P A LL +L+ DPK R A
Sbjct: 208 TLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262
Query: 309 EALADPYFKGL 319
E P+FKGL
Sbjct: 263 EIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+++ E +G GS+G V A TGE AIK K ++ + + + +E +L L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + ++ F +VV + + L + + +D+ + F+ +++ A +Y+
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK----FYHAELVLAFEYL 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+N+L + +KV DFG A+ D T+ T Y APE+
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTL-----CGTPEYLAPEVIQ 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
S + A+D W++G + E + G P F
Sbjct: 189 S--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
++I+E IGKG+YG V + G A+K I DV E I IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-----LHQVIKANDDLTREHHQFFLYQML 136
P++V+ + K +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L+++H + HRD+K NIL +K+ DFG V+ T + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ + Y D+WS+G E+ G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 46/299 (15%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIV 85
++E +G+G+YGVV TG +A+K+I + R+L ++ + +R + P V
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM----LRALKY 141
+ RE D+++ E+M++ L + K D + L ++ ++AL+Y
Sbjct: 64 TFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 142 MHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H+ +V HRD+KP N+L N N ++K+CDFG++ T+ + Y APE
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI----DAGCKPYMAPER 174
Query: 201 CGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ Y D+WS+G E+ TG+ FP S + ++ PSP
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSP------ 226
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ + P FQ F N + L++ + K+RP E L P+F+
Sbjct: 227 ----------QLPAEKFSPEFQDFVN------KCLKK----NYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 72/306 (23%), Positives = 136/306 (44%), Gaps = 44/306 (14%)
Query: 25 YKILEVIGKGSYGVV--CAAIDTH-TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
+++L+V+G G+YG V + H +G+ A+K K + + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RH-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
R P +V + +K Y+ + + L Q + + Q + +++ A
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLA 117
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ + A+D WS+G + E+LTG SP T+
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGA----------------------SPFTVDGE 213
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALAD 313
+N +A ++ +PP P + LA ++QRL+ DPK R P+ A+E
Sbjct: 214 KNSQAEISRRILKSEPPYP-----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 43/285 (15%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T E VAIK I E D I I +E+ +L P I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266
Y DIWS+G E+ G+P S +H + ++ L+ SP T
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN---SDLHPMRVLF-LIPKNSPPT------------ 220
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L KP F++F ++ + DP+ RPTA+E L
Sbjct: 221 LEGQYSKP----FKEF----------VEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 28 LEVIGKGSYGVVCAAIDTH---TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
L+V+GKG YG V TG+ A+K K + + D E +L ++HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV++ K +Y++ E L +L ++ + F+L ++ AL++
Sbjct: 61 FIVDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEH 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + +RDLKP+NIL +A +K+ DFGL + + + +T + T Y APE+
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEIL 172
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
S + A+D WS+G + ++LTG P F ++ +D I
Sbjct: 173 MR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 72/309 (23%), Positives = 132/309 (42%), Gaps = 52/309 (16%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTGEKVAIKKIHDV--------FEHISDAIRILREV 73
+++L V+G G+YG +V G+ A+K + EH R R+V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT----RTERQV 57
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
L + R P +V + +K YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL ++H + +RD+K +NIL ++ + + DFGL++ ++ + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA----------------------SPF 208
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEA 310
T+ +N ++ ++ KPP P + A +Q+L+ DPK R A+E
Sbjct: 209 TVDGEQNSQSEISRRILKSKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 311 LADPYFKGL 319
P+F+G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 53/303 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + +G G+ G V TG +A K +H + S +ILRE++++ R P IV
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
L + +I + E M+ L ++ K + E ++ L Y++
Sbjct: 67 SFYGAFLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 145 AN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRD+KP NIL N+ ++K+CDFG++ + T +V T Y +PE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPERIQG 176
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFP-------GKSVVHQ---LDLITDLLGTPSPE 253
KYT D+WS+G E+ GK FP LDL+ ++ P P
Sbjct: 177 --GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP- 231
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ P FP + + DP +RPT ++ A
Sbjct: 232 ------------------RLPS----SDFP---EDLRDFVDACLLKDPTERPTPQQLCAM 266
Query: 314 PYF 316
P F
Sbjct: 267 PPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-VFEHISDAIRILREVK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ S + + +Y V + + +L ++ +F+ ++ AL Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A SDT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
Y +D W +G + E+L G P F + V D I
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLR---LLRHPDIVE 86
IGKG++G V T A+K + + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+K S D+Y+V + M +L ++ + + +F++ +++ AL+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ +D T + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 61/299 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++L +G G +G V + +T VA+K + D L E ++++ LR
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLR 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--FLYQMLR 137
HP ++++ + + E IY+V ELM+ L + ++ + Q Q+
Sbjct: 60 HPKLIQLYAVC---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDYV 190
+ Y+ N HRDL +N+L N KV DFGLARV D + WT
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT--- 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGT 249
APE + +++++ D+WS G + E++T G+ +PG + L +
Sbjct: 172 ------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM 223
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P P P L+ ++ DP DRPT E
Sbjct: 224 PCPPGC-------------------PKELYD-----------IMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 61/294 (20%)
Query: 29 EVIGKGSYGVVCAAIDT-HTGEKVAIK-KIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
IG+G +G V + EK+A+ K S + L+E ++R HP IV+
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 87 -IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMH 143
I I P +++V EL +L ++ N L + YQ+ AL Y+
Sbjct: 72 LIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR------WYRA 197
+ HRD+ +N+L ++ +K+ DFGL+R D + Y A++ W A
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDE------SYYKASKGKLPIKWM-A 176
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSPETI 255
PE F ++T A D+W G E+L KP G + + I
Sbjct: 177 PESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVKNNDVI 218
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ N ++ P+P PN P L+ + A+DP RP E
Sbjct: 219 GRIENG----------ERLPMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ IGKG +G V + + G+KVA+K + D + A L E ++ LRHP++V
Sbjct: 9 KLGATIGKGEFGDV--MLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELME---------SDLHQVIKANDDLTREHHQFFLYQML 136
++ ++L + +Y+V E M S VI T F +
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVC 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---TPMTVFWTDYVATR 193
++Y+ N HRDL +N+L + + KV DFGLA+ A + V WT
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT------ 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVV 237
APE K++ D+WS G + E+ + G+ P P K VV
Sbjct: 167 ---APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L L ++L+ L Y+H+
Sbjct: 67 YYGSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + + ++K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIK 88
IG G+ G V I TG A+K I+ E D +R I RE+++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCH 138
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL----YQMLRALKYMHT 144
+ +I V+ E M+ + + T + FL Q+L + Y+H
Sbjct: 139 DMF-----DHNGEIQVLLEFMD-------GGSLEGTHIADEQFLADVARQILSGIAYLHR 186
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPE---- 199
++ HRD+KP N+L N+ +K+ DFG++R+ A + P V T Y +PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC----NSSVGTIAYMSPERINT 242
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
L + Y A DIWS+G E G+ FP
Sbjct: 243 DLNHGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 48/232 (20%)
Query: 27 ILEVIGKGSYGVV-----CAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ +G+G++G V + E VA+K + + +DA + RE +LL +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------DLTR 125
H +IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 67 HENIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+ + Y+ + + HRDL +N L + +K+ DFG++R V+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVY 173
Query: 186 WTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
TDY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 174 TTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 60/307 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL--- 79
++ L V+G+G +G V A TGE AIK K D+ D + L K +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANS 58
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
RHP +V + + V E DL I D + F+ ++
Sbjct: 59 ERHPFLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWY 195
L+Y+H + +RDLK N+L + +K+ DFGL + + F D T + T +
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEF 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ + YT A+D W +G + E+L G+ FPG D
Sbjct: 168 LAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------------- 211
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEA 310
++V +E + +F + + A+ +++RL+ +P+ R AE+
Sbjct: 212 SIVNDE---------------VRYPRFLSRE--AISIMRRLLRRNPERRLGSGEKDAEDV 254
Query: 311 LADPYFK 317
P+F+
Sbjct: 255 KKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 42/221 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E+IG+G +G V +TG+KVA+K I DV A L E ++ L H ++V +
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRL 64
Query: 88 KRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLR-------AL 139
++L +Y+V ELM + +L ++ TR + Q+L+ +
Sbjct: 65 LGVIL------HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLDVAEGM 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTVFWTDYVATRWYR 196
+Y+ + + HRDL +NIL + + KV DFGLARV ++ + V WT
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--------- 164
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
APE K++ D+WS G + EV + G+ +P S+
Sbjct: 165 APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 84/273 (30%), Positives = 124/273 (45%), Gaps = 43/273 (15%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF +I E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------ERISE-LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
E +LR L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L+
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVELAIGRYPIPPPDA--KELEA 212
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP 275
I G P VV E+ + R +PP
Sbjct: 213 I---FGRP------VVDGEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK--------LLRLLRH 81
VIGKGS+G V A G+ A+K + AI +E K LL+ ++H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVKH 55
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHH------QFFL 132
P +V + K +Y V + + E H L RE +F+
Sbjct: 56 PFLVGLHYSFQTADK-----LYFVLDYVNGGELFFH--------LQRERSFPEPRARFYA 102
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYV 190
++ AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + S T T +
Sbjct: 103 AEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FC 157
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T Y APE+ Y +D W +G + E+L G P F + D I
Sbjct: 158 GTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 78/313 (24%), Positives = 122/313 (38%), Gaps = 41/313 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y +++ + GS G V A + V +K I L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKRIMLPPSKREFKDIY-VVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ +K ++ I +V SDL+ + L + Q+L L+Y+
Sbjct: 120 IRMKDTLV------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+K +NI N ++ + D G A+ P + V T APE+
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLA 229
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-------GKPLFPGKSVV----HQLDLITDLLGTP- 250
KY DIWS G + E+L P P + V H L +I+ L P
Sbjct: 230 R--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 251 ----SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
P + + E + P FQ+ N+ L+ +++ FD RP+
Sbjct: 288 EFPRDPGS--RLVRGFIEYASLERQPYTRYPCFQRV-NLPIDGEFLVHKMLTFDAAMRPS 344
Query: 307 AEEALADPYFKGL 319
AEE L P F L
Sbjct: 345 AEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 81/312 (25%), Positives = 140/312 (44%), Gaps = 59/312 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLRLLRHPD 83
++I++VIG+G++G V A + E++ KI + +E + A RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVI-KANDDLTREHHQFFLYQMLRA 138
I + F+D ++ +M+ DL ++ K D L + +F++ +M+ A
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ +H + HRD+KP N+L + N +++ DFG D TV + V T Y +P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISP 172
Query: 199 ELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ + KY P D WS+G E+L G+ F +S+V ET
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETY 217
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFP----NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ N + R FQ FP +V A L+QRLI ++R + +
Sbjct: 218 GKIMNHEER--------------FQ-FPSHITDVSEEAKDLIQRLIC--SRERRLGQNGI 260
Query: 312 AD----PYFKGL 319
D +F+G+
Sbjct: 261 EDFKKHAFFEGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 12/228 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y +++VIG+G++G V + + +KV K+ FE I SD+ E ++
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ K +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ + HRD+KP N+L + + LK+ DFG + +T M V V T Y +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGM-VRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
+ S Y D WS+G E+L G F S+V I D
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 16/234 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD---VFEHISDAIRILREVKLLRLLRHPDIV 85
+VIGKGS+G V A G A+K + + + + I R V LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ K +Y V + + +L ++ +F+ ++ A+ Y+H+
Sbjct: 60 GLHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGTPSPETIAV 257
Y +D W +G + E+L G P F + V D ++ L P +T+A
Sbjct: 171 -EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA 223
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 57/291 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
E IGKG++G V + +VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR----ALK 140
+ + + + + IY+V EL+ S L + K + LT + L QM ++
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK----LLQMSLDAAAGME 107
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + N HRDL +N L N LK+ DFG++R + +W APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEA 166
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ +YT D+WS G + E + G +PG S
Sbjct: 167 LN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMS------------------------ 200
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N++ R+ + + P P + P + RL+ + A+DP++RP+ E
Sbjct: 201 NQQTRERIESGYRMPA-------PQLCPEEIYRLMLQCWAYDPENRPSFSE 244
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIQQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 73/315 (23%), Positives = 124/315 (39%), Gaps = 61/315 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+L+ +GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVD 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMES---------DLHQVIKANDDLTREHHQFFLYQMLR 137
+Y+ E M++ + D L R + + + L+
Sbjct: 64 FYGAFFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLK 116
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
LK H N+ HRD+KP N+L N N ++K+CDFG++ + T + + Y A
Sbjct: 117 FLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-----NIGCQSYMA 169
Query: 198 PE----LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---SVVHQLDLITDLLGTP 250
PE + YT D+WS+G E+ G+ +P + ++ QL I D G P
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +P A + + + P RPT +
Sbjct: 228 -----------------------PTLP-----SGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
Query: 311 LADPYFKGLAKIERE 325
L P+ + +
Sbjct: 260 LEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF KI E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------EKISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+ +++ L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTE-MRKKPPVPLFQ 280
+ G P+ + R + +PP+ +F+
Sbjct: 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFE 253
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 51/301 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A TG A K I + E + D + E+ +L +HP+
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPN 63
Query: 84 IVEIKRIMLPPSKR----EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV + +K EF D + +M + LT ++ QML AL
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEAL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAP 198
++H+ V HRDLK NIL + +K+ DFG+ A+ + F + T ++ AP
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF----IGTPYWMAP 172
Query: 199 EL--CGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ C +F Y DIWS+G E+ +P P ++ + ++ +L + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTL- 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
++ K+ + F F L+ + DP DRPTA E L P+
Sbjct: 229 -----DQPSKWSSS---------FNDF----------LKSCLVKDPDDRPTAAELLKHPF 264
Query: 316 F 316
Sbjct: 265 V 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 70/254 (27%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRL 78
D N + L IG G+ G V TG +A+K++ E RIL ++ ++ L
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-L 68
Query: 79 LRH--PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF----- 131
H P IV+ + S D+++ ELM + L D L +
Sbjct: 69 KSHDCPYIVKCYGYFITDS-----DVFICMELMSTCL-------DKLLKRIQGPIPEDIL 116
Query: 132 ---LYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
+++AL Y+ V HRD+KP NIL +A+ +K+CDFG++
Sbjct: 117 GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLV 166
Query: 188 DYVA-TR-----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
D A TR Y APE KY D+WS+G E+ TG+ FP K+ +
Sbjct: 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTE 224
Query: 240 LDLITDLLGTPSPE 253
+++T +L P
Sbjct: 225 FEVLTKILQEEPPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 72/306 (23%), Positives = 118/306 (38%), Gaps = 63/306 (20%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLRH 81
+GKG +G VCA TG+ A KK+ D R+ L E K+L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRA 138
IV + D+ +V LM DL I + F+ Q++
Sbjct: 53 RFIVSLAYAFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V T Y AP
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAP 163
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y ++D +++GC E++ G+ F +
Sbjct: 164 EVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQR------------------------ 197
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + ++ L + V KF P A L + L+ DP+ R +A+E
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254
Query: 314 PYFKGL 319
P FK L
Sbjct: 255 PLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V A + +KV KI + +E + A E R R +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRA-----ETACFREERDV-L 55
Query: 85 VEIKRIMLPPSKREFKD---IYVVFEL-MESDLHQVI-KANDDLTREHHQFFLYQMLRAL 139
V + F+D +Y+V + + DL ++ K D L + +F+L +M+ A+
Sbjct: 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+KP NIL + N +++ DFG D TV + V T Y +PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 173
Query: 200 LCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ + KY P D WS+G E+L G+ F +S+V
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
+V+GKGS+G V A T E AIK + DV D + E ++L L HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP---- 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
L F+ +F +ME DL I+ + +F+ ++ AL ++
Sbjct: 57 ----FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V +RDLK NIL +A K+ DFG+ + + T T + T Y APE+
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQ 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+Y P++D W++G + E++ G+P F
Sbjct: 170 EL--EYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 62/250 (24%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFE-----HISDAIRILREVKLLRLLR 80
++VIG+G++G V TG A+KK+ ++ E H+ IL E
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------ 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
+P +V++ F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 60 NPWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL----------------------AR 174
A+ +H HRD+KP N+L +A +K+ DFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 175 VAFSDTPMT-------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ F PM+ V T Y APE+ + Y D WS+G I
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIM 229
Query: 222 AEVLTGKPLF 231
E+L G P F
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 78/328 (23%), Positives = 135/328 (41%), Gaps = 84/328 (25%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N Y++++ IG G +G V T E K I + +++ EV ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIK------------ANDDLTREHH 128
+IV I R + +++ +Y++ E ++ DL + I+ A D+TR
Sbjct: 73 NIVRYIDRFLNKANQK----LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR--- 125
Query: 129 QFFLYQMLRALKYMHT-------ANVYHRDLKPKNILANANCK----------------- 164
Q+L AL Y H V HRDLKP+NI + +
Sbjct: 126 -----QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
K+ DFGL++ + + V T +Y +PEL Y D+W++GCI E+
Sbjct: 181 AKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+GK F + QL ++E+++ P +P+ K
Sbjct: 237 CSGKTPFHKANNFSQL--------------------------ISELKRGPDLPIKGKSKE 270
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ L++ L+ K+RP+A + L
Sbjct: 271 LN----ILIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 86/324 (26%), Positives = 137/324 (42%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY I+ +IGKG G V A D +VA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ-----FFL---YQ 134
IV + I + Y+ ++S L V + + L++E + FL ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQK-ESLSKELAEKTSVGAFLSIFHK 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTP----- 181
+ ++Y+H+ V HRDLKP NIL ++ + D+G A + D
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 182 ---MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
MT+ V T Y APE L G S+ T DI+++G I ++LT FP
Sbjct: 182 YSSMTIP-GKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FP----- 230
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
R +K RK P+ + + + P ++ + +
Sbjct: 231 --------------------YRRKKGRKISYRDVILSPIEV-APYREIPPFLSQIAMKAL 269
Query: 298 AFDPKDRPTAEEALAD---PYFKG 318
A DP +R ++ + L P+ +G
Sbjct: 270 AVDPAERYSSVQELKQDLEPHLQG 293
|
Length = 932 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 29 EVIGKGSYGVVCAA--IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
VIGKG +G V ID+ + A+K ++ + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMH 143
+ I LP E + V+ + DL I+ ++ ++ F L Q+ + ++Y+
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLA 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N + + + +KV DFGLAR ++ +Y + + +L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVK 167
Query: 204 FFS-------KYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+ + K+T D+WS G + E++T G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 15/218 (6%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHH 128
L+E ++++ LRH +V++ ++ + IY+V E M + L +K
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 129 QF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q Q+ + Y+ N HRDL+ NIL N KV DFGLAR+ D T
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 161
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE + + ++T D+WS G + E+ T G+ +PG LD +
Sbjct: 162 GAKFPIKW-TAPE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
Query: 246 LLGTPSP-ETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
P P E + + + + E ++P Q F
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 65/236 (27%), Positives = 113/236 (47%), Gaps = 26/236 (11%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
+ L D D A ++++EV+G G+YG V TG+ AIK + DV E + I
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEI 59
Query: 68 RILREVKLLRLLRHPDIVE------IKRIMLPPSKREFKDIYVVFELME----SDLHQVI 117
++ E+ +L+ H + IK+ PP + +++V E +DL +
Sbjct: 60 KL--EINMLKKYSHHRNIATYYGAFIKKS--PPGHDD--QLWLVMEFCGAGSVTDLVKNT 113
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K N L + + ++LR L ++H V HRD+K +N+L N ++K+ DFG++
Sbjct: 114 KGNA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS---- 168
Query: 178 SDTPMTVFWTD-YVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ TV + ++ T ++ APE+ + + Y DIWS+G E+ G P
Sbjct: 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVE 86
L IG+G++G V + +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 87 IKRIMLPPSKREFK--DIYVVFELMESDLHQVIK-ANDDLTREHHQFFL----YQMLRAL 139
+ F+ D ++ ELM+ L + K + L + L ++AL
Sbjct: 68 FYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 140 KYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
Y+ + HRD+KP NIL + N +K+CDFG++ T D R Y AP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR---D-AGCRPYMAP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQL 240
E + S Y D+WS+G EV TGK +P SV QL
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 20/225 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRH 81
+ + ++G+G +G V + TG+ A+K + + + E + +L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQML 136
P +P + F+D +Y+V E DL ++ +D E QF+L +++
Sbjct: 61 P--------WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
A+ +H HRD+KP+N+L + +K+ DFG A A V V T Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYI 170
Query: 197 APELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
APE+ G Y D WS+G I E++ G+ F +
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + DV D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ +F +ME DL I+ + +F+ +++ L+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLK N+L ++ +K+ DFG+ + T + + T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS- 169
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ Y PA+D W++G + E+L G+ F G
Sbjct: 170 -YQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 79/342 (23%), Positives = 140/342 (40%), Gaps = 66/342 (19%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISD---------------A 66
+++++ + G++G +CA + T E A + ++ + A
Sbjct: 149 HFRVIDDLPAGAFGKIFICA-LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH-----QVIKAND 121
I++ E+ L L H +I++I+ I+ + + Y++ + + DL+ + D
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKD 262
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
+ + + Q+L A++Y+H + HRD+K +NI N + K+ + DFG A + F +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPF-EKE 320
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
F +V T +PE+ Y DIWS G I ++L+ H
Sbjct: 321 REAFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLS-----------HDFC 367
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP---------NVDPLALRL 292
I D G P + + ++ + E PP LF +V PL L
Sbjct: 368 PIGDGGGKPGKQLLKIID---SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424
Query: 293 ---------LQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
L +++ FD RP A E LA P F A+ E E
Sbjct: 425 GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K + F YV + L + ++D TR F+ +++ AL Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR----FYGAEIVSALDYLHSGKI 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +K+ DFGL + +D + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y A+D W +G + E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + DV D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ P + ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N+L + K+ DFG+ + + T + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLF 231
Y P++D W++G + E+L G F
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 72/313 (23%), Positives = 117/313 (37%), Gaps = 43/313 (13%)
Query: 30 VIGKGSYG--VVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVE 86
+IGK +V A T VA+KKI+ D D + +E+ R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILP 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH---------QFFLYQMLR 137
+ S ++YVV LM + +DL + H F L +L
Sbjct: 64 YVTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS----DTPMTVFWTDYVATR 193
AL Y+H+ HR +K +IL + + K+ + + + F V
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS-- 251
+ +PE+ Y DI+S+G E+ G P K + L+ + GT
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCL 230
Query: 252 ------PETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDR 304
P + ++ R P + F + LQR DP+ R
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR----DPESR 286
Query: 305 PTAEEALADPYFK 317
P+A + L +FK
Sbjct: 287 PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 26 KILEVIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ + +G G +G V A + HT KVA+K + + L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
V++ ++ +E IY++ E M L +K+++ + + F Q+ + +
Sbjct: 64 VKLHAVV----TKE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ N HRDL+ NIL +A+ K+ DFGLARV D T +W APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAI 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
F +T D+WS G + E++T G+ +PG S
Sbjct: 176 N--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 80/333 (24%), Positives = 136/333 (40%), Gaps = 78/333 (23%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD--AIRILREVKLLRLLRH 81
+K ++++GKG G V TG+ A+K + D E I R+L E ++L L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLYQMLRA 138
P + L S + + +V + +L ++++ L+ E +F+ ++L A
Sbjct: 61 PFLPT-----LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM---------------- 182
L+Y+H + +RDLKP+NIL + + + + DF L++ + + P
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 183 ---------TVFWT-DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
F + +V T Y APE+ G + A+D W++G + E+L G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTT 230
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
F G + R+E L KK F P V A
Sbjct: 231 PFKGSN-----------------------RDETFSNIL----KKE--VTFPGSPPVSSSA 261
Query: 290 LRLLQRLIAFDPKDR----PTAEEALADPYFKG 318
L+++L+ DP R A E P+F+G
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 82/317 (25%)
Query: 26 KILEVIGKGSYGVV---CAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+GS+G+V A + +VAIK +++ + + I L E +++
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFN 67
Query: 81 HPDIVEIKRIML---PPSKREFKDIYVVFELM-ESDLHQVIKA---NDD-------LTRE 126
+V + ++ P VV ELM + DL +++ + T +
Sbjct: 68 CHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 127 HHQFFLY--QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+F ++ + Y+ HRDL +N + + +K+ DFG+ R +
Sbjct: 120 --KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DI 169
Query: 185 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ TDY + RW APE +T D+WS G + E+ T + + G S
Sbjct: 170 YETDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQR 295
L + D PE P L L L++
Sbjct: 227 NEEVLKFVIDGGHLDLPEN-------------------CPDKL-----------LELMRM 256
Query: 296 LIAFDPKDRPTAEEALA 312
++PK RPT E ++
Sbjct: 257 CWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 11/145 (7%)
Query: 93 PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152
P S + D V L+ D + + D L+ F YQ+ R ++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +K+CDFGLAR D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPGMIV 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+L+ IGKG +G V + + G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDD--LTREHHQFFLYQMLRALKYM 142
++ +++ E +Y+V E M + L +++ L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DT-PMTVFWTDYVATRWYRAPE 199
N HRDL +N+L + + KV DFGL + A S DT + V WT APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVVHQLD 241
K++ D+WS G + E+ + G+ P P K VV +++
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 87/351 (24%), Positives = 150/351 (42%), Gaps = 54/351 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
KD T A +Y I V+G G+ G V A GE A+K + +D R E
Sbjct: 22 KDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAE 81
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTR--- 125
V L IV+ R +++ ++ +++ DL Q IK+ R
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 126 EHHQFFLY-QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
EH L+ Q+L A+ ++H+ ++ HRD+K NIL +N +K+ DFG +++ ++ T
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATVSDD 200
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244
+ T +Y APE+ Y+ D++S+G + E+LT K F G+++
Sbjct: 201 VGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------ 252
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304
V+ A +Y P+P P++ P ++ L++ DPK R
Sbjct: 253 ------------VMHKTLAGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRR 288
Query: 305 PTAEEALADP----YFKGLAKI-EREPSCQPISKLEFEFERRRVTKDDIRE 350
P++ + L P + GL +I + +P F R I++
Sbjct: 289 PSSSKLLNMPICKLFISGLLEIVQTQPG--------FSGPLRDTISRQIQQ 331
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H N E F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + +++ D GLA + P V T Y AP
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W +GC+ E++ GK F
Sbjct: 171 EVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQ------------------------- 203
Query: 259 RNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
R EK ++ E R K+ +KF A + ++L+ DP R AEE A
Sbjct: 204 RKEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260
Query: 313 DPYFKGL 319
P+F+
Sbjct: 261 HPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 17/233 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V + KVA+K + + L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--DLTREHHQFFLYQMLRALKYM 142
+ ++ +K E IY++ E M + L +K+++ + F Q+ + Y+
Sbjct: 65 RLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ N+L + + K+ DFGLARV D T +W APE
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAIN 177
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
F +T D+WS G + E++T GK +PG S + + P E
Sbjct: 178 --FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/223 (24%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+G G YG V + VA+K + + D + + L+E +++ ++HP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQ- 66
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHT 144
+L RE Y++ E M +L ++ + ++ + Q+ A++Y+
Sbjct: 67 ---LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELC 201
N HRDL +N L N +KV DFGL+R+ DT +T + ++ + APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPE-- 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243
++K++ D+W+ G + E+ T G +PG + +L+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+ F G+
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++++ +G G+YG V A + HTGE A+K I E D I +E+ +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG VA T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
Y DIW++G E+ +P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 57/267 (21%), Positives = 104/267 (38%), Gaps = 57/267 (21%)
Query: 50 KVAIKKIHDVFEHI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108
+VA+K + EHI + LRE ++ L HP IV + + + +V EL
Sbjct: 25 EVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP------LMLVMEL 76
Query: 109 ME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167
L + +K ++ + +Q+ + Y+ + + HRDL +N+L + K+
Sbjct: 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKI 136
Query: 168 CDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCI 220
DFG++R + + Y AT +WY APE C ++ K++ D+WS G
Sbjct: 137 SDFGMSRALGAGS------DYYRATTAGRWPLKWY-APE-CINYG-KFSSKSDVWSYGVT 187
Query: 221 FAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF 279
E + G + + ++ P PE + P ++
Sbjct: 188 LWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE-------------------ECPQEIY 228
Query: 280 QKFPNVDPLALRLLQRLIAFDPKDRPT 306
++ + P+DRPT
Sbjct: 229 S-----------IMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 48/286 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E++GKG++G V VA+K D+ + + I+ L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ ++R+ IY+V EL+ L + K D+L + F + Y+ +
Sbjct: 58 IGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LK+ DFG++R D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+Y+ D+WS G + E + G +PG + N++AR
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMT------------------------NQQAR 204
Query: 265 KYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + + R P QK P+ +++QR + P++RP E
Sbjct: 205 EQVEKGYRMSCP----QKCPDD---VYKVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 61/251 (24%), Positives = 120/251 (47%), Gaps = 21/251 (8%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K S + + V E +L + + + +F+ +++ AL Y+H+ +
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
V +RDLK +N++ + + +K+ DFGL + SD + T Y APE+ +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
Y A+D W +G + E++ G+ F + + +L L+ ++ P T++ +A+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---RFPRTLS----PEAK 223
Query: 265 KYLTEMRKKPP 275
L + KK P
Sbjct: 224 SLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 38/293 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+++++ IG G+YG V A + +TGE AIK I E D + +E+ +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLRRDK-----LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG V+ T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIW++G E+ +P + L L+T P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + F + +AL +PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHHFVKMAL-------TKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + +G G++G V A + KVA+K + H S+ ++ E+K++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMS 93
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLY 133
L H +IV L + I V+ E DL ++ + LT E F Y
Sbjct: 94 HLGNHENIVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+ + + ++ + N HRDL +N+L +K+CDFGLAR +D+ V + +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
W APE F YT D+WS G + E+ + G +PG
Sbjct: 209 WM-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPD 83
++ V+GKG +G VCA TG+ A K++ + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMES---DLHQVIKANDDLTREHHQFFLYQMLRAL 139
+V + E KD + +V +M H N E F+ ++L L
Sbjct: 62 VVNLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ +H N +RDLKP+NIL + +++ D GLA P V T Y APE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ + +YT + D W +GC+ E++ G+ F G+
Sbjct: 172 VLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 28 LEV-IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
L+V +G+G +G V T KVAIK + L+E ++++ LRH +V
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 87 IKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMH 143
+ ++ + IY+V E M + L +K D + Q Q+ + Y+
Sbjct: 66 LYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N HRDL+ NIL N K+ DFGLAR+ D T +W APE +
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AA 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 46 HTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103
+TGE+VA+K K HI+D + +E+++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 104 VVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRALKYMHTANVYHRDLKPKNILANA 161
++ E + S L + + N + Q + Q+ + + Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
++K+ DFGL + +D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 222 AEVLT 226
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ +G G +G V KVA+K + L E ++++ LRH +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ S+ IY+V E M + L +K + + Q+ + Y+
Sbjct: 65 QLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ NIL K+ DFGLAR+ D T +W APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ + ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 52/286 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
E IG+G++G V + VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRL- 58
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR-------ALKY 141
I + K+ IY+V EL++ L E + + ++++ ++Y
Sbjct: 59 -IGVCTQKQP---IYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LK+ DFG++R + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +Y+ D+WS G + E + L P + N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS-------------------LGAVPYAN----LSNQ 203
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ R+ + + + P P + P A+ RL++R +DP RP+
Sbjct: 204 QTREAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 11/211 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ +A +K+ DFG+ + T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ Y ++D W+ G + E+L G+P F G
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156
++ F+ S + DDL T E + +Q+ R ++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + N +K+CDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAEVLT-GKPLFPG 233
S G + E+ + G +PG
Sbjct: 261 SFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRL 78
A ++++E++G G+YG V TG+ AIK + D E I I +L++ R
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQ 134
+ IK+ PP + +++V E +DL + K N L E + +
Sbjct: 65 IATYYGAFIKKN--PPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICRE 119
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATR 193
+LR L ++H V HRD+K +N+L N ++K+ DFG++ + TV + ++ T
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTP 175
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K + F V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSFF 205
V +RD+K +N++ + + +K+ DFGL + SD M F T Y APE+
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF----CGTPEYLAPEVLED-- 169
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN--EKA 263
+ Y A+D W +G + E++ G+ F + +LI E I R +A
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIRFPRTLSPEA 222
Query: 264 RKYLTEMRKKPP 275
+ L + KK P
Sbjct: 223 KSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 40/239 (16%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEH 62
+ K++ K K Y D N + +G GS+G V+ A VAIK+ FE
Sbjct: 19 KEPKRKNKMK-----YEDFN---FIRTLGTGSFGRVILATYKNEDFPPVAIKR----FEK 66
Query: 63 ISDAIR------ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFE-LMESD 112
S I+ + E K+L + HP V + FKD +Y+V E ++ +
Sbjct: 67 -SKIIKQKQVDHVFSERKILNYINHPFCVNLYG--------SFKDESYLYLVLEFVIGGE 117
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + + +K+ DFG
Sbjct: 118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
A+V + T T Y APE+ + + A D W++G E+L G P F
Sbjct: 178 AKVVDTRT------YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 75/328 (22%), Positives = 141/328 (42%), Gaps = 34/328 (10%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + DV D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH- 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L + + + ++ V E + DL I+++ +F+ +++ L+++H
Sbjct: 61 ----LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L + + +K+ DFG+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR-- 264
KY ++D WS G + E+L G+ F G+ E + N++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED---------------EDELFDSILNDRPHFP 216
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324
+++++ K LF++ P +++ F D E+ P FK K++
Sbjct: 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFK--PKVKS 274
Query: 325 EPSCQPISKLEFEFERRRVTKDDIRELI 352
+ EF E+ R++ D ++L+
Sbjct: 275 PSDASNFDR-EFTNEKVRLSPVD-KKLL 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY-------QMLR 137
+ ++ + IY++ E ME+ L +K T E + + Q+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ D T +W A
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKW-TA 171
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
PE + +T D+WS G + E++T G+ +PG
Sbjct: 172 PEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 35/214 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G GS+GVV + +G K VA+K + + +SD + L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ + ++L + +V EL L + + ++ + Q+ +
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCD--YAVQIANGM 110
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--- 196
+Y+ + HRDL +NIL ++ K+K+ DFGL R A D+ +
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN------EDHYVMEEHLKVP 163
Query: 197 ----APELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
APE ++ A D+W G E+ T
Sbjct: 164 FAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 31 IGKGSYGVVCAAI-DTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
I E + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSD-----TPMTVFWTDYVATRWYRAPELCG 202
HRDL +N+L K+ DFGL++ +D W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT 226
+++ K++ D+WS G + E +
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+VIGKGS+G V A H E+ A+++L++ +L+ I+ +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFY------------AVKVLQKKAILKKKEEKHIMSER 46
Query: 89 RIMLPPSKREF-----------KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
++L K F +Y V + + +L ++ +F+ ++
Sbjct: 47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 106
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T + + T Y
Sbjct: 107 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYL 163
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
APE+ Y +D W +G + E+L G P F ++ D I
Sbjct: 164 APEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y++++VIG+G++G V + + KV K+ FE I SD+ E ++
Sbjct: 42 AEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ + +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ HRD+KP N+L + + LK+ DFG + V V T Y +PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ S Y D WS+G E+L G F S+V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 20/125 (16%)
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ LT E + +Q+ R ++++ + HRDL +NIL + N +K+CDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPG 233
+PG
Sbjct: 274 SPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 30 VIGKGSYGVVCAA---IDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + D+F SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKRIML-PPSKREFKDIYVVFELME-SDLHQVIKAND------DLTREHHQFFLYQMLR 137
++ + L +K V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N + N N + V DFGL++ +S + +W
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
L + YT D+W+ G E++T G+ + G
Sbjct: 185 ESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 35/307 (11%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+Y IL + GS G VC +KV +K + + RE+ +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I I L + R + +V + DL + + L E ++L AL Y
Sbjct: 146 RAI-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGT-----PS 251
L Y DIWS G + E+ GK V QL I + P
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVP-LFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + ++ K +Y +R +P + +K+ ++D L+ +++ FD + RP+A++
Sbjct: 316 NGSTNLCKHFK--QYAIVLRPPYTIPPVIRKYGMHMD--VEYLIAKMLTFDQEFRPSAQD 371
Query: 310 ALADPYF 316
L+ P F
Sbjct: 372 ILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+P F G+
Sbjct: 175 --YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 31/228 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V V +K V+ A++IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKRIMLPPSKR-------EFKDIYVVFELME----SDLHQVI-KANDDLTREHHQFFL 132
E + +++ +R F+D ++ +M+ DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+M+ A+ +H HRD+KP N+L + N +++ DFG +D TV V T
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGT 166
Query: 193 RWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
Y +PE+ + +Y P D WS+G E+L G+ F +S+V
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
LT E + +Q+ + ++++ + HRDL +NIL + N +K+CDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPG 233
P V D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 112 DLHQVIKANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL++ IK +EH F YQ++ AL +H+ + HRDLK NI
Sbjct: 151 DLNKQIKQR---LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
+K+ DFG ++ +SD+ + + T +Y APEL +Y+ D+WS+G I E+
Sbjct: 208 IKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYEL 264
Query: 225 LTGKPLFPGKSVVHQLDLITDLL-GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
LT F G S Q +++ +L G P V KA
Sbjct: 265 LTLHRPFKGPS---QREIMQQVLYGKYDPFPCPVSSGMKA-------------------- 301
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
LL L++ +P RPT ++ L + K +A + ++
Sbjct: 302 --------LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+++ L Y+ + + HRD+KP N+L N ++K+CDFG++ + T YV T
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNA 158
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
Y APE +Y D+WS+G F E+ G+ +P
Sbjct: 159 YMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + + +F+ +++
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPET 254
APE+ + Y + D +S+GC+ ++L G F H++D +T + P++
Sbjct: 163 APEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 255 IA 256
+
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 17/238 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ ++V+G G++G V + GEK VAIK + + ++ IL E ++ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASV 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR 137
HP +V + I L + ++ +LM L V D++ ++ + Q+ +
Sbjct: 67 DHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +K+ DFGLA++ D V +W A
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-A 179
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
E YT D+WS G E++T G + G V DL+ P P
Sbjct: 180 LESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK-----VAIKKIHDVFE-HISDAIRILREVKLLRLL 79
+ LE +G+G++G V T E+ VAIK + + E + R +E +L+ L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--QEAELMSDL 65
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQ----------VIKANDDLTREH- 127
+HP+IV + + + + ++FE + DLH+ V + D T +
Sbjct: 66 QHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 128 --HQFFL---YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182
FL Q+ ++Y+ + + HRDL +N L +K+ DFGL+R +S
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
V + RW PE + K+T DIWS G + E+
Sbjct: 181 RVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 51 VAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108
VA+K + D SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 109 ME-SDLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154
M+ DL++ ++A+ +LT+ Q+ + Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
+N L N +K+ DFG++R +S V + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 215 WSIGCIFAEVLT 226
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 94 PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMHTANVYHRD 151
P+K + + ++ D+ I D+L + F YQ+ + + ++ + N HRD
Sbjct: 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239
Query: 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPA 211
L +NIL K+CDFGLAR +D+ V + +W APE F YT
Sbjct: 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFE 296
Query: 212 IDIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDA-IRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E A IR R++ L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI-----LVE 57
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
D + ++ S ++ +++Y++ E + D+ ++ D L+ E QF++ + + A+
Sbjct: 58 ADGAWVVKMFY--SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF----SDTPMTVF---- 185
+H HRD+KP N+L +A +K+ DFGL R F + P + F
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 186 ---------WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I + + + + E ++ + HP
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + L P+ I +V +LM L V + D++ + + Q+ + +
Sbjct: 70 HLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L + +K+ DFGLAR+ D + +W L
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---AL 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+ K+T D+WS G E++T GKP
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLL-RHPDIVE 86
+V+GKGS+G V A GE A+K + I D + + E ++L L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 87 IKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ + K+ ++ V E + DL H K DL R F+ +++ L+++
Sbjct: 61 LY------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRA--TFYAAEIVCGLQFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPELC 201
H+ + +RDLK N++ + + +K+ DFG+ + F D + F T Y APE+
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEIL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KYT ++D WS G + E+L G+ F G
Sbjct: 169 QGL--KYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A + TG A K I E + D + E+++L HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV---EIEILATCNHPY 70
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
IV++ K ++++ E I D LT Q QML AL+Y
Sbjct: 71 IVKLLGAFYWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + HRDLK N+L + +K+ DFG V+ + ++ T ++ APE+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 202 GSFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
K TP DIWS+G E+ +P
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + +F+ +++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLIT-----DLLGT 249
APE+ + Y + D +S+GC+ ++L G F H++D +T +L +
Sbjct: 163 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 250 PSPE 253
SPE
Sbjct: 222 FSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 38/123 (30%), Positives = 57/123 (46%), Gaps = 22/123 (17%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F YQ+ ++++ + N HRDL +N+L +K+CDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 251 SPE 253
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTR 125
L+E+K++ L+ P+I+ + + + + ++ E ME+ DL+Q + + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHHQFFLYQMLR--------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Y L +KY+ + N HRDL +N L N +K+ DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
S + + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 51/246 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHIS-DAIRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E IR R++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI-------- 54
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
+VE + + F+D +Y++ E + D+ ++ D LT E QF++ + +
Sbjct: 55 --LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF---------SDTP 181
A+ +H HRD+KP N+L ++ +K+ DFGL R F SD
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 182 MTVFWTDYVATRWYR----------------APELCGSFFSKYTPAIDIWSIGCIFAEVL 225
+ A W R APE+ + Y D WS+G I E+L
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 226 TGKPLF 231
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 48/220 (21%), Positives = 90/220 (40%), Gaps = 21/220 (9%)
Query: 29 EVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDI 84
+++G+G +G V D + KVA+K + D+ + S+ L E ++ HP++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNV 63
Query: 85 VEIKRIMLPPSKRE-FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML------ 136
+++ + S + V+ M+ DLH + + + Q L
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVD 121
Query: 137 --RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++Y+ N HRDL +N + + + V DFGL++ +S + +W
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
L YT D+W+ G E+ T G+ +PG
Sbjct: 182 IAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 19/226 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRH 81
++ +++I G+YG V T ++ A+KKI+ + + I ++ E +L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P +V + S + + +V E +E D ++K L + + + + + AL+
Sbjct: 61 PFVVS-----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--TRWYRAP 198
Y+H + HRDLKP N+L + +K+ DFGL+++ T + ++ TR +
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDK 174
Query: 199 ELCGS---------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
++CG+ Y +D W++G I E L G F G +
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 63/251 (25%), Positives = 117/251 (46%), Gaps = 20/251 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA- 145
K S + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLK +N++ + + +K+ DFGL + D M F T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF----CGTPEYLAPEVLED- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y A+D W +G + E++ G+ F + +LI + P T++ +A+
Sbjct: 171 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFPRTLS----PEAK 224
Query: 265 KYLTEMRKKPP 275
L+ + KK P
Sbjct: 225 SLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + DV D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
L + + ++++ V E + DL I++ F+ +++ L+++H+
Sbjct: 61 -----LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK NIL + + +K+ DFG+ + T + T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEIL--LG 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KY ++D WS G + E+L G+ F G
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 55/245 (22%)
Query: 24 RYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIH-DVFEHISDAIRILREVKLLR 77
R + + +G+G++G V A +D VA+K + D E D ++ E+++++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMK 70
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAN--------------- 120
++ +H +I+ +L +E +YVV E +L ++A
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ LT++ F YQ+ R ++++ + HRDL +N+L + +K+ DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 180 TPMTVFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GK 228
+ DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 229 PLFPG 233
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 72/316 (22%), Positives = 134/316 (42%), Gaps = 63/316 (19%)
Query: 23 NRYKILEVIGKGSYGVV--CAAID------------THTGEKVAIKKIH-DVFEHISDAI 67
+ ++ E +G+G +G V C A VA+K + DV + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-- 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--------- 117
L+E+K++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTF 117
Query: 118 -KAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
AN+ ++ + + Q+ +KY+ + N HRDL +N L + +K+ DFG++R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+S + + RW + K+T A D+W+ G E+ T P
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFTLCKEQP-Y 233
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKP--PVPLFQKFPNVDPLALRL 292
S++ +I + T RN+ + YL++ P P P+F+ L
Sbjct: 234 SLLSDEQVIEN--------TGEFFRNQGRQIYLSQ---TPLCPSPVFK-----------L 271
Query: 293 LQRLIAFDPKDRPTAE 308
+ R + D KDRPT
Sbjct: 272 MMRCWSRDIKDRPTFN 287
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 74/306 (24%), Positives = 127/306 (41%), Gaps = 51/306 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +++ L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-ALNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + + +++ D GLA P V T Y AP
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W++GC+ E++ G+ F +
Sbjct: 171 EVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQR------------------------ 204
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + R+ + + K+ +KF P A L + L+ DPK+R A E
Sbjct: 205 KKKIKREEVERLVKEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261
Query: 314 PYFKGL 319
P FK +
Sbjct: 262 PLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDL R F Q+ + + ++ + N HRD+ +N+L K+CDFGLAR +D+
Sbjct: 212 DDLLR-----FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
V + +W APE F YT D+WS G + E+ + GK +PG V
Sbjct: 267 NYVVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 31 IGKGSYGVV----CAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V C + + VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND---------------DLTREHHQ 129
+ E + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
Q+ + Y+ + + HRDL +N L +K+ DFG++R +S V
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW PE + K+T DIWS G + E+ T GK + S ++ IT
Sbjct: 186 LPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L+ +G G +GVV G+ VAIK I E + E K++ L H +V
Sbjct: 8 FLKELGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT---REH-HQFFLYQMLR---- 137
++ + +K+ + IY+V E M +N L REH +F Q+L
Sbjct: 63 QLYGVC---TKQ--RPIYIVTEYM---------SNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ Y+ + HRDL +N L + +KV DFGL+R D + + + RW
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW 167
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
PE+ +SK++ D+W+ G + EV +
Sbjct: 168 -SPPEVL--LYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 48/294 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+ +G+G +G V KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKRIMLPPSKRE-FKDIYVVFELME-SDLHQVI---KANDD---LTREHHQFFLYQMLRA 138
+ + L + E + V+ M+ DLH + + D L + F+ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N N + V DFGL++ ++ + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VRNEKARKYLTEMR--KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V N + YL + K+PP L D L L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCL-------DGL-YSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F +Q+ R ++Y+ + HRDL +N+L K+K+ DFGL+R + + +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191
Query: 191 ATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+W A E S F YT D+WS G + E++T G P +PG
Sbjct: 192 PVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHPDIVEI 87
V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALNEKRILEKVNSRFVVSL 65
Query: 88 KRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYMH 143
E KD + +V +M DL H N + F+ ++ L+ +
Sbjct: 66 AYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLKP+NIL + +++ D GLA P V T Y APE+ +
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
KYT + D W +GC+ E++ G+ F
Sbjct: 176 --EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++I+ +G G++G V A + TG A K I E + + E+ +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALKYM 142
V+ +L E +++++ E + + LT + Q L AL Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK NIL + +K+ DFG V+ +T ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 203 SFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
SK P D+WS+G E+ +P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLLRHP 82
+ +++VIG+G++G V + + A+K + FE I SD+ E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV++ K +Y+V E M + +N D+ + +F+ +++ AL +
Sbjct: 104 WIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ HRD+KP N+L + + LK+ DFG + M T V T Y +PE+
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTA-VGTPDYISPEVLK 216
Query: 203 S--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
S Y D WS+G E+L G F S+V
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K + + + I ++ K + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
+ E + +V+ + DL ++ L EH +F+ ++ AL Y+H +
Sbjct: 62 HSCF----QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N+L ++ +K+ D+G+ + T + + T Y APE+
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--ED 172
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 31 IGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V A T VA+K + D ++ RE +LL L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN--------DDLTREHH-QFFLYQM 135
+ + + + +VFE M+ DL++ ++A+ D R+ + L QM
Sbjct: 71 KFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 136 LR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L + Y+ + + HRDL +N L AN +K+ DFG++R +S V
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 186 MLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V + A+K + H + I ++ K + + +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ +++V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A+ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
+Y ++D W++G + E++ G+ F D+ITD
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF---------DIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K I + + I ++ K + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
+GKG +G VCA +TG+ A KK+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 90 IMLPPSKREFKDIYVVFELME-SDL--HQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
SK + +V LM DL H L E + Q+ + ++H+ +
Sbjct: 61 AF--ESKTH---LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RD+KP+N+L + ++ D GLA V D T T Y APE+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPEILKE--E 169
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y+ +D +++GC E++ G+ F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 24 RY-KILEVIGKGSYGVVCA----AIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLL 76
RY K + V+G+G +G V + TGE VA+K K ++ S + E+ +L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINIL 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
+ L H +IV+ K S++ K + ++ E + S + K +L + F Q
Sbjct: 61 KTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLFAQQ 115
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------RVAFSDTPMTV 184
+ + Y+H+ + HRDL +N+L + + +K+ DFGLA RV D V
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGDSPV 174
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
FW A E K++ A D+WS G E+LT
Sbjct: 175 FWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR + +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+W APE F YT D+WS G + E+ T G P +PG V L+ +
Sbjct: 204 KWM-APE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 47/201 (23%)
Query: 51 VAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIVEIKRIML--PPSKREFKDIYVVF 106
VA+K + SD R L+EVK+L L P+I + + PP + ++
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIM 98
Query: 107 ELME-SDLHQVIKANDDLTREH--------HQFFLY---QMLRALKYMHTANVYHRDLKP 154
E ME DL+Q ++ + T LY Q+ ++Y+ + N HRDL
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--------VATRWYRAPELCGSFF- 205
+N L N +K+ DFG++R +S +DY + RW A E S
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYS--------SDYYRVQGRAPLPIRWM-AWE---SVLL 206
Query: 206 SKYTPAIDIWSIGCIFAEVLT 226
K+T D+W+ G E+LT
Sbjct: 207 GKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
IG G +G V + H G +V +K++ + + L+EV+ R L HP++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV--- 57
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR-----ALKY 141
+ E +V E DL +++N + + Q + Q + L +
Sbjct: 58 --LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD---YVATRWYRAP 198
+H A+ H DL +N A+ +K+ D+GL A P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 199 ELCGSFFS-----KYTPAIDIWSIGCIFAEVLT 226
EL T +IWS+G E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)
Query: 31 IGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPD 83
IG+G++G V A + VA+K + E S ++ RE L+ HP+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------------- 121
IV++ + K + ++FE M DL++ ++
Sbjct: 70 IVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 122 -DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ Q+ + Y+ HRDL +N L N +K+ DFGL+R +S
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 185 YYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+ KG Y + ID VAIK + + E S ++RE +++ L +P IV + +
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 91 MLPPSKREFKDIYVVFELMESD-LHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVY 148
E + + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 64 C------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 149 HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELCGSFF 205
HRDL +N+L K+ DFGL++ +D ++ A +W + APE F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN--F 172
Query: 206 SKYTPAIDIWSIGCIFAEVLT--GKP 229
K++ D+WS G E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 4/114 (3%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE F YT D+WS G + E+ T G +PG V L+ +
Sbjct: 201 KWM-APE--ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHD-----VFEHISDAIRILREVKLL 76
+ L+++G G +G V I G+ VAIK I D F+ I+D + +
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS---- 65
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
L H IV + I S + +V +L S L V + D L + + Q
Sbjct: 66 --LDHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + + Y+ + HR+L +NIL ++ +++ DFG+A + + D + +W
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
L F +YT D+WS G E+++
Sbjct: 178 M---ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 71/274 (25%), Positives = 109/274 (39%), Gaps = 52/274 (18%)
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-------ESDLHQVIKAN-DDL 123
E +LLR L HP ++ + D+ VV L SDL+ + A L
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPL 257
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG---LARVAFSDT 180
Q+L A+ Y+H + HRD+K +N+L N + + DFG AR ++S
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-- 315
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKS---- 235
T F T APE+ YTP++DIWS G IF + LF
Sbjct: 316 --TPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371
Query: 236 ---------VVHQLDLITDLLGT-PSPETIAVVRNEKARKYLTEMRKKPPV--PLFQKFP 283
++ Q + D ++ R+ AR ++P P + ++
Sbjct: 372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN------RRPAYTRPAWTRYY 425
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+D L+ R + FD RP+A E L P F+
Sbjct: 426 KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 55/239 (23%)
Query: 31 IGKGSYGVVCAA----IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--------DLTREHHQFF-- 131
+I+ + + +YV+ E + +L + ++A D+T+ +
Sbjct: 79 NIINLLGVCTQEGP-----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 132 ------LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR V
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVH 185
Query: 186 WTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
DY + +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 186 DIDYYKKTSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+EVK+L L+ P+I+ + + + + ++ E ME+ DL+Q + ++
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 121 -DDLTREHHQFFL--YQML--------RALKYMHTANVYHRDLKPKNILANANCKLKVCD 169
+D H Y L +KY+ + N HRDL +N L N +K+ D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
FG++R ++ + + RW A E K+T A D+W+ G E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 24/124 (19%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLD 241
+ +W APE + F + YT D+WS G + E+ T G P +PG V
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 253
Query: 242 LITD 245
L+ +
Sbjct: 254 LLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRH 81
+K ++V+G G++G V + GEKV I I ++ E S IL E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L V + D++ ++ + Q+ + +
Sbjct: 69 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+ + HRDL +N+L +K+ DFGLA++ +D V +W
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ YT D+WS G E++T
Sbjct: 183 I---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 51 VAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE- 107
VAIK + D+ + + +E L+ L HP+IV +L +E + + ++FE
Sbjct: 37 VAIKTLKDINNPQQWGE---FQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEY 88
Query: 108 LMESDLHQVI-----------KANDDLTREH---HQFFLY---QMLRALKYMHTANVYHR 150
L + DLH+ + +++D T + H FL+ Q+ ++Y+ + H+
Sbjct: 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
DL +NIL +K+ D GL+R +S V + RW PE + K++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSS 205
Query: 211 AIDIWSIGCIFAEVLT 226
DIWS G + E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 17/206 (8%)
Query: 31 IGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
IG G +G V+ + I T TG + K + L++ R+L+HP+I++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML----RALKYMHT 144
+ E +VFE E DL + R L +M + +MH
Sbjct: 63 QCV-----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N H DL +N ++ +KV D+G+ + + + V RW APEL G F
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEF 176
Query: 205 F-----SKYTPAIDIWSIGCIFAEVL 225
++ T ++W++G E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A+ G K+ AIK + + F +D E+++L +L HP+I+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNII 66
Query: 86 EIKRIMLPPSKREFKDIYVVFE----------LMESDLHQVIKANDDLTREH---HQFFL 132
+ + R + +Y+ E L +S +V++ + +EH
Sbjct: 67 NL---LGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTASTLTS 118
Query: 133 YQMLR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+L+ ++Y+ HRDL +N+L N K+ DFGL+R T+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM- 177
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 178 --GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-R 77
+ N K +VIG+G++G V A G ++ AIK++ + + D E+++L +
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCK 63
Query: 78 LLRHPDIVEIK-----------RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
L HP+I+ + I P D ++E+D I + T
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 127 HHQF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
Q F + R + Y+ HRDL +NIL N K+ DFGL+R T+
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 183 ---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 31 IGKGSYGVVC--AAID---THTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+G G++G V A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML------- 136
V++ + L + Y++ ELME DL ++ L ++L
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RALKYMHTANVYHRDLKPKNILA-----NANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+ Y+ + HRDL +N L +A+ +K+ DFGLAR + +
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
RW APE K+T D+WS G + E+LT G+ +P +
Sbjct: 177 VRWM-APE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDL-----HQVIKANDDLTREH---HQFFLYQMLR 137
+ + R + + + + + L +V++ + + Q+L
Sbjct: 60 NL---LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+ Y+ HRDL +NIL N K+ DFGL+R T+ +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 26 KILEVIGKGSYGVVCAA--IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ +E +G+ +G V T GE+ VAIK + D E E + L+
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQ 66
Query: 81 HPDIVEI-------KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT----REHHQ 129
HP+IV + + + + S D++ F +M S V +DD T E
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE-FLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 130 FF--LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
F + Q+ ++++ + +V H+DL +N+L +K+ D GL R ++ +
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW +PE + K++ DIWS G + EV +
Sbjct: 186 SLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I I + E+ S IL E ++ + P
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+ + I L + + +V +LM L V + D + + + Q+ + +
Sbjct: 70 YVCRLLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ + HRDL +N+L + +K+ DFGLAR+ D T + D V +W
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALE 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKSV 236
+ ++T D+WS G E++T KP P + +
Sbjct: 182 SI---LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 75/309 (24%)
Query: 30 VIGKGSYGVVCAA----IDTHTGEKVAIKKIHDVFEHISDAIRIL---REVKLLRLLRHP 82
+G+G +G V A I+ GE + + K + D RE+ + R L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---------LTREHHQFFL 132
++V + + RE + Y++ E + DL Q ++A L+ +
Sbjct: 69 NVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
Q+ + ++ A HRDL +N L ++ ++KV L++ ++ +Y
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--------EYYKL 175
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW APE ++ D+WS G + EV T G+ F G S
Sbjct: 176 RNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------- 223
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKD 303
E + ++ K P P L +L+ R A +PKD
Sbjct: 224 ------DEEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMTRCWAVNPKD 262
Query: 304 RPTAEEALA 312
RP+ E ++
Sbjct: 263 RPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 40/159 (25%), Positives = 79/159 (49%), Gaps = 19/159 (11%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
+ I++ I +G++G V + + A+K K + +++ ++ R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA--LALSKS 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQML 136
P IV L S + ++Y+V E + +S LH ++++ ++ ++
Sbjct: 64 PFIVH-----LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----KYISEVA 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
AL Y+H + HRDLKP N+L + +K+ DFGL++V
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRHPD 83
+GKG +G V A TG+ A KK++ +E RIL +V H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-----DLHQVIKANDDLTREHHQFFLYQMLRA 138
+ + L + + D+ +V +M ++ V + N F+ Q++
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V D Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
EL +Y ++D +++G E++ + F
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 32/104 (30%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---- 189
+M+ AL +H + RDL P NIL + +++ F W++
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR-------------WSEVEDSC 139
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 140 DGEAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 63/266 (23%), Positives = 102/266 (38%), Gaps = 75/266 (28%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
+ ++VIGKG++G V TG+ A+K + D H+ +L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFF 131
P +V + F+D ++ +ME DL ++ D + + +F+
Sbjct: 60 -----SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY 106
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA------------------ 173
+ + + A++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 174 -----------RVAFSDTPMTVFWTDYVATRW----------------YRAPELCGSFFS 206
VA +T+ D +AT W Y APE+ F
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQ 222
Query: 207 K-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ Y D WS+G I E L G P F
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 49/223 (21%), Positives = 84/223 (37%), Gaps = 39/223 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
D KI ++G G +G +C ++ IH + SD R L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML- 136
H +IV ++ ++ + + +V E M + A D R+H Q Q++
Sbjct: 63 FDHSNIVRLEGVITRGNT-----MMIVTEYMSNG------ALDSFLRKHEGQLVAGQLMG 111
Query: 137 ------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT------- 183
+KY+ H+ L +L N++ K+ F + S+ T
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
V W APE + ++ A D+WS G + EV++
Sbjct: 172 VLWA---------APEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 58/264 (21%), Positives = 101/264 (38%), Gaps = 73/264 (27%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
++ +G G++G VC A T A+K + ++V L + H V+
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRK------------KDVLLRNQVAH---VKA 50
Query: 88 KRIMLPPSKRE--------FKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
+R +L + E F+D +Y V + + D+ ++ + +F++ ++
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL V
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 180 TPMTVFWTD----------------------------YVATRWYRAPELCGSFFSKYTPA 211
+ W D V T Y APE+ + YT
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQL 228
Query: 212 IDIWSIGCIFAEVLTGKPLFPGKS 235
D WS+G I E+L G+P F ++
Sbjct: 229 CDWWSVGVILYEMLVGQPPFLAQT 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 57/252 (22%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLR-LLRHPDI 84
++ +G G++G VC A T A+K + DV A VK R +L D
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVA-----HVKAERDILAEADN 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ ++ ++ ++Y V + + D+ ++ + +F++ ++ A++ +H
Sbjct: 61 EWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL----------------ARVAFSDTPMTVFWT 187
HRD+KP NIL + + +K+ DFGL + + + W
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 188 D----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219
D V T Y APE+ YT D WS+G
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGV 236
Query: 220 IFAEVLTGKPLF 231
I E+L G+P F
Sbjct: 237 ILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 82/345 (23%), Positives = 130/345 (37%), Gaps = 90/345 (26%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHP 82
+ ++ IG G++G VC T A+K + DV + A + E +L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEADNE 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFEL-----MESDLHQVIKANDDLTREHHQFFLYQMLR 137
+V+ L S ++ ++Y V + M S L ++ +DL R F++ ++
Sbjct: 62 WVVK-----LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR----FYIAELTC 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL------------------ARVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL R +
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 180 TPMTVFWTD----------------------YVATRWYRAPELCGSFFSKYTPAIDIWSI 217
D V T Y APE+ + YT D WS+
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSV 230
Query: 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277
G I E+L G+P F L TP+ ET V N + T +
Sbjct: 231 GVILYEMLVGQPPF--------------LADTPA-ETQLKVINWE-----TTLHIPSQA- 269
Query: 278 LFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+ A L+ RL +DR A+E A P+FKG+
Sbjct: 270 ------KLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 36/119 (30%), Positives = 62/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDF 170
DL ++K L+ + + Q++ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
GL ++ TP Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLL 79
R + +++ +G++G + I E+V +K + D I +L+E LL L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT-LLLQESCLLYGL 65
Query: 80 RHPDIVEIKR----------IMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
H +I+ I ++ P + K L E++ Q + T++
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS-----TQQLV 120
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ Q+ + Y+H V H+D+ +N + + ++K+ D L+R F + +
Sbjct: 121 HMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+W L +S A D+WS G + E++T
Sbjct: 180 NRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 60/224 (26%)
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLA---RVAFSDTPMTV 184
Q + Q+L AL +H+ + HRD+KP+NI+ + + K+ D G A RV + P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 222
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY-LTEMRK----KPPVP 277
++ FP L +D I R K Y L RK +
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 278 LFQKFPNVD---PLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
L + F +D LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 50/247 (20%)
Query: 27 ILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G G++G V + +VA+K + + D L E ++ H
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR--- 137
+IV + + R +++ ELM DL ++ N + +L
Sbjct: 69 QNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 138 ----ALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTD 188
KY+ + HRD+ +N L CK K+ DFG+AR ++
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCL--LTCKGPGRVAKIADFGMAR--------DIYRAS 173
Query: 189 Y--------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237
Y + +W PE L G F SK D+WS G + E+ + G +PG++
Sbjct: 174 YYRKGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 238 HQLDLIT 244
++ +T
Sbjct: 229 EVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 27 ILEVIGKGSYGVVCAAI--DTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G+GS+G+V D GE +VA+K +++ + + I L E +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTC 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA------NDDLTREHHQFFLYQ 134
+V R++ SK + VV ELM DL +++ N+ + Q
Sbjct: 69 HHVV---RLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 135 MLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
M + Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 175
Query: 190 -------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ + D+WS G + E+ +
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 81/342 (23%), Positives = 131/342 (38%), Gaps = 64/342 (18%)
Query: 26 KILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHP 82
++L VIG+G V A TGE V +++I ++ ++ + L+ E+ + +L HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI-NLEACTNEMVTFLQGELHVSKLFNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+IV + + + +++VV M DL D ++ + L +L+A
Sbjct: 60 NIVPYRATFIADN-----ELWVVTSFMAYGSAKDL-ICTHFMDGMSELAIAYILQGVLKA 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS------------DTPMTVFW 186
L Y+H HR +K +IL + + KV GL R S D P
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDG--KVYLSGL-RSNLSMINHGQRLRVVHDFPKYS-- 168
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
V + +PE+ Y DI+S+G E+ G P K + L+ L
Sbjct: 169 ---VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKL 223
Query: 247 LGT----------PSPETIAVVRNEKARKYLTEMR----------KKPPVPLFQKF-PNV 285
GT P+ E A L E + P + F P+
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF 283
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ LQR +P RP+A L +FK +I+R S
Sbjct: 284 HHFVEQCLQR----NPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 48/220 (21%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 31 IGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+GS+G+V I +VAIK +++ + + I L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA-NDDLTREHHQFF--LYQMLR---- 137
+ ++ + + V+ ELM DL +++ ++ Q L +M++
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY----- 189
+ Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 78/332 (23%), Positives = 131/332 (39%), Gaps = 70/332 (21%)
Query: 31 IGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHPDIVEI 87
IG+G + V A T TG V ++ I D+ + ++ L+ EV L RHP+I+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALK 140
+ S ++V+ M + ++K ++ L L+ LR L
Sbjct: 65 WTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLN 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGL------------ARVAFSDTPMTVFWTD 188
Y+H HR++K +IL + + + + GL A+V + D P F T
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ--FSTS 170
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
+ W +PEL Y DI+S+G E+ TG+ P + ++ L+ L G
Sbjct: 171 VLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKG 225
Query: 249 TP-SPETIAVVRNEKAR----------------------KYLTEMRKKPPVPLFQKFPNV 285
P SP I E++R + +T R + P
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSS-----KTF 280
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P L++ + DP+ RP+A L+ +FK
Sbjct: 281 SPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 16/42 (38%), Positives = 28/42 (66%)
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ Q+L L+ +H + HRD+KP+N+L + ++K+ DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 28/203 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
VI +G G G + +K+I+DV ++I E+ + L+HP+IV++
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIP-SSEIADMGKLQHPNIVKLIG 750
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TA 145
+ R K Y++ E +E +L +V++ +L+ E + + +AL+++H +
Sbjct: 751 LC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
V +L P+ I+ + + + L + +DT + + Y APE +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAPETRET-- 852
Query: 206 SKYTPAIDIWSIGCIFAEVLTGK 228
T DI+ G I E+LTGK
Sbjct: 853 KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 31 IGKGSYG-VVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
IG G +G V+ +++ +T +V +K++ V + + ++ L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLH---QVIKANDDLTREHH--QFFLYQMLRALKYM 142
E +V E DL + + + +T + Q ++ L ++
Sbjct: 62 GQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H N H DL +N L A+ +K+ D+GL+ + + +V RW APEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVD 175
Query: 203 SFFSKY-----TPAIDIWSIGCIFAEVL 225
T ++WS+G E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.14 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.99 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.52 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.71 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.43 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.03 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.8 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.52 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.87 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.35 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.34 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 95.12 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.11 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.94 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.77 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.74 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.7 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-81 Score=566.05 Aligned_cols=342 Identities=57% Similarity=0.976 Sum_probs=323.2
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..+....+|..++.||+|+||+|+.|.++.||+.||||++.+.|.+...+++.+||+++|+.++|+||+.+.+++.++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 35567778888999999999999999999999999999999999999999999999999999999999999999998777
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.++++|+|+|+|+.+|.++|++++.+++.+++.+++||++||+|+||.||+||||||+|+|++.++.+||||||+||..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 88999999999999999999999988999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... ....++++++.|+||+|||++... ..|+.++||||+||||+||++|++.|+|.+..+|+..|..++|+|+++.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 655 566778999999999999998764 889999999999999999999999999999999999999999999999999
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.+.++.++.++.+++..++.++...|+++++.|.||+++||.+||.+|+|++|+|.||||..++++++||.+++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998876433
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCcchh
Q 015019 337 EFERRRVTKDDIRELIYREILEYHPQLL 364 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 364 (414)
++.. .+.++|++++++|+..++|...
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 4444 8899999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-68 Score=466.57 Aligned_cols=288 Identities=38% Similarity=0.714 Sum_probs=252.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+++|+.+.++|+|+||+|++|+++.||+.||||++.....+..-.+-.+|||++|++++|||+|.++++| .....
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrk 75 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRK 75 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhcce
Confidence 4689999999999999999999999999999999987666666667789999999999999999999999 55567
Q ss_pred EEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|+|||+.++.+.+... ..++++.++.+++|++.|++|||+++++||||||+|||++.+|.+||||||+|+.....
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 9999999998877777664 57999999999999999999999999999999999999999999999999999987542
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
...+++|+.|+||+|||++.+. ..|+.++||||+||++.||++|.++|+|.++.+|+..|...+|...+.....+..
T Consensus 155 --gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 155 --GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred --cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 3346999999999999998774 7899999999999999999999999999999999999999999998887655443
Q ss_pred HHHHHHHHHhc---CCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 261 EKARKYLTEMR---KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 261 ~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.. ++..+. ...+.++...+++++..+.||++.||+.||.+|++.+|+|.||||.++.+
T Consensus 232 N~---~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 232 NP---FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CC---ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 21 111111 22344567778999999999999999999999999999999999987654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-65 Score=443.94 Aligned_cols=286 Identities=42% Similarity=0.698 Sum_probs=251.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.||...+.||+|.||+||+|+|..||+.||||+++............+|||+.|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 589999999999999999999999999999999986544444455688999999999999999999999 444569
Q ss_pred EEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
.||+|||+.+|..+|+.. ..++..+++.|+.++++||+|||++.|+||||||.|+|++++|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 999999999999999875 4799999999999999999999999999999999999999999999999999998765443
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
. .+..+.|+||+|||++.+. ..|+..+||||+|||++||+.|.|.|+|.++.+|+..|...+|+|.++.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2445899999999998875 78999999999999999999999999999999999999999999999988765542
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
. .|.+ +...+..+....|+..+.++.||+.+||.+||.+|+||.|+|+|+||++..
T Consensus 233 p--dY~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 233 P--DYVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred c--cHHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 2 1211 223444555668999999999999999999999999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-65 Score=476.94 Aligned_cols=292 Identities=38% Similarity=0.655 Sum_probs=256.8
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 96 (414)
....++||.++++||.|.||.||+|..+.+|+.||||++++.+....+ ..-+||++.|++|+ ||||+++.+++.+.
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~-- 81 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDN-- 81 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhcc--
Confidence 345678999999999999999999999999999999999987666443 34569999999998 99999999999432
Q ss_pred CCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+.+|+|||||+.+|.++++.+ ..+++..++.|++||++||+|+|.+|+.|||+||+|||+..+..|||+|||+||.
T Consensus 82 --~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 82 --DRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred --CceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 2389999999999999999875 4799999999999999999999999999999999999999998999999999998
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..+.. .+++|+.|+||+|||++++. ..|+.++||||+|||++|+.+-+++|+|.+..+++.+|.+++|+|....+
T Consensus 160 v~Skp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 160 VRSKP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccCC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 75544 46899999999999998774 78999999999999999999999999999999999999999999998776
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
... ...+...--.++...+.++...++++++++.+||.+||.+||++||||+|+|+||||+.-.
T Consensus 235 ~eg-~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 235 PEG-YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred hhH-HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 543 1122222224556677788888899999999999999999999999999999999998643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-64 Score=450.33 Aligned_cols=297 Identities=39% Similarity=0.609 Sum_probs=257.1
Q ss_pred ccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 16 ~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
+..+...+.|+.+..|++|.||+||+|+|+.|++.||+|+++........-...+|||.+|.+++|||||.+.+++....
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 34555667899999999999999999999999999999999865544444556789999999999999999999997643
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 96 KREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+.+|||||||+.||..++...+ ++...++++++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+||
T Consensus 149 ---~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 149 ---MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred ---cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence 35699999999999999998754 89999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
.+.... ..++..+.|.||+|||++++. ..|+.++||||+|||++||++++|.|+|.+..+|+++|.+++|+|+...
T Consensus 226 ~ygsp~---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 226 EYGSPL---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred hhcCCc---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 886542 235788999999999999885 7899999999999999999999999999999999999999999999998
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCC--CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
+..+..-.+.+.+ .+...+...+...|+. ++..+.||++.+|.+||.+|.||+|+|+|.||....
T Consensus 302 wpg~~~lp~~k~~-~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 302 WPGYSELPAVKKM-TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred CCCccccchhhcc-ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 8776654433321 1223333445555555 459999999999999999999999999999998743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-63 Score=465.65 Aligned_cols=287 Identities=37% Similarity=0.626 Sum_probs=249.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+.|+.+++||+|.||.||+|++..||+.||+|++..............|||.||++|+||||++|.++.... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 4679999999999999999999999999999999987655666677788999999999999999999998654 2357
Q ss_pred EEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|||+|||+.||.-++... -.|++.+++++|+||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9999999999999998874 389999999999999999999999999999999999999999999999999999775544
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
.. .++..+.|.||+|||++++. ..|+.++|+||+||||.||++|++.|+|.+..+|+..|.+++|.|.+..|....-
T Consensus 273 ~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred Cc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 32 36888999999999999885 7899999999999999999999999999999999999999999999988762221
Q ss_pred HHHHHHHHHhcCCC--CCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 261 EKARKYLTEMRKKP--PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 261 ~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
..+.. +.... ..-+.+.+..+++.+.+|+..||..||.+|.||.++|+|+||..
T Consensus 350 P~~~~----~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 350 PHATI----FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred Ccccc----cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 11111 11111 11234457789999999999999999999999999999999954
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-63 Score=456.55 Aligned_cols=263 Identities=33% Similarity=0.548 Sum_probs=222.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh-----HHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++++..... .....+.+|+++|++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 4467999999999999999999999999999999998643322 2234567999999999999999999999
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CCeEEeecC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFG 171 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~vkL~DFG 171 (414)
+.....||||||++ |+|++.+..++.+.+...+.+++|++.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 44456799999999 6999999999999999999999999999999999999999999999999876 889999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCC-CcchhhhHhHHHHHHHhCCCCCCCCChhh-HHHHHHHhcCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGT 249 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 249 (414)
+|+.... ..++.+.|||+.|.|||++.+....+. .++||||||||||.+++|.+||++..... ..++|.+..-.
T Consensus 325 lAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 325 LAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred hhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 9998653 346688999999999999976433344 48999999999999999999998876544 33444321111
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
--...|..+|.++++||.+||.+||++|||++++|+||||+..
T Consensus 401 ---------------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 401 ---------------------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ---------------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 1113456899999999999999999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-61 Score=463.46 Aligned_cols=338 Identities=89% Similarity=1.434 Sum_probs=303.6
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||+|+||.||+|++..++..||||++...........++.+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976545555566788999999999999999999998766555566799
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
+|||||+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654333323
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
......+||+.|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+....|.|....+..+.+...
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 33456789999999999865335789999999999999999999999999999999999999999999998888888888
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhhhccC
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (414)
..++..+....+.++...++.+++.+.+||.+||+.||++|||++++|+||||+++......+...+++..++.++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88888888777777777788899999999999999999999999999999999999888888888899999999999999
Q ss_pred CHHHHHHHHHHHHHHhCc
Q 015019 344 TKDDIRELIYREILEYHP 361 (414)
Q Consensus 344 ~~~~~~~~~~~e~~~~~~ 361 (414)
+.++.+..++++++.|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-60 Score=456.79 Aligned_cols=256 Identities=32% Similarity=0.564 Sum_probs=231.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+|+.++.||+|||+.||.+++..+|+.||+|++.+. .......+++.+||+|.+.|+|||||+++++| ++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 6899999999999999999999999999999999753 23456677899999999999999999999999 67778
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|||.|+|. ++|..+++.++.++|.+++++++||+.||.|||+.+|+|||||..|++++++..|||+|||+|.......
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 8999999999999999999999999999999999999999999999999999999999999998875443
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
... .+.||||.|.|||++.. ..++..+||||+|||||.||.|+|||...+-.+.+..|....
T Consensus 173 Erk---~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------------- 234 (592)
T KOG0575|consen 173 ERK---KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------------- 234 (592)
T ss_pred ccc---ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-------------
Confidence 332 57899999999999987 799999999999999999999999999999888888875311
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+.....+|.+|.|||.+||+.||.+|||++++|.|+||..-
T Consensus 235 ------------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 235 ------------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ------------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 12224789999999999999999999999999999999543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-60 Score=431.23 Aligned_cols=285 Identities=38% Similarity=0.657 Sum_probs=245.8
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.|.-.+.+|+|+||+||+|....+++.||||++-.... --.+|+++|+.++|||||++.-+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 68999999999999999999999999999999753211 123799999999999999999998766543344677
Q ss_pred EEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCcccccC
Q 015019 104 VVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFS 178 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a~~~~~ 178 (414)
+|||||+.+|.++++. +..++.-+++-+++||++||+|||+.|||||||||+|+|+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999999984 5789999999999999999999999999999999999999976 9999999999998776
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
+.+. ..|..|+.|+|||++.+. ..|+.++||||.||+++||+-|++.|+|.+..+|+..|.+.+|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6554 567899999999999885 78999999999999999999999999999999999999999999999999877
Q ss_pred ccHHHHHHHHHhcCCCCCCccC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
.......- .++....++.. .....++++.||+.++|+++|.+|.|+.|+|.||||+.+.++
T Consensus 254 n~~y~~~~---~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFK---FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred Cccccccc---CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 65432111 12222223222 446789999999999999999999999999999999998766
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-59 Score=424.29 Aligned_cols=293 Identities=39% Similarity=0.658 Sum_probs=249.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC-ccccceeecCCCC-CCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSK-REF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~-~~~ 99 (414)
...|..+++||+|+||+||+|+++.+|+.||+|++.-.......-....||+.+|+.++|+| |+.+++++..... +..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688899999999999999999999999999999865443333345679999999999999 9999999976542 234
Q ss_pred ceEEEEEecCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 100 KDIYVVFELMESDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~----~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..+|+|+||+..+|..++.... .++...++.+++||+.||+|||+.||+||||||+|||++++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 4799999999999999998754 588899999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..-.. ..++..++|.||+|||++.+. ..|+..+||||+|||++||+++++.|+|.+..+++..|.+++|+|+.+.|
T Consensus 170 ~~ip~---~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPM---RTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCc---ccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 53222 235778999999999999885 57999999999999999999999999999999999999999999999887
Q ss_pred HhhccHHHHHHHHHhcCCC-CCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKP-PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.....-...+. ...... +.++....+..++.+.||+.+||+.+|.+|.||..+|.||||....
T Consensus 246 p~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 65443211111 222222 4555666677788999999999999999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-59 Score=421.83 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=228.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+.|+++++||+|+||+|++++.+.|++.||+|++++..- ...+...+.+|..||..++||+||+++-.| ++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence 5689999999999999999999999999999999986533 234667789999999999999999999998 5556
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|||+||+. |+|+..++..+.++|..++.++..|+.||.|||++||+||||||+|||++.+|.++|+|||+|+.....
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 7999999999 599999999999999999999999999999999999999999999999999999999999999865444
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
...+ .++|||+.|||||++.+ .+|+.++|+||||+++|+|++|.+||.+.+.....+.|...-
T Consensus 179 ~~~t---~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------ 241 (357)
T KOG0598|consen 179 GDAT---RTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------ 241 (357)
T ss_pred CCcc---ccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------------
Confidence 3322 46899999999999998 799999999999999999999999999999887777775321
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCC-CChHHHHHHHHhccCCCCCCC----CHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dp~~Rp----t~~~lL~hp~~~~~ 319 (414)
. ...+. ++.+++|||+++|+.||++|. ++.++-+||||.++
T Consensus 242 ------------------~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 242 ------------------L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ------------------C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 0 11233 899999999999999999996 68999999999876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-58 Score=418.10 Aligned_cols=259 Identities=27% Similarity=0.476 Sum_probs=221.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.+.+.++.||+|+.|+||+|+|+.|++.+|+|++... ......+++.+|+++++.++|||||++|++|+.... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 3678899999999999999999999999999999532 445667789999999999999999999999965431 59
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+ |+|.++++..++++|.....+++++++||.|||. .+|+||||||+|||++.+|.|||||||.++.....
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 7999999988999999999999999999999995 89999999999999999999999999999876544
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC--ChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
...+++||..|||||.+.+ ..|+.++||||||+.+.||++|+.||... +..+.+..+..++..|++.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~----- 301 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR----- 301 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-----
Confidence 3367899999999999998 79999999999999999999999999774 2222333332222222211
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCC-CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
... .+|+++++||..||+.||.+|||+.|+|+|||++...
T Consensus 302 ----------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 302 ----------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ----------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 112 4899999999999999999999999999999998653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-58 Score=409.92 Aligned_cols=333 Identities=37% Similarity=0.661 Sum_probs=288.0
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-CC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KR 97 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~ 97 (414)
+.+..||.-+..+|.|+- .|..|.|..+++.||+|++..++.+...+++..+|+.++..++|+||++++.+|.+.. .+
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 355689999999999998 8999999999999999999988888888999999999999999999999999998753 34
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
++..+|+|||+|..+|.+.+. -.+....+.++++|++.|++|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 577899999999999999998 458889999999999999999999999999999999999999999999999998653
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ..+++++.|++|+|||++.+ ..|...+||||+|||+.||++|+..|+|.+..+|..+|.+.+|+|.+..+..
T Consensus 170 ~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 170 TD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 32 35689999999999999998 5699999999999999999999999999999999999999999999998776
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCC------------CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (414)
... .++.++...++.....+...+|+ -+..++||+.+||..||++|.+++++|+||||+- +-..++
T Consensus 244 L~~-~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v-w~~~~e 321 (369)
T KOG0665|consen 244 LQP-TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV-WYDPDE 321 (369)
T ss_pred hhH-HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee-eccccc
Confidence 543 34555555444444444444432 2467899999999999999999999999999994 444556
Q ss_pred CCCCCCccchhhhhhccCCHHHHHHHHHHHHHHhCcc
Q 015019 326 PSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 362 (414)
+..+++...+..++.+..+.++|+++|++|+.+|.+.
T Consensus 322 v~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~ 358 (369)
T KOG0665|consen 322 VEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF 358 (369)
T ss_pred ccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence 6665555667778888889999999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-57 Score=424.56 Aligned_cols=261 Identities=30% Similarity=0.520 Sum_probs=228.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
..+|.+++.||.|+|++|++|+++.+++.||||++.+..-. ....+-+.+|-.+|..| .||.|++|+-.| .+.
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ecc
Confidence 46899999999999999999999999999999999764322 12233356888999999 799999999999 455
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+|+||+. |+|+++|+..+.|++..+++++.||+.||+|||++|||||||||+|||+++||++||+|||.|+....
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 57999999999 89999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCc----------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 179 DTPM----------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 179 ~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
.... ......+|||..|++||++.. ...++.+|||+||||+|.|+.|.|||.+.+....+.+|+++.-
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 2111 111256899999999999988 7889999999999999999999999999999988888876533
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.. .+++++.+.|||+++|..||.+|+|++||-+||||.++.
T Consensus 305 ~f-------------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 305 EF-------------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred cC-------------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 22 246789999999999999999999999999999998763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-56 Score=406.70 Aligned_cols=259 Identities=32% Similarity=0.488 Sum_probs=223.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+........+.+..|+.+|+.++|||||.++++.. ..+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCC
Confidence 457899999999999999999999999999999999876556667777889999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC------CCeEEeecCCc
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN------CKLKVCDFGLA 173 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~------~~vkL~DFG~a 173 (414)
.+|||||||+ |||.++|+..+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 7999999999 7999999999999999999999999999999999999999999999999865 35899999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
+...... ...+.||++.|||||++.. +.|+.++|+||+|+|+|+|++|++||...+..+.+..+.+.....
T Consensus 163 R~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~--- 233 (429)
T KOG0595|consen 163 RFLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV--- 233 (429)
T ss_pred hhCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc---
Confidence 9875332 3467899999999999976 799999999999999999999999999988776665443211100
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
+ .....++....+|+..+|+.+|..|.+..+-+.|+++..
T Consensus 234 ---------------------~----~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 234 ---------------------P----VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ---------------------C----chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 0 001235667789999999999999999999999999875
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=426.05 Aligned_cols=283 Identities=37% Similarity=0.638 Sum_probs=236.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-C-----CCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-H-----PDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~ 95 (414)
..||.|++.||+|+||.|.+|.|..|++.||||++++. .....+...|+.+|..|+ | -|+|+++++|+.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-- 259 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-- 259 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--
Confidence 34899999999999999999999999999999999853 455566778999999997 4 389999999954
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC--CCCeEEeecC
Q 015019 96 KREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFG 171 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~--~~~vkL~DFG 171 (414)
.+++|||+|+++.+|.++++.+. .++...++.++.||+.||.+||+.||||+||||+|||+.. ...|||+|||
T Consensus 260 ---r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 260 ---RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ---ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 46799999999999999999864 7899999999999999999999999999999999999875 3579999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
.|+..... ...|+.++.|+|||++++ .+|+.+.||||||||++||++|.|+|+|.+..+|+..|++++|.|+
T Consensus 337 SSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 337 SSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99764322 237899999999999999 7999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhccHHHHHHHHH----------------------------hcCCCCCC-----ccCCCC-CCChHHHHHHHHhc
Q 015019 252 PETIAVVRNEKARKYLTE----------------------------MRKKPPVP-----LFQKFP-NVDPLALRLLQRLI 297 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~-----~~~~~~-~~s~~~~dli~~~L 297 (414)
+..+...... ..|++. .......+ +..... .....+.|||++||
T Consensus 409 ~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 409 PKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred HHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 9988754432 222222 11111111 111222 22345799999999
Q ss_pred cCCCCCCCCHHHHhcCCCCCccccC
Q 015019 298 AFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 298 ~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
++||.+|+|+.++|+||||......
T Consensus 487 ~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred ccCchhcCCHHHHhcCccccccccc
Confidence 9999999999999999999976543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-56 Score=389.85 Aligned_cols=253 Identities=26% Similarity=0.480 Sum_probs=226.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||.|+||.|.+++++.+|..||+|++++.. -...+.+...+|..+|+.+.||+++++++.+ .+.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence 57999999999999999999999999999999997532 2345566788999999999999999999988 55667
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||||||.+ |.|+.++++.+++++.++++++.||+.||+|||+++|++|||||+|||++.+|.+||+|||+|+.....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999 699999999999999999999999999999999999999999999999999999999999999875433
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
..+.||||.|+|||++.. .+|+.++|+|||||++|||+.|.+||.+.+.....++|.+.--
T Consensus 198 -----T~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v------------ 258 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV------------ 258 (355)
T ss_pred -----EEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc------------
Confidence 257799999999999988 8999999999999999999999999999998888888864211
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.-.+.++++++|||+++|++|-.+|. ...++-+||||+++
T Consensus 259 -------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 259 -------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred -------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 11246899999999999999999994 57899999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-57 Score=394.98 Aligned_cols=256 Identities=32% Similarity=0.487 Sum_probs=218.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
..|+|.++||+|+||.||++.+..+|..||.|.+.-...+....+.+..|+.+|++|+|||||++++.-.. ++..-+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 46999999999999999999999999999999998555566667779999999999999999999883222 223348
Q ss_pred EEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 103 YVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT--AN--VYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs--~g--ivHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
+||||||+ |||.++|+. ...++|..++.++.|++.||.+||+ .+ |+||||||.||+++.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999 899999964 4579999999999999999999999 45 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
+...+. ..+..+++|||+||+||++.+ .+|+.++|||||||++|||+.-++||.|.+......+|....-.|-+.
T Consensus 176 r~l~s~---~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 176 RFLSSK---TTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhcch---hHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 987544 334578999999999999988 899999999999999999999999999998777777775532222211
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
...|..+..||..|+.+||+.||+. +|++..+.
T Consensus 251 -----------------------------~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 251 -----------------------------EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred -----------------------------HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 2468889999999999999999986 66665544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-55 Score=418.23 Aligned_cols=257 Identities=32% Similarity=0.525 Sum_probs=220.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC---hHHHHHHHHHHHHHHhCC-CCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 96 (414)
..++|.+++.||+|+||+|+.|.+..++..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 457999999999999999999999999999999987653111 134556779999999998 99999999999544
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a~ 174 (414)
.++|+|||||. |+|++.+...++++|.+++.+++||+.||+|||+.||+||||||+|||++.+ +.+||+|||++.
T Consensus 93 ---~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 ---TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred ---CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 45999999999 5999999999999999999999999999999999999999999999999999 999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCC-CC-CcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~-~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
... .......+.|||+.|+|||++.+. . |+ .++||||+||+||.|++|+.||...+.......|.+.
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~~--~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~------ 238 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSGK--GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG------ 238 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCCC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC------
Confidence 763 123345788999999999999883 4 64 7899999999999999999999987766555554321
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCC-ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.......+ |+++.+||++||..||.+|+|+.+++.||||+.
T Consensus 239 -------------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 -------------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 01112234 999999999999999999999999999999986
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-54 Score=412.84 Aligned_cols=336 Identities=54% Similarity=0.985 Sum_probs=289.8
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++.+.||+|+||+||+|.+..++..||||.+............+.+|+.+++.++|+||+++++++........
T Consensus 2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45679999999999999999999999999999999987654444556677899999999999999999998866554455
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..+|+|+||++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 67999999999999999988889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. .......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+.......+....|.+.+..+....
T Consensus 162 ~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 162 G---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred c---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 1 122456789999999987652 358899999999999999999999999999888899999999999888887777
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhh
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (414)
......++.........++....+.+++.+.+||++||+.||.+|||++++|+||||..+......+..+. .+++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~ 315 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFE 315 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhh
Confidence 77777777766655555555556789999999999999999999999999999999999887777776654 3567777
Q ss_pred hccCCHHHHHHHHHHHHHHhCc
Q 015019 340 RRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
....+.+++++.++.|.+.|||
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 316 EDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhcCHHHHHHHHHHHHhhcCC
Confidence 7779999999999999999886
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=414.39 Aligned_cols=333 Identities=41% Similarity=0.798 Sum_probs=275.1
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.+.+.++|++++.||+|+||+||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3456789999999999999999999999999999999997654444555678899999999999999999998864322
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....+|+++|+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 23456899999999999887764 57999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... ...++||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+......
T Consensus 169 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred CCC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322 2456799999999998663 468999999999999999999999999999889999999999999888877
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.+.......++..+.......+...+...++.+.+||.+||+.||.+|||+.++|+||||.....+...+...+. ..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~ 318 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DE 318 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---cc
Confidence 777776677766665555544555566788899999999999999999999999999999987665544443332 22
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCc
Q 015019 337 EFERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
.......+.+++++..+.+..++.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07878 319 SPENKERTIEEWKELTYEEVSSFKP 343 (343)
T ss_pred chhhhhccHHHHHHHHHHHHHhcCC
Confidence 3334555668888888877766543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-55 Score=420.70 Aligned_cols=261 Identities=29% Similarity=0.496 Sum_probs=229.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+-|++++.||.|+.|.|.+|.+..||+.+|||++.+.. ........+.+||-||+.+.||||+.++++| ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 467999999999999999999999999999999998652 2334456788999999999999999999999 5667
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
++|+|.||+. |.|++++...+++++.+++.+++||+.|+.|||..+||||||||+|+|++..+.+||+|||+|.....+
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 8999999999 799999999999999999999999999999999999999999999999999999999999999875443
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. .+.+.||++.|+|||++.+. ...+.++||||.|||||.||+|+.||.+.+....+.++...
T Consensus 166 k----lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G------------- 227 (786)
T KOG0588|consen 166 K----LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG------------- 227 (786)
T ss_pred c----cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------------
Confidence 2 35788999999999999883 33467999999999999999999999988876666555431
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (414)
.++...++|++|+|||.+||.+||.+|+|.+|+++|||+.+.....
T Consensus 228 ------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 228 ------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 2233468999999999999999999999999999999998876543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-57 Score=385.28 Aligned_cols=260 Identities=30% Similarity=0.497 Sum_probs=227.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..+.|++.+.||+|+|++|+++.+..||+.+|+|++..........+.+.+|++|-+.|+||||+++++.+ .+..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 34679999999999999999999999999999999875444445777899999999999999999999988 4556
Q ss_pred eEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CCeEEeecCCcccc
Q 015019 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~vkL~DFG~a~~~ 176 (414)
..|||+|+|.| +|..-|..+.-++|..+..+++||+.||.|||.+||||||+||+|+|+-+. ..+||+|||+|...
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 78999999995 898888877789999999999999999999999999999999999998543 45999999999876
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.. ...+...+|||.|||||++.. .+|+.++|||+.|||||.|+.|.+||.+.+.....+.|....-..+
T Consensus 164 ~~----g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~----- 232 (355)
T KOG0033|consen 164 ND----GEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP----- 232 (355)
T ss_pred CC----ccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC-----
Confidence 52 223467899999999999988 8999999999999999999999999999888888887764322111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
...|+++++++++|+++||..||.+|+|+.++|+|||+.+
T Consensus 233 ----------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 233 ----------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----------------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 1246899999999999999999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=409.54 Aligned_cols=265 Identities=28% Similarity=0.460 Sum_probs=226.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|+++++||+|+||.||+|+.+.||+.||+|++++... ...+...++.|-.+|....+|+||+|+-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 34689999999999999999999999999999999987543 345567788999999999999999999999 566
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.++||||||++ ||+..+|...+.|+++++++++.+++.||..||+.|++||||||+|+||+..|++||+|||||.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 78999999999 69999999999999999999999999999999999999999999999999999999999999953211
Q ss_pred C--------------------C-Ccc-----------------------ccccccccCccccccccccccCCCCCCcchh
Q 015019 179 D--------------------T-PMT-----------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (414)
Q Consensus 179 ~--------------------~-~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 214 (414)
. . ... ......+|||.|+|||++.+ .+|+..+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 0 000 00124699999999999999 789999999
Q ss_pred hhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHH
Q 015019 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294 (414)
Q Consensus 215 wSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 294 (414)
|||||||||||.|.|||.+.+..+.+..|...-... .. ..-..++++|+|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------------------~f------P~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------------------KF------PEEVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------------------cC------CCcCcccHHHHHHHH
Confidence 999999999999999999999999888887532110 00 001356799999999
Q ss_pred HhccCCCCCCCC---HHHHhcCCCCCccc
Q 015019 295 RLIAFDPKDRPT---AEEALADPYFKGLA 320 (414)
Q Consensus 295 ~~L~~dp~~Rpt---~~~lL~hp~~~~~~ 320 (414)
+||. ||++|.. ++||-+||||+++.
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999 9999985 89999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=413.75 Aligned_cols=259 Identities=34% Similarity=0.577 Sum_probs=233.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+++|-+.+.||+|+||.||+|+.+.|.+.||||.+.+......+.+.+.+|++|++.++||||+.+++.| +...+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~ 75 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAH 75 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccce
Confidence 3689999999999999999999999999999999998888888899999999999999999999999999 66678
Q ss_pred EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
+++|+|||.|+|+.++...+.++|+.++.+++|++.||.|||+.+|+|||+||.|||+..+|.+|+||||+|+....+
T Consensus 76 ~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred EEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999987554
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
+...+..-|||.|||||++.+ ++|+..+|+||||||+|||..|+|||...+..+....|..
T Consensus 154 -t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---------------- 214 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---------------- 214 (808)
T ss_pred -ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc----------------
Confidence 334567789999999999987 8999999999999999999999999988776655555532
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
....+ ..++|..+.+||+.+|..||.+|+|-.+++.|||.++-..
T Consensus 215 -----------d~v~~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 215 -----------DPVKP----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred -----------CCCCC----cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 11111 2378999999999999999999999999999999976443
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-53 Score=408.91 Aligned_cols=329 Identities=36% Similarity=0.643 Sum_probs=261.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~ 98 (414)
...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45689999999999999999999999999999999998765555667788899999999999999999998865432 34
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 457899999999999988864 588999999999999999999999999999999999999999999999999976432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|.++.....
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 2245679999999999987 68999999999999999999999999999999999999999999887765543
Q ss_pred ccHHHHHHHHHhcCCCCCCccC------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQ------------KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (414)
... ...+...........+.. .....+..+++||.+||+.||.+|||+.++|+||||..+.++...+
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 253 QPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred hHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 322 223333222211111111 1122457899999999999999999999999999998776655443
Q ss_pred CCCCCccchhhhhhccCCHHHHHHHHHHHHHH
Q 015019 327 SCQPISKLEFEFERRRVTKDDIRELIYREILE 358 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 358 (414)
...+. .-+...+.+..+.++|++.++.+++.
T Consensus 332 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 332 APPPK-IPDKQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCCC-CCCccchhhhccHHHHHHHHHHHHHc
Confidence 22221 11223344567777888888887754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=399.34 Aligned_cols=285 Identities=36% Similarity=0.655 Sum_probs=234.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++++.||.|+||+||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++. ..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 75 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TE 75 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CC
Confidence 456789999999999999999999999999999999864322 122345678999999999999999999984 34
Q ss_pred ceEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...|+||||+.++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 5689999999999999887644 589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+|++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|..+.+...
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 156 PTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred CCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 211 12445789999999988653 56899999999999999999999999999999999999999999988776554
Q ss_pred ccH-HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 259 RNE-KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 259 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
... ....+. .......+.....+.+++++.|||++||++||.+|||++|+|+||||
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 322 111111 11112222333446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=408.86 Aligned_cols=329 Identities=42% Similarity=0.714 Sum_probs=260.3
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.|++.+.||+|+||+||+|.+..+++.||||++...........++.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999976555556667889999999999999999999999765433445799
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
+||||+.++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999986433221
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
......++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.+....+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 123455789999999998763 4588999999999999999999999999999999999999999998876654432 22
Q ss_pred HHHHHHhcCCCCC--CccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC-------------------
Q 015019 264 RKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI------------------- 322 (414)
Q Consensus 264 ~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~------------------- 322 (414)
...+.......+. .........++.+.+||.+||+.||.+|||+.++|+||||....-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYT 316 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCC
Confidence 2322222222111 0112234568899999999999999999999999999999873210
Q ss_pred -CCCCCCCCCccchhhhhhccCCHHHHHHHHHHHHHH
Q 015019 323 -EREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358 (414)
Q Consensus 323 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 358 (414)
..+|. ....+++..+....+..++++.+..++.+
T Consensus 317 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (372)
T cd07853 317 SDFEPS--ANPPFDDEYEKNLTSVRQVKEELHQFILE 351 (372)
T ss_pred cccCCC--CCCCCCcccccccCCHHHHHHHHHHHHHH
Confidence 11111 11223445555556667777777766554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=406.05 Aligned_cols=326 Identities=37% Similarity=0.669 Sum_probs=253.7
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~ 98 (414)
...++|++++.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35689999999999999999999999999999999998665555666778899999999999999999999865432 34
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...+|+||||++++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999998888753 589999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.|........
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 2245679999999999987 68999999999999999999999999999988899999999998887665443
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCC------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKF------------PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (414)
.. ....+...........+...+ ...++.+.+||.+||..||++|||+.|+|+||||..+..+....
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 328 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccccc
Confidence 22 222333222222221211111 12467899999999999999999999999999998765443332
Q ss_pred CCCCCccchhhhhhccCCHHHHHHHHHHH
Q 015019 327 SCQPISKLEFEFERRRVTKDDIRELIYRE 355 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 355 (414)
...+. ......+.+....+.+++.+...
T Consensus 329 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 356 (359)
T cd07876 329 APPPQ-IYDAQLEEREHAIEEWKELIYKE 356 (359)
T ss_pred CCCcc-ccccccccccccHHHHHHHHHHH
Confidence 22221 11222234445556666655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=403.03 Aligned_cols=334 Identities=50% Similarity=0.872 Sum_probs=276.6
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++.+.||+|+||+||+|.+..+|+.||||++... .......++.+|+.+++.++||||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4568999999999999999999999999999999998642 223445667889999999999999999998876655556
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..+|+|+||+.++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 67999999999999988854 57999999999999999999999999999999999999999999999999999765433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
..........+||+.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...++.+..+.+....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 2222223456789999999987542 568899999999999999999999999999888899999999999888777666
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhh
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (414)
......++.........++....+.+++.+.+||.+||+.||++|||+.++++||||+.+.+...++..++...++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence 66666666555544444444445678999999999999999999999999999999999887767776655444555444
Q ss_pred hccCCHHHHHHHHHHHHH
Q 015019 340 RRRVTKDDIRELIYREIL 357 (414)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~ 357 (414)
.....+.+++.++.+++
T Consensus 319 -~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 319 -DDLPKEKLKELIFEEIM 335 (336)
T ss_pred -cccCHHHHHHHHHHHhc
Confidence 44557888998888875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-55 Score=357.42 Aligned_cols=280 Identities=38% Similarity=0.644 Sum_probs=241.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.+|.-+++||+|.||+|++|+++.+++.||+|.+.....+.......+||+-+|+.++|.|||+++++.. ..+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCcee
Confidence 4678889999999999999999999999999999865555555567889999999999999999999984 34569
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
.+|+|||..+|..+..+ ++.+..+.++.++.|+++||.|+|+.++.||||||+|+||+.+|.+||+|||+|+..+-.
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence 99999999999999977 678999999999999999999999999999999999999999999999999999875322
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
...++..+.|.||++|.++.+. .-|+...||||.|||++|+.. |+|+|+|.+..+|+..|..++|.|+.+.+..+..
T Consensus 155 -vrcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred -eEeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 1234566889999999998875 679999999999999999987 8899999999999999999999999887765432
Q ss_pred HHHHHHHHHhcCCCCC-------CccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 261 EKARKYLTEMRKKPPV-------PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~-------~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
++...+. .+.+..|+++...+||++++|.-+|.+|++|+.+|+||||....
T Consensus 233 ---------lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 233 ---------LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred ---------CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 2222222 23445567788899999999999999999999999999998653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-55 Score=384.41 Aligned_cols=295 Identities=38% Similarity=0.633 Sum_probs=238.8
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
++-..|++++.||+|.||.||+|..+.++. .+|||+++.............||+.+++.++||||+.+..+|...
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~- 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH- 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence 444679999999999999999997665543 689999975433334445677999999999999999999999753
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC----CCeE
Q 015019 96 KREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLK 166 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~----~~vk 166 (414)
...+++++||.+.+|+.+|+-. ..++...++.|++||+.|++|||++-|+||||||.|||+..+ |.||
T Consensus 100 ---d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 100 ---DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ---CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 3579999999999999999632 468999999999999999999999999999999999999887 8999
Q ss_pred EeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC---------hh
Q 015019 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---------VV 237 (414)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~---------~~ 237 (414)
|+|||+||.....-..-......+.|.||+|||++++. ..|++++||||+|||++||++-.|.|.+.. ..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999875433222223556889999999999885 789999999999999999999999997643 35
Q ss_pred hHHHHHHHhcCCCCHHHHHhhcc-HHHHHHHHHhcCCCCCC-----ccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 015019 238 HQLDLITDLLGTPSPETIAVVRN-EKARKYLTEMRKKPPVP-----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (414)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL 311 (414)
+|+..|++++|+|+...|..+.+ +.....+..++.....+ .......-++.+.+|+.+||++||-+|+|++|+|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 79999999999999988776554 22223333333221111 1222334566799999999999999999999999
Q ss_pred cCCCCCcc
Q 015019 312 ADPYFKGL 319 (414)
Q Consensus 312 ~hp~~~~~ 319 (414)
+|+||...
T Consensus 336 eh~yF~~d 343 (438)
T KOG0666|consen 336 EHPYFTED 343 (438)
T ss_pred cccccccC
Confidence 99999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-55 Score=381.51 Aligned_cols=293 Identities=42% Similarity=0.724 Sum_probs=252.3
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+.+--+.||.|+||+||.+.|..+|+.||+|++...+.+....+++.+|+++|..++|.|++..+++..++..+.+..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34456889999999999999999999999999998888888999999999999999999999999999888777788899
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
+|+|+|..+|+.+|.+.+.++.++++-+++||++||+|||+.||+||||||.|+|+++|+.+||||||+|+...... .
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~--~ 211 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD--R 211 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh--h
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999864433 3
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
..++.-+.|.+|+|||++.+. ..|+.++||||+|||+.||+..+.+|...+..++++.|.+++|+|+.+.+..--...-
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 345677889999999999885 7899999999999999999999999999999999999999999999988765433322
Q ss_pred HHHHHHhcCCCCCC-ccCCCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 264 RKYLTEMRKKPPVP-LFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 264 ~~~~~~~~~~~~~~-~~~~~~--~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...+..-.+.+..+ ++.... ....++.+++..||.+||++|++.++++.|+|+...
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 22222222221111 111111 334578999999999999999999999999999764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-52 Score=400.11 Aligned_cols=327 Identities=36% Similarity=0.655 Sum_probs=254.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~ 98 (414)
...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34579999999999999999999999999999999998765566667788899999999999999999999865432 34
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 456899999999999888764 589999999999999999999999999999999999999999999999999976433
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+.++.....
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cc----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 2245679999999999977 68999999999999999999999999999998888888888888887765544
Q ss_pred ccHHHHHHHHHhcCCCCCCc------------cCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPL------------FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (414)
.. ....+...........+ .......+..+.+||.+||+.||++|||+.|+|+||||..+.++....
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 324 (355)
T cd07874 246 QP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVE 324 (355)
T ss_pred cH-HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhcc
Confidence 32 22333332221111000 011123467889999999999999999999999999998765443222
Q ss_pred CCCCCccchhhhhhccCCHHHHHHHHHHHH
Q 015019 327 SCQPISKLEFEFERRRVTKDDIRELIYREI 356 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 356 (414)
..++ .......+.+..+.+.+++.++.++
T Consensus 325 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (355)
T cd07874 325 APPP-QIYDKQLDEREHTIEEWKELIYKEV 353 (355)
T ss_pred CCCc-cccccchhhhhccHHHHHHHHHHHh
Confidence 1111 1111122334445566776666654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=396.59 Aligned_cols=333 Identities=43% Similarity=0.819 Sum_probs=285.6
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.+...++|++.+.||+|++|.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 4456789999999999999999999999999999999987654444555678899999999999999999998865432
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 34456899999999999998875 57999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+....+.+..+.+..+.+.+..+.
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 322 2455789999999987652 467889999999999999999999999999888899999999999988888
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.+.......++..+.......+...+...++.+.+||.+||..||.+|||+.++++||||..+...++++... ..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~---~~~~ 318 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP---PYDQ 318 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccccc---ccCc
Confidence 8877777777777666655555555667899999999999999999999999999999999987776665532 3456
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCc
Q 015019 337 EFERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
+++...++..+|+.+++.++++|+|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 319 SFESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred chhhhhcCHHHHHHHhHHHHHhccC
Confidence 7888999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=398.13 Aligned_cols=330 Identities=50% Similarity=0.921 Sum_probs=279.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++.+.||.|++|.||+|.++.++..||+|++............+.+|+.+|+.++||||+++++++.... ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCc
Confidence 457899999999999999999999999999999999865444455667889999999999999999999886543 3456
Q ss_pred eEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.+|+||||+.++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 79999999999999999888889999999999999999999999999999999999999999999999999997653322
Q ss_pred Cc-cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. .......+|+.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+....|.|....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 1122345789999999987653 458899999999999999999999999999999999999999999988887777
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhh
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (414)
......+..........++...++..+..+.++|++||+.||++|||++++|.||||.+...+..++.+.+ .+++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~ 318 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP--PFDFDFE 318 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCC--CCCCChh
Confidence 77676766666655555555556778999999999999999999999999999999999988887777544 3566677
Q ss_pred hccCCHHHHHHHHHH
Q 015019 340 RRRVTKDDIRELIYR 354 (414)
Q Consensus 340 ~~~~~~~~~~~~~~~ 354 (414)
....+.+.+.+.+.+
T Consensus 319 ~~~~~~~~~~~~~~~ 333 (334)
T cd07855 319 AIELSREQLKEAIVK 333 (334)
T ss_pred hhhcChhhHHHHhhc
Confidence 777777777776543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=392.97 Aligned_cols=289 Identities=34% Similarity=0.591 Sum_probs=225.7
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+|..++|++.+.||+|+||+||+|.++.+++.||||++..... ......+.+|+.+++.++||||+++++++. +
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIH-----T 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEe-----c
Confidence 3567899999999999999999999999999999999875322 122345678999999999999999999984 3
Q ss_pred CceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...+|+||||+.++|.+.+... +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 4579999999999999888764 579999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.. ..+.+..+....+.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 221 112446789999999998653 468899999999999999999999998754 445667777777777654433
Q ss_pred hhccHHHHHHH-HHhcCCCCCCccCCC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYL-TEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...... .+. .......+..+...+ ...++.+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 231 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 231 GVHSLP--HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred chhhcc--ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 221100 000 000000111111111 1356789999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=406.48 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=223.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 100 (414)
+.|.++++||+|+||+|++|..+.+++.||||++++..- ...+.+....|.+|+...+ ||.+++++.+| +...
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT~~ 442 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QTKE 442 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----ccCC
Confidence 579999999999999999999999999999999987532 3345667889999998885 99999999999 5556
Q ss_pred eEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
++|+||||+.| + .-.+...+.+++..+++|+..|+.||.|||++||+|||||.+|||+|.+|.+||+|||+|+.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 89999999995 6 444455678999999999999999999999999999999999999999999999999999875533
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... .+++||||.|+|||++.+ ..|+.++|+|||||+|||||.|.+||+|.+..+..+.|..-.
T Consensus 522 g~~---TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~------------ 584 (694)
T KOG0694|consen 522 GDR---TSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE------------ 584 (694)
T ss_pred CCc---cccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------
Confidence 332 378999999999999998 899999999999999999999999999999998888885311
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~~ 320 (414)
. .....+|.++.+++++||..||++|.. ++++..||||+.+.
T Consensus 585 --------------~-----~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 585 --------------V-----RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred --------------C-----CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 0 112468999999999999999999985 58899999999763
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=395.09 Aligned_cols=263 Identities=32% Similarity=0.504 Sum_probs=227.2
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCC-CCCccccceeecCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 96 (414)
......|++.+.||+|.||+||.|+++.||+.||+|.+.+.... ......+.+|+.+|+++. ||||+.++++|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----- 105 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----- 105 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 34557899999999999999999999999999999999765432 224567889999999998 99999999999
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC----CCeEEeecC
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDFG 171 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~----~~vkL~DFG 171 (414)
++...+|+|||+|. |+|++.|... .+++..+..++.||+.|++|||+.||+||||||+|+|+... +.+|++|||
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 44557999999999 6999999876 49999999999999999999999999999999999998543 579999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
+|..... .......|||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|....-
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--- 255 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--- 255 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---
Confidence 9987654 223477899999999999987 7999999999999999999999999999987766665533211
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.-....|+.+|..++|||++||..||.+|+|+.++|+|||+++..
T Consensus 256 ------------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 256 ------------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ------------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 112345788999999999999999999999999999999998753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-54 Score=372.10 Aligned_cols=263 Identities=28% Similarity=0.481 Sum_probs=223.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-----C-hHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-----H-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
..|.-.+.||+|..++|.++.++.+|..+|+|++..... . ..-.+...+|+.||+++ .||+|+++.++|.+.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 568889999999999999999999999999999863211 1 11233466899999998 5999999999995554
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+++|+|.|. |.|++++.+.-.+++.+.+.|++||+.|+.|||.++||||||||+|||++++.++||+|||+|+
T Consensus 97 -----F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 -----FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred -----hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 4899999999 8999999998899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccc----cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
....+. .+.+.||||.|.|||.+.- ...+|+..+|+||+|||||.|+.|.+||......-.+..|++.--..
T Consensus 172 ~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 172 QLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred ccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 765443 3468899999999998742 23579999999999999999999999998877666666665422221
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
. ...|.++|..++|||.+||++||.+|+|++++|.||||.++..
T Consensus 248 ~---------------------------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 248 R---------------------------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred C---------------------------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 1 2345789999999999999999999999999999999977643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=406.89 Aligned_cols=288 Identities=35% Similarity=0.593 Sum_probs=230.3
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC---C
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---R 97 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~ 97 (414)
..++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++..... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3468999999999999999999999999999999986421 223479999999999999999998755322 2
Q ss_pred CCceEEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCC
Q 015019 98 EFKDIYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGL 172 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~ 172 (414)
....+|+||||++++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 2235789999999998887753 45799999999999999999999999999999999999999665 699999999
Q ss_pred cccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
|+....... ...++||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+...+|.|..
T Consensus 218 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 986533221 2356789999999988653 46899999999999999999999999999999999999999999987
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
+.+........ .. .+....+..+...+ ...++++.+||.+||++||.+|||+.|+|+||||..+...
T Consensus 293 ~~~~~~~~~~~-~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 293 DQLKEMNPNYA-DI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred HHHHHhchhhh-cc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 76543321110 00 00111111111122 2478899999999999999999999999999999887543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=387.40 Aligned_cols=285 Identities=36% Similarity=0.643 Sum_probs=226.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|+||+||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++ .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 479999999999999999999999999999999876444344456778999999999999999999988 344579
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+.+++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999766665543 45799999999999999999999999999999999999999999999999999986533221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....+..+...+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234679999999999977 67899999999999999999999999998888888888887777665544322211
Q ss_pred HHHHHHHHhcCCCCCC-ccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 262 KARKYLTEMRKKPPVP-LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
........-....+.. .......+|..+.+||++||+.||++|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1000000000000000 001123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-52 Score=382.47 Aligned_cols=274 Identities=28% Similarity=0.418 Sum_probs=228.0
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..+.|++...||.|..++||+|+...+++.||||++.-... ..+...+.+|+..|+.++||||++++..|... .
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc-~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~ 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC-NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----S 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh-hhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----c
Confidence 35789999999999999999999999999999999975433 34477899999999999999999999999544 4
Q ss_pred eEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
.+|+||.||. |+++++++.. ..++|..++.|++++++||.|||.+|-+|||||+.||||+++|.|||+|||.+....
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 6999999999 7999999873 469999999999999999999999999999999999999999999999999987765
Q ss_pred CCCCccccc-cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
......... .+++||++|||||++.....+|+.++||||||++..||.+|..||........+ +.++-|.|+.....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLTS 255 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCcccc
Confidence 544333222 788999999999997665588999999999999999999999999876654433 34455555422111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
....+ .....+..++.+|..||+.||.+||||+++|+|+||+....
T Consensus 256 ~~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 256 GLDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cCChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 11111 12345678999999999999999999999999999987543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=393.45 Aligned_cols=330 Identities=56% Similarity=0.975 Sum_probs=283.6
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||+|++|.||+|.+..++..||||++..........+.+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455667788999999999999999999998765444556799
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
+||||+.++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999887899999999999999999999999999999999999999999999999999998754432211
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
.......++.+|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+....|.+....+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999998773 2789999999999999999999999999999999999999999999888777777777
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhhhccC
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (414)
..++.........++....+.++..+.+||.+||+.||++|||++++|+||||+++..++.++.......+. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 777777766666666667778999999999999999999999999999999999998887777666554331 4566778
Q ss_pred CHHHHHHHHHHH
Q 015019 344 TKDDIRELIYRE 355 (414)
Q Consensus 344 ~~~~~~~~~~~e 355 (414)
++++.+++++.|
T Consensus 319 ~~~~~~~~~~~~ 330 (330)
T cd07834 319 TEEELKELIYEE 330 (330)
T ss_pred CHHHHhHHhhcC
Confidence 888888887653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=387.12 Aligned_cols=284 Identities=35% Similarity=0.595 Sum_probs=229.4
Q ss_pred CCeeEeeeecccCceeEEEEEECC-CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~ 98 (414)
.+|++++.||+|+||+||+|.+.. ++..||+|++..............+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 468899999875433333344556777777665 6999999999986543344
Q ss_pred CceEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...+|+||||+.++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999998753 45899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|.+..+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1245579999999999877 678999999999999999999999999999999999999888887765432
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
....- . -..+......++....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVAL-P---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcc-c---chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 21100 0 00112223333444456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=384.98 Aligned_cols=264 Identities=30% Similarity=0.458 Sum_probs=214.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
..++..++.||+|+||.||++.+..+|..+|||.+... +....+.+.+|+.+|+.++|||||++++...... . ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-ee
Confidence 45789999999999999999999999999999998754 2222667889999999999999999999642221 1 36
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~DFG~a~~~~~ 178 (414)
+++.|||+. |+|.+++...+ .+++..++.+++||++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 899999999 79999999876 7999999999999999999999999999999999999999 79999999999986543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC-ChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-SVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
............||+.|||||++... ...++++|||||||++.||+||.+||... .....+..|.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig------------- 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG------------- 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh-------------
Confidence 11111223467899999999999751 23345999999999999999999999863 2222121111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
... ..| .....+|+++++||.+||..||++||||.++|+|||..+..
T Consensus 237 -------------~~~-~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 237 -------------RED-SLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -------------ccC-CCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 011 111 33456999999999999999999999999999999997643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=377.96 Aligned_cols=254 Identities=29% Similarity=0.523 Sum_probs=225.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...||++.+.||+|.||.|-+|++...|+.||||.+++. .....+...+.|||+||..|+||||+.+|++| +..
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence 346999999999999999999999999999999998754 34556777899999999999999999999999 555
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+.|||||.. |+|.++|...+.+++.+++.|++||+.|+.|||.++++|||||.+|||++.|+.+||+|||++..+..
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 67999999998 79999999999999999999999999999999999999999999999999999999999999977643
Q ss_pred CCCccccccccccCccccccccccccCCCC-CCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..+++++||++.|.+||++.+ .+| ++.+|.||||++||.|+.|..||+|.+....+.+|....-.
T Consensus 206 ----~kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------- 271 (668)
T KOG0611|consen 206 ----KKFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------- 271 (668)
T ss_pred ----ccHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--------
Confidence 346789999999999999988 455 68899999999999999999999999987777766431110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
-|.-+..+.-||+.||.+||++|.|++++.+|=|++
T Consensus 272 ------------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 ------------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 134567789999999999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=396.28 Aligned_cols=260 Identities=29% Similarity=0.501 Sum_probs=224.4
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.-+....|....+||+|+.|.||.|....+++.||||.+....+ ...+-+++|+.+|+..+|+|||++++.|.-.
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--- 342 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG--- 342 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc---
Confidence 34555689999999999999999999999999999999975333 3344588999999999999999999998544
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.+++|||||+ |+|.+++.. ..++|.+++.|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|...
T Consensus 343 --deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 343 --DELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred --ceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 56999999999 587777764 46999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... .....+||++|||||++.. ..|++++||||||+++.||+-|.|||-..+....+..|.. .|+|.
T Consensus 420 ~~~~~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~----- 488 (550)
T KOG0578|consen 420 SEEQS---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPK----- 488 (550)
T ss_pred ccccC---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCC-----
Confidence 55443 3467899999999999988 7999999999999999999999999988777666666642 23322
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
......+|+.++|||.+||+.|+++|+||.+||.||||+.
T Consensus 489 ----------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 489 ----------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ----------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 2234579999999999999999999999999999999953
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=398.10 Aligned_cols=282 Identities=27% Similarity=0.372 Sum_probs=222.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||.||+|.+..+++.||+|+... ..+.+|+.+|+.++||||+++++++. .....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFT-----YNKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCee
Confidence 579999999999999999999999999999997532 34678999999999999999999984 34568
Q ss_pred EEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 103 YVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
|+|||++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999975322211
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC-------ChhhHHHHHHHhcCCCCHHHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~ 255 (414)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+. +...++..+....|.++.+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 12245679999999999987 68999999999999999999999776543 234567777777776654321
Q ss_pred HhhccHHHHHHHHHhcCCCCC----CccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPV----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
..........+.......... +.......++.++.+||.+||++||.+||||.|+|+||||..+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 111111111111111111111 111112246778999999999999999999999999999987643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=386.56 Aligned_cols=291 Identities=38% Similarity=0.668 Sum_probs=238.7
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
++..++|.+++.||+|+||.||+|+++.+++.||+|++..... ......+.+|+.+++.++||||+++++++. .
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVH-----T 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEe-----e
Confidence 3456789999999999999999999999999999999874322 222345678999999999999999999984 3
Q ss_pred CceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
.+..|+||||+.++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 4568999999999999888654 458999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .....++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2211 12345689999999988653 4688999999999999999999999999999999999999999998876655
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.......... ......+.+.....+.+++++.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 4332211111 1222233333445567899999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=385.96 Aligned_cols=267 Identities=27% Similarity=0.441 Sum_probs=219.5
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc------------CChHHHHHHHHHHHHHHhCCCCCcccc
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF------------EHISDAIRILREVKLLRLLRHPDIVEI 87 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~~E~~~l~~l~hpniv~l 87 (414)
-.-++|++++.||+|.||+|.+|++..+++.||||++.+.. ......+++++||.+|++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34478999999999999999999999999999999997431 112234588999999999999999999
Q ss_pred ceeecCCCCCCCceEEEEEecCC-CCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCe
Q 015019 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~-l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~v 165 (414)
+++.-++ ....+|||+|||. |.+. +....++ +++.+++.|++.++.||.|||.+||+||||||+|+|++++|.|
T Consensus 174 iEvLDDP---~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDP---ESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCc---ccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 9998554 4467999999999 5443 3333445 9999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCC--CCccccccccccCcccccccccccc--CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHH
Q 015019 166 KVCDFGLARVAFSD--TPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241 (414)
Q Consensus 166 kL~DFG~a~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~ 241 (414)
||+|||.+...... ......+...+|||.|+|||.+.+. ....+.+.||||+||+||.|+.|+.||-+....+...
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999998754222 2222334557999999999988652 1335678999999999999999999999998888888
Q ss_pred HHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+|.+.--. ....+.+.+.++|||.+||++||++|++..++-.|||...-
T Consensus 330 KIvn~pL~-----------------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLE-----------------------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCccc-----------------------------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 77541100 11224678999999999999999999999999999999764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=386.26 Aligned_cols=333 Identities=40% Similarity=0.749 Sum_probs=278.0
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.+...++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4567889999999999999999999999999999999987544444455678899999999999999999999865432
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....+|+||||++++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 22346799999998899888864 57999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+.......+.+..+.+......
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 169 DSE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 322 1344688999999988652 357889999999999999999999999988888888888888887777766
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.........+...+....+..+....+.+++.+.++|.+||..||.+|||+.+++.||||+.....+.++...+ +..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~---~~~ 318 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDD 318 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC---ccc
Confidence 66666666666666655544444556788999999999999999999999999999999998876655554443 445
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCc
Q 015019 337 EFERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
.+++...+.++|+.+..-||+++.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 319 SFDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred cHHhhccchHHHHHHHHHHHHhcCC
Confidence 6777788899999999999998865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=388.91 Aligned_cols=326 Identities=37% Similarity=0.659 Sum_probs=259.2
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~ 98 (414)
...++|++.+.||+|+||+||+|.+..+++.||||++.+..........+.+|+.+++.++||||+++++++..... .+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34689999999999999999999999999999999987655555566778899999999999999999999865432 34
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...+|+||||+.++|.+.+... +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 4568999999999999988654 89999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...+|.|..+.....
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 171 SFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 221 234568899999999977 68999999999999999999999999999988999999999999887765543
Q ss_pred ccHHHHHHHHHhcCCCCCCccCC-------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQK-------------FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (414)
... ...+..........++... ....++.+.+||.+||+.||++|||+.++|.||||+.+....+.
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~ 323 (353)
T cd07850 245 QPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV 323 (353)
T ss_pred hhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence 322 2222222221111111111 12346678999999999999999999999999999877654433
Q ss_pred CCCCCCccchhhhhhccCCHHHHHHHHHHH
Q 015019 326 PSCQPISKLEFEFERRRVTKDDIRELIYRE 355 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 355 (414)
.... ....+...+.+..+.++|++.++.+
T Consensus 324 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 324 EAPP-PAPYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCC-CCccccccccccccHHHHHHHHHhh
Confidence 2221 2223444566777888888877765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=381.58 Aligned_cols=283 Identities=35% Similarity=0.595 Sum_probs=227.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCCCCCc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~~ 100 (414)
+|++++.||+|+||+||+|.++.+++.||+|.+............+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875433222233455677766655 799999999998655444456
Q ss_pred eEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+++||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 79999999999999988764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ......||..|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+....+.+....+...
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QM----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cc----cCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 21 1234578999999999977 67999999999999999999999999999888888888888877765443211
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
..... .........+.....+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 0011112222333446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=381.62 Aligned_cols=253 Identities=24% Similarity=0.398 Sum_probs=215.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 479999999999999999999999999999999864321 223455678999999999999999999887 34467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999997653221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23579999999999987 67899999999999999999999999887765544444210
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
.. .....+++.+.+||++||+.||.+||+ ++++++||||..+
T Consensus 214 ------------~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 214 ------------KL-----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred ------------Cc-----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 00 111346889999999999999999995 9999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=381.87 Aligned_cols=332 Identities=42% Similarity=0.809 Sum_probs=276.1
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-C
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~ 97 (414)
+...++|.+++.||+|+||.||+|.+..+++.||+|++.+..........+.+|+.+++.++||||+++++++..... .
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 456689999999999999999999999999999999997654444456678899999999999999999998864322 2
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
....+|+++++++++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3456899999999999888765 469999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. .....|+.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+.+.....
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 1345689999999987652 4688899999999999999999999999888888888888889888888777
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhh
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (414)
+.......++..+.......+...+...++.+.+||.+||+.||.+|||+.++|+||||.++..++.++...+ .+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~---~~~~ 321 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQS 321 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCC---ccCc
Confidence 7666666666666555444444445567899999999999999999999999999999999887776665443 4455
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCc
Q 015019 338 FERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
+..+.+-.+++....|.++..|.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 322 FESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred chhcccCHHHHHHHHHHHHHhcCC
Confidence 555666678899999999887754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=401.94 Aligned_cols=285 Identities=27% Similarity=0.433 Sum_probs=224.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC------CCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH------PDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.+.| .+++++++++..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 478999999999999999999999999999999986421 222334557777766654 457888887743
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCC-----------
Q 015019 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANC----------- 163 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~----------- 163 (414)
+..++|+|||+++++|.+++...+.+++..++.|+.||+.||+|||+ .||+||||||+|||++.++
T Consensus 203 --~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 --ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 23579999999999999999888899999999999999999999998 5999999999999998765
Q ss_pred -----CeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh
Q 015019 164 -----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238 (414)
Q Consensus 164 -----~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~ 238 (414)
.+||+|||++...... .+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCccc------cccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999988643211 245689999999999987 789999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCC----cc-----CCC--CCCChHHHHHHHHhccCCCCCCCCH
Q 015019 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP----LF-----QKF--PNVDPLALRLLQRLIAFDPKDRPTA 307 (414)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-----~~~--~~~s~~~~dli~~~L~~dp~~Rpt~ 307 (414)
.+..+.+.+|.++..+...........++.......+.. .. ..+ ...++.+.|||.+||++||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 999999999988776554333333333332222111000 00 000 0124678899999999999999999
Q ss_pred HHHhcCCCCCcccc
Q 015019 308 EEALADPYFKGLAK 321 (414)
Q Consensus 308 ~~lL~hp~~~~~~~ 321 (414)
+|+|+||||.....
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=380.61 Aligned_cols=331 Identities=39% Similarity=0.742 Sum_probs=268.3
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.|...++|.+.+.||+|+||.||+|.+..+|+.||+|++.+..........+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 4456689999999999999999999999999999999987654433444567899999999999999999999865432
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....+|+|+||+..+|..++. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 90 DEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 2335679999999988877653 46899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....|.+.+....
T Consensus 168 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 168 DAE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 221 1345688999999988652 458899999999999999999999999998888888888888888888777
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.........+...........+...++..++.+.+||.+||+.||.+|||++++|.||||+.+...+.++...+ ++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~ 317 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDD 317 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccc
Confidence 66665555555544444444444556778999999999999999999999999999999999876554444322 334
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhC
Q 015019 337 EFERRRVTKDDIRELIYREILEYH 360 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~ 360 (414)
..+......+++...+|.|+.++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T cd07879 318 SLENEKLSVDEWKKHIYKEVKSFS 341 (342)
T ss_pred hhhhhhCCHHHHHHHhhhhhhccC
Confidence 445556667888888888866543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=384.62 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=211.1
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
+.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 469999999999999999999999999875322 233455678999999999999999999988 34457999999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
|+. ++|.+.+..++.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 69999998888999999999999999999999999999999999999999999999999999975322211 12
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (414)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------------------- 210 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------- 210 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 45679999999999987 68999999999999999999999999877654443333210
Q ss_pred HHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. ......+++.+.+||++||+.||++|| ++.++++||||.++
T Consensus 211 ------~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 211 ------E-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred ------C-----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 011246789999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=384.88 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=215.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+.|++.+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++. +.+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 368999999999999999999999999999999986432 12234456889999999999999999999984 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 7999999998 699999998889999999999999999999999999999999999999999999999999999765322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.. +
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~----------- 230 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA--G----------- 230 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--C-----------
Confidence 1 24579999999999987 6789999999999999999999999987765544433321 0
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
.. .....++..+.+||++||+.||.+||+ ++++++||||.+.
T Consensus 231 -------------~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 231 -------------RL-----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred -------------Cc-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 00 111347889999999999999999997 7999999999863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=361.39 Aligned_cols=306 Identities=32% Similarity=0.520 Sum_probs=251.2
Q ss_pred ccccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceee
Q 015019 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (414)
Q Consensus 12 ~~~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 91 (414)
+..+++-+...+.|+-+.+||+|.||.||+|+.+.+|+.||+|++-............++|+++|..++|+|++.+++++
T Consensus 6 ~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 6 DSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred hcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 34456677888999999999999999999999999999999998754333334445678999999999999999999988
Q ss_pred cCCC---CCCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEE
Q 015019 92 LPPS---KREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (414)
Q Consensus 92 ~~~~---~~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL 167 (414)
.... ......+|+||.+|+.+|.-++... .+++..+++.++.+++.||.|+|++.|+|||+||.|+||+.+|.+||
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred hhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 6432 2234569999999999999998765 58999999999999999999999999999999999999999999999
Q ss_pred eecCCcccccCC-CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 015019 168 CDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (414)
+|||+|+..... ......++..+.|.||++||.+.+. ..|+++.|||..||||++|.+|.+.|.+.+...++..|..+
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999764332 2233346778899999999998885 78999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccHHHHHHHHH--hcCCCCCCccCCC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTE--MRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
+|..+++.|....+-...+.++. +.+.......... -.-++++.||+.+||..||.+|+++.++|+|.||..
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 99999998877665443333211 1111111111111 123578999999999999999999999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=369.23 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=223.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.+++++.||.|.-|+||+|+.+.++..+|+|++.+... ......++..|-.||+.++||.++.||..| +....
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccce
Confidence 578999999999999999999999999999999987533 244556788899999999999999999999 55567
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+|||||. |+|+.+.+.+ +.+++..+++++..++.||+|||-.|||+|||||+||||.++|.|.|+||.++.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999 6999888764 5799999999999999999999999999999999999999999999999999843210
Q ss_pred ---------------------------------C-C-------------------CccccccccccCccccccccccccC
Q 015019 179 ---------------------------------D-T-------------------PMTVFWTDYVATRWYRAPELCGSFF 205 (414)
Q Consensus 179 ---------------------------------~-~-------------------~~~~~~~~~~gt~~y~aPE~~~~~~ 205 (414)
. . +.......+|||-.|+|||++.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-- 309 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-- 309 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec--
Confidence 0 0 00011235799999999999999
Q ss_pred CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCC
Q 015019 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285 (414)
Q Consensus 206 ~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (414)
.+.+.++|+|+||+.+|||+.|..||.|.+..+.+..|... + .. ....+.+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~---~-----------------------l~---Fp~~~~v 360 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ---P-----------------------LK---FPEEPEV 360 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC---C-----------------------Cc---CCCCCcc
Confidence 78999999999999999999999999999988887776431 1 00 0112367
Q ss_pred ChHHHHHHHHhccCCCCCCCC----HHHHhcCCCCCccc
Q 015019 286 DPLALRLLQRLIAFDPKDRPT----AEEALADPYFKGLA 320 (414)
Q Consensus 286 s~~~~dli~~~L~~dp~~Rpt----~~~lL~hp~~~~~~ 320 (414)
+..++|||+++|.+||.+|+. |.||-+||||+++.
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 899999999999999999998 99999999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=377.54 Aligned_cols=281 Identities=35% Similarity=0.603 Sum_probs=215.1
Q ss_pred eeeecccCceeEEEEEEC--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
.++||+|+||+||+|.++ .++..||+|.+.... ....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 468999999999999976 467899999986532 1234678999999999999999999885432 3568999
Q ss_pred EecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE----cCCCCeEEeecCC
Q 015019 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (414)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl----~~~~~vkL~DFG~ 172 (414)
|||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999888532 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 015019 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (414)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~---------~~~~~~i 243 (414)
|+...............+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+... .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223456899999999998763 4689999999999999999999999975442 4667888
Q ss_pred HHhcCCCCHHHHHhhccH-HHHHHHHHhcCCCC--CC----ccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 244 TDLLGTPSPETIAVVRNE-KARKYLTEMRKKPP--VP----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~----~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
....|.|....+...... .............. .. ........+..+.|||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 888888877655443211 01111111111000 00 001112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=349.18 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=224.5
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
...++|++++.||+|-||.||+|+.+.++..||+|++.+.. ........+.||++|...|+||||+++|++|.+.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~---- 94 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS---- 94 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc----
Confidence 44568999999999999999999999999999999987542 1223345688999999999999999999999544
Q ss_pred CceEEEEEecCC-CCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 99 FKDIYVVFELME-SDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~--~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..+||++||.. |+++..+. ...++++..++.+++|++.||.|||.++++||||||+|+|++.+|.+||+|||.+..
T Consensus 95 -~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 95 -KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred -ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 46999999999 89999998 566899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...+ ...+.|||..|.+||...+ ..++..+|+||+|++.||++.|.+||...+..+....|.+..-.
T Consensus 174 ~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~------ 240 (281)
T KOG0580|consen 174 APSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK------ 240 (281)
T ss_pred cCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc------
Confidence 4322 2367899999999999988 78999999999999999999999999998887777777653211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
....++..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 241 -------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 -------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -------------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 11578999999999999999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=375.91 Aligned_cols=327 Identities=47% Similarity=0.816 Sum_probs=266.2
Q ss_pred CeeEeeeecccCceeEEEEEECCC--CcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 100 (414)
+|++.+.||+|+||.||+|.+..+ +..||+|++............+.+|+.+++.+ +||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 89999999876544444456778999999999 5999999998754322 2345
Q ss_pred eEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.+|+++||++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997643321
Q ss_pred C-ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 P-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ........+||..|+|||.+.+. ..++.++||||+||++|+|++|.+||.+.+..+.+..+...+|.|....+....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 11112346799999999987552 468999999999999999999999999999999999999999999888777666
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhh
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (414)
......+...........+....+..+..+.+|+.+||+.||.+|||+.+++.||||+.++.+...+.|......+|+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 6655555555555555555555677899999999999999999999999999999999998877777776544333322
Q ss_pred hccCCHHHHHHHHHHH
Q 015019 340 RRRVTKDDIRELIYRE 355 (414)
Q Consensus 340 ~~~~~~~~~~~~~~~e 355 (414)
..+.+++++.|.++
T Consensus 318 --~~~~~~~~~~~~~~ 331 (332)
T cd07857 318 --EDSMEELRDMIIEE 331 (332)
T ss_pred --cccHHHHHHHHhhc
Confidence 23455666665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=385.77 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=214.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 479999999999999999999999999999999875322 223345677899999999999999999998 44467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 6999999888899999999999999999999999999999999999999999999999999987532211
Q ss_pred Cc--------------------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC
Q 015019 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (414)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~ 228 (414)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001134589999999999987 68999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCC---CCC
Q 015019 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK---DRP 305 (414)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~---~Rp 305 (414)
+||.+.+..+....+....... .+ .....+++.+.+||.+|+. +|. .||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~-p~~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETL--------------------------IF-PPEVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcc--------------------------cC-CCcCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9999887666555554311110 00 1113578999999999876 454 458
Q ss_pred CHHHHhcCCCCCcc
Q 015019 306 TAEEALADPYFKGL 319 (414)
Q Consensus 306 t~~~lL~hp~~~~~ 319 (414)
+++++++||||++.
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=380.23 Aligned_cols=261 Identities=26% Similarity=0.472 Sum_probs=219.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++ .....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 479999999999999999999999999999999875322 223445678999999999999999999998 44467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 69999998888899999999999999999999999999999999999999999999999999976433
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------- 218 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence 1245679999999999987 6899999999999999999999999998776655544432111000
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+ ........+++++.+||.+||..+|.+|||+.++++||||...
T Consensus 219 -------------~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 219 -------------RP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -------------CC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 00 0001113578999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=373.51 Aligned_cols=290 Identities=37% Similarity=0.639 Sum_probs=231.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~ 76 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIH-----TE 76 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEe-----cC
Confidence 4457899999999999999999999999999999998643221 22345678999999999999999999984 34
Q ss_pred ceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+||||+.++|.+.+... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 77 KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 569999999999999988753 5789999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....+.+....+...
T Consensus 157 ~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 157 PTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 211 12344678999999988653 46888999999999999999999999999988888888888888876554332
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
........ ...............+.+++.+.+||.+||+.||.+|||++++|+||||+.+.
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 233 LSNEEFKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hccccccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 11100000 00000001111122346889999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=382.12 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=215.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCC-cEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.+... .......+.+|+.+++.++||||+++++++. +
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----D 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----e
Confidence 3467999999999999999999876655 6899999864321 2234556789999999999999999999983 4
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...+|+|||||. |+|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 457999999997 6999999988899999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 244 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------- 244 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------
Confidence 21 134579999999999977 678999999999999999999999998877554444432210
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
......+++.+.+||++||+.||.+|+ |++++++||||.++
T Consensus 245 ---------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 245 ---------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 011245788999999999999999995 89999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-51 Score=357.88 Aligned_cols=269 Identities=30% Similarity=0.474 Sum_probs=221.6
Q ss_pred cccCCCCCeeE-eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 015019 17 TEYGDANRYKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (414)
Q Consensus 17 ~~~~~~~~Y~i-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 94 (414)
+.+.+.++|++ -++||-|-.|.|..+.++.|++.+|+|++. +..+..+|+++.-.. .|||||.++++|...
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 67778889988 478999999999999999999999999975 345677899985555 699999999998554
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCCeEEe
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVC 168 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~vkL~ 168 (414)
- .....+.+|||.|+ |+|+..|+.++ .++|.++..|++||..||.|||+.+|.||||||+|+|... |..+||+
T Consensus 128 ~-~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 128 Y-QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred c-cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 3 45678999999999 69999998876 4999999999999999999999999999999999999864 5679999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh----HHHHHH
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH----QLDLIT 244 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~----~~~~i~ 244 (414)
|||+|+..... ..+.+-|-|++|.|||++.. ..|+...|+||+|||||.|++|.|||....... .-.+|.
T Consensus 207 DfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 207 DFGFAKETQEP----GDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred ccccccccCCC----ccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 99999865432 23456789999999999988 789999999999999999999999997654311 112221
Q ss_pred Hh-cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCC
Q 015019 245 DL-LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (414)
Q Consensus 245 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (414)
.. ...| ...|..+|..++|+|+.||..+|.+|.|++++++|||+.+.....
T Consensus 281 ~gqy~FP----------------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 281 TGQYEFP----------------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred ccCccCC----------------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 11 1112 233567899999999999999999999999999999999876555
Q ss_pred CCCC
Q 015019 324 REPS 327 (414)
Q Consensus 324 ~~~~ 327 (414)
..+.
T Consensus 333 ~tpl 336 (400)
T KOG0604|consen 333 QTPL 336 (400)
T ss_pred CCCc
Confidence 4443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=387.57 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=214.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+|++++.||+|+||+||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++. +...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 69999999999999999999999999999999875321 2234556889999999999999999999984 44579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999998 69999998888899999999999999999999999999999999999999999999999999753210000
Q ss_pred --------------------------------------------ccccccccccCccccccccccccCCCCCCcchhhhH
Q 015019 182 --------------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217 (414)
Q Consensus 182 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSl 217 (414)
........+||+.|+|||++.+ ..|+.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEec
Confidence 0000123579999999999987 689999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhc
Q 015019 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297 (414)
Q Consensus 218 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L 297 (414)
||++|+|++|++||.+.+..+....+...... .. ......+++++.+||.+|+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------------~~---~p~~~~~s~~~~~li~~l~ 287 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTS------------------------LH---IPPQAKLSPEASDLIIKLC 287 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC------------------------cC---CCCcccCCHHHHHHHHHHc
Confidence 99999999999999887765444433221100 00 0112467999999999987
Q ss_pred cCCCCCCCC---HHHHhcCCCCCccc
Q 015019 298 AFDPKDRPT---AEEALADPYFKGLA 320 (414)
Q Consensus 298 ~~dp~~Rpt---~~~lL~hp~~~~~~ 320 (414)
.||.+|++ ++++++||||+...
T Consensus 288 -~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 288 -RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred -cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 49999997 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=386.38 Aligned_cols=263 Identities=22% Similarity=0.361 Sum_probs=213.4
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.|++++.||+|+||+||+|++..+++.||||++.+.. ........+.+|+.+++.++||||+++++++. +...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 6999999999999999999999999999999997532 23344567889999999999999999999984 44579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999998 69999998888899999999999999999999999999999999999999999999999999753210000
Q ss_pred --------------------------------------------ccccccccccCccccccccccccCCCCCCcchhhhH
Q 015019 182 --------------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217 (414)
Q Consensus 182 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSl 217 (414)
........+||+.|+|||++.+ ..|+.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence 0000124579999999999977 679999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhc
Q 015019 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297 (414)
Q Consensus 218 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L 297 (414)
||++|+|++|.+||.+.+..+....+....+.. .......+++++.+||.+||
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------------------HIPPQVKLSPEAVDLITKLC 287 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------------------CCCCCCCCCHHHHHHHHHHc
Confidence 999999999999998877554444332211100 00112357899999999976
Q ss_pred cC--CCCCCCCHHHHhcCCCCCccc
Q 015019 298 AF--DPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 298 ~~--dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.. +|..|+|++++++||||+++.
T Consensus 288 ~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 288 CSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred cCcccccCCCCHHHHhcCcccCCCC
Confidence 54 455599999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=377.63 Aligned_cols=329 Identities=44% Similarity=0.762 Sum_probs=267.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++.+.||+|+||.||+|.+..+++.||+|++...+........+.+|+.+++.+ +||||+++++++... +.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 45789999999999999999999999999999999876544445556778899999999 999999999987432 23
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
...|+||||+.++|.+++... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999999999998766 7899999999999999999999999999999999999999999999999999865432
Q ss_pred CCc--cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... ......++||.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+....+....+....+.+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 1223456799999999987552 5678899999999999999999999999999999999998889888877776
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhh
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (414)
.........+.........+.....+.++..+.+||.+||+.||++|||+.++++||||+.+.....++.........+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~- 318 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPL- 318 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCc-
Confidence 6655555555555555555555566778999999999999999999999999999999999876655554332222222
Q ss_pred hhhccCCHHHHHHHHHHH
Q 015019 338 FERRRVTKDDIRELIYRE 355 (414)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e 355 (414)
.+.+.+...+.+..+|+|
T Consensus 319 ~~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 319 DDNVKLSVAEYRNKLYEE 336 (337)
T ss_pred cccceeeHHHHHhhhhhc
Confidence 245556666666666665
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=385.76 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=215.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence 47999999999999999999999999999999997532 12234456778999999999999999999984 4467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999888899999999999999999999999999999999999999999999999999987532211
Q ss_pred Cc-----------------------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHH
Q 015019 181 PM-----------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (414)
Q Consensus 181 ~~-----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll 225 (414)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 00 001123579999999999977 68999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC
Q 015019 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305 (414)
Q Consensus 226 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp 305 (414)
+|.+||.+.+..+....+..... ... + .....+++.+.+||++||. +|.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~------------------------~~~--~-~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE------------------------TLQ--F-PDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC------------------------ccC--C-CCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 99999988776554444432110 000 0 1112578999999999997 999999
Q ss_pred C---HHHHhcCCCCCcc
Q 015019 306 T---AEEALADPYFKGL 319 (414)
Q Consensus 306 t---~~~lL~hp~~~~~ 319 (414)
+ +.++|+||||+..
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=376.30 Aligned_cols=260 Identities=28% Similarity=0.482 Sum_probs=229.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
.+.+-|.+-+.||+|.|.+|-+|++.-||+.||||++.+...+......+..|+++|+.++|||||++|++. +..
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence 355789999999999999999999999999999999998766666667889999999999999999999998 444
Q ss_pred ceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEE-EcCCCCeEEeecCCcccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLARVA 176 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NIL-l~~~~~vkL~DFG~a~~~ 176 (414)
..+|||+|+-+ |+|+++|.+. ..++|+.++.++.||+.|+.|||...+|||||||+||. +..-|-|||.|||++...
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 56999999998 6999998664 57999999999999999999999999999999999986 456799999999999765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCC-CcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.... .+++.||+..|-|||++++ ..|+ +++||||||||||-|++|++||...++.+.+.+|++.--
T Consensus 170 ~PG~----kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------- 236 (864)
T KOG4717|consen 170 QPGK----KLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------- 236 (864)
T ss_pred CCcc----hhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-------
Confidence 4433 3478899999999999998 5666 689999999999999999999999999999988876322
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.....+|.+++|||.+||..||.+|.|.++|.+|+|++....
T Consensus 237 ------------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 237 ------------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred ------------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 223468999999999999999999999999999999987643
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=375.76 Aligned_cols=248 Identities=31% Similarity=0.472 Sum_probs=209.2
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~ 109 (414)
||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++. ..+.+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 799999999999999999999999986432 12344566789999999999999999999883 445799999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccc
Q 015019 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (414)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 188 (414)
. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 69999998888999999999999999999999999999999999999999999999999999975432221 1245
Q ss_pred cccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHH
Q 015019 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (414)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (414)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 679999999999987 6899999999999999999999999987765443333321
Q ss_pred HhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCcc
Q 015019 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP---TAEEALADPYFKGL 319 (414)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp---t~~~lL~hp~~~~~ 319 (414)
.. ......+++.+.+||.+||+.||.+|| ++.++|+||||...
T Consensus 208 ---~~-----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ---EP-----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---CC-----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 00 011246789999999999999999997 58999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=386.65 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=213.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 479999999999999999999999999999999864321 2234456788999999999999999999984 4457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997 6999999888899999999999999999999999999999999999999999999999999996321100
Q ss_pred Cc------------c--------------------------------ccccccccCccccccccccccCCCCCCcchhhh
Q 015019 181 PM------------T--------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (414)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwS 216 (414)
.. . ......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00013579999999999977 68999999999
Q ss_pred HhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHh
Q 015019 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (414)
Q Consensus 217 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 296 (414)
|||++|+|++|.+||.+.+..+.+..+...... . . ......++.++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------------~--~-~p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRET------------------------L--Y-FPDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc------------------------c--C-CCCCCCCCHHHHHHHHHH
Confidence 999999999999999887765555444321100 0 0 011135789999999999
Q ss_pred ccCCCCCC---CCHHHHhcCCCCCcc
Q 015019 297 IAFDPKDR---PTAEEALADPYFKGL 319 (414)
Q Consensus 297 L~~dp~~R---pt~~~lL~hp~~~~~ 319 (414)
|. +|.+| +|+.++++||||.+.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=371.30 Aligned_cols=322 Identities=46% Similarity=0.849 Sum_probs=270.0
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+...++|++++.||.|+||.||+|.+..+++.||+|++.+..........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---- 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence 4567899999999999999999999999999999999875444444556788999999999999999999988432
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
....|+||||++++|.+++.. .++++..+..++.||+.||+|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 245899999999999888764 4689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. .....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.........+.+.+|.++.+.....
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1345688899999987542 46899999999999999999999999999888888888899999988877766
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhh
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
.......++..+....+.+.....+.++..+.++|++||+.+|++|||+++++.||||.....+..++... .++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~--~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAE--EKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCch--hhcCCch
Confidence 55555555555555555555556677899999999999999999999999999999999887765555432 3678888
Q ss_pred hhccCCHHHHHHHHHH
Q 015019 339 ERRRVTKDDIRELIYR 354 (414)
Q Consensus 339 ~~~~~~~~~~~~~~~~ 354 (414)
+...+..+.|+-.+|.
T Consensus 312 ~~~~~~~~~~~~~~~~ 327 (328)
T cd07856 312 NDADLPVDTWKVMMYS 327 (328)
T ss_pred hcccCCHHHHHHHhcC
Confidence 8889999999877664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=369.57 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=211.4
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++|+||+++++++. +.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 38899999999999999999999999999999865322 1223345778999999999999999999883 44579
Q ss_pred EEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+|||||. |+|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 688877754 346899999999999999999999999999999999999999999999999999764322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. .....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV------------ 217 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh------------
Confidence 1 1234579999999999987 689999999999999999999999998765432222221110
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~~ 320 (414)
. .........++..+.+||++||+.||.+||| ++++++||||.+..
T Consensus 218 -----------~----~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 218 -----------K----EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred -----------h----cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0 0011123468899999999999999999997 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=381.35 Aligned_cols=263 Identities=30% Similarity=0.487 Sum_probs=218.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++||||+++++++ .+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 479999999999999999999999999999999875322 123445678899999999999999999988 34467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 6999999888899999999999999999999999999999999999999999999999999997654322
Q ss_pred --------------------------CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC
Q 015019 181 --------------------------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (414)
Q Consensus 181 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~ 234 (414)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 00011234579999999999988 68999999999999999999999999887
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-HHHHhcC
Q 015019 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALAD 313 (414)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-~~~lL~h 313 (414)
+.......+...... ... .....+++.+.+||.+||. ||.+|++ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~~~------------------------~~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKES------------------------LRF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCCc------------------------ccC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 765554444321110 000 1113478999999999998 9999999 9999999
Q ss_pred CCCCccc
Q 015019 314 PYFKGLA 320 (414)
Q Consensus 314 p~~~~~~ 320 (414)
|||+.+.
T Consensus 286 p~~~~~~ 292 (350)
T cd05573 286 PFFKGID 292 (350)
T ss_pred CCcCCCC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=376.07 Aligned_cols=250 Identities=24% Similarity=0.456 Sum_probs=210.2
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 469999999999999999999999999975322 233456778999999999999999999988 34457999999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
|+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 68999998888899999999999999999999999999999999999999999999999999875432211 12
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (414)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 45679999999999977 6789999999999999999999999987765443333211
Q ss_pred HHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.. ......+++.+.+||++||+.||.+|+ ++.++++||||.+.
T Consensus 210 -----~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -----ED-----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -----CC-----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 011246789999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=385.29 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=213.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+|+.++||||+++++.+ .+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 369999999999999999999999999999999864321 123345677999999999999999999998 34467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999985321000
Q ss_pred C----------------------------------------ccccccccccCccccccccccccCCCCCCcchhhhHhHH
Q 015019 181 P----------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (414)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~i 220 (414)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999987 689999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCC
Q 015019 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (414)
Q Consensus 221 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 300 (414)
+|+|++|+.||.+.+..+....+...... ........+++.+.+||.+|+ .+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETT---------------------------LHIPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCcc---------------------------ccCCCCCCCCHHHHHHHHHHh-cC
Confidence 99999999999887765544333211000 000112467899999999987 59
Q ss_pred CCCCC---CHHHHhcCCCCCcc
Q 015019 301 PKDRP---TAEEALADPYFKGL 319 (414)
Q Consensus 301 p~~Rp---t~~~lL~hp~~~~~ 319 (414)
|.+|+ |+.++++||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=363.89 Aligned_cols=282 Identities=37% Similarity=0.626 Sum_probs=227.3
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++++.||+|++|.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++. ....+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 489999999999999999999999999999998754333334456778999999999999999999984 345689
Q ss_pred EEEecCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||||+.++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999999888642 568999999999999999999999999999999999999999999999999987543221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
.......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+....+.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112344678999999987653 4578899999999999999999999999888887777777777766554433221
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...+..................+++++.+||++||+.||.+|||+.++++||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 --LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred --hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 112222222222222223345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=373.97 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=210.3
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 469999999999999999999999999875322 2234456778999999999999999999984 3457999999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
|+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 69999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (414)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------------------- 210 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------- 210 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------------
Confidence 34679999999999977 68899999999999999999999999877655444333210
Q ss_pred HHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. ......+++.+.+||.+||+.||.+|+ ++.++++||||.+.
T Consensus 211 ------~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 211 ------E-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred ------C-----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 011235789999999999999999998 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=376.40 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=230.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..+.|.+++.+|+|+||.+++++++..+..||+|++.-.............|+.+++++.|||||.+.+.|.. +..
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQ 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCc
Confidence 3578999999999999999999999999999999998665555566678899999999999999999999943 223
Q ss_pred eEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
.+||||+||+ |+|.+.|+.. .-++++.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 4999999999 6999999764 469999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... ....+.+||+.|++||++.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|......|.+
T Consensus 158 ~~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----- 227 (426)
T KOG0589|consen 158 PED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----- 227 (426)
T ss_pred Cch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-----
Confidence 543 23467899999999999999 89999999999999999999999999999998888888765544432
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...+.+++.||+.||..+|..||+|.++|.+|.+...
T Consensus 228 -------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 228 -------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred -------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 3578999999999999999999999999999988643
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=365.72 Aligned_cols=282 Identities=38% Similarity=0.599 Sum_probs=223.8
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 699999999999999999999999999999998754332233345778999999999999999999984 345689
Q ss_pred EEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
+|+||++++|.+.+.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999998865 56799999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
......++..|+|||.+.+. ..++.++|||||||++|+|++|..| |.+.+....+..+.+..+.+....+......
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345678999999988653 4578999999999999999998866 6777777788888888887765544322110
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
....... ............+.+++.+.+||.+||+.||.+|||++++|+||||
T Consensus 232 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYP--MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccC--CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000000 0000011123345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=373.85 Aligned_cols=257 Identities=29% Similarity=0.448 Sum_probs=221.0
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
....|+.++.||+|+||.||+|.+..+++.||||++... ....+...+..|+.+|.+++++||.++|+.|+...
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~----- 84 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT----- 84 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----
Confidence 345788899999999999999999999999999999754 23345667889999999999999999999996654
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.++++||||+ |++.+.++..+.+.+.++..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+......
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 4899999999 699999998888899999999999999999999999999999999999999999999999999765443
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... ..+++||+.|||||++.+ ..|+.++||||||++.+||++|.|||........+..|
T Consensus 165 ~~r---r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------------- 223 (467)
T KOG0201|consen 165 VKR---RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------------- 223 (467)
T ss_pred hhc---cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------
Confidence 322 368899999999999987 79999999999999999999999999887653322222
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
++..+..+ -..+|+.+++|+..||+.||+.||||.+||+|+|++.
T Consensus 224 -----------pk~~PP~L---~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 224 -----------PKSAPPRL---DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----------cCCCCCcc---ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 11111111 1268999999999999999999999999999999976
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=372.35 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=209.9
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|.++.+++.||||++.+... .......+.+|..++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999999875321 223445667888888876 6999999999983 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
|||. ++|.+.+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875422211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------------------ 212 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE------------------ 212 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------------
Confidence 244679999999999977 688999999999999999999999999877665554442210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCccc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~------~~lL~hp~~~~~~ 320 (414)
......++..+.+||++||+.||.+||++ +++++||||..+.
T Consensus 213 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 213 -------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred -------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 01123578899999999999999999998 9999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=371.68 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=213.4
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCC-CccccceeecCCCCCCCce
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~~ 101 (414)
+|++++.||+|+||.||+|.+..+++.||||++.+... .......+..|+.++..+.|+ +|+.+++++. ..+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 48999999999999999999999999999999875322 223455678899999999765 5888888873 3457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. |+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 1 1234679999999999987 678999999999999999999999998877655554443210
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (414)
......+++.+.+||.+||..||.+|+++ +++++||||...
T Consensus 218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 01123578999999999999999999986 899999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=377.35 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=214.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++ .+..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 468999999999999999999999999999999986432 1223344577899999999999999999988 4445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||. |+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 7999999998 689988865 46899999999999999999999999999999999999999999999999999764322
Q ss_pred CCccccccccccCcccccccccccc--CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+.......|.....
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------- 264 (370)
T cd05596 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN--------- 264 (370)
T ss_pred Cc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---------
Confidence 11 112356799999999998652 13488999999999999999999999998776555444432100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (414)
.. .......+|.++.+||++||+.+|.+ |+|++++++||||++.
T Consensus 265 -----------------~~-~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 265 -----------------SL-TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred -----------------cC-CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 00 01112357999999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=373.81 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=215.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++.+.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 469999999999999999999999999999999975422 2234456778999999999999999999883 4457
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 6999999875 68999999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccccccCcccccccccccc----CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------- 226 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR------- 226 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 211 12345799999999998631 14678999999999999999999999988776555444432100
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.......+.+++.+.+||++||. ||.+|||++++++||||..+
T Consensus 227 --------------------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 227 --------------------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred --------------------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 00011124688999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=373.07 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=209.4
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
+.||+|+||.||+|.+..++..||+|++.+... .......+.+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 469999999999999999999999999975322 223445677899999999999999999988 34457999999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
|+. ++|...+.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 6899988888889999999999999999999998 7999999999999999999999999999875332211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------------------- 211 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------- 211 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 234679999999999977 68899999999999999999999999877654444333210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. ......+++.+.+||++||+.||.+|+ ++.++++||||.+.
T Consensus 212 -------~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 212 -------E-----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred -------C-----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 0 011235789999999999999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=370.29 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=209.2
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHH---HhCCCCCccccceeecCCCCCCCc
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLL---RLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 7899999999999999999999999999999975321 223345566776665 4567999999999983 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+. ++|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 7999999999 588877754 57999999999999999999999999999999999999999999999999998753322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------------ 217 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE------------ 217 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 21 1245679999999999987 688999999999999999999999998877655544442210
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. .....+++.+.+||.+||+.||.+|| ++.++++||||+.+
T Consensus 218 --------------~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 218 --------------V-----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred --------------C-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 0 11235789999999999999999999 79999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=377.68 Aligned_cols=263 Identities=26% Similarity=0.372 Sum_probs=213.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++. +..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----DDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCC
Confidence 468999999999999999999999999999999986422 12233455778999999999999999999983 446
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||. |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 7999999998 6999988654 6899999999999999999999999999999999999999999999999999765322
Q ss_pred CCccccccccccCccccccccccccC--CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|++||.+.+.......|.......
T Consensus 196 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------- 266 (370)
T cd05621 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL------- 266 (370)
T ss_pred Cc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc-------
Confidence 11 1124567999999999986521 237889999999999999999999999887665555543211100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (414)
. ......++..+.+||.+||..++.+ |+|+.++++||||+..
T Consensus 267 -------------------~-~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 267 -------------------N-FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -------------------C-CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0 0111357899999999999865544 8899999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=371.17 Aligned_cols=261 Identities=24% Similarity=0.400 Sum_probs=209.6
Q ss_pred CeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 97 (414)
.|++++.||+|+||+||+|.+. .+++.||+|++.+.. ........+.+|+.+++.+ +||||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 478999999986432 1223445678899999999 599999999988 3
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..+.+|+||||+. |+|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 4457999999998 699999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----------- 221 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----------- 221 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-----------
Confidence 332221 12346799999999998762 3578899999999999999999999975432211111110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.+.... ......+++.+.+||.+||+.||++|| +++++++||||+..
T Consensus 222 ------------~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 222 ------------RILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred ------------HHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 000000 011245789999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=365.20 Aligned_cols=295 Identities=41% Similarity=0.638 Sum_probs=233.6
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HL 80 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CC
Confidence 456789999999999999999999999999999999864333322233466899999999999999999998543 23
Q ss_pred ceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+||||+.++|.+++.. ...+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 46899999999999988875 36799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ..+...++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+...
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 221 12334568889999988652 46889999999999999999999999999999999999998888776554332
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
..-.....+ .........+...+...++.+.+||.+||++||++|||+.++|.||||+....+
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 237 SDLPLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred hcccccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 211100000 000011111122234568999999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=369.38 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=210.0
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|.+..+++.||||++.+... .......+..|..++..+ +||||+++++++. ..+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 469999999999999999999999999875321 223445577889988866 7999999999984 445699999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999977 68999999999999999999999999988766655544321
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-------CHHHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-------TAEEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-------t~~~lL~hp~~~~~ 319 (414)
.. .....++.++.+||.+||+.||++|| +++++++||||..+
T Consensus 212 -------~~-----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 -------DV-----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------CC-----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 00 01134788999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=368.81 Aligned_cols=251 Identities=29% Similarity=0.490 Sum_probs=209.2
Q ss_pred eeeecccCceeEEEEEEC---CCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 28 LEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++.||+|+||.||+|.+. .+++.||+|++.+.. ........+.+|+.+|+.++||||+++++++. ..+.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeE
Confidence 468999999999999864 478899999987532 12233456778999999999999999999984 34579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998 59999998888899999999999999999999999999999999999999999999999999875432221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------------- 215 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------------- 215 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence 1234579999999999977 67899999999999999999999999887765544443210
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. ....+.+++.+.+||++||+.||++|| +++++++||||...
T Consensus 216 -----------~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 216 -----------K-----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred -----------C-----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 112246789999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=375.83 Aligned_cols=262 Identities=25% Similarity=0.413 Sum_probs=214.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.|++++.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.++..++||||+++++.+ .+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 469999999999999999999999999999999864321 223445678899999999999999999998 44467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 6999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred Cc--------------------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC
Q 015019 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (414)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~ 228 (414)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 001124579999999999987 78999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC---
Q 015019 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP--- 305 (414)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp--- 305 (414)
+||.+.+.......+...... ..+ .....+++.+.+||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~--------------------------~~~-p~~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNWKET--------------------------LVF-PPEVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcCCCc--------------------------eec-CCCCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887766555444321000 000 0112478999999999875 999998
Q ss_pred CHHHHhcCCCCCcc
Q 015019 306 TAEEALADPYFKGL 319 (414)
Q Consensus 306 t~~~lL~hp~~~~~ 319 (414)
+++++++||||.++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (360)
T cd05627 286 GVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHhcCCCCCCC
Confidence 48999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=366.11 Aligned_cols=279 Identities=24% Similarity=0.385 Sum_probs=218.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++|+.++||||+++++++.. .+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 368999999999999999999999999999999987532 23445678899999999999999999999843 356
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999 59999998888899999999999999999999986 5999999999999999999999999998754322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH-----
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET----- 254 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 254 (414)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... .+.+....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234579999999999987 6799999999999999999999999987665433222 11111000
Q ss_pred -------------H-----HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 255 -------------I-----AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 255 -------------~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
. ...........+..+....... .....+++++.+||.+||+.||++|||+.++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0 0000001111122221111111 0113478899999999999999999999999999999
Q ss_pred Ccc
Q 015019 317 KGL 319 (414)
Q Consensus 317 ~~~ 319 (414)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=367.62 Aligned_cols=255 Identities=23% Similarity=0.393 Sum_probs=213.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCce
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+|++++.||+|+||.||+|.+..+++.||+|++.+... ..........|..++..+ .|++|+.+++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48999999999999999999999999999999875322 223344567788888877 588999999988 34457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------ 218 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------ 218 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 1 1245679999999999987 6899999999999999999999999998776655554432110
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
.....++..+.+|+.+||+.||.+|++ ..++++||||+.+
T Consensus 219 -------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 219 -------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred -------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 112357899999999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=367.12 Aligned_cols=304 Identities=39% Similarity=0.667 Sum_probs=232.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC---
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--- 96 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 96 (414)
+..++|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 457899999999999999999999999999999999865322 344567889999999999999999988755321
Q ss_pred ------CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEee
Q 015019 97 ------REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCD 169 (414)
Q Consensus 97 ------~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~D 169 (414)
.+...+|+||||++++|.+.+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 12246899999999999888864 47999999999999999999999999999999999999974 56789999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
||+++................|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+.+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997643221111122334688999999987542 56888999999999999999999999988887777666655544
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCC
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~ 328 (414)
+.........+... ............+.....+.++.++.+||.+||+.||.+|||+.++|+||||+.+..+.+.+..
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~ 315 (342)
T cd07854 238 VREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVS 315 (342)
T ss_pred CChHHhhhhhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCC
Confidence 44433222211111 1111111112222333345788999999999999999999999999999999977655444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=367.07 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=206.5
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|.++.+|+.||+|++++... ..........|..++..+ +||||+++++++ .+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999875321 112344566788887754 899999999998 3446799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999987432211 12
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------------------- 211 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------------------- 211 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 245679999999999987 68999999999999999999999999887655444333210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH-HHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~-~~lL~hp~~~~~ 319 (414)
. ......++..+.+||++||+.||.+|||+ +++++||||...
T Consensus 212 --------~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 212 --------T----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred --------C----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 0 01113478899999999999999999998 588899999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=357.94 Aligned_cols=285 Identities=40% Similarity=0.698 Sum_probs=232.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++++.||.|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 6999999999999999999999999999999987654334455678899999999999999999999843 45789
Q ss_pred EEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
+||||++++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999998899998865 45799999999999999999999999999999999999999999999999999976543321
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
.......|+.+|+|||.+.+. ..++.++||||+||++|+|++|.++|.+.+....+..+....+.+....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345789999999988652 457899999999999999999999999998888888888888888765544322111
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
.... .........++...+++.+..+.+||++||..||.+|||++++|+||||.
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNK-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhc-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 00111122223334567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=368.64 Aligned_cols=250 Identities=27% Similarity=0.456 Sum_probs=207.2
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|.+..+|+.||||++.+... .......+.+|.. +++.++||||+++++++. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999865321 2233445566655 467889999999999883 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|..++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------------- 211 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK------------------- 211 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999977 67999999999999999999999999887655444433210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (414)
.....+.+++.+.+||++||+.||.+||++ .++++||||...
T Consensus 212 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 212 ------------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 011235678999999999999999999998 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=366.31 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=212.8
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+++.++|+||+++++++ .+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 47999999999999999999999999999999986421 1223345577899999999999999999998 34467
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 699999976 467999999999999999999999999999999999999999999999999998764332
Q ss_pred CCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 211 11234699999999998631 1457889999999999999999999998877655554443211
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (414)
....+....+.++..+.+||++||..++.+ |+++.++++||||.+.
T Consensus 225 -----------------~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 225 -----------------EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred -----------------CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 111112223458999999999999765544 7899999999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=364.26 Aligned_cols=281 Identities=35% Similarity=0.592 Sum_probs=212.2
Q ss_pred eeeecccCceeEEEEEECC--CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
..+||+|+||+||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEE
Confidence 4689999999999999654 56789999986532 223567899999999999999999988543 23568999
Q ss_pred EecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE----cCCCCeEEeecCC
Q 015019 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (414)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl----~~~~~vkL~DFG~ 172 (414)
|||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999999887531 258899999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 015019 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (414)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~---------~~~~~~i 243 (414)
|+...............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||..... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654332222223456789999999998652 4589999999999999999999999975432 3566777
Q ss_pred HHhcCCCCHHHHHhhccHH-HHHHHHHhcCCC--CCC----ccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 244 TDLLGTPSPETIAVVRNEK-ARKYLTEMRKKP--PVP----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~----~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...+|.+....+....... ............ ... ........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7788877665544322110 000000000000 000 001112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=358.54 Aligned_cols=280 Identities=33% Similarity=0.577 Sum_probs=225.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC--CCC----ccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPD----IVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpn----iv~l~~~~~~~~ 95 (414)
.+||++++.+|+|.||.|..+.|..++..||||+++.. ....+..+-|+++|.+++ .|+ ++.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 68999999999999999999999999999999998743 122334556999999994 232 55555556
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC------------
Q 015019 96 KREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA------------ 161 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~------------ 161 (414)
+..+++|||+|.++.++++.++.++ +++..+++.+.+||+++++|||+.+++|.||||+|||+.+
T Consensus 161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 5667899999999999999998865 7999999999999999999999999999999999999632
Q ss_pred --------CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCC
Q 015019 162 --------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (414)
Q Consensus 162 --------~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~ 233 (414)
+..|||+|||.|+..... .+..+.|+.|+|||++++ -+++.++||||+||||+||.+|..+|.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 234999999999865332 256789999999999999 6899999999999999999999999999
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhc---------------CCCCCCccCCCCCCC---hHHHHHHHH
Q 015019 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR---------------KKPPVPLFQKFPNVD---PLALRLLQR 295 (414)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~s---~~~~dli~~ 295 (414)
.++.+.+..+..++|.++...+.... ..+++.... ...+.++.......+ .++.|||++
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 99999999999999977766655442 222222210 111222222222222 347899999
Q ss_pred hccCCCCCCCCHHHHhcCCCCCccc
Q 015019 296 LIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 296 ~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
||.+||.+|+|+.|+|.||||+.+.
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcCC
Confidence 9999999999999999999998753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=365.40 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=206.1
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|.+..+++.||||+++.... ..........|..++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999999875321 223344556677777654 8999999999983 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. |+|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9998 6999999888899999999999999999999999999999999999999999999999999997543222 12
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------------- 211 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------------------- 211 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999987 67899999999999999999999999987765444433210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH-HHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~-~~lL~hp~~~~~ 319 (414)
. ......++..+.+||.+||+.||.+||++ .++++||||...
T Consensus 212 --------~----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 212 --------R----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred --------C----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 0 01123578899999999999999999986 588899999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=356.12 Aligned_cols=282 Identities=38% Similarity=0.623 Sum_probs=227.7
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.|++++.||.|++|.||+|.+..++..||||++............+.+|+++++.++||||+++++++. +....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 489999999999999999999999999999998754333333456889999999999999999999883 345689
Q ss_pred EEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 104 VVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
+||||+.++|.+++.. ...+++..++.++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899988865 35789999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+.....
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 12334578899999987652 4468899999999999999999999999888888888888888776554432221
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...+...........+....+.+++.+.++|.+||+.||.+|||++++|+||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 -LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111112222222222333345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=368.85 Aligned_cols=251 Identities=28% Similarity=0.461 Sum_probs=210.4
Q ss_pred eeeecccCceeEEEEEE---CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 28 LEVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
++.||+|+||.||++.+ ..+|+.||+|++.+..........+.+|+.+|+.++||||+++++++. ....+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEE
Confidence 36799999999999986 357899999999754333344556778999999999999999999984 4457999
Q ss_pred EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 105 VFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 105 V~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
||||+. ++|.+.+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 69999998888899999999999999999999999999999999999999999999999999976433211
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------- 214 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------- 214 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 1235679999999999977 678999999999999999999999998877655544442110
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
......+++.+.+||++||+.||.+||| +.++++||||..+
T Consensus 215 ---------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 215 ---------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0112357899999999999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=365.18 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=208.8
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|.+..++..||||++.+... .......+.+|+.+++.+ +||||+++++++. ..+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999999875321 223345667899999888 6999999999984 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------------------- 211 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------------------- 211 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 234579999999999987 68999999999999999999999999877655444333210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (414)
.. .....++..+.+||++||..||.+|||+ .++++||||+..
T Consensus 212 -------~~-----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 212 -------EV-----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CC-----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 1123578999999999999999999999 999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=365.79 Aligned_cols=259 Identities=23% Similarity=0.404 Sum_probs=205.8
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|.+..+++.||+|++++... .......+.+|..+++.+ +||||+++++++. ..+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence 469999999999999999999999999975432 223445678899999888 6999999999984 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
|||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+.... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~-----~~~~-- 213 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNT-----EDYL-- 213 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccc-----hHHH--
Confidence 245679999999999987 688999999999999999999999996422110 000000 0000
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt------~~~lL~hp~~~~~ 319 (414)
...+.... ......++..+.+||++||+.||.+|+| ++++++||||..+
T Consensus 214 -~~~~~~~~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 214 -FQVILEKQ----IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred -HHHHHcCC----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00011110 1122457899999999999999999997 7899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=372.92 Aligned_cols=281 Identities=23% Similarity=0.291 Sum_probs=217.5
Q ss_pred CCCeeEeeeecccCceeEEEEEEC--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++ ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~-----~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAY-----RWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeE-----eeC
Confidence 357999999999999999999764 45678999987642 2245799999999999999999988 344
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..+|+|||++.++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 57999999999999999977788999999999999999999999999999999999999999999999999999764432
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC---hhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---VVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.. ...++..+.+.++..+.+...
T Consensus 239 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PD-TPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc-cccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 21 112235679999999999987 689999999999999999999999997654 345566666655544332211
Q ss_pred hhccHHHHHHHHHhcCCC--CCCccCC--CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKP--PVPLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.. .......+....... +...... ...++..+.+||++||..||.+|||+.++|+||||..
T Consensus 316 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NG-STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cc-chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 11 111111111111111 1111111 1245778999999999999999999999999999975
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=370.22 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=212.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++. +..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DDR 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence 479999999999999999999999999999999986422 12233455778999999999999999999983 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||. |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 7999999998 6899888654 6899999999999999999999999999999999999999999999999999765322
Q ss_pred CCccccccccccCccccccccccccC--CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|.+||.+.+.......|......
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-------- 265 (371)
T cd05622 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-------- 265 (371)
T ss_pred Cc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc--------
Confidence 11 1123567999999999986521 23889999999999999999999999987765555444321110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (414)
.. ......++..+.+||.+||..++.+ |++++++++||||++.
T Consensus 266 ------------------~~-~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 266 ------------------LT-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred ------------------cc-CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 00 1122468999999999999844433 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=358.91 Aligned_cols=298 Identities=34% Similarity=0.521 Sum_probs=229.9
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
+...+.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 34456678999999999999999999999999999999986543333334456789999999999999999998865431
Q ss_pred ---CCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 97 ---REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 97 ---~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
......|+||||++++|.+.+... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred cccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 233568999999999998888754 3789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc-cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 173 ARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 173 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
+......... ........++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+.......+..+.|..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9765332211 1112345678899999987652 4578899999999999999999999999888888888888888766
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCcc--CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLF--QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
+..............+. .......... -.....++.+.+||.+||..||.+|||++++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 65443322111110000 0000000000 0011246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=356.87 Aligned_cols=286 Identities=43% Similarity=0.661 Sum_probs=231.7
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC---hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
+|++.+.||+|++|.||+|.+..+++.||||++...... ......+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 589999999999999999999999999999999754332 2334456789999999999999999999843 45
Q ss_pred eEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+.++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 799999999889999998766 7999999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.++|.+.+..+.+..+....+.+....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334578899999987542 467899999999999999999999999988888888887777777655443211
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
... .+ .........+....+...+..+.+||.+||+.||++|||+.++|.||||++...
T Consensus 232 ~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 232 SLP--DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccc--cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 110 10 011112223333445677899999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=362.52 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=212.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCce
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~ 101 (414)
+|++.+.||+|+||+||+|.++.+++.||+|++.+... .......+..|..++..+. |++|+++++++. ..+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCE
Confidence 47889999999999999999999999999999875321 2233456778999988886 577888888873 3457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. |+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999888899999999999999999999999999999999999999999999999999987532221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 1 1234579999999999977 679999999999999999999999998877655544443210
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
......++..+.+|+.+||+.||.+|++ .+++++||||..+
T Consensus 218 ------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 218 ------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0112357889999999999999999997 5799999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=355.31 Aligned_cols=282 Identities=39% Similarity=0.702 Sum_probs=219.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|++|.||+|.++.+++.||+|++..........+.+.+|+.+++.++||||+++++++. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 4799999999999999999999999999999998654322233345778999999999999999999984 34578
Q ss_pred EEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||++++ |..++.....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999999964 555555566799999999999999999999999999999999999999999999999999986543321
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+....+....+...+.........
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999987652 45788999999999999999999999988877776666655544333211111000
Q ss_pred HHHHHHHHhcCCC---CCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 262 KARKYLTEMRKKP---PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 262 ~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.+........ ..+....++.++..+.+||.+||+.||++|||+.+++.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000000 011112245678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=362.53 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=206.6
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|.+..+++.||||+++.... ..........|..+++.. +||||+++++++. +...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999875321 122334566788888764 8999999999984 345699999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. |+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------------- 211 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------------------- 211 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 235579999999999977 67999999999999999999999999887654444333110
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHH-HHhcCCCCCccc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGLA 320 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~-~lL~hp~~~~~~ 320 (414)
.+ .....++..+.+||.+||+.||.+||++. ++++||||..+.
T Consensus 212 --------~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 212 --------NP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred --------CC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 00 01134788999999999999999999996 899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=363.63 Aligned_cols=259 Identities=23% Similarity=0.400 Sum_probs=204.8
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++..+ +||||+++++++. ..+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 479999999999999999999999999976432 233445677899988776 7999999999984 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9999 68999888888999999999999999999999999999999999999999999999999999975322211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~~~-----~~~~-- 213 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNT-----EDYL-- 213 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCC----------ccccc-----HHHH--
Confidence 235679999999999987 6889999999999999999999999953211000 00000 0000
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt------~~~lL~hp~~~~~ 319 (414)
....... .......++..+.+||++||+.||.+||| +.++++||||+..
T Consensus 214 -~~~i~~~----~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 214 -FQVILEK----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred -HHHHhcC----CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0000000 01122467899999999999999999998 5899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=379.97 Aligned_cols=269 Identities=26% Similarity=0.355 Sum_probs=221.7
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.....++|++.+.||+|+||+||+|.+..+++.||||++............+.+|+.++..++|+||+++++.+.....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3345689999999999999999999999999999999997655555666778899999999999999999887754321
Q ss_pred --CCCceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEee
Q 015019 97 --REFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 97 --~~~~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~D 169 (414)
.....+++||||+. |+|.+.+.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 12234789999998 699998865 34689999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
||+++....... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+... .
T Consensus 187 FGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~--~ 261 (496)
T PTZ00283 187 FGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--R 261 (496)
T ss_pred cccCeecccccc-ccccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--C
Confidence 999976533211 112245679999999999987 67999999999999999999999999887655444333210 0
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.....+.+++.+.+|+.+||+.||.+|||+.++|+|||++.+
T Consensus 262 ----------------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 262 ----------------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 001234688999999999999999999999999999998764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=363.42 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=213.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.++..++|+||+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 47999999999999999999999999999999986421 12223345778999999999999999999983 4457
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999998 799999976 467999999999999999999999999999999999999999999999999998754322
Q ss_pred CCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (332)
T cd05623 156 GTV--QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (332)
T ss_pred Ccc--eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------
Confidence 211 12345799999999998531 1468899999999999999999999999877666555543210
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (414)
...++......+++.+.+||++||..++.+ |+|++++++||||.++
T Consensus 225 -----------------~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 225 -----------------ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred -----------------ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 111112223468999999999999765554 6899999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=364.37 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=206.4
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|.+..+|+.||+|++.+... .......+.+|.. +++.++||||+++++++. ..+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 469999999999999999999999999865321 2233445566665 467789999999999883 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|...+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 68999998888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~------------------- 211 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK------------------- 211 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999987 68899999999999999999999999887655444333210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (414)
. ....+..+..+.++|++||+.||.+||++ .++++||||...
T Consensus 212 -------~-----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 212 -------P-----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------C-----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 01224678999999999999999999976 599999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=354.88 Aligned_cols=288 Identities=37% Similarity=0.631 Sum_probs=227.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998754333333456788999999995 699999999886544333345
Q ss_pred EEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEeecCCccc
Q 015019 102 IYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARV 175 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~DFG~a~~ 175 (414)
+|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999988642 35899999999999999999999999999999999999998 89999999999875
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... ......++++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+....+.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 11334578899999987552 46789999999999999999999999999888888888877777765543
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
....... ... ......+.......+.++..+.+||.+||..||.+|||+.++|.||||+
T Consensus 237 ~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLR--DWH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhcc--chh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 2211110 000 0111111222233456899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=354.81 Aligned_cols=285 Identities=38% Similarity=0.691 Sum_probs=223.8
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++.+.||+|++|.||+|.++.+++.||||.+...... .....+.+|+.+++.++|+||+++++++. +.
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 75 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIH-----TK 75 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEe-----cC
Confidence 4567899999999999999999999999999999998653221 12234668999999999999999999984 44
Q ss_pred ceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 76 KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 579999999999999988764 4689999999999999999999999999999999999999999999999999875422
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... ......++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.. ..+++..+.+..+.+.+..+..
T Consensus 156 ~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 156 PSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred CCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 111 11233578889999987652 458889999999999999999999998766 5667777778888777665433
Q ss_pred hccHHHHHHHH-HhcCCCCCCccCCCCCCC--hHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 258 VRNEKARKYLT-EMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 258 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s--~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
..... .+.. ........+.....+.++ ..+.++|.+||+.||.+|||+.++|+||||
T Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNP--EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhcc--ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 22100 0000 000111112222333455 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=374.61 Aligned_cols=281 Identities=25% Similarity=0.320 Sum_probs=211.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|+.++|+||+++++++.. .+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV-----GGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 4579999999999999999999999999999996421 235689999999999999999998743 356
Q ss_pred EEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.|+|||++.++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999988764 469999999999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCCCC------hhhHHHHHHHhcCCCCHH
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKS------VVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~~~------~~~~~~~i~~~~~~~~~~ 253 (414)
. .......+||+.|+|||++.+ ..++.++|||||||+||||++|..+ |.... ...++..+....+....+
T Consensus 315 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 S-TPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred c-cccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1 111234579999999999987 6799999999999999999998754 43321 123344444333322111
Q ss_pred HHHhhccHHHHHHHHHhc----CCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 254 TIAVVRNEKARKYLTEMR----KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
............+..... .....+....+..++..+.+||.+||++||.+|||+.|+|+||||++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 110000111111111110 00111112223457788999999999999999999999999999974
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=354.30 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=203.2
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~ 109 (414)
||+|+||+||+|.++.+++.||+|++..... .......+..|+.+++.++||||+++.+++. ....+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence 7999999999999999999999999875322 1223356778999999999999999999883 445699999999
Q ss_pred C-CCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccc
Q 015019 110 E-SDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (414)
Q Consensus 110 ~-g~L~~~i~----~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (414)
. |+|.+.+. .+..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 68887764 2456999999999999999999999999999999999999999999999999999764332211
Q ss_pred cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHH
Q 015019 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (414)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (414)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------- 211 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------------- 211 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------------
Confidence 234579999999999987 6889999999999999999999999976543211111110
Q ss_pred HHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.... ........+++.+.+|+.+||+.||++|| |++++++||||++.
T Consensus 212 ----~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 212 ----RILN----DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ----hhcc----cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 0000 00112245889999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=353.12 Aligned_cols=258 Identities=34% Similarity=0.587 Sum_probs=213.1
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999998654433444445679999999999999999999944 467899
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
|||++.+ +|.+++.....+++..+..++.||+.||++||+.||+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999996 9999998778899999999999999999999999999999999999999999999999999975411 11
Q ss_pred ccccccccCcccccccccc-ccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 184 VFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
.......++..|+|||++. + ..++.++||||||+++++|++|..||......+....+...........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-------- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH--------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccccc--------
Confidence 2235667999999999987 5 6789999999999999999999999988754444444433221111100
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.. .....+..+.++|.+||+.||++|||+.++++||||
T Consensus 223 -------~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 -------SQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------TT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------cc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 001223789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=365.11 Aligned_cols=278 Identities=24% Similarity=0.345 Sum_probs=209.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
..|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++.. ....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe-----CCee
Confidence 4699999999999999999999999999999985432 23468999999999999999999843 3568
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|||++.++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99999999999998865 4579999999999999999999999999999999999999999999999999997532221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC-CCCCCCCh---------hhHHHHHHHhcCCCC
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV---------VHQLDLITDLLGTPS 251 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~-~pf~~~~~---------~~~~~~i~~~~~~~~ 251 (414)
......||+.|+|||++.+ ..++.++|||||||++|+|+++. ++|.+... ...+..+....+..+
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ---ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 1234579999999999987 67999999999999999999855 45543221 122333333344332
Q ss_pred HHHHHhhccHHHHHHHHHhcC-CCCCCcc--CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 252 PETIAVVRNEKARKYLTEMRK-KPPVPLF--QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..............++..... ..+.... ....+++..+.+||.+||+.||.+||||.|+|+||||+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 221111111111222211110 0111100 0113567889999999999999999999999999999863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=354.08 Aligned_cols=287 Identities=39% Similarity=0.663 Sum_probs=228.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||.|++|+||+|.++.+++.||+|++............+.+|+++++.++||||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 5799999999999999999999999999999998654333333456778999999999999999999984 34579
Q ss_pred EEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEeecCCcccccCC
Q 015019 103 YVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~DFG~a~~~~~~ 179 (414)
|+||||++++|.+.+.... .+++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999999999998887644 3588889999999999999999999999999999999985 567999999999754332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ..+...+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345678999999987652 468899999999999999999999999988888888887777877655543221
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
. ...+................+.+++.+.++|.+||+.||++|||+.++|+||||..+.
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred c--chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1 1111111111111122223457889999999999999999999999999999998764
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=356.25 Aligned_cols=287 Identities=41% Similarity=0.671 Sum_probs=230.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+.|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 45799999999999999999999999999999999754333333445678999999999999999999885432 257
Q ss_pred EEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887643 59999999999999999999999999999999999999999999999999998654332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|.+..+..+..
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12345678899999988652 3468899999999999999999999999998888888888888887766543321
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCC--CChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
-..... ..............++. +++.+.+||++||+.||++|||+.|+|.||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 100000 00111111122233444 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=357.89 Aligned_cols=297 Identities=37% Similarity=0.622 Sum_probs=232.0
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.+...++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 3445689999999999999999999999999999999986433322233456789999999999999999998765432
Q ss_pred --CCCceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 97 --REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 97 --~~~~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
.....+|+||||+.++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++
T Consensus 83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 83 SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred ccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 23456899999999998888765 357999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc--------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 015019 174 RVAFSDTPM--------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (414)
Q Consensus 174 ~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (414)
+........ ....+...|++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 764332211 1112345678999999987652 4688999999999999999999999999999888888888
Q ss_pred hcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
..+.+.+..+.....-..... .......+......+..+++.+.++|.+||+.||.+|||+.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 888776654432211000000 0000111112222345667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=352.69 Aligned_cols=285 Identities=37% Similarity=0.677 Sum_probs=222.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 479999999999999999999999999999999865433333445677899999999999999999998 344579
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+.+ .|..+......+++..++.++.||+.||+|||+.||+||||+|+||++++++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 555555555679999999999999999999999999999999999999999999999999987653322
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
...+...++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+....+.............
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 123456789999999988652 45788999999999999999999999988877777777665555433221111110
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...............+....++.++..+.+|+.+||..||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000001111223356789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=362.32 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=206.0
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|++..+++.||+|++.+... .......+.+|.. +++.++||||+++++++. ..+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 469999999999999999999999999864321 1122334455554 467889999999999883 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------------------- 211 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------------------- 211 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 245679999999999987 68999999999999999999999999887765544443210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHH----HHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE----EALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~----~lL~hp~~~~~ 319 (414)
+ ....+.+++.+.+||.+||+.||.+|+++. ++++|+||...
T Consensus 212 ---------~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 212 ---------P---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred ---------C---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0 012357899999999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=346.45 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=224.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+.|..+++||+|.||.|-+++.+.+++.||||++++..- ...+....+.|-++|+..+||.+..+.-.| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 4678899999999999999999999999999999986533 334556678899999999999999998877 4456
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||.. |.|+-.+.....+++..++++...|+.||.|||+++||.||||.+|+|++.+|.+||.|||+++.....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 7999999998 699999988889999999999999999999999999999999999999999999999999999865443
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ...++||||.|+|||++.. ..|+.++|+|.+||+||||++|+.||.+.+.......|.-..-
T Consensus 322 g~---t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~----------- 385 (516)
T KOG0690|consen 322 GD---TTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL----------- 385 (516)
T ss_pred cc---eeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-----------
Confidence 33 2478999999999999988 7899999999999999999999999999888777666642100
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.-...+|++++.|+..+|..||.+|. .|.++.+|+||.++
T Consensus 386 --------------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 386 --------------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred --------------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 11246899999999999999999997 48999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=353.06 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=210.3
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++. ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 48999999999999999999999999999999864322 2222345678999999999999999999883 33579
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+||||+. ++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 6888877543 46999999999999999999999999999999999999999999999999999764322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 11 134578999999999977 67899999999999999999999999876543332222111
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
+... .......+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 217 ----------~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 ----------VKED----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------hhhc----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0000 0112245788999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=349.92 Aligned_cols=281 Identities=40% Similarity=0.665 Sum_probs=229.2
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++|||++++++++. +....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 78899999999999999999999999999998754333333456778999999999999999999984 3457999
Q ss_pred EEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 105 VFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 105 V~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
||||++++|.+++.... .+++..+..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999997765 799999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
......++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+.+..++|....+.....
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS-- 229 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh--
Confidence 11334578899999987652 4578899999999999999999999999888888888888888887665433211
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...+................+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 112222222222223333456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=360.07 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=212.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.++..++|+||+.+++++ .+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986521 1223344577899999999999999999998 44467
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999976 468999999999999999999999999999999999999999999999999999765332
Q ss_pred CCccccccccccCccccccccccccC---CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE--------- 224 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC---------
Confidence 211 113357999999999886421 357889999999999999999999998877655544443210
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (414)
...++......++..+.+||.+||..++.+ |++++++++||||+..
T Consensus 225 -----------------~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 225 -----------------ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred -----------------CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 111122233467899999999999976654 5699999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=365.98 Aligned_cols=258 Identities=24% Similarity=0.315 Sum_probs=204.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+.|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++ ...+.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 357899999999999999999999999999999986432 233456788999999999999999999998 44567
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||.+ +|.. ....++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999994 6643 2346788889999999999999999999999999999999999999999999998653321
Q ss_pred CccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
. .....+||..|+|||++... ...++.++|||||||++|+|++|+.||......+....+...
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----------- 288 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----------- 288 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----------
Confidence 1 12345799999999987431 123456899999999999999999999743322211111110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.... .......++..+.+||.+||+.||++|||+.|+|+||||..-
T Consensus 289 -------------~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 289 -------------CMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -------------hccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0000 011224678999999999999999999999999999999874
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=365.23 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=203.6
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCCCCCceEEEEE
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
||+|+||+||+|.+..+++.||||++.+... ..........|..++..+ .||||+++++++ .....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 7999999999999999999999999864221 222334456677777665 699999999998 3445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------- 212 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG------------------- 212 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 2456799999999998652 45899999999999999999999999887654443333210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC----CHHHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp----t~~~lL~hp~~~~~ 319 (414)
.... ....+++.+.+||++||+.||.+|| ++.++++||||...
T Consensus 213 -------~~~~----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 213 -------KVRF----PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred -------CCCC----CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 0000 0124788999999999999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=360.38 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=204.8
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||+||+|.+..+++.||+|++.+... .......+.+|.. +++.++||||+++++++ .+.+.+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 479999999999999999999999999864321 2223344556654 57889999999999988 3445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
|||. ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 68998888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999977 6799999999999999999999999988765444333321
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (414)
.. ....+..+..+.++|.+||+.||.+|+++ .++++||||..+
T Consensus 211 ------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 ------KP-----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred ------CC-----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 00 01224578899999999999999999975 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=351.42 Aligned_cols=281 Identities=38% Similarity=0.677 Sum_probs=226.3
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++++.||.|++|.||+|.+..+|..||||++..... ......+.+|+.+++.++||||+++++.+.. .+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEE
Confidence 58999999999999999999999999999999875422 2234456789999999999999999999843 35689
Q ss_pred EEEecCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||||+.++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||++++++.++|+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999988754 368999999999999999999999999999999999999999999999999997543221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .....+++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+....+.+..+.|....+.....
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678999999987552 4578899999999999999999999999998888888888888887665443321
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
. ..+................+..+..+.++|.+||+.||.+|||+.++++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111111122234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=344.81 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=212.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC---hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+.|++.+.||+|++|.||.|.+..++..||+|.+...... ......+.+|+.+++.++||||+++++++. +.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 4699999999999999999999999999999998643222 123456788999999999999999999983 34
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+|+||+. ++|.+.+...+.+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 57999999998 59999998888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
............|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------- 223 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP----------- 223 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-----------
Confidence 2221111134568899999999987 568999999999999999999999997655433322221100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
........++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 224 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 ------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0011224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=357.98 Aligned_cols=283 Identities=23% Similarity=0.365 Sum_probs=216.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||.|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++.. .+.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCE
Confidence 368999999999999999999999999999999887532 23445678899999999999999999999843 457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 69999998888899999999999999999999985 7999999999999999999999999998754322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHH-hcCCCCHHHHHh-
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGTPSPETIAV- 257 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~- 257 (414)
. ....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.. ..+.+.......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 134579999999999977 6789999999999999999999999987654332221110 111111000000
Q ss_pred ----------hc-----cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 ----------VR-----NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ----------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.. ................... .....+.++.+||.+||+.||++|||+.+++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00 0000011111111111111 012367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=356.34 Aligned_cols=253 Identities=29% Similarity=0.397 Sum_probs=208.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcE-EEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.....+.+.||+|+||+||+|... |.. ||+|++............+.+|+.+|..++|||||++++++..+..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 345566777999999999999765 556 9999998655444447789999999999999999999999954431
Q ss_pred eEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCCEEEcCCC-CeEEeecCCccc
Q 015019 101 DIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANC-KLKVCDFGLARV 175 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~g-ivHrDlkp~NILl~~~~-~vkL~DFG~a~~ 175 (414)
.++||||||. |+|.+++.. ...++...+..|+.||++|+.|||+++ ||||||||+|||++.++ .+||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 5899999999 799999987 578999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... ...+...||..|||||++.+....|+.++||||+|++||||+||+.||.+.........+.....+|.
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 54432 12244679999999999984116899999999999999999999999999887444333322111111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....++.+..|+.+||..||.+||+..+++.
T Consensus 267 -------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 -------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11237889999999999999999999998875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=348.43 Aligned_cols=280 Identities=39% Similarity=0.727 Sum_probs=222.4
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
|++++.||+|+||.||+|.+..+++.||+|+++....... .....+|+.+++.+. |+||+++++++... ..+.+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 7899999999999999999999999999999876433322 234457999998885 99999999998543 225689
Q ss_pred EEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
+||||+.++|.+.+... ..+++..+..++.||+.||+|||+.||+||||||+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999988763 57899999999999999999999999999999999999999 9999999999976533222
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
.....++..|+|||.+... ..++.++|||||||++|+|++|.+||++.+..+.+..+....|.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1345688999999976442 457889999999999999999999999999888888888888887765532221111
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...+ ..............+.++..+.+||.+||..||++|||++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000001111112234678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=358.18 Aligned_cols=258 Identities=21% Similarity=0.385 Sum_probs=205.6
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++..+ .||||+.+++++. ..+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 479999999999999999999999999975422 223445678899999888 6999999999983 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
|||. ++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---------~~-----------~~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TE-----------DY 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------cH-----------HH
Confidence 245679999999999987 688999999999999999999999996432110000 00 00
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCccc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGLA 320 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt------~~~lL~hp~~~~~~ 320 (414)
........ + ......++..+.++|++||+.||.+|++ .+++++||||+.+.
T Consensus 211 ~~~~~~~~-~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 211 LFQVILEK-P---IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHhC-C---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 00000000 0 0122457899999999999999999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=362.68 Aligned_cols=259 Identities=29% Similarity=0.539 Sum_probs=220.3
Q ss_pred CCCCeeE--eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 21 DANRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+..-|+| -+.||+|.||+||-|.++.+|+.||||++.+..........+.+|+.||+.+.||.||.+.-.|. .
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-----T 634 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-----T 634 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-----C
Confidence 3344655 47899999999999999999999999999876555566678889999999999999999999884 4
Q ss_pred CceEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CCeEEeecCCc
Q 015019 99 FKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLA 173 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~vkL~DFG~a 173 (414)
...+++|||-+.|++.++|.+ .+++++...++++.||+.||.|||-+||+|+||||+|||+.+. -++||||||+|
T Consensus 635 ~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 635 PERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred CceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccce
Confidence 456999999999999998875 4689999999999999999999999999999999999999765 35999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh-hHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 252 (414)
|...+.. +....+||+.|.|||++.+ +.|...-||||+|||+|--+.|..||....+. +|++.- .+.-.|
T Consensus 715 RiIgEks----FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-aFMyPp-- 785 (888)
T KOG4236|consen 715 RIIGEKS----FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-AFMYPP-- 785 (888)
T ss_pred eecchhh----hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-ccccCC--
Confidence 9976543 4567899999999999988 79999999999999999999999999654432 222211 111111
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..|..+++++.|||..+|++.-++|.|++..|.|||+++..
T Consensus 786 ---------------------------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 786 ---------------------------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ---------------------------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 23568999999999999999999999999999999998753
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=348.57 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=217.6
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
-|.++.+||+|+||.||+|+++.+|..||||++.. ..+.+.+..|+.||++++.|++|++|+.|.- ..+++
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceE
Confidence 47889999999999999999999999999999864 3678889999999999999999999998844 34699
Q ss_pred EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 104 VVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
+|||||+ |+..++++. +++++++++..+++..+.||.|||...-+|||||..|||++.+|..||+|||.|.......
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM- 183 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM- 183 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence 9999999 899999976 5689999999999999999999999999999999999999999999999999997653322
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
....+.+||+.|||||++.. -.|+..+||||||+...||..|+|||.+-.....+-.|
T Consensus 184 --AKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------ 241 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------ 241 (502)
T ss_pred --HhhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------------
Confidence 22356789999999999987 78999999999999999999999999775543322211
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+. .+.|.......+|.++.|++++||..+|++|.||-++++|||+++-
T Consensus 242 ---------PT-~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 ---------PT-KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ---------cC-CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 11 1112223334578999999999999999999999999999999863
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=350.69 Aligned_cols=286 Identities=40% Similarity=0.690 Sum_probs=224.8
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|++|.||+|.+..+++.||+|+++...........+.+|+++++.++|+||+++++++.. .+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 47999999999999999999999999999999987543434445678899999999999999999999843 4569
Q ss_pred EEEEecCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQV-IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~-i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+++++.+. ......+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999765554 44456799999999999999999999999999999999999999999999999999977544332
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....++++.+|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+....+...+.........
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998772 37889999999999999999999999988888777777777776655433222111
Q ss_pred HHHHHHHHhcCCCCCCccCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
....-...............++. ++..+.+||++||..||++|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000000000000001111223 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=352.90 Aligned_cols=288 Identities=37% Similarity=0.617 Sum_probs=219.8
Q ss_pred CeeEeeeecccCceeEEEEEECC--CCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
+|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 59999999999999999999988 89999999987532 1122335577899999999999999999998543 225
Q ss_pred eEEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC----CCCeEEeecC
Q 015019 101 DIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA----NCKLKVCDFG 171 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~----~~~vkL~DFG 171 (414)
.+|+||||++++|.+.+... ..+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 79999999999888877532 36899999999999999999999999999999999999999 8999999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh---------hHHHH
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---------HQLDL 242 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~---------~~~~~ 242 (414)
+++...............+++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998654332211122345789999999987652 46889999999999999999999999866543 34566
Q ss_pred HHHhcCCCCHHHHHhhccH-HHHHHHHHhcCCCCCC------ccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 243 ITDLLGTPSPETIAVVRNE-KARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
+...++.+.+......... ......+... ....+ ....+...+..+.++|.+||+.||++|||+.++++|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 6666776655443221111 1111111110 00000 00111257788999999999999999999999999999
Q ss_pred C
Q 015019 316 F 316 (414)
Q Consensus 316 ~ 316 (414)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=372.17 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=213.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCC-CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
..|.+.+.||+|++|.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++++. ..+.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCE
Confidence 3599999999999999999998887 78899997653 23344556778999999999999999999984 4457
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+||||||+. |+|.+.+.. ..++++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 699887753 457999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.. +..
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--~~~------ 288 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--GKY------ 288 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC------
Confidence 33221 112245679999999999987 6899999999999999999999999988776554444321 100
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
. .....+++.+.+||.+||..||++|||+.++|.|||++.+
T Consensus 289 -----------------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 -----------------D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -----------------C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0 1123578899999999999999999999999999999754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=384.39 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=215.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.++||||++++++|... ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence 445789999999999999999999999999999999876545555667788999999999999999999988543 23
Q ss_pred ceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccCCCCCCCEEEcC------
Q 015019 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-------NVYHRDLKPKNILANA------ 161 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~-------givHrDlkp~NILl~~------ 161 (414)
..+|||||||. ++|.++|.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999998 699998865 35799999999999999999999995 4999999999999964
Q ss_pred -----------CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC
Q 015019 162 -----------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (414)
Q Consensus 162 -----------~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p 230 (414)
.+.+||+|||++....... .....+||+.|+|||++.+....++.++||||||||||+|++|..|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2348999999997653222 1234579999999999865335689999999999999999999999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
|...+....+..... .... ......+..+.+||..||..+|.+|||+.|+
T Consensus 243 F~~~~~~~qli~~lk--------------------------~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 243 FHKANNFSQLISELK--------------------------RGPD----LPIKGKSKELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred CCcCCcHHHHHHHHh--------------------------cCCC----CCcCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence 976554433222211 1110 1123568899999999999999999999999
Q ss_pred hcCCCCCccc
Q 015019 311 LADPYFKGLA 320 (414)
Q Consensus 311 L~hp~~~~~~ 320 (414)
|.|||+..+.
T Consensus 293 L~h~~ik~i~ 302 (1021)
T PTZ00266 293 LGYQIIKNVG 302 (1021)
T ss_pred hccHHHhhcC
Confidence 9999998654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=345.46 Aligned_cols=285 Identities=37% Similarity=0.611 Sum_probs=218.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++++.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++. ..
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~ 75 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIH-----TK 75 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cC
Confidence 345789999999999999999999999999999999864322 122335678999999999999999999984 34
Q ss_pred ceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...|+||||+.++|.+.+.. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 56899999999988887765 35688999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .....++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+ ..+.+..+....|.|.+.....
T Consensus 156 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQT---YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCC---CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 2111 1334578999999988652 457889999999999999999999997655 3456666666777776554332
Q ss_pred hccHHHHHHHHH-hcCCCCCCccCCCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 258 VRNEKARKYLTE-MRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 258 ~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.... ..+... .....+......+. ..++.+.+++.+||..||.+|||+.|++.||||
T Consensus 232 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 2110 000000 00111111111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=335.72 Aligned_cols=279 Identities=25% Similarity=0.389 Sum_probs=218.8
Q ss_pred eeE-eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceE
Q 015019 25 YKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 25 Y~i-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~ 102 (414)
|++ .+.||+|+|+.|-.+....||..||||++.+... -...++.||++++.+++ |+||+.++++| ++...+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 444 5789999999999999999999999999987533 34568999999999995 99999999999 566679
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CCeEEeecCCcccccC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAFS 178 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~vkL~DFG~a~~~~~ 178 (414)
|||||-|. |.|...|..+..+++.++..+++.|+.||.|||.+||.||||||+|||-... ..||||||.++.....
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999998 6999999999999999999999999999999999999999999999997654 4599999999865433
Q ss_pred CCC----ccccccccccCccccccccc---cccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 179 DTP----MTVFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 179 ~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
+.+ .+..+.+.||+..|||||+. .+....|+...|.||||||+|.||+|.+||.|.-..+.- --.|.+-
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~C 307 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEVC 307 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCcc
Confidence 222 22334567899999999975 343467999999999999999999999999875432100 0000000
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
..=-...+..+......-....|..+|.+++|||+.+|..|+.+|.+|.++|+|||++.....
T Consensus 308 --------r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 308 --------RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred --------HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 000011222232222222234567899999999999999999999999999999999887544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=323.68 Aligned_cols=288 Identities=30% Similarity=0.584 Sum_probs=231.4
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 96 (414)
.||..+.|++++++|+|.|+.|+.|++..+++.++||+++. ...+++.||+.||+.|. ||||++++++..++.
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~- 106 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE- 106 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc-
Confidence 78999999999999999999999999999999999999874 55678999999999997 999999999997653
Q ss_pred CCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCcc
Q 015019 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a~ 174 (414)
.....||+||.+. +...+. +.++.-.++.+++||+.||.||||+||.|||+||.|++|+.. -.++|+|+|+|.
T Consensus 107 --SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 --SKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred --ccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 2456899999994 665554 358999999999999999999999999999999999999965 569999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCCCHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
.+..... ++-.+.+++|--||++... ..|+..-|||||||+|+.|+..+.| |.|.++.+|+.+|.+++|+..-.
T Consensus 182 FYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 182 FYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred hcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 7654432 3456789999999999875 7899999999999999999998855 58999999999999999975432
Q ss_pred -HHHhhccHHHHHHHHHhcCCCCCCccCCC-----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 254 -TIAVVRNEKARKYLTEMRKKPPVPLFQKF-----PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.+..+.-....++-..+......++..-. .-+++++.|||.++|..|..+|+||.+++.||||.....
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 22222221112222212222221111110 125799999999999999999999999999999986543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.10 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=227.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..+-|.+.+.||+|.|++|.+|++..|+..||||.+++...+......+.+|+++|+.++|||||+++.+.. ...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-----t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-----TEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-----ecc
Confidence 345799999999999999999999999999999999988777777777999999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+. |++++++..++++.+..++.++.|++.|++|||+++|||||||++|||++.+..+||+|||++......
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 6999999998 799999999999999999999999999999999999999999999999999999999999999876533
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ...++||++.|.|||++.+. ...++.+|+||+|+++|.|+.|..||.|.+....-...
T Consensus 209 ~----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------- 267 (596)
T KOG0586|consen 209 L----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------- 267 (596)
T ss_pred c----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh----------------
Confidence 2 34688999999999999885 45678999999999999999999999998744322111
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
-.......-.++.++.+||++||..+|.+|++.+++..|.|.......
T Consensus 268 ---------------l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 268 ---------------LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ---------------eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 111112223578999999999999999999999999999999766543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.63 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=208.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++|++|+.+++.+. ....+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 48889999999999999999999999999999864322 2223345778999999999999999999883 34579
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+||||+. ++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 6898888543 36899999999999999999999999999999999999999999999999998754322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+............
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-------------- 215 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------- 215 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh--------------
Confidence 11 123479999999999977 6799999999999999999999999976542211111100
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
...... ......+++.+.+||.+||+.||.+||| ++++++||||..+
T Consensus 216 ------~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 216 ------LVKEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ------hhhhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 000000 0112457889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=354.04 Aligned_cols=293 Identities=39% Similarity=0.590 Sum_probs=231.5
Q ss_pred cCCCCCeeE-eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChH------------HHHHHHHHHHHHHhCCCCCcc
Q 015019 19 YGDANRYKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS------------DAIRILREVKLLRLLRHPDIV 85 (414)
Q Consensus 19 ~~~~~~Y~i-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpniv 85 (414)
++..+||.. .+.||+|+||+||+|.+..+++.||||++........ ....+.+|+.+++.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 456788975 5779999999999999999999999999864322110 012467899999999999999
Q ss_pred ccceeecCCCCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCe
Q 015019 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (414)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~v 165 (414)
++++++. .....|+||||+.++|.+++.....+++..+..++.||+.||+|||+.||+||||+|+||+++.++.+
T Consensus 84 ~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYV-----EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEe-----cCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 9999984 33568999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCC-----------CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC
Q 015019 166 KVCDFGLARVAFSDT-----------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (414)
Q Consensus 166 kL~DFG~a~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~ 234 (414)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997654111 011112334578899999988653 45789999999999999999999999999
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 015019 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (414)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp 314 (414)
+..+.+..+....+.|....+..... ...+ .......+.......+..+..+.++|.+||+.||++|||++++|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKK--LPLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhh--cccc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 98888888888888877653321110 0000 00111111222233456788999999999999999999999999999
Q ss_pred CCCccc
Q 015019 315 YFKGLA 320 (414)
Q Consensus 315 ~~~~~~ 320 (414)
||+...
T Consensus 315 ~~~~~~ 320 (335)
T PTZ00024 315 YFKSDP 320 (335)
T ss_pred ccCCCC
Confidence 998754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=335.93 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=211.4
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.|++++.||+|++|.||+|.++.+++.||+|++............+.+|+.+++.++|+|++++++.+.. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4999999999999999999999999999999987544444556678899999999999999999887632 234589
Q ss_pred EEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||||+. ++|.+++.. ...+++..++.++.|++.||++||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 689998876 3468999999999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ......|++.|+|||++.+ ..++.++|+|||||++++|++|+.||.+.+.......+... .
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--~----------- 218 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--K----------- 218 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--C-----------
Confidence 1 1234568999999999877 67899999999999999999999999876644433322110 0
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.......+++.+.+||.+||+.||++|||+.+++.||||
T Consensus 219 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 219 -----------------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 001123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=343.90 Aligned_cols=282 Identities=47% Similarity=0.765 Sum_probs=232.1
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
|++.+.||+|++|.||+|.+..+++.+|+|++............+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 678899999999999999999999999999987654443455678899999999999999999998843 356999
Q ss_pred EEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 105 VFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 105 V~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
|+||+.++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 999999999988876 3589999999999999999999999999999999999999999999999999997654432
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
.......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||++.+..+.+..+....+.+.+..+.....-.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA- 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh-
Confidence 122345688899999998762 378999999999999999999999999999988888888888888766554433211
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...................+.++..+.+||.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111122222222233445688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=343.87 Aligned_cols=281 Identities=43% Similarity=0.717 Sum_probs=232.3
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 678899999999999999999999999999998654333445567789999999999999999999843 356999
Q ss_pred EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
||||++++|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5899999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
......++..|+|||.+.+. ..++.++|||||||++++|++|++||.+.+..+.+..+...++.+.+..+....+-.
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12344567889999998662 478999999999999999999999999999988999998888888876654433221
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.+-..............++.++..+.++|++||..||++|||+.++++||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111112222223334456778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.69 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=200.6
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~ 109 (414)
||+|+||.||++.++.+|+.||+|++...... ......+..|+.+++.++||||+++++++ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 79999999999999999999999998643221 12233456799999999999999999988 3445799999999
Q ss_pred C-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 110 E-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 110 ~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
. ++|.+.+... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++........ .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----I 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----e
Confidence 8 6898887543 3589999999999999999999999999999999999999999999999999876533221 2
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (414)
....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR--------------------- 208 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---------------------
Confidence 34568999999999977 5699999999999999999999999976432111111100
Q ss_pred HHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCccc
Q 015019 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGLA 320 (414)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~----~~lL~hp~~~~~~ 320 (414)
..... ........+++++.+||++||+.||.+|||+ ++++.||||+.+.
T Consensus 209 --~~~~~---~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 209 --RTLED---EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred --Hhhcc---ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 00000 0001123578999999999999999999999 7788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=353.33 Aligned_cols=267 Identities=27% Similarity=0.438 Sum_probs=210.1
Q ss_pred cccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceee
Q 015019 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIM 91 (414)
Q Consensus 13 ~~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~ 91 (414)
..+++..| ..|++++.||+||.+.||++... ....||+|++.....+......+..|+..|.+|+ |.+||.|+++-
T Consensus 353 ~~~i~Vkg--~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 353 NEIIKVKG--REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred CeeEEECc--chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 34555544 67999999999999999999754 4456888887766667778888999999999995 99999999987
Q ss_pred cCCCCCCCceEEEEEecCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeec
Q 015019 92 LPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~-l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DF 170 (414)
.. .+.+||||||-+.||..++++... ++.-.++.+.+|+|.|++++|..||||.||||.|+|+-. |.+||+||
T Consensus 430 v~-----d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDF 503 (677)
T KOG0596|consen 430 VT-----DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDF 503 (677)
T ss_pred cc-----CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeee
Confidence 54 356999999999999999988653 444688999999999999999999999999999998764 58999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCC---------CCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHH
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~ 241 (414)
|+|......+ ........+||+.|||||.+..... ..++++||||||||||+|+.|++||.. ...++.
T Consensus 504 GIA~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--~~n~~a 580 (677)
T KOG0596|consen 504 GIANAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--IINQIA 580 (677)
T ss_pred chhcccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--HHHHHH
Confidence 9998765543 3334467899999999998854211 267899999999999999999999953 222222
Q ss_pred HHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCC--hHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
++..+. .|. -.-.|+.++ .++.++++.||..||.+|||+.++|+|||+..
T Consensus 581 Kl~aI~-~P~--------------------------~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 581 KLHAIT-DPN--------------------------HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHhhc-CCC--------------------------ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 222111 111 011233333 23899999999999999999999999999975
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=345.11 Aligned_cols=283 Identities=25% Similarity=0.386 Sum_probs=215.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++++.++||||+++++++. ..+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEE
Confidence 36999999999999999999999999999999987532 2334556889999999999999999999984 44579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999998 599999999999999999999999999987543221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH------
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET------ 254 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 254 (414)
....+|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+...........
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 234578999999999876 6789999999999999999999999987664332222211100000000
Q ss_pred ---HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 255 ---IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 255 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
....................+ + ......++.++.+|+.+||..||++|||+.++++||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPP-P-KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCC-c-cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 000000001111111111111 0 011123688899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=384.19 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=226.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|.|+++||+|+||.|.+++++.|++.||+|++++... ...+...+..|-.+|-.-+.+=|+.++-.| .+.+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 3679999999999999999999999999999999986322 234556688899999988999999999988 6667
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
++|+|||||. |||..++...+++++..+++|+..|+.||.-||+.|+|||||||+|||++..|+|||+|||.|-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 8999999998 699999998889999999999999999999999999999999999999999999999999999766543
Q ss_pred CCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....||||.|.|||++... .+.|++.+|+||+||++|||++|..||...+..+.+.+|++--
T Consensus 229 G~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk--------- 297 (1317)
T KOG0612|consen 229 GTV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK--------- 297 (1317)
T ss_pred CcE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh---------
Confidence 322 33567999999999998532 1569999999999999999999999999999998888887521
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGLA 320 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt---~~~lL~hp~~~~~~ 320 (414)
....|. .-..+|++++|||+++|. +|+.|.. ++++-+||||.++.
T Consensus 298 -----------------~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 298 -----------------ESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred -----------------hhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 011111 113599999999999998 8899998 99999999998863
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=342.60 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=210.7
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+|+.++|+||+.+.+.+. ..+.+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence 48889999999999999999999999999999865322 2223345778999999999999999998883 34579
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+||||+. ++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999 5888777543 46999999999999999999999999999999999999999999999999998754322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+......
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~---------- 219 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE---------- 219 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc----------
Confidence 1 1234579999999999977 67999999999999999999999999876654333332211100
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
. .......+++.+.+|+.+||+.||.+||| +.+++.||||+..
T Consensus 220 -------------~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 220 -------------T----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -------------c----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0 00122457889999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=342.15 Aligned_cols=254 Identities=25% Similarity=0.472 Sum_probs=214.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 479999999999999999999999999999999864321 2334567889999999999999999999983 4457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||+|.||+++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999995 799999988889999999999999999999999999999999999999999999999999999765433
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
....+|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.. +.
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~----------- 214 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GK----------- 214 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC-----------
Confidence 134468999999999876 5788999999999999999999999987664333333221 00
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCccc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (414)
. .....++..+.++|++||..||.+|+ +++++++||||+.+.
T Consensus 215 -------------~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 215 -------------V-----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -------------c-----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 0 11235688999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.65 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=199.5
Q ss_pred CCeeEeeeecccCceeEEEEEE-----CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|++++.||+|+||.||+|.+ ..+++.||+|++... ........+.+|+.+|..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 6899999999999999999975 345678999998743 2234456788999999999 899999999987432
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC-------------------------------------------------------
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------- 120 (414)
...+|+|||||. |+|.+++...
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 245899999998 7999988642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCc
Q 015019 121 -------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (414)
Q Consensus 121 -------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~ 193 (414)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~ 240 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPL 240 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCc
Confidence 24778889999999999999999999999999999999999999999999999764322111 1112334667
Q ss_pred cccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcC
Q 015019 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (414)
Q Consensus 194 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (414)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..... .
T Consensus 241 ~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~--------------------------~ 292 (338)
T cd05102 241 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK--------------------------D 292 (338)
T ss_pred cccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh--------------------------c
Confidence 8999999877 679999999999999999997 9999987553322211110 0
Q ss_pred CCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... .......++.+.+|+.+||+.||.+|||+.++++
T Consensus 293 ~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 293 GTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=333.08 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=212.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++. +.+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 488999999999999999999999999999998754444556677889999999999999999999984 345799
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 6999998764 578999999999999999999999999999999999999999999999999988654332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ......|+..|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------- 217 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 1 1234568899999999877 678999999999999999999999998776544333322100
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.......++..+.++|.+||+.+|++||++.+++.|||+
T Consensus 218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 -----------------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 001112567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=345.23 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=215.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++.+.||+|++|+||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 4799999999999999999999999999999999764332 23556788999999999999999999998 34467
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999998 5999988754 5799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCc--------------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCC
Q 015019 179 DTPM--------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (414)
Q Consensus 179 ~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~ 232 (414)
.... .......+||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 2110 001124578999999999987 678999999999999999999999998
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC----HH
Q 015019 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT----AE 308 (414)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt----~~ 308 (414)
+.+....+..+.. .... ......++..+.++|.+||..||++||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KEVT---FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CCcc---CCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 7775544433321 0000 0111237899999999999999999999 99
Q ss_pred HHhcCCCCCccc
Q 015019 309 EALADPYFKGLA 320 (414)
Q Consensus 309 ~lL~hp~~~~~~ 320 (414)
++|+||||++..
T Consensus 285 ~ll~~~~~~~~~ 296 (316)
T cd05574 285 EIKQHPFFRGVN 296 (316)
T ss_pred HHHcCchhhcCC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=340.53 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=209.0
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.+++.++||||+++++++. ...
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~ 79 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRD 79 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCC
Confidence 346899999999999999999999999999999998653 2233456778999999999999999999883 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 7899999998 699999988889999999999999999999999999999999999999999999999999998754322
Q ss_pred CCccccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ......|+..|+|||.+.. ....++.++|+|||||++|+|++|.+||........+..+...
T Consensus 160 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06645 160 IA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS------------ 224 (267)
T ss_pred cc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc------------
Confidence 11 1234578999999998742 1146889999999999999999999998655432222111100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
...+ +.......++..+.++|.+||..||++|||++++++|||
T Consensus 225 -------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 -------------NFQP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------CCCC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0000 001111246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=351.83 Aligned_cols=286 Identities=21% Similarity=0.294 Sum_probs=207.8
Q ss_pred Eeeeeccc--CceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 27 ILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 27 i~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
++++||+| +||+||++.++.+|+.||+|++............+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence 57889999 67899999999999999999997654444455667789999999999999999999843 356899
Q ss_pred EEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 105 VFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 105 V~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 6999988653 4689999999999999999999999999999999999999999999999987644321111
Q ss_pred c----cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC------
Q 015019 182 M----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS------ 251 (414)
Q Consensus 182 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 251 (414)
. .......+++..|+|||++.+....|+.++|||||||++|+|++|..||............. .+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCcccccccc
Confidence 0 01112235778899999986532468999999999999999999999998765433322221 11111
Q ss_pred ---HHHHHhhccHH-HH-HHHHHh------cCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 252 ---PETIAVVRNEK-AR-KYLTEM------RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 252 ---~~~~~~~~~~~-~~-~~~~~~------~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
++.+....... .. ...... ..............+++.+.+||++||+.||++|||++++|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00000000000 00 000000 0000000011123467899999999999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=345.36 Aligned_cols=291 Identities=38% Similarity=0.627 Sum_probs=227.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-----C
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-----K 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 96 (414)
.++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 36899999999999999999999999999999998754332233345678999999999999999999885532 1
Q ss_pred CCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+...+|+|+||+++++...+... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123479999999999888888764 4699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
....... ......++..|+|||.+.+. ..++.++|||||||++++|++|++||...+..+.+..+....+.+.+..+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5433221 11233567889999987652 45788999999999999999999999988888888888888887766543
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
............+.. ..........+..++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 222110000000000 000011122344678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=336.98 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=208.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 469999999999999999999999999999999864322 223445688999999999999999999987432 23
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+++||+. ++|.+.+...+.+++...+.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 56899999998 59999998878899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
............++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||........+..+.. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~------- 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT------- 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC-------
Confidence 1111111233458889999999877 6789999999999999999999999976543332222110 000
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
. ......+++.+.+|| +||..+|++|||++++++||||+
T Consensus 227 -----------------~--~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 -----------------N--PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -----------------C--CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0 011134678889999 57778999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=342.40 Aligned_cols=263 Identities=27% Similarity=0.470 Sum_probs=215.4
Q ss_pred ccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 16 ~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
...-+...+|++++.||+|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.+.||||+++++.+..
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-- 88 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-- 88 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEe--
Confidence 3444666899999999999999999999999999999999875322 334668899999999999999999998843
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
....|+||||+. ++|.+++.. ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 89 ---~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 89 ---GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred ---CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccch
Confidence 356899999998 589988864 468999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
....... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+.. .+
T Consensus 165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~------ 232 (296)
T cd06654 165 QITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NG------ 232 (296)
T ss_pred hcccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CC------
Confidence 6432211 1234568999999999877 6788999999999999999999999987664333222210 00
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+.......++..+.+||.+||..||.+|||+.++++||||...
T Consensus 233 ---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 233 ---------------------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ---------------------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00111124578889999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=341.77 Aligned_cols=283 Identities=40% Similarity=0.679 Sum_probs=227.1
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|||++++++++.... ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999865433344556789999999999999999999985431 257999
Q ss_pred EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
||||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.+||+|||++.........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-
Confidence 9999999999988765 57999999999999999999999999999999999999999999999999999865443211
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
..+...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....+..+.+..+.+....+.....-..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 12344578899999977652 4688999999999999999999999999988888888888888776655432221100
Q ss_pred HHHHHHhcCCC--CCCccCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 264 RKYLTEMRKKP--PVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 264 ~~~~~~~~~~~--~~~~~~~~~~-~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
........ +..+...+.. .++.+.++|++||..||.+|||+.+++.||||
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 ---FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ---hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000 0011112233 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.85 Aligned_cols=263 Identities=23% Similarity=0.387 Sum_probs=211.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...+.|++++.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----D 81 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----C
Confidence 344789999999999999999999999999999999875 234456678899999999999999999998843 3
Q ss_pred ceEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
+.+|+||||+.+ +|..++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 569999999994 77776654 4578999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
.... ......++..|+|||.+.+. ...++.++|+|||||++|+|++|.+||...+.......+..
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------- 229 (292)
T cd06644 162 KTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------- 229 (292)
T ss_pred cccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---------
Confidence 2211 11345688899999988531 14578899999999999999999999976554332222211
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
. ..+.......++..+.+||.+||..||++|||++++++||||..+.
T Consensus 230 ------------------~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 230 ------------------S-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ------------------C-CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 0011112245788899999999999999999999999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=337.86 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=208.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++. ..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SR 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eC
Confidence 34468999999999999999999999999999999986432 233446778999999999999999999984 33
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 56899999999 69999998888899999999999999999999999999999999999999999999999999976532
Q ss_pred CCCccccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... ......|+..|+|||.+.. ....++.++|+||+||++|+|++|..||...........+...
T Consensus 159 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 224 (267)
T cd06646 159 TIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----------- 224 (267)
T ss_pred ccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-----------
Confidence 211 1134568899999998743 1145788999999999999999999999654432221111000
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
....+.......++..+.+||++||..||++|||++++|+|+|
T Consensus 225 ---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 ---------------NFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ---------------CCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000001112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=338.45 Aligned_cols=282 Identities=37% Similarity=0.623 Sum_probs=222.9
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCCCCCce
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~~~ 101 (414)
|++++.||+|+||.||+|.++.++..||+|++............+.+|+.+++.+ +||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999975444333344566788877666 5999999999986654334446
Q ss_pred EEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|++|||+.++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 5899999999999999999999999999999999999999999999999999765332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 133457889999999977 678999999999999999999999999998888888887766655433221111
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.... ...............+.+++.+.+||.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPR----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccch----hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000 0011111122223334678889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=339.76 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=214.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
...+|++++.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+. ...
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFL-----VGD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCc
Confidence 4468999999999999999999999999999999986432 233456789999999999999999999984 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|+||+. ++|..++.. ..+++.++..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 7999999998 588887764 46999999999999999999999999999999999999999999999999998764332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... +
T Consensus 169 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~----------- 231 (296)
T cd06655 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G----------- 231 (296)
T ss_pred cc---cCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-----------
Confidence 21 1134568899999999877 67889999999999999999999999887654443332110 0
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.+.......+++.+.+||++||..||.+|||+.+++.||||+...
T Consensus 232 ----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 232 ----------------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ----------------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 011112246788999999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=338.54 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=208.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCC-CC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR-EF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~-~~ 99 (414)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 468999999999999999999999999999999986432 2334677899999998 699999999998654322 23
Q ss_pred ceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 6999988763 46899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
..... ......|+..|+|||++.+. ...|+.++||||+||++|+|++|..||...........+..
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-------- 230 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------- 230 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------
Confidence 32211 12345789999999998531 14688899999999999999999999975543322211110
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.. ........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 231 -------------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 -------------------NP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 0001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.96 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=210.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh-------HHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
+|.+...||.|++|.||+|.+..++..||+|.+....... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 5888999999999999999999999999999886532221 12346778999999999999999999884
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
+....++||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||+++.
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 3456899999998 59999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCc---cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 176 AFSDTPM---TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 176 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
....... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN------ 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc------
Confidence 5432111 111123568899999999877 67889999999999999999999999876543332222110
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
........++..+.++|++||+.||.+|||+.++++||||
T Consensus 228 ------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=338.60 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=212.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCe
Confidence 4679999999999999999999998999999999864 334556678899999999999999999999843 456
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 899999999 5898888763 57999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....|+..|+|||.+... ...++.++|+|||||++|+|++|++||.+.+....+..+.. +.
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~------- 224 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--SE------- 224 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--CC-------
Confidence 211 1345689999999987421 14577899999999999999999999987654433322211 00
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+.......++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 225 -------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 225 -------------------PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -------------------CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00111123578899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=337.65 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=212.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeE
Confidence 47999999999999999999999999999999987532 23445567899999999999999999998843 3579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|+||+. ++|.+++... ++++..++.++.||+.||.|||+.|++||||+|+||++++++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5899998765 899999999999999999999999999999999999999999999999999977543321
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+...
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 213 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--------------- 213 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---------------
Confidence 1234568899999999987 56899999999999999999999999766543322222110
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+... ....++..+.++|.+||..||++|||++++++||||...
T Consensus 214 ------------~~~~~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 214 ------------NPPSL--EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ------------CCCCC--cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 00000 011278889999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=337.97 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=208.6
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
|++.+.||.|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence 68899999999999999999999999999998642 33456678899999999999999999998843 356899
Q ss_pred EEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 105 VFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 105 V~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
||||+. ++|..++.. ..++++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999998 577776654 46799999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccCccccccccccc---cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 183 TVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
......|+..|+|||++.. ....++.++||||+||++|+|++|++||...+.......+.....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~----------- 225 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP----------- 225 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC-----------
Confidence 1234568999999998742 114578899999999999999999999987665444333321100
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
+.......++..+.+||.+||+.||.+|||++++++||||..
T Consensus 226 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 226 -----------------PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -----------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 000112357889999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=340.27 Aligned_cols=257 Identities=24% Similarity=0.410 Sum_probs=220.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 100 (414)
..|..+.+||+|+||.|.+|..+.|.+.||||++++..- ...+.+-.+.|-++|... +-|.++.++.+| +..+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhhh
Confidence 478899999999999999999999999999999986432 223344455677777766 578899999999 4556
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+. |+|...|+.-+++.|..+.+++..|+-||-+||++||+.||||.+||+++.+|.+||+|||+++.....
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 7999999999 699999999999999999999999999999999999999999999999999999999999999864443
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... ..++||||.|+|||++.- ++|+.++|+||+||+||||+.|++||.|.+..+....|++-.-
T Consensus 504 ~~T---TkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv----------- 567 (683)
T KOG0696|consen 504 GVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV----------- 567 (683)
T ss_pred Ccc---eeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-----------
Confidence 332 257899999999999976 8999999999999999999999999999999888888864211
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCCCccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGLA 320 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~-----~~lL~hp~~~~~~ 320 (414)
.....+|.++.++.+.+|...|.+|..+ .++-.||||+.+.
T Consensus 568 --------------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 568 --------------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred --------------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 1235789999999999999999999854 6788999998753
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=329.55 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=214.9
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++++.||.|+||.|+.+.+..+++.||+|++............+.+|+.+++.++|+||+++++++. +...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 699999999999999999999999999999998765444556667889999999999999999999994 345799
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|||||. ++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 6999999764 468999999999999999999999999999999999999999999999999997654332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ......|++.|+|||.+.+ ..++.++|+|||||++++|++|..||.+.+..+....+.. +.+
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------- 218 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNY---------- 218 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCC----------
Confidence 1 1234568999999999877 5688899999999999999999999987765554444421 111
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
......++..+.++|.+||..||.+|||+.++|+|||+
T Consensus 219 ------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 219 ------------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 01114578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=331.65 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=209.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..|++.+.||+|+||.||.|.+..++..||||++..... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 579999999999999999999999999999998853221 223456788999999999999999999987432 12
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+||||+. ++|.+++.....+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 46899999998 69999998877899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
............|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+......+..+. ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~------- 226 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPT------- 226 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCC-------
Confidence 1111111234568899999999877 678999999999999999999999997654333222211 1100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
. ......++..+.++|.+||. +|.+|||++++++|||+.
T Consensus 227 -----------------~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 -----------------N--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -----------------C--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 01123567889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=340.32 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=214.0
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..+...+|++++.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+.
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~----- 86 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYL----- 86 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----
Confidence 3455589999999999999999999999999999999986532 233456789999999999999999999984
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 87 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred cCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 3457899999998 588888864 46899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.
T Consensus 166 ~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~------- 232 (297)
T cd06656 166 TPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT------- 232 (297)
T ss_pred cCCcc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC-------
Confidence 32221 1234568899999999877 6789999999999999999999999977654322211110 011
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
+.......++..+.+||.+||..||++|||+.++|+||||....
T Consensus 233 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 233 --------------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred --------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 11111235778899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=332.69 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=208.7
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC----ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... .......+.+|+.+++.++|+||+++++++. +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 588999999999999999986 4788999998864321 1233456889999999999999999999983 34
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+||||+. ++|.+++.....+++..+..++.||+.||+|||+.||+|+||+|+||++++++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 67999999998 59999998878899999999999999999999999999999999999999999999999999875421
Q ss_pred CC---CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 179 DT---PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 179 ~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.. ..........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG------- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-------
Confidence 11 11112234568999999999877 6789999999999999999999999976554332222211000
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
........++..+.++|++||+.+|.+|||+.++|+||||
T Consensus 226 ---------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 226 ---------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0111224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=335.25 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=209.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +|||++++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 57899999999999999999999999999999998642 12334567899999998 799999999998654333445
Q ss_pred eEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..|+||||+. ++|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 7899999998 588888753 45789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCccccccccccCccccccccccccC---CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
....... .....|+..|+|||.+.... ..++.++|||||||++|+|++|++||...+....+..+...
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~------ 248 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN------ 248 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC------
Confidence 5332211 12346889999999875421 23688999999999999999999999876544333222110
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
.. +........+..+.+||.+||+.||++|||+.++++||||+
T Consensus 249 ---------------------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 ---------------------PP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------------CC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 00011234677899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=331.80 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=212.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||.|+||+||+|....++..||+|++....... ....+.+|+.+++.++|+||+++++.+. .....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEE
Confidence 47999999999999999999999899999999987543332 5667889999999999999999999883 34578
Q ss_pred EEEEecCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 103 YVVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
|+|||++. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||++++++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5899998764 4589999999999999999999999999999999999999999999999999976544
Q ss_pred CCCcc-ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMT-VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..... ......+|+..|+|||.+... ..++.++|+|||||++++|++|..||...+.......+... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~------- 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DP------- 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CC-------
Confidence 32221 112345689999999998763 36889999999999999999999999766543332222110 00
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
........+..+++.+.+|+.+||..||++|||+.++++||||
T Consensus 225 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 ----------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000011124678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=338.63 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=212.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 369999999999999999999999999999999875322 223445678999999999999999999988 34457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. ++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987421111
Q ss_pred Cc------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 181 PM------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 181 ~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
.. ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~- 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD- 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Confidence 00 001123467889999999877 678999999999999999999999998766544333322100
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCcc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (414)
...+ .....++..+.++|++||+.||++||| +.++|+||||...
T Consensus 233 -------------------------~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 233 -------------------------IEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -------------------------cCCC--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 0000 111257889999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=330.68 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=210.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCE
Confidence 368999999999999999999999999999999987532 235567889999999999999999999883 4457
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|++|||++ ++|.+++... ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999 5898888776 78999999999999999999999999999999999999999999999999998764332
Q ss_pred CCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. .....+++..|+|||.+.+. ...++.++|+|||||++|+|++|.+||.+.+.......+....-.+
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 223 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-------- 223 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Confidence 11 11345688899999998651 1268889999999999999999999998766544433322110000
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
........++..+.+||++||..||..|||+.+++.|||
T Consensus 224 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 ------------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 000111345778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=330.08 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=211.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||+|+||.||.+.+..+++.||+|++............+.+|+.+++.++||||+++++++ ...+..|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 69999999999999999999999999999999875433344556788999999999999999999988 4446799
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||||+. ++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 5999988764 358999999999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
.. .....|++.|+|||++.+ ..++.++|+|||||++++|++|..||...+..+....+.. +..
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------- 218 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSY---------- 218 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCC----------
Confidence 11 123458889999999877 6788999999999999999999999987665544433321 100
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.......+..+.++|.+||+.+|.+||++.++|+||||
T Consensus 219 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 ------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=336.97 Aligned_cols=261 Identities=24% Similarity=0.420 Sum_probs=210.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. ..+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeE
Confidence 47999999999999999999999999999999986532 2334567889999999999999999999884 34579
Q ss_pred EEEEecCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 103 YVVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
|+||||+. ++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999 5888888763 379999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCccccccccccCcccccccccccc----CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
... ....+|+..|+|||.+.+. ...++.++|||||||++|+|++|+.||...........+.....
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 224 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD----- 224 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-----
Confidence 221 1334688899999987542 12468899999999999999999999976543332222211110
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
. ......+.+++.+.+||.+||..+|++|||++++++||||.....
T Consensus 225 -------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 225 -------------------G---DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred -------------------c---CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 0 011223457899999999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=364.86 Aligned_cols=287 Identities=23% Similarity=0.296 Sum_probs=204.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCC-cEEEEEEe--------------CC-ccCChHHHHHHHHHHHHHHhCCCCCcc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKI--------------HD-VFEHISDAIRILREVKLLRLLRHPDIV 85 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~--------------~~-~~~~~~~~~~~~~E~~~l~~l~hpniv 85 (414)
.++|++++.||+|+||+||+|..+... ..+++|.+ .+ ..........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998765332 22222211 10 011223345678999999999999999
Q ss_pred ccceeecCCCCCCCceEEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
++++++. .....|+|++++.++|..++... .......++.++.||+.||+|||++||+||||||+|||++
T Consensus 227 ~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 9999984 34568999999999998887542 2345677889999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCC--CChh
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPG--KSVV 237 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~--~~~~ 237 (414)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|+|++|..+ |.+ ....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986543221 11234679999999999987 6899999999999999999998854 432 2334
Q ss_pred hHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcC-CCCCCccCC--CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 015019 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK-KPPVPLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (414)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp 314 (414)
.++..+...++.+..+... .......++..... ..+..+... ...++..+.++|.+||++||.+|||+.|+|.||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPD--PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCC--cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 4555555544433222100 00111122211110 000000000 124677889999999999999999999999999
Q ss_pred CCCcc
Q 015019 315 YFKGL 319 (414)
Q Consensus 315 ~~~~~ 319 (414)
||...
T Consensus 456 ~f~~~ 460 (501)
T PHA03210 456 LFSAE 460 (501)
T ss_pred hhhcC
Confidence 99763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=335.08 Aligned_cols=280 Identities=42% Similarity=0.726 Sum_probs=224.7
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
|++.+.||+|++|+||+|....+++.||||++...... .......+|+..++.++ ||||+++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78899999999999999999999999999998754332 23334567999999999 9999999999844 45689
Q ss_pred EEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 104 VVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
+||||++++|.+.+.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999999999987754 789999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....++..|+|||++.+. ..++.++|+|||||++++|++|++||++.+..+....+....+.+....+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2446789999999987542 46789999999999999999999999999988888888888888876543211100
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
....-..............++..+..+.+||++||+.||++|||+.|++.||||
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 -ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred -hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000111111111222334557889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=335.80 Aligned_cols=261 Identities=24% Similarity=0.413 Sum_probs=209.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC-CC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-RE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~-~~ 98 (414)
..++|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ +|+||+++++++..... ..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 447899999999999999999999999999999998642 23345677899999988 69999999999864322 23
Q ss_pred CceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
...+|+||||++ ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 467899999998 5899988653 4588999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
...... .....+|++.|+|||.+... ...++.++|+|||||++|+|++|.+||........+..+..
T Consensus 171 ~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~------- 240 (282)
T cd06636 171 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------- 240 (282)
T ss_pred hhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-------
Confidence 432211 12345689999999987521 24688899999999999999999999976554332221110
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.. ........++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 241 --------------------~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 241 --------------------NP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 0001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=332.75 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=210.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC----hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 488899999999999999999999999999998743221 12356788999999999999999999998 444
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~a~~~~ 177 (414)
+.+++||||+. ++|.+++...+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 57999999999 58999998888899999999999999999999999999999999999998776 59999999987654
Q ss_pred CCCCc-cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 32111 111123468889999999877 678999999999999999999999997554332222221110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
.. .........+++.+.+++.+||..||.+|||+.++++||||+
T Consensus 225 ---------------~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 ---------------SA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------cc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00 000112235788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=332.34 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=211.3
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+|++.+.||.|+||.||+|.+..+++.||+|++.+... .......+.+|+++++.++||||+++++++ .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 59999999999999999999999999999999975432 224566788999999999999999999988 445679
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|+||+. ++|.+.+.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++........
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999998 59999998877899999999999999999999999999999999999999999999999999876543321
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh--hHHHHHHHhcCCCCHHHHHhhc
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.. +.+...
T Consensus 156 ----~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 213 (258)
T cd05578 156 ----TTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK---------------- 213 (258)
T ss_pred ----ccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----------------
Confidence 134568889999999877 56899999999999999999999999876632 111111
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH--HHHhcCCCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA--EEALADPYF 316 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~--~~lL~hp~~ 316 (414)
... ........++..+.++|.+||+.||.+||++ .++++||||
T Consensus 214 ----------~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 214 ----------QET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------hcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 000 0011224577899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=329.66 Aligned_cols=255 Identities=32% Similarity=0.503 Sum_probs=213.4
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||.|+||.||+|.+..++..||+|++...........++..|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999876544556667788999999999999999999977542 235689
Q ss_pred EEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 104 VVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LH-----s~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
++|||+. ++|.+++.. ...+++..+..++.||+.||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 699988865 467999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
........ ......|+..|+|||.+.+ ..++.++|+|||||++++|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 225 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG------- 225 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-------
Confidence 87543321 1234578999999999877 66889999999999999999999999877643333222110
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.........+..+.+|+.+||+.+|++|||+.++|+|||+
T Consensus 226 -----------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 -----------------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0111223578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=334.61 Aligned_cols=258 Identities=23% Similarity=0.386 Sum_probs=204.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++++.++||||+++++.+.. .+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEE
Confidence 36899999999999999999999999999999986532 23345568899999999999999999999843 3568
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
++||||+.+ +|... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999995 55432 357899999999999999999999999999999999999999999999999997643221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
....+||..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......... +...
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~~-------- 206 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMPL-------- 206 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cchH--------
Confidence 234579999999999987 67899999999999999999999999653211100 0000
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
........... ........++.+.+||.+||+.||++||+++++++||||...
T Consensus 207 ---~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 207 ---QLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ---HHHHHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00000000000 001123478899999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=355.29 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=215.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+-+.|+..||-|+||.||+|.++.++-.-|.|++.- ........++-||.||..+.||+||++++.|+.. +.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nk 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NK 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----Cc
Confidence 3456889999999999999999999998888898853 3456677889999999999999999999999654 45
Q ss_pred EEEEEecCCCC-HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELMESD-LHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~g~-L~~~i~-~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
++|..|||+|. ...++. -...+++.++..+++|+|.||.|||+++|+|||||..|||++-+|.++|+|||.+......
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999999964 444443 3568999999999999999999999999999999999999999999999999998654332
Q ss_pred CCccccccccccCccccccccccc---cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.. ....++|||+|||||+..- ...+|+.++||||||++|.||..+.||-..-+....+-.|.+--
T Consensus 184 ~q---kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--------- 251 (1187)
T KOG0579|consen 184 RQ---KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--------- 251 (1187)
T ss_pred Hh---hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC---------
Confidence 22 2357899999999998521 12689999999999999999999999998877766665554311
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
| |.......++..+.|+|++||..||+.||+++++|+||||.+.
T Consensus 252 ------------------P-PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 252 ------------------P-PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ------------------C-CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 1 1112235688899999999999999999999999999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=334.10 Aligned_cols=258 Identities=25% Similarity=0.453 Sum_probs=203.8
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHH-HHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||.||+|.++.+|+.||||++....... ....+..|+.+ ++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 46999999999999999999999999999999987643332 33455667665 667789999999999843 346
Q ss_pred EEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 102 IYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+|+||||++++|.+++.. ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999999998887754 34689999999999999999999997 9999999999999999999999999998764
Q ss_pred cCCCCccccccccccCcccccccccccc--CCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~ 253 (414)
..... .+...|+..|+|||.+.+. ...++.++|+|||||++|+|++|+.||.... ..+.+..+..
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 222 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-------- 222 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--------
Confidence 32211 1234688899999987541 1357889999999999999999999996432 1122211110
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..... .....+|.++.+||.+||..+|.+|||+.++++||||...
T Consensus 223 -------------------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 223 -------------------EPSPQ--LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -------------------cCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00000 0012478899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=331.63 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=210.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC-CCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-REF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~-~~~ 99 (414)
.++|++.+.||.|++|.||+|.++.+++.||+|++.... .....+.+|+.+++.+ .|+||+++++++..... ...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 479999999999999999999999999999999987432 2345688999999999 69999999999866543 345
Q ss_pred ceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
..+|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 67899999999 588888764 3579999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
....... ......|+..|+|||++... ...++.++|||||||++|+|++|.+||........+..+...
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----- 233 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN----- 233 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-----
Confidence 6433221 12345689999999987431 135788999999999999999999999765443333222110
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
. .+.......++..+.+||.+||..||++|||+.++++|||+
T Consensus 234 ----------------------~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 ----------------------P-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------------C-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 00001112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=352.44 Aligned_cols=258 Identities=28% Similarity=0.393 Sum_probs=219.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+.-..|.-++.||.|+||.||-|++..+.+.||||+++.... .......++.|++.|++++|||++.+.++|.-..
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--- 99 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--- 99 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc---
Confidence 344578889999999999999999999999999999986543 3344567999999999999999999999996443
Q ss_pred CceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
..|||||||-|+-.+++.- .+++.+.++..|+.+.+.||+||||.+.+|||||..|||+++.|.|||+|||.|....
T Consensus 100 --TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 100 --TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred --hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 3699999999987777754 4689999999999999999999999999999999999999999999999999987642
Q ss_pred CCCCccccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
. ...++|||+|||||+++. ..+.|+-++||||||++..||.-.+||+-+.+....+.-|..-.
T Consensus 178 P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe--------- 241 (948)
T KOG0577|consen 178 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------- 241 (948)
T ss_pred c-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC---------
Confidence 2 257899999999998753 23679999999999999999999999998888777666664311
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.|. -..+.+|..++.|+..||+.-|.+|||++++|.|+|+..
T Consensus 242 -----------------sPt---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 242 -----------------SPT---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred -----------------CCC---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 000 012467889999999999999999999999999999864
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.00 Aligned_cols=252 Identities=28% Similarity=0.474 Sum_probs=210.0
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 699999999999999999999999999999998765444455677889999999999999999999883 345789
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCcccccCC
Q 015019 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSD 179 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a~~~~~~ 179 (414)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999763 358999999999999999999999999999999999999865 45899999999865433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... ....|+..|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 156 ~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~------------- 216 (256)
T cd08220 156 SKA----YTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG------------- 216 (256)
T ss_pred ccc----cccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-------------
Confidence 221 23568889999999877 67889999999999999999999999876654433332210
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
. .......++..+.+++.+||..||++|||+.++|+||||
T Consensus 217 --------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 217 --------------T---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred --------------C---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0 001123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=311.74 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=208.7
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.+-..+||++.+.||.|||+.|+++.+..++..||+|++... ...+.+..++|+..-++++|||++++++.......+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 345568999999999999999999999999999999999764 356778899999999999999999999887665544
Q ss_pred CCceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCCeEEeec
Q 015019 98 EFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDF 170 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~vkL~DF 170 (414)
.....||+++|.. |+|.+.|.. ...++|.++..|+.+|++||++||+.. .+||||||.|||+++.+.++|+||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 5567999999999 899999864 237999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCcc---c---cccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHH
Q 015019 171 GLARVAFSDTPMT---V---FWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243 (414)
Q Consensus 171 G~a~~~~~~~~~~---~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i 243 (414)
|.++...-..... . .+..-..|..|+|||++.-. ....+.++|||||||+||.|+.|..||.-.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~-------- 245 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY-------- 245 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh--------
Confidence 9987532111100 0 01223467889999998431 2457889999999999999999999995211
Q ss_pred HHhcCCCCHHHHHhhccHHHHHHHHHhcCC-CCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. -|-.- .+.-. ....+.. -..+|..+.+||+.||++||.+||++.+++.+
T Consensus 246 -~-~GgSl-----------------aLAv~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 246 -Q-QGGSL-----------------ALAVQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred -h-cCCeE-----------------EEeeeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 00000 00000 0001111 12488999999999999999999999999874
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=353.36 Aligned_cols=252 Identities=31% Similarity=0.492 Sum_probs=208.9
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEec
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~ 108 (414)
-+||+|.||+||.|+|..|....|||.+.. ......+.+..||.+.++|+|.|||++++.+ .+.+.+-|.||-
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQ 653 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeec
Confidence 369999999999999999999999999864 3445667788999999999999999999987 555678899999
Q ss_pred CC-CCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEeecCCcccccCCCCcc
Q 015019 109 ME-SDLHQVIKAN-DDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 109 ~~-g~L~~~i~~~-~~l--~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
++ |+|..++++. +++ .|..+.++.+||++||+|||.+.|||||||-+|+|++. .|.+||+|||-++....-.+
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 98 6999999874 777 88999999999999999999999999999999999985 68999999999976543332
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
...++.||..|||||++.....+|+.++|||||||++.||.||+|||....... +
T Consensus 732 -~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------------------------A 786 (1226)
T KOG4279|consen 732 -CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------------------------A 786 (1226)
T ss_pred -cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------------------------H
Confidence 335678999999999998766889999999999999999999999996432211 1
Q ss_pred HHHHHH-hcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 264 RKYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 264 ~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..|--. .+.-+ .....+|.+++.+|.+|+.+||.+||+|.++|..||++.-
T Consensus 787 AMFkVGmyKvHP-----~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 787 AMFKVGMYKVHP-----PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhhhcceecCC-----CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 111000 01111 1224578889999999999999999999999999999754
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=326.34 Aligned_cols=261 Identities=30% Similarity=0.460 Sum_probs=212.3
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
||++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.++|+||++++++.. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 699999999999999999999999999999998765444456778899999999999999999999873 345689
Q ss_pred EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
+|+||+. ++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 699999988778999999999999999999999999999999999999999999999999999765433222
Q ss_pred ccc-ccccccCccccccccccccC-CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 183 TVF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 183 ~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
... .....++..|+|||.+.+.. ..++.++||||+||++++|++|+.||............... +
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~------------ 222 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-G------------ 222 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-C------------
Confidence 111 22456888999999987631 23788999999999999999999999765322221111100 0
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
..+.......+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 223 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 223 --------------HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --------------CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 001111223468899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=338.48 Aligned_cols=258 Identities=28% Similarity=0.517 Sum_probs=210.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++||||+++++.+. ..+..
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeE
Confidence 5667788899999999999999999999999998642 2344556889999999999999999999884 34568
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+.+ +|.+++. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999984 7877764 45799999999999999999999999999999999999999999999999999875432221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....+|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+.....
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------------- 235 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP------------- 235 (292)
T ss_pred ---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------------
Confidence 1234568999999999877 6789999999999999999999999987665443332211100
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
+........+..+.++|.+||..||.+|||++++|+||||.....
T Consensus 236 ---------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 236 ---------------PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ---------------CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 000112356888999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.30 Aligned_cols=286 Identities=29% Similarity=0.473 Sum_probs=226.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-----C---CCccccceeecCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----H---PDIVEIKRIMLPP 94 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~~ 94 (414)
+||.+.++||+|.|++||+|.|..+.+.||+|+.+. ..-..+..+.||++|++++ | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 799999999999999999999999999999999873 2344556789999999984 3 3699999999776
Q ss_pred CCCCCceEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCC---------
Q 015019 95 SKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANAN--------- 162 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~--------- 162 (414)
+ ..+.++|||+|+++.+|+.+|+.. ..++...++.|++|||.||.|||+. ||+|-||||+|||+..+
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 6 567899999999999999999864 5799999999999999999999975 99999999999997110
Q ss_pred --------------------------------------------------------------------------------
Q 015019 163 -------------------------------------------------------------------------------- 162 (414)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (414)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CCe
Q 015019 163 -----------------------------------------------------------------------------CKL 165 (414)
Q Consensus 163 -----------------------------------------------------------------------------~~v 165 (414)
.++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 014
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC------ChhhH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK------SVVHQ 239 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~------~~~~~ 239 (414)
||+|||-|..... .++.-+.|+.|+|||++.+ ..|+..+||||++|+++||+||..+|... .+.+.
T Consensus 394 KIaDlGNACW~~k------hFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 394 KIADLGNACWVHK------HFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred EEeeccchhhhhh------hhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 5555555543211 2345578999999999999 89999999999999999999999999543 35678
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHH------HhcCCCCCCccCCC---CCCC----hHHHHHHHHhccCCCCCCCC
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLT------EMRKKPPVPLFQKF---PNVD----PLALRLLQRLIAFDPKDRPT 306 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~---~~~s----~~~~dli~~~L~~dp~~Rpt 306 (414)
+..|++++|..+...+...+ ..+.|+. .+.+-.+.++...+ ..+| .++.|||.-||+++|++|||
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk--~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGK--YSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHhhccHHHHhcCc--chHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 99999999999887765332 2334433 23333333332221 1233 45789999999999999999
Q ss_pred HHHHhcCCCCCccccC
Q 015019 307 AEEALADPYFKGLAKI 322 (414)
Q Consensus 307 ~~~lL~hp~~~~~~~~ 322 (414)
|.++|+|||+.....+
T Consensus 544 A~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccCCCCC
Confidence 9999999999977554
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=333.39 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=207.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++........
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 4579999999999999999999999999999999876421 2234567899999999 69999999998865443445
Q ss_pred ceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
..+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 67999999998 588887652 3578999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
....... ......|++.|+|||++... ...++.++||||+||++|+|++|..||........+..+..
T Consensus 173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------ 243 (286)
T cd06638 173 QLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR------ 243 (286)
T ss_pred ecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc------
Confidence 6532211 12344689999999987531 14588999999999999999999999976554332211110
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
... +........+..+.+||.+||+.||++|||+.++|+|+||
T Consensus 244 ---------------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 ---------------------NPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ---------------------cCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000 0000112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=327.82 Aligned_cols=252 Identities=31% Similarity=0.523 Sum_probs=209.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|+||.||+|.+..++..||+|.+... .....+.+|+.+++.++||||+++++.+.. ...+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcE
Confidence 6899999999999999999999988999999998643 225678899999999999999999999843 3569
Q ss_pred EEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999 599998875 4578999999999999999999999999999999999999999999999999987654332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ......|+..|+|||.+.+ ..++.++||||+||++|+|++|++||...+.......+..
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 213 (256)
T cd06612 154 A---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--------------- 213 (256)
T ss_pred c---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---------------
Confidence 1 1133458889999999877 6789999999999999999999999986554332211110
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
. ..+.......++..+.++|.+||+.||++|||+.++|.||||
T Consensus 214 ------------~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 214 ------------K-PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------C-CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 001111123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.12 Aligned_cols=262 Identities=26% Similarity=0.452 Sum_probs=208.7
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC--------hHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--------ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 689999999999999999999999999999988532111 112345778999999999999999999883
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
....+++||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 3456899999998 6999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
........ .......|+..|+|||.+......++.++|+|||||++++|++|..||........+..+...
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 227 (272)
T cd06629 157 KSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK-------- 227 (272)
T ss_pred cccccccc-cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--------
Confidence 64322111 112345688899999998763234889999999999999999999999755443222211100
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...........+.++..+.++|.+||..||++|||++++|+||||
T Consensus 228 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 228 -----------------RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -----------------ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 000000112234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=349.28 Aligned_cols=268 Identities=28% Similarity=0.456 Sum_probs=225.0
Q ss_pred ccccccccCCCCCe-eEeeeecccCceeEEEEEECCCCcEEEEEEeC--CccCChHHHHHHHHHHHHHHhCCCCCccccc
Q 015019 12 DKDFFTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHPDIVEIK 88 (414)
Q Consensus 12 ~~~~~~~~~~~~~Y-~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 88 (414)
+...+-..+..+|| +...+||+|+|-+||+|.|..+|..||+-.++ +........+++..|+.+|+.|+||||++++
T Consensus 28 ~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy 107 (632)
T KOG0584|consen 28 DESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFY 107 (632)
T ss_pred ccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeee
Confidence 34455566777888 66889999999999999999999999987654 3345566778999999999999999999999
Q ss_pred eeecCCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCC-CC
Q 015019 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANAN-CK 164 (414)
Q Consensus 89 ~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~-~~ 164 (414)
+.|.+... ..+-+|+|+|. |+|..+++..+.++...++.|++||++||.|||++. |+|||||.+||+|+.+ |.
T Consensus 108 ~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~ 184 (632)
T KOG0584|consen 108 DSWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE 184 (632)
T ss_pred eheecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc
Confidence 99977543 56899999998 899999999999999999999999999999999996 9999999999999976 99
Q ss_pred eEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH
Q 015019 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 165 vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (414)
|||+|+|+|....... ....+|||.|||||++.. .|+..+||||||++|.||+|+.+||.-..+..++.+-+
T Consensus 185 VKIGDLGLAtl~r~s~-----aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSH-----AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred eeecchhHHHHhhccc-----cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 9999999998764432 245689999999999864 79999999999999999999999998877766554332
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
. -|. .|..+.. --.+++++||.+||.. ...|+||.|||.||||..-
T Consensus 257 ~-SGi------------------------KP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 257 T-SGI------------------------KPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred H-cCC------------------------CHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1 111 1111111 1268899999999999 8999999999999999863
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=330.62 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=210.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|+||.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++++.. .+.+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEE
Confidence 468899999999999999999999999999999876432 2445678899999999999999999999844 3579
Q ss_pred EEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+|+||+. ++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999875 789999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh--hhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ......+
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-------------- 213 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH--------------
Confidence 11 12568889999999877 6889999999999999999999999975431 0001111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
......... ..... +++.+.++|.+||..||++|||+.+++.||||+.+
T Consensus 214 ----------~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 214 ----------QYIVNEPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ----------HHHhcCCCC---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 111111000 11112 78899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=325.26 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=209.6
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
+|+..+.||+|++|+||+|.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 58889999999999999999998999999999864321 1234567889999999999999999999873 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|+||+. ++|.+++.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 6899999998 599999988878999999999999999999999999999999999999999999999999998765332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ......|+..|+|||.+... ..++.++|+|||||++|+|++|+.||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345688999999998762 23889999999999999999999999765533322222110
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.........+++.+.+++.+||+.+|.+|||+.++|.|||+
T Consensus 218 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 ----------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00111234578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=331.83 Aligned_cols=246 Identities=20% Similarity=0.238 Sum_probs=201.2
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCChH-HHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
..||+|++|.||+|.. +|+.||||++........ ..+.+.+|+.+|+.++||||+++++++.... +....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5789999999999976 689999999976433222 2456779999999999999999999885421 22356899999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||. |+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 69999998888899999999999999999999984 99999999999999999999999999997643221
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
...+|+..|+|||++.+....++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 241 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------- 241 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC---------------
Confidence 2346889999999986533578999999999999999999999998876555444432211110
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......++.+.+|+.+||+.||++|||+.++++
T Consensus 242 --------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 --------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 011257889999999999999999999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=333.27 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=199.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECC----------------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCcc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 85 (414)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3689999999999999999998542 34479999987532 334456788999999999999999
Q ss_pred ccceeecCCCCCCCceEEEEEecCC-CCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 015019 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-------------------DLTREHHQFFLYQMLRALKYMHTA 145 (414)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~-------------------~l~~~~~~~i~~qil~al~~LHs~ 145 (414)
++++++.. ...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999843 345899999998 69999886532 367788999999999999999999
Q ss_pred CcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHH
Q 015019 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (414)
Q Consensus 146 givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll 225 (414)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999764332211 11123346788999999876 67999999999999999998
Q ss_pred h--CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC
Q 015019 226 T--GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (414)
Q Consensus 226 ~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~ 303 (414)
+ +..||.+.+..+.+..+.... . ...........+.++..+.+|+.+||+.||.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF--------------------R---DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh--------------------h---hccccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 557887665544333322110 0 00000011122457889999999999999999
Q ss_pred CCCHHHHhc
Q 015019 304 RPTAEEALA 312 (414)
Q Consensus 304 Rpt~~~lL~ 312 (414)
|||+.++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=334.39 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=211.5
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
-....+|.+.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~---- 86 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR---- 86 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe----
Confidence 3445679999999999999999999999999999999864322 23344678899999999999999999999843
Q ss_pred CCceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....|+||||+.|++.+.+.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++...
T Consensus 87 -~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 87 -EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred -CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 346899999999998888764 457999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
... ....++..|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 166 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--------- 229 (307)
T cd06607 166 SPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------- 229 (307)
T ss_pred CCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---------
Confidence 221 234688899999987421 256888999999999999999999999876654433222110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.+.. .....++..+.+||.+||..||++|||+.+++.||||..
T Consensus 230 ------------------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 230 ------------------DSPT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ------------------CCCC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000 001236788999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=323.87 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=210.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 47999999999999999999999999999999875321 1233456788999999999999999999987442 23
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+++||||+. ++|.+.+...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 46899999998 58999998877899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
............|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||........+..+ ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~------ 227 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTK------ 227 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCC------
Confidence 2111111234568999999999877 67889999999999999999999999766544333222 111110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
......+++.+.++|.+||+ +|..|||+.++++|||.
T Consensus 228 --------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 --------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 11234688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.28 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=205.9
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~ 109 (414)
||.|++|.||+|.+..++..||+|++.+... .......+.+|+.+++.++||||+++++.+. +...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 7999999999999999999999999875432 2234567889999999999999999999884 345689999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccc
Q 015019 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (414)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 188 (414)
. ++|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 6999999888889999999999999999999999999999999999999999999999999997654332 1134
Q ss_pred cccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC--hhhHHHHHHHhcCCCCHHHHHhhccHHHHHH
Q 015019 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS--VVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (414)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (414)
..|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.... .......+...
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 209 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-------------------- 209 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc--------------------
Confidence 568899999999876 678999999999999999999999997765 22222222100
Q ss_pred HHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
... .......++.+.++|.+||..||++||| ++|+++||||+++
T Consensus 210 ----~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 210 ----NGK-----LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ----CCC-----CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 000 0111235789999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=325.63 Aligned_cols=259 Identities=30% Similarity=0.468 Sum_probs=214.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+.|++.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+.++..++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeE
Confidence 3689999999999999999999999999999998764332 455678899999999999999999999843 3569
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999997654332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+....
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 216 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------- 216 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------
Confidence 21 134568889999999877 678999999999999999999999997664211111111111
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.... ...... ++..+.++|.+||..+|++|||+.++++||||+..
T Consensus 217 -----------~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 217 -----------DGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -----------cCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 1000 111223 78899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=326.34 Aligned_cols=251 Identities=19% Similarity=0.271 Sum_probs=201.8
Q ss_pred CCCeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++.+.||+|+||.||+|..+ ..+..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----- 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----
Confidence 357999999999999999999765 345689999987542 23344568899999999999999999999843
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+|++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 356899999998 5888888764 57899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+....
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------ 227 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence 221111 0112235678999999877 689999999999999999775 99999887765544443221110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....++..+.+++.+||+.+|.+|||++++++
T Consensus 228 ------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 112457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=337.64 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=214.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh-HHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+.|..-++||+||||.||.+.-+.||+.||+|++.+..... ......+.|-.||..++.+.||.+--.| +...
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 357889999999999999999999999999999986532222 2233567899999999999999998888 4456
Q ss_pred eEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 101 DIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
.+|+|+..|+ |||.-+|-..+ .+++..+.+++.+|+.||.+||+.+||+|||||+|||+|+.|+++|+|.|+|....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 7999999999 69988886544 89999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
...+. ...+||..|||||++.+ ..|+..+|+|||||++|+|+.|+.||...........+-.
T Consensus 339 ~g~~~----~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr------------ 400 (591)
T KOG0986|consen 339 EGKPI----RGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR------------ 400 (591)
T ss_pred CCCcc----ccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH------------
Confidence 54432 45589999999999988 6799999999999999999999999975443322211111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
+-.. .......+.|+++++|.+.+|..||.+|. +++++-+||||+.+
T Consensus 401 ------------r~~~---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 401 ------------RTLE---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ------------HHhc---chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 0000 11122246899999999999999999998 57899999999876
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=327.84 Aligned_cols=257 Identities=29% Similarity=0.532 Sum_probs=211.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
..|...+.||+|++|.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++.+.. .+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeE
Confidence 4567778999999999999999999999999998642 22344567899999999999999999998843 3568
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|+||+. ++|.+++.. .++++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999997 599988876 6799999999999999999999999999999999999999999999999998875433222
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
. .....|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------------- 230 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------------- 230 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---------------
Confidence 1 133568999999999877 67899999999999999999999999876654433333211
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
. .+.......++..+.+||.+||..||++|||+.++++||||+...
T Consensus 231 ------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 231 ------------L-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ------------C-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0 011111234788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=331.78 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=205.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.|+..+.||+|+||.||++.+..++..||+|++...... .....+.+|+.++.++. |+||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCc
Confidence 4577889999999999999999999999999998754322 44557889999999996 9999999998843 345
Q ss_pred EEEEEecCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 102 IYVVFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+++|||+.+++.++.. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999976655432 246799999999999999999999985 999999999999999999999999999975
Q ss_pred ccCCCCccccccccccCccccccccccccC-CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
...... .....|++.|+|||.+.+.. ..++.++||||+||++|+|++|+.||..... ....+......
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~----- 226 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKG----- 226 (288)
T ss_pred hccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCC-----
Confidence 433211 12345888999999986621 2688999999999999999999999976541 11112111110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..+.-.......++..+.+||.+||+.||++|||+++++.||||+..
T Consensus 227 ------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 227 ------------------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ------------------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 00000011123578899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=322.82 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=208.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|.+.+.||+|+||.||+|.++.+|..||+|.+............+.+|+.+++.++|+||+++++.+. ....+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 589999999999999999999999999999998653333344556789999999999999999999883 445799
Q ss_pred EEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC-eEEeecCCcccccCC
Q 015019 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-LKVCDFGLARVAFSD 179 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~-vkL~DFG~a~~~~~~ 179 (414)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+||++++++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999998 59999887543 5799999999999999999999999999999999999998864 699999999765432
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ......|++.|+|||.+.+ ..++.++|+|||||++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1133468899999999876 6789999999999999999999999987654433322211
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.......+.++..+.++|.+||..+|++|||+.++++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ----------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00111234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=327.94 Aligned_cols=256 Identities=31% Similarity=0.545 Sum_probs=212.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 100 (414)
++|.+.+.||+|+||.||+|.+..++..||+|++.+... .......+.+|+.+++.+. ||||+++++++. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence 479999999999999999999999999999999875322 2334456789999999998 999999999883 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||++. ++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 6899999995 799999998889999999999999999999999999999999999999999999999999999765432
Q ss_pred CCc-----------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHH
Q 015019 180 TPM-----------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (414)
Q Consensus 180 ~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~ 242 (414)
... ........|+..|+|||.+.+ ..++.++|+|||||++++|++|+.||...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011234567889999999877 5688999999999999999999999987764333332
Q ss_pred HHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCC
Q 015019 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYF 316 (414)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~----~~lL~hp~~ 316 (414)
+... .......+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 234 ~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKL-------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhc-------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2210 001123568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=328.73 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=196.9
Q ss_pred eecccCceeEEEEEECCCCcEEEEEEeCCccCChH-HHHHHHHHHHHHH---hCCCCCccccceeecCCCCCCCceEEEE
Q 015019 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIRILREVKLLR---LLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
.||+|+||.||+|.+..+++.||+|.+.+...... ......+|..+++ ...||||+.+++.+.. .+..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 48999999999999999999999999865432211 1223344444433 3479999999998843 3468999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccc
Q 015019 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (414)
|||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 6999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHH
Q 015019 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (414)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (414)
.....|+..|+|||.+.+. ..++.++||||+||++|+|++|..||.+....... .+...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~------------------ 210 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRM------------------ 210 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHH------------------
Confidence 1234689999999987532 56889999999999999999999999754322111 01000
Q ss_pred HHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCccc
Q 015019 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (414)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (414)
.... .......+++.+.++|++||..||.+|+ |+.++++||||+++.
T Consensus 211 ------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 211 ------TLTV---NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ------hhcC---CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0000 0112346789999999999999999999 699999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=333.75 Aligned_cols=258 Identities=28% Similarity=0.531 Sum_probs=210.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
..-|.....||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.+.||||+++++.+. ....
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~ 92 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEE 92 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCe
Confidence 345667778999999999999999999999999986432 233456789999999999999999999884 3456
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 899999999 578776654 578999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
.. ....+|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+.+..+.. .
T Consensus 172 ~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~----------- 232 (297)
T cd06659 172 PK---RKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---S----------- 232 (297)
T ss_pred cc---ccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---c-----------
Confidence 11 234578999999999977 6789999999999999999999999987665444333211 0
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..+.......++..+.++|.+||+.+|.+|||+.++++||||....
T Consensus 233 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 233 --------------PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred --------------CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0111122346788999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=356.07 Aligned_cols=256 Identities=24% Similarity=0.425 Sum_probs=203.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCcccccee-ecCCCCCC-C
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRI-MLPPSKRE-F 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~~~~~~-~ 99 (414)
.+++|.+.|.+|||+.||+|.+...|..||+|++-.. +......+.+||.+|+.|+ |+|||.+++. ........ .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4789999999999999999999988899999998653 5566677889999999997 9999999994 32221122 3
Q ss_pred ceEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
-.++|.||||. |+|.+++.. ...|++.++..|++|+++||++||... |+|||||-|||||+.+|..||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 46899999999 699999975 346999999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccc---cc---cccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 175 VAFSDTPMTV---FW---TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 175 ~~~~~~~~~~---~~---~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
.......... .. -....|+.|||||.+.-. ..+.+.++|||+|||+||-|+....||.+......+ +
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----n-- 268 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----N-- 268 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----e--
Confidence 5433221110 00 012468999999976321 157889999999999999999999999876322111 0
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
|. --...++.++..+.+||+.||+.||++||++.|++.+
T Consensus 269 g~---------------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GN---------------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cc---------------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 00 0012236789999999999999999999999998864
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=322.80 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=206.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||.|+||.||++.+..++..||+|.+.... .....+.+.+|+.+++.++||||+++++.+ ...+.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence 5899999999999999999999999999999986432 234556788999999999999999999998 3446799
Q ss_pred EEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 689988865 3468999999999999999999999999999999999999999999999999987653322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 215 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-------------- 215 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC--------------
Confidence 1 1234578999999999877 67899999999999999999999999876654433332210
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. .......++..+.+||.+||+.||++|||+.++++-
T Consensus 216 -------------~---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 -------------S---YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------------C---CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 001123577889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.29 Aligned_cols=283 Identities=31% Similarity=0.498 Sum_probs=228.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC------CCccccceeecCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH------PDIVEIKRIMLPP 94 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~ 94 (414)
..++|.+....|.|-||+|..|.|...|..||||+|.+. ..-.+.=++|+.||+.|+. -++++++..|
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F--- 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF--- 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh---
Confidence 347999999999999999999999999999999999752 2223345689999999962 3788888887
Q ss_pred CCCCCceEEEEEecCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeec
Q 015019 95 SKREFKDIYVVFELMESDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDF 170 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~g~L~~~i~~~~---~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DF 170 (414)
...+++|||+|-+.-+|.++++..+ .|....+..++.|++.||..|..+||+|.||||+|||+++. ..+|||||
T Consensus 504 --~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 504 --KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred --hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 4557899999999999999998754 68889999999999999999999999999999999999975 67999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
|.|.....+. .++|..++.|+|||++++ .+|+.+.|+||+||+||||.||+..|+|.++.+.+...+++-|..
T Consensus 582 GSA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 582 GSASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred cccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 9997654432 367888999999999999 799999999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcc--HHHHHHH-------H---------HhcCCCC-CCccCC------C----CCCChHHHHHHHHhccCCC
Q 015019 251 SPETIAVVRN--EKARKYL-------T---------EMRKKPP-VPLFQK------F----PNVDPLALRLLQRLIAFDP 301 (414)
Q Consensus 251 ~~~~~~~~~~--~~~~~~~-------~---------~~~~~~~-~~~~~~------~----~~~s~~~~dli~~~L~~dp 301 (414)
+..++....- +.+...+ + -+....| ..+... + +.+-.++.+||.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 9887764321 1100000 0 0001111 111000 1 1123468999999999999
Q ss_pred CCCCCHHHHhcCCCCCc
Q 015019 302 KDRPTAEEALADPYFKG 318 (414)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~ 318 (414)
.+|.|+.|+|.||||+.
T Consensus 735 ~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITE 751 (752)
T ss_pred hhcCCHHHHhcCCcccC
Confidence 99999999999999974
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=328.91 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=211.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
...|+.++.||.|+||.||+|.+..++..||+|.+... ........+.+|+.+++.+.||||+++++++. +...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTK 76 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence 35688999999999999999999999999999998743 22345567889999999999999999999984 4457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.|+||||+. ++|.+++.. +++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998 589988865 579999999999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+.......+..
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--------------- 215 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--------------- 215 (277)
T ss_pred c---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc---------------
Confidence 1 1133468889999999877 6789999999999999999999999987654332221110
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.. .......++..+.++|.+||+.+|.+|||+.++++||||...
T Consensus 216 ------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 216 ------------NN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ------------CC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 00 011123467889999999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=343.37 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=198.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||.||+|++..++ ..||+|++.... .......+.+|+.+++.+ +|+||+++++.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT--- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence 457999999999999999999865443 579999997542 223455688999999999 8999999999884
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC------------------------------------------------------
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (414)
....+|+|||||. |+|.+++...
T Consensus 113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 3356899999998 6999888532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccc
Q 015019 121 ----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (414)
Q Consensus 121 ----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (414)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~- 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee-
Confidence 247888999999999999999999999999999999999999999999999997653322111
Q ss_pred cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||........+..+....
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~---------------- 331 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG---------------- 331 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc----------------
Confidence 1122335567999999877 689999999999999999997 999997654332222111100
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... .....+++++.+++.+||+.||.+|||+.++++
T Consensus 332 --------~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 332 --------YQM-----SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------cCc-----cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 011246889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=330.91 Aligned_cols=260 Identities=29% Similarity=0.499 Sum_probs=212.1
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++++.||+|+||+||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++.. .
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~ 88 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLV-----G 88 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeee-----C
Confidence 3457999999999999999999999989999999998642 22334568899999999999999999998843 3
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...|+|+||+. ++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 46899999998 6899888653 588999999999999999999999999999999999999999999999998875433
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+.. .+
T Consensus 168 ~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~---------- 231 (293)
T cd06647 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG---------- 231 (293)
T ss_pred ccc---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CC----------
Confidence 221 1234468899999999876 6789999999999999999999999987654333221110 00
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.+.......++..+.++|++||..+|.+|||+.+++.||||+...
T Consensus 232 -----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 232 -----------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred -----------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 011112234678899999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=312.79 Aligned_cols=259 Identities=24% Similarity=0.417 Sum_probs=211.8
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~ 102 (414)
..+.+..||+|+.|+||+++.+.+|...|||.+.+. .+..+.+++++.+.++.... +|+||+++++|.... ++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV 166 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DV 166 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hH
Confidence 345678899999999999999999999999999875 45577889999999876664 899999999996654 48
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
++.||.|..-+..+++. .++++|..+-.+...++.||.||..+ ||+|||+||+|||+++.|.+||||||++-......
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99999998655555443 46799999999999999999999876 79999999999999999999999999997654432
Q ss_pred CccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHHhh
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. .+...|-+.|||||.+.-. ...|+..+||||||+.++||.||+.||.+.+ +.+.+..|.+
T Consensus 247 A----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln------------- 309 (391)
T KOG0983|consen 247 A----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN------------- 309 (391)
T ss_pred c----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-------------
Confidence 2 2455799999999988542 3579999999999999999999999999854 3444444432
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..+ |....-.++|+.+.+|+..||..|+.+||...++|+|||+....
T Consensus 310 --------------~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 310 --------------EEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred --------------cCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 111 11112235899999999999999999999999999999998653
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.73 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=203.1
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~ 109 (414)
||+|+||+||+|.+..+|+.||+|.+...... ......+.+|+.+|+.++||||+++++++ ...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 69999999999999999999999998643221 22344567899999999999999999988 3445789999999
Q ss_pred C-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 110 E-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 110 ~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----I 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----c
Confidence 8 69999987755 799999999999999999999999999999999999999999999999999876432211 1
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (414)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 209 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-------------------- 209 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--------------------
Confidence 33467889999999877 56899999999999999999999999765432111111100
Q ss_pred HHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCccc
Q 015019 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (414)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (414)
. ..........+++.+.++|++||+.||.+|| ++.++++||||..+.
T Consensus 210 ---~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 210 ---T----LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ---c----ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 0 0001112245789999999999999999999 999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=338.53 Aligned_cols=245 Identities=28% Similarity=0.418 Sum_probs=203.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.+++++.||+|-||.||.|.... ...||+|.++.. .-....+.+|+++|++|+|++||++++++.. ..-+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceE
Confidence 46889999999999999997653 337999998753 2234567799999999999999999999943 23599
Q ss_pred EEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
||||||. |+|.++++. ...+...+...++.||++|++||+++++|||||-..||||++++.+||+|||+|+....+.
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999 999999987 4579999999999999999999999999999999999999999999999999999433221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
-. ...+.--..-|.|||.+.. ..++.+||||||||+|+||+| |+.|+++.+..+.+..+.+...-|
T Consensus 358 Y~--~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp--------- 424 (468)
T KOG0197|consen 358 YT--ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP--------- 424 (468)
T ss_pred ee--ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC---------
Confidence 10 0011112334899999987 789999999999999999999 889999999988888776432222
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL 311 (414)
....+|+.+.+++..|+..+|++|||.+.+.
T Consensus 425 ---------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ---------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 1257899999999999999999999998664
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=328.10 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=204.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
++|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK---- 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----
Confidence 47999999999999999999876655 68999998643 223345568899999999999999999999843
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
....|++|||+. ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus 80 -~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 -EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 345899999998 6999999764 4578899999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhH
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~ 239 (414)
.++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999976432211 111234457888999999877 678999999999999999998 9999988765544
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
...+... .. ......+++.+.+|+.+||+.||.+|||+.+++++
T Consensus 236 ~~~i~~~---------------------------~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSR---------------------------QL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcC---------------------------Cc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3333210 00 01124678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=323.21 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=200.1
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
...||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++. ....+|+|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEe
Confidence 35799999999999999999999999988653 3345667889999999999999999999884 3457999999
Q ss_pred cCC-CCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEeecCCcccccCCCCc
Q 015019 108 LME-SDLHQVIKAN-DDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 108 ~~~-g~L~~~i~~~-~~l--~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~DFG~a~~~~~~~~~ 182 (414)
|+. ++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 6999998764 455 88889999999999999999999999999999999976 67899999999876433221
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
......|+..|+|||.+.+....++.++|+||+||++|+|++|.+||..............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----------------- 225 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----------------- 225 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-----------------
Confidence 1233458899999999865334588999999999999999999999965432111100000
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.... .......+++.+.+|+.+||+.+|.+|||+.+++.||||
T Consensus 226 -------~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 226 -------MFKI----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -------hhcc----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0000 001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=341.81 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=198.3
Q ss_pred CCeeEeeeecccCceeEEEEEE-----CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|++.+.||+|+||+||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 4799999999999999999964 3466789999987432 234456788999999999 8999999999984
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCC------------------------------------------------------
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~------------------------------------------------------ 121 (414)
.....|+|||||. |+|.+++....
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 3446899999999 69998886421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 122 ---------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 122 ---------------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47788899999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------------- 331 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-------------- 331 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH--------------
Confidence 111 1112335567999999977 689999999999999999998 8899976543322211110
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..... ......+.++.+||.+||+.||++|||+.++++.
T Consensus 332 ------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 ------------EGYRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ------------hCccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00000 0112457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=319.68 Aligned_cols=253 Identities=30% Similarity=0.502 Sum_probs=213.4
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|.+.+.||+|+||.||+|.+..++..||+|++............+.+|+++++.++|||++++++.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 59999999999999999999999999999999976555556667788999999999999999999998443 5789
Q ss_pred EEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 104 VVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+|+++ ++|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999998 5999988763 6799999999999999999999999999999999999999999999999999976544
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+..
T Consensus 156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TVD---LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Ccc---eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 321 1234578899999999877 6788999999999999999999999977664333322211
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
... .......+..+.+++.+||..+|++|||+.++|+||||
T Consensus 218 --------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 --------------GQY---PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 000 11123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=325.92 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=197.0
Q ss_pred eecccCceeEEEEEECCCCcEEEEEEeCCccCCh-HHHHHHHHH---HHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILRE---VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E---~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
.||+|+||.||+|.+..+++.||+|++.+..... ........| +.+++...||+|+.+++++. ....+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 4899999999999999999999999987532221 111122333 34455568999999999883 44569999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccc
Q 015019 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (414)
|||+. ++|.+++...+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 6899988888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHH
Q 015019 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (414)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (414)
....+|+..|+|||.+.+. ..++.++||||+||++|+|++|+.||.+............
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------- 210 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------------- 210 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-------------------
Confidence 1234799999999998652 4688999999999999999999999976532211110000
Q ss_pred HHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. ... ........+..+.++|.+||..||.+|| |+.++++||||+..
T Consensus 211 -----~-~~~---~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 211 -----T-LTM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred -----h-hcc---CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0 000 0111234689999999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=323.79 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=207.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....++.+|+++++.++||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 479999999999999999999999999999999875322 24456788999999999999999999988543 23468
Q ss_pred EEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 103 YVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588877643 3568999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh--hhHHHHHHHhcCCCCHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 255 (414)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .........
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 219 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY---------- 219 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----------
Confidence 2211 23457889999999877 6789999999999999999999999976532 001111100
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCC---CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQK---FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+. ......+... -..+++.+.+||.+||..||.+|||+.|++.||||...
T Consensus 220 -----------~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 220 -----------IV---NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -----------Hh---cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 00 0000000000 01356789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.38 Aligned_cols=248 Identities=23% Similarity=0.429 Sum_probs=202.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
..|.+.+.||+|+||.||+|.++.+++.||+|++... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCc
Confidence 4699999999999999999999999999999998743 234556889999999999999999999884 33468
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999998 6999998753 36899999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+....
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------- 222 (263)
T cd05052 158 TYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY----------- 222 (263)
T ss_pred eeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----------
Confidence 2111 112234567999999877 678999999999999999998 999998876544333322100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. ......++..+.++|.+||+.||++|||+.++++
T Consensus 223 ----------------~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ----------------R---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----------------C---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 0112457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=316.64 Aligned_cols=253 Identities=31% Similarity=0.502 Sum_probs=213.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+++++.++|||++++++++. +.+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 589999999999999999999999999999999865444456677899999999999999999999884 335799
Q ss_pred EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
+||||++ ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998 599999988888999999999999999999999999999999999999999999999999999875443321
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 213 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ----------------- 213 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-----------------
Confidence 234568889999999877 5688999999999999999999999976553322221110
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
. ........++..+.+++.+||..+|++|||+.++++||||
T Consensus 214 ----------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 214 ----------D---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----------c---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0 0011224678899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=329.40 Aligned_cols=255 Identities=28% Similarity=0.396 Sum_probs=208.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+.|++++.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCce
Confidence 468889999999999999999999999999999874322 234567889999999999999999999884 34568
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999 588888764 5799999999999999999999999999999999999999999999999999876433211
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 1123468889999999877 678999999999999999999999997554322221110
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.... .......+..+.++|.+||+.+|++|||+.++++||||..+
T Consensus 215 ----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 215 ----------KNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ----------cCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0000 01113467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=322.43 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=200.5
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHH-HHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||.|+||.||+|.+..+++.||+|++.+.... ......+..|..+ ....+|+|++++++++. ..+.+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 5799999999999999999999999998653221 1222334455554 34458999999999983 445799999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
.....|+..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.......+....
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 209 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR------------------ 209 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------------------
Confidence 123468889999999877 558999999999999999999999998766544333321100
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCcc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (414)
..........+++.+.++|.+||+.||++||| ++|+|+||||...
T Consensus 210 ---------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 210 ---------INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ---------cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 00001122357899999999999999999995 5899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=327.63 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=210.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|.+..++..||+|++.... .......+.+|+++++.++||||+++++.+.. ...+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEE
Confidence 57999999999999999999999999999999886432 23445678899999999999999999999843 3579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999998 5898888887889999999999999999999997 599999999999999999999999999986542221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
....+|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||........... ..
T Consensus 159 -----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~-------- 215 (284)
T cd06620 159 -----ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DP-------- 215 (284)
T ss_pred -----cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hh--------
Confidence 123468999999999876 6788999999999999999999999986543211000 00
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
......+..........+ ....++..+.+||.+||+.||++|||+.++++||||..-
T Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 216 MGILDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hHHHHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000011111111110000 011367889999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=325.52 Aligned_cols=257 Identities=31% Similarity=0.493 Sum_probs=208.6
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCCCCCc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~ 100 (414)
.|++++.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+. |||++++++++. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCC
Confidence 48889999999999999999999999999999875322 234556788999999986 999999999884 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 6899999998 589888865 47999999999999999999999999999999999999999999999999999765443
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.........+..
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------- 216 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------- 216 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc--------------
Confidence 32 12345789999999987652 4578899999999999999999999977654322211100
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..+..+ ....++..+.+++.+||+.||++|||+.+++.||||+...
T Consensus 217 -------------~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 217 -------------SKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -------------CCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 000000 0113678999999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=324.73 Aligned_cols=259 Identities=22% Similarity=0.370 Sum_probs=204.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--- 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 4689999999999999999997652 34589999886432 23344567889999999999999999999843
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCe
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~v 165 (414)
....|+||||+. |+|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 --GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred --CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 346899999998 7999999752 234667888999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (414)
||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999997543322111 1122345677999999877 678999999999999999998 788998766544333221
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc------CCCCCc
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA------DPYFKG 318 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~------hp~~~~ 318 (414)
.. .........++.+.+++.+||+.||++|||+.++++ ||||.+
T Consensus 236 ~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 DG------------------------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred cC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 10 000111345788999999999999999999999987 999986
Q ss_pred c
Q 015019 319 L 319 (414)
Q Consensus 319 ~ 319 (414)
+
T Consensus 286 ~ 286 (288)
T cd05061 286 V 286 (288)
T ss_pred C
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.47 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=211.2
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
....+.|...+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++|||++++++++.
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 91 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL----- 91 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----
Confidence 3444568888999999999999999999999999999864322 2334456889999999999999999999984
Q ss_pred CCceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+....|+||||+.+++.+.+.. ..++++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 92 KEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred eCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 3456899999999999888865 457899999999999999999999999999999999999999999999999998643
Q ss_pred cCCCCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.. .....|+..|+|||.+... ...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 172 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------- 235 (313)
T cd06633 172 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------- 235 (313)
T ss_pred CC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------
Confidence 21 1345688999999987421 146888999999999999999999999876654443333210
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
..+ ......++..+.+|+.+||+.+|.+|||+.+++.||||+.
T Consensus 236 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 236 -----------------DSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred -----------------CCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 0112356778999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=319.56 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=198.5
Q ss_pred eecccCceeEEEEEE--CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 30 VIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
.||+|+||.||+|.. ..++..||+|+++...........+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 689999999999964 4567899999987654445556678899999999999999999998732 34699999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
|+. ++|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 6899999887889999999999999999999999999999999999999999999999999997654332211111
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+.+..+....+.+.
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~------------------- 214 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG------------------- 214 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-------------------
Confidence 22334678999999876 678899999999999999998 99999876654444333210
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. ......+++.+.+||.+||+.||++|||++++..
T Consensus 215 --------~~---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 215 --------ER---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CC---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00 0122457899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=335.32 Aligned_cols=285 Identities=20% Similarity=0.242 Sum_probs=205.0
Q ss_pred eeeccc--CceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
..||+| +||+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 456666 99999999999999999999987554444556778899999999999999999999943 45689999
Q ss_pred ecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 107 ELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 107 E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999 5999888764 358999999999999999999999999999999999999999999999998654322211100
Q ss_pred -cc---ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 184 -VF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 184 -~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. .....++..|+|||++.+....++.++||||+||++|+|++|.+||.+.........+.. +.+.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK--GPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc--CCCCCCcccccc
Confidence 00 011234567999999866334578999999999999999999999987765444333322 111100000000
Q ss_pred cHHHH-------HHH----HHhcC-----CCC-CCc-cCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 260 NEKAR-------KYL----TEMRK-----KPP-VPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 260 ~~~~~-------~~~----~~~~~-----~~~-~~~-~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..... ... ..... ... ... .......++.+.+||++||+.||++|||+.++|+||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00000 000 00000 000 000 001124677899999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=343.86 Aligned_cols=243 Identities=30% Similarity=0.458 Sum_probs=201.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 100 (414)
...|++...+|.|+||.|..+.+..++...++|++.+.. ....+|+.++... +||||+++++++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 467999999999999999999999999999999998641 2233566554444 799999999999 5667
Q ss_pred eEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE-cCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA-NANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl-~~~~~vkL~DFG~a~~~~~ 178 (414)
++|+|||++.| .+.+.+.....++ .++..|++||+.|+.|||++|++||||||+|||+ +..+.++|+|||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 89999999995 7777777665555 8888999999999999999999999999999999 6889999999999976533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. +...|-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... ..|...++.+..
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~------ 531 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF------ 531 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc------
Confidence 2 234467889999999986 89999999999999999999999999765443 122222221110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...+|..|+|||++||++||.+|+++.+++.||||
T Consensus 532 -----------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 -----------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 04689999999999999999999999999999999
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.15 Aligned_cols=253 Identities=32% Similarity=0.519 Sum_probs=207.0
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~ 109 (414)
||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999999999999999865322 224456788999999999999999999887 3446799999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc-----c
Q 015019 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----T 183 (414)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~-----~ 183 (414)
. ++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998765433211 1
Q ss_pred ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.. +..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~------------- 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKI------------- 218 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc-------------
Confidence 11234568889999999877 5688999999999999999999999987665444333321 000
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH---HHHhcCCCCCcc
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKGL 319 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~---~~lL~hp~~~~~ 319 (414)
.. .....++..+.+++.+||+.+|.+|||+ .++|+||||+.+
T Consensus 219 -------------~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 219 -------------EW-PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred -------------CC-CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 00 0011258899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.77 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=203.4
Q ss_pred CCeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+++|+.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTE---- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence 579999999999999999998753 467899999875422 2345678899999999999999999999844
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND--------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~--------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~ 162 (414)
....|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 356899999998 69999997542 47889999999999999999999999999999999999999
Q ss_pred CCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHH
Q 015019 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (414)
Q Consensus 163 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~ 241 (414)
+.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred CeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999754322111 11123346788999999977 679999999999999999998 999998776554443
Q ss_pred HHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+.... .......++..+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQGR------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 332100 00112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=334.57 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=200.6
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||.|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 368999999999999999999754 345789999987542 234456678999999999 799999999987533
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC------------------------------------------------------
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (414)
...+|+||||+. ++|.+++...
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 246899999999 6898888542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCc
Q 015019 121 -------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (414)
Q Consensus 121 -------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~ 193 (414)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCc
Confidence 25788999999999999999999999999999999999999999999999999865332211 1112344667
Q ss_pred cccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcC
Q 015019 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (414)
Q Consensus 194 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (414)
.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+..... .
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------------------------~ 291 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK--------------------------E 291 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh--------------------------c
Confidence 8999999877 689999999999999999997 9999987543222211110 0
Q ss_pred CCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.... ......++.+.+++.+||+.+|++|||+.++++|
T Consensus 292 ~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 GTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 1113567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=323.25 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=196.6
Q ss_pred CCeeEeeee--cccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVI--GKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~l--g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
+.|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+ +||||+++++.+.. .
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~-----~ 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT-----L 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec-----C
Confidence 456666666 99999999999999999999999986432111 122222222 79999999999843 3
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~a~~~~ 177 (414)
+.+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 46999999998 69999998888999999999999999999999999999999999999999998 99999999987643
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhH-HHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 256 (414)
.. ....|+..|+|||++.+ ..++.++||||+||++|+|++|..||........ ...+.
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 220 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL------------ 220 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH------------
Confidence 22 23458899999999977 6789999999999999999999999975443210 01110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-HHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-~~~lL~hp~~~~ 318 (414)
... .......+.+++.+.+||.+||+.||.+||+ ++++|+||||..
T Consensus 221 -----------~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 221 -----------KRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -----------Hhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 000 0011223468999999999999999999996 599999999963
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=332.29 Aligned_cols=275 Identities=22% Similarity=0.265 Sum_probs=201.1
Q ss_pred CceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCC-CCH
Q 015019 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDL 113 (414)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~-g~L 113 (414)
++|.||.+.+..+++.||||++............+.+|+.+++.++|+||+++++++.. ....|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence 44566677777899999999997654445667789999999999999999999999843 356899999999 689
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC----cccccc
Q 015019 114 HQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP----MTVFWT 187 (414)
Q Consensus 114 ~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~~~~ 187 (414)
.+++... ..+++..++.+++||+.||+|||++||+||||||+||+++.++.+||+|||.+........ ......
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 8888753 4689999999999999999999999999999999999999999999999999875432211 111123
Q ss_pred ccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHH
Q 015019 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (414)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (414)
...++..|+|||++.+....|+.++||||+||++++|++|..||........... ...+....... ... .....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~-~~~---~~~~~ 240 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD-KST---YPLYE 240 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCccccc-cCc---hhhhc
Confidence 4457888999999866334688999999999999999999999987654433211 11111110000 000 00000
Q ss_pred HHhcC---------CCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 268 TEMRK---------KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 268 ~~~~~---------~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..... ............++..+.+|+.+||..||++|||++++|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000 000000011123567889999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=357.02 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=202.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||.||+|.+..+++.||+|++..... ......++.+|+.+++.++||||+++++++ .+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 689999999999999999999999999999999975432 233456788999999999999999999988 34457
Q ss_pred EEEEEecCC-CCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEee
Q 015019 102 IYVVFELME-SDLHQVIKAN-----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-----------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~D 169 (414)
.|+||||++ ++|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 899999998 5999888641 2355677889999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCc---------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC
Q 015019 170 FGLARVAFSDTPM---------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (414)
Q Consensus 170 FG~a~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~ 234 (414)
||+|+........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999765211100 001123579999999999987 67899999999999999999999999775
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
........ .....| .. ...+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i~~P-------------------------~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVILSP-------------------------IE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhccCh-------------------------hh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221111 000000 00 01124678899999999999999999887766654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.24 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=210.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+.+++.++|+||+++++++.. ....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 5899999999999999999999999999999987654444556677899999999999999999998843 35799
Q ss_pred EEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 104 VVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999998 589988865 35789999999999999999999999999999999999999999999999999977544
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 123468889999999877 6789999999999999999999999987664433222211
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.. ........+.++.++|.+||..+|++|||+.++++||++
T Consensus 216 --------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------GK---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CC---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 001113567889999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=322.22 Aligned_cols=253 Identities=21% Similarity=0.376 Sum_probs=200.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 4689999999999999999998652 3568999998642 2334455688999999999999999999998
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCe
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAND----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~----------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~v 165 (414)
......++||||+. ++|.+++.... .++...+..++.|++.||+|||+.|++||||||+||++++++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 34456899999998 69999986522 35778889999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (414)
||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred EECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999987543321111 1112345778999999877 678999999999999999999 789998766544433332
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
... ........++.+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCC------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 001123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.49 Aligned_cols=256 Identities=22% Similarity=0.360 Sum_probs=202.8
Q ss_pred eeEeeeecccCceeEEEEEECCCCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CCCce
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~~~ 101 (414)
|.+.+.||+|+||.||+|.+..++. .||+|.++...........+.+|+.+++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578899999999999999887775 69999987654555667788899999999999999999997754321 22346
Q ss_pred EEEEEecCC-CCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 102 IYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~------~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.++||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 699887742 2358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 653322110 1122345678999999887 678999999999999999999 8899987665433332221
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
... ....+.++..+.++|.+||+.||++|||+.+++++
T Consensus 230 -------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNR---LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 01124577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.21 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=203.7
Q ss_pred eeEeeeecccCceeEEEEEECC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CCCc
Q 015019 25 YKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFK 100 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~~ 100 (414)
|++++.||+|+||.||.|.... ++..||+|+++...........+.+|+.+++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998765 34789999987654455566778999999999999999999998765432 3344
Q ss_pred eEEEEEecCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 101 DIYVVFELME-SDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
..++||||+. ++|..++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5899999998 6998888432 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+...
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG------ 231 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence 8653322110 0112234667999999876 678999999999999999999 88999876654433322210
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. ........+..+.+++.+||+.||.+|||+.+++.+
T Consensus 232 ---------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 232 ---------------------N---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---------------------C---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 011224678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=328.05 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=201.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcE----EEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..+|++.+.||+|+||+||+|.+..++.. ||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 35799999999999999999998766654 899998643 2334556788999999999999999999988542
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..++|+||+. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 3689999998 7999999874 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (316)
T cd05108 159 LGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------- 226 (316)
T ss_pred ccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54322111 1122334667999999877 688999999999999999997 9999987654332221110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.... ...+..+..+.+++.+||..||.+|||+.+++.+
T Consensus 227 ------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 ------------------GERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 1123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=325.60 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=209.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
..|.....||+|+||.||++.+..++..||||++... .......+.+|+.+++.++|+||+++++.+. .....
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEE
Confidence 3455567899999999999999999999999998542 2234556889999999999999999999984 44579
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+.+ +|.+++. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999985 7777664 45789999999999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
......|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+......+..+....
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------------- 232 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 232 (292)
T ss_pred ---cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--------------
Confidence 1134568899999999876 678899999999999999999999998766544333221100
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
+ +.......+++.+.+++.+||+.||.+|||+.++|+||||....
T Consensus 233 -------------~-~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 233 -------------P-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -------------C-cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0 00112245788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=357.19 Aligned_cols=148 Identities=24% Similarity=0.431 Sum_probs=133.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|.+++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+++.++||||++++.++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 468999999999999999999999999999999987532 2334456788999999999999999999888 3445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
++||||||+. ++|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7999999997 6999999887889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=326.69 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=210.7
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+....|...+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++|||++++++++..
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 96 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR----- 96 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 333568999999999999999999999999999999875422 23445578899999999999999999999843
Q ss_pred CceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
....|+||||+.|+|.+.+.. ..++++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....
T Consensus 97 ~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 97 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 346899999999998888754 4579999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.. ....|+..|+|||.+.. ....++.++||||+||++|+|++|.+||.+.+....+..+......
T Consensus 177 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 242 (317)
T cd06635 177 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------- 242 (317)
T ss_pred Cc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-------
Confidence 21 23468899999998742 1146888999999999999999999999776554444333221000
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
......+++.+.+||.+||+.+|.+|||+.++++|+|+..
T Consensus 243 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 ----------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0011346788999999999999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=314.04 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=213.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++||||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999998765444456678889999999999999999999885431 25689
Q ss_pred EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
+|+||+. ++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988779999999999999999999999999999999999999999999999999999876544321
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ....+....
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~--------------- 217 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIG--------------- 217 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcc---------------
Confidence 01134568889999999877 5689999999999999999999999977651 111111110
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
. ..........++..+.++|.+||+.||++|||+.++++||||
T Consensus 218 ---------~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 ---------S--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------c--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0 011112234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=321.48 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=208.8
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+-|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeE
Confidence 35788999999999999999999999999999876432 2344567889999999999999999999983 44568
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||++ ++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999998 588888764 5789999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
......|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+..
T Consensus 157 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 215 (277)
T cd06641 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---------------- 215 (277)
T ss_pred ---hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc----------------
Confidence 1234568889999999876 6788899999999999999999999976554332222210
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.. .......++..+.++|.+||+.+|.+||++.++++||||...
T Consensus 216 -----------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 -----------NN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred -----------CC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00 001123578889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=371.72 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=217.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.-|+.-...||.|.||.||.|.+..||+..|+|.+.-..........+.+|.++|..++|||+|+.+++-.+. ..
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ek 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EK 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HH
Confidence 3467778899999999999999999999999999864333344455677999999999999999999987544 34
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+||.||||. |+|.+.+......++...+.+..|++.|++|||+.|||||||||.||+++.+|.+|++|||.|.....+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 899999999 7999999887778888889999999999999999999999999999999999999999999998765543
Q ss_pred -CccccccccccCccccccccccccC-CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 181 -PMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 181 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.......++.||+.|||||++.+.. .+.+.|+|||||||++.||+||+.||..-+..-++ +-+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--My~------------- 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--MYH------------- 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--HhH-------------
Confidence 2223456789999999999997642 45778999999999999999999999765533221 111
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
-.....++ ....+|++++|||.+||+.||.+|.++.|+|.|-|-+.-
T Consensus 1454 ---------V~~gh~Pq-----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1454 ---------VAAGHKPQ-----IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ---------HhccCCCC-----CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 01111222 223589999999999999999999999999999998653
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=316.93 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=200.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|+||.||+|..+ .+..+|+|.+.... .....+.+|+.+|+.++||||+++++++. ....+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCE
Confidence 57999999999999999999875 45679999876432 22356788999999999999999999883 34568
Q ss_pred EEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+||||+. |+|.+++... +.+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||.++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999998 6999988753 468999999999999999999999999999999999999999999999999987643222
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+..+.+..+......
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------- 220 (256)
T cd05114 155 YTS--SSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------- 220 (256)
T ss_pred eec--cCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------
Confidence 111 122335567999999876 678999999999999999999 89999887765555444321100
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+..+.+|+.+||+.||.+|||++++++
T Consensus 221 --------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 --------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=323.56 Aligned_cols=262 Identities=23% Similarity=0.390 Sum_probs=208.6
Q ss_pred CeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 97 (414)
.|++.+.||.|+||.||.|.+. .+|..||+|++..... .......+.+|+.+++.+ +|+||+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----- 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence 4899999999999999999875 4789999999864321 223445678899999999 5999999999883
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 3456899999999 699999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 332111 1234568999999999875334578899999999999999999999965432211111111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.+....+ .....+++.+.+|+++||..||++|| +++++++||||...
T Consensus 223 ------------~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 223 ------------RILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ------------HhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 0100000 01235788899999999999999997 89999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=318.70 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=202.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++.+.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++.. .+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 57999999999999999999999999999999886422 233445568899999999999999999998843 356
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.|+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 588887753 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh-hHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 255 (414)
..... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... ..+.......+.++
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 227 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP---- 227 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC----
Confidence 33221 1134568889999999877 67889999999999999999999999654321 11111111111000
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+..+.++|.+||+.+|++|||+.++++
T Consensus 228 ------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 ------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011246788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=357.75 Aligned_cols=264 Identities=32% Similarity=0.460 Sum_probs=203.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC--------
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP-------- 94 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------- 94 (414)
.+|+.+..||+||||.||+|+++-+|+.||||++.-.. ......++.+|+..|.+|+|||||+++..|...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35688999999999999999999999999999998655 556677899999999999999999998877100
Q ss_pred ----------------------------------------------C-------C-------------------------
Q 015019 95 ----------------------------------------------S-------K------------------------- 96 (414)
Q Consensus 95 ----------------------------------------------~-------~------------------------- 96 (414)
+ .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred ---------------------CC-------CceEEEEEecCCCCHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHCC
Q 015019 97 ---------------------RE-------FKDIYVVFELMESDLHQVIKANDDL--TREHHQFFLYQMLRALKYMHTAN 146 (414)
Q Consensus 97 ---------------------~~-------~~~~~lV~E~~~g~L~~~i~~~~~l--~~~~~~~i~~qil~al~~LHs~g 146 (414)
.+ ...+||-||||+.++...+...+.+ ....++++++||++||+|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 00 0248999999996555555444444 47889999999999999999999
Q ss_pred cccCCCCCCCEEEcCCCCeEEeecCCccccc---C------------CCCccccccccccCccccccccccccC-CCCCC
Q 015019 147 VYHRDLKPKNILANANCKLKVCDFGLARVAF---S------------DTPMTVFWTDYVATRWYRAPELCGSFF-SKYTP 210 (414)
Q Consensus 147 ivHrDlkp~NILl~~~~~vkL~DFG~a~~~~---~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~ 210 (414)
|+||||||.||++++++.|||+|||+|.... . ........+..+||-.|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0 011122346789999999999998742 16999
Q ss_pred cchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCcc-CCCCCCChHH
Q 015019 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLA 289 (414)
Q Consensus 211 ~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~ 289 (414)
++||||||+||+||+. ||.. .++....+.++-. ...|.. ..+.+--+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~-------------------------g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRK-------------------------GSIPEPADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhccc-------------------------CCCCCCcccccccchHH
Confidence 9999999999999984 4643 3444444433221 111111 1122233556
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 290 LRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 290 ~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
..+|+.||+.||.+||||.|+|++-||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 7899999999999999999999999985
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=315.29 Aligned_cols=245 Identities=22% Similarity=0.372 Sum_probs=194.6
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEec
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~ 108 (414)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEee
Confidence 46999999999999999999999999886532 23445678899999999999999999999843 3568999999
Q ss_pred CC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 109 ME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 98 6999998764 468999999999999999999999999999999999999999999999999987543211100 00
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999877 678999999999999999997 8899976554332222211
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.... ......+..+.+|+.+||+.||++|||+.++++
T Consensus 212 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112346789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=322.13 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=201.9
Q ss_pred CCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..|.+.+.||+|+||.||++.+. .++..||+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 77 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 77 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 57999999999999999999853 34567999988653 2344567889999999999999999999984
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND-------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~ 163 (414)
....+|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||+.|++||||||+||++++++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 3356899999998 69999987543 489999999999999999999999999999999999999999
Q ss_pred CeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHH
Q 015019 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDL 242 (414)
Q Consensus 164 ~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~ 242 (414)
.+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999975433211 111223446778999999877 678999999999999999998 9999987765544443
Q ss_pred HHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
+.... . .......+..+.+|+.+||+.||.+|||+.+++.
T Consensus 235 i~~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQGR---------------------------V---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHcCC---------------------------c---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 32110 0 0112356789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=320.28 Aligned_cols=252 Identities=21% Similarity=0.372 Sum_probs=201.1
Q ss_pred CCeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
+.|++.+.||+|++|.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 579999999999999999999987 7789999987643 223344568899999999999999999998843
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC---CeE
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND-------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLK 166 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~---~vk 166 (414)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+|
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 345799999997 69999987643 589999999999999999999999999999999999998765 599
Q ss_pred EeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 015019 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245 (414)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 245 (414)
|+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999865222111 00112233567999999876 679999999999999999997 9999988765544333321
Q ss_pred hcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.. . ......++..+.+++.+||+.||++|||+.++|+|
T Consensus 237 ~~---------------------------~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GG---------------------------R---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CC---------------------------c---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0 01124578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=323.02 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=199.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
++|++.+.||.|+||.||+|.++.++. .+|+|.++. .........+.+|+.++.++ +||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cC
Confidence 579999999999999999999887765 478888763 23334456788999999999 7999999999883 33
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC
Q 015019 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~ 162 (414)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 46899999998 69999986532 48889999999999999999999999999999999999999
Q ss_pred CCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHH
Q 015019 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (414)
Q Consensus 163 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~ 241 (414)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864321111 011223456999999877 678999999999999999997 999998776544333
Q ss_pred HHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.+... . .......++..+.+||.+||+.||.+|||++++++.
T Consensus 230 ~~~~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQG---------------------------Y---RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhcC---------------------------C---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32110 0 001123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=312.30 Aligned_cols=251 Identities=30% Similarity=0.523 Sum_probs=208.8
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.|++.+.||+|++|.||+|.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48899999999999999999999999999999875322 3556788999999999999999999988443 5689
Q ss_pred EEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 104 VVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
+++||++ ++|.+++... ..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999998775 5899999999999999999999999999999999999999999999999999976544321
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+.. ..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~------------- 213 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NG------------- 213 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cC-------------
Confidence 234568889999999877 5688999999999999999999999987654433332221 00
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
.+.......++..+.++|.+||+.||.+|||+.++|+|||
T Consensus 214 --------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 214 --------------PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred --------------CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000011224788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=322.41 Aligned_cols=260 Identities=32% Similarity=0.516 Sum_probs=215.3
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.+..+.|++...||+|++|.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++..
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 86 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV----- 86 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----
Confidence 3556789999999999999999999998999999999875322 45667899999999999999999999844
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....|+|+||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 356899999999 69999998876 8999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 167 ~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~---------- 231 (286)
T cd06614 167 TKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK---------- 231 (286)
T ss_pred ccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Confidence 33221 1123457889999999877 67899999999999999999999999876554333322110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.. +.......++..+.+||.+||+.+|.+|||+.++|+||||...
T Consensus 232 -----------------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 232 -----------------GI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -----------------CC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00 0011123478889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=316.48 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=203.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++.+.||+|+||+||+|....+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+. .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----K 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----c
Confidence 35799999999999999999988654 4579999887532 2334556889999999999999999999883 3
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...+|+||||+. ++|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 456899999998 5999998764 47899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.+....
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05033 157 EDSEATY-TTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------ 227 (266)
T ss_pred cccccce-eccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 4211111 1112234678999999877 678999999999999999998 99999776654444333221100
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......+..+.+|+.+||+.+|++|||+.+++++
T Consensus 228 ------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 ------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=325.17 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=197.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcE--EEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
+.|++.+.||+|+||.||+|.++.++.. +|+|.+... ........+.+|+.++..+ +||||+++++++. ..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 5799999999999999999998877764 577776532 2234456788899999999 8999999999983 34
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC
Q 015019 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~ 162 (414)
+.+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 56899999998 69999986432 57899999999999999999999999999999999999999
Q ss_pred CCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHH
Q 015019 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (414)
Q Consensus 163 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~ 241 (414)
+.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred CcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 9999999999864221111 011224567999999876 678999999999999999998 999997765443322
Q ss_pred HHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.+. .... ......+++.+.+||.+||+.+|++|||++++|.+
T Consensus 235 ~~~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLP---------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHh---------------------------cCCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 0000 01112467889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=336.72 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=225.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
...+++..||-||||.|=++.-......+|+|++++.. -.....+.+..|-+||..++.|.||++|..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 35678899999999999999776666679999987642 2345566789999999999999999999998 56678
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+.||-|- |+|+.+++.++.+.+..+++++..+++|++|||++||++|||||+|++++.+|.+||.|||+|+....+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999986 7999999999999999999999999999999999999999999999999999999999999999876554
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ..++|||+.|+|||++++ ...+.++|.||||+++|||++|.|||++.+.....+.|.+.+...
T Consensus 575 K----TwTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------- 638 (732)
T KOG0614|consen 575 K----TWTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------- 638 (732)
T ss_pred c----eeeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------
Confidence 3 257899999999999998 789999999999999999999999999999999998886533211
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
.....++..+.+||+++-..+|.+|.. +.++-.|.||.++
T Consensus 639 -------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 639 -------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred -------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 112468899999999999999999986 8999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=316.55 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=201.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|+++++||+|++|.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++|+||+++++++. ..+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCC
Confidence 468999999999999999999865 5667999987642 223567889999999999999999999883 3456
Q ss_pred EEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 699999865 35688999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+....
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---------- 221 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1123345678999999876 678999999999999999998 999998766544443332110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. ......++..+.+++.+||..||++|||++++++
T Consensus 222 -----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 222 -----------------R---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------------C---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 0122457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=314.87 Aligned_cols=245 Identities=20% Similarity=0.316 Sum_probs=197.0
Q ss_pred eeecccCceeEEEEEECCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
+.||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+++.++||||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEE
Confidence 47999999999999876554 78999998754332 45567889999999999999999999863 2357999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccc
Q 015019 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (414)
|||+. ++|.+++.....+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999998888899999999999999999999999999999999999999999999999999986543322111
Q ss_pred cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHH
Q 015019 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (414)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (414)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------------- 214 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------------
Confidence 1111123457999999877 679999999999999999998 99999776654333332210
Q ss_pred HHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. ......++..+.++|.+||..||++|||+.++++
T Consensus 215 ----------~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 ----------ER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------Cc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=325.43 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=209.5
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...+|...+.||.|+||.||+|++..++..||+|.+.... .......++.+|+.+++.++|+|++++++++.. .
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----E 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----C
Confidence 4467999999999999999999999999999999986432 223344567899999999999999999999843 3
Q ss_pred ceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...|+||||+.+++.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 46899999999998887754 45689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
. ....|+..|+|||.+.+. ...++.++|||||||++|+|++|..||...+..+....+...
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 229 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----------- 229 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc-----------
Confidence 1 234688899999987421 145788999999999999999999999765543333222110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.. + .......+..+.+||++||..+|.+|||++++++|||+...
T Consensus 230 ---------------~~--~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 230 ---------------ES--P-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---------------CC--C-CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00 0 00123577889999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=319.32 Aligned_cols=252 Identities=21% Similarity=0.376 Sum_probs=201.5
Q ss_pred CCeeEeeeecccCceeEEEEEEC----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
..|++.+.||+|+||+||+|... .++..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----- 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----
Confidence 57999999999999999999853 45678999998753 233444678899999999999999999998843
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
....|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 345899999998 6999988532 2478889999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhH
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~ 239 (414)
.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCcce-ecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999765332211 11133446778999999876 678999999999999999998 9999987664433
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
...+.. .. .......+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQ---LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 333321 00 011223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=314.55 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=203.8
Q ss_pred eeecccCceeEEEEEECCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999999866 8899999987643332 46678899999999999999999999844 4568999
Q ss_pred EecCC-CCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 106 FELME-SDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~---------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.++.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 7899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
...... ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------- 223 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-------- 223 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------
Confidence 644321 111234557889999999877 578999999999999999999 69999887654444333210
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
........++..+.+++.+||+.||.+|||+.++++|
T Consensus 224 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 ----------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=334.57 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=198.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||+||+|.+... +..||||++... ......+.+.+|+.+|+.+. ||||+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--- 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--- 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence 46899999999999999999987533 347999998753 22344567889999999996 999999999983
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC------------------------------------------------------
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (414)
+...+|||||||. |+|.+++..+
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 --KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred --cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 3456999999998 6998887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEE
Q 015019 121 ------------------------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (414)
Q Consensus 121 ------------------------------------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NIL 158 (414)
..+++..+..++.||+.||+|||+.||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 24778888999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChh
Q 015019 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (414)
Q Consensus 159 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~ 237 (414)
++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYV-SKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceecccccccc-ccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999997653322111 1123356788999999877 678999999999999999997 99999765432
Q ss_pred hHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..+.... ...... .....++..+.+++.+||+.||++|||+.++.+
T Consensus 347 ~~~~~~~--------------------------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKI--------------------------KSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHH--------------------------hcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 2211111 000000 112357889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=316.60 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=203.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++.+.||+|+||.||+|.++.++. .||+|.+.... .......+.+|+.+++.++||||+++++++. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----K 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 4689999999999999999999875543 79999986532 2344567889999999999999999999984 3
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.+.+|+||||+. ++|.+++... +.++...+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 356899999998 6899998764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..............++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL------ 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC------
Confidence 432211111112223567999999877 678999999999999999886 99999876655444443221110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+++.+.+++.+||+.+|.+|||+.++++
T Consensus 229 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 112356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=314.87 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=199.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||.||+|.+..++ .||+|++..... ....+.+|+.+++.++||||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence 468999999999999999999887654 599999875322 23467889999999999999999987622 34
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||.++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999998 6999999753 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..... .....++..|+|||...+ ..++.++|||||||++|+|++ |.+||.+.........+.....
T Consensus 155 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------- 221 (262)
T cd05071 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 221 (262)
T ss_pred ccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---------
Confidence 22111 123346678999998876 678999999999999999999 8899987765444433321100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. .....++..+.+|+.+||+.||++|||+.++++
T Consensus 222 ------------------~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 ------------------M---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------------C---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 112357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=314.95 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=199.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||.|.... +..||+|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCC
Confidence 4579999999999999999997653 4569999886432 223567899999999999999999999843 345
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 6899998764 46899999999999999999999999999999999999999999999999998764332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 219 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR---------- 219 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC----------
Confidence 2111 112235677999999876 678999999999999999998 9999977665443333321110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. ......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 220 -----------------~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 220 -----------------L---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------------C---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0 0112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.17 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=199.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|++|.||+|.+. +++.||+|.++... .....+.+|+.+++.++||||+++++++. ..+..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI 76 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence 57999999999999999999875 45689999987532 23456788999999999999999999873 34568
Q ss_pred EEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999995 79999997654 7899999999999999999999999999999999999999999999999999875422
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+.....
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (261)
T cd05068 157 IYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR---------- 222 (261)
T ss_pred cccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 1111 111223457999999877 678999999999999999999 9999987765444433321100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. ......+..+.+++.+||+.||.+|||+.++++
T Consensus 223 -----------------~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 -----------------M---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----------------C---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=320.98 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=201.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|++.+.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 87 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--- 87 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC---
Confidence 68999999999999999999876443 689999987542 234456688999999999 79999999998843
Q ss_pred CCCceEEEEEecCC-CCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE
Q 015019 97 REFKDIYVVFELME-SDLHQVIKA----------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~----------------~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl 159 (414)
...+|+||||+. ++|..++.. ...+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 346899999998 699999854 2468999999999999999999999999999999999999
Q ss_pred cCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhh
Q 015019 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVH 238 (414)
Q Consensus 160 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~ 238 (414)
+.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred cCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999998654322111 1122234567999999877 678999999999999999997 999998766544
Q ss_pred HHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
....+.. .. ........+..+.+|+.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKE---------------------------GY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHc---------------------------CC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3332211 00 001123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=315.31 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=199.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCce
Confidence 46899999999999999999876 466899999864322 2345778999999999999999999883 33568
Q ss_pred EEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+||||+. ++|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999997 6899998764 468999999999999999999999999999999999999999999999999997653321
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 155 ~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------- 219 (256)
T cd05059 155 YTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------- 219 (256)
T ss_pred ccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-----------
Confidence 111 111223457999999877 678999999999999999999 8999987665444333321100
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.......+..+.+++.+||..+|++|||+.++++.
T Consensus 220 -------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 -------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=316.32 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=200.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..+|++++.||+|+||+||+|.+..++. .||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 3579999999999999999999877776 4899998653 2334456788999999999999999999988532
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..++++||+. |+|.+.+..+ +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 3689999998 7999999764 5699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK--------- 226 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---------
Confidence 5332211 11122235677999999877 678999999999999999998 8999976554332222211
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... .......+..+.+++.+||..||++|||+.+++.
T Consensus 227 ------------------~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 ------------------GER---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCc---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0112457889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=315.73 Aligned_cols=252 Identities=22% Similarity=0.384 Sum_probs=202.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++.+.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC---
Confidence 36899999999999999999988644 478999998643 233445568899999999999999999999843
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCe
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~v 165 (414)
....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+
T Consensus 81 --~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 --GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 356899999998 7999998653 236788999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (414)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999764332211 11123456788999999876 678999999999999999998 999998766544333322
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. + . ........+..+.+||.+||+.+|++|||+.++++
T Consensus 236 ~--~-------------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 D--G-------------------------G---HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred c--C-------------------------C---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0 0 00112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=313.00 Aligned_cols=251 Identities=29% Similarity=0.448 Sum_probs=202.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .........+.+|+.+++.++|+||+++++.+.. .+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 5899999999999999999999999999999988642 2233345678899999999999999999999843 356
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 699988864 345899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh--hHHHHHHHhcCCCCHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLITDLLGTPSPET 254 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 254 (414)
...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... +....+.
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 221 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------- 221 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh----------
Confidence 332211 134568899999999877 67899999999999999999999999654311 1111110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+ ......+..+.++|.+||..+|++|||+.++++
T Consensus 222 -----------------~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 222 -----------------KCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----------------cCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000000 001256788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.24 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=202.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
++|+..+.||+|+||.||+|.++.++. .||+|++.... .......+..|+.+++.++||||+++.+++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 478999999999999999999876654 79999886532 2344567889999999999999999999983 34
Q ss_pred ceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...|+||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 56899999999 589888875 3578999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......|
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~------ 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP------ 230 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC------
Confidence 33221111111223457999999876 678999999999999999997 999998766555444443211110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+..+.+|+.+||+.||++||++.++++
T Consensus 231 ------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=320.27 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=201.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.+|.+++.||.|+||.||+|.+..+ +..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~---- 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK---- 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----
Confidence 4688999999999999999987543 5789999987532 22334567899999999999999999999843
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
...+++++||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 80 -~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 -EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 345899999998 6898888532 3478889999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhH
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~ 239 (414)
+++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998764332211 11223446778999999876 678999999999999999998 8899987766554
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
+..+...... .....++..+.+|+.+||+.+|.+|||+.+++..
T Consensus 236 ~~~i~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVL------------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcC------------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4444321100 1123578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.74 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=203.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC----------------cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG----------------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 86 (414)
++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 58999999999999999999876544 468999987542 2345667889999999999999999
Q ss_pred cceeecCCCCCCCceEEEEEecCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 015019 87 IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (414)
Q Consensus 87 l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp 154 (414)
+++++.. ....++|||++. ++|.+++.... .+++..+..++.|++.||+|||+.||+||||||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 9998843 356899999998 69999987655 689999999999999999999999999999999
Q ss_pred CCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh--CCCCCC
Q 015019 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (414)
Q Consensus 155 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~--g~~pf~ 232 (414)
+||+++.++.++|+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hceeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999876433211 111123456778999999877 678999999999999999998 678887
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..+..+.+..+...... ..........+..+.++.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRD-----------------------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhcccc-----------------------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 66544443333221100 0000111122456789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.91 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=199.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 358999999999999999999765 566799999875322 23457899999999999999999988722 34
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||++++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 6999998753 3589999999999999999999999999999999999999999999999999976433
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---------- 220 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence 22111 122335667999999876 678999999999999999999 899998776555444432110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. ......+..+.+|+.+||..||++|||+.++++
T Consensus 221 -----------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 -----------------RM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------------CC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 112356888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=315.67 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=203.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.+|++++.||.|+||.||+|.+.. +..+|+|.+... .......+.+|+.+++.++||||+++++++. +....
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 469999999999999999999887 889999998753 2234556889999999999999999999883 33568
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999998 5999999753 46899999999999999999999999999999999999999999999999999765322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 223 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--------- 223 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------
Confidence 111 123345678999999877 678999999999999999998 89999877655444443211000
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......++.+.+++.+||+.||.+|||+.++++
T Consensus 224 ---------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ---------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.43 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=205.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+.|++.+.||+|++|.||+|.+..+++.||||.+..... ......+.+|+.++... .||||+++++++. +..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~ 87 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDS 87 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCC
Confidence 4679999999999999999999999999999999875422 23345567788776666 4999999999984 345
Q ss_pred eEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+||||+.+++.+++.. ...+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 6999999999888887765 4579999999999999999999998 5999999999999999999999999999875432
Q ss_pred CCCccccccccccCccccccccccccC--CCCCCcchhhhHhHHHHHHHhCCCCCCCCCh-hhHHHHHHHhcCCCCHHHH
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 255 (414)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------- 233 (296)
T cd06618 168 SKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---------- 233 (296)
T ss_pred CCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc----------
Confidence 221 12335788899999986531 3478899999999999999999999965322 111111111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
... +.......++..+.+||.+||..||.+|||+++++.||||....
T Consensus 234 ----------------~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 234 ----------------EEP--PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred ----------------CCC--CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 000 00011124678899999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.83 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=202.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++.+.||+|++|.||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++. ..+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 57999999999999999999999999999999886432 23344567889999999999999999999884 3456
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 899999998 589888863 356899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh--hHHHHHHHhcCCCCHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLITDLLGTPSPET 254 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 254 (414)
..... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.... .....+
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 220 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------- 220 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh-----------
Confidence 33221 1234568899999999877 67889999999999999999999999754321 111111
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+ ......++.+.+||.+||..||.+|||+.++++
T Consensus 221 ----------------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 221 ----------------EQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------------hcCCCCC--CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0000000 011347789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=317.61 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=200.9
Q ss_pred CCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
++|.+.+.||+|+||.||+|.+. .++..+|+|.+.. ........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 77 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCG----- 77 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----
Confidence 56999999999999999999854 3455799998764 22344456889999999999999999999984
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
.....++||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 3346899999998 69999997542 388999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhH
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~ 239 (414)
.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999976433221 111234457888999999877 678999999999999999998 9999977665443
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
+..+... . ........+..+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQG---------------------------R---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhCC---------------------------C---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 3332110 0 00112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=309.59 Aligned_cols=245 Identities=30% Similarity=0.485 Sum_probs=204.4
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~ 109 (414)
||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+ .....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999998999999999875322 223455788999999999999999999988 4456799999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccc
Q 015019 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (414)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 188 (414)
. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999998887899999999999999999999999999999999999999999999999999976543321 1234
Q ss_pred cccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHH
Q 015019 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (414)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (414)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. +
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~-------------------- 208 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D-------------------- 208 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C--------------------
Confidence 568889999999877 5688899999999999999999999977664332222211 0
Q ss_pred HhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH---HHHhcCCCC
Q 015019 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYF 316 (414)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~---~~lL~hp~~ 316 (414)
........+..+.++|++||..||++|||+ +++++||||
T Consensus 209 ---------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 209 ---------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 001123458889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=320.66 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=199.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 93 (414)
.++|.+.+.||+|+||.||+|.+.. +...||+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence 3689999999999999999998643 2347999998753 2234456788999999999 7999999999983
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
....+|+||||+. ++|.+++.... .++...+..++.||+.||+|||+.|++||||||+|
T Consensus 95 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 95 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 3356899999998 69999997532 47889999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
|+++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+..
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998754321110 00112234567999999877 678999999999999999998 889997765
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+....+.. ... ......++.++.+||.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKE---------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHc---------------------------CCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4333322211 000 11224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=311.52 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=201.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||+||+|.+. ++..||||.+.... .....+.+|+.+++.++|+||+++++++. ....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCc
Confidence 468999999999999999999876 45779999987432 23456889999999999999999999873 3345
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++... ..++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 5999999764 3689999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......++..|+|||.+.+ ..++.++||||+||++|+|++ |+.||.+.+....+..+......
T Consensus 156 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (261)
T cd05034 156 DEYT--AREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------- 223 (261)
T ss_pred hhhh--hhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2111 0112234567999999877 678999999999999999998 99999887765555444321111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+..+.+++.+||+.||++|||++++++
T Consensus 224 ----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 111345788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.58 Aligned_cols=252 Identities=28% Similarity=0.478 Sum_probs=202.2
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
||.+.+.||+|+||+||+|.+..++..+++|.++... ........+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 6999999999999999999998887777777765321 122344567789999999999999999998843 34
Q ss_pred eEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 5899999998 588887753 457999999999999999999999999999999999999975 5699999999876
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
....... .....|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+.......+.. +.
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~------ 221 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GP------ 221 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CC------
Confidence 5433221 134468889999998866 6788899999999999999999999976654333322211 00
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.......++..+.++|.+||..||++|||+.++++||||
T Consensus 222 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 ----------------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 001123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=312.14 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=202.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.+.|++.+.||+|+||.||+|.++.+++ .||||.+.... .......+.+|+.+++.++||||+++++++. .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----K 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----C
Confidence 3569999999999999999999887665 69999987532 3445567889999999999999999999883 3
Q ss_pred CceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....++||||+. ++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 456899999998 589888876 356899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCccccccccc--cCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 177 FSDTPMTVFWTDYV--ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 177 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
.............. .+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~---- 230 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL---- 230 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC----
Confidence 43222111111111 2457999999876 678999999999999999886 99999876654444333211100
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....++..+.+++.+||..+|.+|||+.+++.
T Consensus 231 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 --------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.80 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=200.6
Q ss_pred CCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.+|.+.++||+|+||.||+|... .++..+|+|.+... .......+.+|+++++.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE---- 78 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec----
Confidence 47899999999999999999743 35678999987642 33455678899999999999999999998843
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND---------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~---------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~ 161 (414)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||+++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 79 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred -CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 345899999998 69999987542 4789999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHH
Q 015019 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (414)
Q Consensus 162 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~ 240 (414)
++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 999999999999754332211 11123345678999999877 678999999999999999998 99999776654443
Q ss_pred HHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..+.... . ......+++.+.+||.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~---------------------------~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGR---------------------------E---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCc---------------------------c---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3332110 0 0112357889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=311.66 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=200.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|+++++||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 367999999999999999999865 567899999875322 23567899999999999999999988622 34
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 799999998 6999988653 4689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......++..|+|||.+.. ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 155 ~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 222 (260)
T cd05067 155 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------- 222 (260)
T ss_pred CCcc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------
Confidence 2111 1122345678999999877 678999999999999999999 99999887755444333211100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+.++.++|.+||..||++|||++++++
T Consensus 223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 ----------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=316.59 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=199.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC--------------cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG--------------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 88 (414)
++|++.+.||+|+||.||+|.+..++ ..||+|+++... .......+.+|+++++.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 359999987532 334455688999999999999999999
Q ss_pred eeecCCCCCCCceEEEEEecCC-CCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015019 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKAND------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (414)
Q Consensus 89 ~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~ 155 (414)
+++.. ...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+
T Consensus 84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 99843 346899999998 69999886432 3688899999999999999999999999999999
Q ss_pred CEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh--CCCCCCC
Q 015019 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPG 233 (414)
Q Consensus 156 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~--g~~pf~~ 233 (414)
||+++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999764322111 11122345678999999877 678999999999999999988 6678877
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+..+.+..+.... .... ........+..++.+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFF--------------------RNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhh--------------------hhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66544433322110 0000 00011123456889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=317.64 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=200.2
Q ss_pred CCeeEeeeecccCceeEEEEEE-----CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|.+.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 4899999999999999999975 2345689999987532 234456788999999999 79999999998843
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
.+.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 345899999998 69999997643 3899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+........ .......++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+....+.......
T Consensus 189 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------- 258 (302)
T cd05055 189 RDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------- 258 (302)
T ss_pred ccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH-------
Confidence 765432211 11122346778999999877 678999999999999999998 9999977554332221110
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..... ......++.+.+|+.+||..+|++|||+.++++
T Consensus 259 -------------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 -------------------EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------------------cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00000 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=314.39 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=199.2
Q ss_pred CCe-eEeeeecccCceeEEEEE----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y-~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
+|| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 466 999999999999998864 34567899999987532 223455678999999999999999999987432
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....+|+||||+. ++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2346899999999 6898888754 6999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHH-hcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~ 255 (414)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ...+.. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~---- 229 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT---- 229 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc----
Confidence 432211111122345677999999876 67899999999999999999999998654321 111110 000000
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......... ..... ......+..+.+++.+||+.||++|||++++++
T Consensus 230 ----~~~~~~~~~---~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 ----VVRLIELLE---RGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ----hhhhhhhhh---cCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000111111 11110 112457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=310.03 Aligned_cols=243 Identities=25% Similarity=0.420 Sum_probs=197.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
..+|++.+.||+|+||.||++... +..||+|.+... .....+.+|+.+++.++|+|++++++++.. ....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCc
Confidence 357999999999999999999654 788999998642 234568899999999999999999987632 2345
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999998 69999987643 488999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 214 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12235567999999877 678999999999999999997 9999987654433322211
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... ......+++.+.+++.+||+.||++|||+.++++
T Consensus 215 ---------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 ---------------GYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 0122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=315.90 Aligned_cols=263 Identities=23% Similarity=0.373 Sum_probs=205.8
Q ss_pred CeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 97 (414)
.|++.+.||.|++|.||+|.+. .+++.||||.+.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----- 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----- 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence 4899999999999999999864 4678999999864321 123345677899999999 5999999999883
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....+|+||||+. ++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 3456899999998 599999987778999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
...... ......|+..|+|||.+.+.....+.++|+||||+++|+|++|..||...........+.+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 332211 1123468899999999866323478899999999999999999999964332111111100
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGLA 320 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt---~~~lL~hp~~~~~~ 320 (414)
. ..... ......+++.+.++|.+||+.||++||| +.++|+||||+.+.
T Consensus 223 --------~----~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 223 --------R----ILKSK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred --------H----HHccC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 0 00000 0112357889999999999999999998 57789999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=310.44 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=198.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|.+.+.||+|++|.||+|.+..+ ..||+|.+.... .....+.+|+.+++.++|||++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence 36799999999999999999987655 469999876432 223567789999999999999999988732 34
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 799999998 5999999764 3588999999999999999999999999999999999999999999999999976533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 155 ~~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05069 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY---------- 220 (260)
T ss_pred Cccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1122345677999998876 678999999999999999999 899998776554443332110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. ......+..+.+++++||..||++|||++++++
T Consensus 221 -----------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 221 -----------------RM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----------------CC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=308.61 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=198.7
Q ss_pred eeecccCceeEEEEEECC-CCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
+.||+|++|+||+|.+.. +++ .||||.+...... .....+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999999865 333 6999998764333 556678899999999999999999998843 568999
Q ss_pred EecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 106 FELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
|||+. ++|.+.+..+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 79999997754 6899999999999999999999999999999999999999999999999999875442221
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111123456788999999877 678999999999999999998 99999876655444333210
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. .........+..+.+++.+||+.+|.+|||+.++++
T Consensus 217 ---------~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 ---------G-----ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---------C-----CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 000111346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=308.18 Aligned_cols=243 Identities=26% Similarity=0.429 Sum_probs=200.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+.|++.+.||.|+||.||+|... |+.||+|.+..... ...++.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence 467999999999999999999764 88999999975422 46678899999999999999999999844 356
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||.++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999999 69999997765 799999999999999999999999999999999999999999999999999976522
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....++..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------ 214 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12234567999999876 678899999999999999997 9999976654333222211
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... .......++.+.++|.+||..+|.+|||+.+++.
T Consensus 215 ---------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ---------------GYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------CCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 0112356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=317.39 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=199.7
Q ss_pred CCeeEeeeecccCceeEEEEEECC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 94 (414)
++|.+.+.||+|+||.||+|.+.. ....||+|.+.... .......+.+|+.+++.+ .||||+++++++.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 689999999999999999997632 34579999887532 234456788999999999 6999999999884
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCE
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NI 157 (414)
....+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 3346899999998 6999999653 3488899999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCCh
Q 015019 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (414)
Q Consensus 158 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~ 236 (414)
|++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999997653221111 0112234467999999877 678999999999999999999 8899987665
Q ss_pred hhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+....+... .. ......++..+.+|+.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLREG---------------------------HR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHcC---------------------------CC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4444333210 00 0112456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=312.59 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=197.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
++|++++.||+|+||+||+|....++. .||+|.+... ........+..|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 579999999999999999999887776 4777776432 122334567788889999999999999998732
Q ss_pred CceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...++|+||+. |+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 24689999998 799999976 457899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.... .....+...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.+
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (279)
T cd05111 160 YPDD-KKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---------- 226 (279)
T ss_pred cCCC-cccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----------
Confidence 3322 1112234457778999999876 679999999999999999998 9999987654332222211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
....+ .....+..+.+++.+||..||.+|||+.++++
T Consensus 227 -----------------~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -----------------GERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00000 11235677899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=308.89 Aligned_cols=244 Identities=21% Similarity=0.326 Sum_probs=193.2
Q ss_pred eecccCceeEEEEEEC--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEe
Q 015019 30 VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
.||+|+||.||+|... .++..||+|++... ........+.+|+.+++.++||||+++++++.. ...|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 4899999999999765 44567999998653 223445668899999999999999999998732 35799999
Q ss_pred cCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 108 LME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 108 ~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
|+. ++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++...........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 699998875 457899999999999999999999999999999999999999999999999999754332211111
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (414)
.....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------------ 214 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG------------------ 214 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC------------------
Confidence 122223567999999876 678999999999999999996 99999876654433333210
Q ss_pred HHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. .......++++.++|.+||..||++||++.++++
T Consensus 215 ---------~~---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 215 ---------KR---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0112456889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=323.62 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=197.4
Q ss_pred CCeeEeeeecccCceeEEEEEE-----CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|++.+.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+|..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 6899999999999999999984 3567899999987532 233455788999999999 689999999987432
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC-------------------------------------------------------
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------- 120 (414)
...+|+|||||. |+|.+++...
T Consensus 84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 245899999999 6999988642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccc
Q 015019 121 ------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (414)
Q Consensus 121 ------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 188 (414)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~ 240 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGD 240 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hcCC
Confidence 136778888999999999999999999999999999999999999999999997643222111 1122
Q ss_pred cccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHH
Q 015019 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (414)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (414)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+.....
T Consensus 241 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---------------------- 296 (343)
T cd05103 241 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---------------------- 296 (343)
T ss_pred CCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh----------------------
Confidence 345677999999876 678999999999999999997 9999976543222111100
Q ss_pred HHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..... ......++.+.+++.+||+.||.+|||+.++++|
T Consensus 297 ----~~~~~---~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 297 ----EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----ccCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 0112357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=312.98 Aligned_cols=269 Identities=22% Similarity=0.391 Sum_probs=200.9
Q ss_pred CCeeEeeeecccCceeEEEEE----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.+|++++.||+|+||+||.|. +..++..||+|++... .......+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---
Confidence 579999999999999999997 4567889999998653 3345567889999999999999999999875432
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 245899999997 6999998754 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..++...... .. ...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~----~~~~~~~~~--- 228 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FM----RMMGNDKQG--- 228 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hh----hhccccccc---
Confidence 332211111112234456999999877 67899999999999999999998776443211 11 111111000
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..........+...... .....++..+.+||.+||..+|++|||+.++++
T Consensus 229 ---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 229 ---QMIVYHLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---ccchHHHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000111111111111 123467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=317.13 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=201.2
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-------CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 93 (414)
.++|.+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence 368999999999999999999753 234579999886432 234456788999999999 7999999999984
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
....+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 3356899999998 6999998753 247788899999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
|+++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999765332211 11122345678999999877 678999999999999999998 789998776
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+....+... .. ......++..+.+||.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcC---------------------------Cc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 54443333110 00 01123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.89 Aligned_cols=265 Identities=16% Similarity=0.192 Sum_probs=195.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC---CcEEEEEEeCCccCChHHH---------HHHHHHHHHHHhCCCCCccccce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDA---------IRILREVKLLRLLRHPDIVEIKR 89 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~l~~ 89 (414)
.++|++.+.||+|+||+||+|.+..+ +..+|+|+........... .....++..+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999998877 6677777643221111110 11223445566678999999998
Q ss_pred eecCCCCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEee
Q 015019 90 IMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 90 ~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~D 169 (414)
+..... ......++++|++..++.+.+......++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 764332 1122457899998888888877666678999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 015019 170 FGLARVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (414)
Q Consensus 170 FG~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (414)
||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...........+
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99998653322110 11123469999999999887 6899999999999999999999999987643222211110
Q ss_pred hcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..++..+.... ...+..++.+.++++.|+..+|++||+.+++++
T Consensus 248 ------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 ------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 01111111110 112456788999999999999999999999874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.41 Aligned_cols=263 Identities=24% Similarity=0.411 Sum_probs=214.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.-|..++.||-|+||.|++++...|...||+|.+.+.. .....+..+..|-.||..-..+-||+||-.| .+...
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 35888999999999999999999999999999987532 2334556677899999999999999999988 55667
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. |++..++-..+-|.|+.+++++..|.+|+++.|..|++||||||+|||||.+|.+||.|||||.-.....
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998 6999999888999999999999999999999999999999999999999999999999999996421100
Q ss_pred Cc---------------------------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHH
Q 015019 181 PM---------------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (414)
Q Consensus 181 ~~---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il 221 (414)
.. .......+||+.|+|||++.. ..|+..+|+||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 00 000124689999999999988 7899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCC
Q 015019 222 AEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301 (414)
Q Consensus 222 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp 301 (414)
|||+.|++||.+.+..+...+|.+ ++.++. .....++|+++.+||.++.. ++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~n-----------------w~~~l~----------~~~~~~ls~e~~~li~kLc~-sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVIN-----------------WRNFLH----------IPYQGNLSKEALDLIQKLCC-SA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeee-----------------hhhccc----------cccccccCHHHHHHHHHHhc-Ch
Confidence 999999999987775544433322 111111 01124789999999998654 78
Q ss_pred CCCCC---HHHHhcCCCCCccc
Q 015019 302 KDRPT---AEEALADPYFKGLA 320 (414)
Q Consensus 302 ~~Rpt---~~~lL~hp~~~~~~ 320 (414)
+.|.. ++|+-.||||+++.
T Consensus 914 d~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhcccchhhhhcCccccccc
Confidence 88874 77899999999874
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=314.21 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=197.5
Q ss_pred CeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----Q 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----c
Confidence 48899999999999999998753 23578888886532 2344567889999999999999999999884 3
Q ss_pred CceEEEEEecCC-CCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlk 153 (414)
....|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 345899999999 6999887642 247889999999999999999999999999999
Q ss_pred CCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCC
Q 015019 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (414)
Q Consensus 154 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~ 232 (414)
|+|||+++++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999997643322110 1122345678999998876 678999999999999999998 999998
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
+.........+.... . ......++..+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKTGY---------------------------R---MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhCCC---------------------------C---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 765443332221100 0 0112357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=313.54 Aligned_cols=270 Identities=23% Similarity=0.376 Sum_probs=203.6
Q ss_pred CCeeEeeeecccCceeEEEEEE----CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAID----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.-|++++.||+|+||.||+|.. ..++..||+|.+... ........+.+|+.+++.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3579999999999999999974 457889999998643 2234456788999999999999999999988543 2
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 245899999997 6999998764 36899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..............++..|+|||.+.+ ..++.++|||||||++|+|++++.|+..... ...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~-- 230 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQM-- 230 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccc--
Confidence 433222122234557778999999877 6789999999999999999998876533211 1111112111110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
........+..... ......++..+.+|+.+||+.||.+|||+.+++++
T Consensus 231 -----~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 -----TVTRLVRVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -----cHHHHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00111111111111 11234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=319.88 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=200.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCC-------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 94 (414)
.+|++++.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4799999999999999999986432 236999987643 2234456788999999999 79999999999843
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCE
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NI 157 (414)
...+|+||||+. ++|.+++.... .++...+..++.||+.||+|||++||+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 346899999998 69999987532 477888899999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCCh
Q 015019 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (414)
Q Consensus 158 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~ 236 (414)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999765332111 11122234567999999977 678999999999999999998 8899987765
Q ss_pred hhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.+....+... .. .......+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEG---------------------------HR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcC---------------------------CC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4444333210 00 01123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=311.80 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=196.4
Q ss_pred eEeeeecccCceeEEEEEEC----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 26 KILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++++.++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 57899999999999999987 4466899999964 23445578899999999999999999999999632 34
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+++|||||. |+|.+++... ..+++.....|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 7999999886 6899999999999999999999999999999999999999999999999999987632
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .......+...|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.+..+....+.+..-
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------- 223 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------- 223 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---------
T ss_pred cccc-cccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccc---------
Confidence 2211 11233446678999999877 568999999999999999999 7899988766554444422110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......++..+.++|.+||..||++|||+.++++
T Consensus 224 ---------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 ---------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0112357889999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.79 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=199.2
Q ss_pred CCeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 579999999999999999998753 67899999987532 2334456889999999999999999999884
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN----------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~----------------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp 154 (414)
.....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 3346899999999 6999998643 2478888999999999999999999999999999
Q ss_pred CCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCC
Q 015019 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233 (414)
Q Consensus 155 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~ 233 (414)
+||+++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred hheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999987543322111 0122234667999999877 678999999999999999997 8889877
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+..+....+.. .. ........+..+.+||.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRD---------------------------GN---VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhc---------------------------CC---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 655443332211 00 00112356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.80 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=201.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
.+|.+.+.||.|+||.||+|.+..+ ...||||...... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 4699999999999999999987654 3479999876432 23455678899999999999999999998743
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 23689999998 69999997644 58999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ..+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---------- 224 (270)
T cd05056 159 DESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG---------- 224 (270)
T ss_pred cccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----------
Confidence 32111 1122334567999999876 678999999999999999986 99999887765444333211
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
... ...+.++..+.++|.+||..+|++|||+.+++..
T Consensus 225 -----------------~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 225 -----------------ERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -----------------CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 1234678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.58 Aligned_cols=258 Identities=22% Similarity=0.364 Sum_probs=197.1
Q ss_pred CCeeEeeeecccCceeEEEEEECC----------------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 86 (414)
++|++.+.||+|+||+||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 3457999998743 22344567889999999999999999
Q ss_pred cceeecCCCCCCCceEEEEEecCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 015019 87 IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (414)
Q Consensus 87 l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp 154 (414)
+++++.. ...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 9999844 345899999998 69999987532 366788999999999999999999999999999
Q ss_pred CCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh--CCCCCC
Q 015019 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (414)
Q Consensus 155 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~--g~~pf~ 232 (414)
+|||++.++.++|+|||+++......... ......++..|+|||...+ ..++.++|||||||++|+|++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999997643322111 1122334678999998766 678999999999999999998 678887
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..+..+.+..... ++..... .........+++.+.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGE--------------------FFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHH--------------------HHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6554333221110 0000000 0011122456788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=309.05 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=201.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.++|++.+.||+|+||+||+|.++.+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4689999999999999999999877665 68999876542 23455678899999999999999999998854
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
...++||||+. |+|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 35899999998 6999998764 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
........ ......++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+....+....+...
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 227 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-------- 227 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC--------
Confidence 54322111 1112223567999999876 678999999999999999998 99999876654433333210
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... ......+..+.+++.+||..||.+|||+.++++
T Consensus 228 -------------------~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 228 -------------------ERL---PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------CCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 112346788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=324.86 Aligned_cols=237 Identities=26% Similarity=0.393 Sum_probs=196.4
Q ss_pred eEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
.-++-||+|+.|.||+++- .++.||||+++.. -..+|+-|++|+||||+.+.+|+... -.+|||
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIi 190 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCII 190 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEe
Confidence 3467899999999999954 5889999998531 11478889999999999999999443 458999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccc
Q 015019 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (414)
||||. |-|.++++....++......|..+|+.|++|||...|+|||||.-||||+.+..|||+|||-++.......
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--- 267 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--- 267 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh---
Confidence 99999 89999999999999999999999999999999999999999999999999999999999999876533311
Q ss_pred cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHH
Q 015019 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (414)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (414)
.-.++||..|||||++.+ .+.+.++|||||||+|+|||||..||.+-+... .|. ..|...-
T Consensus 268 -kMSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---IIw-GVGsNsL------------ 328 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---IIW-GVGSNSL------------ 328 (904)
T ss_pred -hhhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchhe---eEE-eccCCcc------------
Confidence 135789999999999998 799999999999999999999999997644321 111 1111100
Q ss_pred HHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. ......+++.++=||++||+-.|..||+..++|.|
T Consensus 329 --------~-----LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 329 --------H-----LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred --------c-----ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0 01123567788899999999999999999999999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=326.96 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=203.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+...++..||+|.||+||+|++-. .||||++..........+.+..|+.++++-+|.||+-+.+++..+. +
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------~ 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------L 462 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------e
Confidence 466889999999999999997643 5999999987777788889999999999999999999999986543 4
Q ss_pred EEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.||+-+|+| +|+.++.- ...|.......|+.||++|+.|||.++|+|||||..||++.+++.|||+|||++.....-.
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999997 89988864 3478999999999999999999999999999999999999999999999999997532211
Q ss_pred CccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH-HhcCCCCHHHHHhh
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT-DLLGTPSPETIAVV 258 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 258 (414)
. ........|...|||||++... ..+|++.+||||+||++|||++|..||.. +..+++-.++ ...+.|
T Consensus 543 g-~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l~p-------- 612 (678)
T KOG0193|consen 543 G-EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYLMP-------- 612 (678)
T ss_pred c-ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEecccccCc--------
Confidence 1 1112334577889999998542 25799999999999999999999999984 4344332111 111111
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.......+.+.++++|+..||.+++++||+..+||.
T Consensus 613 ------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 ------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 111223456779999999999999999999999986
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=304.51 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=199.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence 478999999999999999999754 4567999987642 2334578899999999999999999998843 45
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.|+||||+. ++|.+++... ..++...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 799999998 6999999763 4678889999999999999999999999999999999999999999999999976432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+....
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05073 155 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------- 220 (260)
T ss_pred CCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC----------
Confidence 2111 1122345677999999876 678999999999999999998 999998776544433332110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
........+.++.+++.+||+.||++|||+.++++
T Consensus 221 --------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 --------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00122457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.60 Aligned_cols=278 Identities=21% Similarity=0.270 Sum_probs=185.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCC----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHT----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS- 95 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~- 95 (414)
..++|++.+.||+|+||.||+|.+..+ +..||+|++..... .+....| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 456899999999999999999999988 89999999864211 1111111 122222333333333322211
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDD--------------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~--------------------l~~~~~~~i~~qil~al~~LHs~givHrDlkp 154 (414)
......+++|+||++ ++|.+++..... .....+..++.||+.||+|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 134567899999999 689888865321 12345678999999999999999999999999
Q ss_pred CCEEEcC-CCCeEEeecCCcccccCCCCccccccccccCccccccccccccC--------------------CCCCCcch
Q 015019 155 KNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (414)
Q Consensus 155 ~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~~~~~~D 213 (414)
+|||++. ++.+||+|||+|+...... ......+++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 5899999999997543221 11224578999999999653311 12345679
Q ss_pred hhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCc---cCCCCCCChHHH
Q 015019 214 IWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPL---FQKFPNVDPLAL 290 (414)
Q Consensus 214 iwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~ 290 (414)
||||||+||||+++..+ ..+...++..+....+.....+... ......... ...+...+..+.
T Consensus 362 VwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKL------------VEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHh------------hccccchhhhhhhhhccccchHHH
Confidence 99999999999986544 4444444444444333322111110 000000000 111122345677
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 291 dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
|||.+||+.||++|||+.++|+||||+...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 999999999999999999999999998753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=305.11 Aligned_cols=264 Identities=22% Similarity=0.421 Sum_probs=212.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 100 (414)
+.|.++++||+|+|..|.+++.+.|.+.||+|++++..- ...+..-...|-.+..+. +||.+|.++.+|.+. .
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-----s 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-----S 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----c
Confidence 579999999999999999999999999999999986543 223344456677777665 699999999999544 4
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+++|.||.+ |+|.-.++...++++++++++...|+.||.|||+.||+.||||.+|+|++..|.+||.|+|.++.....
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 5999999999 688888888889999999999999999999999999999999999999999999999999999875544
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
... .+++||||.|.|||++.+ ..|+..+|+|+|||+|+||+.|+.||.- .|..+++.
T Consensus 405 gd~---tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdi-------------vgm~n~d~----- 461 (593)
T KOG0695|consen 405 GDT---TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI-------------VGMDNPDM----- 461 (593)
T ss_pred Ccc---cccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcce-------------ecCCCccc-----
Confidence 433 368999999999999999 7999999999999999999999999952 11111000
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt------~~~lL~hp~~~~~ 319 (414)
+....-+.-.+.++... ...+|..+..+++..|..||.+|.. ..++-.|+||+.+
T Consensus 462 ntedylfqvilekqiri-----prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 462 NTEDYLFQVILEKQIRI-----PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred chhHHHHHHHhhhcccc-----cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 00000000111222222 2467888899999999999999974 6899999999865
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.58 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=199.1
Q ss_pred CCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 96 (414)
++|.+.+.||+|+||.||+|++. .++..||+|++..... ......+.+|+.+|..+. ||||+++++++..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--- 112 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK--- 112 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence 57889999999999999999854 3556899999975422 233456889999999997 9999999999843
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCC------------------------------------------------------
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~------------------------------------------------------ 121 (414)
...+|+|||||. |+|.+++..+.
T Consensus 113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 346899999999 79999986431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCE
Q 015019 122 --------------------------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (414)
Q Consensus 122 --------------------------------------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NI 157 (414)
.++...+..++.||+.||.|||+.||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 356677888999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCCh
Q 015019 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (414)
Q Consensus 158 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~ 236 (414)
|++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999998643322111 1123457788999999877 678999999999999999998 8899976543
Q ss_pred hhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.+....... .... ......++..+.+|+.+||..+|.+|||+.++++.
T Consensus 348 ~~~~~~~~~--------------------------~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIK--------------------------RGYR---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHH--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332221110 0000 01123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=307.78 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=191.4
Q ss_pred eeecccCceeEEEEEECCCCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
+.||+|+||.||+|.+..++. .+|+|.+... ........+.+|+.+++.+ +||||+++++++.. .+.+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEE
Confidence 368999999999999988776 4688887632 2234456788999999999 79999999999843 3458999
Q ss_pred EecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEe
Q 015019 106 FELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~ 168 (414)
|||+. ++|.+++..+. .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 69999987532 47899999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhc
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 247 (414)
|||+++....... ......+..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-- 226 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 226 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--
Confidence 9999863221110 111234567999999876 678999999999999999997 9999977654333322210
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... .......+..+.+|+.+||..||.+|||+.+++.
T Consensus 227 -------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 -------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------------------CCC---CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 0112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=303.93 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=201.6
Q ss_pred eeEeeeecccCceeEEEEEECCCC----cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
+++.+.||.|+||.||+|.+..++ ..||+|++... ........+..|+.+++.++|+||+++++++.. .+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CC
Confidence 357889999999999999998766 89999998653 222256678899999999999999999999844 35
Q ss_pred eEEEEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 101 DIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
..|+||||+. ++|.+++..... +++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||+++...
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 6899999998 599999976544 9999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
....... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+...
T Consensus 155 ~~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---------- 220 (258)
T smart00219 155 DDDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG---------- 220 (258)
T ss_pred ccccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----------
Confidence 3311110 11236788999999866 678999999999999999998 88999876554443333211
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. .......+..+.+++.+||..||++|||+.++++
T Consensus 221 -----------------~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 221 -----------------YR---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----------------CC---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 00 0112347889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=304.10 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=199.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+++++.++||||+++++++. ....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCc
Confidence 457999999999999999999875 467899998874322 2345778999999999999999999884 3346
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.|+||||+. ++|.+++... +.++++.+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5898888764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+....
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----------- 218 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----------
Confidence 1111 112235568999999876 678999999999999999998 999998766544333331100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.. ......+..+.+|+.+||+.+|++|||+.+++++
T Consensus 219 ----------------~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 ----------------RL---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------------CC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00 0012357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=304.81 Aligned_cols=228 Identities=26% Similarity=0.369 Sum_probs=185.5
Q ss_pred cCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCC-CC
Q 015019 34 GSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SD 112 (414)
Q Consensus 34 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~-g~ 112 (414)
|.+|.||+|.++.+++.||+|++.... ...+|...+....||||+++++++. .....|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCC
Confidence 889999999999999999999987531 1223444455567999999999884 3457999999999 69
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccC
Q 015019 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (414)
Q Consensus 113 L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt 192 (414)
|.+++.....+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876543221 233467
Q ss_pred ccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcC
Q 015019 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (414)
Q Consensus 193 ~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (414)
..|+|||.+.+ ..++.++|+||+||++|+|++|..||...... + ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------------------------~~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------------------------NT 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------------------------cc
Confidence 78999999876 67899999999999999999999887532210 0 00
Q ss_pred CCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCC
Q 015019 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYF 316 (414)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~-----~~lL~hp~~ 316 (414)
... ......+++.+.+||.+||+.||++|||+ +++++||||
T Consensus 192 ~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTT---LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccc---cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 000 01123578899999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=303.61 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=195.1
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEec
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~ 108 (414)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++|+||+++++++. .....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEc
Confidence 479999999999999887 999999998764332 35567889999999999999999999884 33568999999
Q ss_pred CC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 109 ME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 109 ~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 689998865 3568999999999999999999999999999999999999999999999999997543211110 00
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+....+
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------- 213 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------- 213 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-----------------
Confidence 11223566999999876 678999999999999999998 8899977664433332211000
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.......+..+.+++.+||..+|.+|||+.++|+
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0111356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=307.34 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=200.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.+|++++.||+|+||.||+|+.+.+ ...||+|.+... ........+.+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCR----- 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----
Confidence 5799999999999999999997643 467999987642 22234567889999999999999999999883
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEE
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND---------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~---------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL 167 (414)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 3346899999998 69999998655 6899999999999999999999999999999999999999999999
Q ss_pred eecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 015019 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 246 (414)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~- 233 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA- 233 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence 99999875432211 11233456778999998876 568899999999999999998 7889976554333222210
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.... ......++..+.+++.+||+.||.+|||+.+++++
T Consensus 234 -------------------------~~~~---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 -------------------------GKLE---LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------CCcC---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000 01123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=308.00 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=202.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEECC----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 34689999999999999999999876 3578999988643 3445567788999999999999999999987543
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEE
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~--------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL 167 (414)
....++++||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 245799999998 7999988653 45899999999999999999999999999999999999999999999
Q ss_pred eecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 015019 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 246 (414)
+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|++++ |++||...+..+....+..
T Consensus 159 ~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 159 TDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCCCCcccccCCceE-EeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 999999764332211 11122345677999999877 678999999999999999998 9999987654332222211
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.... .....+++.+.+++.+||..||++|||+.++++
T Consensus 235 --------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 --------------------------GYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=305.09 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=188.6
Q ss_pred eeecccCceeEEEEEECC--CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+.. ....|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEE
Confidence 469999999999996432 3457888887643 223344567899999999999999999998843 34589999
Q ss_pred ecCC-CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 107 ELME-SDLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
||+. |+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 69999987643 34677889999999999999999999999999999999999999999999986532221
Q ss_pred CccccccccccCcccccccccccc-----CCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
... ......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+..+.....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------ 227 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD------ 227 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC------
Confidence 110 01223456779999987431 1357889999999999999999 7889987665544333321110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
...+.......++....+++..|+ .||++|||++++++
T Consensus 228 -------------------~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 228 -------------------IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -------------------ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 001111122457888899999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=306.90 Aligned_cols=256 Identities=22% Similarity=0.347 Sum_probs=201.3
Q ss_pred eeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC-CCc
Q 015019 25 YKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR-EFK 100 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~~~ 100 (414)
|++.+.||+|+||.||+|... .++..||||++............+.+|+++++.++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 3578999999976555556677788999999999999999999988654322 122
Q ss_pred eEEEEEecCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 101 DIYVVFELME-SDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
..++++||+. ++|.+++... ..++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 4588999998 6888877432 25789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+......... ......++..|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN----- 232 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 8653322111 1122345677999999877 678899999999999999999 889998766543333222100
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.....+..+..+.+++.+||+.+|++|||+.+++.+
T Consensus 233 -------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 -------------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001113567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=308.13 Aligned_cols=238 Identities=18% Similarity=0.277 Sum_probs=186.9
Q ss_pred eeecccCceeEEEEEECCCCc-------EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 29 EVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.||+|+||+||+|.+..++. .||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 469999999999999866544 4888887542 233455678899999999999999999998543 45
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC--------eEEeecC
Q 015019 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--------LKVCDFG 171 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~--------vkL~DFG 171 (414)
.++||||+. |+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 799999998 68999997654 5899999999999999999999999999999999999987764 6999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC-CCCCCCChhhHHHHHHHhcCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
++...... ....++..|+|||.+.+. ..++.++|||||||++|+|++|. +||...+.........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~------ 219 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE------ 219 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH------
Confidence 88654221 234688899999998652 45789999999999999999985 6665544322211110
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
... ......+..+.+||.+||+.||++|||++++++.
T Consensus 220 ---------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 ---------------------DRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------ccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 000 1112456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=300.22 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=193.8
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEec
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~ 108 (414)
+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.+++.++||||+++++++. .....++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEEC
Confidence 46999999999999864 688999999875432 334456889999999999999999999884 33468999999
Q ss_pred CC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccc
Q 015019 109 ME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (414)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (414)
+. ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6999888653 468999999999999999999999999999999999999999999999999987533221110 0
Q ss_pred cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHH
Q 015019 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (414)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (414)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------------------- 210 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------------------- 210 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 11234567999999876 678999999999999999998 99999876654333222110
Q ss_pred HHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. .......++..+.+|+.+||..+|++|||+.++++
T Consensus 211 --------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 211 --------Y---RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred --------C---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0 00112457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=303.33 Aligned_cols=240 Identities=26% Similarity=0.436 Sum_probs=196.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence 579999999999999999985 57889999998643 234567899999999999999999998743 236
Q ss_pred EEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 69999997643 5899999999999999999999999999999999999999999999999998754321
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+..+....+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12234567999999876 678999999999999999997 9999987765443322211
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.... .....++..+.+|+.+||+.+|.+|||+++++.
T Consensus 213 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 --------------GYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=309.80 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=199.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
++|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 578999999999999999999887776 47888876432 223344678999999999999999999988432
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..++|+||+. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred --CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 3579999998 79999987654 6899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (303)
T cd05110 160 EGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK---------- 226 (303)
T ss_pred cCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC----------
Confidence 332211 11123345778999999876 678999999999999999997 8999977653332222211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.... ...+..+..+.+++.+||..||++|||+.++++.
T Consensus 227 -----------------~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 227 -----------------GERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=303.94 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=184.5
Q ss_pred eeecccCceeEEEEEECC------------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 29 EVIGKGSYGVVCAAIDTH------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
+.||+|+||.||+|.... ....||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 368999999999997432 2236888987642 233445678899999999999999999998433
Q ss_pred CCCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC-------eEE
Q 015019 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-------LKV 167 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~-------vkL 167 (414)
...++||||++ ++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +|+
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 35799999999 577777764 457999999999999999999999999999999999999987664 899
Q ss_pred eecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHH-hCCCCCCCCChhhHHHHHHHh
Q 015019 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll-~g~~pf~~~~~~~~~~~i~~~ 246 (414)
+|||++...... ....++..|+|||.+... ..++.++|||||||++|+|+ +|..||.+....+......
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-- 223 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-- 223 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh--
Confidence 999998654321 234578889999988642 57899999999999999998 5888887654322111000
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.. .......+.++.+||.+||+.||.+|||+.++|++
T Consensus 224 -------------------------~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 224 -------------------------GQ-----CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------------------cC-----ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 01112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.90 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=190.6
Q ss_pred eeecccCceeEEEEEECC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++... .+..|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEE
Confidence 468999999999998653 3457999987542 2334566788999999999999999999976432 2347899
Q ss_pred EecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcc
Q 015019 106 FELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 183 (414)
|||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6999998764 456788888999999999999999999999999999999999999999999997543221100
Q ss_pred -ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 184 -VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 184 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---------------- 217 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---------------- 217 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc----------------
Confidence 00123345678999999876 678999999999999999999 5677876554333222211
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.... .....+++.+.+++.+||..+|++|||+.++++.
T Consensus 218 -----------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 218 -----------GRRL---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -----------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0000 0112457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=298.87 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=209.5
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHH-HHhCCCCCccccceeecCCCCCCCceEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.+-+..||.|+||+|++..++.+|+..|||+++... ...+.++++.|+.. ++.-++||||++|+.... .+..+
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcW 139 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCW 139 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCcee
Confidence 344678999999999999999999999999997542 24667788899987 455579999999998844 34689
Q ss_pred EEEecCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 104 VVFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 104 lV~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
|.||+|+-+|..+.+ ....++|+.+-.|....+.||.||... .|+|||+||+|||++..|.|||||||++....
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999977665443 345799999999999999999999875 79999999999999999999999999997654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh-hhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 256 (414)
.+-. -+.-.|-+.|||||.+.....+|+..+|+||||++|||+.||+.|+.+.+. .+|+.++. .|-|+.-
T Consensus 220 ~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l--- 290 (361)
T KOG1006|consen 220 DSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPIL--- 290 (361)
T ss_pred HHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCee---
Confidence 3322 244568999999999976556799999999999999999999999976553 34444332 2322210
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
......-..|..+..+|.-||..|-+.||...+++.+||++...
T Consensus 291 --------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 291 --------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred --------------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 01111235789999999999999999999999999999998754
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.08 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=188.6
Q ss_pred eeecccCceeEEEEEEC--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEE
Confidence 46899999999999754 3556899999875432 2334568889999999999999999998843 34589999
Q ss_pred ecCC-CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 107 ELME-SDLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
||+. |+|.+++.... ..++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 69999986532 45677888999999999999999999999999999999999999999999997543221
Q ss_pred CccccccccccCccccccccccccC-----CCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
. ........|+..|+|||++.+.. ..++.++|||||||++|+|++ |..||......+....... +
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~------ 225 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--E------ 225 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh--c------
Confidence 1 11112345778899999985421 136789999999999999996 9999977654433222110 0
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+........++.+.+++++|+ .+|++|||+++++.
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 226 -----------------QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -----------------ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000001111246778999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=305.23 Aligned_cols=237 Identities=19% Similarity=0.254 Sum_probs=184.0
Q ss_pred eecccCceeEEEEEECCC------------------------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCcc
Q 015019 30 VIGKGSYGVVCAAIDTHT------------------------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 85 (414)
.||+|+||.||+|....+ ...||+|.+... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 236889988642 223445678899999999999999
Q ss_pred ccceeecCCCCCCCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC
Q 015019 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (414)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~ 163 (414)
++++++.. ....|+||||++ ++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEe-----CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99999843 345799999999 588888765 46789999999999999999999999999999999999997643
Q ss_pred -------CeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHH-hCCCCCCCCC
Q 015019 164 -------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKS 235 (414)
Q Consensus 164 -------~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll-~g~~pf~~~~ 235 (414)
.+|++|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999988643221 223577889999988653 56899999999999999985 6899997655
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+....+. . ... .....++.+.++|.+||+.+|++|||+.++|++
T Consensus 227 ~~~~~~~~~------------------------~---~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFYE------------------------K---KHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHHH------------------------h---ccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 332211110 0 000 012345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.53 Aligned_cols=276 Identities=26% Similarity=0.418 Sum_probs=215.8
Q ss_pred ccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeC--Ccc---CChHHHHHHHHHHHHHHhCCCCCccccc
Q 015019 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVF---EHISDAIRILREVKLLRLLRHPDIVEIK 88 (414)
Q Consensus 14 ~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~ 88 (414)
.|..--...+||-++..||+|||+.||+|.|....+.||+|+-. +.. ......+...||..|.+.|.||.||++|
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 35555566789999999999999999999999999999999743 221 1223445678999999999999999999
Q ss_pred eeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcC---C
Q 015019 89 RIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA---N 162 (414)
Q Consensus 89 ~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~---~ 162 (414)
++|.-.. ..+|-|+|||+| +|.-+++.+.-+++.+++.|+.||+.||.||.... |+|-||||.|||+.. -
T Consensus 534 DyfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 534 DYFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccc
Confidence 9995433 357999999997 78888888889999999999999999999999875 999999999999754 3
Q ss_pred CCeEEeecCCcccccCCCCc----cccccccccCccccccccccc--cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh
Q 015019 163 CKLKVCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (414)
Q Consensus 163 ~~vkL~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~ 236 (414)
|.+||.|||++++....... ....+...||.||++||.+.- .....+.++||||+|||+|.++.|+.||.....
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 78999999999986554322 112345789999999997633 124578899999999999999999999965443
Q ss_pred hhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...+-.-..+ +.. .... +..-|-+++++++||++||.+.-++|..+.++..||||
T Consensus 690 QQdILqeNTI--------------------lkA----tEVq-FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 690 QQDILQENTI--------------------LKA----TEVQ-FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred HHHHHhhhch--------------------hcc----eecc-CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 2211110000 000 0000 11125689999999999999999999999999999999
Q ss_pred Cc
Q 015019 317 KG 318 (414)
Q Consensus 317 ~~ 318 (414)
..
T Consensus 745 lP 746 (775)
T KOG1151|consen 745 LP 746 (775)
T ss_pred cc
Confidence 64
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=325.93 Aligned_cols=264 Identities=25% Similarity=0.436 Sum_probs=221.1
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 98 (414)
+..+.+++...||.|.||.||++.++.+++..|+|+..... ...+.+..|.++|+.. .|||++.++++|.-.....
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 45578999999999999999999999999999999987432 2334566789998888 5999999999998766667
Q ss_pred CceEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.++++||||||+ |+.-++++. ..++.|..+.+|++.++.|+.+||.+.++|||||-.|||++.++.|||+|||.+..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 789999999999 688888865 46899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
...... ...+.+||+.|||||++... ...|+..+|+||||++..||.-|.||+-+......+-.| ...|+
T Consensus 173 ldsT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPP- 245 (953)
T KOG0587|consen 173 LDSTVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPP- 245 (953)
T ss_pred eecccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCC-
Confidence 644332 23678899999999998432 245788999999999999999999999877655443322 11121
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
+....+..++.++.|+|..||..|..+||+..++|.|||+.
T Consensus 246 ------------------------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 246 ------------------------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ------------------------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 22233467899999999999999999999999999999997
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=303.77 Aligned_cols=269 Identities=23% Similarity=0.401 Sum_probs=202.1
Q ss_pred CCeeEeeeecccCceeEEEEEEC----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+.|++.+.||+|+||.||+|... .++..||+|.+...... .....+.+|+++++.++||||+++++++... .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP---G 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC---C
Confidence 56899999999999999999854 34789999998754332 3566788999999999999999999987442 2
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 356899999998 69999997654 6999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..............++..|+|||.+.+ ..++.++|||||||++++|++|..||....... ....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~--- 229 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQ--- 229 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccc---
Confidence 432211111122345567999999877 678899999999999999999999886543211 0111110000
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.........+......+ .....+..+.+|+.+||+.||.+|||+.+++.
T Consensus 230 ----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 230 ----MIVTRLLELLKEGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ----ccHHHHHHHHHcCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00011111111111111 12346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.82 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=193.1
Q ss_pred eeecccCceeEEEEEECCCC------cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 29 EVIGKGSYGVVCAAIDTHTG------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+.||+|+||.||+|.+.... ..||||.+.+... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCe
Confidence 46999999999999876544 6899998865321 2345568899999999999999999998843 3458
Q ss_pred EEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-----CeEEee
Q 015019 103 YVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCD 169 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-----~vkL~D 169 (414)
|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+++|+||||+||+++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-- 229 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-- 229 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC--
Confidence 99997543221111 1122345678999999877 678999999999999999998 99999876654433332110
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
........++..+.+||.+||..+|.+|||+.++++
T Consensus 230 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 ----------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000122457788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=299.59 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=200.0
Q ss_pred CeeEeeeecccCceeEEEEEECC-CCcEEEEEEeCCcc--------CChHHHHHHHHHHHHHHh-CCCCCccccceeecC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVF--------EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLP 93 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 93 (414)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.. ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 38899999999999999999987 68899999875321 122344567789988765 79999999999984
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEE
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKV 167 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL 167 (414)
+.+..|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 4457999999998 588877643 4579999999999999999999996 68999999999999999999999
Q ss_pred eecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
+|||++....... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999997653322 2245568899999999977 678999999999999999999999997665443333322111
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.. +. .....++.+.++|.+||+.||++|||+.++..+
T Consensus 230 ~~---------------------------~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 YE---------------------------PL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CC---------------------------cC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 00 00 012467899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=298.64 Aligned_cols=236 Identities=19% Similarity=0.272 Sum_probs=187.1
Q ss_pred eeecccCceeEEEEEECCCC----------cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 29 EVIGKGSYGVVCAAIDTHTG----------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 357888765321 225678899999999999999999998844
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-------CeEEee
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-------KLKVCD 169 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-------~vkL~D 169 (414)
...++||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 34699999998 69999998765 799999999999999999999999999999999999999887 799999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
||++...... ....++..|+|||.+.+....++.++|||||||++|+|++ |..||...+.........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 9999765331 2335677899999987622378999999999999999999 578886654222111110
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..... .......+.++|.+||..+|.+|||+.++++
T Consensus 221 -----------------------~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 -----------------------DQHRL-----PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------------------cCCCC-----CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 0112378899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.93 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=187.4
Q ss_pred eeecccCceeEEEEEECCC--CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
+.||+|+||.||+|....+ ...+++|.+... ........+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVF 74 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEE
Confidence 3699999999999975433 335677776542 223445678899999999999999999999843 34589999
Q ss_pred ecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 107 ELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 107 E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
||+. ++|.+++... ..+++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999 6999998753 3467778889999999999999999999999999999999999999999999864322111
Q ss_pred ccccccccccCcccccccccccc-----CCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
. ......+|+..|+|||++... ...++.++|||||||++|+|++ |.+||...+..+.+..+.....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------- 226 (268)
T cd05086 155 I-ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ------- 226 (268)
T ss_pred h-hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc-------
Confidence 0 111345688899999987531 1245789999999999999997 5788877665544443321100
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. .........+++.+.+++..|+ .+|++|||++++++
T Consensus 227 ----------------~~--~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 227 ----------------VK--LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----------------cc--cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00 0001112346788999999999 68999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=309.71 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=193.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+.|.--..||+|+||.||+|.-.. |..||||++....... ...+.+|+.+|..++|||+|+|++++..... +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 456667899999999999997654 4899999887533221 4459999999999999999999999954321 58
Q ss_pred EEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~g---ivHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+||+|||. |+|.+.+.... ++++.....|+.++++||+|||... |+||||||+|||+|++...||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999 89999997754 8999999999999999999999964 999999999999999999999999999765
Q ss_pred cCCCCcccccccc-ccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhH--HHHHHHhcCCCCHH
Q 015019 177 FSDTPMTVFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ--LDLITDLLGTPSPE 253 (414)
Q Consensus 177 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 253 (414)
... ... .... .||..|+|||.+.. +..+.++||||+|++|.||++|+.+.+....... +....
T Consensus 228 ~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~--------- 293 (361)
T KOG1187|consen 228 PEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA--------- 293 (361)
T ss_pred Ccc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH---------
Confidence 431 111 1122 79999999999876 6789999999999999999999988865431111 11110
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCC--CCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
...+....+...++..... ...+ ..-..+..+..+|++.+|.+||++.|++.
T Consensus 294 -~~~~~~~~~~eiiD~~l~~------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 294 -KPLLEEGKLREIVDPRLKE------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -HHHHHCcchhheeCCCccC------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0000011111111100000 0001 01122567889999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.72 Aligned_cols=208 Identities=30% Similarity=0.459 Sum_probs=175.7
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-CCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~ 98 (414)
+...-+..-+.||+||||.||+++++.||+.||||.++... .....++..+|+++|++++|+|||++.++-.+.. .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 34456678899999999999999999999999999987643 4466777889999999999999999998864332 001
Q ss_pred CceEEEEEecCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc--CCCC--eEEeec
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCK--LKVCDF 170 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~--~~~~--vkL~DF 170 (414)
...-.+|||||. |||..++.+. ..+++.+...++..+..||.|||++||+||||||.||++- .+|+ -||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 234689999999 7999999753 4799999999999999999999999999999999999863 4444 799999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCC
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~ 233 (414)
|.|+....+. .++..+||+.|.+||++-.. ..|+..+|.||+||++|+++||..||-.
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999765544 45788999999999998742 6899999999999999999999999943
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.73 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=203.2
Q ss_pred CeeEeeeecccCceeEEEEEECCCCc---E-EEEEEeCC-ccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGE---K-VAIKKIHD-VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~---~-vaiK~~~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
+-.+.++||+|+||.||+|.-+..+. . ||+|..+. ..........+.+|.++|++++|||||+++|+.....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--- 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--- 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence 34556999999999999998765422 3 89998874 2245566778999999999999999999999985544
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
-+|||||+|. |+|.++++.++ .++..+...++++.+.||+|||+++++||||-..|+|++.++.+||+|||+++..
T Consensus 235 --Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 235 --PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred --ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 4899999999 69999999887 4999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHH-hcCCCCHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD-LLGTPSPET 254 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 254 (414)
....... ...--...|+|||.+.. ..|+.++||||+||++||+.+ |..||++....+....|.. ....+
T Consensus 313 ~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~---- 383 (474)
T KOG0194|consen 313 SQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP---- 383 (474)
T ss_pred cceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC----
Confidence 3111110 01123456999999988 689999999999999999999 7899999988776666632 11111
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+..+..++.+|+..||++|||+.++.+
T Consensus 384 --------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 --------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11256677889999999999999999998865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.57 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=206.0
Q ss_pred CeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.-+..+.||+|+||.||+|+-.. ....||||.+++. ......+.|.||+.+|..|+|||||++++++ .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~ 560 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVC-----RE 560 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----cc
Confidence 46778999999999999997532 3457999999864 2333567899999999999999999999999 44
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND----------D----LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~----------~----l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~ 163 (414)
.+-+|||+|||. |||.++++.+. . ++..+...|+.||+.|+.||-++.+|||||-..|+||+++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 556999999999 99999997432 2 88999999999999999999999999999999999999999
Q ss_pred CeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHH
Q 015019 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDL 242 (414)
Q Consensus 164 ~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~ 242 (414)
.|||+|||++|......--.. .....-...|||||.+.- +.|+.+|||||+||+|+|+++ |..||.+-++.+.++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~-~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKV-RGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhhhhhhcc-cCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 999999999997654322110 001122456999998876 799999999999999999998 8899999999888877
Q ss_pred HHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
|... .......+.+.++.+|+..|++.+|.+|||+.||
T Consensus 718 i~~g------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRAG------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHcC------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 7531 1112235789999999999999999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=296.83 Aligned_cols=287 Identities=29% Similarity=0.430 Sum_probs=213.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 95 (414)
...+.|.++++||.|.|++||+|.+.. ..+.||+|.+... +...++.+|+++|..+. +.||+++.+++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 345679999999999999999999887 7889999998653 44567899999999994 89999999998
Q ss_pred CCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCc
Q 015019 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA 173 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a 173 (414)
...+++.+|+||++. +..++... ++..+++.+++.++.||+++|.+|||||||||+|+|.+.. +.-.|+|||+|
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 566789999999994 66666553 7789999999999999999999999999999999999864 77899999999
Q ss_pred ccccC--------------CCC---------------------------ccccccccccCccccccccccccCCCCCCcc
Q 015019 174 RVAFS--------------DTP---------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAI 212 (414)
Q Consensus 174 ~~~~~--------------~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 212 (414)
..... ..+ .....-...||+.|+|||++... ..-++++
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~Qttai 259 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAI 259 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCcc
Confidence 72100 000 00001235799999999999775 5678899
Q ss_pred hhhhHhHHHHHHHhCCCCC-CCCChhhHHHHHHHhcCCCCHHHHHhhc------c-------HHHHHHHHHh-----cCC
Q 015019 213 DIWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPETIAVVR------N-------EKARKYLTEM-----RKK 273 (414)
Q Consensus 213 DiwSlG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~------~-------~~~~~~~~~~-----~~~ 273 (414)
||||.|+|+..+++++.|| ...++.+.+..|..+.|........... . ......+..+ .+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999876 5556666666666665543222111100 0 0111111111 111
Q ss_pred CC--CCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 274 PP--VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 274 ~~--~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.. ..........+..+.||+.+||..||.+|+||+++|.||||...
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 11 01111122346689999999999999999999999999999854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.20 Aligned_cols=251 Identities=23% Similarity=0.406 Sum_probs=206.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..-++.+.||+|+||.||.|.-.... ..||||.+.+. ....+...+++|..+|+.++||||+++++++...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--- 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--- 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---
Confidence 45688999999999999999865432 35999998764 4556778899999999999999999999999764
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEee
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~D 169 (414)
...+|++|||+ |||..+|+.. ..++..+...++.+|++|++||+++++|||||-..|+|++....|||+|
T Consensus 768 --~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 --GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred --CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 34799999999 7999999864 3689999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
||+|+........... ..-.-...|||||.+.. ..++.++|||||||++||+++ |..||++.++.+.+....+.-
T Consensus 846 FGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred cchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence 9999954332211110 01011245999999987 789999999999999999999 889999998877665443210
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+.++..+.+|+..||+.+|++||+...|++
T Consensus 922 -----------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -----------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11223578888999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=304.42 Aligned_cols=278 Identities=16% Similarity=0.229 Sum_probs=187.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEEC----------------CCCcEEEEEEeCCccCChH------------HHHHHHHH
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDT----------------HTGEKVAIKKIHDVFEHIS------------DAIRILRE 72 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~----------------~~~~~vaiK~~~~~~~~~~------------~~~~~~~E 72 (414)
..++|++.++||+|+||+||+|... ..++.||||++........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 3456799999864211100 01123346
Q ss_pred HHHHHhCCCCCc-----cccceeecCCC---CCCCceEEEEEecCC-CCHHHHHHhC-----------------------
Q 015019 73 VKLLRLLRHPDI-----VEIKRIMLPPS---KREFKDIYVVFELME-SDLHQVIKAN----------------------- 120 (414)
Q Consensus 73 ~~~l~~l~hpni-----v~l~~~~~~~~---~~~~~~~~lV~E~~~-g~L~~~i~~~----------------------- 120 (414)
+.++..++|.++ +++++++.... .......++||||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 55666554321 112346899999999 6898887532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccc
Q 015019 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199 (414)
Q Consensus 121 -~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE 199 (414)
..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 123567788999999999999999999999999999999999999999999997543322111 11223578999999
Q ss_pred cccccCC------------------CCC--CcchhhhHhHHHHHHHhCCC-CCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAEVLTGKP-LFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 200 ~~~~~~~------------------~~~--~~~DiwSlG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.+..... .|+ ..+||||+|||+|+|++|.. ||.+.......... .
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~--------------~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ--------------Y 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh--------------c
Confidence 8754210 122 24799999999999999874 77543221110000 0
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCC---CCCCCHHHHhcCCCCCc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP---KDRPTAEEALADPYFKG 318 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp---~~Rpt~~~lL~hp~~~~ 318 (414)
.+ .... ..... ... .....+...++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 447 ~~-~~~~-~r~~~-~~~-~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 447 DN-DLNR-WRMYK-GQK-YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cc-hHHH-HHhhc-ccC-CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0000 00010 011 1122456789999999999999876 78999999999999963
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=278.48 Aligned_cols=242 Identities=39% Similarity=0.646 Sum_probs=197.7
Q ss_pred CceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCCC-CH
Q 015019 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113 (414)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L 113 (414)
+||.||+|.+..+++.||+|++........ ...+.+|++.++.++|+||+++++.+.. ....++|+|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCH
Confidence 589999999998999999999875322211 5678899999999999999999998843 3568999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCc
Q 015019 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (414)
Q Consensus 114 ~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~ 193 (414)
.+++.....++...+..++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877669999999999999999999999999999999999999999999999999998754432 223456888
Q ss_pred cccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhH-HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcC
Q 015019 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (414)
Q Consensus 194 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (414)
.|+|||.+.+ ..++.++||||||+++++|++|..||........ ...+..
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------------------------- 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK--------------------------- 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---------------------------
Confidence 9999999876 6788899999999999999999999977332222 211111
Q ss_pred CCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
...........++..+.+++.+||..||++|||+.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0000001111277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=313.00 Aligned_cols=248 Identities=29% Similarity=0.426 Sum_probs=191.0
Q ss_pred eeeecccCce-eEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCceEEEE
Q 015019 28 LEVIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 28 ~~~lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
-+.+|.|+.| .||+|.- .|+.||||.+-. .....+.||+..|+.. .|||||++++.- .+.+..||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 4678999987 5699954 588999998753 3445677999999988 599999998875 455679999
Q ss_pred EecCCCCHHHHHHhC-C---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---C--CCeEEeecCCcccc
Q 015019 106 FELMESDLHQVIKAN-D---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---N--CKLKVCDFGLARVA 176 (414)
Q Consensus 106 ~E~~~g~L~~~i~~~-~---~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~--~~vkL~DFG~a~~~ 176 (414)
.|+|..+|.+++... . ....-....++.|++.||++||+.+||||||||+||||+. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999873 1 1122445788999999999999999999999999999976 3 46899999999876
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhC-CCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..+...-.......||-.|+|||++.. ..-+.++|||||||++|..++| ..||...-. +-..|.. |...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~--~~~~---- 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILT--GNYT---- 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhc--Cccc----
Confidence 554443333566789999999999987 5567799999999999999986 799964332 2122211 1110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+...-+....+|.|||.+||.+||..||||.++|.||+|-..
T Consensus 732 ----------------------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 732 ----------------------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ----------------------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 001111222289999999999999999999999999999654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.62 Aligned_cols=242 Identities=26% Similarity=0.456 Sum_probs=198.5
Q ss_pred eEeeeecccCceeEEEEEECCC----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 26 KILEVIGKGSYGVVCAAIDTHT----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++.+.||.|.||.||.|....- .-.||||..+... .....+.++.|..+|++++||||+++++++... -
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 4457899999999999985432 2369999987643 344578899999999999999999999999443 4
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
++||||++. |.|..+++.+. .++......+++||+.||+||||.++|||||-..|||+.+...|||+|||++|.....
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 899999999 99999998764 7899999999999999999999999999999999999999999999999999976443
Q ss_pred CCcccccccccc--CccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.- +....| ..-|||||-+.- ..++.++|||.|||+|+|++. |..||.|-.+.+.+..|.+...
T Consensus 545 ~y----YkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------- 610 (974)
T KOG4257|consen 545 AY----YKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------- 610 (974)
T ss_pred ch----hhccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC--------
Confidence 21 122223 334999999865 789999999999999999887 8899998776665544432111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
....+++++.+..|+.+|+.+||.+||+..++
T Consensus 611 ----------------------lP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 611 ----------------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ----------------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 12236899999999999999999999987654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=257.14 Aligned_cols=210 Identities=25% Similarity=0.435 Sum_probs=173.9
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHH-hCCCCCccccceeecCCCCCCCceEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
...+..||+|+||+|-+.++..+|...|+|.+..... ....++.++|+.+.. ...+|++|.+++.+ ....+++
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regdvw 121 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGDVW 121 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccccEE
Confidence 3456789999999999999999999999999976533 456678889999854 45799999999987 3445799
Q ss_pred EEEecCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 104 VVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 104 lV~E~~~g~L~~~i----~~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+.||.|..+|..+. +.++.++|..+-.|+..++.||.|||++ .++|||+||+|||++.+|+||+||||.+-....
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999998877554 4577899999999999999999999997 799999999999999999999999999976544
Q ss_pred CCCccccccccccCcccccccccccc--CCCCCCcchhhhHhHHHHHHHhCCCCCCC-CChhhHHHHHH
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLIT 244 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwSlG~il~~ll~g~~pf~~-~~~~~~~~~i~ 244 (414)
+... +-..|...|||||.+... ...|+-++||||||+.+.||.+++.||+. .+..+++.++.
T Consensus 202 SiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 202 SIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 3322 224578889999987432 24799999999999999999999999964 45566666554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.84 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=219.7
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
-+...-+|-++||.|.||.||+|+-+..|+ .||||.++.. ........++.|..||-+++||||++|.++..
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT---- 700 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT---- 700 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe----
Confidence 344556889999999999999999887664 7999999853 44566677999999999999999999999983
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
...-+.||+|||+ |+|..+++.+ +.++.-+...+++.|+.|++||-+.|.|||||-..|||++.+-..|++|||++|
T Consensus 701 -ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 701 -KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred -cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 3345899999999 8999999875 579999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccc--CccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 175 VAFSDTPMTVFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
....+.+. .++...| ...|.|||.+.- .+++.++|+||+|++|+|.++ |..||.+.++.+.+..|.+-..-|+
T Consensus 780 vledd~~~--~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 780 VLEDDPEA--AYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred ecccCCCc--cccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 76555422 2233333 256999999976 789999999999999999766 8999999999999999987665554
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC--CCCCc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD--PYFKG 318 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h--p~~~~ 318 (414)
+ .+++..+..|+..|+++|...||+..||+++ ..+++
T Consensus 856 P------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 856 P------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred C------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3 4688899999999999999999999999873 44443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=295.25 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=207.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCC-Cc--EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHT-GE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
++.++.+.||+|.||+|++|..... |+ .||||++...... .....+++|+.+|.+|+|||+++||+++.+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~q----- 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ----- 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeeccc-----
Confidence 4567789999999999999987643 33 7999999754333 3677899999999999999999999999753
Q ss_pred ceEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
-+.||||++. |+|++.+.+ ...|-....+.|+.||+.|+.||.++++|||||-..|+|+-..-.|||||||+.|..
T Consensus 184 -p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 184 -PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred -hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 2689999999 899999976 456888999999999999999999999999999999999999989999999999987
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..+.....+....--...|+|||.+.. ..++.++|+|++||+++||++ |..||.|......+..|-+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------
Confidence 665543322112223456999999987 789999999999999999999 67999999987777666321
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+.++..+.++++.||..+|.+|||...|..
T Consensus 332 ---------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ---------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ---------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 111223567888999999999999999999988753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=292.38 Aligned_cols=200 Identities=25% Similarity=0.401 Sum_probs=174.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC--C----hHHHHHHHHHHHHHHhCC---CCCccccceeecC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H----ISDAIRILREVKLLRLLR---HPDIVEIKRIMLP 93 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~----~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~ 93 (414)
..|+.++.+|.|+||.|++|+++.+...|+||.+.+..- + ....-.+-.||+||..++ |+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-- 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-- 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence 469999999999999999999999999999999875321 0 011113446999999997 99999999999
Q ss_pred CCCCCCceEEEEEecCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecC
Q 015019 94 PSKREFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG 171 (414)
++.+++||+||--+ | +|+++|.-...++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|||
T Consensus 639 ---Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 ---EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ---ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 66678999999988 5 999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~ 233 (414)
.|....+. .+..++||..|.|||++.+. ...+.+-|||+||++||.++....||.+
T Consensus 716 saa~~ksg-----pfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSG-----PFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCC-----CcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98764332 24678999999999999884 4457789999999999999999888853
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=286.92 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=202.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.+-.++++||+|-||.|.+|.-. .+..||+|+++.. ........+.+|+++|.+|+||||+.+++++.... -+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence 45688999999999999999643 4689999998753 22333467999999999999999999999996543 48
Q ss_pred EEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
++|+|||+ |+|.+++..+. .........|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||.+|.....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 99999998763 3345566779999999999999999999999999999999999999999999965443
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh--CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..-.. -...+-...|||+|.+.. .+++.++|+|++|+++||+++ ...||...++.+..+....++..+....
T Consensus 691 ~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 691 DYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--- 764 (807)
T ss_pred Cceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---
Confidence 32111 012344577999998776 689999999999999999765 6789987776655554444333222211
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL 311 (414)
.....+-++..+.+|+.+|+..|-.+|||.+++.
T Consensus 765 --------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 765 --------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred --------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 1122345677889999999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.44 Aligned_cols=263 Identities=25% Similarity=0.413 Sum_probs=218.1
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|+++..+|+|.||.||+|+|+.+++..|+|+++.. ...+..-+..|+-+++.++||||+.+++.|...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~----- 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR----- 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhh-----
Confidence 5667999999999999999999999999999999999753 223445577899999999999999999988543
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..++++||||+ |+|.++..-.+++++.++.++.+..++||+|||++|-+|||||-.|||+++.|.+|++|||.+-.+..
T Consensus 85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 35899999999 69999988889999999999999999999999999999999999999999999999999999876644
Q ss_pred CCCccccccccccCcccccccccc-ccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... ...+++||++|||||+-. +....|...+|||++|+...||-.-++|.........+..+.+-...|+
T Consensus 165 ti~---KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp------ 235 (829)
T KOG0576|consen 165 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP------ 235 (829)
T ss_pred hhh---hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC------
Confidence 332 236789999999999742 1226799999999999999999888877665554444433332211111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
..+.-..+++.+.+|++.+|..+|.+|||++-+|.|||..+
T Consensus 236 --------------------~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 --------------------TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------------------cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11222467889999999999999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=283.30 Aligned_cols=242 Identities=24% Similarity=0.440 Sum_probs=203.0
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+.++..+||.|.||.||.+..+.-.-.||||.++. +......++.|..+|+.++|||+|+|+++|.... -+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFY 339 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFY 339 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeE
Confidence 45778999999999999999999999999999873 4466788999999999999999999999995543 389
Q ss_pred EEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
||+|||. |+|+++++... .++.-...+++.||..|+.||..++++||||-..|+|+.++..||++|||+++.....+
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999998 99999998643 46666778888999999999999999999999999999999999999999999875543
Q ss_pred Ccccccccccc---CccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 181 PMTVFWTDYVA---TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 181 ~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
- +...| ..-|.|||-+.- ..++.++|||+|||+|+|+.| |..||+|-+..+....+.+...
T Consensus 420 Y-----TAHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR-------- 484 (1157)
T KOG4278|consen 420 Y-----TAHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR-------- 484 (1157)
T ss_pred e-----ecccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--------
Confidence 2 22223 345999998755 678999999999999999998 7899999876655544432110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
.....++++....|++.||+++|.+||+..++
T Consensus 485 ----------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 485 ----------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ----------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 11234789999999999999999999999887
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.23 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=184.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
..|...+.||+|+||.||+|.+..++..||+|++...... ..+|+.+++.++||||+++++++... ...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-----KGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-----CCC
Confidence 3466778999999999999999999999999998643221 12468889999999999999999443 457
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LH---s~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
|+|||||. |+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 79999986 3889999999999999999999 6799999999999999999888876 665543211
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh-hHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 257 (414)
. ....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||...... ..+.......-
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~--------- 896 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY--------- 896 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc---------
Confidence 1 23368899999999877 68999999999999999999999999532211 11111110000
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
........++ .... ...........++.+++.+||+.||++|||+.|+++.
T Consensus 897 -~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 897 -SDCHLDMWID---PSIR-GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -CccchhheeC---cccc-CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000 0000 0000001112356789999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=266.44 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=193.2
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC--CCCCccccceeecCCCCCCCce
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL--RHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~~~~~~~ 101 (414)
-.++.+.||+|.||.||+| +-+++.||||++.. .+.+.+..|-+|.+.. +|+||+++++.-.... .....
T Consensus 211 pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehh--hccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccc
Confidence 4677899999999999999 45679999999863 4556677777776654 7999999988754433 22457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCCEEEcCCCCeEEeecC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVCDFG 171 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~---------givHrDlkp~NILl~~~~~vkL~DFG 171 (414)
++||++|.. |+|.++++.+ .+++....+++..+++||+|||+- .|+|||||..|||+..|++..|+|||
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 899999998 9999999875 699999999999999999999973 49999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCC-----CcchhhhHhHHHHHHHhCCCCCC-CCChhhHHHHHHH
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEVLTGKPLFP-GKSVVHQLDLITD 245 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~~DiwSlG~il~~ll~g~~pf~-~~~~~~~~~~i~~ 245 (414)
+|.......+... .-..+||..|||||++.+. .... ...||||+|.+|+||+++...+. +....-++-.-.+
T Consensus 362 LAl~~~p~~~~~d-~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 362 LALRLEPGKPQGD-THGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred eeEEecCCCCCcc-hhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 9988654443332 2347999999999998663 2222 35899999999999999875553 2222222221222
Q ss_pred hcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCC--CCChHHHHHHHHhccCCCCCCCCHHH
Q 015019 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEE 309 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dp~~Rpt~~~ 309 (414)
+-..|+-+.+. .++-.-+.++. +...|. ..-..+.+.+..|++.|++-|.||.=
T Consensus 440 vG~hPt~e~mq--------~~VV~kK~RP~--~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 440 VGNHPTLEEMQ--------ELVVRKKQRPK--IPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hcCCCCHHHHH--------HHHHhhccCCC--ChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 22233333221 12111112211 112222 23356789999999999999999853
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=259.08 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=192.9
Q ss_pred cccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHH--hCCCCCccccceeec
Q 015019 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR--LLRHPDIVEIKRIML 92 (414)
Q Consensus 15 ~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~--~l~hpniv~l~~~~~ 92 (414)
++-.-.+..+-.+++.||+|.||.||+|..+ |+.||||++.. .+.....||.+|.+ .|+|+||+.+++.-.
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 4445566788999999999999999999664 99999999874 33444556666654 469999999988654
Q ss_pred CCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCCEEEcCCC
Q 015019 93 PPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANC 163 (414)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~--------givHrDlkp~NILl~~~~ 163 (414)
... ....+++||++|-+ |+|+|++.. ..++.+....++..++.||+|||-. .|.|||||..|||+..+|
T Consensus 276 ~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 276 KDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred cCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 333 45568999999999 999999987 5799999999999999999999963 399999999999999999
Q ss_pred CeEEeecCCcccccCC-CCccccccccccCccccccccccccCCC--C--CCcchhhhHhHHHHHHHhC----------C
Q 015019 164 KLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSFFSK--Y--TPAIDIWSIGCIFAEVLTG----------K 228 (414)
Q Consensus 164 ~vkL~DFG~a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~--~~~~DiwSlG~il~~ll~g----------~ 228 (414)
..-|+|+|+|....+. .......+..+||..|||||++...-.. + -.-+||||||.|++|++.. +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999999775544 3334455778999999999998652110 1 1258999999999999873 3
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCC-CCCccCCCCCCC--hHHHHHHHHhccCCCCCCC
Q 015019 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKP-PVPLFQKFPNVD--PLALRLLQRLIAFDPKDRP 305 (414)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s--~~~~dli~~~L~~dp~~Rp 305 (414)
+||.+-...+ |+.+.+ .+-+..+. .......|.+.+ ..+..|++.|+..||.-|.
T Consensus 434 ~Pyyd~Vp~D-----------Ps~eeM-----------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl 491 (513)
T KOG2052|consen 434 LPYYDVVPSD-----------PSFEEM-----------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL 491 (513)
T ss_pred CCcccCCCCC-----------CCHHHH-----------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence 6664432111 111111 11111111 111122222222 2356789999999999999
Q ss_pred CHHHH
Q 015019 306 TAEEA 310 (414)
Q Consensus 306 t~~~l 310 (414)
||--+
T Consensus 492 tALri 496 (513)
T KOG2052|consen 492 TALRI 496 (513)
T ss_pred HHHHH
Confidence 98654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=278.82 Aligned_cols=247 Identities=27% Similarity=0.458 Sum_probs=197.1
Q ss_pred eEeeeecccCceeEEEEEEC----C---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCC
Q 015019 26 KILEVIGKGSYGVVCAAIDT----H---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 97 (414)
.+.+.||+|+||.|++|.-. . ....||||.++..... .+.+.+..|+++|+.+ .|+||+.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 67779999999999999743 1 1457999998865444 6778899999999999 59999999999854
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
.+.+++|+|||. |+|.++++.+. .++..+...+.+||+.|++||++..++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 456999999999 89999998654 389999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccC--ccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC-h
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS-V 236 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt--~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~-~ 236 (414)
.+..+||+|||+|+.......... ....|+ ..|||||.+.. ..|+.++||||+|++|||+++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986443322111 112222 23999999987 789999999999999999999 779998743 2
Q ss_pred hhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+.+..+. .-. + .......++++.++++.|++.+|++||+..++..
T Consensus 529 ~~l~~~l~------------------------~G~-r-----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLK------------------------EGN-R-----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHh------------------------cCC-C-----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 22222111 110 1 1122456899999999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=246.59 Aligned_cols=266 Identities=26% Similarity=0.414 Sum_probs=203.4
Q ss_pred ccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCC
Q 015019 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (414)
Q Consensus 16 ~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 94 (414)
.+..+..+.|.|.+.||+|.||.+-+|+|+.+++.+|+|.+.++ ......+.+|...--.| .|.||+.-|++....
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 34556678899999999999999999999999999999998864 45566788999875555 499999999876433
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc--CCCCeEEeecC
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCKLKVCDFG 171 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~--~~~~vkL~DFG 171 (414)
.+.+.+++||++ |+|..-+... .+.|...+.++.|++.||.|||++++||||||.+||||- +..+|||||||
T Consensus 94 ----~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 94 ----SDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred ----CceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecc
Confidence 346789999999 8999887664 589999999999999999999999999999999999974 33579999999
Q ss_pred CcccccCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
+.+..+..-... --+-.|.+||++... .-...+.+|+|.||+|+|.+++|.+||......
T Consensus 169 ~t~k~g~tV~~~------~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~----------- 231 (378)
T KOG1345|consen 169 LTRKVGTTVKYL------EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM----------- 231 (378)
T ss_pred cccccCceehhh------hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-----------
Confidence 987643321111 123458899976431 123567899999999999999999999743322
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCC---CCHHHHhcCCCCCc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKG 318 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R---pt~~~lL~hp~~~~ 318 (414)
+..+.++........+ .....|..+|+.+..+.++-|..++++| -++......-|...
T Consensus 232 -----------d~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 232 -----------DKPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred -----------CchHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 1222223332222222 3445677889999999999999999999 56666666667654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=237.02 Aligned_cols=212 Identities=37% Similarity=0.624 Sum_probs=181.1
Q ss_pred ecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCC
Q 015019 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME 110 (414)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~ 110 (414)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++... ...++++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999987532221 346788999999999999999999998443 56899999999
Q ss_pred -CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEeecCCcccccCCCCcccccc
Q 015019 111 -SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWT 187 (414)
Q Consensus 111 -g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~ 187 (414)
++|.+++... ..++...+..++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999998765 57899999999999999999999999999999999999999 89999999999976533321 123
Q ss_pred ccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHH
Q 015019 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (414)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (414)
...+...|++||.+... ..++.++|+||+|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 34578889999998762 2788999999999999999
Q ss_pred HHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 015019 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (414)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp 314 (414)
..+.+++.+||+.||++|||+.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1257899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.22 Aligned_cols=207 Identities=16% Similarity=0.208 Sum_probs=148.7
Q ss_pred CCC-CCccccceeecCCCCC--CCceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q 015019 79 LRH-PDIVEIKRIMLPPSKR--EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (414)
Q Consensus 79 l~h-pniv~l~~~~~~~~~~--~~~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp 154 (414)
++| +||.++++.+...... ....+++++|+++++|.+++.. ...+++.+++.+++||+.||+|||++||+||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 445 5788888876332211 2245789999999999999975 34699999999999999999999999999999999
Q ss_pred CCEEEcCCC-------------------CeEEeecCCcccccCCC-------------CccccccccccCcccccccccc
Q 015019 155 KNILANANC-------------------KLKVCDFGLARVAFSDT-------------PMTVFWTDYVATRWYRAPELCG 202 (414)
Q Consensus 155 ~NILl~~~~-------------------~vkL~DFG~a~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~ 202 (414)
+|||++..+ .+|++|||+++...... +........+||++|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 999996544 45555666554321100 0000012246899999999998
Q ss_pred ccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCC
Q 015019 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282 (414)
Q Consensus 203 ~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (414)
+ ..|+.++|||||||+||||++|.+|+..... .+..+.... .| + ..
T Consensus 189 ~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~------------------------~-----~~ 234 (793)
T PLN00181 189 G--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LP------------------------P-----QI 234 (793)
T ss_pred c--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cC------------------------h-----hh
Confidence 7 6899999999999999999999888753221 111110000 00 0 00
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 283 PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 283 ~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
....+.+.+++.+||..||.+|||+.++|+||||...
T Consensus 235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 1123556789999999999999999999999999764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=267.03 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=200.5
Q ss_pred CeeEeeeecccCceeEEEEEECCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..+..++||+|+||+||+|...-.|+ +||||++... ........+++|.-+|..+.|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch----
Confidence 45567899999999999999865554 7899987643 44455677899999999999999999999986543
Q ss_pred ceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
+-||++||. |.|.++++.+ ..+-.+....|.+||++|+.|||.+++|||||-..|||+.+-..+||.|||+|+...
T Consensus 772 --~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 772 --LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred --HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 689999999 8999999864 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.....- .....--.+-|||-|.+.. ..|+.++||||+||.++|++| |..|+.+....+.-+.+.+
T Consensus 850 ~d~~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----------- 915 (1177)
T KOG1025|consen 850 PDEKEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----------- 915 (1177)
T ss_pred cccccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-----------
Confidence 433211 1111112345888888876 789999999999999999998 8899988775443333221
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..+. ...+..+.++.-++.+||..|+..||+++++..
T Consensus 916 --------------geRL-----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 --------------GERL-----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------------cccC-----CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0111 223677888999999999999999999998865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-31 Score=236.57 Aligned_cols=199 Identities=37% Similarity=0.662 Sum_probs=172.1
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~l 104 (414)
|.+.+.||.|++|.||+|.+..++..+|+|.+...... .....+.+|+..++.++|+|++++++.+.. ....++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEE
Confidence 67889999999999999999988999999998754322 256678899999999999999999998743 346899
Q ss_pred EEecCCC-CHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 105 VFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~-l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
++|++.+ +|.+++..... +++..+..++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999987766 899999999999999999999999999999999999999999999999999876443211
Q ss_pred cccccccccCccccccccc-cccCCCCCCcchhhhHhHHHHHHHhCCCCCCC
Q 015019 183 TVFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~ 233 (414)
......++..|++||.+ .. ..++.++|+||||+++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~~~--~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLGG--KGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcCC--CCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345688889999998 44 6788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=275.17 Aligned_cols=269 Identities=26% Similarity=0.332 Sum_probs=206.0
Q ss_pred CCe-eEeeeecccCceeEEEEEECCCCcEEEEEEeCC----ccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD----VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y-~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..| .....+|.|++|.|+.+......+.++.|.... ..........+..|+.+-..+.|||++.....+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-- 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-- 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--
Confidence 456 567889999999999998887777777776541 1112222223667888888999999988877764332
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
..+-+||||.++|+..+.+.+.++..++..++.||+.||+|||+.||.||||||+|+++..+|.+||+|||.+....
T Consensus 395 ---~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 395 ---GILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred ---cchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 23444999999999999988899999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCc-cccccccccCccccccccccccCCCCCC-cchhhhHhHHHHHHHhCCCCCCCCChhhHHH-HHHHhcCCCCHHH
Q 015019 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGTPSPET 254 (414)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~ 254 (414)
..... .......+|+..|+|||++.+ ..|++ .+||||.|+++..|.+|+.||.-....+... .+..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--------- 540 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--------- 540 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------
Confidence 33322 234467899999999999988 56665 6899999999999999999996544322211 0000
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.............+..++...+.+|.+||++||.+|+|+++|++.+||+.+..
T Consensus 541 --------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 541 --------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred --------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00011111222333457788899999999999999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=222.60 Aligned_cols=165 Identities=22% Similarity=0.259 Sum_probs=128.0
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccccccc
Q 015019 111 SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (414)
Q Consensus 111 g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~ 189 (414)
|+|.+++..+ ..+++..++.|+.||+.||+|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6899999874 56999999999999999999999999 999999999999999 9998765332 12
Q ss_pred ccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh-HHHHHHHhcCCCCHHHHHhhccHHHHHHHH
Q 015019 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (414)
Q Consensus 190 ~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (414)
.||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||....... .+..+...
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~---------------------- 120 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG---------------------- 120 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH----------------------
Confidence 58999999999987 689999999999999999999999997654322 11111111
Q ss_pred HhcCCCCCCccCCCCCCCh--HHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 269 EMRKKPPVPLFQKFPNVDP--LALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~--~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
.....+.. ......++. .+.++|.+||..||.+|||+.+++.|+|+.
T Consensus 121 -~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 121 -MPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred -hccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00000000 000112333 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=230.80 Aligned_cols=181 Identities=20% Similarity=0.211 Sum_probs=135.1
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECC-CCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
-..++|.+.+.||+|+||+||+|+++. +++.||||++..... .......+.+|+++|+.++|+|++..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345789999999999999999999876 677889998753211 223455688999999999999998533221
Q ss_pred CCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCCEEEcCCCCeEEeecCCc
Q 015019 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDl-kp~NILl~~~~~vkL~DFG~a 173 (414)
+..|+|||||.| +|. .+.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 236999999985 665 2221 11 1568899999999999999999999 999999999999999999999
Q ss_pred ccccCCCCccc-----cccccccCccccccccccccCCC----CCCcchhh
Q 015019 174 RVAFSDTPMTV-----FWTDYVATRWYRAPELCGSFFSK----YTPAIDIW 215 (414)
Q Consensus 174 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~----~~~~~Diw 215 (414)
+.......... ..+..++++.|+|||.+...... .+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 87544322111 12456788899999988542222 23446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=218.25 Aligned_cols=266 Identities=33% Similarity=0.514 Sum_probs=205.4
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChH-HHHHHHHHHHHHHhCCCC-CccccceeecCCCCCCCceE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~~~ 102 (414)
|.+...||.|+||.||.+.+. ..+|+|.+........ ....+.+|+.++..+.|+ +|+++.+.+.. ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-----EGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-----CCEE
Confidence 889999999999999999887 7899999986554443 567788999999999988 79999999832 2348
Q ss_pred EEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCCccccc
Q 015019 103 YVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~a~~~~ 177 (414)
+++++++. +++.+.+.... .+++..+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||.++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999 57887777664 799999999999999999999999999999999999999998 79999999997543
Q ss_pred CCCCcc---ccccccccCccccccccccccC-CCCCCcchhhhHhHHHHHHHhCCCCCCCCCh---hhHHHHHHHhcCCC
Q 015019 178 SDTPMT---VFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGTP 250 (414)
Q Consensus 178 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~ 250 (414)
...... ......+||.+|+|||.+.+.. ..++...|+||+|++++++++|..||..... ...........+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 322211 1346778999999999987621 3678899999999999999999999877663 22222222221111
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.......... ......+.+++.+++..+|..|.+..+...++|.....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 0000000000 12235789999999999999999999999997776543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=216.27 Aligned_cols=252 Identities=18% Similarity=0.291 Sum_probs=196.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.|+++...+-+|.||.||.|+.+... +.|-+|.++.. ...-+...++.|--.+..+.|||+..+.++...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie---- 358 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE---- 358 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----
Confidence 47888899999999999999766433 35667776542 233455678889999999999999999998753
Q ss_pred CCceEEEEEecCC-CCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEe
Q 015019 98 EFKDIYVVFELME-SDLHQVIKA--------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~--------~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~ 168 (414)
+....++++.+++ |+|..++.. .+.++..+...++.|+..|++|||+.||+|.||-..|++|++.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 3345688999999 899999872 1257778888899999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhc
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 247 (414)
|=.++|......-...--. --....|||||.+.+ ..|+.++|+|||||+|+||+| |+.|+..-+..+....+.+.
T Consensus 439 DsaLSRDLFP~DYhcLGDn-EnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG- 514 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDN-ENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG- 514 (563)
T ss_pred cchhccccCcccccccCCC-CCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-
Confidence 9999987654322111001 112345899999988 789999999999999999998 88898766655444333221
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+. ...-++++++..++.-|+..+|++||+.+|+..
T Consensus 515 ------------------------yRl-----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ------------------------YRL-----AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------------------cee-----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 011 112478999999999999999999999999853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-26 Score=217.82 Aligned_cols=256 Identities=20% Similarity=0.206 Sum_probs=188.6
Q ss_pred CeeEeeeecccCceeEEEEEECCCC-cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC----CCccccceeecCCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRH----PDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~~~~~~~~ 98 (414)
+|++.+.||+|+||.||.|.+..++ ..+|+|.......... . .+..|+.++..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-S-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-c-cchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 6788888764322111 1 45578888888762 57777777663 13
Q ss_pred CceEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-----CCeEEeecC
Q 015019 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-----CKLKVCDFG 171 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-----~~vkL~DFG 171 (414)
...-|+||+.++.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3457999999999999988654 589999999999999999999999999999999999999765 359999999
Q ss_pred Ccc--cccCCCC-----ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH
Q 015019 172 LAR--VAFSDTP-----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 172 ~a~--~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (414)
+|+ ....... .......+.||..|+++....+ ...++..|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 3222211 1111134669999999999888 788999999999999999999999997765433322221
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.... ...... .....+.+..++...+-..+...+|....+...
T Consensus 251 ~~~~-----------------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPR-----------------------KLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhh-----------------------hhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1000 000000 112344566777777777888889987776553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=196.74 Aligned_cols=210 Identities=26% Similarity=0.347 Sum_probs=167.3
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC-CCccccceeecCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPS 95 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 95 (414)
...-..++|+++++||+|+||.+|.|....+|+.||||.-+....+ ..+..|.++.+.|++ ..|..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~---- 80 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYG---- 80 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhc----
Confidence 3445678999999999999999999999999999999986543222 245678888888864 5566555544
Q ss_pred CCCCceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CCeEEeecC
Q 015019 96 KREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFG 171 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~vkL~DFG 171 (414)
.+..+-.+||++.+.+|.+++.- ...++...+..++-|++.-|+|+|..+++||||||+|+|..-+ ..+.|+|||
T Consensus 81 -~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 81 -TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred -cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 34455689999999998888864 4579999999999999999999999999999999999997533 569999999
Q ss_pred CcccccCCCCcc-c---cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh
Q 015019 172 LARVAFSDTPMT-V---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237 (414)
Q Consensus 172 ~a~~~~~~~~~~-~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~ 237 (414)
+|+.+....... . .-....||..|.+-....+ ..-+...|+-|+|.+|..+..|..||.|-...
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 998764432211 1 1135679999999887766 45678899999999999999999999886543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-28 Score=233.60 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=196.0
Q ss_pred eecccCceeEEEEEEC---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceEEEE
Q 015019 30 VIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~~lV 105 (414)
.+|.|+||.|++++.. ..+..+|+|+.++.............|-.++...+ ||.+++++-.+.+ ...+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 3799999999988643 45678999998765443333334556778888886 9999999999844 4568999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccc
Q 015019 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (414)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (414)
+++.. |+|+..+.....+.+...+.+...++-|++++|+.||+|||+|++||+++.+|.+|+.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99998 5999999888889999999999999999999999999999999999999999999999999998754332
Q ss_pred cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHH
Q 015019 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (414)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (414)
..|||..|||||++. .+..++|+||+|+++++|++|..||.+ +....|.+..-
T Consensus 152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~---------------- 204 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL---------------- 204 (612)
T ss_pred ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc----------------
Confidence 228999999999986 467899999999999999999999987 33444432110
Q ss_pred HHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCccc
Q 015019 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (414)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~~ 320 (414)
.....++..+.+++..|+..+|..|.- +.++++|+||..+.
T Consensus 205 ---------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 205 ---------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred ---------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 011357888999999999999999985 58999999998764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-25 Score=198.52 Aligned_cols=241 Identities=21% Similarity=0.290 Sum_probs=188.0
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 99 (414)
++-.|+|+++||.|+||+.+.+.+.-+++.||||.-.. .+++-.+..|.+..+.|. .++|...|-+- .++
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 34579999999999999999999999999999997543 245556778888888885 67777665332 344
Q ss_pred ceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-----CeEEeecCCc
Q 015019 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCDFGLA 173 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-----~vkL~DFG~a 173 (414)
.+-.||+|+++.+|.+++.-. .+++...+..++.|++.-++|+|++++|.|||||+|+||..-+ .|.++|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 566899999999888888654 4799999999999999999999999999999999999997543 4899999999
Q ss_pred ccccCCCCcc-c---cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCC---CChhhHHHHHHHh
Q 015019 174 RVAFSDTPMT-V---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG---KSVVHQLDLITDL 246 (414)
Q Consensus 174 ~~~~~~~~~~-~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~---~~~~~~~~~i~~~ 246 (414)
+.+....... . ......||..||+=.-.++ ..-+...|+-|||-++...|.|..||.| .+..+..++|-+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 8865432211 1 1245679999999988777 6778999999999999999999999976 4566677777665
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcC
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRK 272 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (414)
-...+.+.++..-...+..|+...+.
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~ 280 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRR 280 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHh
Confidence 55555555554444455555554443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=235.52 Aligned_cols=231 Identities=26% Similarity=0.401 Sum_probs=173.1
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.+......|..++.|-.|+||-||.++|+.+.+++|+| +++. .. ++|- ++.....|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq----~l---ilRn--ilt~a~np-------------- 132 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ----NL---ILRN--ILTFAGNP-------------- 132 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-cccc----ch---hhhc--cccccCCc--------------
Confidence 33344567999999999999999999999999999995 4321 11 1110 22222222
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
++| ||=...++.-++++.+. +.|++|||+.||+|||+||+|.+|+.-|.+|+.|||+++..
T Consensus 133 ------fvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 133 ------FVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ------cee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 333 44444555555666554 78999999999999999999999999999999999999764
Q ss_pred cCCCCcc------------ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH
Q 015019 177 FSDTPMT------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 177 ~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (414)
....... ......|||+.|+|||++.. +.|+..+|+|++|+|+|+.+-|..||.|++..+.+..++
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 3322111 01134599999999999988 799999999999999999999999999998877766654
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCccc
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP---TAEEALADPYFKGLA 320 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp---t~~~lL~hp~~~~~~ 320 (414)
.-...-. +.-...+++++++|.++|+.+|..|. .+-++-+|+||+.+.
T Consensus 272 sd~i~wp----------------------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 272 SDDIEWP----------------------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred hhhcccc----------------------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 3221111 11245789999999999999999995 567788999998764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=230.76 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=184.7
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.|...+.||++.|=.|.+|.+.+ | .|+||++-+... ......+.++|++ ....++||.+.+..+.. ....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~-----t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV-----TDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH-----hhHH
Confidence 78999999999999999997653 3 499999865432 3344555566777 66678999998877753 3345
Q ss_pred EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
-|||-+|...+|+|.+..+.-+..-+.+.|+.||+.||+-+|..||+|||||.+||||++-+.+.|+||..-+...-...
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 69999999999999999888899999999999999999999999999999999999999999999999987654322111
Q ss_pred c----cccccccccCcccccccccccc--------CCC-CCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHH-h
Q 015019 182 M----TVFWTDYVATRWYRAPELCGSF--------FSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD-L 246 (414)
Q Consensus 182 ~----~~~~~~~~gt~~y~aPE~~~~~--------~~~-~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~-~ 246 (414)
. ..++.+...-..|.|||.+... ..+ .+++-||||+||+++||++ |+|||.-.. ... .
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLAYR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHhHh
Confidence 1 1122222223459999987441 012 5678999999999999998 789994211 110 0
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.|. .......++.+ -+...+.||..|++.||++|.+|++.|+-
T Consensus 249 ~~~----------~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGN----------ADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccC----------ccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000 00011111111 12357899999999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=195.93 Aligned_cols=176 Identities=11% Similarity=0.108 Sum_probs=133.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChH-HHHH------HHHHHHHHHhCCCCCccccceeecCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIR------ILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~------~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
.++|++++.||.|+||.||++.+ ++..+|||.+........ ...+ +.+|++.+..+.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57999999999999999999754 466899999975433222 2222 56899999999999999998886543
Q ss_pred CCC---CCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeec
Q 015019 95 SKR---EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (414)
Q Consensus 95 ~~~---~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DF 170 (414)
... ..+..+|||||++| +|.++. .+++ ....+++.+|..||+.|++||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 211 12458999999997 787763 2333 2466999999999999999999999999999998 999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHH
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll 225 (414)
|.++........ ..+... ..|+.++|+||||+.+..+.
T Consensus 179 g~~~~~~e~~a~---------------d~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK---------------DRIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH---------------HHHHHH--hHhcccccccceeEeehHHH
Confidence 988654221110 012333 56778999999999887764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=199.89 Aligned_cols=240 Identities=20% Similarity=0.267 Sum_probs=152.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCC----------CCccccceeec
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRH----------PDIVEIKRIML 92 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h----------pniv~l~~~~~ 92 (414)
.+..++.||.|++|.||.+.|..||+.+|+|++..... .....+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778999999999999999999999999999754322 22344555555544433322 23333333332
Q ss_pred CCCC-------CCCc-----eEEEEEecCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q 015019 93 PPSK-------REFK-----DIYVVFELMESDLHQVIKA---NDD----LTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (414)
Q Consensus 93 ~~~~-------~~~~-----~~~lV~E~~~g~L~~~i~~---~~~----l~~~~~~~i~~qil~al~~LHs~givHrDlk 153 (414)
-... .+.. ..+++|+-+.++|.+++.. ... +.......+..|+++.+++||+.|++|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1110 0111 3478999999998887652 221 2222224456899999999999999999999
Q ss_pred CCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCcccccccccccc------CCCCCCcchhhhHhHHHHHHHhC
Q 015019 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTG 227 (414)
Q Consensus 154 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~~ll~g 227 (414)
|+|++++.+|.++|+||+.....+... .....+..|.+||..... ...++.+.|.|+||+++|.|.+|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999876543321 112345779999976331 13578899999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCC
Q 015019 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (414)
Q Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R 304 (414)
+.||......... . ..+.. ..+++...++||..||+.||.+|
T Consensus 247 ~lPf~~~~~~~~~----------~------------------------~~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP----------E------------------------WDFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS----------G------------------------GGGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc----------c------------------------ccchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 9999765421100 0 01112 23788999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=191.82 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=109.1
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHH------------------------HHHHHHHHHHHHhCCCCC
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD------------------------AIRILREVKLLRLLRHPD 83 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~hpn 83 (414)
.+.||+|++|.||+|.+. +|+.||||+++........ .....+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999998643211100 122345999999998887
Q ss_pred ccccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCCEEEcC
Q 015019 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILANA 161 (414)
Q Consensus 84 iv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~L-Hs~givHrDlkp~NILl~~ 161 (414)
+.....+.. ...+|||||++| ++...+.....+++..+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744333221 113899999996 4544444456899999999999999999999 799999999999999998
Q ss_pred CCCeEEeecCCcccc
Q 015019 162 NCKLKVCDFGLARVA 176 (414)
Q Consensus 162 ~~~vkL~DFG~a~~~ 176 (414)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=185.87 Aligned_cols=141 Identities=21% Similarity=0.189 Sum_probs=111.5
Q ss_pred EeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChH------------------------HHHHHHHHHHHHHhCCCC
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS------------------------DAIRILREVKLLRLLRHP 82 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~hp 82 (414)
+.+.||+|++|.||+|.+. +|+.||||+++....... ......+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999875421100 012345799999999999
Q ss_pred CccccceeecCCCCCCCceEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEc
Q 015019 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILAN 160 (414)
Q Consensus 83 niv~l~~~~~~~~~~~~~~~~lV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~ 160 (414)
++.....+... ..||||||++|. +.........++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 87555444321 138999999963 43333344678899999999999999999999 9999999999999999
Q ss_pred CCCCeEEeecCCcccc
Q 015019 161 ANCKLKVCDFGLARVA 176 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~ 176 (414)
++.++|+|||+|+..
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=193.25 Aligned_cols=198 Identities=25% Similarity=0.342 Sum_probs=143.9
Q ss_pred CCCCccccceeecCC----------------------CCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHH
Q 015019 80 RHPDIVEIKRIMLPP----------------------SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR 137 (414)
Q Consensus 80 ~hpniv~l~~~~~~~----------------------~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~ 137 (414)
+|||||++...|.+. ...+...+|+||..+..+|.+++-.+ ..+.....-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence 699999998887432 12344579999999999999999765 4777888899999999
Q ss_pred HHHHHHHCCcccCCCCCCCEEEc--CCC--CeEEeecCCcccccCCC---CccccccccccCccccccccccccCCC---
Q 015019 138 ALKYMHTANVYHRDLKPKNILAN--ANC--KLKVCDFGLARVAFSDT---PMTVFWTDYVATRWYRAPELCGSFFSK--- 207 (414)
Q Consensus 138 al~~LHs~givHrDlkp~NILl~--~~~--~vkL~DFG~a~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~--- 207 (414)
|+.|||..||.|||+|.+|||+. +|+ .+.|+|||+|-...... +.....-+..|.-.-||||+.....++
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999974 443 37899999985432211 111112344577789999997552111
Q ss_pred -CCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCC
Q 015019 208 -YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286 (414)
Q Consensus 208 -~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 286 (414)
.-.++|.|+.|.+.||+++...||.+...... + .+. .....+......++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~---------~r~-------Yqe~qLPalp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------D---------TRT-------YQESQLPALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhee-------------c---------hhh-------hhhhhCCCCcccCC
Confidence 11368999999999999999999976332110 0 000 01111222334688
Q ss_pred hHHHHHHHHhccCCCCCCCCH
Q 015019 287 PLALRLLQRLIAFDPKDRPTA 307 (414)
Q Consensus 287 ~~~~dli~~~L~~dp~~Rpt~ 307 (414)
+.+++|+..+|+.||++|+++
T Consensus 484 p~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hHHHHHHHHHhcCCccccCCc
Confidence 999999999999999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-23 Score=177.39 Aligned_cols=192 Identities=15% Similarity=0.036 Sum_probs=137.9
Q ss_pred eEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC--hHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceE
Q 015019 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.+...|++|+||+|+.+.. .+..++.+.+...... ......+.+|+++|++|. |+++++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 4678899999999998854 6778887776532211 112235779999999995 57888887742 36
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDl-kp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|++|||+.| +|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999997 56543321 12357889999999999999999999 7999999999999999999998543322
Q ss_pred Cccc--cc-------c-ccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC
Q 015019 181 PMTV--FW-------T-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235 (414)
Q Consensus 181 ~~~~--~~-------~-~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~ 235 (414)
.... .. + -...++.|++|+...-....--...++++.|+-+|.++|++.++.++.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1000 00 0 012567788888543321222256799999999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=173.59 Aligned_cols=136 Identities=21% Similarity=0.221 Sum_probs=106.7
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-----CCCCccccceeecCCCCCCCceE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-----RHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.+.||+|+||.||. +..++.. +||++.... ......+.+|+.+++.+ .||||+++++++.+.. ..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 57899999999995 7777666 699886421 22445688999999999 5799999999996542 12344
Q ss_pred E-EEEecCC---CCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCCEEEcCC----CCeEEeecCCc
Q 015019 103 Y-VVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRAL-KYMHTANVYHRDLKPKNILANAN----CKLKVCDFGLA 173 (414)
Q Consensus 103 ~-lV~E~~~---g~L~~~i~~~~~l~~~~~~~i~~qil~al-~~LHs~givHrDlkp~NILl~~~----~~vkL~DFG~a 173 (414)
+ +||||++ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 6999999764 56666 46788988888 89999999999999999999743 37999995533
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=176.67 Aligned_cols=144 Identities=17% Similarity=0.142 Sum_probs=111.8
Q ss_pred CeeEeeeecccCceeEEEEE-ECCCCcEEEEEEeCCccCC--------------------hH--HHHHHHHHHHHHHhCC
Q 015019 24 RYKILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEH--------------------IS--DAIRILREVKLLRLLR 80 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~-~~~~~~~vaiK~~~~~~~~--------------------~~--~~~~~~~E~~~l~~l~ 80 (414)
-|.+.+.||.|++|.||+|. +..+|+.||||++...... .. ....+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 6778999999998643210 00 1123568999999997
Q ss_pred CCCccccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCCEE
Q 015019 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNIL 158 (414)
Q Consensus 81 hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g-ivHrDlkp~NIL 158 (414)
+. .+.+..++.. ...|+||||++| +|.........+....+..++.||+.+|++||+.| |+||||||+||+
T Consensus 109 ~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 3333333321 124899999997 55555444556777778899999999999999999 999999999999
Q ss_pred EcCCCCeEEeecCCccc
Q 015019 159 ANANCKLKVCDFGLARV 175 (414)
Q Consensus 159 l~~~~~vkL~DFG~a~~ 175 (414)
++ ++.++|+|||.|..
T Consensus 182 i~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 182 VH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EE-CCCEEEEEChhhhc
Confidence 99 88999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-22 Score=190.72 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=166.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccce-------ee
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR-------IM 91 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-------~~ 91 (414)
...+.+.+..+.+++|.+....-... .+.++-+.... .+........+++-.+....|-+..-+.+ .+
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~--d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV--DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhc--cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 34556666666666666655543322 22233332221 12133334455666655554433332222 11
Q ss_pred cCCCCCCCceEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEE
Q 015019 92 LPPSKREFKDIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL 167 (414)
.........++||.|++|. .+|.++|..+. ..+....+.++.|+..|++| +|.+|||+||.||+...++.+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 1111122346899999999 79999997543 56778889999999999999 99999999999999999999999
Q ss_pred eecCCcccccCCC---CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH
Q 015019 168 CDFGLARVAFSDT---PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (414)
.|||+........ +.....+..+||.|||+||.+.+ ..|+.++||||||+||+||+.- |.. ..+.+....
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~t~~ 470 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQ---FST--QFERIATLT 470 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHH---hcc--HHHHHHhhh
Confidence 9999987654433 11223467789999999999998 7899999999999999999872 211 111111111
Q ss_pred Hh-cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 245 DL-LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 245 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
++ .|..++. +..-.+...+|+.+||...|.+||++.+.--|+|.
T Consensus 471 d~r~g~ip~~----------------------------~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 471 DIRDGIIPPE----------------------------FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhcCCCChH----------------------------HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11 0111111 11123556799999999999999988877777765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=201.89 Aligned_cols=204 Identities=25% Similarity=0.313 Sum_probs=156.0
Q ss_pred hhcccccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC---CCCcc
Q 015019 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIV 85 (414)
Q Consensus 9 ~~~~~~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv 85 (414)
.+..+..+...+ ..|.|-+.||.|+||.||.|.+.. |+.||+|+=+...... ++-=.+++.+|+ -+.|+
T Consensus 686 ~l~~~~~~~~~~--~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~ 757 (974)
T KOG1166|consen 686 KLNPNTEFEVGG--EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIM 757 (974)
T ss_pred ccCccceeeecc--eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchH
Confidence 344444455443 579999999999999999999877 9999999865322111 111123333443 23445
Q ss_pred ccceeecCCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---
Q 015019 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--- 161 (414)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~--- 161 (414)
.+...+... +..+||+||.+ |+|.+++..++.+++..+..+..|++..|++||..+|||+||||+|+||..
T Consensus 758 ~~~~a~~~~-----~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~ 832 (974)
T KOG1166|consen 758 HISSAHVFQ-----NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC 832 (974)
T ss_pred HHHHHHccC-----CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC
Confidence 554444322 23589999999 999999998899999999999999999999999999999999999999742
Q ss_pred ----CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC
Q 015019 162 ----NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (414)
Q Consensus 162 ----~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~ 228 (414)
+--++|+|||.|-...--... ..+...++|-.+-.+|...+ .+|+..+|.|.|..+++-||.|+
T Consensus 833 ~~~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 833 ADSDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred CCCcccceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 234999999998654332222 22456778889999999988 89999999999999999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-22 Score=205.14 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=209.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC-CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 99 (414)
...|.+.+.||+|+|+.|-.+....+ ...+|.|.+...........++..|..+-+.+. |.|++.+++.. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 45799999999999999988876443 446778877655434445556667888888887 99999999987 344
Q ss_pred ceEEEEEecCC-CCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCCEEEcCCC-CeEEeecCCcc
Q 015019 100 KDIYVVFELME-SDLHQVI-KAND-DLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i-~~~~-~l~~~~~~~i~~qil~al~~LH-s~givHrDlkp~NILl~~~~-~vkL~DFG~a~ 174 (414)
+..+++++|.. ++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+|+.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 56799999977 5888888 5544 6888899999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCcccccccccc-CccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 175 VAFSDTPMTVFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
...............+| ++.|+|||...+. ...++..|+||.|+++..+++|..||......+..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------- 239 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------- 239 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc-------------
Confidence 76652233333466788 9999999998773 35678899999999999999999999765433210
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
+..... .........|..++..+.+++.++|..+|..|.+.+++-.+||+..
T Consensus 240 ------------~~~~~~-~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 ------------YSSWKS-NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------ceeecc-cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000000 0111123446788999999999999999999999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.2e-20 Score=163.03 Aligned_cols=136 Identities=22% Similarity=0.295 Sum_probs=109.4
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh------HHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++.||+|++|.||+|.+ .|..|++|+........ ....++.+|+.++..+.|++|.....++... ..
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----EN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CC
Confidence 36799999999999976 67789999865322111 1234577899999999999887766665322 34
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.++||||++| +|.+.+..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||+++.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 6899999985 88888865432 7788999999999999999999999999999999 78899999999865
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=164.68 Aligned_cols=241 Identities=16% Similarity=0.231 Sum_probs=180.8
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
...+.-+|.....|..|+++. .|..+++|++....-.......+..|.-.|+-+.||||+.+++.+..+ -++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCce
Confidence 345567788999999999965 466778888764433344455688899999999999999999998444 4589
Q ss_pred EEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCCeEE--eecCCcccc
Q 015019 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKV--CDFGLARVA 176 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~vkL--~DFG~a~~~ 176 (414)
++..||. |+|+.++.... .....++..++..+++|++|||+.. |.---|....++++++.+.+| +|--++...
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999 89999997643 4677889999999999999999985 445568888999999876555 343222111
Q ss_pred cCCCCccccccccccCccccccccccccC-CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
....-++.||+||.+.... ...-.++|||||.++++||.|...||..-+..+.--+|.
T Consensus 344 ----------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----------- 402 (448)
T KOG0195|consen 344 ----------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----------- 402 (448)
T ss_pred ----------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------
Confidence 1223567899999986631 123357999999999999999999998877655433221
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
++.++ ....|+++.....|++-|+.-||.+||..+.+
T Consensus 403 -----------leglr-------v~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 403 -----------LEGLR-------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred -----------hcccc-------ccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 11111 13457899999999999999999999987665
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=158.33 Aligned_cols=137 Identities=21% Similarity=0.215 Sum_probs=105.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChH--------------------HHHHHHHHHHHHHhCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS--------------------DAIRILREVKLLRLLRHPD 83 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--------------------~~~~~~~E~~~l~~l~hpn 83 (414)
.|.+.+.||+|+||.||+|... +|+.||||++........ ......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999875 799999998754221100 1123567899999888775
Q ss_pred c--cccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 84 I--VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 84 i--v~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
+ ...++ ....++||||+.| +|...... .....++.+|+.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPID---------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceee---------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 33222 1235899999996 66544321 34577899999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccc
Q 015019 161 ANCKLKVCDFGLARVA 176 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~ 176 (414)
.++.++|+|||+|...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=157.90 Aligned_cols=131 Identities=27% Similarity=0.362 Sum_probs=101.7
Q ss_pred eecccCceeEEEEEECCCCcEEEEEEeCCc-cCC-----hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEH-----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.||+|++|.||+|. .++..|++|+.... ... .....++.+|+++++.+.|+++....-++.. ....+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence 48999999999997 46788999986432 111 1123567789999999988875544333322 12358
Q ss_pred EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
+||||++| +|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||+++.
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887754321 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=150.16 Aligned_cols=137 Identities=23% Similarity=0.262 Sum_probs=97.0
Q ss_pred EeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHH----------------------HHHHHHHHHhCCCCC-
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----------------------ILREVKLLRLLRHPD- 83 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~hpn- 83 (414)
+.+.||+|+||+||+|.+. +++.||||++............ ...|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999876 8999999998643221111111 135666666664433
Q ss_pred -ccccceeecCCCCCCCceEEEEEecCCC-CHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEE
Q 015019 84 -IVEIKRIMLPPSKREFKDIYVVFELMES-DLH-QVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILA 159 (414)
Q Consensus 84 -iv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~-~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl 159 (414)
+.+.+.+ ...++||||+++ .+. ..+... .. ...+..++.+++.++.++|+ .||+||||||+||++
T Consensus 80 ~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 80 PVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CCCceEec---------CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 3333322 125899999996 221 111111 11 16788999999999999999 999999999999999
Q ss_pred cCCCCeEEeecCCcccc
Q 015019 160 NANCKLKVCDFGLARVA 176 (414)
Q Consensus 160 ~~~~~vkL~DFG~a~~~ 176 (414)
+ ++.++|+|||.|...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=171.98 Aligned_cols=137 Identities=23% Similarity=0.311 Sum_probs=106.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEe-CCccCC-----hHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEH-----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~-~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..|...+.||+|+||+||++... +..+++|+. .+.... .....++.+|+++++.++|++++....+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34567899999999999999764 334455543 221111 12245678999999999999988766555332
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
...++||||++ ++|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+|+.
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 23689999998 48888775 356789999999999999999999999999999 678899999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=166.34 Aligned_cols=207 Identities=24% Similarity=0.338 Sum_probs=152.0
Q ss_pred HHhCCCCCccccceeecCCCCCCCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccCCC
Q 015019 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANV-YHRDL 152 (414)
Q Consensus 76 l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~gi-vHrDl 152 (414)
|+.+.|.|+.++++..... ..+++|.+||. |+|.+.+.. ...++.-....+++.|+.||.|||+.-| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4578899999999999655 46899999999 899999987 4578888888999999999999999866 99999
Q ss_pred CCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCcccccccccccc--CC---CCCCcchhhhHhHHHHHHHhC
Q 015019 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAEVLTG 227 (414)
Q Consensus 153 kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~---~~~~~~DiwSlG~il~~ll~g 227 (414)
++.|++++..-.+||.|||+......... ........-...|.|||++.+. .. .-+.+.||||+|++++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccc-ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999876532111 1111112234458999998662 01 146779999999999999999
Q ss_pred CCCCCCCChhh----HHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC
Q 015019 228 KPLFPGKSVVH----QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (414)
Q Consensus 228 ~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~ 303 (414)
.-||+...... .+..+.+ .+ .....|.........+.+..++++|+.-+|..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-~~-----------------------~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-GG-----------------------SNPFRPSIELLNELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred cCccccccccCChHHHHHHHHh-cC-----------------------CCCcCcchhhhhhcchHHHHHHHHhcccChhh
Confidence 99997643221 2222211 00 01111111111145567899999999999999
Q ss_pred CCCHHHHhc
Q 015019 304 RPTAEEALA 312 (414)
Q Consensus 304 Rpt~~~lL~ 312 (414)
||+++++-.
T Consensus 211 rPs~~~i~~ 219 (484)
T KOG1023|consen 211 RPSIEQIRS 219 (484)
T ss_pred CccHHHHHh
Confidence 999988743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-17 Score=148.60 Aligned_cols=139 Identities=21% Similarity=0.280 Sum_probs=103.1
Q ss_pred eeec-ccCceeEEEEEECCCCcEEEEEEeCCcc------C-----ChHHHHHHHHHHHHHHhCCCCCc--cccceeecCC
Q 015019 29 EVIG-KGSYGVVCAAIDTHTGEKVAIKKIHDVF------E-----HISDAIRILREVKLLRLLRHPDI--VEIKRIMLPP 94 (414)
Q Consensus 29 ~~lg-~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~-----~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 94 (414)
..|| .||.|+||.+.. .+..+|||.+.... . ......++.+|+.++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 777888888854 37789999875311 0 11234567899999999998875 5555553222
Q ss_pred CCCCCceEEEEEecCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 95 SKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~g--~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111234699999995 78888764 4566543 67899999999999999999999999999999999999998
Q ss_pred ccc
Q 015019 173 ARV 175 (414)
Q Consensus 173 a~~ 175 (414)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-18 Score=165.98 Aligned_cols=258 Identities=25% Similarity=0.226 Sum_probs=200.7
Q ss_pred CCeeEeeeecc--cCceeEEEEEE--CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGK--GSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~--G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 97 (414)
.++.+...+|+ |.+|.||.+.. ..++..+|+|+-+..+.......+-++|+...+.++ |+|.++.+..+ +
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 46778899999 99999999998 889999999986655554445555667888777774 99999977777 5
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecC
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR----ALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFG 171 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~-l~~~~~~~i~~qil~----al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG 171 (414)
+.+..|+-+|+|+.+|..+...... +++..++..+.+... ||.++|+.+++|-|+||.||+...+ ...+++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 5667999999999999998877554 899999999999999 9999999999999999999999999 889999999
Q ss_pred CcccccCCCCccccc--cccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC--ChhhHHHHHHHhc
Q 015019 172 LARVAFSDTPMTVFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLL 247 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~ 247 (414)
+........-...+. ...-|...|++||+..+ -++.+.||+|+|.++.+-.+|..+.... +...++..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence 998765543222111 11246677999999876 6889999999999999999887665433 2111111100
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
-..+...+.+..+...+..|++.+|..|++++.+++|+++....
T Consensus 343 -----------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 343 -----------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred -----------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence 00011234566667799999999999999999999999997643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=131.11 Aligned_cols=131 Identities=22% Similarity=0.230 Sum_probs=106.0
Q ss_pred EeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC--CCccccceeecCCCCCCCceEEE
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~~~~l 104 (414)
+++.||.|.++.||++.... ..+++|....... ...+.+|+.+++.+.| .++++++..... .+..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEE
Confidence 46789999999999998753 7899999865322 4567789999999976 478887776632 246899
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~---givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
+|||+.| .+... +......++.+++.+|++||.. +++|+|++|.||+++..+.++++|||.++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34322 5566778899999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-17 Score=166.15 Aligned_cols=264 Identities=23% Similarity=0.254 Sum_probs=194.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+.+.+++.+-+|++|.++.+.-..+|...++|.......- ....+.+.++-+++-...+|.++...-.+ .-..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 35678888999999999999988888877777765432111 11222333444444434556665543332 2234
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..+||++|.+ ++|...+..-+..+.+-++.+...+.+++++||+..+.|||++|.|+|+..++..++.|||.......-
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 5899999998 689988888788888888999999999999999999999999999999999999999999843221110
Q ss_pred CC--------------------------cc--ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCC
Q 015019 180 TP--------------------------MT--VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (414)
Q Consensus 180 ~~--------------------------~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf 231 (414)
.+ .. ..-...+||+.|.+||...+ ...+.++|+|++|+++++.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 00 00123578999999999988 67889999999999999999999999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHH---
Q 015019 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE--- 308 (414)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~--- 308 (414)
...+.......|.. ... ++.......+..+++++..+|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~--------------------------~~~--~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN--------------------------RDI--PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhcccc--------------------------CCC--CCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence 88776555443321 111 11122235788999999999999999999887
Q ss_pred HHhcCCCCCccc
Q 015019 309 EALADPYFKGLA 320 (414)
Q Consensus 309 ~lL~hp~~~~~~ 320 (414)
+.-.||||+...
T Consensus 1088 e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVD 1099 (1205)
T ss_pred ccccCCccCCCC
Confidence 888999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.2e-17 Score=144.77 Aligned_cols=249 Identities=19% Similarity=0.214 Sum_probs=167.4
Q ss_pred eEEEEEECCCCcEEEEEEeCCccC-Ch-HHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCC-CCHH
Q 015019 38 VVCAAIDTHTGEKVAIKKIHDVFE-HI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLH 114 (414)
Q Consensus 38 ~V~~a~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~ 114 (414)
.||++.+...|..|+.-.+..... +. ........-+..|-++-|.||++++.+|.+...++...+.+++|||. |++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 466777777777666554421100 00 11112223345566678999999999998776667778999999999 7988
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCCeEEeecCCcccccC-CCCcccccc
Q 015019 115 QVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFS-DTPMTVFWT 187 (414)
Q Consensus 115 ~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~~ 187 (414)
..++. ...+.....++|+-||+.||.|||+.. |+|+++..+.|++..+|.+|+.--........ .........
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 88864 346899999999999999999999996 99999999999999999888853221111000 000000011
Q ss_pred ccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHH
Q 015019 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (414)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (414)
-..+-++|.|||.-.. ...+-++|||++|....+|..+..- -.+.+....-..|.+..
T Consensus 241 ~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------- 299 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------- 299 (458)
T ss_pred ccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence 2345678999997544 5667799999999999999887732 22222211111111100
Q ss_pred HHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
+.--...-++++.+||+-.|..||++.++|.||.+-.++..
T Consensus 300 ---------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 300 ---------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred ---------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence 00112234678999999999999999999999998766543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-14 Score=141.18 Aligned_cols=185 Identities=23% Similarity=0.328 Sum_probs=137.6
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
-|.+ ...+-++.+..-.|..+.++.+|.|...+.... .....+.+-++.|+.++||||+++++.+ +....+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~y 85 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLY 85 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceE
Confidence 4666 555556655444566778899999998875422 3345577888999999999999999988 4556799
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LH-s~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
||+|-+.. |..+++. +....++..++||+.||.||| .++++|++|.-+-|+++..|..||++|.++.........
T Consensus 86 lvTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 86 LVTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred EEeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 99998873 3334443 347888899999999999997 678999999999999999999999999988654332211
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhC
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g 227 (414)
.....--..|..|+.+.. -+-..|.|-|||++++++.|
T Consensus 162 ---~~~~~~~~s~~~P~~~~~----s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 ---AKSLYLIESFDDPEEIDP----SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cccchhhhcccChhhcCc----cccchhhhhHHHHHHHHhCc
Confidence 011112223677776543 12467999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.3e-15 Score=143.59 Aligned_cols=251 Identities=22% Similarity=0.219 Sum_probs=184.3
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
..++..+..||.|.|+.|+.+... .++..|++|.+.+..........-+.|+.+...+ .|.++++.+..| ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----ccc
Confidence 357889999999999999988755 6788999999877655555555566777777766 499999988887 344
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a~~~~ 177 (414)
.+.|+-.|||. +++...+.....+.+...+.+..|++.|+.++|+..++|+|+||+||++..+ +.-++.|||.+....
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 56789999997 4555555444568899999999999999999999999999999999999886 778999999886321
Q ss_pred CCCCccccccccccCcccc-ccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
-.. ......-++. ..|++... ..+..++|++|||.-+.+.++|.+.-+..+... .|
T Consensus 419 ~~~------~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i------------- 475 (524)
T KOG0601|consen 419 FSS------GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TI------------- 475 (524)
T ss_pred eec------ccccccccccccchhhccc-cccccccccccccccccccccCcccCcccccce---ee-------------
Confidence 111 1122333344 35554443 678889999999999999999885433222110 00
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
........+....++..+.+.|+..++..|+.+.++..|.=|..
T Consensus 476 ------------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 476 ------------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00011122344577889999999999999999999988876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.5e-14 Score=121.88 Aligned_cols=139 Identities=19% Similarity=0.216 Sum_probs=100.2
Q ss_pred eeeecccCceeEEEEEECC------CCcEEEEEEeCCcc----------------C----ChHHHHH----HHHHHHHHH
Q 015019 28 LEVIGKGSYGVVCAAIDTH------TGEKVAIKKIHDVF----------------E----HISDAIR----ILREVKLLR 77 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~------~~~~vaiK~~~~~~----------------~----~~~~~~~----~~~E~~~l~ 77 (414)
...||.|--+.||.|.... .+..+|||+.+-.. . ....... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 35799999874210 0 0111222 338999999
Q ss_pred hCCC--CCccccceeecCCCCCCCceEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCC
Q 015019 78 LLRH--PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLK 153 (414)
Q Consensus 78 ~l~h--pniv~l~~~~~~~~~~~~~~~~lV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~al~~L-Hs~givHrDlk 153 (414)
++.. -++...+++. .-+|||||++++ +..-......+++..+..++.|++.+|..| |+.||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9853 4555555542 238999999863 322222233566677788899999999999 89999999999
Q ss_pred CCCEEEcCCCCeEEeecCCcccc
Q 015019 154 PKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 154 p~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.|||+. ++.+.|+|||.|...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-14 Score=145.49 Aligned_cols=142 Identities=20% Similarity=0.301 Sum_probs=95.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC---------------------------h-----HHHHH--
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---------------------------I-----SDAIR-- 68 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------------------------~-----~~~~~-- 68 (414)
..|.. +.||+|++|.||+|+.+.+|+.||||+++..... . .....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 7999999999999999888999999998642100 0 01112
Q ss_pred ----HHHHHHHHHhCC----CCCccccceeecCCCCCCCceEEEEEecCCC-CHHHH--HHhCC----CCCHHHHHHHHH
Q 015019 69 ----ILREVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKAND----DLTREHHQFFLY 133 (414)
Q Consensus 69 ----~~~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~--i~~~~----~l~~~~~~~i~~ 133 (414)
+.+|...+.++. +.+.+.+-.++.. ....-+|||||+.| .+.++ +...+ .+.+..+..++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 334444444432 3333333344321 12335899999996 67653 33333 355666666777
Q ss_pred HHHHHHHHHHHCCcccCCCCCCCEEEcCCC----CeEEeecCCcccc
Q 015019 134 QMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVA 176 (414)
Q Consensus 134 qil~al~~LHs~givHrDlkp~NILl~~~~----~vkL~DFG~a~~~ 176 (414)
|++ ..|++|+|+||.||+++.+| .++++|||++...
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 765 48999999999999999988 9999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=136.08 Aligned_cols=140 Identities=19% Similarity=0.254 Sum_probs=93.0
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCChH--------------------------------------HHHHHH
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS--------------------------------------DAIRIL 70 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--------------------------------------~~~~~~ 70 (414)
+.||+|++|.||+|+.+ +|+.||||+.+......- ....+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999865 789999999753210000 001234
Q ss_pred HHHHHHHhCC----CCCccccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 015019 71 REVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLR-ALKYMH 143 (414)
Q Consensus 71 ~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~-al~~LH 143 (414)
+|...+..+. |.+-+.+-.++... ...-+|||||++| +|.+..... .... ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 4555555542 33333333333211 1235899999986 666655421 1222 2345556655 467899
Q ss_pred HCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 144 s~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..|++|+|+||.||+++.++.++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=117.23 Aligned_cols=127 Identities=18% Similarity=0.170 Sum_probs=92.4
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCcc-ccceeecCCCCCCCceEEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~~~~lV~ 106 (414)
++.|+.|.++.||++... +..|++|....... ......+|+.+++.+.+.+++ +++.... ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEE
Confidence 567899999999999754 77899998754321 122356789999888655543 3443321 1237999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV-----YHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 107 E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~gi-----vHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
|+++| ++... ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99997 44322 11123467899999999999985 9999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-11 Score=116.32 Aligned_cols=215 Identities=17% Similarity=0.205 Sum_probs=156.8
Q ss_pred CceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCC--CC
Q 015019 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SD 112 (414)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~--g~ 112 (414)
...+.|+|....+|..|++|+++-... ...-+...-+++++++.|+|||.+.++|.... -....+++|++|.. ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence 346889999999999999999942111 11112224568889999999999999998554 34457999999998 47
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 113 LHQVIKA---------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 113 L~~~i~~---------------~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
|.+..-. +...+|+.+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+++|..-|+.....
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8876521 2357889999999999999999999999999999999999999889998777665433
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCC-CCCChhhH-HHHHHHhcCCCCHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVVHQ-LDLITDLLGTPSPETI 255 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf-~~~~~~~~-~~~i~~~~~~~~~~~~ 255 (414)
.+. + |.+.+ -..-|.=.||.+++.|.||..-= ........ +..|
T Consensus 445 ~d~----------~-------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------ 490 (655)
T KOG3741|consen 445 EDP----------T-------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------ 490 (655)
T ss_pred CCC----------C-------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------
Confidence 221 0 11211 23568889999999999997331 11111111 1111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.+..|.+++++|.-+...++++ -++.+++.|
T Consensus 491 --------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1467888999999999988887 788888875
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.1e-11 Score=101.02 Aligned_cols=130 Identities=22% Similarity=0.329 Sum_probs=93.1
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEe-CCccCChHH-----HHHHHHHHHHHHhCCCCCc--cccceeecCCCCCCCc
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISD-----AIRILREVKLLRLLRHPDI--VEIKRIMLPPSKREFK 100 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~-~~~~~~~~~-----~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~~~~~~ 100 (414)
..+++|+-+.++.+.. -|..+++|.- .+...+..- ..+..+|..++..+.--.| .-++++. + .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~-----~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P-----D 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C-----C
Confidence 4678999999999944 3555777753 344443332 2356789999988854333 3344433 2 2
Q ss_pred eEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
...|+|||.+| .|.+.+... . ..+++.+-.-+.-||.+||+|+||.++||++..++ +.++|||++..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 24799999998 555577654 1 45667777777889999999999999999998775 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4e-11 Score=100.66 Aligned_cols=143 Identities=22% Similarity=0.299 Sum_probs=104.5
Q ss_pred EeeeecccCceeEEEEEECCCCcEEEEEEe-CCccCChH-----HHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHIS-----DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~-~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+..|-+|+-+.|+++. ..|+.++||.- .+...++. ...+..+|.++|.++.--.|.--.-++.+. .
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence 57788899999999994 56888888863 33333332 345677899999887644443333333222 2
Q ss_pred eEEEEEecCCC--CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC---eEEeecCCc
Q 015019 101 DIYVVFELMES--DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLA 173 (414)
Q Consensus 101 ~~~lV~E~~~g--~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~---vkL~DFG~a 173 (414)
.-.|+|||..| ++.+++.+.. .........++.+|-+.|.-||.++|+|+||..+||++.+++. +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23799999998 8888887632 3333444788999999999999999999999999999876643 589999998
Q ss_pred ccc
Q 015019 174 RVA 176 (414)
Q Consensus 174 ~~~ 176 (414)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.8e-10 Score=103.74 Aligned_cols=137 Identities=15% Similarity=0.104 Sum_probs=94.4
Q ss_pred ceeEEEEEECCCCcEEEEEEeCCccCCh---------HHHHHHHHHHHHHHhCCCCCcccc--ceeecCCCCCCCceEEE
Q 015019 36 YGVVCAAIDTHTGEKVAIKKIHDVFEHI---------SDAIRILREVKLLRLLRHPDIVEI--KRIMLPPSKREFKDIYV 104 (414)
Q Consensus 36 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~l--~~~~~~~~~~~~~~~~l 104 (414)
...|.++. -.|+.|.||......-.. .....+.+|+..+..|..-+|... +.+...........-++
T Consensus 35 ~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 35 GRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 33455653 357789999764321000 011136789998888854444333 33332211111345789
Q ss_pred EEecCCC--CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-------CCCeEEeecCCc
Q 015019 105 VFELMES--DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-------NCKLKVCDFGLA 173 (414)
Q Consensus 105 V~E~~~g--~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-------~~~vkL~DFG~a 173 (414)
|||++++ +|.+++.. ....+......++.+++..+.-||.+||+|+|+++.|||++. +..+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999996 78888764 345667788899999999999999999999999999999975 467999999977
Q ss_pred c
Q 015019 174 R 174 (414)
Q Consensus 174 ~ 174 (414)
+
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 5
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.7e-12 Score=124.30 Aligned_cols=152 Identities=25% Similarity=0.381 Sum_probs=112.7
Q ss_pred HHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccc--------cccCccccccccccccCCC
Q 015019 137 RALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--------YVATRWYRAPELCGSFFSK 207 (414)
Q Consensus 137 ~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~--------~~gt~~y~aPE~~~~~~~~ 207 (414)
.|+.|+|. .++||++|.|++|.++.++.+||+.|+++........ ..+.. ..-...|.|||++.+ ..
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~ 185 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG--TT 185 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc--cc
Confidence 89999996 4899999999999999999999999999876544222 11111 123457999999988 67
Q ss_pred CCCcchhhhHhHHHHHHH-hCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCC
Q 015019 208 YTPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286 (414)
Q Consensus 208 ~~~~~DiwSlG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 286 (414)
.++++|++|+||++|.+. .|+..+.+.........-.... .........+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---------------------------~~~~~~~s~~~p 238 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---------------------------NAGAFGYSNNLP 238 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---------------------------ccccccccccCc
Confidence 899999999999999998 5666665543221111110000 001111225789
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 287 ~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+++++=|.++|..++..||++..++..|||.+.
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 999999999999999999999999999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-10 Score=103.65 Aligned_cols=143 Identities=17% Similarity=0.265 Sum_probs=101.6
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCC--CccccceeecCCCCCCCceEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~~~~~~lV 105 (414)
.+.||.|..+.||++... +|..+++|........ .....+.+|+.+++.+.+. ++.+++.+..... ..+..++|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEE
Confidence 367899999999999764 3678999987643221 1234577899999999753 4566665542211 12356899
Q ss_pred EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 015019 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT---------------------------------------- 144 (414)
Q Consensus 106 ~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs---------------------------------------- 144 (414)
|||++| ++.+.+.. ..+++.....++.+++++|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999996 44443321 356777777778888888888874
Q ss_pred ----------------CCcccCCCCCCCEEEcC--CCCeEEeecCCccc
Q 015019 145 ----------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARV 175 (414)
Q Consensus 145 ----------------~givHrDlkp~NILl~~--~~~vkL~DFG~a~~ 175 (414)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23599999999999998 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-09 Score=100.94 Aligned_cols=259 Identities=17% Similarity=0.184 Sum_probs=162.5
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC----CCCCCc
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP----SKREFK 100 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~~~ 100 (414)
....+.||+|+-+.+|..-. -+.. +.|+....... ...+...|+ -+.-.||-+-. .+..+. +.+...
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~-VAKIYh~Pppa--~~aqk~a~l--a~~p~~p~~~~--rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQ-VAKIYHAPPPA--AQAQKVAEL--AATPDAPLLNY--RVAWPQATLHGGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecch--hhch-hheeecCCCch--HHHHHHHHh--ccCCCCcchhh--hhcccHHHhhCCCccc
Confidence 35678999999999998732 2333 45887754222 111222222 12224664432 111110 112233
Q ss_pred eEEEEEecCCC--CHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 101 DIYVVFELMES--DLHQVIK------ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 101 ~~~lV~E~~~g--~L~~~i~------~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
.+-+.|+.+.| ....++. +.....+....+..+.|+.|.+.||..|-+-+|+.++|+|+++++.|.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 47889999885 4555443 234577888899999999999999999999999999999999999999998543
Q ss_pred cccccCCCCccccccccccCcccccccccc-c-c-CCCCCCcchhhhHhHHHHHHHhC-CCCCCCCChhhHHHHHHHhcC
Q 015019 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCG-S-F-FSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~-~~~~~~~~DiwSlG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~ 248 (414)
-....+ ...+..-+|...|.+||.-. . . ...-+...|-|.||+++++|+.| +.||+|-.. ...
T Consensus 164 fqi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ 230 (637)
T COG4248 164 FQINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISD 230 (637)
T ss_pred eeeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCC
Confidence 322211 12234557999999999753 1 0 12346689999999999999997 899987431 111
Q ss_pred CCCHH--HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCC--CCCCCCHH
Q 015019 249 TPSPE--TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD--PKDRPTAE 308 (414)
Q Consensus 249 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--p~~Rpt~~ 308 (414)
.|++- .+....-..+.+ ......+.+....|.-+++.+..|..+|+..- +.-|||++
T Consensus 231 ap~p~E~~Ia~g~f~ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 231 APNPLETDIAHGRFAYASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred CCCcchhhhhcceeeechh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 22221 222211111111 22333444555556678899999999998743 55799974
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.2e-10 Score=98.52 Aligned_cols=128 Identities=22% Similarity=0.308 Sum_probs=93.0
Q ss_pred CCcEEEEEEeCCcc-----CChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCCCCCceEEEEEecCCC--CHHHHH
Q 015019 47 TGEKVAIKKIHDVF-----EHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVI 117 (414)
Q Consensus 47 ~~~~vaiK~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~~~~lV~E~~~g--~L~~~i 117 (414)
.++.+-+|...... .......+..+|...+..|..-+ ..+.+.+..... ......++|+|++++ +|.+++
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHH
Confidence 34566666543211 11133446778888888875433 334444443222 112456899999985 799998
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC---CeEEeecCCccc
Q 015019 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARV 175 (414)
Q Consensus 118 ~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~---~vkL~DFG~a~~ 175 (414)
......+......++.++...++-||++||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 8755577888899999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-10 Score=97.84 Aligned_cols=127 Identities=27% Similarity=0.293 Sum_probs=82.2
Q ss_pred eEEEEEECCCCcEEEEEEeCCc----------------cC-------C-hHHHHHHHHHHHHHHhCCCC--Cccccceee
Q 015019 38 VVCAAIDTHTGEKVAIKKIHDV----------------FE-------H-ISDAIRILREVKLLRLLRHP--DIVEIKRIM 91 (414)
Q Consensus 38 ~V~~a~~~~~~~~vaiK~~~~~----------------~~-------~-~~~~~~~~~E~~~l~~l~hp--niv~l~~~~ 91 (414)
.||.|.. ..|..+|+|+.+.. +. . ........+|.+.|..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 35779999986421 00 0 01123567899999999755 456665543
Q ss_pred cCCCCCCCceEEEEEecCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccCCCCCCCEEEcCCCCeEEe
Q 015019 92 LPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKY-MHTANVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~qil~al~~-LHs~givHrDlkp~NILl~~~~~vkL~ 168 (414)
.-+|||||++ |.....+... .++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1279999999 6333333322 12245667788888886555 589999999999999999988 89999
Q ss_pred ecCCcccc
Q 015019 169 DFGLARVA 176 (414)
Q Consensus 169 DFG~a~~~ 176 (414)
|||.|...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.7e-09 Score=95.44 Aligned_cols=137 Identities=27% Similarity=0.240 Sum_probs=100.5
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCC-------cc---------CC----hHHHHHHHHHHHHHHhCCCC--
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-------VF---------EH----ISDAIRILREVKLLRLLRHP-- 82 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-------~~---------~~----~~~~~~~~~E~~~l~~l~hp-- 82 (414)
+.++..||-|--|.||.|.+. .|..+|||.=+- .. .+ ........+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467899999999999999876 688999995220 00 00 11233567899999998644
Q ss_pred CccccceeecCCCCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC
Q 015019 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (414)
Q Consensus 83 niv~l~~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~ 162 (414)
.+.+.++. +.-.+|||+.+|-...-+ ++....+..++..|++-+..+-..||||+|+.+-||+++++
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC
Confidence 45544432 335899999998322211 22456667778888888877779999999999999999999
Q ss_pred CCeEEeecCCccc
Q 015019 163 CKLKVCDFGLARV 175 (414)
Q Consensus 163 ~~vkL~DFG~a~~ 175 (414)
|.+.++||-.+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999987754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-08 Score=89.10 Aligned_cols=141 Identities=18% Similarity=0.152 Sum_probs=101.5
Q ss_pred cccCceeEEEEEECCCCcEEEEEEeCC----ccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCCCCCceEEEE
Q 015019 32 GKGSYGVVCAAIDTHTGEKVAIKKIHD----VFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 32 g~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~~~~lV 105 (414)
|+||-|.|+..... |..+-+|.-.. ..........+.+|+..|+.|..-+ +.+.. .+.-........-+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56888889887533 44688887541 1111234456889999999986433 33333 1111111223457899
Q ss_pred EecCC--CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC--eEEeecCCccc
Q 015019 106 FELME--SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (414)
Q Consensus 106 ~E~~~--g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~--vkL~DFG~a~~ 175 (414)
+|-++ .+|.+++... .+.++.....++.++..+++-||+.|+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99888 4899888653 35678888899999999999999999999999999999987777 99999987754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.8e-08 Score=87.21 Aligned_cols=143 Identities=20% Similarity=0.251 Sum_probs=90.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHH-HH------HHHHHHHHHHhCCCCCcccc---ceee
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-AI------RILREVKLLRLLRHPDIVEI---KRIM 91 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-~~------~~~~E~~~l~~l~hpniv~l---~~~~ 91 (414)
.++|.+.+.+-......|.+. ...|..+++|........... .. ...+++..+..+...++..+ +.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 468999999988888878777 456788999987642211100 00 12244444444433333332 2222
Q ss_pred cCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeec
Q 015019 92 LPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DF 170 (414)
.-..........|||||++| .|.+... +++ .+.-.|..++.-||+.|++|+|..|.|++++.++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 21121222345689999998 5544321 232 2445677889999999999999999999998665 999999
Q ss_pred CCccc
Q 015019 171 GLARV 175 (414)
Q Consensus 171 G~a~~ 175 (414)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 86653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.4e-07 Score=83.84 Aligned_cols=138 Identities=19% Similarity=0.169 Sum_probs=96.1
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccC--------------------ChHHHH--HHHHHHHHHHhCC--CCC
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--------------------HISDAI--RILREVKLLRLLR--HPD 83 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------------------~~~~~~--~~~~E~~~l~~l~--hpn 83 (414)
...|.+|--+.||+|.. .++..||+|++..... +..... -..+|+..|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 45677888889999964 4688999999853211 111111 1347888888874 444
Q ss_pred ccccceeecCCCCCCCceEEEEEecCCCC--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEc
Q 015019 84 IVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILAN 160 (414)
Q Consensus 84 iv~l~~~~~~~~~~~~~~~~lV~E~~~g~--L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~ 160 (414)
+.+-+.+. .-.|||||++.. -.-.++ .-++...++..+..++++.+.-|-. +|+||+||+.-|||+.
T Consensus 132 vP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 132 VPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CCCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 44444443 347999999853 111111 1234444788889999999998877 9999999999999999
Q ss_pred CCCCeEEeecCCccccc
Q 015019 161 ANCKLKVCDFGLARVAF 177 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~ 177 (414)
++.+.++|||.|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 7889999999986543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.5e-07 Score=93.83 Aligned_cols=135 Identities=22% Similarity=0.348 Sum_probs=86.2
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCcc----------------------CC----------------hHHHHHHH
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----------------------EH----------------ISDAIRIL 70 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------------------~~----------------~~~~~~~~ 70 (414)
..|+.++-|.||+|+-+ +|+.||||+.+... .. ......+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 78999999999999866 49999999875211 00 00111344
Q ss_pred HHHHHHHhCC----CCCccccceeecCCCCCCCceEEEEEecCCC-CHHHH--HHhCCCCCHHH-----HHHHHHHHHHH
Q 015019 71 REVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKANDDLTREH-----HQFFLYQMLRA 138 (414)
Q Consensus 71 ~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~--i~~~~~l~~~~-----~~~i~~qil~a 138 (414)
+|...+..++ ...-+.+=.+|..- .+.-.|+|||++| .+.+. +++ ..++... +..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~-- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc----cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH--
Confidence 5666655552 22222333333221 1224899999997 45544 444 3344323 233333333
Q ss_pred HHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 139 l~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..|++|.|..|.||+++.+|.+.+.|||+....
T Consensus 283 -----~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 -----RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred -----hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 389999999999999999999999999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-08 Score=100.17 Aligned_cols=243 Identities=16% Similarity=0.132 Sum_probs=164.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC-ccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~~ 101 (414)
.-|.....+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++ +.+....
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~ 308 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDY 308 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCcccc
Confidence 45778889999999999999877766655 6665432 33445889999999999 333333 2355567
Q ss_pred EEEEEecCCCC--HHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELMESD--LHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~g~--L~~~i-~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+++++++++. ....+ .+.-.+.+-+...+.+.-+++++++|+.--+|+| ||+..+ +..|..||+.+.....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence 89999999842 22211 1222344455566677778899999999889999 777655 6799999998866533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC-HHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS-PETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~ 257 (414)
.. ..+...+|+.++|||+... ..+....|.|++|+--.+|.-|-+|-...-. ... ..|..+ ...
T Consensus 384 ~~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~----~~g~~p~s~~--- 448 (829)
T KOG0576|consen 384 TM----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLP----MIGNGPNSPM--- 448 (829)
T ss_pred cc----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCcc--ccC----CCCCCCCccc---
Confidence 32 2356679999999998877 6888999999999887788777777644210 000 001000 000
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHH-HHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA-LRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~-~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+... ...++.. .++...|+..-|..|++...++.|.+|++-
T Consensus 449 --------------------L~~~-~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 449 --------------------LTDK-SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred --------------------cchh-hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0000 0111111 247788999999999999999999999763
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-06 Score=79.06 Aligned_cols=133 Identities=17% Similarity=0.190 Sum_probs=78.4
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+.+. +..+...+||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence 56899999999984 25567888875422 2344678999998886433 34555554 2223467899
Q ss_pred ecCCCC--HHHHH---------------------HhC--CCCCHHH-HHHHHHHH----------HH-HHHHHHH----C
Q 015019 107 ELMESD--LHQVI---------------------KAN--DDLTREH-HQFFLYQM----------LR-ALKYMHT----A 145 (414)
Q Consensus 107 E~~~g~--L~~~i---------------------~~~--~~l~~~~-~~~i~~qi----------l~-al~~LHs----~ 145 (414)
|+++|. +...+ .+- ....... ...+..++ .. ...+|.+ .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999973 11111 000 0111110 01111111 11 1112221 2
Q ss_pred CcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 146 NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 146 givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.1e-07 Score=93.92 Aligned_cols=205 Identities=16% Similarity=0.205 Sum_probs=139.3
Q ss_pred HHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 015019 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147 (414)
Q Consensus 69 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~gi 147 (414)
..-|+..+....|+|++.++.+-....... -.+.+..++|.. ++...+..-+..+.+..+.+..+++.||+|+|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 445677788889999999887664332111 134566777884 888888888899999999999999999999999966
Q ss_pred ccCCCCCC---CEEEcCCCCeEEe--ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHH
Q 015019 148 YHRDLKPK---NILANANCKLKVC--DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (414)
Q Consensus 148 vHrDlkp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ 222 (414)
.|.-+..+ +--.+..+.+.+. ||+..+........ ....-+..+.+||.............|+|++|..+.
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 66555444 3334555667766 88877654322211 122334557788877663233334479999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCCh-HHHHHHHHhccCCC
Q 015019 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAFDP 301 (414)
Q Consensus 223 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~dli~~~L~~dp 301 (414)
.+..|..+-.-.. .+.. ..+..+. ...+++.+|+.-++
T Consensus 384 ~~~~~~~i~~~~~------~~~~-----------------------------------~l~~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA------VPVS-----------------------------------LLDVLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred hhhhcCccccccc------chhh-----------------------------------hhccccchhhhhhhhhhcchhh
Confidence 9988764321110 0000 0011121 67889999999999
Q ss_pred CCCCCHHHHhcCCCCCcc
Q 015019 302 KDRPTAEEALADPYFKGL 319 (414)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~ 319 (414)
++|+++.++|.|||.+..
T Consensus 423 ~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhccchhhhhhchhcccc
Confidence 999999999999998643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.2e-06 Score=76.18 Aligned_cols=139 Identities=18% Similarity=0.227 Sum_probs=79.4
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCCCCCceEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~~~~lV 105 (414)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+.... +.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997654 48999987542 45567778999988885333 44555432111 222347999
Q ss_pred EecCCC-CHHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 015019 106 FELMES-DLHQ----------------VIK---AN----DDLTREH------HQFF---------------LYQMLR-AL 139 (414)
Q Consensus 106 ~E~~~g-~L~~----------------~i~---~~----~~l~~~~------~~~i---------------~~qil~-al 139 (414)
|+++.| .+.. .+. .. ..+.... .... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999986 4444 110 11 1111100 0000 011112 23
Q ss_pred HHHHH-------CCcccCCCCCCCEEEc-CCCCeEEeecCCcc
Q 015019 140 KYMHT-------ANVYHRDLKPKNILAN-ANCKLKVCDFGLAR 174 (414)
Q Consensus 140 ~~LHs-------~givHrDlkp~NILl~-~~~~vkL~DFG~a~ 174 (414)
..+++ ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 3599999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.3e-06 Score=85.24 Aligned_cols=139 Identities=23% Similarity=0.331 Sum_probs=85.1
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh-----------------------------------HHHHHHHHH
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----------------------------------SDAIRILRE 72 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------------------------------~~~~~~~~E 72 (414)
-+.||.-+.|.|++|+-+. |+.||||+-+...... .....+.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3679999999999998775 9999999865321110 001123344
Q ss_pred HHHHHhC----CCCCc---cccceeecCCCCCCCceEEEEEecCCC----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015019 73 VKLLRLL----RHPDI---VEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQMLRALKY 141 (414)
Q Consensus 73 ~~~l~~l----~hpni---v~l~~~~~~~~~~~~~~~~lV~E~~~g----~L~~~i~~~~~l~~~~~~~i~~qil~al~~ 141 (414)
.+....+ .|-+. |.+=.++..-+ ..-.|+||||+| |+ +.|.+.+ ++...+ ...+.++...
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i---~~~l~~~~~~ 315 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDI---LNKLVEAYLE 315 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHHHH---HHHHHHHHHH
Confidence 4443333 34441 11223332221 124899999996 45 4555543 444433 3333332222
Q ss_pred -HHHCCcccCCCCCCCEEEcC----CCCeEEeecCCcccc
Q 015019 142 -MHTANVYHRDLKPKNILANA----NCKLKVCDFGLARVA 176 (414)
Q Consensus 142 -LHs~givHrDlkp~NILl~~----~~~vkL~DFG~a~~~ 176 (414)
|=..|++|.|-.|.||++.. ++.+.+.|||+....
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 33468999999999999984 678999999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.7e-06 Score=68.64 Aligned_cols=132 Identities=17% Similarity=0.231 Sum_probs=90.8
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.-.+.+.||+|.+|.||++.. .|..+|+|+-... +....+..|.++|..++-.++..=+-.+ +...
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~ 88 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF 88 (201)
T ss_pred hhhhhhhhhcccccEEEEeec--cCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence 346688999999999999965 4668999986532 3445577899999988876665432222 1135
Q ss_pred EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-CCCEEEcCCCCeEEeecCCcccc
Q 015019 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLK-PKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlk-p~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.|||..| .|.+..... . +.-+..++++---|-..||-|+.|. |..+++..++.+-|+||..|+.-
T Consensus 89 i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 66999998 666544321 2 2233445555555778899999997 55555555558999999998743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-05 Score=72.17 Aligned_cols=70 Identities=13% Similarity=0.062 Sum_probs=44.7
Q ss_pred eecccCc-eeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceEEEEEe
Q 015019 30 VIGKGSY-GVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 30 ~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
.|-.|.+ ..||++... +..+++|...... ...+.+|+.+++.+. +--+.+++..... .+.-++|||
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEE
Confidence 4556666 788999543 4678888765321 334667888888884 3334455554422 134689999
Q ss_pred cCCC
Q 015019 108 LMES 111 (414)
Q Consensus 108 ~~~g 111 (414)
+++|
T Consensus 73 ~i~G 76 (244)
T cd05150 73 AVPG 76 (244)
T ss_pred eeCC
Confidence 9987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-05 Score=70.29 Aligned_cols=132 Identities=27% Similarity=0.320 Sum_probs=90.8
Q ss_pred CCeeEeeeecccCc-eeEEEEEECCCCcEEEEEEeCCc-----------cC-Ch-------HHHHHHHHHHHHHHhC---
Q 015019 23 NRYKILEVIGKGSY-GVVCAAIDTHTGEKVAIKKIHDV-----------FE-HI-------SDAIRILREVKLLRLL--- 79 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~-----------~~-~~-------~~~~~~~~E~~~l~~l--- 79 (414)
..++.++.||.|.- |.||++. -.|..||+|.+..- +. .. .....+..|.+..-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999995 46889999994310 00 00 1223456676665544
Q ss_pred CCCCc--cccceeecCCCC-------------CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015019 80 RHPDI--VEIKRIMLPPSK-------------REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144 (414)
Q Consensus 80 ~hpni--v~l~~~~~~~~~-------------~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs 144 (414)
.+.++ +++++++.-... .......||.||....- .++.. =+.+|++-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHHHHHH
Confidence 45666 888888743310 11123468888877432 23333 34677888889999
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
.||+-+|+++.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999987 3589999964
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.7e-05 Score=77.16 Aligned_cols=176 Identities=23% Similarity=0.355 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015019 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144 (414)
Q Consensus 65 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs 144 (414)
....++...++++.+.|+|....+++-.+. .....+|||+++.+|.+.++.+. +-.... +
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~-l~~~s~-------~-------- 84 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN-LKDESL-------L-------- 84 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc-cchhhh-------c--------
Confidence 455677888999999999999887765332 23489999999999999987654 221111 1
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHH
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~l 224 (414)
+|| +-+.|+ ++.+| .++ +. | | ...++++||||+|.++.++
T Consensus 85 ---~~~-~~~~~~-------~~~td-~~~-------------t~------~--~-------~~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 85 ---AHG-VLHLNI-------IYITD-HFL-------------TK------Y--P-------SPIGPKSDVWSLGFIILEL 124 (725)
T ss_pred ---ccc-cceehh-------hhccc-ccc-------------cc------C--C-------CCCCcchhhhhHHHHHHHH
Confidence 222 111222 23333 111 00 1 1 1223599999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCC
Q 015019 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (414)
Q Consensus 225 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R 304 (414)
.-|...|......+++..|.++...+.....-... . .+. -.++....+++.+|+-..|..|
T Consensus 125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-~----~~~--------------~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAME-H----LIQ--------------LLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHH-H----HHH--------------HhhhHhHHHHhccCCccccccc
Confidence 99999998888888888777654433322111100 0 000 1245667889999999999999
Q ss_pred CCHHHHhcCCCCCcc
Q 015019 305 PTAEEALADPYFKGL 319 (414)
Q Consensus 305 pt~~~lL~hp~~~~~ 319 (414)
|...++.+|+-|...
T Consensus 186 ~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 186 PLPMELSKRCSFTEV 200 (725)
T ss_pred cchhHHhcCccHHHH
Confidence 999999999999765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.4e-05 Score=81.89 Aligned_cols=147 Identities=16% Similarity=0.308 Sum_probs=88.7
Q ss_pred EeeeecccCceeEEEEEECCCC--cEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCc--cccceeecCCCCCCCce
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTG--EKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDI--VEIKRIMLPPSKREFKD 101 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~~~~~~~~ 101 (414)
-+..++.|.++.+|+......+ ..+++|+..... .......+.+|+.+|+.+. |.++ .+++.++.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3677899999999998765432 467888754321 1122346779999999995 6664 5555554332 12345
Q ss_pred EEEEEecCCCCH-HH--------------------HH---HhCC----C---------CCHHHHHHHHHH----------
Q 015019 102 IYVVFELMESDL-HQ--------------------VI---KAND----D---------LTREHHQFFLYQ---------- 134 (414)
Q Consensus 102 ~~lV~E~~~g~L-~~--------------------~i---~~~~----~---------l~~~~~~~i~~q---------- 134 (414)
.|+||||++|.. .+ .+ ..-. . ....++..|..|
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999998742 10 11 1100 0 111233332222
Q ss_pred -----HHHHHHHHHH-----------CCcccCCCCCCCEEEcCC-CC-eEEeecCCcccc
Q 015019 135 -----MLRALKYMHT-----------ANVYHRDLKPKNILANAN-CK-LKVCDFGLARVA 176 (414)
Q Consensus 135 -----il~al~~LHs-----------~givHrDlkp~NILl~~~-~~-vkL~DFG~a~~~ 176 (414)
+...+.+|.. ..+||+|++|.|||++.+ +. +-|.||+++...
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 1223455532 249999999999999853 34 579999998764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.2e-06 Score=92.37 Aligned_cols=212 Identities=17% Similarity=0.104 Sum_probs=142.2
Q ss_pred HHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH
Q 015019 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMH 143 (414)
Q Consensus 69 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~al~~LH 143 (414)
.+.|..-++...|+++.....-..+. +....|.+++|+. |.++++|-+. ..+.+.-+-....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 34455556667899887665544332 2334689999998 7999988653 24444445555555577888888
Q ss_pred HCC-----cccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHh
Q 015019 144 TAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218 (414)
Q Consensus 144 s~g-----ivHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG 218 (414)
+.. .+|++||+-|.+|..+..+|++++|+.+... +...+....++++.|++|++... -.++.++|+|..|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn---p~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN---PVLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRS 1427 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccC---chHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHH
Confidence 752 7999999999999999999999999998432 22233455678899999999877 6788889999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhcc
Q 015019 219 CIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298 (414)
Q Consensus 219 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 298 (414)
+-+|.+..|.++|-. +++.+.+ |.-. .. .+.....-.|.++-.....+|-
T Consensus 1428 ~~ly~rs~~n~~fi~-----flq~~Lk--giid--------------------n~---tf~sIe~l~pgdaNve~~~~Ll 1477 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIF-----FLQPALK--GIID--------------------NH---TFFSIEKLKPGDANVEALHRLL 1477 (2724)
T ss_pred HHHHHHhcccHHHHH-----HHHHHHc--Cccc--------------------cc---ccccccccCCCcccHHHHHHHH
Confidence 999999999887721 1111111 1000 00 0000111123344455666666
Q ss_pred CCCCCCCCHHHHhcCCCCCc
Q 015019 299 FDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 299 ~dp~~Rpt~~~lL~hp~~~~ 318 (414)
+....||.-...+.-+.|..
T Consensus 1478 ~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1478 WKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHhhhcchhhhhcccccccc
Confidence 77778999888888877743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.9e-05 Score=70.43 Aligned_cols=31 Identities=35% Similarity=0.489 Sum_probs=25.8
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+++|+|+.|.||+++.++..-|+||+.|..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998765567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00017 Score=63.22 Aligned_cols=129 Identities=19% Similarity=0.235 Sum_probs=87.2
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCcc--------------CChHHHHHHHHHHHHHHhCC------CCCcccc
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--------------EHISDAIRILREVKLLRLLR------HPDIVEI 87 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------hpniv~l 87 (414)
...||+|+.=.||.- ..+ ....||+..... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999888876 433 345688886533 11122345566776665555 7889999
Q ss_pred ceeecCCCCCCCceEEEEEecCC---C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 88 KRIMLPPSKREFKDIYVVFELME---S----DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~~lV~E~~~---g----~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
++...+ ...+.+|+|... | +|.+++.. +.+++ .. ...+-+-..||-+.+|+.+||+|.||++.
T Consensus 83 ~G~veT-----~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVET-----NLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEec-----CCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence 999843 345788888863 2 68888854 45665 33 33344455688999999999999999986
Q ss_pred CC--C--CeEEee
Q 015019 161 AN--C--KLKVCD 169 (414)
Q Consensus 161 ~~--~--~vkL~D 169 (414)
.+ + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 43 2 477887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00033 Score=63.39 Aligned_cols=72 Identities=13% Similarity=0.229 Sum_probs=44.2
Q ss_pred eeeecccCceeEEEEEECC-CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCCCCCceEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVV 105 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~~~lV 105 (414)
++.|..|-...||++.... .+..|++|+...... ......+|+.+++.+...++ .+++... .. .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEE
Confidence 5678888888999996433 356888997653211 11123468888888854333 3333322 11 379
Q ss_pred EecCCC
Q 015019 106 FELMES 111 (414)
Q Consensus 106 ~E~~~g 111 (414)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00029 Score=66.68 Aligned_cols=150 Identities=15% Similarity=0.117 Sum_probs=83.3
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP- 94 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~- 94 (414)
.++. +...-++.++.|....||++.. ++..+++|+..... ....+..|+.++..|...+ +.+++......
T Consensus 18 ~y~~-~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~ 90 (307)
T TIGR00938 18 GYDL-GELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQ 90 (307)
T ss_pred hcCC-CCceeccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCe
Confidence 3444 3455577888888889999853 23467888765421 1234456777777774322 33333211000
Q ss_pred CCCCCceEEEEEecCCCC-H-----H------HHH---Hh-CCCC--------CHHHH-----H----------HHHHHH
Q 015019 95 SKREFKDIYVVFELMESD-L-----H------QVI---KA-NDDL--------TREHH-----Q----------FFLYQM 135 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~g~-L-----~------~~i---~~-~~~l--------~~~~~-----~----------~i~~qi 135 (414)
.....+..+++++|++|. + . ..+ .. ...+ ..... . .....+
T Consensus 91 ~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l 170 (307)
T TIGR00938 91 LSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAEL 170 (307)
T ss_pred ehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHH
Confidence 001234578999998762 1 1 111 00 0011 00100 0 001122
Q ss_pred HHHHHHHHH-------CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 136 LRALKYMHT-------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 136 l~al~~LHs-------~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
...++++.. .++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 334555532 589999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00017 Score=66.26 Aligned_cols=132 Identities=17% Similarity=0.253 Sum_probs=74.3
Q ss_pred eecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCCCCCceEEEEEec
Q 015019 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVFEL 108 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~~~lV~E~ 108 (414)
.+..|-.+.+|+.. .++..+++|......... .....+|..+++.+...++ .+++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence 35667788999885 456788888754321111 0124578888888864333 2333222 1 2689999
Q ss_pred CCCC-HH--------------HHHH---hC----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCcc
Q 015019 109 MESD-LH--------------QVIK---AN----DDLTR-EHHQFFLYQM---------LRALKYMHT--------ANVY 148 (414)
Q Consensus 109 ~~g~-L~--------------~~i~---~~----~~l~~-~~~~~i~~qi---------l~al~~LHs--------~giv 148 (414)
++|. +. +.+. +- .+++. ..+..+..++ ...+..+-+ ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 9862 21 1111 11 11121 1222222222 111222222 2489
Q ss_pred cCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 149 HRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 149 HrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
|+|+.|.||+++.++ +.|+||..|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999887 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00085 Score=65.26 Aligned_cols=77 Identities=19% Similarity=0.159 Sum_probs=51.5
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCcc----C-ChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCCCCC
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----E-HISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~-~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~ 99 (414)
.+.||.|.+..||++.+...++.|+||.-.... . ......+...|...|+.+. -.++.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------E 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------C
Confidence 578999999999999886444689999843110 1 0124456777888888763 23456665542 1
Q ss_pred ceEEEEEecCCC
Q 015019 100 KDIYVVFELMES 111 (414)
Q Consensus 100 ~~~~lV~E~~~g 111 (414)
..-++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 235899999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00014 Score=63.43 Aligned_cols=96 Identities=22% Similarity=0.243 Sum_probs=76.5
Q ss_pred HHHHHHHhCCC-CCccccceeecCCCCCCCceEEEEEecCC-CCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 015019 71 REVKLLRLLRH-PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQV---IKANDDLTREHHQFFLYQMLRALKYMHT- 144 (414)
Q Consensus 71 ~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~---i~~~~~l~~~~~~~i~~qil~al~~LHs- 144 (414)
.|.-+|+.+.+ +++.+++|.+ + -++|+||.+ +++... +..--..++.....|+.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 58888888875 6899999988 1 267889988 455421 1112246889999999999999999988
Q ss_pred --CCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 145 --ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 145 --~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..+.-.|++|+|+-++++|++|++|...+..
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3488899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.001 Score=63.26 Aligned_cols=30 Identities=30% Similarity=0.296 Sum_probs=25.9
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.|+||+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999976556899999774
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00043 Score=65.05 Aligned_cols=143 Identities=13% Similarity=0.029 Sum_probs=81.4
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCC-CCCCCce
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP-SKREFKD 101 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~-~~~~~~~ 101 (414)
..-++.|..|....+|++.. .+..+++|+... .....+..|+.++..+.+.+ +.+++...... .....+.
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 33467788888889999853 345788998753 12345667888888875333 33333211000 0012245
Q ss_pred EEEEEecCCCCHH------------HHH---Hh-CCCCC--------HHHHH------------HHHHHHHHHHHHHHH-
Q 015019 102 IYVVFELMESDLH------------QVI---KA-NDDLT--------REHHQ------------FFLYQMLRALKYMHT- 144 (414)
Q Consensus 102 ~~lV~E~~~g~L~------------~~i---~~-~~~l~--------~~~~~------------~i~~qil~al~~LHs- 144 (414)
.++|+++++|... ..+ .. ...+. ..... .....+..++.++.+
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 6899999986211 111 00 00000 00000 011112334445443
Q ss_pred ------CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 145 ------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 145 ------~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00084 Score=63.28 Aligned_cols=142 Identities=22% Similarity=0.285 Sum_probs=96.4
Q ss_pred eEeeeecccCceeEEEEEECCCCcEEEEEEeCCc----------------c------CChHHHHHH--HHHHHHHHhCCC
Q 015019 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV----------------F------EHISDAIRI--LREVKLLRLLRH 81 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----------------~------~~~~~~~~~--~~E~~~l~~l~h 81 (414)
.|-..|..|--+.||-|. ..+|..+|||+++-. | .+.....++ ..|++.|++++.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 455678889999999996 457888999987521 0 112222333 357777888876
Q ss_pred CCccccceeecCCCCCCCceEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCCEEE
Q 015019 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILA 159 (414)
Q Consensus 82 pniv~l~~~~~~~~~~~~~~~~lV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~al~~L-Hs~givHrDlkp~NILl 159 (414)
-.|...--+.+ ..-.|||++++++ ...=....-.++...+..+-.|++.-+.-| |.+++||.||.--|+|+
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 55543322221 1237999999943 211112234688888888888888888776 66799999999999998
Q ss_pred cCCCCeEEeecCCcccc
Q 015019 160 NANCKLKVCDFGLARVA 176 (414)
Q Consensus 160 ~~~~~vkL~DFG~a~~~ 176 (414)
.+ |.+.|+|.+.+.-.
T Consensus 299 hd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVEH 314 (520)
T ss_pred EC-CEEEEEEccccccC
Confidence 65 57999999977543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0015 Score=61.43 Aligned_cols=79 Identities=15% Similarity=0.130 Sum_probs=51.9
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC---CCccccceeecCCCCCCCce
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH---PDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~~~~~~~~ 101 (414)
-.-.+.||.|..+.||..... +..+++|..+. . .....+.+|...|+.+.- -.+.++++++... ...+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS--QGNPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcC--CCCEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCC
Confidence 344678999999999999532 23466776432 1 122467789999988853 3566666655332 12244
Q ss_pred EEEEEecCCC
Q 015019 102 IYVVFELMES 111 (414)
Q Consensus 102 ~~lV~E~~~g 111 (414)
-++|||+++|
T Consensus 88 ~~LVmE~i~G 97 (297)
T PRK10593 88 DVLLLERLRG 97 (297)
T ss_pred eEEEEeccCC
Confidence 7999999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00094 Score=62.98 Aligned_cols=29 Identities=38% Similarity=0.406 Sum_probs=26.1
Q ss_pred CcccCCCCCCCEEEcCC----CCeEEeecCCcc
Q 015019 146 NVYHRDLKPKNILANAN----CKLKVCDFGLAR 174 (414)
Q Consensus 146 givHrDlkp~NILl~~~----~~vkL~DFG~a~ 174 (414)
+++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0003 Score=65.17 Aligned_cols=136 Identities=18% Similarity=0.213 Sum_probs=94.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCC---cc--------------CChH---HHHHHHHHHHHHHhCC-CC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD---VF--------------EHIS---DAIRILREVKLLRLLR-HP 82 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~~--------------~~~~---~~~~~~~E~~~l~~l~-hp 82 (414)
=|.++..||-|--+-||.+-+. .|++.++|.=.. .| ...+ ......+|+..|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678999999999999999765 578888884210 00 0000 1123567999998885 32
Q ss_pred C-ccccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 83 D-IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 83 n-iv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
. +.+.++ .+.-++|||++.| .|.++-.- ..+..+...+..-+.-|-..|+||+|..-=||++.
T Consensus 172 fpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPID---------HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCccc---------ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 2 333332 3346899999986 45443321 12344556666777788999999999999999999
Q ss_pred CCCCeEEeecCCccc
Q 015019 161 ANCKLKVCDFGLARV 175 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~ 175 (414)
+++.++++||-.+..
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999987654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0053 Score=58.61 Aligned_cols=81 Identities=16% Similarity=0.053 Sum_probs=50.9
Q ss_pred eecccCceeEEEEEECCCCcEEEEEEeC----Cc-cCChHHHHHHHHHHHHHHhCC--CC-CccccceeecCCCCCCCce
Q 015019 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH----DV-FEHISDAIRILREVKLLRLLR--HP-DIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~----~~-~~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~~~~ 101 (414)
.||.|....||++.+...++.|+||.-. .. ....-...+..-|...|+... .| .+.+++.+- ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence 5899999999999976444689999742 11 122344556777888887763 34 344444321 123
Q ss_pred EEEEEecCCC--CHHHHH
Q 015019 102 IYVVFELMES--DLHQVI 117 (414)
Q Consensus 102 ~~lV~E~~~g--~L~~~i 117 (414)
..+|||+++. .|.+.+
T Consensus 75 ~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ceehHhhCccchHHHHHH
Confidence 4699999863 444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0041 Score=57.78 Aligned_cols=30 Identities=30% Similarity=0.517 Sum_probs=25.4
Q ss_pred CcccCCCCCCCEEEcCCCC-eEEeecCCccc
Q 015019 146 NVYHRDLKPKNILANANCK-LKVCDFGLARV 175 (414)
Q Consensus 146 givHrDlkp~NILl~~~~~-vkL~DFG~a~~ 175 (414)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.011 Score=55.50 Aligned_cols=146 Identities=18% Similarity=0.217 Sum_probs=81.2
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCCCCCceE
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~~~ 102 (414)
-.++..+-.|....+|...+. ++.+++. ..........+....+|+.+++.+.--- +...++++.... ....
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~p 100 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTP 100 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCc
Confidence 345555544544555666443 7778877 3322233445566778888888774322 223333332211 3467
Q ss_pred EEEEecCCCC-H------------------HHHHHh-------C-------CCCCHHHHHHHHHHH--------------
Q 015019 103 YVVFELMESD-L------------------HQVIKA-------N-------DDLTREHHQFFLYQM-------------- 135 (414)
Q Consensus 103 ~lV~E~~~g~-L------------------~~~i~~-------~-------~~l~~~~~~~i~~qi-------------- 135 (414)
|.||++++|. + .+.+.. . +.....++..+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9999999871 1 111110 0 001112222222222
Q ss_pred HHHHHHHHHC--------CcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 136 LRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 136 l~al~~LHs~--------givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..-..+|+.. .++|+|+.+.||+++.++.+=|.||+++...
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1222334332 3799999999999999988999999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.011 Score=55.89 Aligned_cols=29 Identities=28% Similarity=0.384 Sum_probs=25.5
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.008 Score=58.12 Aligned_cols=83 Identities=20% Similarity=0.183 Sum_probs=54.1
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeC----CccCChHHHHHHHHHHHHHHhCC--CCC-ccccceeecCCCCCCCc
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLLR--HPD-IVEIKRIMLPPSKREFK 100 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~~~~~~~ 100 (414)
++.||-|.-..||++.+...++.|+||.-. ......-...|..-|...|+... .|. +.+++.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-------D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-------DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-------CcH
Confidence 778999999999999875445679999632 11122345667788888888764 343 4444432 122
Q ss_pred eEEEEEecCCC--CHHHHH
Q 015019 101 DIYVVFELMES--DLHQVI 117 (414)
Q Consensus 101 ~~~lV~E~~~g--~L~~~i 117 (414)
...+|||+++. .|.+.+
T Consensus 107 ~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 107 MNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred HhhHHHHhCcccHHHHHHH
Confidence 35789999863 444444
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.021 Score=55.53 Aligned_cols=76 Identities=14% Similarity=0.156 Sum_probs=49.5
Q ss_pred EeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-----ChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCCCC
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-----HISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~ 98 (414)
..+.||.|....||++.+. +..|+||.-..... ..-...+...|...|+.+. ...+.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 4788999999999999763 45688997541111 0113455666777777664 236666766652
Q ss_pred CceEEEEEecCCC
Q 015019 99 FKDIYVVFELMES 111 (414)
Q Consensus 99 ~~~~~lV~E~~~g 111 (414)
..-++|||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 224788999975
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.013 Score=55.46 Aligned_cols=30 Identities=17% Similarity=0.118 Sum_probs=27.7
Q ss_pred CcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 146 NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 146 givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
++||+|+.+.|||++.++.+-++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.018 Score=55.34 Aligned_cols=139 Identities=14% Similarity=0.151 Sum_probs=76.4
Q ss_pred CCeeEeeeecccCceeEEEEEECC----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~ 97 (414)
.... +..|-.|-...+|++.... +++.|++|+...... ....-.+|+.+++.+..-++ .++++.+ .
T Consensus 37 ~~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~ 107 (344)
T PLN02236 37 EALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFDRDDEIRTFECMSRHGQGPRLLGRF-----P 107 (344)
T ss_pred CcEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeechHHHHHHHHHHHHcCCCCceEEEE-----C
Confidence 3444 4456568888999986322 346899998754211 11122468888888854333 3444444 1
Q ss_pred CCceEEEEEecCCC-CHH-----------HH---HH---hCC------CCCHHHHHHHHHHHH-----------------
Q 015019 98 EFKDIYVVFELMES-DLH-----------QV---IK---AND------DLTREHHQFFLYQML----------------- 136 (414)
Q Consensus 98 ~~~~~~lV~E~~~g-~L~-----------~~---i~---~~~------~l~~~~~~~i~~qil----------------- 136 (414)
. ..|.+|++| .+. .+ +. +.. ....+.+..++.++.
T Consensus 108 ~----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 108 N----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred C----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 1 157788764 221 11 11 100 111233333332221
Q ss_pred HHHHHH----H----HCCcccCCCCCCCEEEcC-CCCeEEeecCCcc
Q 015019 137 RALKYM----H----TANVYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (414)
Q Consensus 137 ~al~~L----H----s~givHrDlkp~NILl~~-~~~vkL~DFG~a~ 174 (414)
..+..| . ...++|+|+++.|||++. ++.+.|+||..|.
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111112 1 225899999999999986 4789999999774
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.022 Score=54.50 Aligned_cols=28 Identities=32% Similarity=0.433 Sum_probs=24.8
Q ss_pred cccCCCCCCCEEEcC-CCCeEEeecCCcc
Q 015019 147 VYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (414)
Q Consensus 147 ivHrDlkp~NILl~~-~~~vkL~DFG~a~ 174 (414)
++|.|+.+.|||+++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999773
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.016 Score=54.89 Aligned_cols=75 Identities=21% Similarity=0.359 Sum_probs=59.1
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+..+.|++|++-++.+.-+ ..-..+++..|+++-+..++-+..+ ..-|||+...||||+ +|.|.|+||-+||.
T Consensus 296 de~~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CCceEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34457889999988766422 1234577788888888777777665 689999999999999 99999999999985
Q ss_pred c
Q 015019 176 A 176 (414)
Q Consensus 176 ~ 176 (414)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.065 Score=50.01 Aligned_cols=74 Identities=15% Similarity=0.123 Sum_probs=43.2
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCCCCCce
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~~ 101 (414)
-+-.+.++.|....+|+.. .++..+.||+-.. .....+..|..-|+.|. --.+.+.+.+.... +.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SC
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CC
Confidence 4557889999999999985 6788899998653 22234667888888773 23455666654322 22
Q ss_pred EEEEEecCC
Q 015019 102 IYVVFELME 110 (414)
Q Consensus 102 ~~lV~E~~~ 110 (414)
-||||||++
T Consensus 87 ~fLlle~l~ 95 (288)
T PF03881_consen 87 AFLLLEFLE 95 (288)
T ss_dssp CEEEEE---
T ss_pred ceEEEEeec
Confidence 499999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.092 Score=50.62 Aligned_cols=60 Identities=20% Similarity=0.184 Sum_probs=40.9
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccCCCCCCCEEEcCC
Q 015019 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY-MHTANVYHRDLKPKNILANAN 162 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~-LHs~givHrDlkp~NILl~~~ 162 (414)
..||-+|+.| ++...++. ...+++-.+.+..--..|+-- |--.+++|.|+.|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4577777777 67766654 345555666666655555544 345689999999999998543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.093 Score=51.10 Aligned_cols=29 Identities=31% Similarity=0.315 Sum_probs=24.0
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
...+|.|+-+.|||.+++ .+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 457999999999997654 59999998663
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.03 Score=52.23 Aligned_cols=136 Identities=21% Similarity=0.272 Sum_probs=90.3
Q ss_pred eEeeeecccCceeEEEEEE-------CC---CCcEEEEEEeCCc--------------------c--CChHHHHHHHH--
Q 015019 26 KILEVIGKGSYGVVCAAID-------TH---TGEKVAIKKIHDV--------------------F--EHISDAIRILR-- 71 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~-------~~---~~~~vaiK~~~~~--------------------~--~~~~~~~~~~~-- 71 (414)
.|-.+|..|.-++|+-|.- .. ..+.+|||+++-. | .+.....++..
T Consensus 255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk 334 (531)
T KOG2269|consen 255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK 334 (531)
T ss_pred hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence 3456788888888888742 11 2356899986411 0 12222333333
Q ss_pred HHHHHHhC-----CCCCccccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HH
Q 015019 72 EVKLLRLL-----RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HT 144 (414)
Q Consensus 72 E~~~l~~l-----~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~L-Hs 144 (414)
|...|.++ .+|-+|.+.. -.|||-+++. .+..=-.++-.++.++.+....|++.++.-| |.
T Consensus 335 EmhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~E 402 (531)
T KOG2269|consen 335 EMHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKE 402 (531)
T ss_pred HHHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHh
Confidence 44444444 3566655433 2689999883 2221112234689999999999999999887 77
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
+-+||-|+.--|+|...+ .+-++|...+.
T Consensus 403 c~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 403 CLLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred hheeecchhhhhheecCC-ceEEEechhcc
Confidence 889999999999999887 89999987664
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.046 Score=51.09 Aligned_cols=61 Identities=23% Similarity=0.244 Sum_probs=37.8
Q ss_pred eEEEEEecCCCC-----HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCCCCEEEcC
Q 015019 101 DIYVVFELMESD-----LHQVIKANDDLTREHHQFFLYQMLRALKYMH----TANVYHRDLKPKNILANA 161 (414)
Q Consensus 101 ~~~lV~E~~~g~-----L~~~i~~~~~l~~~~~~~i~~qil~al~~LH----s~givHrDlkp~NILl~~ 161 (414)
.-.+|++++..+ +....+.+-.--.+-++.++.||+.-.-.+- -.+.+|-||||+|||+-+
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 346888886532 2222222222234567888899876553332 236999999999999743
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.12 Score=45.68 Aligned_cols=99 Identities=19% Similarity=0.225 Sum_probs=61.5
Q ss_pred EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCCC--CHHHHHHhCCCCCHHH
Q 015019 50 KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREH 127 (414)
Q Consensus 50 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~g--~L~~~i~~~~~l~~~~ 127 (414)
...+|++....... ...-+..+.+++.++. .|+++.. +..-.+-++.|.|.. .+.
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~------------- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINF------------- 143 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccch-------------
Confidence 34456654321111 2233456777776543 4555542 233457799999973 111
Q ss_pred HHHHHHHHHHHHHHHHHC--CcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 128 HQFFLYQMLRALKYMHTA--NVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 128 ~~~i~~qil~al~~LHs~--givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
..++.-=+.+|.-.|+. +.+|+|-.|+||+-+..|.+||.|-+.
T Consensus 144 -~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 144 -SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 01111224567778854 699999999999999999999999774
|
The function of this family is unknown. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.13 Score=50.60 Aligned_cols=29 Identities=24% Similarity=0.326 Sum_probs=23.2
Q ss_pred cccCCCCCCCEEEcCCCC-----eEEeecCCccc
Q 015019 147 VYHRDLKPKNILANANCK-----LKVCDFGLARV 175 (414)
Q Consensus 147 ivHrDlkp~NILl~~~~~-----vkL~DFG~a~~ 175 (414)
++|+||...|||.+.++. ..|+||-.+..
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 799999999999987543 46888877654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.77 Score=41.05 Aligned_cols=67 Identities=16% Similarity=0.230 Sum_probs=40.2
Q ss_pred eeEEEEEECCCC-cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEEecCC
Q 015019 37 GVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME 110 (414)
Q Consensus 37 g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~ 110 (414)
|.|..|....+| ..|.+|+-. ......+..|+.-|+.+.-.|-+.+-.++... ....+.|+||||++
T Consensus 27 G~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~L~ 94 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEYLP 94 (286)
T ss_pred ccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEeecc
Confidence 444444444444 468888733 24455677888888877544433333333222 35567999999987
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.026 Score=48.85 Aligned_cols=28 Identities=25% Similarity=0.382 Sum_probs=25.2
Q ss_pred cccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 147 VYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 147 ivHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998887 99999998854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 414 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-89 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-89 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-82 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-82 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-82 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-82 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-82 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-82 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-82 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-82 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-82 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-82 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-82 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-82 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-82 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-81 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-81 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-81 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-81 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-81 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-80 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-80 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-80 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-80 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-79 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-78 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-77 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-76 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-76 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-74 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-74 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-74 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-74 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-74 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-74 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-74 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-74 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-74 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-74 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-74 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-74 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-74 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-74 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-74 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-74 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-74 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-74 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-74 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-74 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-74 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-74 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-74 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-74 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-74 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-74 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-74 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-74 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-74 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-74 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-74 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-74 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-74 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-74 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-74 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-74 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-74 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-74 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-74 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-74 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-74 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-74 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-73 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-73 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-73 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-73 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-73 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-73 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-73 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-73 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-73 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-73 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-73 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-73 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-73 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-73 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-72 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-72 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-71 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-71 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-70 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-66 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-66 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-66 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-65 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-62 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-57 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-57 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-56 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-56 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-55 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-55 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-55 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-55 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-55 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-55 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-55 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-55 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-55 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-55 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-54 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-54 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-54 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-54 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-54 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-54 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-54 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-54 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-54 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-54 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-54 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-54 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-53 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-53 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-53 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-53 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-53 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-53 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-53 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-53 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-52 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-51 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-51 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-48 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-48 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-46 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-45 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-43 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-43 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-43 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-43 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-43 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-43 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-43 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-43 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-43 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-43 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-43 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-43 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-43 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-43 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-43 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-43 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-43 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-43 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-43 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-43 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-43 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-43 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-43 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-43 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-43 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-42 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-42 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-42 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-42 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-40 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-39 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-39 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-39 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-39 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-39 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-39 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-39 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-39 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-39 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-39 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-39 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-39 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-39 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-38 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-38 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-38 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-38 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-38 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-38 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-38 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-38 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-38 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-38 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-38 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-38 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-37 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-36 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-36 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-36 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-36 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-34 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-30 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-24 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-24 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-23 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-22 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-22 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-21 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-21 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-21 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-21 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 7e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 557 bits (1436), Expect = 0.0
Identities = 134/426 (31%), Positives = 214/426 (50%), Gaps = 52/426 (12%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M ++ +F + + Y I +IG+GSYG V A D +T + VAIKK++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI 117
+FE + D RILRE+ +L L+ I+ + +++P +F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K LT EH + LY +L ++H + + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 SDTPMTV-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
S+ + T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAEVLTG-----------KPLFPG-----------------KSVVHQLDLITDLLGTP 250
CIFAE+L PLFPG KS QL++I +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ + + + + KY+ + P+ L QK+P++ + LL+ ++ F+P R T ++A
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYING 370
L PY K + K + E L F+ + +++ +R + +E+ +HP+L+ +
Sbjct: 360 LDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFT 418
Query: 371 TEGTNF 376
NF
Sbjct: 419 IHENNF 424
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 551 bits (1422), Expect = 0.0
Identities = 156/362 (43%), Positives = 219/362 (60%), Gaps = 5/362 (1%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + RY L IG+G+YG+VC+A D +VAIKKI FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
H + R LRE+K+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L+ +H +FLYQ+LR LKY+H+ANV HRDLKP N+L N C LK+CDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
I +LG+PS E + + N KAR YL + K VP + FPN D AL LL +++ F+P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 302 KDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
R E+ALA PY + EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQP 360
Query: 362 QL 363
Sbjct: 361 GY 362
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 550 bits (1419), Expect = 0.0
Identities = 148/351 (42%), Positives = 220/351 (62%), Gaps = 13/351 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
Y ++ +++ ++G+G+YGVVC+A TGE VAIKKI + F+ A+R LRE+K+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKIL 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +H +I+ I I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDY 189
RA+K +H +NV HRDLKP N+L N+NC LKVCDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG+ HQL LI ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 250 PSPE-TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P + + + + +AR+Y+ + P PL + FP V+P + LLQR++ FDP R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEF--ERRRVTKDDIRELIYREIL 357
EAL PY + EP +PI FEF + +T D+++LI+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 531 bits (1370), Expect = 0.0
Identities = 120/368 (32%), Positives = 183/368 (49%), Gaps = 21/368 (5%)
Query: 5 QTKKELKDKDFF-TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD----- 58
Q K E +D + + Y + I GSYG VCA +D+ G VAIK++ +
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDG 61
Query: 59 ----VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH 114
+ R+LRE++LL HP+I+ ++ I + + +Y+V ELM +DL
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 115 QVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI ++ +H Q+F+Y +L L +H A V HRDL P NIL N + +CDF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R +D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 182 REDTADANK----THYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRL 292
+ +QL+ I +++GTP E + + + AR YL P P DP+AL L
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 293 LQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
+ +++ F+P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIF 353
Query: 353 YREILEYH 360
E+ ++
Sbjct: 354 TAEVERFN 361
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 530 bits (1367), Expect = 0.0
Identities = 136/385 (35%), Positives = 213/385 (55%), Gaps = 43/385 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y++++ +GKG+YG+V +ID TGE VA+KKI D F++ +DA R RE+ +L L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + +D+Y+VF+ ME+DLH VI+AN L H Q+ +YQ+++ +KY+
Sbjct: 70 NIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYL 125
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV------------------AFSDTPMTV 184
H+ + HRD+KP NIL NA C +KV DFGL+R +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG S ++QL+ I
Sbjct: 186 ILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF----------------PNVDP 287
++ PS E + +++ A+ + +++K + K + +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
AL LL +L+ F+P R +A +AL P+ EP+C I + + + + DD
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDD 362
Query: 348 IRELIYREILEYHPQLLKDYINGTE 372
R L+Y EI +L+ + +
Sbjct: 363 YRNLVYSEISRRKRELISNKHQNVQ 387
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = 0.0
Identities = 132/341 (38%), Positives = 203/341 (59%), Gaps = 12/341 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 83 DIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P + +F D Y+V M +DL +++K L + QF +YQML+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E + ++++
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+A+ Y+ + + N PLA+ LL++++ D + R TA EALA PYF+ L
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
E EP Q + F+ T D+ + + Y+E+L + P
Sbjct: 317 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPP 354
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 530 bits (1366), Expect = 0.0
Identities = 145/417 (34%), Positives = 207/417 (49%), Gaps = 57/417 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
Q +K +++ +RY+I +IG GSYG VC A D VAIKKI VFE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
+ D RILRE+ +L L H +V++ I++P +F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA----- 176
LT H + LY +L +KY+H+A + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAEVLT-----------GKPLFPGKSVV--------------------HQLDLITDL 246
GCIFAE+L PLFPG S QL++I ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTPS E I + E A++Y+ K+ L ++FP A+ LL+R++ F+P R T
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
E LA P+FK + E E + +L F + + + +R +EI YHP++
Sbjct: 391 INECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 525 bits (1354), Expect = 0.0
Identities = 131/340 (38%), Positives = 195/340 (57%), Gaps = 12/340 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +G G+YG VC+AID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P S R F D Y+V M++DL +++ + E Q+ +YQML+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A V HRDLKP N+ N +C+LK+ DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S+ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P E + + ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
A+ Y+ + + P Q FP P A LL++++ D R TA +AL P+F+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E Q + E ++T D+ ++ IY+EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 523 bits (1348), Expect = 0.0
Identities = 142/372 (38%), Positives = 210/372 (56%), Gaps = 18/372 (4%)
Query: 1 MQQDQTKKELKDKDFF------TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
M + F+ T + RY+ L +G G+YG VCAA DT TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F+ I A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ ++K LT +H QF +YQ+LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R T YVATRWYRAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ QL LI L+GTP E + + +E AR Y+ + + P + F +PLA+ LL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIY 353
++++ D R TA +ALA YF + EP P + E R + D+ + L Y
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTY 349
Query: 354 REILEYHPQLLK 365
E++ + P L
Sbjct: 350 DEVISFVPPPLD 361
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 512 bits (1320), Expect = 0.0
Identities = 127/400 (31%), Positives = 203/400 (50%), Gaps = 29/400 (7%)
Query: 1 MQQDQTKKELKDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
+ K D F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F++ + A R RE+ L++ + H +I+ + + P E F+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI+ +L E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R A + T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTAGTSF----MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-------- 285
+ + Q + + + LGTP PE + + R Y+ K + + FP+
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 286 ----DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERR 341
A LL +++ DP R + ++AL PY P + + + R
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDER 383
Query: 342 RVTKDDIRELIYREILEYHPQLLKDYINGTEGTNFLYPSA 381
T ++ +ELIY+E++ + + G + ++
Sbjct: 384 EHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNS 423
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 504 bits (1301), Expect = e-180
Identities = 122/353 (34%), Positives = 188/353 (53%), Gaps = 23/353 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L++ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 83 DIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E + LYQML +K+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 142
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + T YV TR+YRAPE+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVI 198
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + + + LGTP PE + +
Sbjct: 199 LGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QP 255
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEE 309
R Y+ K + FP+V A LL +++ D R + +E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
AL PY + P + + + R T ++ +ELIY+E+++
Sbjct: 316 ALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEWKELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 493 bits (1272), Expect = e-176
Identities = 119/315 (37%), Positives = 174/315 (55%), Gaps = 15/315 (4%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+RY L+ +G G G+V +A+D ++VAIKKI V LRE+K++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + Q+ LI + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
E + + Y+ +P PL Q P + A+ L++++ F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 312 ADPYFKGLAKIEREP 326
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-162
Identities = 107/350 (30%), Positives = 172/350 (49%), Gaps = 27/350 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+R+++ + G+G++G V + TG VAIKK+ + R L+ ++ L +L H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQM 135
P+IV+++ +R+ +DIY VV E + LH+ + + FL+Q+
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 136 LRALKYMH--TANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+R++ +H + NV HRD+KP N+L N A+ LK+CDFG A+ P Y+ +
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV----AYICS 194
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G + QL I +LG PS
Sbjct: 195 RYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF----PNVDPLALRLLQRLIAFDPKDRPTAE 308
E + + L +P F A LL L+ + P++R
Sbjct: 254 EVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 309 EALADPYFKGLAKIERE-PSCQPISKLEFEFERR--RVTKDDIRELIYRE 355
EAL PYF L + P+ + + + F F V + + + R+
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-148
Identities = 116/376 (30%), Positives = 191/376 (50%), Gaps = 31/376 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +VIG GS+GVV A + E VAIKK+ D RE++++R+++HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL------QDKRFKNRELQIMRIVKHP 92
Query: 83 DIVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLR 137
++V++K K++ + +V E + +++ K + + ++YQ+LR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+L Y+H+ + HRD+KP+N+L + LK+ DFG A++ + P Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----SYICSRYYR 208
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT IDIWS GC+ AE++ G+PLFPG+S + QL I +LGTPS E I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P + F P P A+ L+ RL+ + P R TA EAL P
Sbjct: 267 KTMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 315 YFKGLAKIE-REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
+F L E R P+ + + L F + + + +R + ++ H + + G +
Sbjct: 324 FFDELRTGEARMPNGRELPPL-FNWTKE---ELSVRPDLISRLVPQHAE-AELLSRGIDV 378
Query: 374 TNFLYPSAIGQFRKQF 389
NF P + +
Sbjct: 379 HNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-146
Identities = 98/392 (25%), Positives = 180/392 (45%), Gaps = 66/392 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+ +Y + + +G GS+G+VC D +G++ A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 82 PDIVEIKRIM---------------------------------LPPSKREFKDIYVVFEL 108
+I+++ + + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 109 MESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-C 163
+ LH+V+ ++ + ++YQ+ RA+ ++H+ + HRD+KP+N+L N+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 222
LK+CDFG A+ P Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
E++ GKPLF G++ + QL I ++GTP+ E + + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKIL 290
Query: 283 PNVDP-LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC----------QPI 331
P P LA+ LL++++ ++P R EA+A P+F L Q I
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 332 SKL-EFEFERRRVTKDDIRELIYREILEYHPQ 362
+L F + ++ I + + +
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 412 bits (1062), Expect = e-143
Identities = 108/339 (31%), Positives = 169/339 (49%), Gaps = 25/339 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRA 138
IV ++ K++ + +V + + +++V + A L + + ++YQ+ R+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PEL G+ + YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + P + F P P A+ L RL+ + P R T EA A +
Sbjct: 283 EMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 316 FKGLAKIE-REPSCQPISKL-EFEFERRRVTKDDIRELI 352
F L + P+ + L F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-130
Identities = 91/318 (28%), Positives = 154/318 (48%), Gaps = 24/318 (7%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +I RE+K
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 75 LLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+L LR P+I+ + I+ P V + +D Q+ LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMY 137
Query: 134 QMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA V VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVAS 193
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPS 251
R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL I +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 252 PET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-----VDPLALRLLQRLIAFDPKDRP 305
I E ++ + + + + V P AL L +L+ +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 306 TAEEALADPYFKGLAKIE 323
TA EA+ PYF + K +
Sbjct: 313 TAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-123
Identities = 109/307 (35%), Positives = 167/307 (54%), Gaps = 12/307 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ + IG+GSYGVV + TG+ VAIKK + + LRE+++L+ L+HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 63 NLVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H N HRD+KP+NIL + +K+CDFG AR + P + D VATRWYR+PE L
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELL 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G ++Y P +D+W+IGC+FAE+L+G PL+PGKS V QL LI LG P V
Sbjct: 175 VGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ + + PL KFPN+ AL LL+ + DP +R T E+ L PYF+ +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 321 KIEREPS 327
+IE
Sbjct: 293 EIEDLAK 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 341 bits (877), Expect = e-116
Identities = 99/297 (33%), Positives = 161/297 (54%), Gaps = 12/297 (4%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ L ++G+GSYG+V + TG VAIKK + + +RE+KLL+ LRH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ + +
Sbjct: 85 NLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ N+ HRD+KP+NIL + + +K+CDFG AR + P V+ D VATRWYRAPEL
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELL 196
Query: 202 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G KY A+D+W+IGC+ E+ G+PLFPG S + QL I LG P +
Sbjct: 197 VGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K PL +++P + + + L ++ + DP RP E L +F+
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-104
Identities = 115/301 (38%), Positives = 159/301 (52%), Gaps = 18/301 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRL 78
A RY+ L+ +G+G + V A D +T + VAIKKI D I LRE+KLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR 137
L HP+I+ + S I +VF+ ME+DL +IK N LT H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L+Y+H + HRDLKP N+L + N LK+ DFGLA+ +F P + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L G+ Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ Y + P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 239 DMC--SLPDY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
Query: 317 K 317
Sbjct: 296 S 296
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-104
Identities = 101/303 (33%), Positives = 146/303 (48%), Gaps = 18/303 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLL 79
+RY+ + IG G+YG V A D H+G VA+K + + I +REV LLR L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + L E + + Q
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L ++H + HRDLKP+NIL + +K+ DFGLAR +S M T V T W
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSY-QMA--LTPVVVTLW 184
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P +
Sbjct: 185 YRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 243 WPRD--VSLPRG--AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
Query: 315 YFK 317
Y
Sbjct: 299 YLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-103
Identities = 119/325 (36%), Positives = 174/325 (53%), Gaps = 24/325 (7%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
++ G +Y+ LE +G+G+YGVV A D+ G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAE 58
Query: 64 SDAIRI--LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-N 120
+ I +RE+ LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + +LYQ+LR + + H + HRDLKP+N+L N++ LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
P+ + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG + Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDLITDLLGTPSPET---IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L I +LGTP+P + + K R + + P P + LL +
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
+ FDP R +A +A+ PYFK L
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDP 309
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-103
Identities = 114/299 (38%), Positives = 165/299 (55%), Gaps = 19/299 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y LE IG+G+YGVV A + GE A+KKI E + I +RE+ +L+ L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV++ ++ + + +VFE ++ DL +++ L + FL Q+L +
Sbjct: 59 HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR AF P+ + T + T WYRAP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V
Sbjct: 171 VLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 229 T--ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-103
Identities = 113/331 (34%), Positives = 169/331 (51%), Gaps = 28/331 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
Y L+ +G+G+Y V T VA+K+I E + +REV LL+ L+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + I+ + +VFE ++ DL Q + + + + + FL+Q+LR L
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR A S P + + V T WYR P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET---I 255
L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET I
Sbjct: 171 ILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
K Y K L P +D LL +L+ F+ ++R +AE+A+ P+
Sbjct: 229 LSNEEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 316 FKGL----AKIEREPSCQPISKLEFEFERRR 342
F L K+ S + +++ + E
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-102
Identities = 115/302 (38%), Positives = 166/302 (54%), Gaps = 19/302 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ + + + LRE+ LL+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N DL E + FL+Q+L+ L
Sbjct: 60 HKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ +FGLAR AF P+ + + V T WYR P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPD 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP+ E
Sbjct: 172 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 230 MT--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 318 GL 319
Sbjct: 288 DF 289
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-102
Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 23/306 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+RY+ + +G+G+YG V AIDT T E VAIK+I EH + + +REV LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +I+E+K ++ + ++++FE E+DL + + N D++ + FLYQ++ +
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ H+ HRDLKP+N+L + + LK+ DFGLAR AF P+ F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG S + QL I ++LG P T
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K L + +D L LL ++ DP R +A+ AL
Sbjct: 262 WPGV--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 314 PYFKGL 319
PYF
Sbjct: 320 PYFSHN 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-102
Identities = 103/322 (31%), Positives = 161/322 (50%), Gaps = 26/322 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLL 79
+Y+ + IG+G+YG V A D + G VA+K++ + + + + +REV +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR +S M T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSF-QMA--LTSVVVTLW 184
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 185 YRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ K P+ + ++D L LL + + F+P R +A AL+ P
Sbjct: 243 WPRD--VALPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 315 YFKGLAKIEREPSCQPISKLEF 336
YF+ L C+
Sbjct: 299 YFQDL------ERCKENLDSHL 314
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-101
Identities = 112/338 (33%), Positives = 165/338 (48%), Gaps = 24/338 (7%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRL 78
+ ++Y+ L IG+G++G V A TG+KVA+KK+ E+ + I LRE+K+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 79 LRHPDIVEIKRIM---LPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQ 134
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---VA 191
+L L Y+H + HRD+K N+L + LK+ DFGLAR AFS Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 251 SPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTA 307
+PE V E K E+ K + + DP AL L+ +L+ DP R +
Sbjct: 249 TPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRR 342
++AL +F + ++ S S E+ RR
Sbjct: 307 DDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = e-100
Identities = 108/312 (34%), Positives = 172/312 (55%), Gaps = 29/312 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLL 79
++++K LE +G G+Y V ++ TG VA+K++ + + +RE+ L++ L
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--LDS-EEGTPSTAIREISLMKEL 60
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN------DDLTREHHQFFLY 133
+H +IV + ++ +K + +VFE M++DL + + + L ++F +
Sbjct: 61 KHENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+L+ L + H + HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTL 172
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG + QL LI D++GTP+
Sbjct: 173 WYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF-----PNVDPLALRLLQRLIAFDPKDRPTA 307
V K KY ++++PP L Q +D + L L+ +P R +A
Sbjct: 231 SLWPSV--TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 308 EEALADPYFKGL 319
++AL P+F
Sbjct: 289 KQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 3e-86
Identities = 105/368 (28%), Positives = 170/368 (46%), Gaps = 58/368 (15%)
Query: 22 ANRYKIL-EVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+ ++ +G+G+YG V A D + A+K+I IS + RE+ LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRE 74
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF-------- 130
L+HP+++ ++++ L + + ++++F+ E DL +IK +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 131 -FLYQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVF 185
LYQ+L + Y+H V HRDLKP NIL ++K+ D G AR F+ P+
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPL 189
Query: 186 --WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------- 235
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 236 --VVHQLDLITDLLGTPS----------PETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
QLD I +++G P+ PE ++++ + Y + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY---TNCSLIKYMEKHKV 304
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQP-ISKLEFEFERRR 342
D A LLQ+L+ DP R T+E+A+ DPYF E + + + +R
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKRE 359
Query: 343 VTKDDIRE 350
++ +
Sbjct: 360 FLTEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 7e-75
Identities = 93/398 (23%), Positives = 153/398 (38%), Gaps = 65/398 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHP 82
+ +V+G G+ G + VA+K+I +D REV+LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
+++ ++++ + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 MHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K + DFGL + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE L T +DI+S GC+F V++ GKS+ Q +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------------- 239
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + D +A L++++IA DP+ RP+A+ L P+
Sbjct: 240 -------------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 316 FKGLAK-----------IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE------ 358
F L K IE+E PI K + E R V K D RE I +
Sbjct: 287 FWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKFR 345
Query: 359 -YHPQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEEN 395
Y ++D + Y + R+ L ++
Sbjct: 346 TYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDD 383
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 214 bits (545), Expect = 5e-66
Identities = 47/343 (13%), Positives = 90/343 (26%), Gaps = 61/343 (17%)
Query: 15 FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILRE 72
+ R K++E + G VV D E A+K S+ R+
Sbjct: 53 VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112
Query: 73 VKLLRLLRHPDIVE---------------------IKRIMLPPSKREFKDIYVVFELMES 111
L E ++ + ++
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172
Query: 112 DLHQVIKANDDLTREHH-------QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL + D + Q++R + + + H P N+ + +
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR 232
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
L + D + P + Y E + + +T A++ W +G V
Sbjct: 233 LMLGDVSALWKVGTRGPASSV------PVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
F + + L P ++ F
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDS----------------------LAFGSCTP 324
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ L+ R + FD + R EA+ P F +++ E S
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEIS 364
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-64
Identities = 93/344 (27%), Positives = 151/344 (43%), Gaps = 48/344 (13%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ D A RY++L+VIGKGS+G V A D + VA+K + + +
Sbjct: 83 DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAA 141
Query: 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTR 125
E+++L LR D ++ F++ I + FEL+ +L+++IK N +
Sbjct: 142 E--EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMT 183
+ F + +L+ L +H + H DLKP+NIL +KV DFG + + +
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVY 257
Query: 184 VFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
Y+ +R+YRAPE + G+ +Y ID+WS+GCI AE+LTG PL PG+ QL
Sbjct: 258 T----YIQSRFYRAPEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 243 ITDLLGTPSPETI---------------------------AVVRNEKARKYLTEMRKKPP 275
+ +LLG PS + + +VV N +
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 276 VPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKG 318
D L++ + +DP R T +AL P+ +
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-61
Identities = 70/358 (19%), Positives = 136/358 (37%), Gaps = 69/358 (19%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ F + G N + ++ +G G++G V + A+K + ++ + + + +
Sbjct: 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAK 79
Query: 69 ILREVKLLRLLRHPD-----IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD 122
I E +L+ +++ D IV+ + D + ++FE + L+++I N+
Sbjct: 80 I--EADILKKIQNDDINNNNIVKYHGKF------MYYDHMCLIFEPLGPSLYEIITRNNY 131
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---------------------- 158
E + + ++L+AL Y+ ++ H DLKP+NIL
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 159 ---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 214
+ +K+ DFG A F + TR YRAPE + + + D+
Sbjct: 192 QIYRTKSTGIKLIDFGCA--TFKSDYHG----SIINTRQYRAPEVILNL---GWDVSSDM 242
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL------- 267
WS GC+ AE+ TG LF + L ++ ++ + KY+
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 268 ------TEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + V + L L ++ DP RP+ E L + +
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-61
Identities = 72/327 (22%), Positives = 113/327 (34%), Gaps = 47/327 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
++ F + Y IL+ IG G V ++ + AIK ++
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 62 HISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA 119
E+ L L+ I+ + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ + + ML A+ +H + H DLKP N L + LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T V + V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 TTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F I+ + + + P +
Sbjct: 239 FQQII-----------------NQISKLHAIIDPNH------EIEFP-----DIPEKDLQ 270
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFK 317
+L+ + DPK R + E LA PY +
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 6e-61
Identities = 93/354 (26%), Positives = 154/354 (43%), Gaps = 57/354 (16%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDA 66
+ D+ + G+ +RY+I +IGKGS+G V A D E VAIK I F + +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-- 97
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--L 123
EV+LL L+ D I+ F++ + +VFE++ +L+ +++ + +
Sbjct: 98 ---QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154
Query: 124 TREHHQFFLYQMLRALKYMHT--ANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSD 179
+ + F QM AL ++ T ++ H DLKP+NIL +K+ DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLG 212
Query: 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
+ Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG+PLF G + V Q
Sbjct: 213 QRIY----QYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 240 LDLITDLLGTPSPETI--------------------------AVVRNEKARKYLTEMRKK 273
++ I ++LG P + + L +
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 274 PPVPLFQKFPN------VDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ D L + L+ R++ +DPK R AL +FK A
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 9e-61
Identities = 94/356 (26%), Positives = 145/356 (40%), Gaps = 51/356 (14%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAI 67
K+ GD RY+I+ +G+G++G V +D G +VA+K I +V +A
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAA 63
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LT 124
R+ E+ +L+ ++ D +L F + + FEL+ + + +K N+
Sbjct: 64 RL--EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-------------------ANANCKL 165
H + YQ+ AL+++H + H DLKP+NIL + N +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEV 224
+V DFG A F T VATR YR PE + + D+WSIGCI E
Sbjct: 182 RVADFGSA--TFDHEHHT----TIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEY 232
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------------ARKYLTEMR 271
G LF L ++ +LG I R +K + +
Sbjct: 233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292
Query: 272 KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
KP + L++R++ FDP R T EAL P+F GL ER
Sbjct: 293 CKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-59
Identities = 92/338 (27%), Positives = 144/338 (42%), Gaps = 51/338 (15%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ RY+I++ +G+G++G V ID G VA+K + +V + +A R E+++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLR 137
D R + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 ALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVAFS 178
++ ++H+ + H DLKP+NIL N +KV DFG A +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 188 DEHHS----TLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 238 HQLDLITDLLGTPSPETIAVVRNEK--------------ARKYLTEMRKKPPVPLFQKFP 283
L ++ +LG I R K A +Y++ KP
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR-ACKPLKEFMLSQD 299
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
L+Q+++ +DP R T EAL P+F L K
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-58
Identities = 71/331 (21%), Positives = 116/331 (35%), Gaps = 47/331 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 68 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V T Y PE
Sbjct: 123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEA 180
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 224
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 225 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
A PY + + + ++++ +
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-57
Identities = 80/377 (21%), Positives = 126/377 (33%), Gaps = 57/377 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 115 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V Y PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEA 227
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 271
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 272 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 319
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGT 371
A PY +I+ P Q E + + +L+ + K
Sbjct: 320 AHPYV----QIQTHPVNQMAKGTTEEMKYV------LGQLVGLNSPNSILKAAKTLYEHY 369
Query: 372 EGTNFLYPSAIGQFRKQ 388
G S+ F K+
Sbjct: 370 SGGESHNSSSSKTFEKK 386
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 72/296 (24%), Positives = 104/296 (35%), Gaps = 46/296 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
++ L +G GSYG V G A+K+ F D R L EV ++ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
V +++ + E +Y+ EL L Q +A E +L L AL +
Sbjct: 118 CCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + H D+KP NI + K+ DFGL + V Y APEL
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPELL 228
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y A D++S+G EV L G QL
Sbjct: 229 Q---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--------------------- 264
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ P +L ++ DPK R TAE LA P +
Sbjct: 265 --------RQGYLPPEFTAGLS---SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-56
Identities = 75/338 (22%), Positives = 130/338 (38%), Gaps = 55/338 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
RY ++ +G G + V A D VA+K + + ++A E+KLL+ +
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVN 73
Query: 81 HPDIVEIKRIMLPPSKREFKD-----------IYVVFELMESDLHQVIKANDD--LTREH 127
D + + M + D + +VFE++ +L +IK + + +
Sbjct: 74 DADNTK-EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 128 HQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCK------LKVCDFGLARVAFSDT 180
+ Q+L L YMH + H D+KP+N+L +K+ D G A + D
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 181 PMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--- 236
T+ + TR YR+PE L G + + DIWS C+ E++TG LF
Sbjct: 191 HY----TNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243
Query: 237 ---VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-- 291
+ I +LLG + + R + + + +P D L +
Sbjct: 244 TKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 301
Query: 292 -----------LLQRLIAFDPKDRPTAEEALADPYFKG 318
L ++ DP+ R A + P+ K
Sbjct: 302 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 88/310 (28%), Positives = 134/310 (43%), Gaps = 55/310 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAI+ I A+ + E+++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + M T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----RTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 363
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 364 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 395
Query: 309 EALADPYFKG 318
EAL P+ +
Sbjct: 396 EALRHPWLQD 405
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 79/347 (22%), Positives = 134/347 (38%), Gaps = 49/347 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + +Y L+ IG+GS+G T G + IK+I+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--IS 60
Query: 62 HISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+S R REV +L ++HP+IV+ + S E +Y+V + E DL + I
Sbjct: 61 RMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRIN 115
Query: 119 -ANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
L +E + Q+ ALK++H + HRD+K +NI + +++ DFG+ARV
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
S + + T +Y +PE+C + Y DIW++GC+ E+ T K F S+
Sbjct: 176 NSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQR 295
+ + I P+ LR L+ +
Sbjct: 231 KNLVLKI---------------------------ISGSFPPV----SLHYSYDLRSLVSQ 259
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
L +P+DRP+ L + + P F +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-55
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 24/314 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T P + + P + L +L ++ D + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS--RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKI 322
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-55
Identities = 82/312 (26%), Positives = 126/312 (40%), Gaps = 62/312 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
Y++L IG GSYG G+ + K++ + +++A + ++ EV LLR L+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP+IV ++ R +Y+V E E DL VI + Q+
Sbjct: 64 HPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKG----TKERQYLDEEFVLRV 116
Query: 132 LYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ ALK H + V HRDLKP N+ + +K+ DFGLAR+ DT
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--- 173
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
+V T +Y +PE Y DIWS+GC+ E+ P F S
Sbjct: 174 KTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------- 221
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRP 305
E +R K F++ P L ++ R++ RP
Sbjct: 222 -----KELAGKIREGK----------------FRRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 306 TAEEALADPYFK 317
+ EE L +P
Sbjct: 261 SVEEILENPLIL 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-55
Identities = 71/323 (21%), Positives = 117/323 (36%), Gaps = 65/323 (20%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+K +E+IG G +G V A G+ IK++ + + REVK L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVE-----------IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA--NDDLTREH 127
+IV + S+ + K +++ E + L Q I+ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+ + + Y+H+ + +RDLKP NI ++K+ DFGL +D T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246
T Y +PE S Y +D++++G I AE+L F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
+ + D LLQ+L++ P+DRP
Sbjct: 232 -------------------------RDGIIS-----DIFDKKEKTLLQKLLSKKPEDRPN 261
Query: 307 AEEALADPYFKGLAK--IEREPS 327
E L + ER +
Sbjct: 262 TSEILRTLTVWKKSPEKNERHTA 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-55
Identities = 75/323 (23%), Positives = 124/323 (38%), Gaps = 54/323 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A+ ++ + V+G+G++G V A + AIKKI E +S IL EV LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNH 61
Query: 82 PDIVEIK--------RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFF 131
+V + + ++ +++ E E L+ +I + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW----- 186
Q+L AL Y+H+ + HRDLKP NI + + +K+ DFGLA+ +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 187 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T + T Y A E+ Y ID++S+G IF E++ P G V+ L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+ R N + ++++ LI D
Sbjct: 239 KKL---------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 301 PKDRPTAEEALADPYFKGLAKIE 323
P RP A L + + E
Sbjct: 272 PNKRPGARTLLNSGWLPVKHQDE 294
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-55
Identities = 70/324 (21%), Positives = 122/324 (37%), Gaps = 55/324 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIV-------EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF---F 131
IV E +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT---------PM 182
Q+ A++++H+ + HRDLKP NI + +KV DFGL D P
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
T V T+ Y +PE + Y+ +DI+S+G I E+L P
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQM-------- 231
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
E + + + + K+ PP+ P ++Q +++ P
Sbjct: 232 ----------ERVRTLTDVRNLKF-------PPLF-----TQKYPCEYVMVQDMLSPSPM 269
Query: 303 DRPTAEEALADPYFKGLAKIEREP 326
+RP A + + F+ L +
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTV 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 89/319 (27%), Positives = 135/319 (42%), Gaps = 55/319 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAIK I A+ + E+++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + T T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGE---TSLMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 238
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 239 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 309 EALADPYFKGLAKIEREPS 327
EAL P+ + +
Sbjct: 271 EALRHPWLQDEDMKRKFQD 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 65/351 (18%), Positives = 126/351 (35%), Gaps = 31/351 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD--L 246
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 247 LGTPSPETIAVVRNEKAR-KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
G PS V + E + +M + + L +L ++ D +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCW 295
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
++ A+ + S Q ++ + T EL+Y++
Sbjct: 296 GFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQT 345
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-52
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 53/304 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 90
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP++++ S E ++ +V EL ++ DL ++IK ++ +
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTVWKY 141
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+ AL++MH+ V HRD+KP N+ A +K+ D GL R S T V
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVG 198
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE + Y DIWS+GC+ E+ + F G +
Sbjct: 199 TPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------ 244
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
++ + + Y PP+P + L + DP+ RP
Sbjct: 245 ----SLCKKIEQCDY-------PPLPSDHYSEELRQLVNMCINP----DPEKRPDVTYVY 289
Query: 312 ADPY 315
Sbjct: 290 DVAK 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 8e-52
Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 50/320 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+RYK V+GKGS+G V D TG++ A+K I + +D +LREV+LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ YMH + HRDLKP+N+L + + +++ DFGL+ + M D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM----KDKIGTAY 193
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ Y D+WS G I +L+G P F G + L +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------- 239
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ KY + V A L+++++ + P R +A +AL
Sbjct: 240 -------EKGKY--TFELPQ-------WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283
Query: 315 YFKGLAKIEREPSCQPISKL 334
+ + K + +
Sbjct: 284 WIQTYTKEQISVDVPSLDNA 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-52
Identities = 91/337 (27%), Positives = 143/337 (42%), Gaps = 51/337 (15%)
Query: 5 QTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKAN 120
D ILREV+LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAF 177
+ + Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 178 SDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+T M D + T +Y APE L G Y D+WS G I +L+G P F GK+
Sbjct: 176 QNTKM----KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L + + KY + + A L++++
Sbjct: 228 YDILKRV------------------ETGKY--AFDLPQ-------WRTISDDAKDLIRKM 260
Query: 297 IAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ F P R TA + L P+ + + S P +
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-51
Identities = 83/318 (26%), Positives = 136/318 (42%), Gaps = 49/318 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ ++ +G G+YG V D T + AIK I S ++L EV +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+++ F+D Y+V E + +L I + Q+L
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 139 LKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ Y+H N+ HRDLKP+N+L + +K+ DFGL+ V + M + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERLGTAYY 204
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ KY D+WSIG I +L G P F G++ L +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV------------ 249
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ KY + NV A L+++++ FD + R +A++AL P+
Sbjct: 250 ------EKGKY--TFDSPE-------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 316 FKGLAKIEREPSCQPISK 333
K + + P
Sbjct: 295 IKEMCSKKESGIELPSLA 312
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-50
Identities = 75/360 (20%), Positives = 132/360 (36%), Gaps = 74/360 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRH 81
N +++G GS G V + G VA+K++ F I L E+KLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQVIKANDDLTREHHQF-------F 131
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL-------------ANANCKLKVCDFGLAR-VAF 177
L Q+ + ++H+ + HRDLKP+NIL N ++ + DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 178 SDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
+ + + + + ++ A
Sbjct: 241 GD-------------------------KYSRESNIIRGIFSLDEMK-CLHDRSLIAEATD 274
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
L+ ++I DP RPTA + L P F +K + +S E E R + +
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-50
Identities = 89/321 (27%), Positives = 141/321 (43%), Gaps = 51/321 (15%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+ D IL
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
REV+LL+ L HP+I+++ I+ + Y+V EL +L I +
Sbjct: 70 REVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+ +T M
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---- 180
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
D + T +Y APE L G Y D+WS G I +L+G P F GK+ L +
Sbjct: 181 KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-- 234
Query: 246 LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
G P+ + + A L+++++ F P
Sbjct: 235 ETGKYAFDLPQ----------------------------WRTISDDAKDLIRKMLTFHPS 266
Query: 303 DRPTAEEALADPYFKGLAKIE 323
R TA + L P+ + + E
Sbjct: 267 LRITATQCLEHPWIQKYSSEE 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-50
Identities = 69/321 (21%), Positives = 125/321 (38%), Gaps = 42/321 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ Q + + + R+ K IG+GS+ V +DT T +VA ++ D
Sbjct: 4 RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK 63
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA 119
S+ R E ++L+ L+HP+IV K + K I +V ELM S L +K
Sbjct: 64 LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKR 122
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLARVA 176
+ + + + Q+L+ L+++HT + HRDLK NI +K+ D GLA +
Sbjct: 123 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE+ KY ++D+++ G E+ T + +
Sbjct: 183 RASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
Q+ Y P + P +++
Sbjct: 235 AAQI-------------------------YRRVTSGVKPASFDK---VAIPEVKEIIEGC 266
Query: 297 IAFDPKDRPTAEEALADPYFK 317
I + +R + ++ L +F+
Sbjct: 267 IRQNKDERYSIKDLLNHAFFQ 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-50
Identities = 82/340 (24%), Positives = 128/340 (37%), Gaps = 63/340 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 247
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P ++P+A L+Q+++ DP RPT E L
Sbjct: 248 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 290
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
D +F R P F + + + L
Sbjct: 291 NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 1e-49
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 22/343 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ E +G G +G V I TGE+VAIK+ + R E+++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMES-DLHQVIKANDD---LTREHHQFFLYQMLRA 138
+V + + K D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ + K+ D G A+ T F V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----REKSNEH 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
VV ++ P L + R LQ ++ + + R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHL---SGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
F+ L I ++ + VT+++ + + + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-49
Identities = 81/331 (24%), Positives = 130/331 (39%), Gaps = 62/331 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-----------HDVFEHISDAIRILR 71
Y + +G G+YG V + + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREH 127
E+ LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTV 184
+ Q+L + Y+H N+ HRD+KP+NIL N+ +K+ DFGL+ D +
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
D + T +Y APE L KY D+WS G I +L G P F G++ + +
Sbjct: 206 --RDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ KY + N+ A L++ ++ +D
Sbjct: 260 ------------------EKGKY--YFDFND-------WKNISDEAKELIKLMLTYDYNK 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R TAEEAL + K A + + +
Sbjct: 293 RCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 78/349 (22%), Positives = 126/349 (36%), Gaps = 85/349 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLL 79
+Y + IG+GSYGVV AI+ T AIK + + D RI EV+L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF-------- 130
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQMLRALKYMHTANVYHRDLKPKNIL 158
+ Q+ AL Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N + ++K+ DFGL++ + + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETIAVVRNEKARKYLTEMRK 272
S G + +L G FPG + + + L +P
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLCFENPN------------------- 299
Query: 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+ + PLA LL L+ + +R A AL P+ +
Sbjct: 300 ---------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 63/306 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 221
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P +++P+A L+Q+++ DP RPT E L
Sbjct: 222 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 264
Query: 312 ADPYFK 317
D +F
Sbjct: 265 NDEFFT 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-49
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 47/300 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + IG+GS+G V A+ T + A KKI + D R +E+++++ L HP+
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPN 67
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + DIY+V EL +L + + + +L A+ Y
Sbjct: 68 IIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H NV HRDLKP+N L + + LK+ DFGLA M V T +Y +P+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RTKVGTPYYVSPQ 178
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G Y P D WS G + +L G P F + + I
Sbjct: 179 VLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------------- 219
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + +K + NV P A L++RL+ PK R T+ +AL +F+
Sbjct: 220 ---REGTF--TFPEKD-------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 50/315 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPET 254
E L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE- 230
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V P A L+ ++ +PK R TA++AL P
Sbjct: 231 ---------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 315 YFKGLAKIEREPSCQ 329
+ ++ Q
Sbjct: 264 WICNRERVASAIHRQ 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 7e-48
Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 49/299 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H+ V HRD+KP+N+L + +LK+ DFG + A S + T DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+WS+G + E L GKP F + I
Sbjct: 178 MIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------------- 219
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ FP+ V A L+ RL+ +P RP E L P+
Sbjct: 220 --SRVEF--------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-47
Identities = 79/320 (24%), Positives = 130/320 (40%), Gaps = 55/320 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
Y+ E++G+G VV I T ++ A+K I E L+EV +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
Y APE + S Y +D+WS G I +L G P F + + L +I + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 250 ---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
SPE + + L+ R + P+ R T
Sbjct: 246 YQFGSPE----------------------------WDDYSDTVKDLVSRFLVVQPQKRYT 277
Query: 307 AEEALADPYFKGLAKIEREP 326
AEEALA P+F+ E
Sbjct: 278 AEEALAHPFFQQYVVEEVRH 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 85/327 (25%), Positives = 139/327 (42%), Gaps = 50/327 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP+
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 90 IVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +PE
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSPE 200
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 201 VLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE-- 253
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ ++ +PK R TA++AL P+
Sbjct: 254 --------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
++ Q +F RR
Sbjct: 288 ICNRERVASAIHRQDTVDCLKKFNARR 314
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-47
Identities = 62/303 (20%), Positives = 105/303 (34%), Gaps = 43/303 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y ++ +G+G + V H G A+K+I E D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQ-QDREEAQREADMHRLFNHPN 87
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRA 138
I+ + L + + +++ + L I+ + LT + + L + R
Sbjct: 88 ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP------MTVFWTDYVAT 192
L+ +H HRDLKP NIL + + D G A W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 193 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV----------------- 249
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+K ++ + +P + +LL ++ DP RP L
Sbjct: 250 --------FQKGDSVALAVQNQLSIPQSPRHS---SALWQLLNSMMTVDPHQRPHIPLLL 298
Query: 312 ADP 314
+
Sbjct: 299 SQL 301
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-47
Identities = 82/327 (25%), Positives = 134/327 (40%), Gaps = 49/327 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ E +GKG++ VV + G++ A I+ D ++ RE ++ RLL+HP+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + E Y++F+L+ +L + I A + + + Q+L A+ +
Sbjct: 72 IVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H V HR+LKP+N+L +K+ DFGLA + W + T Y +PE
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPE 183
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y +D+W+ G I +L G P F + I G PSPE
Sbjct: 184 VLRK---DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPE-- 236
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ +++ +P R TA EAL P+
Sbjct: 237 --------------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
+ + Q +F RR
Sbjct: 271 ISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 52/335 (15%), Positives = 97/335 (28%), Gaps = 73/335 (21%)
Query: 22 ANRYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLR 77
R + L V+G+ A D TGE + + S+AI ++ EV LR
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 78 LLR----------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQ 115
LLR P ++ R+ L + ++ M+S+L
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 116 VIKANDDLTREHHQ-------FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVL 225
F A A + + T A D W++G +
Sbjct: 254 GFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
+ + + I R +P
Sbjct: 312 CADLPNTDDAALGGSEWI--------------------------FRSCKNIP-------- 337
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
LL+ + + +DR +A+ P ++ L
Sbjct: 338 -QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 49/313 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+ + I +GKG +G V A + +A+K + E ++ RE+++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + + IY++ E +L++ ++ + + F+ ++ AL
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H V HRD+KP+N+L +LK+ DFG + A S T+ T DY+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+W G + E L G P F S I
Sbjct: 183 MIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI---------------- 224
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
KFP + + L+ +L+ + P R + + P+ K
Sbjct: 225 --VNVDL--------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
Query: 319 LAKIEREPSCQPI 331
++ P Q
Sbjct: 269 NSRRVLPPVYQST 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 52/335 (15%), Positives = 102/335 (30%), Gaps = 81/335 (24%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLR-- 80
V+G+ A D TGE + + S+AI+ ++ EV LRLLR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 81 --------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
P ++ R+ L + ++ M+S+L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ H Q++R L +H + H L+P +I+ + + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEV 224
+ +V +R + PEL + T + D W++G + +
Sbjct: 254 VRDGARVVSSV-------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+ + + I R +P
Sbjct: 307 WCADLPITKDAALGGSEWI--------------------------FRSCKNIP------- 333
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
LL+ + + +DR +A+ P ++ L
Sbjct: 334 --QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 75/317 (23%), Positives = 124/317 (39%), Gaps = 53/317 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y++ E +G G + +V TG++ A K I I REV +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+RHP+I+ + I D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ N ++K+ DFG+A + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTP 175
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G++ L I
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SAVNYDFD 231
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F N LA ++RL+ DPK R T ++
Sbjct: 232 EEY----------------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
Query: 311 LADPYFKGLAKIEREPS 327
L + K + +
Sbjct: 264 LEHSWIKAIRRRNVRGE 280
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-46
Identities = 73/308 (23%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+K+ ++GKGS+ V A HTG +VAIK I R+ EVK+ L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRAL 139
P I+E+ + +Y+V E+ + ++++ +K + + F++Q++ +
Sbjct: 71 PSILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYV 190
Y+H+ + HRDL N+L N +K+ DFGLA TP +Y+
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP------NYI 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+PE+ S + D+WS+GC+F +L G+P F +V + L+ +
Sbjct: 180 ------SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------- 224
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEE 309
Y + P+ + A L+ +L+ +P DR +
Sbjct: 225 -----------VLADY--------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSS 259
Query: 310 ALADPYFK 317
L P+
Sbjct: 260 VLDHPFMS 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 75/358 (20%), Positives = 136/358 (37%), Gaps = 62/358 (17%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
++ E K + Y++ +V+G G G V TG+K A+K +
Sbjct: 12 LEVLFQGPEPKKYAVT------DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL--- 62
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI 117
D+ + +EV + P IV I + + + + ++ E ME +L I
Sbjct: 63 ----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRI 117
Query: 118 KANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKV 167
+ R F + + A++++H+ N+ HRD+KP+N+L + LK+
Sbjct: 118 QE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ + + T +Y APE+ G KY + D+WS+G I +L G
Sbjct: 173 TDFGFAKE-TTQNAL----QTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCG 225
Query: 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
P F T + + R + +Y + V
Sbjct: 226 FPPFYSN--------------TGQAISPGMKRRIRLGQY--GFPNPE-------WSEVSE 262
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
A +L++ L+ DP +R T + + P+ + + P E + V +
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 54/310 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLL 76
+Y +VIG+G VV + TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
R + HP I+ + +++VF+LM +L + L+ + + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L A+ ++H N+ HRDLKP+NIL + N ++++ DFG + + + T
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPG 264
Query: 195 YRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
Y APE L S Y +D+W+ G I +L G P F + + L +I + G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQY 322
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
SPE + + L+ RL+ DP+ R TA
Sbjct: 323 QFSSPE----------------------------WDDRSSTVKDLISRLLQVDPEARLTA 354
Query: 308 EEALADPYFK 317
E+AL P+F+
Sbjct: 355 EQALQHPFFE 364
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 80/337 (23%), Positives = 133/337 (39%), Gaps = 63/337 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLLR 80
Y++ EVIGKG + VV I+ TG++ A+K + + RE + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLY------ 133
HP IVE+ +Y+VFE M+ +DL ++ + F+Y
Sbjct: 85 HPHIVELLETY-----SSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVAS 133
Query: 134 ----QMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q+L AL+Y H N+ HRD+KP +L + +K+ FG+A +
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---A 190
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V T + APE + Y +D+W G I +L+G F G
Sbjct: 191 GGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYG------------ 235
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
+ KY +M + + ++ A L++R++ DP +R
Sbjct: 236 -------TKERLFEGIIKGKY--KMNPRQ-------WSHISESAKDLVRRMLMLDPAERI 279
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
T EAL P+ K + + + +F RR
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 60/325 (18%), Positives = 101/325 (31%), Gaps = 71/325 (21%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLR 80
+ LE IG G +G V + G AIK+ D LREV L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR---EHH-QFFLYQM 135
H +V + E + + E L I N + E + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 136 LRALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVA 176
R L+Y+H+ ++ H D+KP NI A+ K+ D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+P + A E+ ++ + P DI+++ +PL
Sbjct: 185 --SSPQVE-----EGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
H++ R+ + Q LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
I DP+ RP+A + ++
Sbjct: 264 IHPDPERRPSAMALVKHSVLLSASR 288
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 77/317 (24%), Positives = 136/317 (42%), Gaps = 53/317 (16%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + + + +G G++G V + +G + IK I + +I
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIE 68
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD----LTR 125
E+++L+ L HP+I++I + ++ ++Y+V E E +L + I + L+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPM 182
+ + QM+ AL Y H+ +V H+DLKP+NIL + + +K+ DFGLA + SD
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T+ T Y APE T DIWS G + +LTG F G S+
Sbjct: 184 ----TNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFD 300
P+ + + P A+ LL++++ D
Sbjct: 236 KA--TYKEPN---------------------------YAVECRPLTPQAVDLLKQMLTKD 266
Query: 301 PKDRPTAEEALADPYFK 317
P+ RP+A + L +FK
Sbjct: 267 PERRPSAAQVLHHEWFK 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 71/325 (21%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ H +++ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TSVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F + LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 77/347 (22%), Positives = 132/347 (38%), Gaps = 62/347 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 135 MLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+L + Y+H+ + H DLKP+NI+ ++K+ DFGLA
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI----F 178
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
T + APE+ + D+WSIG I +L+G F G + L +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--SAVNY 234
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
F N LA ++RL+ DPK R T
Sbjct: 235 EFEDEY----------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+++L P+ K + R+ S + K + R++ L
Sbjct: 267 QDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGL 313
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 73/325 (22%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TAVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDTQQAMVRRESVVNLE 295
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-45
Identities = 78/339 (23%), Positives = 152/339 (44%), Gaps = 54/339 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++L+ IGKG++ V A TG +VAIK I + + ++ REV+++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +A+ +K+ DFG + + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
F KY P +D+WS+G I +++G F G++
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------------------ 218
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK-G 318
L E+R++ ++ + LL+R + +P R T E+ + D + G
Sbjct: 219 -------LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 319 LAKIEREPSCQPISKLEFEF-----ERRRVTKDDIRELI 352
+ E +P +P + + ++++I+E +
Sbjct: 272 HEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-45
Identities = 62/321 (19%), Positives = 129/321 (40%), Gaps = 62/321 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------------------HD 58
N+Y + + IGKGSYGVV A + + A+K +
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 59 VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
+ ++ +E+ +L+ L HP++V++ ++ P++ +Y+VFEL+ + +V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVP 129
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
L+ + +F+ +++ ++Y+H + HRD+KP N+L + +K+ DFG++
Sbjct: 130 T-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NE 186
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE ++ A+D+W++G + G+ F + +
Sbjct: 187 FKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
+ I + P P++ L+ R+
Sbjct: 246 MCLHSKI--------------------------KSQALEFP---DQPDIAEDLKDLITRM 276
Query: 297 IAFDPKDRPTAEEALADPYFK 317
+ +P+ R E P+
Sbjct: 277 LDKNPESRIVVPEIKLHPWVT 297
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 83/375 (22%), Positives = 139/375 (37%), Gaps = 71/375 (18%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
++K +Y +V+G G G V + T EK A+K + D +
Sbjct: 53 QIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPK 100
Query: 69 ILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTRE 126
REV+L R + P IV I + K + +V E ++ +L +
Sbjct: 101 ARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELF------SRIQDR 153
Query: 127 HHQFF--------LYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARV 175
Q F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
S + T T +Y APE+ G KY + D+WS+G I +L G P F
Sbjct: 214 TTSHNSL----TTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267
Query: 236 VVHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
+ + +G P+PE + V
Sbjct: 268 GLAISPGMKTRIRMGQYEFPNPE----------------------------WSEVSEEVK 299
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
L++ L+ +P R T E + P+ K+ + P E + V ++
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSA 359
Query: 351 LIYREILEYHPQLLK 365
L + ++ K
Sbjct: 360 LATMRVDYEQIKIKK 374
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 76/345 (22%), Positives = 136/345 (39%), Gaps = 51/345 (14%)
Query: 10 LKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+KD F+ Y + + +G+GS+ + + + + A+K I E
Sbjct: 1 MKDSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-----NT 52
Query: 70 LREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLT 124
+E+ L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFS 104
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTP 181
+ + +++ A+ +MH V HRDLKP+N+L N N ++K+ DFG AR+ D
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T Y APE L + Y + D+WS+G I +L+G+ F
Sbjct: 165 P---LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+++ + I K + + + NV A L+Q L+ D
Sbjct: 219 TSAVEIM-----KKI------KKGDF--SFEGEA-------WKNVSQEAKDLIQGLLTVD 258
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
P R + + + +++ P P K
Sbjct: 259 PNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVK 303
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-44
Identities = 69/306 (22%), Positives = 129/306 (42%), Gaps = 40/306 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D+WS G + +L G+ + S D +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY--------------- 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KGLA 320
+ + P + +D L LL +++ +P R T + D ++ K L
Sbjct: 219 --SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KIEREP 326
K + P
Sbjct: 271 KGAKRP 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 68/362 (18%), Positives = 122/362 (33%), Gaps = 100/362 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 64
Query: 83 DIV-------------------------------------------------EIKRIMLP 93
IV
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 94 PSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ---FFLYQMLRALKYMHTAN 146
+ ++ M+ +L + L H Q+ A++++H+
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARV---------AFSDTPMTVFWTDYVATRWYRA 197
+ HRDLKP NI + +KV DFGL + P T V T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE + Y+ +DI+S+G I E+L E + +
Sbjct: 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFS--------------------TQMERVRI 282
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + + K+ P + F P ++Q +++ P +RP A + + + F+
Sbjct: 283 ITDVRNLKF-------PLL-----FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
Query: 318 GL 319
L
Sbjct: 331 NL 332
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-44
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 55/306 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ +G+G+ +V T + A+K + + D + E+ +L L HP+
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPN 109
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++K I P++ I +V EL+ +L I + + Q+L A+ Y+
Sbjct: 110 IIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + LK+ DFGL+++ M T Y APE
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM----KTVCGTPGYCAPE 220
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT---PSPET 254
L G Y P +D+WS+G I +L G F + + I L SP
Sbjct: 221 ILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI--LNCEYYFISPW- 274
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V A L+++LI DPK R T +AL P
Sbjct: 275 ---------------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307
Query: 315 YFKGLA 320
+ G A
Sbjct: 308 WVTGKA 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-44
Identities = 54/340 (15%), Positives = 117/340 (34%), Gaps = 56/340 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---------------DVFEHISDAI 67
N Y+I+ + +G + + + A+KK D S
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTRE 126
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 127 HHQ--------FFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ + +L + Y+H N+ HRD+KP NIL + N ++K+ DFG +
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 178 SDTPMTVFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T +++ PE + S +DIWS+G + F K
Sbjct: 204 DKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKAR---KYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ E +R + + + + L
Sbjct: 258 L--------------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ + +P +R T+E+AL + + + + K
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-43
Identities = 70/315 (22%), Positives = 130/315 (41%), Gaps = 40/315 (12%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D+WS G + +L G+ + S D +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY--------------- 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KGLA 320
+ + P + +D L LL +++ +P R T + D ++ K L
Sbjct: 219 --SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KIEREPSCQPISKLE 335
K + P E
Sbjct: 271 KGAKRPRVTSGGVSE 285
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 73/336 (21%), Positives = 130/336 (38%), Gaps = 62/336 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQF-------F 131
++ + F+D + ++ E + +L D + E ++ +
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELF------DRIAAEDYKMSEAEVINY 154
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q LK+MH ++ H D+KP+NI+ +K+ DFGLA D + V
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---- 210
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
AT + APE+ D+W+IG + +L+G F G+
Sbjct: 211 TATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------------- 254
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
ET+ V+ + E F +V P A ++ L+ +P+ R T +
Sbjct: 255 -DLETLQNVK--RCDWEFDE----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
AL P+ KG + + +
Sbjct: 302 ALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 38/313 (12%)
Query: 24 RYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-H 81
Y++ +V+G+G++ V I+ T ++ A+K I HI + REV++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGH 70
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARV----AFSDTPMTVFWTDYV 190
AL ++H + HRDLKP+NIL N +K+CDF L T
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 191 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
+ + KY E K + ++ A L+ +L+ D K R +A
Sbjct: 243 PACQNMLFESI---QEGKY--EFPDKD-------WAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 308 EEALADPYFKGLA 320
+ L P+ +G A
Sbjct: 291 AQVLQHPWVQGCA 303
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 70/310 (22%), Positives = 118/310 (38%), Gaps = 48/310 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G+GS+G V D TG + A+KK+ E E+ L
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVACAGLS 108
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
P IV + + RE + + EL+E S L Q+IK L + ++L Q L
Sbjct: 109 SPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQALEG 162
Query: 139 LKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA-RVAFSDTPMTVFWTDYVA-TRWY 195
L+Y+HT + H D+K N+L +++ + +CDFG A + ++ DY+ T +
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ +DIWS C+ +L G + + L + P P
Sbjct: 223 MAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKIASEPPP--- 274
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+P P+ PL + +Q + +P R +A E
Sbjct: 275 -----------------IREIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
Query: 316 FKGLAKIERE 325
+
Sbjct: 313 KALQEVGGLK 322
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 60/319 (18%), Positives = 127/319 (39%), Gaps = 54/319 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDAIRILREVKLLRLLRH 81
+Y + +++G+GSYG V +D+ T + A+K + + + + +E++LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+++++ ++ K + +Y+V E ++ + + H +F Q++
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-CQLIDG 121
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---- 194
L+Y+H+ + H+D+KP N+L LK+ G+A + F D
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA------LHPFAADDTCRTSQGSP 175
Query: 195 -YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
++ PE+ + ++ +DIWS G + TG F G +
Sbjct: 176 AFQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----------------- 217
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ ++ + + + P LL+ ++ ++P R + +
Sbjct: 218 --------------IYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 313 DPYF-KGLAKIEREPSCQP 330
+F K E P
Sbjct: 264 HSWFRKKHPPAEAPVPIPP 282
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 73/327 (22%), Positives = 132/327 (40%), Gaps = 50/327 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDL-HQVIKANDDLTREHHQFFLYQMLR 137
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +MH N H DLKP+NI+ + +LK+ DFGL + V T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEF 322
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ D+WS+G + +L+G F G++ ET+
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETL 365
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
V K+ + M F + +++L+ DP R T +AL P+
Sbjct: 366 RNV---KSCDW--NMDDSA-------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
R+ + +
Sbjct: 414 LTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-42
Identities = 62/307 (20%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y I E +G+G +G+V ++T + + K + + +E+ +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHR 61
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQMLR 137
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----FTAPEY 169
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + A D+WS+G + +L+G F + T+ +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAE---------TN------QQI 211
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +Y ++ F + A+ + RL+ + K R TA EAL P
Sbjct: 212 IENI---MNAEY--TFDEEA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 315 YFKGLAK 321
+ K +
Sbjct: 260 WLKQKIE 266
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-42
Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 55/315 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + V+GKG+YG+V A D ++AIK+I + S + E+ L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLK 77
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM------TVFWTDY 189
LKY+H + HRD+K N+L N + LK+ DFG ++ P T+ +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM-- 190
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
APE+ Y A DIWS+GC E+ TGKP F ++L
Sbjct: 191 -------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELG-------- 229
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E A + + + P +P ++ A + + DP R A +
Sbjct: 230 ---EPQAAMF------KVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACAND 275
Query: 310 ALADPYFKGLAKIER 324
L D + K +K ++
Sbjct: 276 LLVDEFLKVSSKKKK 290
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-42
Identities = 75/324 (23%), Positives = 123/324 (37%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
Y++ E IG GSY V I T + A+K I E++ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++Y+H V HRDLKP NIL + +++CDFG A+ ++ T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLMTPCYTAN 185
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGT--- 249
+ APE L Y A DIWS+G + +LTG F +++ G
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ +V A L+ +++ DP R TA
Sbjct: 243 SGGY----------------------------WNSVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 310 ALADPYFKGLAKIEREPSCQPISK 333
L P+ ++ + + +
Sbjct: 275 VLRHPWIVHWDQLPQYQLNRQDAP 298
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 76/360 (21%), Positives = 126/360 (35%), Gaps = 90/360 (25%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++K +Y +V+G G G V + T EK A+K +
Sbjct: 3 HVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML------ 51
Query: 63 ISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN 120
D + REV+L R + P IV I + K + +V E ++ +L I+
Sbjct: 52 -QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD- 108
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDF 170
R F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DF
Sbjct: 109 ----RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
G A E G KY + D+WS+G I +L G P
Sbjct: 165 GF------------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPP 197
Query: 231 FPGKSVVHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
F + + +G P+PE + V
Sbjct: 198 FYSNHGLAISPGMKTRIRMGQYEFPNPE----------------------------WSEV 229
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
L++ L+ +P R T E + P+ K+ + P E + V +
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P+ ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 182
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F +
Sbjct: 183 SG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------------------- 215
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++ LL ++ DP R T ++ +FK
Sbjct: 216 ------VPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-41
Identities = 66/331 (19%), Positives = 123/331 (37%), Gaps = 58/331 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
R ++ V+ +G + V A D +G + A+K++ + I++EV ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVI---KANDDLTREHHQFFLYQML 136
+IV+ + L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 137 RALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--- 191
RA+++MH + HRDLK +N+L + +K+CDFG A +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 192 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YR PE+ +S DIW++GCI + + F + +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+V KY PP + L++ ++ +P++
Sbjct: 260 ------------RIVN----GKY-----SIPP------HDTQYTVFHSLIRAMLQVNPEE 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R + E + + +A PI++L
Sbjct: 293 RLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-41
Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y I E +G+GS+G V A T +KVA+K I + + +R+ RE+ L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP+N+L + N +K+ DFGL+ + + + Y APE+
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----CGSPNYAAPEVIN 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y P +D+WS G + +L G+ F +
Sbjct: 181 G--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-------------------------- 212
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK ++ + P A L++R+I DP R T +E DP+F
Sbjct: 213 -----IPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 74/327 (22%), Positives = 121/327 (37%), Gaps = 62/327 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++ ++GKG +G V A +VAIK I + +SD++ EV LL +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 80 R----HPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLY 133
HP ++ + +V E DL I L + F
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG-----FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q++ A+++ H+ V HRD+K +NIL + K+ DFG + D P T F T
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF----DGT 201
Query: 193 RWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
R Y PE +Y +WS+G + +++ G F +
Sbjct: 202 RVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------------- 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ + P +V P L++R +A P RP+ EE L
Sbjct: 246 ------------------LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 312 ADPYFK-GLAKIEREPSCQPISKLEFE 337
DP+ + + PS + L +
Sbjct: 283 LDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
+Y++ ++G G +G V + I VAIK + + + + R+ EV LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
L A+++ H V HRD+K +NIL + N +LK+ DFG + DT T F TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF----DGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y PE + +Y + +WS+G + +++ G F +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------- 255
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+R + V L++ +A P DRPT EE
Sbjct: 256 ----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 314 PYFKG 318
P+ +
Sbjct: 295 PWMQD 299
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 67/309 (21%), Positives = 120/309 (38%), Gaps = 58/309 (18%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N Y + + +G+G + VV I TG++ A K + IL E+ +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI--KANDDLTREHHQFFLYQ 134
P ++ + + +++ I ++ E ++ + + + ++ + Q
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 135 MLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+L + Y+H N+ H DLKP+NIL +K+ DFG++R + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----MG 195
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT-- 249
T Y APE+ + T A D+W+IG I +LT F G+ I
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--SQVNVD 251
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
F +V LA +Q L+ +P+ RPTAE
Sbjct: 252 YSEET----------------------------FSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 309 EALADPYFK 317
L+ + +
Sbjct: 284 ICLSHSWLQ 292
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 85/362 (23%), Positives = 136/362 (37%), Gaps = 55/362 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY ++ IG G++GV D T E VA+K I D + RE+ R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDE-NVQREIINHRSLRHPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K ++L P+ + ++ E +L++ I + + +FF Q+L + Y
Sbjct: 78 IVRFKEVILTPTH-----LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 143 HTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
H+ + HRDLK +N L + +LK+CDFG ++ + + V T Y APE+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 188
Query: 201 CGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
+Y D+WS G +L G F
Sbjct: 189 ----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY----------------- 227
Query: 258 VRNEKARKYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
RK + + K +P + P L+ R+ DP R + E +F
Sbjct: 228 ------RKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278
Query: 317 -KGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEGTN 375
K L S E E + + D I ++I P + ++ N
Sbjct: 279 LKNLPADLMNESNTGSQFQEPEQPMQSL--DTIMQIISEAT---IPAVRNRCLDDFMTDN 333
Query: 376 FL 377
Sbjct: 334 LD 335
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 57/303 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLLR 77
+Y + +G G++G V A+D ++V +K I D + ++ E+ +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
+ H +I+++ I +V E S DL I + L + Q+
Sbjct: 85 RVEHANIIKVLDIFENQGF-----FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ A+ Y+ ++ HRD+K +NI+ + +K+ DFG A F T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF----CGTIEY 195
Query: 196 RAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE+ + Y P +++WS+G ++ + F
Sbjct: 196 CAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCE--------------------- 232
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ PP V + L+ L+ P+ R T E+ + DP
Sbjct: 233 ---LEETVEAAI------HPP-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276
Query: 315 YFK 317
+
Sbjct: 277 WVT 279
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-40
Identities = 89/347 (25%), Positives = 143/347 (41%), Gaps = 63/347 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++ EV+G+G++GVVC A + VAIK+I E A E++ L +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIES--ESERKAFI--VELRQLSRVN 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQFFLYQML 136
HP+IV++ L P + +V E E L+ V+ + T H + Q
Sbjct: 60 HPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 137 RALKYMHTAN---VYHRDLKPKNILANANCK-LKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+ + Y+H+ + HRDLKP N+L A LK+CDFG A T M T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHM----TNNKGS 166
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE+ S Y+ D++S G I EV+T + F +G P+
Sbjct: 167 AAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAF 211
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ V N +PP+ N+ L+ R + DP RP+ EE +
Sbjct: 212 RIMWAVHN----------GTRPPLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIV- 255
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEY 359
K + + R L++ + +D R Y + E+
Sbjct: 256 ----KIMTHLMRYFPGADE-PLQYPCQHSLPPGEDGRVEPYVDFAEF 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 54/315 (17%)
Query: 23 NRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ Y + E++G G +G V +T TG K+A K I + D + E+ ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKRIMLPPSKREF---KDIYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQM 135
H +++++ F DI +V E ++ +L ++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 136 LRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++MH + H DLKP+NIL ++K+ DFGLAR + V T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTP 252
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE + F + D+WS+G I +L+G F G D
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGD---------ND------A 294
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
ET+ + R L + ++F ++ A + +L+ + R +A EAL
Sbjct: 295 ETLNNIL--ACRWDLED----------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 313 DPYFKGLAKIEREPS 327
P+ R +
Sbjct: 343 HPWLSDHKLHSRLSA 357
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 68/298 (22%), Positives = 109/298 (36%), Gaps = 54/298 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-----REVKLLRLLR 80
+ + IGKG +G+V VAIK + + REV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI-KANDDLTREHHQFFLYQMLRA 138
HP+IV++ +M P +V E + DL+ + + + +
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYMHTAN--VYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
++YM N + HRDL+ NI NA KV DFGL++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGN---- 189
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
+W APE G+ YT D +S I +LTG+ F S
Sbjct: 190 FQW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ I ++R E R P +P + P +++ + DPK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 187
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F
Sbjct: 188 SG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDH------------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++P + LL+ ++ DP R T ++ +FK
Sbjct: 221 ------VPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 38/287 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + IG GS+G V G+ VA+K ++ EV +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMH 143
P + +V + E S L+ + A++ + Q R + Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
++ HRDLK NI + + +K+ DFGLA S + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ D+++ G + E++TG+ + + I +V
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------------NNRDQIIEMV---- 238
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
R L V N RL+ + +RP+
Sbjct: 239 GRGSL--SPDLSKVR-----SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-38
Identities = 77/339 (22%), Positives = 134/339 (39%), Gaps = 33/339 (9%)
Query: 4 DQTKKELKDKDFFTEYG---DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+Q +K L+ + + ++ + +G G+ GVV +G +A K IH +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE 69
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKA 119
+ +I+RE+++L P IV +I + E M+ L QV+K
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKK 124
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
+ + +++ L Y+ + HRD+KP NIL N+ ++K+CDFG++
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LI 183
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D+ F V TR Y +PE L G + Y+ DIWS+G E+ G+ P
Sbjct: 184 DSMANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF---QKFPNVDPLALRLLQ 294
+ + + ET R M +PP+ +F N P L
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
Query: 295 RLIAF----------DPKDRPTAEEALADPYFKGLAKIE 323
+ F +P +R ++ + + K E
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
I E IG GS+G V A G VA+K + + H LREV +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKY 141
+ P + +V E + L++++ + L Y + + + Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H N + HR+LK N+L + +KVCDFGL+R+ S + T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ D++S G I E+ T + + ++ ++ AV
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGN---LNPAQVV-----------AAVGF 253
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
K+ +P N++P +++ +P RP+
Sbjct: 254 K----------CKRLEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 53/314 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+I E+IGKG +G V GE VAI+ I ++ REV R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 86 E-IKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALKYM 142
+ M PP + ++ L + L+ V+ A L + ++++ + Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--APEL 200
H + H+DLK KN+ + N K+ + DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 201 -------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
++ D++++G I+ E+ + F + P+
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---------------PAEA 250
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I + KP + + +L AF+ ++RPT + +
Sbjct: 251 IIWQMGT----------GMKPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMD- 295
Query: 314 PYFKGLAKIEREPS 327
+ L K R S
Sbjct: 296 -MLEKLPKRNRRLS 308
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 71/385 (18%), Positives = 133/385 (34%), Gaps = 53/385 (13%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ L + + + Y++L VIGKG V A TGE V +++I ++
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLE 63
Query: 61 EHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVI 117
++ + + E+ + +L HP+IV + + ++ ++VV M S +I
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGS-AKDLI 117
Query: 118 KA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
D + + L +L+AL Y+H HR +K +IL + + K+ +
Sbjct: 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 176 AFSD----TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-- 229
S + F V + +PE+ Y DI+S+G E+ G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 230 --------LF----------PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271
L S + +L + + ++ +
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 272 KKPPV-----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
P P F F V+ + LQR +P RP+A L +FK + + E
Sbjct: 298 PSHPYHRTFSPHFHHF--VE----QCLQR----NPDARPSASTLLNHSFFKQIKRRASEA 347
Query: 327 SCQPISKLEFEFERRRVTKDDIREL 351
+ + + D +
Sbjct: 348 LPELLRPVTPITNFEGSQSQDHSGI 372
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 60/296 (20%), Positives = 102/296 (34%), Gaps = 48/296 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EV+GKG +G TGE + +K++ E L+EVK++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRCLEHPNVL 70
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ I + + + E ++ L +IK+ D F + + Y+
Sbjct: 71 KFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ N+ HRDL N L N + V DFGLAR+ + + + G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 203 SF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ Y +D++S G + E++ P P
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTM 230
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ P PN P + R DP+ RP+ +
Sbjct: 231 DFGLNVRGFLD---------RYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVK 272
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 58/298 (19%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIR-ILREVKLLRLLRHPD 83
+ E+IG G +G V A G++VA+K D E IS I + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ ++ + L + +V E L++V+ + + + Q+ R + Y+
Sbjct: 68 IIALRGVCLKEPN-----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYL 121
Query: 143 HTANVY---HRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
H + HRDLK NIL +N LK+ DFGLAR T M+
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA---- 177
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
W APE+ + S ++ D+WS G + E+LTG+ F G
Sbjct: 178 YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID---------------G 219
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V K P+P +L++ DP RP+
Sbjct: 220 LAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 84/374 (22%), Positives = 141/374 (37%), Gaps = 91/374 (24%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY ++ +G G + V + D + VA+K + EH ++ E++LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 82 PDIVEIKRIMLPPSKREFKD-------IYVVFELMESDLHQVIKANDD--LTREHHQFFL 132
D + R M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 133 YQMLRALKYMHT-ANVYHRDLKPKNILANAN----------------------------- 162
Q+L+ L Y+HT + H D+KP+NIL + N
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 163 --------------------CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
K+K+ D G A + T TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQ----TRQYRSLEVL- 265
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIA 256
S Y DIWS C+ E+ TG LF S + LI +LLG + I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 257 VVRNEKARKY------LTEMRKKPPVPLFQ------KFPNVD-PLALRLLQRLIAFDPKD 303
+ ++++ L + K P LF+ ++ + L ++ P+
Sbjct: 325 --AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 304 RPTAEEALADPYFK 317
R TA E L P+
Sbjct: 383 RATAAECLRHPWLN 396
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 82/303 (27%), Positives = 129/303 (42%), Gaps = 54/303 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
RYKI++ +G G V A DT KVAIK I + + R REV L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 81 HPDIVEIKRIMLPPSKREFKDI-------YVVFELME-SDLHQVIKANDDLTREHHQFFL 132
H +IV + D+ Y+V E +E L + I+++ L+ + F
Sbjct: 70 HQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV-A 191
Q+L +K+ H + HRD+KP+NIL ++N LK+ DFG+A+ A S+T +T T++V
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQ--TNHVLG 174
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y +PE DI+SIG + E+L G+P F G +
Sbjct: 175 TVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNG----------------ET 216
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEA 310
+IA+ ++ P ++ ++ R D +R T +E
Sbjct: 217 AVSIAIKH----------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
Query: 311 LAD 313
D
Sbjct: 267 KDD 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 48/289 (16%), Positives = 93/289 (32%), Gaps = 52/289 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L + + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 86 EIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
+ PP+ ++ M L+ V+ + + Q F M R + +
Sbjct: 71 PVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAP 198
+HT + L ++++ + + ++ + S M W AP
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWV---------AP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E L + D+WS + E++T + F S + E
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMK 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
V E R P +P P + P +L++ + DP RP
Sbjct: 223 VALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 72/299 (24%), Positives = 118/299 (39%), Gaps = 52/299 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHP 82
Y++ ++G+G G V A DT VA+K + + R+ RE + L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 83 DIV------EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQM 135
+V EI + YV L+ DL +++ L + Q+
Sbjct: 95 HVVPIHDFGEIDGQL-----------YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL H A HRD+KP+NIL +A+ + DFG+A A +D +T V T +Y
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYY 201
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE S T DI+++ C+ E LTG P + G + +
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQG-------------------DQL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALAD 313
+V ++ + P + ++ R +A +P+DR T + A
Sbjct: 241 SV-----MGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 66/313 (21%), Positives = 113/313 (36%), Gaps = 47/313 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVK-LLRL 78
+ N + L +G G+ G V TG +A+K++ + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKS 80
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE-HHQFFLYQMLR 137
P IV+ + + D+++ ELM + ++ K E +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 138 ALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+ V HRD+KP NIL + ++K+CDFG++ Y
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYM 191
Query: 197 APE---LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSP 252
APE Y D+WS+G E+ TG+ P K+ L + P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEPP 248
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + FQ F L + D + RP + L
Sbjct: 249 ------LLPGHMGFSGD---------FQSFVK------DCLTK----DHRKRPKYNKLLE 283
Query: 313 DPYFKGLAKIERE 325
+ K +E +
Sbjct: 284 HSFIKRYETLEVD 296
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 85/375 (22%), Positives = 144/375 (38%), Gaps = 70/375 (18%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M LKD D + + + L IG GS+G V A D E VAIKK+
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 58 DVFEHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQV 116
+ ++ + I++EV+ L+ LRHP+ ++ + L ++V E +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDL 143
Query: 117 IKANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
++ + +E + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 ---RVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EVLTGK 228
+F TP +W APE+ +Y +D+WS+G I E+ K
Sbjct: 204 MAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERK 250
Query: 229 -PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
PLF N A L + + P Q +
Sbjct: 251 PPLF----------------------------NMNAMSALYHIAQNES-PALQS-GHWSE 280
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
+ + P+DRPT+E L + +P + + +R + +
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---------RERPPTVIMDLIQRTKDAVRE 331
Query: 348 IRELIYREILEYHPQ 362
+ L YR++ + Q
Sbjct: 332 LDNLQYRKMKKILFQ 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-36
Identities = 85/383 (22%), Positives = 140/383 (36%), Gaps = 88/383 (22%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---H 57
M D + L + D A ++++E++G G+YG V TG+ AIK +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELME----SD 112
D E I I +L++ H +I + + D +++V E +D
Sbjct: 62 DEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L + K N L E + ++LR L ++H V HRD+K +N+L N ++K+ DFG+
Sbjct: 117 LIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 173 A---------RVAFSDTPMTVFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCI 220
+ R F TP +W APE C + Y D+WS+G I
Sbjct: 176 SAQLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-I 222
Query: 221 FA-EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV--- 276
A E+ G P + L LI R P
Sbjct: 223 TAIEMAEGAPPLCDMHPMRALFLIP--------------------------RNPAPRLKS 256
Query: 277 ----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPIS 332
FQ F ++ L + + RP E+ + P+ + Q
Sbjct: 257 KKWSKKFQSF--IE----SCLVK----NHSQRPATEQLMKHPFIRDQPNER-----QVRI 301
Query: 333 KLEFEFERRRVTKDDIRELIYRE 355
+L+ +R + + + E Y
Sbjct: 302 QLKDHIDRTKKKRGEKDETEYEY 324
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-36
Identities = 80/320 (25%), Positives = 121/320 (37%), Gaps = 39/320 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ IGKG YG V GEKVA+K + R E+ L+RH +I+
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFT--TEEASWFR-ETEIYQTVLMRHENIL 94
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I + +Y++ + E+ L+ +K+ L + Y + L ++H
Sbjct: 95 GFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLH 151
Query: 144 TANVY--------HRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVATRW 194
T HRDLK KNIL N + D GLA SDT + + V T+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 195 YRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y PE L S + + D++S G I EV G +QL + P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSDP 270
Query: 251 SPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
S E + +V +K R P P +L+ A +P R TA
Sbjct: 271 SYEDMREIVCIKKLR---------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 310 ALADPYFKGLAKIEREPSCQ 329
K LAK+ +
Sbjct: 322 VK-----KTLAKMSESQDIK 336
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 79/328 (24%), Positives = 139/328 (42%), Gaps = 64/328 (19%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
+ +Q K L+ + GD IG+GS G+VC A + H+G +VA+K +
Sbjct: 25 VTHEQFKAALRM---VVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD-- 79
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+ EV ++R +H ++VE+ + L + ++V+ E ++ L ++
Sbjct: 80 LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-----LWVLMEFLQGGALTDIVS 134
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----- 173
L E +L+AL Y+H V HRD+K +IL + ++K+ DFG
Sbjct: 135 QVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 174 ----RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
R + TP +W APE+ S Y +DIWS+G + E++ G+P
Sbjct: 194 DVPKRKSLVGTP---YWM---------APEVISR--SLYATEVDIWSLGIMVIEMVDGEP 239
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
+ ++ + + +R PP P + V P+
Sbjct: 240 PY---------------------------FSDSPVQAMKRLRDSPP-PKLKNSHKVSPVL 271
Query: 290 LRLLQRLIAFDPKDRPTAEEALADPYFK 317
L+R++ DP++R TA+E L P+
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 70/311 (22%), Positives = 128/311 (41%), Gaps = 46/311 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A+ + + +G+G+YGVV +G+ +A+K+I + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHHQFFLYQM 135
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 136 LRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++AL+++H+ +V HRD+KP N+L NA ++K+CDFG++ D + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKP 174
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
Y APE Y+ DIWS+G E+ + FP S + ++ PSP
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSP 232
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ L + F F + + L++ + K+RPT E +
Sbjct: 233 Q-------------LPADKFSAE---FVDFTS------QCLKK----NSKERPTYPELMQ 266
Query: 313 DPYFKGLAKIE 323
P+F
Sbjct: 267 HPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 46/307 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A K L IG+G+YG V + +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHH-QFFLYQ 134
P IV+ + D ++ ELM + V DD+ E
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 135 MLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
++AL ++ + HRD+KP NIL + + +K+CDFG++ ++ T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCR 189
Query: 194 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250
Y APE + Y D+WS+G E+ TG+ P SV QL +
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK---GD 246
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P+ + N + R++ F F N L + D RP +E
Sbjct: 247 PPQ----LSNSEEREFSPS---------FINFVN------LCLTK----DESKRPKYKEL 283
Query: 311 LADPYFK 317
L P+
Sbjct: 284 LKHPFIL 290
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 75/325 (23%), Positives = 132/325 (40%), Gaps = 64/325 (19%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++L+ GD +Y E IG+G+ G V A+D TG++VAI++++ +
Sbjct: 3 EEILEKLRS---IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQ 57
Query: 63 ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND 121
I+ E+ ++R ++P+IV L + ++VV E + L V+
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETC 112
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------- 173
+ + L+AL+++H+ V HRD+K NIL + +K+ DFG
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 174 -RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
R TP +W APE+ Y P +DIWS+G + E++ G+P +
Sbjct: 172 KRSTMVGTP---YWM---------APEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPY- 216
Query: 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRL 292
NE + L + P Q + +
Sbjct: 217 --------------------------LNENPLRALYLIATNGT-PELQNPEKLSAIFRDF 249
Query: 293 LQRLIAFDPKDRPTAEEALADPYFK 317
L R + D + R +A+E L + K
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 79/304 (25%), Positives = 129/304 (42%), Gaps = 51/304 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + R RE + L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 81 HPDIVEI--------KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFF 131
HP IV + LP Y+V E ++ L ++ +T +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV- 190
+ +AL + H + HRD+KP NI+ +A +KV DFG+AR A +D+ +V T V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVI 180
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T Y +PE D++S+GC+ EVLTG+P F G S
Sbjct: 181 GTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------------- 223
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEE 309
++V A +++ E P+P + + ++ + +A +P++R TA E
Sbjct: 224 ---PVSV-----AYQHVRE----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271
Query: 310 ALAD 313
AD
Sbjct: 272 MRAD 275
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 73/324 (22%), Positives = 119/324 (36%), Gaps = 47/324 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ E IGKG +G V GE+VA+K R E+ +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ K +++V + E L + +T E L
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 140 KYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYV 190
++H + HRDLK KNIL N + D GLA S T V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 191 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L S K+ + DI+++G +F E+ + G +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV +K R P +P + + ++++ + R
Sbjct: 272 PSDPSVEEMRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 306 TAEEALADPYFKGLAKIEREPSCQ 329
TA K L+++ ++ +
Sbjct: 323 TALRIK-----KTLSQLSQQEGIK 341
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 59/312 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
A +Y++ I G G + A+D + G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV+I + + Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ +LK+ D G + T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYL------YGTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + T A DI+++G A + P G+ V P
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP--------- 285
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALADPYFKG 318
P+ + + + L R + DP+ R TAEE A
Sbjct: 286 --------------EDDPVLKTYDSYGRLLRRAIDP----DPRQRFTTAEEMSAQ----- 322
Query: 319 LAKIEREPSCQP 330
L + RE Q
Sbjct: 323 LTGVLREVVAQD 334
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 39/308 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + Y++ EVIG G+ VV AA EKVAIK+I ++ + + +L+E++ +
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCH 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD-----LTREHHQFF 131
HP+IV + + +++V +L+ D+ + I A + L
Sbjct: 72 HPNIVSYYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDY 189
L ++L L+Y+H HRD+K NIL + +++ DFG++ D +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
V T + APE+ Y DIWS G E+ TG + + ++ L
Sbjct: 187 VGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
P V++++ K F+K ++L L + DP+ RPTA E
Sbjct: 243 DPPSLETGVQDKEMLKKYG--------KSFRKM-----ISLCLQK-----DPEKRPTAAE 284
Query: 310 ALADPYFK 317
L +F+
Sbjct: 285 LLRHKFFQ 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 37/277 (13%), Positives = 81/277 (29%), Gaps = 49/277 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + ++G+G++ V A D +K +K + + + ++
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMER 120
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK-----ANDDLTREHHQ 129
L+ ++ L + +V EL L I + +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL-----------ANANCKLKVCDFGLARVAFS 178
F +ML ++ +H + H D+KP N + + + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
T+F T ++ E L + ID + + +L G +
Sbjct: 236 FPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 238 HQL---------------DLITDLLGTPSPETIAVVR 259
+ +L P + +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 84/341 (24%), Positives = 128/341 (37%), Gaps = 82/341 (24%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
M + L D + LE IGKGS+G V ID T + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQNLKA--DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DL 57
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ 115
E + I +E+ +L P + + L +K ++++ E + DL +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDLLE 112
Query: 116 VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
L L ++L+ L Y+H+ HRD+K N+L + + ++K+ DFG+A
Sbjct: 113 ----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
Query: 174 -------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
R F TP FW APE+ S Y DIWS+G E+
Sbjct: 169 LTDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLGITAIELAR 214
Query: 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV------PLFQ 280
G+P + L LI + PP +
Sbjct: 215 GEPPHSELHPMKVLFLIP--------------------------KNNPPTLEGNYSKPLK 248
Query: 281 KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+F V+ L + +P RPTA+E L + AK
Sbjct: 249 EF--VE----ACLNK----EPSFRPTAKELLKHKFILRNAK 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 69/331 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
++ +++LK D + + +LE +G+GSYG V AI TG+ VAIK++ V
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVE 65
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQV 116
+ + I++E+ +++ P +V+ + +++V E SD+ ++
Sbjct: 66 SDLQE---IIKEISIMQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRL 117
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--- 173
N LT + L L+ L+Y+H HRD+K NIL N K+ DFG+A
Sbjct: 118 R--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 174 ------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLT 226
R TP FW APE+ Y DIWS+G I A E+
Sbjct: 176 TDTMAKRNTVIGTP---FWM---------APEVIQE--IGYNCVADIWSLG-ITAIEMAE 220
Query: 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286
GKP P + + + + PP P F+K
Sbjct: 221 GKP--P-------------------------YADIHPMRAIFMIPTNPP-PTFRKPELWS 252
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+++ + P+ R TA + L P+ +
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 47/318 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+LE +GKG YG V + GE VA+K R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
++ ++++ E L+ ++ L + + L
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYMHTANVY--------HRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYV 190
++H HRDLK KNIL N + + D GLA + + S + V V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L + +DIW+ G + EV G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV ++ R P +P +L++ +P R
Sbjct: 238 PNDPSFEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 306 TAEEALADPYFKGLAKIE 323
TA K L KI+
Sbjct: 289 TALRIK-----KTLTKID 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 68/335 (20%), Positives = 124/335 (37%), Gaps = 69/335 (20%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
+K + + + ++I+ +G G++G V A + TG A K I + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEEL 60
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD 122
+ E+++L HP IV++ K ++++ E + +++ +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRG 113
Query: 123 LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--------- 173
LT Q QML AL ++H+ + HRDLK N+L +++ DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EVLTGK- 228
R +F TP +W APE+ K Y DIWS+G I E+ +
Sbjct: 174 RDSFIGTP---YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
Query: 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPL 288
P + L ++ K P P
Sbjct: 221 PHH----------------------------ELNPMRVLLKIAKSDP-PTLLTPSKWSVE 251
Query: 289 ALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
L+ + +P+ RP+A + L P+ + +
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 55/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + + + RE ++ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHP 90
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
V++ F+D +Y ++ +L + I+ +F+ +++ A
Sbjct: 91 FFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+Y+H + HRDLKP+NIL N + +++ DFG A+V ++ + +V T Y +P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSP 201
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
EL + D+W++GCI +++ G P F + I
Sbjct: 202 ELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--------------- 244
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALA 312
++ + P P A L+++L+ D R A
Sbjct: 245 -----------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288
Query: 313 DPYFKGL 319
P+F+ +
Sbjct: 289 HPFFESV 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 71/325 (21%), Positives = 120/325 (36%), Gaps = 49/325 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++LEV +G +G V A E VA+K + + EV L ++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMK 76
Query: 81 HPDIVE-IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +I++ I S D++++ E L +KAN ++ M R
Sbjct: 77 HENILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARG 133
Query: 139 LKYMHTANVY----------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L Y+H HRD+K KN+L N + DFGLA F
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHG 192
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V TR Y APE+ +F ID++++G + E+ + G + L +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 246 LLGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAF---- 299
+ PS E + VV ++K R P + + +L I
Sbjct: 253 IGQHPSLEDMQEVVVHKKKR---------PVLR-----DYWQKHAGMAMLCETIEECWDH 298
Query: 300 DPKDRPTAEEALADPYFKGLAKIER 324
D + R +A + + +++R
Sbjct: 299 DAEARLSAGCVG-----ERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 54/343 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + K+LE+IG+G YG V + VA+K + + + L+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVF---SFANRQNFINEKNIYRVPLME 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + +V E + L + + + + + R L
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGL 124
Query: 140 KYMHTANVY---------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
Y+HT HRDL +N+L + + DFGL+ + + D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 190 ----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVV-H 238
V T Y APE L G+ +D++++G I+ E+ LFPG+SV +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 239 QLDLITDLLGTPSPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
Q+ T++ P+ E +V EK R P P + + LA+R L+ I
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQR---------PKFP---EAWKENSLAVRSLKETI 292
Query: 298 ----AFDPKDRPTAEEALADPYFKGLAKI----EREPSCQPIS 332
D + R TA+ A + +A++ ER S P +
Sbjct: 293 EDCWDQDAEARLTAQXAE-----ERMAELMMIWERNKSVSPTA 330
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 70/328 (21%), Positives = 135/328 (41%), Gaps = 63/328 (19%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+++ F +IL IGKGS+G VC T + A+K ++ +
Sbjct: 4 PVFDENEDVNFDHF----------EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK--Q 51
Query: 62 HI--SDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLH 114
+ +R + +E+++++ L HP +V + F+D +++V +L+ DL
Sbjct: 52 KCVERNEVRNVFKELQIMQGLEHPFLVNLWY--------SFQDEEDMFMVVDLLLGGDLR 103
Query: 115 QVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
++ N E + F+ +++ AL Y+ + HRD+KP NIL + + + + DF +A
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ +T +T T+ Y APE + Y+ A+D WS+G E+L G+ +
Sbjct: 164 MLPRETQITTM----AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
R+ + K + + V +P + L
Sbjct: 220 -------------------------RSSTSSKEIVHTFETTVV----TYPSAWSQEMVSL 250
Query: 293 LQRLIAFDPKDR-PTAEEALADPYFKGL 319
L++L+ +P R + PY +
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 68/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 64
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKE 175
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 176 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 228
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 229 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 277
Query: 306 T 306
+
Sbjct: 278 S 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 95
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D Y
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKE 206
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 207 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 259
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 260 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 308
Query: 306 T 306
+
Sbjct: 309 S 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 69/296 (23%), Positives = 127/296 (42%), Gaps = 45/296 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
K + +G+G +G V +TGE+VA+K + E + I + +E+++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP--ESGGNHIADLKKEIEILRNLY 81
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +IV+ K I ++ I ++ E + S L + + N + + + + Q+ +
Sbjct: 82 HENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+ + HRDL +N+L + ++K+ DFGL + +D Y
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDSP 192
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WY APE SK+ A D+WS G E+LT S + L ++G
Sbjct: 193 VFWY-APE--CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPTH 244
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + L E ++ P P P + +L+++ F P +R +
Sbjct: 245 GQ----MTVTRLVNTLKEGKRLPC-------PPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 67
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + ++ Y++ E M +L ++ + +++ + Q+
Sbjct: 68 HPNLVQLLGVC---TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HRDL +N L N +KV DFGL+R+ DT Y A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 174
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 175 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 71/332 (21%), Positives = 118/332 (35%), Gaps = 67/332 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---- 57
+ + L DF + +IG+G +G V TG+ A+K +
Sbjct: 178 KNVELNIHLTMNDF----------SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 58 ---DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113
+ +L V P IV + P K + + +LM DL
Sbjct: 228 KMKQGETLALNERIMLSLVSTGD---CPFIVCMSYAFHTPDK-----LSFILDLMNGGDL 279
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
H + + + +F+ +++ L++MH V +RDLKP NIL + + +++ D GLA
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
P V T Y APE+ Y + D +S+GC+ ++L G F
Sbjct: 340 CDFSKKKPHA-----SVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
K + + M V + P + P L
Sbjct: 394 -------------------------HKTKDKHEIDRMTLTMAV----ELPDSFSPELRSL 424
Query: 293 LQRLIAFDPKDR-----PTAEEALADPYFKGL 319
L+ L+ D R A+E P+F+ L
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V + KVAIK I E + E +++ L
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP +V++ + L E I +V E ME L ++ E +
Sbjct: 62 HPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+ A V HRDL +N L N +KV DFG+ R D Y ++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE FS+Y+ D+WS G + EV + GK + +S VV +
Sbjct: 169 VKWA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF---WTDYVATRW 194
A++Y+ N HRDL +N+L + + KV DFGL + A S WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+L+ +G G +GVV VA+K I E +E + + L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRA 138
HP +V+ + + IY+V E + + L ++++ L Y +
Sbjct: 62 HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ ++ + HRDL +N L + + +KV DFG+ R D YV++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + KY+ D+W+ G + EV + GK + + VV ++
Sbjct: 169 VKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 26 KILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++LE +G GS+GVV + VA+K + DV +REV + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
+++ + ++L P + +V EL L ++ + + Q+ +
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 193 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G + ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
DA I +V+G G +G VC+ +K VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
+ +KY+ HRDL +NIL N+N KV DFGL RV D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW +PE + K+T A D+WS G + EV++ G+ + S V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 49/307 (15%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++IL+VIG+G++G V + + A+K ++ ++ E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 84 IVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQVIKANDDLTREHHQFFLYQMLRA 138
I + F+D +Y+V + DL + K D L E +F+L +M+ A
Sbjct: 136 ITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ +H + HRD+KP NIL + N +++ DFG D + V T Y +P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SV-AVGTPDYISP 245
Query: 199 EL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ +Y P D WS+G E+L G+ F +S+V I
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------------ 293
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALA 312
M K + +V A L++RLI + R E+
Sbjct: 294 --------------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKK 338
Query: 313 DPYFKGL 319
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 57/251 (22%), Positives = 105/251 (41%), Gaps = 33/251 (13%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K + +GKG++G V +TG VA+K++ H + D RE+++L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALH 82
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
IV+ + + P + + + +V E + S L ++ + L + Q+ +
Sbjct: 83 SDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + HRDL +NIL + +K+ DFGLA++ D YV
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK------DYYVVREPGQSP 193
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGT 249
WY APE + ++ D+WS G + E+ T K P + + D
Sbjct: 194 IFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VP 248
Query: 250 PSPETIAVVRN 260
+ ++
Sbjct: 249 ALSRLLELLEE 259
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 56/249 (22%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILE-VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHIS 64
+E++ K+ + D + + +G G++G V VA+K + + +
Sbjct: 4 EEIRPKEVYL---DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDL 123
+L E +++ L +P IV + I S +V E+ E L++ ++ N +
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 114
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
++ ++Q+ +KY+ +N HRDL +N+L K+ DFGL++ +D
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--- 171
Query: 184 VFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
Y A +WY APE + K++ D+WS G + E + G+ + G
Sbjct: 172 ---NYYKAQTHGKWPVKWY-APE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 236 ---VVHQLD 241
V L+
Sbjct: 226 GSEVTAMLE 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
R ++ IG+G +G V I VAIK SD++R L+E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 69
Query: 76 LRLLRHPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ AL Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 174
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 175 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 29/236 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+A+R I ++IG G G VC G+ VAIK + + L E ++
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMG 105
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQM 135
HP+I+ ++ ++ + +V E ME+ L ++ +D T L +
Sbjct: 106 QFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
++Y+ HRDL +N+L ++N KV DFGL+RV D Y T
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGK 215
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE F ++ A D+WS G + EVL G+ + + V+ ++
Sbjct: 216 IPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 72/331 (21%), Positives = 120/331 (36%), Gaps = 61/331 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+ L+ DF +IL+VIG+G++ V TG+ A+K ++
Sbjct: 51 VRLKEVRLQRDDF----------EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQV 116
+ E +L I ++ F+D +Y+V E DL +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLHF--------AFQDENYLYLVMEYYVGGDLLTLL 152
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
K + + E +F+L +++ A+ +H HRD+KP NIL + +++ DFG
Sbjct: 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 177 FSDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+D + V T Y +PE+ G Y P D W++G E+ G+ F
Sbjct: 213 RADGTVRS-LV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
S I + K + L V A
Sbjct: 271 YADSTAETYGKI--------------------------VHYKEHLSLPLVDEGVPEEARD 304
Query: 292 LLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+QRL+ P+ R A + P+F GL
Sbjct: 305 FIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 54/235 (22%), Positives = 102/235 (43%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + Y++ E M +L ++ + +++ + Q+
Sbjct: 275 HPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HR+L +N L N +KV DFGL+R+ DT Y A
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 381
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 382 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 34/238 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLL 76
+ L+V+G G +G V + GE V IK I D + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAI 69
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
L H IV + + S + +V + + L ++ + L + + Q
Sbjct: 70 GSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ + + Y+ + HR+L +N+L + +++V DFG+A + D +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSE 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 177 AKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D L+ +G G +GVV VAIK I E + E K++ L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 77
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +V++ + + + I+++ E M + L ++ + + A
Sbjct: 78 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + HRDL +N L N +KV DFGL+R D +Y ++
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFP 184
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW PE +SK++ DIW+ G + E+ + GK + + +
Sbjct: 185 VRWS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 71/328 (21%), Positives = 122/328 (37%), Gaps = 61/328 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+K +D+ ++++VIG+G++G V T + A+K +
Sbjct: 59 NKIRDLRMKAEDY----------EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI 117
SD+ E ++ P +V++ F+D +Y+V E M DL ++
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-RVA 176
N D+ + +F+ +++ AL +H+ HRD+KP N+L + + LK+ DFG ++
Sbjct: 161 S-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 177 FSDTPMTVFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
T V T Y +PE Y D WS+G E+L G F
Sbjct: 220 KEGMVRC--DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
S+V I M K + F ++ A L+
Sbjct: 277 SLVGTYSKI--------------------------MNHKNSLT-FPDDNDISKEAKNLIC 309
Query: 295 RLIAFDPKDR---PTAEEALADPYFKGL 319
+ D + R EE +FK
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFKND 336
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 37/291 (12%), Positives = 69/291 (23%), Gaps = 65/291 (22%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
RY++L G A+DT +VA+ + L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + ++ VV E + L +V + + + + A
Sbjct: 90 KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H A V P + + + + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
P DI IG +L + P V +A
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGV---------------RSGLAPAE 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ A P+ ++ + R + D R +
Sbjct: 216 RDTA---------GQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 100
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
H +I+ ++ ++ SK + + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVI---SKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 193 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE + K+T A D+WS G + EV+T G+ + S V+ ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPD 83
+ E IG+G++G V + VA+K E + ++ L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
IV + + ++++ IY+V EL++ D ++ L + + ++Y
Sbjct: 174 IVRLIGVC---TQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + HRDL +N L LK+ DFG++R V +W APE
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE-- 285
Query: 202 GSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+ + +Y+ D+WS G + E + G +P S ++
Sbjct: 286 -ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/323 (20%), Positives = 123/323 (38%), Gaps = 57/323 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDI 84
V+G+G +G V A TG+ A KK++ + + E K+L + I
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DL----HQVIKANDDLTREHHQFFLYQMLRAL 139
V + + + +V +M D+ + V + N F+ Q++ L
Sbjct: 248 VSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H N+ +RDLKP+N+L + + +++ D GLA + T Y T + APE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT---KGYAGTPGFMAPE 359
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L +Y ++D +++G E++ + F R
Sbjct: 360 LLLG--EEYDFSVDYFALGVTLYEMIAARGPFRA-------------------------R 392
Query: 260 NEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
EK K L + + V +P P + + L+ DP+ R + +
Sbjct: 393 GEKVENKELKQRVLEQAV----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 313 DPYFKGL--AKIER---EPSCQP 330
P F+ + ++E P P
Sbjct: 449 HPLFRDISWRQLEAGMLTPPFVP 471
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ ++G+G +G V + T+ VA+K + + + + E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVI 66
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
++ L HP IV++ I+ +++ EL +L ++ N + L +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ +A+ Y+ + N HRD+ +NIL + +K+ DFGL+R + DY
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKAS 172
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 173 VTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 320
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 321 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 426
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 427 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 237
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 238 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 343
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 344 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++ V+GKG +G VCA TG+ A KK+ + L E ++L +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + +V LM DL H F+ ++ L+
Sbjct: 246 VVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLKP+NIL + + +++ D GLA V T V T Y APE
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-----RVGTVGYMAPE 355
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +YT + D W++GC+ E++ G+ F R
Sbjct: 356 VVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQ-------------------------R 388
Query: 260 NEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
+K R+ + + K+ P ++ P A L +L+ DP +R +A E
Sbjct: 389 KKKIKREEVERLVKEVPE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 313 DPYFKGL 319
P FK L
Sbjct: 445 HPLFKKL 451
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
+ K+L+ IGKG +G V + G KVA+K I + DA L E ++
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQ 242
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQM 135
LRH ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 243 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
A++Y+ N HRDL +N+L + + KV DFGL + A S +W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT 353
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 354 -APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 66/296 (22%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
K + +G+G +G V + TGE VA+K K +H S +E+ +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTL 90
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+H + HRDL +N+L + + +K+ DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WY APE K+ A D+WS G E+LT S +L+G
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQ 252
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + + L + P P+ P + L++ + RPT
Sbjct: 253 GQ----MTVLRLTELLERGERLPR-------PDKCPAEVYHLMKNCWETEASFRPT 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 81
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +KY+ + HRDL +N + + +KV DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
Query: 245 D 245
Sbjct: 247 Q 247
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 89 RIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTAN 146
+ + + +V E+ LH+ + + + + L+Q+ +KY+ N
Sbjct: 77 GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPE 199
HRDL +N+L K+ DFGL++ +D Y A +WY APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-APE 183
Query: 200 LCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 184 ---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 37/236 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQML 136
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT---- 192
+ ++ N HRDL+ NIL + K+ DFGLAR+ + +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + +T D+WS G + E++T G+ +PG + V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 30/244 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
D N + +++G+G +G V KVA+K + + L E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQF 130
HP+++ + + + S + V+ M+ DLH + + + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-Y 189
F+ + ++Y+ N HRDL +N + + + V DFGL++ ++ D Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYY 203
Query: 190 VAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241
+W A E YT D+W+ G E+ T G +PG D
Sbjct: 204 RQGRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 242 LITD 245
+
Sbjct: 261 YLLH 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 145
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +K++ + HRDL +N + + +KV DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 245 D 245
Sbjct: 311 Q 311
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF 60
+ ++ + F ++ +G GS+G V +G A+K V
Sbjct: 31 ETPSQNTAQLDQF----------DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 61 -----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-- 110
EH + RIL+ V P +V+++ FKD +Y+V E +
Sbjct: 81 KLKQIEHTLNEKRILQAV------NFPFLVKLEF--------SFKDNSNLYMVMEYVAGG 126
Query: 111 ---SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167
S L ++ + ++ R F+ Q++ +Y+H+ ++ +RDLKP+N+L + ++V
Sbjct: 127 EMFSHLRRIGRFSEPHAR----FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ T WT T APE+ S Y A+D W++G + E+ G
Sbjct: 183 TDFGFAKRVKGRT-----WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAG 234
Query: 228 KPLF 231
P F
Sbjct: 235 YPPF 238
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ + +G G +G V A KVA+K + + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLV 246
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ + IY++ E M L +K+++ + + F Q+ + ++
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWY 195
N HRDL+ NIL +A+ K+ DFGLARV + +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE F +T D+WS G + E++T G+ +PG S V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 31/227 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRL 401
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTA 145
+ + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 402 IGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAP 198
N HR+L +N+L K+ DFGL++ +D Y A +WY AP
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-AP 508
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
E F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 509 E--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 36/233 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ IG+G +G V I VAIK + S + L+E +R HP
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHP 451
Query: 83 DIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
IV++ ++ P ++++ EL +L ++ L + YQ+ AL
Sbjct: 452 HIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKLPI 556
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 557 KWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 54/245 (22%), Positives = 99/245 (40%), Gaps = 31/245 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
++ + ++GKG +G V A KVA+K + SD LRE ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 78 LLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQ 129
HP + ++ + L +K V+ M+ DLH + A+ +L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
F+ + ++Y+ + N HRDL +N + + + V DFGL+R ++ DY
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDY 192
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240
+ +W A E + YT D+W+ G E++T G+ + G
Sbjct: 193 YRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 241 DLITD 245
+ +
Sbjct: 250 NYLIG 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-22
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+ VIGKG +GVV + + AIK + + E + LRE L+R
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMR 77
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
L HP+++ + IMLPP +V+ M DL Q I++ + T + F Q+
Sbjct: 78 GLNHPNVLALIGIMLPPEGL----PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
R ++Y+ HRDL +N + + + +KV DFGLAR +Y +
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR--------EYYSVQQH 185
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E ++T D+WS G + E+LT G P + + H L
Sbjct: 186 RHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 40/239 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRL 78
E +G+G++ + + G+ +V +K + H + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSK 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQML 136
L H +V + + + +V E ++ L +K N + + Q+
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 RALKYMHTANVYHRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
A+ ++ + H ++ KNIL +K+ D G++ D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------D 175
Query: 189 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W PE C A D WS G E+ + G + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 8e-22
Identities = 74/315 (23%), Positives = 125/315 (39%), Gaps = 77/315 (24%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
++IL +G GS+G V H G A+K K V E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQ 134
I+ + F+D I+++ + +E S L + + + + + F+ +
Sbjct: 67 FIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAE 114
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-----DY 189
+ AL+Y+H+ ++ +RDLKP+NIL + N +K+ DFG A+ T +T DY
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDY 169
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
+ APE+ + Y +ID WS G + E+L G F + + + I
Sbjct: 170 I------APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------ 215
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----- 304
+ + P P + LL RLI D R
Sbjct: 216 --------------------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 305 PTAEEALADPYFKGL 319
E+ P+FK +
Sbjct: 251 NGTEDVKNHPWFKEV 265
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-21
Identities = 78/311 (25%), Positives = 133/311 (42%), Gaps = 64/311 (20%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L V+GKG YG V +TG+ A+K K + + D E +L ++
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ EL + ++ + F+L +
Sbjct: 80 HPFIVDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAE 129
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H + +RDLKP+NI+ N +K+ DFGL + + D +T + T
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIE 186
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE L S + A+D WS+G + ++LTG P F G++ +D I
Sbjct: 187 YMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI---------- 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AE 308
++ K +P P + A LL++L+ + R P A
Sbjct: 234 ----------------LKCKLNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 309 EALADPYFKGL 319
E A P+F+ +
Sbjct: 273 EVQAHPFFRHI 283
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L+++GKG++G V + TG A+K + +V + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ +K + + V E +L + T E +F+ +++ AL+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE L
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLE 178
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 179 D---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------ 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ ++ P + P A LL L+ DPK R A+E + +F
Sbjct: 218 --------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 317 KGL 319
+
Sbjct: 265 LSI 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 49/301 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
L+++GKG++G V + TG A+K + +V + L E ++L+ RHP +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+K + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 212 ALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
NV +RDLK +N++ + + +K+ DFGL + D + T Y APE+
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED 323
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 324 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------------------- 361
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFKG 318
+ ++ P + P A LL L+ DPK R A+E + +F G
Sbjct: 362 ------LMEEIRFP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
Query: 319 L 319
+
Sbjct: 411 I 411
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 70/324 (21%), Positives = 125/324 (38%), Gaps = 59/324 (18%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVF 60
++ + +LK +DF + +++GKGS+G V A T + AIK + DV
Sbjct: 6 ERPSLQIKLKIEDF----------ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 61 EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
D + E ++L L HP + + ++ V E + DL I+
Sbjct: 56 LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQ 110
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VA 176
+ F+ +++ L+++H+ + +RDLK NIL + + +K+ DFG+ + +
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T + T Y APE+ KY ++D WS G + E+L G+ F G+
Sbjct: 171 GDAKTNT-----FCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
I P P ++ A LL +L
Sbjct: 224 EELFHSI--------------------------RMDNPFYP-----RWLEKEAKDLLVKL 252
Query: 297 IAFDPKDR-PTAEEALADPYFKGL 319
+P+ R + P F+ +
Sbjct: 253 FVREPEKRLGVRGDIRQHPLFREI 276
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 9e-20
Identities = 60/305 (19%), Positives = 112/305 (36%), Gaps = 53/305 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ L V+GKGS+G V + T E A+K + DV D + E + L + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ + +Y V E + DL I+ H F+ ++ L +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRAPE 199
+ + + +RDLK N++ ++ +K+ DFG+ + + T T + T Y APE
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGTPDYIAPE 512
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ Y ++D W+ G + E+L G+ F G+ I
Sbjct: 513 IIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---------------- 554
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADP 314
M P ++ A+ + + L+ P R +
Sbjct: 555 ----------MEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599
Query: 315 YFKGL 319
+F+ +
Sbjct: 600 FFRYI 604
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 70/310 (22%), Positives = 127/310 (40%), Gaps = 64/310 (20%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L+V+G+GS+G V + + A+K K + D +R E +L +
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVN 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ +L + L + + ++ + F+L +
Sbjct: 85 HPFIVKLHYAFQTEGK-----LYLILDFLRGGDLF-TRLSKEVMFTEEDVK----FYLAE 134
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H+ + +RDLKP+NIL + +K+ DFGL++ + + T
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVE 191
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ +T + D WS G + E+LTG F GK + +I
Sbjct: 192 YMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI----------- 238
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEE 309
++ K +P + P A LL+ L +P +R EE
Sbjct: 239 ---------------LKAKLGMP-----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278
Query: 310 ALADPYFKGL 319
+F +
Sbjct: 279 IKRHSFFSTI 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 52/257 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ +G+G++G V A VA+K + + S++ R RE
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREA 94
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-- 130
+LL +L+H IV + E + + +VFE M DL++ ++++ +
Sbjct: 95 ELLTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Q+ + Y+ + HRDL +N L +K+ DFG++R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-- 207
Query: 178 SDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
++ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ------IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 229 PLFPGKSVVHQLDLITD 245
+ S +D IT
Sbjct: 259 QPWYQLSNTEAIDCITQ 275
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 65/251 (25%), Positives = 105/251 (41%), Gaps = 49/251 (19%)
Query: 26 KILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ +G+G++G V A T VA+K + D + RE +LL L+
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQ 75
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDLTREHHQF 130
H IV+ + + + +VFE M+ DL++ ++A+ + +
Sbjct: 76 HEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 131 FLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
L QML + Y+ + + HRDL +N L AN +K+ DFG++R
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD-------- 182
Query: 184 VFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
V+ TDY RW PE + K+T D+WS G I E+ T GK +
Sbjct: 183 VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 235 SVVHQLDLITD 245
S ++ IT
Sbjct: 240 SNTEVIECITQ 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 65/306 (21%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A+K + ++ D + E + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 71 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 182
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 183 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 221 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 277 PFFRNV 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 63/331 (19%), Positives = 115/331 (34%), Gaps = 69/331 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI----- 56
+ + +K DF L V+GKGS+G V + T E A+K +
Sbjct: 9 DNNGNRDRMKLTDF----------NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV 58
Query: 57 --HDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113
D E R+L + P + ++ + +Y V E + DL
Sbjct: 59 IQDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDL 108
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
I+ H F+ ++ L ++ + + +RDLK N++ ++ +K+ DFG+
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ D T + T Y APE+ Y ++D W+ G + E+L G+ F G
Sbjct: 169 KENIWDGVTT---KTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ I M P ++ A+ +
Sbjct: 224 EDEDELFQSI--------------------------MEHNVAYP-----KSMSKEAVAIC 252
Query: 294 QRLIAFDPKDR----PT-AEEALADPYFKGL 319
+ L+ P R P + +F+ +
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 37/167 (22%), Positives = 67/167 (40%), Gaps = 30/167 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
+++ + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLAR 174
Q++ ++Y+H+ N+ +RD+KP+N L + + DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 64/306 (20%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A++ + ++ D + E + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 114 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 225
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 226 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 263
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 264 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 320 PFFRNV 325
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 58/305 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHPDI 84
L+VIGKGS+G V A A+K + + I+ E LL+ ++HP +
Sbjct: 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 85 VEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
V + K +Y V EL H ++ +F+ ++ A
Sbjct: 102 VGLHFSFQTADK-----LYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASA 151
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T T + T Y AP
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAP 208
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y +D W +G + E+L G P F ++ D I
Sbjct: 209 EVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------------- 251
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PTAEEALADP 314
+ K + PN+ A LL+ L+ D R E +
Sbjct: 252 -----------LNKPLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
Query: 315 YFKGL 319
+F +
Sbjct: 296 FFSLI 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 54/259 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ + +E +G+ +G V + VAIK + + +R E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEA 63
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDL 123
L L+HP++V + ++ +K + + ++F DLH+ + DD
Sbjct: 64 MLRARLQHPNVVCLLGVV---TKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 124 TREHHQFFLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
+ ++Y+ + +V H+DL +N+L +K+ D GL R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE- 177
Query: 177 FSDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-- 226
V+ DY RW APE + K++ DIWS G + EV +
Sbjct: 178 -------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFSYG 227
Query: 227 GKPLFPGKSVVHQLDLITD 245
+P + G S +++I +
Sbjct: 228 LQP-YCGYSNQDVVEMIRN 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 84
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 85 LIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 193 -IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 249 KSNQEVLEFVTS 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 68/305 (22%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 27 ILEVIGKGSYG---VVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
+L+V+G G+YG +V TG+ A+K + + + E ++L +R
Sbjct: 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 82 -PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V + +K ++++ + + +L + + T Q ++ +++ AL
Sbjct: 118 SPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H + +RD+K +NIL ++N + + DFGL++ +D + + T Y AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YD-FCGTIEYMAPD 230
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ S + A+D WS+G + E+LTG F + I+ +
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------------ 278
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALADP 314
++ +PP P + LA L+QRL+ DPK R P A+E
Sbjct: 279 ----------LKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 315 YFKGL 319
+F+ +
Sbjct: 324 FFQKI 328
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 50/254 (19%), Positives = 97/254 (38%), Gaps = 54/254 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+GS+G+V + + +VAIK ++ E S RI L E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 81
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF---- 130
++ +V + ++ + + V+ ELM DL +++ +
Sbjct: 82 MKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 131 ------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
++ + Y++ HRDL +N + + +K+ DFG+ R +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------I 188
Query: 185 FWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+ TDY YR +PE +T D+WS G + E+ T + +
Sbjct: 189 YETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 232 PGKSVVHQLDLITD 245
G S L + +
Sbjct: 242 QGLSNEQVLRFVME 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 56/307 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
++ + V+GKGS+G V A TG+ A+K + DV D + E + L HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ P + ++ V E + DL I+ + +F+ +++ AL +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLK N+L + K+ DFG+ + T T + T Y APE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGTPDYIAPE 194
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L Y PA+D W++G + E+L G F ++ + I
Sbjct: 195 ILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------------- 236
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR------PTAEEALA 312
+ + P + A +L+ + +P R L
Sbjct: 237 -----------LNDEVVYP-----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280
Query: 313 DPYFKGL 319
P+FK +
Sbjct: 281 HPFFKEI 287
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 125
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 126 LIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 234 -IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 290 KSNQEVLEFVTS 301
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 30/166 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
NRY++ IG GS+G + D GE+VAIK E + L E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I I+ E +V EL+ L + +F L
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLAR 174
QM+ ++Y+H+ N HRD+KP N L N + + DFGLA+
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAK 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.1 bits (199), Expect = 4e-17
Identities = 52/349 (14%), Positives = 93/349 (26%), Gaps = 75/349 (21%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------HDVFEHI 63
F+ + + E IG+G +G V I HT VAIK I FE I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 64 SDAIRILREVKLLRLL---RHPDIVEIKRIML-------------------------PPS 95
I I +E+ LL R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKP 154
+ +++V E + + + L+Q+ +L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + T+ + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK------SSTIPSCGLQVSII------------DYTLSRLE 232
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------ARKYL 267
+F +V + LF G +Q D I L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + + ++ F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 32/168 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
YK+ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL------ANANCKLKVCDFGLAR 174
QML ++ +H ++ +RD+KP N L NAN + V DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 28/165 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
N++++ IG GS+G + + T E+VAIK E++ L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ E +V +L+ L + + L
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCS------RKLSLKTVLMLA 109
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
QM+ ++++H+ + HRD+KP N L ++ + DFGLA+
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 34/177 (19%), Positives = 68/177 (38%), Gaps = 35/177 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N++ + + IG G +G++ A T+ EK A + E+ + + E+K + +
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAK 92
Query: 82 PDIVEIKRIMLPPSKREFKDIY--------------VVFELMESDLHQVIKANDDLTREH 127
D ++ Y +V E + DL ++ ++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-------QKISGQN 145
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
F +ML L+Y+H H D+K N+L N + ++ + D+GL+
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 50/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREVKL 75
+R K+ + +G+G++G V A T T VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
D DYV +W APE F YT D+WS G + E+ + G
Sbjct: 200 KD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 230 LFPGKSVVHQL 240
+PG + +
Sbjct: 250 PYPGVKIDEEF 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 62/279 (22%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDV 59
K D + D N K +VIG+G++G V A G + AIK++ +
Sbjct: 5 HHHHHGKNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES- 111
D E+++L +L HP+I+ +L +Y+ E
Sbjct: 64 ASK-DDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHG 111
Query: 112 DLHQVIKANDDLTREHHQF----------------FLYQMLRALKYMHTANVYHRDLKPK 155
+L ++ + L + F + R + Y+ HRDL +
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171
Query: 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKY 208
NIL N K+ DFGL+R + YV RW A E +S Y
Sbjct: 172 NILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVY 218
Query: 209 TPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
T D+WS G + E+++ G P + G + + +
Sbjct: 219 TTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQ 256
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/272 (20%), Positives = 105/272 (38%), Gaps = 76/272 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
N + + IG+G++G V A + + VA+K + E S ++ RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKRIML--PPSKREFKDIYVVFELMES-DLHQVIKANDD---------- 122
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 123 --------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
L+ Q+ + Y+ HRDL +N L N +K+
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 215
DFGL+R ++ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 216 SIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+ G + E+ + +P + G + + + D
Sbjct: 261 AYGVVLWEIFSYGLQP-YYGMAHEEVIYYVRD 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 62/251 (24%), Positives = 98/251 (39%), Gaps = 49/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLL- 76
NR + +G G++G V A + VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF----- 130
L H +IV +L V+ E DL ++ D
Sbjct: 82 YLGNHMNIVN----LLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
+D ++YV +W APE F YT D+WS G E+ + G
Sbjct: 197 ND-------SNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 230 LFPGKSVVHQL 240
+PG V +
Sbjct: 247 PYPGMPVDSKF 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLL- 76
N + + +G G++G V A G+ KVA+K + H + ++ E+K++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMS 104
Query: 77 RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
L +H +IV +L P + V+ E DL ++ +
Sbjct: 105 HLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 130 F--------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR- 174
F F Q+ + + ++ + N HRD+ +N+L K+ DFGLAR
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 175 -------VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
+ + + V W APE F YT D+WS G + E+ +
Sbjct: 214 IMNDSNYIVKGNARLPVKWM---------APE--SIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 227 GKPLFPGKSVVHQL 240
G +PG V +
Sbjct: 263 GLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 64/266 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+G +G V A + G VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------------- 120
L+ + HP +++ + ++ + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 121 ----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT F +Q+ + ++Y+ + HRDL +NIL K+K+ DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 171 GLARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIF 221
GL+R V+ D YV +W A E S F YT D+WS G +
Sbjct: 195 GLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLL 242
Query: 222 AEVLT--GKPLFPGKSVVHQLDLITD 245
E++T G P +PG +L+
Sbjct: 243 WEIVTLGGNP-YPGIPPERLFNLLKT 267
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 62/263 (23%), Positives = 110/263 (41%), Gaps = 63/263 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRILREVKL 75
++ + + +G+G++G V A ID + VA+K + D D ++ E+++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEM 93
Query: 76 L-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKAN------- 120
+ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 94 MKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 121 ---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 172 LARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
LAR + D Y T +W APE F YT D+WS G + E
Sbjct: 203 LARDINNI--------DYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLMWE 251
Query: 224 VLT-GKPLFPGKSVVHQLDLITD 245
+ T G +PG V L+ +
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKE 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 57/260 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRI--LREV 73
++ + + +G+G +G V A ID + VA+K + + ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN----------- 120
+++ + +H +I+ +L ++ +YV+ E +L + ++A
Sbjct: 138 EMMKMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 121 -----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 176 AFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT 226
+ D Y T +W APE + F YT D+WS G + E+ T
Sbjct: 253 INNI--------DYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 227 -GKPLFPGKSVVHQLDLITD 245
G +PG V L+ +
Sbjct: 301 LGGSPYPGIPVEELFKLLKE 320
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 26/180 (14%), Positives = 61/180 (33%), Gaps = 40/180 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREVK 74
++K+ + + G++ A T T +K ++K + R+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKDG--RLFNEQN 94
Query: 75 LL-RLLRHPDIVEIKRIMLPPS----------KREFKDIYVVFELMESDLHQVIKANDDL 123
R + + + K++ P + K ++V + L + +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP-- 152
Query: 124 TREHHQFFL-------YQMLRALKYMHTANVYHRDLKPKNILANANCKLKV--CDFGLAR 174
H ++L AL+++H H ++ +NI + + +V +G A
Sbjct: 153 ---KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 32/177 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A +K+ IG+G +G + A D ++ E V V SD + E+K +
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 82 PDIVEIKRIMLPPS--------------KREFKDIYVVFELMESDLHQVIKANDDLTREH 127
P+ ++ K +++ + SDL ++ +AN
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
+F ++L L+Y+H H D+K N+L N + ++ + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 65/264 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-------DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R + + +G+G++G V A + KVA+K + D ++ E+++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEM 127
Query: 76 L-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKAN------- 120
+ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 128 MKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 121 ---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFG
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236
Query: 172 LARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFA 222
LAR + D Y T +W APE + F YT D+WS G +
Sbjct: 237 LARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLW 284
Query: 223 EVLT-GKPLFPGKSVVHQLDLITD 245
E+ T G +PG V L+ +
Sbjct: 285 EIFTLGGSPYPGVPVEELFKLLKE 308
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 58/258 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLL- 76
+ +V+G G++G V A T +VA+K + + S+ ++ E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMT 103
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------------------------SD 112
+L H +IV +L IY++FE
Sbjct: 104 QLGSHENIVN----LLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
+ + + LT E F YQ+ + ++++ + HRDL +N+L +K+CDFGL
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 173 AR-VAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAE 223
AR + YV +W APE S F YT D+WS G + E
Sbjct: 219 ARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWE 266
Query: 224 VLT-GKPLFPGKSVVHQL 240
+ + G +PG V
Sbjct: 267 IFSLGVNPYPGIPVDANF 284
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 56/241 (23%), Positives = 91/241 (37%), Gaps = 88/241 (36%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRH 81
+IG G +G V + G KVA+K+ F E++ L RH
Sbjct: 46 LIGHGVFGKVYKGVLRD--GAKVALKRRTPESSQGIEEF---------ETEIETLSFCRH 94
Query: 82 PDIV-------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY- 133
P +V E ++L +++ ME N +L + H LY
Sbjct: 95 PHLVSLIGFCDERNEMIL------------IYKYME---------NGNL--KRH---LYG 128
Query: 134 -----QML-------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ R L Y+HT + HRD+K NIL + N K+ DFG+++
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK- 187
Query: 176 AFSDTPMTVFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGK 228
++ T +++T Y PE +F + T D++S G + EVL +
Sbjct: 188 KGTELDQT-----HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 229 P 229
Sbjct: 239 S 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 61/228 (26%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIV- 85
+G+G +GVV ++ VA+KK+ + + ++ ++ +E+K++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL--YQML- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL--LDRLSCLDGTPPLS 131
Query: 137 ------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPM 182
+ ++H + HRD+K NIL + K+ DFGLAR + F+ T M
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + V T Y APE L G + TP DI+S G + E++TG P
Sbjct: 192 T---SRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+E + D LT EH + +Q+ + ++++ + HRDL +NIL + +K+C
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AEVLT-GKPLFPGKSVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 43/219 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
++G+G +G V G VA+K++ + + + EV+++ + H +++ ++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 94
Query: 90 IMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDL---TREHHQFFLYQM------ 135
+ P++R +V+ M S L + ++ L R
Sbjct: 95 FCMTPTER-----LLVYPYMANGSVASCLRERPESQPPLDWPKR---------QRIALGS 140
Query: 136 LRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVA 191
R L Y+H + HRD+K NIL + + V DFGLA++ + DT +T T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRG 197
Query: 192 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
T + APE G K + D++ G + E++TG+
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 6e-08
Identities = 60/404 (14%), Positives = 117/404 (28%), Gaps = 115/404 (28%)
Query: 43 IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101
+D TGE + K I VFE DA + K D+ ++ + +L SK E
Sbjct: 7 MDFETGEHQYQYKDILSVFE---DAFVDNFDCK--------DVQDMPKSIL--SKEEIDH 53
Query: 102 I----------YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQM--------LRALKYM 142
I +F + S ++++ +++ R +++F + + + Y+
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113
Query: 143 HTANVYHRD-----------LKPKNILANANCKLKVCD---------FG---LARVAFSD 179
+ + D L+P L A +L+ G +A
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 180 T------PMTVFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAEVL 225
+FW + + +PE L +T D S + +
Sbjct: 174 YKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 226 TGKP--LFPGKSVVHQLDLITD-----------------LLGTPSPETIAVVRNEKARKY 266
+ L K + L L+ LL T + +
Sbjct: 231 QAELRRLLKSKPYENCL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA-DPYFKGL-AKIER 324
+ LL + + P+D P E L +P + A+ R
Sbjct: 290 SLDHHSMT----LTP-----DEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIR 338
Query: 325 EPSCQPISKLEFEFER-RRVTKDDIRELIYREILEYHPQLLKDY 367
+ ++ + V D + +I + P +
Sbjct: 339 DGLAT--------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.6 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.63 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.04 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.93 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.14 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.78 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-74 Score=558.29 Aligned_cols=344 Identities=48% Similarity=0.866 Sum_probs=300.1
Q ss_pred cccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 015019 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 15 ~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
+-..++++++|++++.||+|+||+||+|+++.+|+.||||++++........+++.+|+++|+.++|||||++++++...
T Consensus 46 ~~~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 46 FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp --CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cCCCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 33445677899999999999999999999999999999999987767777788899999999999999999999998654
Q ss_pred C-CCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 95 S-KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 95 ~-~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
. ..+.+++|||||||+|+|.+++..++.+++.+++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 2 345678999999999999999999899999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDT-PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+...... ......+.++||++|||||++.+. ..|+.++||||+|||+|||++|++||.+.+..+++..|....|.|+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8653322 122234678999999999998763 46799999999999999999999999999999999999999999999
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPIS 332 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~ 332 (414)
..+..........++..+....+.++...++.+|+++.|||.+||++||.+||||+|+|+||||+....+.++|.+.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~-- 362 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP-- 362 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--
Confidence 888777777788888888888888888888999999999999999999999999999999999999988887777654
Q ss_pred cchhhhhhccCCHHHHHHHHHHHHHHhCc
Q 015019 333 KLEFEFERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
.+++.++...++.+++++.+++|+..+|.
T Consensus 363 ~~~~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 363 PFDFAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp CCCCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCccchhhcCHHHHHHHHHHHHHHHHH
Confidence 35677788889999999999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-67 Score=481.40 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=207.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....++.+|+.+|+.++|||||++++++. +.+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence 6899999999999999999999999999999999754322 233457889999999999999999999994 4467
Q ss_pred EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
+|+|||||+|+|.+.+..++++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998653322
Q ss_pred ccccccccccCccccccccccccCCCC-CCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
...+.+||+.|||||++.+ ..| +.++|||||||++|+|++|++||.+.+....+..|.+..
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------- 228 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------- 228 (275)
T ss_dssp -----------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------
T ss_pred ---ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 2356789999999999987 454 689999999999999999999999887766555553311
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
. .....+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 229 -------------~-----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 -------------Y-----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------C-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------C-----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0 112468999999999999999999999999999999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-67 Score=491.51 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=225.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+++|+.++|||||+++++| ++.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 3579999999999999999999999999999999975321 122346788999999999999999999999 4456
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|||||||. |+|.+++...+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 7999999998 599999999889999999999999999999999999999999999999999999999999999875433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. .....+.|||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+..-
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~----------- 251 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY----------- 251 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 22 223467899999999999988 7899999999999999999999999999888777766643110
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHH------HhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~------lL~hp~~~~~ 319 (414)
.....+|++++|||.+||+.||.+|||++| +++||||+++
T Consensus 252 --------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 252 --------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred --------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 112468999999999999999999999987 5899999876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-66 Score=494.47 Aligned_cols=257 Identities=29% Similarity=0.516 Sum_probs=222.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
...|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|. +.+.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 3579999999999999999999999999999999975322 22345789999999999999999999994 4467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|||||||+ |+|.+++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999 599998876 579999999999999999999999999999999999999999999999999998754332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.....
T Consensus 225 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------ 287 (346)
T 4fih_A 225 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------ 287 (346)
T ss_dssp C---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------------
T ss_pred C---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 2 2357899999999999987 7899999999999999999999999999888777766643211
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+....+..+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 288 ----------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 288 ----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp ----------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 1112235689999999999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-67 Score=496.58 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=221.0
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.........++.+|+++|+.++|||||++++++. +.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECC
Confidence 457999999999999999999999999999999999876666667788999999999999999999999994 446
Q ss_pred eEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
.+|||||||. |+|.++|... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 7999999998 6999999754 357999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....+..+||+.|||||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..|.....
T Consensus 177 ~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------- 242 (350)
T 4b9d_A 177 ST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--------- 242 (350)
T ss_dssp HH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------
T ss_pred CC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------
Confidence 22 112356789999999999988 7899999999999999999999999999988777766643211
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
......+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 243 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 243 ---------------------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 0123468999999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-65 Score=475.69 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=219.4
Q ss_pred CCCCe-eEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y-~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..+|| ++.++||+|+||+||+|.++.++..||+|++...........++.+|+.+|+.++|||||++++++.... ...
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCC
Confidence 34566 7888999999999999999999999999999866566667778999999999999999999999985432 234
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcC-CCCeEEeecCCccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~-~~~vkL~DFG~a~~ 175 (414)
..+|||||||. |+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 56899999999 699999998889999999999999999999999999 999999999999984 79999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.... .....+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+.+....+...... +.++.
T Consensus 182 ~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~--- 249 (290)
T 3fpq_A 182 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA--- 249 (290)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG---
T ss_pred CCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCC---
Confidence 4322 2356789999999999865 6999999999999999999999999876654443322211 11100
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
......++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 250 ------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 ------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 112357889999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-65 Score=495.65 Aligned_cols=257 Identities=29% Similarity=0.516 Sum_probs=223.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|. +.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCE
Confidence 3579999999999999999999999999999999975322 23456889999999999999999999994 4457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|||||||. |+|.+++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999 599998875 469999999999999999999999999999999999999999999999999998754332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ..+..|||++|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.....
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------ 364 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------ 364 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 2 2357899999999999987 7899999999999999999999999999887777766643211
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+....+..+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 365 ----------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 365 ----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ----------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1112345789999999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-66 Score=483.93 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=216.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
++++|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+.+|+.++|||||++++++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----- 96 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ----- 96 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----
Confidence 3468999999999999999999984 46789999999754333233346778999999999999999999994
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.+.+|||||||. |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 4467999999999 699999999889999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.. +
T Consensus 177 ~~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~------ 243 (304)
T 3ubd_A 177 IDHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--L------ 243 (304)
T ss_dssp ----C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------
T ss_pred cCCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--C------
Confidence 33222 2356789999999999987 789999999999999999999999999998877776664311 0
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
.....+|+++.+||++||+.||.+||| ++|+++||||+++
T Consensus 244 -----------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 244 -----------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 112468999999999999999999998 5899999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-63 Score=493.55 Aligned_cols=350 Identities=37% Similarity=0.666 Sum_probs=300.5
Q ss_pred cccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeec
Q 015019 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIML 92 (414)
Q Consensus 13 ~~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 92 (414)
.+.+..+.+.++|++++.||+|+||+||+|.++.+++.||||++.+.........++.+|+.+|+.++||||+++++++.
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 34567788899999999999999999999999999999999999887777778889999999999999999999999997
Q ss_pred CCCCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 93 PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
.........+|+||||++++|.+++.....+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 76555567899999999999999999888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc-------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-------
Q 015019 173 ARVAFSDTPM-------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------- 226 (414)
Q Consensus 173 a~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~------- 226 (414)
|+........ ....+.++||++|+|||++... ..|+.++||||||||+|+|++
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccc
Confidence 9875432211 0124678999999999986442 679999999999999999997
Q ss_pred ----CCCCCCCCC-----------------hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCC
Q 015019 227 ----GKPLFPGKS-----------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285 (414)
Q Consensus 227 ----g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (414)
|.++|++.+ ..+++..|.+++|.|+.+.+..+....+..++..+....+.++...++.+
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 667777765 47899999999999999999999999999999998888888888888999
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhhhccCCHHHHHHHHHHHHHHhCcchh
Q 015019 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLL 364 (414)
Q Consensus 286 s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 364 (414)
++.+.+||++||++||.+|||++|+|+||||+++.....++.+.......+. +...++.+++++.+++|+..++|++.
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCcccc
Confidence 9999999999999999999999999999999999887777654432222222 23568899999999999999998864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-64 Score=498.52 Aligned_cols=346 Identities=41% Similarity=0.719 Sum_probs=287.8
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.+...++|++++.||+|+||+||+|+++.+++.||||++.+........+++.+|+.+|+.++||||+++++++.....+
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 48 DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp SCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence 45667899999999999999999999999999999999987777777888999999999999999999999999776656
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
....+|+||||++++|.+++.....+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 128 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 128 KFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp TCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred cCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 66789999999999999999988899999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCc------------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-------
Q 015019 178 SDTPM------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------- 226 (414)
Q Consensus 178 ~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~------- 226 (414)
..... ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 22111 1134667899999999986442 679999999999999999998
Q ss_pred ----CCCCCCCCC--------------------hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCC
Q 015019 227 ----GKPLFPGKS--------------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282 (414)
Q Consensus 227 ----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (414)
|+++|++.+ ..+++..|.+.+|.|..+.+..........++..+.......+...+
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 888898765 36889999999999999999999999999999988888888888899
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhhhhccCCHHHHHHHHHHHHHHhCcc
Q 015019 283 PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362 (414)
Q Consensus 283 ~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 362 (414)
+.+++.+.+||++||.+||.+|||++|+|+||||+++.....++.........+. +...++..++++.+++|+..++|+
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~ 445 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPE 445 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCcc
Confidence 9999999999999999999999999999999999998877666554332222222 335688899999999999999987
Q ss_pred hhh
Q 015019 363 LLK 365 (414)
Q Consensus 363 ~~~ 365 (414)
...
T Consensus 446 ~~~ 448 (458)
T 3rp9_A 446 IQL 448 (458)
T ss_dssp CCC
T ss_pred ccC
Confidence 643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-64 Score=474.44 Aligned_cols=258 Identities=26% Similarity=0.344 Sum_probs=217.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||++++++. +.+.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~-----~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVR-----EGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEE-----ETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 3579999999999999999999999999999999975322 247999999999999999999994 4467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~a~~~~~~ 179 (414)
+|||||||. |+|.++++..+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999 69999999888999999999999999999999999999999999999999987 6999999999875433
Q ss_pred CCcc--ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPMT--VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------- 271 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----------- 271 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-----------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-----------
Confidence 2111 11234689999999999988 78999999999999999999999999987766655555431
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH-------------hcCCCCCcccc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA-------------LADPYFKGLAK 321 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l-------------L~hp~~~~~~~ 321 (414)
+.++...++.+|+.+.+||.+||+.||.+|||+.|+ |+|||+.....
T Consensus 272 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 272 -----------------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp -----------------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred -----------------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 112223456899999999999999999999999997 67999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-62 Score=473.20 Aligned_cols=335 Identities=39% Similarity=0.736 Sum_probs=286.1
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-C
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-K 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~ 96 (414)
.+...++|++++.||+|+||+||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... .
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 456778999999999999999999999999999999999876666677788999999999999999999999997653 2
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....+|+||||++++|.+++.. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 100 DDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 34467899999998899999986 57999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .+..+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+..|.|+.+.+.
T Consensus 179 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 179 DSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 322 2567899999999998663 578999999999999999999999999999999999999999999999999
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.+.+.....++..+.......+...++.+++.+.+||.+||+.||.+|||++++|+||||+.+.....++...+ +++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~---~~~ 328 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDD 328 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCC
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCC---CCC
Confidence 99999999999999888888888888999999999999999999999999999999999999988877776653 456
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCcch
Q 015019 337 EFERRRVTKDDIRELIYREILEYHPQL 363 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~~~ 363 (414)
.++....+.++|++.+++|+..++|..
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 329 SFDDVDRTLDEWKRVTYKEVLSFKPPR 355 (367)
T ss_dssp C-----CCHHHHHHHHHHHHHTCCC--
T ss_pred ChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence 677778889999999999999998874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-63 Score=474.66 Aligned_cols=286 Identities=28% Similarity=0.443 Sum_probs=223.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
..++|++++.||+|+||+||+|+++ .+++.||||++.+. ....++.+|+++|+.+ +||||++++++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~----- 89 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCF----- 89 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----
Confidence 4578999999999999999999875 46789999998653 2345678999999998 699999999999
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a~ 174 (414)
.+.+++|||||||+ |+|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 44567999999998 69999884 59999999999999999999999999999999999999877 799999999997
Q ss_pred cccCCCCc-------------------------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCC
Q 015019 175 VAFSDTPM-------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229 (414)
Q Consensus 175 ~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~ 229 (414)
........ ....+..+||++|||||++.+. ..|+.++||||+|||+|+|++|++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCC
Confidence 64322110 1123457899999999998763 469999999999999999999998
Q ss_pred CC-CCCChhhHHHHHHHhcCCCCHHHHHhhc-----------cHHHHHHHHHhcCC------------CCCCccCCCCCC
Q 015019 230 LF-PGKSVVHQLDLITDLLGTPSPETIAVVR-----------NEKARKYLTEMRKK------------PPVPLFQKFPNV 285 (414)
Q Consensus 230 pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~------------~~~~~~~~~~~~ 285 (414)
|| .+.+..+++..|...+|++......... ..........+... ........+..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 88 6677889999999998875443322110 01111111111100 001112345678
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 286 s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
|++++|||++||++||.+||||+|+|+||||+++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-62 Score=472.35 Aligned_cols=335 Identities=41% Similarity=0.791 Sum_probs=283.1
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-C
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-K 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~ 96 (414)
.+...++|++++.||+|+||+||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... .
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 456678999999999999999999999999999999999877666777888999999999999999999999996542 2
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....+|+|||+++++|.+++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred ccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 34467899999999999998875 57999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .+..+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|..+.+.
T Consensus 183 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 183 ADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 321 2456899999999998763 578999999999999999999999999999999999999999999999999
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.+.+.....++..+......++...++..++.+.+||.+||+.||.+|||+.++|+||||+.+..+.+++...+ +++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~ 332 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQ 332 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCc
Confidence 99999999999888887777777788899999999999999999999999999999999999988887776654 456
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCcch
Q 015019 337 EFERRRVTKDDIRELIYREILEYHPQL 363 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~~~ 363 (414)
.++......++|++.+++|+..++|..
T Consensus 333 ~~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 333 SLESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp GGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred chhhccCCHHHHHHHHHHHHHHhccCc
Confidence 677778899999999999999998774
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-62 Score=474.20 Aligned_cols=339 Identities=39% Similarity=0.735 Sum_probs=271.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.........++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 36899999999999999999999999999999999877777788888999999999997 99999999998643 335
Q ss_pred eEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.+|+|||||+++|.+++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 6999999999999999986 479999999999999999999999999999999999999999999999999998643211
Q ss_pred ------------------CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHH
Q 015019 181 ------------------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (414)
Q Consensus 181 ------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~ 242 (414)
......+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234567999999999998763 5789999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHhhccHHHHHHHHHhcCCC---CCCccCCC-------------CCCChHHHHHHHHhccCCCCCCCC
Q 015019 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKP---PVPLFQKF-------------PNVDPLALRLLQRLIAFDPKDRPT 306 (414)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------------~~~s~~~~dli~~~L~~dp~~Rpt 306 (414)
|...+|.|..+.+..........++..+.... .......+ ..+++.+.+||.+||++||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999999888777666666655544322 22222222 278999999999999999999999
Q ss_pred HHHHhcCCCCCccccCCCCCCCCCCccchhhhhhccCCHHHHHHHHHHHHHHhCcchhhh
Q 015019 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366 (414)
Q Consensus 307 ~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~ 366 (414)
++|+|+||||+.+..+..++.+.......+. +....+.+++++.+++++..+++++..+
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISN 381 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhh
Confidence 9999999999999888877776554322222 2346788999999999999988776543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-61 Score=479.23 Aligned_cols=335 Identities=36% Similarity=0.656 Sum_probs=265.7
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~ 98 (414)
...++|++++.||+|+||+||+|.+..+++.||||++.+.........++.+|+.+|+.++||||+++++++..... ++
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 34589999999999999999999999999999999998776677778889999999999999999999999976532 45
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...+|+|||||+++|.+.+.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 578999999999999888854 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ..+..+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|.++.+...
T Consensus 217 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp CC----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred Cc----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 22 2356789999999999988 68999999999999999999999999999999999999999999999887765
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCC------------ChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (414)
. .....++..........+...++.. ++++.+||.+||++||.+|||++|+|+||||+.+.++.+..
T Consensus 291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~ 369 (464)
T 3ttj_A 291 Q-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 369 (464)
T ss_dssp C-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHS
T ss_pred c-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccccc
Confidence 4 4455555444433333332222221 57799999999999999999999999999999876554332
Q ss_pred CCCCCccchhhhhhccCCHHHHHHHHHHHHHHhCcchh
Q 015019 327 SCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLL 364 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 364 (414)
.. +....+..++....+.+++++.+++|+..++....
T Consensus 370 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 406 (464)
T 3ttj_A 370 AP-PPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTK 406 (464)
T ss_dssp CC-C-----------CCCHHHHHHHHHHHHHC------
T ss_pred CC-CCccCCcchhhccCCHHHHHHHHHHHHHHhhhccc
Confidence 21 22234556677788899999999999988765543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-61 Score=453.54 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=201.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-------
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK------- 96 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------- 96 (414)
+|++++.||+|+||+||+|+++.+|+.||||+++.. ......+++.+|+.+|+.++|||||+++++|.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 599999999999999999999999999999999753 234455678999999999999999999999865431
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
....++|||||||. |+|.+++..... .++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12346899999998 699999987654 44567889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc---------cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHH
Q 015019 173 ARVAFSDTPM---------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243 (414)
Q Consensus 173 a~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i 243 (414)
|+........ ....+..+||+.|||||++.+ ..|+.++|||||||++|||++ ||.+.. +....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 9875432211 112345789999999999988 789999999999999999996 775432 222222
Q ss_pred HHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
........+. .++..++.+.+||++||+.||.+|||+.|+|+||||+++.
T Consensus 238 ~~~~~~~~p~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFPP---------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCCH---------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCCC---------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 2221111111 1123467789999999999999999999999999998763
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-59 Score=451.60 Aligned_cols=341 Identities=45% Similarity=0.815 Sum_probs=291.0
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.++..++|++++.||+|+||.||+|.+..++..||||++... ........+.+|+.+|+.++||||+++++++......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 345668999999999999999999999999999999999743 3445567788999999999999999999999776555
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
....+|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 56779999999999999999764 69999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|.|..+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 433333334567899999999987552 5689999999999999999999999999999999999999999999999988
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhh
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (414)
..+.....+..........++...++.+++.+.+||.+||+.||.+|||+.|+|+||||+.......++..... +.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~--~~~~ 336 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 336 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--CCCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCc--CCcc
Confidence 88888888888777777777777778899999999999999999999999999999999998766655544433 2344
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCcch
Q 015019 338 FERRRVTKDDIRELIYREILEYHPQL 363 (414)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 363 (414)
.+...+..+++++.+++|+..++|..
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC--
T ss_pred cccccCCHHHHHHHHHHHHHHhhhhc
Confidence 45567889999999999999888764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=477.19 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=228.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++.. ........+.+|+.+|+.++|||||+++++| .+...
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCE
Confidence 4689999999999999999999999999999999975 3445567788999999999999999999999 44567
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC--CCeEEeecCCccccc
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVAF 177 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~--~~vkL~DFG~a~~~~ 177 (414)
+|||||||. |+|.+++.. .+.+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998 699999964 4689999999999999999999999999999999999999854 899999999998764
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... .....+||++|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......+.
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 376 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------ 376 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC------
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC------
Confidence 332 2356789999999999988 7899999999999999999999999999998888777755332222
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
...++.+|++++|||++||+.||.+|||+.|+|+||||+....+
T Consensus 377 ---------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 377 ---------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp ---------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred ---------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 12346789999999999999999999999999999999875443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=447.74 Aligned_cols=334 Identities=40% Similarity=0.735 Sum_probs=285.1
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..+...++|.+++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 36 ~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 36 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 45667789999999999999999999999999999999998766666667889999999999999999999999965432
Q ss_pred -CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 -REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 -~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.....+|+||||+.++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 116 ~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp STTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred cccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 1223459999999999988874 3599999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.+..+..
T Consensus 194 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 194 ADAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 4322 2456799999999998663 57899999999999999999999999999999999999999999999988
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccch
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLE 335 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~ 335 (414)
..........+...+.......+...++.+++.+.+||.+||+.||.+|||+.|+|+||||+.+..+..+..... .++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~ 344 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFD 344 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCC
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcC
Confidence 888888888888887777766666677889999999999999999999999999999999998876554443322 223
Q ss_pred hhhhhccCCHHHHHHHHHHHHHHhCc
Q 015019 336 FEFERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
...+....+.+++++.+++|+.+++|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 345 DSLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp CTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred cchhhcccchHHHHHHHHHHHHhccc
Confidence 34456678899999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=475.06 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=214.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc----CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ..........+++.+++.++|||||+++++|.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~----- 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-----
Confidence 367999999999999999999999999999999996431 11222223344567778889999999999994
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+...+|||||||. |+|.++|...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 4567999999999 699999999899999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... ....|||+.|||||++.+. ..|+.++||||||||+|+|++|++||.+.+..+....+....
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--------- 407 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------- 407 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---------
Confidence 4332 2457999999999998642 579999999999999999999999998754333221111100
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
... ...+..+|+++++||.+||+.||.+|++ ++|+++||||+++
T Consensus 408 --------------~~~-----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 408 --------------TMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp --------------HCC-----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred --------------CCC-----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 001 1123568999999999999999999998 8999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=431.52 Aligned_cols=257 Identities=22% Similarity=0.271 Sum_probs=207.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+++++.+.||+|+||+||+|... ..||||+++.........+.+.+|+.+|+.++|||||++++++.. +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 468999999999999999999754 359999997655566667789999999999999999999998732 34
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|||||||+ |+|.+++... .++++..+..|+.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 799999999 7999999764 57999999999999999999999999999999999999999999999999999865332
Q ss_pred CCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ....+..+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+....
T Consensus 186 ~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----------- 253 (307)
T 3omv_A 186 SG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----------- 253 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT-----------
T ss_pred Cc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-----------
Confidence 21 1123556899999999998642 2468999999999999999999999998877655544432210
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
...........++++.+.+||.+||+.||++|||+.|++++
T Consensus 254 --------------~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 254 --------------YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp --------------CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred --------------CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01111223446789999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=431.31 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=213.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
..++|.+.+.||+|+||+||+|.+. .++..||||+++. ......+.+.+|+++|++++|||||++++++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-- 86 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-- 86 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--
Confidence 3467999999999999999999865 4678999999975 344556779999999999999999999999943
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~-------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~ 161 (414)
.+.+|||||||. |+|.+++... ..+++.++..|+.||+.||+|||+++|+||||||+|||++.
T Consensus 87 ---~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 87 ---GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp ---SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred ---CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence 356999999999 7999999764 36999999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHH
Q 015019 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (414)
Q Consensus 162 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~ 240 (414)
++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred CCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999865332211 11234579999999999987 789999999999999999998 89999998877666
Q ss_pred HHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..+..... . .....+|+++.+||.+||+.||++|||+.++ |+|++.+.
T Consensus 241 ~~i~~~~~-------------------------~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 241 ECITQGRV-------------------------L-----QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHHHHTCC-------------------------C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HHHHcCCC-------------------------C-----CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 55543110 0 1124688999999999999999999999999 56776653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=430.89 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=204.7
Q ss_pred CCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.+|.+.++||+|+||+||+|..+ .++..||||+++. ......+.+.+|+.+|+.++|||||++++++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----- 113 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCT----- 113 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 57899999999999999999864 4688999999975 34455677999999999999999999999994
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN---------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~---------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~ 161 (414)
+...+|||||||. |+|.+++... +++++.++..|+.||+.||+|||+++|+||||||+|||++.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 3456999999999 7999999753 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHH
Q 015019 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (414)
Q Consensus 162 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~ 240 (414)
++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp TTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred CCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999865333211 12245679999999999988 789999999999999999998 89999998877666
Q ss_pred HHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+.... .. .....+++++.+|+.+||+.||++|||+.|++++
T Consensus 271 ~~i~~g~-------------------------~~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQGR-------------------------EL-----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHTC-------------------------CC-----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHcCC-------------------------CC-----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5554311 00 1124689999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=432.60 Aligned_cols=333 Identities=39% Similarity=0.732 Sum_probs=283.4
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.+...++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 19 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 3445689999999999999999999999999999999998766666667788999999999999999999999965432
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.....+|+||||+.++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 99 RNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp GGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 1234569999999999888774 35999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..|.+..+...
T Consensus 177 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 177 DAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred CCC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322 2456799999999998653 578999999999999999999999999999999999999999999999888
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.........++..+.......+...++.+++.+.+||.+||+.||.+|||++++|+||||+.+..++.++.... .++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~ 327 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDD 327 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCcc
Confidence 88888778888777776666666777889999999999999999999999999999999998876554443322 2345
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCc
Q 015019 337 EFERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
..+....+.++|++.+++|+.++.|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 328 SLEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred chhhccCCHHHHHHHHHHHHHhhcc
Confidence 5566788999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-57 Score=435.88 Aligned_cols=330 Identities=36% Similarity=0.662 Sum_probs=257.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-CCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~~ 99 (414)
..++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 457999999999999999999999999999999999876666667778899999999999999999999996543 2344
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..+|+|||||+++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred cceEEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 57999999999999998863 5999999999999999999999999999999999999999999999999999865332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.|.++.+....
T Consensus 181 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 181 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp -------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 2245689999999999987 689999999999999999999999999999999999999999999888766543
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCC------------CChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~ 327 (414)
. ....+...........+...++. .++.+.+||++||+.||.+|||++|+|+||||+.+..+.....
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~ 333 (371)
T 2xrw_A 255 P-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 333 (371)
T ss_dssp H-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred h-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence 2 33333333222222111111111 2567999999999999999999999999999987654322111
Q ss_pred CCCCccchhhhhhccCCHHHHHHHHHHHHHHhC
Q 015019 328 CQPISKLEFEFERRRVTKDDIRELIYREILEYH 360 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 360 (414)
. +....+...+.+..+.++|++.++.++..++
T Consensus 334 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 334 P-PPKIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp C-CCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred C-CCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 1 1111223445667788999999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=427.72 Aligned_cols=336 Identities=43% Similarity=0.804 Sum_probs=278.2
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
....++|++.+.||+|+||+||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++.......
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 45678999999999999999999999999999999999642 34455667889999999999999999999987665555
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...+|+||||+.++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 678999999999999999876 4799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcc-------ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 179 DTPMT-------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 179 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.|.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 21111 112346799999999987542 5789999999999999999999999999999999999999988876
Q ss_pred H-HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCC
Q 015019 252 P-ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQP 330 (414)
Q Consensus 252 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~ 330 (414)
. .............++..+......++...++.+++.+.+||.+||+.||.+|||+.++|+||||+.......++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~ 323 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEP 323 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCC
Confidence 3 333444455566666666555555555566789999999999999999999999999999999999877666655554
Q ss_pred Cc--cchhhhhhccCCHHHHHHHHHHHHH
Q 015019 331 IS--KLEFEFERRRVTKDDIRELIYREIL 357 (414)
Q Consensus 331 ~~--~~~~~~~~~~~~~~~~~~~~~~e~~ 357 (414)
++ .+++...+...+.+++++.+++|+.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 324 IPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 43 3455556678899999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=426.64 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=209.7
Q ss_pred CCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.++++++.||+|+||+||+|... .+++.||||+++.... ....+.+.+|+.+|+.++|||||++++++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---- 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTK---- 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----
Confidence 57899999999999999999853 4678999999975422 2334678999999999999999999999944
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
...+|||||||. |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 345899999999 7999999643 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhH
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~ 239 (414)
+++.+||+|||+|+....... ....+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999986543221 112345689999999999987 789999999999999999998 8999999887766
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
+..+..... . .....+++.+.+|+.+||+.||.+|||+.|++++
T Consensus 257 ~~~i~~~~~-------------------------~-----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQV-------------------------L-----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCC-------------------------C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCC-------------------------C-----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 655532111 0 1224688999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=423.08 Aligned_cols=292 Identities=39% Similarity=0.647 Sum_probs=236.9
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..-+..++|++++.||+|+||+||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++.
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 89 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH---- 89 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc----
Confidence 34467789999999999999999999985 5899999999765444445567889999999999999999999984
Q ss_pred CCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
+...+|+|||||+++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 90 -~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 90 -SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp -CSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred -cCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 44569999999999999988765 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.+..+
T Consensus 169 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 169 FGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred cCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 533221 22456799999999998653 56899999999999999999999999999999999999999998887655
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
........... .........+.....+.+++++.+||.+||+.||.+|||++|+|+||||+++
T Consensus 245 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 245 PQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GGGTTSHHHHS-CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhhccchhhh-cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 43322111000 0001111122233446789999999999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=421.00 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=225.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.........++.+|+.+|+.++||||+++++++. ..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence 46899999999999999999999999999999999876666677788999999999999999999999984 4457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999997 6999999888899999999999999999999999999999999999999999999999999997654332
Q ss_pred CccccccccccCccccccccccccCCCC-CCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.....+||++|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 169 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------ 230 (328)
T 3fe3_A 169 ----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK------------ 230 (328)
T ss_dssp ----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred ----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 2356789999999999977 454 579999999999999999999999988766655553211
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
. .....+++.+.+||++||+.||.+|||++|+|+||||+....
T Consensus 231 --------------~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 231 --------------Y-----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp --------------C-----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred --------------C-----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 0 112357899999999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-56 Score=414.66 Aligned_cols=287 Identities=37% Similarity=0.599 Sum_probs=235.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 6899999999999999999999999999999999866555566677889999999999999999999984 44579
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|||||++++.+.+.. ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887765 57899999999999999999999999999999999999999999999999999986533221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+....+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456799999999998762 3489999999999999999987655 788888889999999999887765433221
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.. .+................+.+++.+.+||++||+.||.+|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cc--cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 00 00000000011122334467899999999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=426.09 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=209.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC-CCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||+||+|.+..+ ++.||||++... ......+.+.+|+.+|+.++| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 36899999999999999999987654 368999999753 334556678999999999975 8999999998533
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEE
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NIL 158 (414)
.+.+|||||||. |+|.++++.. ..+++.++..|+.||+.||+|||+++|+||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 245899999999 7999999753 34899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChh
Q 015019 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (414)
Q Consensus 159 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~ 237 (414)
+++++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999865443221 22345689999999999988 789999999999999999998 99999887644
Q ss_pred hHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
+.+..+..- | ... .....+++++.+||.+||+.||.+|||+.++++|
T Consensus 295 ~~~~~~i~~-g-----------------------~~~-----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKE-G-----------------------TRM-----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHH-T-----------------------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHc-C-----------------------CCC-----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 433322210 0 001 1124578999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-55 Score=419.86 Aligned_cols=266 Identities=28% Similarity=0.437 Sum_probs=228.9
Q ss_pred ccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhCCCCCccccceee
Q 015019 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIM 91 (414)
Q Consensus 16 ~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~ 91 (414)
++.....++|++++.||+|+||+||+|.++.+|+.||+|++.+..... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 444566688999999999999999999999999999999997543221 1345788999999999999999999999
Q ss_pred cCCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC----CeE
Q 015019 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLK 166 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~----~vk 166 (414)
. +...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 85 ~-----~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 E-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp E-----CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred E-----eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEE
Confidence 4 4467999999997 79999998888999999999999999999999999999999999999998877 799
Q ss_pred EeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 015019 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (414)
|+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|...
T Consensus 160 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 160 LIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp ECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99999998754332 1245689999999999987 68999999999999999999999999998887777777554
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.....+. .+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 234 SYDFDEE---------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CCCCCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCCCch---------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 3332222 125689999999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=417.12 Aligned_cols=332 Identities=35% Similarity=0.647 Sum_probs=263.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC---------ChHHHHHHHHHHHHHHhCCCCCcccccee
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---------HISDAIRILREVKLLRLLRHPDIVEIKRI 90 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 90 (414)
...++|++++.||+|+||.||+|.+.. +..||||++..... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345789999999999999999999865 89999999864322 22334678999999999999999999999
Q ss_pred ecCCCCCCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEee
Q 015019 91 MLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~D 169 (414)
+..........+|+||||+.|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 876554556689999999999999998764 3799999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
||+++....... ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975433221 2456799999999988653 56899999999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCC-CCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCC
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKP-PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~ 328 (414)
|...............++....... ........+..++.+.+||.+||+.||.+|||+.++|+||||+++..+.+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 9988877766666665544333222 222333456789999999999999999999999999999999987654433221
Q ss_pred CCCccchhhhhhccCCHHHHHHHHHHHHHHhC
Q 015019 329 QPISKLEFEFERRRVTKDDIRELIYREILEYH 360 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 360 (414)
.. . .+.+.....+..++++.++.|+.+++
T Consensus 333 ~~-~--~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 LS-E--RFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp CC-C--CCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred cc-c--ccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 11 1 23345566778899999999998763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=411.10 Aligned_cols=284 Identities=38% Similarity=0.638 Sum_probs=229.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|.+ .+++.||+|++............+.+|+.+++.++||||+++++++.. .+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence 6899999999999999999998 678999999997543333334567899999999999999999999843 3569
Q ss_pred EEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+.++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999764 6799999999999999999999999999999999999999999999999999976532211
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12455799999999998653 46899999999999999999999999999999999999888887765443221110
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
..+........+.+.......+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000011111222333445678999999999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=412.80 Aligned_cols=288 Identities=34% Similarity=0.567 Sum_probs=231.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC---hHHHHHHHHHHHHHHhC---CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 47999999999999999999999999999999998643211 11123455677766665 5999999999997654
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 96 KREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~~--l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
......+|+||||++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 344456899999999999999987654 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+...
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 86533222 245689999999999977 679999999999999999999999999999999999999988887765
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+........ .......+.+.....+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 4322111000 0111122223333456789999999999999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=410.73 Aligned_cols=290 Identities=37% Similarity=0.666 Sum_probs=230.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++. ..+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 46899999999999999999999999999999999766555555677889999999999999999999984 4457
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||++ +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999995 677777777889999999999999999999999999999999999999999999999999998654322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+....+.+..+...+.....+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 22456799999999998653 5689999999999999999999999999999999999988888877654332211
Q ss_pred HHHHHHHHHhcCC---CCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCC
Q 015019 261 EKARKYLTEMRKK---PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (414)
Q Consensus 261 ~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (414)
... ....... ...+....++.+++.+.+||.+||+.||.+|||++|+|+||||+++...+
T Consensus 233 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 233 NQY---FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CGG---GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccc---cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 100 0000000 00111223467899999999999999999999999999999999876544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=438.35 Aligned_cols=322 Identities=26% Similarity=0.416 Sum_probs=244.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|+++.++..||+|++.+..........+.+|+.+|+.++||||+++++++. +...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence 4799999999999999999999999999999999765433334567889999999999999999999994 44579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CCeEEeecCCcccccC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAFS 178 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~vkL~DFG~a~~~~~ 178 (414)
|+|||||. |+|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5999999888899999999999999999999999999999999999999764 5599999999987543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 257 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD------- 257 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 32 2345689999999999864 689999999999999999999999999888777666654322211
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhhh
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
...+..+|+.+.+||++||+.||.+|||+.++|+||||+............+........
T Consensus 258 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 317 (494)
T 3lij_A 258 --------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIEN 317 (494)
T ss_dssp --------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHH
T ss_pred --------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHH
Confidence 122457899999999999999999999999999999998753221111111111111112
Q ss_pred hhccCCHHHHHHHHHHHHHHhCcchhhhhhhcCCCCCCCCCchhhhHHHHHHHHHhhCCCC
Q 015019 339 ERRRVTKDDIRELIYREILEYHPQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRS 399 (414)
Q Consensus 339 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~ 399 (414)
-+.......++..+...+... ..++.+++.+++.|+.+|.|++|.
T Consensus 318 ~~~~~~~~~l~qa~l~~ia~~----------------~~~~~~~~~l~~~F~~~D~d~dG~ 362 (494)
T 3lij_A 318 MRKFQNSQKLAQAALLYMASK----------------LTSQEETKELTDIFRHIDKNGDGQ 362 (494)
T ss_dssp HHTTTTCCHHHHHHHHHHHHH----------------SCCHHHHHHHHHHHHHHCTTCSSE
T ss_pred HHHHHHhHHHHHHHHHHHHHh----------------cccHHHHHHHHHHHHHhCcCCCCe
Confidence 222222333444443333321 135567788889999998887663
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=415.44 Aligned_cols=290 Identities=34% Similarity=0.608 Sum_probs=219.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.++.+|+.||+|++.... .......+.+|+.+|+.++||||+++++++. ..+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 76 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIH-----TEN 76 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECC
Confidence 3568999999999999999999999999999999987532 2223356779999999999999999999984 445
Q ss_pred eEEEEEecCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 101 DIYVVFELMESDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+|+|||||+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 79999999999999998653 359999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..|.+....
T Consensus 157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 157 AFGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp ETTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred ecCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 6533221 12456799999999998653 4689999999999999999999999999999999999999988887654
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCc-----cCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPL-----FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
+....... .+........+..+ ......+++.+.+||.+||+.||.+|||++|+|+||||++....
T Consensus 233 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 233 WPSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CGGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 43221100 00000000000000 01123578999999999999999999999999999999987544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=415.84 Aligned_cols=289 Identities=36% Similarity=0.628 Sum_probs=231.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+|+.++||||+++++++. ..+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEE
Confidence 689999999999999999999999999999999864321 111123457999999999999999999984 34568
Q ss_pred EEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 999999999999998875 4699999999999999999999999999999999999999999999999999976432221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.|....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22456789999999998653 56899999999999999999999999999999999999999999887765543322
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
...... ..............+.+++.+.+||.+||+.||.+|||++|+|+||||.++...
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 111110 111112222233456789999999999999999999999999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=438.39 Aligned_cols=261 Identities=32% Similarity=0.537 Sum_probs=221.3
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.++.+++.||||++.+..........+.+|+.+|+.++||||+++++++. +..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCC
Confidence 346899999999999999999999999999999998643322234567889999999999999999999984 446
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc---CCCCeEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~---~~~~vkL~DFG~a~~~ 176 (414)
.+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 7999999998 69999998888999999999999999999999999999999999999995 4567999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 175 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 242 (486)
T 3mwu_A 175 QQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----- 242 (486)
T ss_dssp CCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-----
T ss_pred CCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence 4332 1245689999999999865 589999999999999999999999999887777666644221111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
...+..+|+.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 243 ----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 243 ----------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ----------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ----------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 122356899999999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=416.88 Aligned_cols=257 Identities=24% Similarity=0.407 Sum_probs=217.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
.++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|..+|+.+ +||||+++++++. +.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----TP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----eC
Confidence 3689999999999999999999999999999999975311 122345677899999988 7999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 57999999998 59999998888999999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|.....
T Consensus 177 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------- 241 (353)
T 3txo_A 177 NGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------- 241 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred CCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 221 2356789999999999987 6899999999999999999999999999888777766643110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (414)
.....+++.+.+||++||+.||.+||++ +++++||||+++
T Consensus 242 ---------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 242 ---------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 1113578999999999999999999999 999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=409.87 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=220.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 3689999999999999999999999999999999975311 1123456789999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 7999999998 599999988889999999999999999999999999999999999999999999999999999864322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.......|...
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 220 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 220 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 21 2356789999999999987 68999999999999999999999999988766555544321
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.. .....+++.+.+||.+||+.||.+|| |++++++||||.++
T Consensus 221 -------------~~-----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 221 -------------EI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------CC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------CC-----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 00 11236899999999999999999999 99999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-54 Score=422.96 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=224.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++ .+.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 4689999999999999999999999999999999976555555667789999999999999999999998 44567
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc---CCCCeEEeecCCccccc
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAF 177 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~---~~~~vkL~DFG~a~~~~ 177 (414)
+|+|||||. |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999998 59999999999999999999999999999999999999999999999998 45789999999997654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 165 ~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------- 232 (444)
T 3soa_A 165 GEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF------- 232 (444)
T ss_dssp TTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-------
T ss_pred CCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-------
Confidence 3322 2346789999999999987 689999999999999999999999999988776666664322111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
....++.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 233 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 233 --------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp --------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred --------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 112346789999999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=420.43 Aligned_cols=288 Identities=35% Similarity=0.644 Sum_probs=233.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~~~ 101 (414)
.+|++++.||+|+||+||+|.+..++. ||+|++...... ..+|+.+|+.++||||+++++++..... .+...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 579999999999999999999987766 888887542211 2379999999999999999999865443 33455
Q ss_pred EEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc-CCCCeEEeecCCcccc
Q 015019 102 IYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~-~~~~vkL~DFG~a~~~ 176 (414)
+|+|||||.+++...+. ....+++..++.+++||+.||+|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 88999999987776654 356899999999999999999999999999999999999999 7899999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ...++||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|..+.+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456799999999998663 469999999999999999999999999999999999999999999988765
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (414)
........ ..+....+.++...+ +.+++++.+||.+||+.||.+|||+.++|+||||+.+......
T Consensus 268 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 268 TMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred hhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence 43321100 001111122222222 3489999999999999999999999999999999988765433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=411.41 Aligned_cols=289 Identities=36% Similarity=0.570 Sum_probs=224.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++. ..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence 4457999999999999999999999999999999999765444444566789999999999999999999984 44
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc-----CCCCeEEeecCCcc
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-----ANCKLKVCDFGLAR 174 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~-----~~~~vkL~DFG~a~ 174 (414)
..+|+|||||+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 5799999999999999999988999999999999999999999999999999999999994 44569999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.|....
T Consensus 186 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 186 AFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 6533221 12456789999999998763 4589999999999999999999999999999999999998888877654
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCC-CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQK-FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+....... .+...........+... ...+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 262 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 262 WPGVTALP--DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTGGGST--TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhh--hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 33221100 00000000000000000 01268899999999999999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=410.49 Aligned_cols=301 Identities=33% Similarity=0.527 Sum_probs=238.0
Q ss_pred cccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 015019 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 15 ~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
.+...+..++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 45555677899999999999999999999999999999999876544444445677999999999999999999998654
Q ss_pred CC---CCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeec
Q 015019 95 SK---REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (414)
Q Consensus 95 ~~---~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DF 170 (414)
.. ...+.+|+|||||+++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 21 124579999999999998888764 57999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCC-ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 171 GLARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 171 G~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
|+|+....... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99986542211 12223556899999999988653 56899999999999999999999999999999999999999888
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCC--CCccCCC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPP--VPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+.+..+.......... .+..... ......+ ...++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYE---KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp CCTTTSTTGGGCGGGT---SSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred CChhhccccccchhhc---ccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 8766544332211000 0000000 0000000 0137789999999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=405.41 Aligned_cols=258 Identities=24% Similarity=0.433 Sum_probs=223.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.+..+++.||+|.+... ......+.+|+.+|+.++||||+++++++. +..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCC
Confidence 457999999999999999999999999999999998742 344566889999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC--CCCeEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~--~~~vkL~DFG~a~~~ 176 (414)
.+|+|||||. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 7999999998 5999999765 47999999999999999999999999999999999999987 789999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+...
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 225 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh---
Confidence 4332 1245679999999999987 678999999999999999999999999988877777765543333222
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.++.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 226 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 226 ------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 135789999999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=428.68 Aligned_cols=262 Identities=29% Similarity=0.430 Sum_probs=221.2
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh-----------HHHHHHHHHHHHHHhCCCCCccccc
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----------SDAIRILREVKLLRLLRHPDIVEIK 88 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~l~ 88 (414)
...++|++++.||+|+||+||+|.++.++..||||++.+..... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34579999999999999999999999999999999987532211 2245688999999999999999999
Q ss_pred eeecCCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC---C
Q 015019 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---K 164 (414)
Q Consensus 89 ~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~---~ 164 (414)
+++. +...+|+|||||. |+|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFE-----DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEE-----CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEE-----cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 9994 4467999999998 59999998888999999999999999999999999999999999999999876 6
Q ss_pred eEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH
Q 015019 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 165 vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (414)
+||+|||+|+...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 188 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998654332 2245679999999999865 68999999999999999999999999998877777765
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.....+... .+..+|+.+.+||++||+.||.+|||++|+|+||||+...
T Consensus 261 ~~~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 261 KGKYYFDFN---------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HCCCCCCHH---------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cCCCCCCcc---------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 432222211 1357899999999999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=410.90 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=224.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++. +.+.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 35899999999999999999999999999999999865555666778899999999999999999999984 4457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC---CeEEeecCCccccc
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARVAF 177 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~---~vkL~DFG~a~~~~ 177 (414)
.|+|||||. ++|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 899999998 59999998888999999999999999999999999999999999999998654 59999999997654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.......+.......+
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------ 250 (362)
T 2bdw_A 183 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------ 250 (362)
T ss_dssp TCC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred CCc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 322 2245689999999999987 6899999999999999999999999998887666655543211111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...+..+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 251 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 251 ---------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 12234689999999999999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=416.04 Aligned_cols=287 Identities=31% Similarity=0.648 Sum_probs=230.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC----
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---- 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 96 (414)
..++|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 346899999999999999999999999999999998643221 2379999999999999999999865432
Q ss_pred -----------------------------CCCceEEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Q 015019 97 -----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMH 143 (414)
Q Consensus 97 -----------------------------~~~~~~~lV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~al~~LH 143 (414)
.....+|+|||||+++|.+.+. ....+++..++.++.||+.||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2345689999999998777765 3578999999999999999999999
Q ss_pred HCCcccCCCCCCCEEEc-CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHH
Q 015019 144 TANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (414)
Q Consensus 144 s~givHrDlkp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ 222 (414)
++||+||||||+|||++ .++.+||+|||+|+....... ....+||+.|+|||++.+. ..|+.++|||||||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999998 688999999999986543322 2456799999999998763 45899999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccC-CCCCCChHHHHHHHHhccCCC
Q 015019 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDP 301 (414)
Q Consensus 223 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dp 301 (414)
+|++|++||.+.+..+++..+.+..|.|..+.+.......... .........+.. .....++.+.+||.+||+.||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999987765433211000 000001111111 123578999999999999999
Q ss_pred CCCCCHHHHhcCCCCCcccc
Q 015019 302 KDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.+|||+.|+|+||||+.+..
T Consensus 311 ~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHHH
T ss_pred hhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=403.90 Aligned_cols=263 Identities=28% Similarity=0.445 Sum_probs=224.6
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
....++|++.+.||+|+||+||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 84 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-- 84 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--
Confidence 344568999999999999999999999999999999987543221 13567889999999999999999999984
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC----CeEEee
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCD 169 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~----~vkL~D 169 (414)
....+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 85 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 85 ---NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp ---CSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred ---eCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 4457999999997 69999998888999999999999999999999999999999999999999887 799999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 162 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 162 FGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp CTTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 999987543221 245679999999999977 68999999999999999999999999998877766666543322
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.... .++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 236 ~~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 236 FEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CCHH---------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cCcc---------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 2221 124678999999999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=400.46 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=219.5
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++++.||+|+||+||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 89 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV-----G 89 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----C
Confidence 4557899999999999999999999999999999998653222 24567899999999999999999999843 4
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+.+|+|||||. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 56899999997 6999998765 699999999999999999999999999999999999999999999999999976543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.......+..... +
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~-------- 234 (297)
T 3fxz_A 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-P-------- 234 (297)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-C--------
T ss_pred ccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C--------
Confidence 322 2245689999999999987 6899999999999999999999999988876655544432110 0
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 235 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 235 -------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 011124578999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=430.60 Aligned_cols=262 Identities=29% Similarity=0.489 Sum_probs=224.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||+||+|.++.+++.||||++.+... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 34689999999999999999999999999999999865432 2334567889999999999999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE---cCCCCeEEeecCCccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl---~~~~~vkL~DFG~a~~ 175 (414)
+.+|+|||||. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 67999999998 6999999988899999999999999999999999999999999999999 5678999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 179 ~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 247 (484)
T 3nyv_A 179 FEASKK----MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---- 247 (484)
T ss_dssp BCCCCS----HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----
T ss_pred cccccc----cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 543321 245679999999999865 689999999999999999999999999888777666644222111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
...+..+|+.+.+||++||+.||.+|||+.++|+||||+....
T Consensus 248 -----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 248 -----------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp -----------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred -----------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 1223568999999999999999999999999999999987643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=416.28 Aligned_cols=289 Identities=34% Similarity=0.601 Sum_probs=232.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~~~ 101 (414)
.+|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+++|+.++||||+++++++..... .+...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 379999999999999999999999999999999864321 12379999999999999999999865332 23345
Q ss_pred EEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCCcccc
Q 015019 102 IYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~a~~~ 176 (414)
+++||||+.++|.+.+. ....+++..++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998877664 35689999999999999999999999999999999999999965 56899999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ...++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456899999999998662 479999999999999999999999999999999999999999999887664
Q ss_pred hhccHHHHHHHHHhcCCCCCCccC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (414)
...... ..+ .+......++.. ..+.+++++.+||.+||+.||.+|||+.|+|+||||+.+......
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 349 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 349 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCC
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccccc
Confidence 322100 000 000000111111 123578999999999999999999999999999999988765443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-54 Score=409.68 Aligned_cols=256 Identities=31% Similarity=0.522 Sum_probs=215.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|.+..+++.||||++.+.... .....++.+|+.+|+.++||||+++++++.. ..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 36899999999999999999999999999999998642111 1112467899999999999999999999943 45
Q ss_pred eEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
.+|+||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 69999999999999999888899999999999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccccCccccccccccccCCCC-CCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.......
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------- 217 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------- 217 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------------
Confidence 2356689999999999977 454 78999999999999999999999875532211
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.............+++.+.+||++||+.||.+|||++|+++||||+.-
T Consensus 218 ------------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 ------------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ------------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ------------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 111111122234589999999999999999999999999999999753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=402.37 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=219.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 3689999999999999999999999999999999875311 1123456778999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 7999999998 599999998889999999999999999999999999999999999999999999999999999864322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.......|....
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------ 219 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------ 219 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 235689999999999987 689999999999999999999999999888766665554311
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. ...+.+++.+.+||++||..||.+|| +++++++||||+++
T Consensus 220 --------------~-----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 220 --------------L-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp --------------C-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred --------------C-----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 0 11245789999999999999999999 99999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=406.00 Aligned_cols=273 Identities=22% Similarity=0.209 Sum_probs=194.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|.+.+.||+|+||+||+|.+ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 46799999999999999999976 5899999999742 122222335666677889999999999986432 22346
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~--------givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
+|||||||+ |+|.++++.. +++++.+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 7999999764 699999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCcc-ccccccccCccccccccccccC----CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 173 ARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
|+......... ......+||++|||||++.+.. ..|+.++|||||||+||||+||.+||........... ....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~-~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch-hccc
Confidence 98754433221 1223568999999999986521 1467899999999999999999988754332110000 0000
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCC---CCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKK---PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+.. .......... +..+........+..+.+|+.+||+.||++|||+.++++.
T Consensus 234 ~~~~~-----------~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSV-----------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCH-----------HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchH-----------HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000 0111111111 1111111111233567899999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=408.52 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=220.0
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|..+++.+ +||||+++++++. +
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----T 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----C
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----e
Confidence 34789999999999999999999999999999999975311 112344577899998876 8999999999994 4
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 457999999997 6999999988889999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....|....
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 234 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------- 234 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 2221 2356789999999999987 689999999999999999999999999888766665553210
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHH-HHhcCCCCCccc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGLA 320 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~-~lL~hp~~~~~~ 320 (414)
. .....+++.+.+||.+||+.||.+|||+. ++++||||+++.
T Consensus 235 ----------------~-----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 235 ----------------P-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp ----------------C-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ----------------C-----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 0 11135789999999999999999999998 999999998763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=402.55 Aligned_cols=267 Identities=22% Similarity=0.391 Sum_probs=216.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
.++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.+ +||||+++++++. +.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence 3579999999999999999999999999999999976433 344566788999999988 8999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 57999999998 69999998888899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||......+.... ..
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~------- 223 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT------- 223 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------C-------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------cc-------
Confidence 221 2356789999999999987 6899999999999999999999999965321100000 00
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCccc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~------~~lL~hp~~~~~~ 320 (414)
.......+. .... .....+++.+.+||++||+.||.+|||+ +++++||||+++.
T Consensus 224 -~~~~~~~i~--~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 224 -EDYLFQVIL--EKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp -HHHHHHHHH--HCCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred -HHHHHHHHH--cCCC-----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 000000000 1111 1124689999999999999999999995 8999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=411.30 Aligned_cols=266 Identities=22% Similarity=0.398 Sum_probs=214.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
.++|++++.||+|+||+||+|+++.+++.||+|++++.... ......+.+|..+|+.+ +||||+++++++. +.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence 46899999999999999999999999999999999764332 23344577899999877 8999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+|||||. |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 57999999998 59999998888999999999999999999999999999999999999999999999999999986332
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+.... ..
T Consensus 206 ~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~------- 266 (396)
T 4dc2_A 206 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT------- 266 (396)
T ss_dssp TTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CC-------
T ss_pred CCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hh-------
Confidence 222 2356789999999999988 7899999999999999999999999975432110000 00
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (414)
.......+ ..... .....+++.+.+||++||+.||.+||++ +|+++||||+++
T Consensus 267 -~~~~~~~i--~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 267 -EDYLFQVI--LEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp -HHHHHHHH--HHCCC-----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred -HHHHHHHH--hcccc-----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 00000000 01111 1224689999999999999999999995 899999999876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=410.83 Aligned_cols=297 Identities=21% Similarity=0.297 Sum_probs=221.8
Q ss_pred CCCCCeeEeeeeccc--CceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 20 GDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
...++|++++.||+| +||+||+|.++.+++.||||++............+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----- 96 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI----- 96 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence 456899999999999 9999999999999999999999876555666777889999999999999999999994
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
..+.+|+|||||. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 3457999999998 6999999875 679999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCC----ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC--
Q 015019 175 VAFSDTP----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG-- 248 (414)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-- 248 (414)
....... ........+||+.|+|||++.+....|+.++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 5432211 1111233579999999999876435789999999999999999999999988776655544322110
Q ss_pred ------CCCHHHHHhhc-cHHHHHHHHHh------cCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 249 ------TPSPETIAVVR-NEKARKYLTEM------RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 249 ------~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
.+......... ........... ......+.......+++.+.+||.+||+.||.+|||+.|+|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 00000000000 00000000000 000011112234568999999999999999999999999999999
Q ss_pred CCcccc
Q 015019 316 FKGLAK 321 (414)
Q Consensus 316 ~~~~~~ 321 (414)
|+++..
T Consensus 337 f~~~~~ 342 (389)
T 3gni_B 337 FKQIKR 342 (389)
T ss_dssp GGGC--
T ss_pred HHHHhh
Confidence 998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=405.77 Aligned_cols=289 Identities=34% Similarity=0.594 Sum_probs=230.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++. ...
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCC
Confidence 347999999999999999999999999999999998766555556667889999999999999999999983 446
Q ss_pred eEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 79999999996 56666666778999999999999999999999999999999999999999999999999999765332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.+.....+.
T Consensus 178 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 21 22456799999999998762 478999999999999999999999999999999999998888887765433221
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
......-...-......+....++.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 11000000000000111122234578999999999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=405.34 Aligned_cols=293 Identities=23% Similarity=0.391 Sum_probs=233.5
Q ss_pred hhcccccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-----CCC
Q 015019 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----HPD 83 (414)
Q Consensus 9 ~~~~~~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpn 83 (414)
+..+-.+-...-..++|++++.||+|+||+||+|.+..+++.||||++.. .........+|+.+++.+. |||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 34444444555567899999999999999999999999999999999874 2344556778999999996 999
Q ss_pred ccccceeecCCCCCCCceEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC
Q 015019 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (414)
Q Consensus 84 iv~l~~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~ 161 (414)
|+++++++. ....+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 98 iv~~~~~~~-----~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 98 IVKYHGKFM-----YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp BCCEEEEEE-----ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred eecccceee-----ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 999999984 345799999999889999998754 5999999999999999999999999999999999999975
Q ss_pred -------------------------CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhh
Q 015019 162 -------------------------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (414)
Q Consensus 162 -------------------------~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwS 216 (414)
++.+||+|||+|+..... ....+||+.|+|||++.+ ..|+.++||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Diws 244 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN--LGWDVSSDMWS 244 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT--CCCCTTHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC--CCCCCccchHH
Confidence 788999999999864322 135679999999999987 68999999999
Q ss_pred HhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCc---------------cCC
Q 015019 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPL---------------FQK 281 (414)
Q Consensus 217 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~ 281 (414)
|||++|+|++|+.||.+.+..+.+..+....+.++...+..........++.........+. ...
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 99999999999999999999999999999888887665443221111000000000000000 000
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 282 FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 282 ~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
....++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 012347788999999999999999999999999995
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=412.91 Aligned_cols=281 Identities=32% Similarity=0.531 Sum_probs=230.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC------CCCCccccceeecCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL------RHPDIVEIKRIMLPP 94 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~ 94 (414)
...+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-- 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-- 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE--
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc--
Confidence 456899999999999999999999999999999999742 34445677788888776 5779999999984
Q ss_pred CCCCCceEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC--eEEeec
Q 015019 95 SKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDF 170 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~--vkL~DF 170 (414)
....+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 170 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 ---FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ---ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred ---cCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 345799999999999999998754 5999999999999999999999999999999999999999987 999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
|+|+..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+++..+.+.+|.|
T Consensus 247 G~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 247 GSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999764322 245689999999999987 689999999999999999999999999999999999999999999
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCC-----------------------------CCCccC-CCCCCChHHHHHHHHhccCC
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKP-----------------------------PVPLFQ-KFPNVDPLALRLLQRLIAFD 300 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~-~~~~~s~~~~dli~~~L~~d 300 (414)
....+..... ...++..-.... ...+.. .....++.+.+||++||++|
T Consensus 319 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 319 SQKLLDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CHHHHHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CHHHHHhhhh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 9887654322 112211100000 000000 01134788999999999999
Q ss_pred CCCCCCHHHHhcCCCCCcc
Q 015019 301 PKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 301 p~~Rpt~~~lL~hp~~~~~ 319 (414)
|.+|||++|+|+||||+..
T Consensus 397 P~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTTSCCHHHHHTSTTTC--
T ss_pred hhhCCCHHHHhCChhhccC
Confidence 9999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=399.18 Aligned_cols=303 Identities=39% Similarity=0.636 Sum_probs=233.7
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC--
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-- 95 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-- 95 (414)
.+...++|++++.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 34567899999999999999999999999999999999864 34456677889999999999999999999985432
Q ss_pred -------CCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc-CCCCeEE
Q 015019 96 -------KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKV 167 (414)
Q Consensus 96 -------~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~-~~~~vkL 167 (414)
..+...+|+||||++++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 134467999999999999999864 5799999999999999999999999999999999999997 5679999
Q ss_pred eecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
+|||+++................+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998654322222223455789999999987553 578999999999999999999999999999888888888777
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCC
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (414)
+.+........... ...++.........+.....+.++..+.+||.+||+.||.+|||++++|+||||+....+..+
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 242 PVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318 (320)
T ss_dssp CCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred CCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence 76665543322111 011111112222233334456789999999999999999999999999999999876544433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-53 Score=405.33 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=219.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
.++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+|..+ +||||+++++++. ..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----CS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----cC
Confidence 4689999999999999999999999999999999875311 112345677899999888 7999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 57999999998 69999998888899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|....
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------- 237 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 237 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 221 2356789999999999987 689999999999999999999999999888766666554310
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. .....+++.+.+||++||+.||.+|| +++++++||||+.+
T Consensus 238 ---------------~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 238 ---------------V-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp ---------------C-----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred ---------------C-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 0 11246899999999999999999999 47999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=406.23 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=205.1
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
......++|++++.||+|+||+||+|.++.+++.||||++...... ...+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 87 (361)
T 3uc3_A 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT--- 87 (361)
T ss_dssp CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee---
Confidence 3445668999999999999999999999999999999999753222 2457799999999999999999999943
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC--eEEeecCCc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLA 173 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~--vkL~DFG~a 173 (414)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 88 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 88 --PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred --CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 456999999997 699999988888999999999999999999999999999999999999987765 999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCC-cchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+...... .....+||++|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.........+....
T Consensus 166 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~----- 234 (361)
T 3uc3_A 166 KSSVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI----- 234 (361)
T ss_dssp -------------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH-----
T ss_pred ccccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-----
Confidence 7532222 1245679999999999877 45554 4899999999999999999998765433322221100
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...... ......+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 235 -----------------~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 235 -----------------LSVKYS---IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -----------------HTTCCC---CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -----------------hcCCCC---CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000000 01123578999999999999999999999999999999653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=416.32 Aligned_cols=266 Identities=25% Similarity=0.392 Sum_probs=220.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|+.++..++||||+++++++. +..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCC
Confidence 4689999999999999999999999999999999864211 0011223778999999999999999999994 446
Q ss_pred eEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+|||||. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 7999999997 799999987 57899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCccccccccccCccccccccccc---cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
... ...+..+||+.|+|||++.. ....|+.++|||||||++|+|++|++||.+.+..+....|......
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------ 299 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER------ 299 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc------
Confidence 322 12245689999999999862 1156899999999999999999999999998887777766531100
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~~ 320 (414)
..+...+..+|+++.+||++||..+|++ |++++|+++||||+++.
T Consensus 300 --------------------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 300 --------------------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp --------------------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred --------------------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 0111223568999999999999998888 99999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=405.90 Aligned_cols=288 Identities=38% Similarity=0.596 Sum_probs=227.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh---HHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG----- 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----
Confidence 4578999999999999999999999999999999987432211 11236779999999999999999999994
Q ss_pred CCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....+|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 34568999999999999998765 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.
T Consensus 163 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 33221 23456799999999998652 468999999999999999999999999999999999999888887765433
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
...... .+ .........+....+..+++.+.+||.+||+.||.+|||+.|+|+||||....
T Consensus 239 ~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 239 DMCSLP--DY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTSST--TC-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhccCc--cc-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 211100 00 00001111122223467789999999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=404.48 Aligned_cols=255 Identities=21% Similarity=0.380 Sum_probs=220.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cC
Confidence 44789999999999999999999999999999999864211 1123456789999999999999999999984 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 57999999997 69999999888899999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....|....
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------- 254 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------- 254 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred C------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 2 135689999999999987 689999999999999999999999999888766665554310
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
. .....+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 255 ---------------~-----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 255 ---------------V-----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ---------------C-----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ---------------C-----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 0 112467999999999999999999998 9999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=406.67 Aligned_cols=261 Identities=25% Similarity=0.450 Sum_probs=216.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+|+.++||||+++++++. +..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 368999999999999999999999999999999986421 11123456889999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 7999999997 699999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------ 232 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------ 232 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------
Confidence 2 23567899999999998642 146899999999999999999999999765432221111110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-HHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-~~~lL~hp~~~~~ 319 (414)
. ... ......+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 233 ---------~--~~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 233 ---------E--TTV-----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ---------H--HCC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ---------h--hcc-----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 0 000 1122467899999999999999999998 9999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=396.28 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=210.6
Q ss_pred CCCeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++++.||+|+||.||+|++. .+++.||+|++.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 468999999999999999999985 6899999999976432 22344567789999999999999999999943
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+.+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 --GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp --SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 456999999998 69999998888899999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 171 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------- 238 (327)
T 3a62_A 171 SIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------
T ss_pred cccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-------
Confidence 432221 1245679999999999987 6899999999999999999999999998887666655543110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
...+.+++.+.+||.+||+.||.+|| |++++++||||+.+
T Consensus 239 ------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 239 ------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 11246789999999999999999999 89999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=385.30 Aligned_cols=263 Identities=29% Similarity=0.473 Sum_probs=225.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCC
Confidence 467999999999999999999999999999999999766556666778899999999999999999999983 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC---eEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~---vkL~DFG~a~~~ 176 (414)
..|+||||+. ++|.+.+.....+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 6899999998 599999988888999999999999999999999999999999999999987655 999999999765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 226 (284)
T 3kk8_A 159 NDSEA----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------ 226 (284)
T ss_dssp CSSCB----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------
T ss_pred ccCcc----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC------
Confidence 43221 245679999999999987 678999999999999999999999999887766555553321111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
....+..+++.+.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 227 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 227 ---------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ---------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ---------------------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 11223578999999999999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=398.31 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=215.5
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++. +.
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 77 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EG 77 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence 345789999999999999999999999999999999864322 223356789999999999999999999984 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+..|+|||||. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 67899999998 59999998888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+............
T Consensus 158 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------- 224 (323)
T 3tki_A 158 NNR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----------- 224 (323)
T ss_dssp TTE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-----------
T ss_pred CCc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-----------
Confidence 221 1223467899999999998762 234778999999999999999999998766432221111100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
......+..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 225 -----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 225 -----------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -----------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 001112346889999999999999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=402.35 Aligned_cols=260 Identities=29% Similarity=0.453 Sum_probs=213.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++.+.||+|+||+||+|.++.+++.||||++.... ........+.+|+.+++.++||||+++++++. +
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 368999999999999999999999999999999986321 11113456889999999999999999999984 4
Q ss_pred CceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC---eEEeec
Q 015019 99 FKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDF 170 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~---vkL~DF 170 (414)
.+.+|+|||||. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 457999999998 699887754 235899999999999999999999999999999999999987654 999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
|+++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.. ......+.......
T Consensus 178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp TTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred cceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99987543221 2245689999999999987 679999999999999999999999998754 23333332211111
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+ ..+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 252 ~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 252 NP---------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred Cc---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 11 1124689999999999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=403.30 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=221.2
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||+||+|.++.+++.||+|++... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~ 120 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DK 120 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CS
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eC
Confidence 3457899999999999999999999999999999998753 2344567889999999999999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC--CCCeEEeecCCccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~--~~~vkL~DFG~a~~ 175 (414)
..+|+|||||. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 67999999998 69999987653 7999999999999999999999999999999999999974 47799999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 201 ~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 268 (387)
T 1kob_A 201 LNPDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE------ 268 (387)
T ss_dssp CCTTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC------
T ss_pred cCCCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 543221 234579999999999987 67999999999999999999999999988876666555432111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.....+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 269 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 269 ---------------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ---------------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1112345789999999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=392.93 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=224.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
...++|++++.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 85 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE--- 85 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe---
Confidence 44568999999999999999999999999999999987543221 13567889999999999999999999984
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC----CeEEeec
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDF 170 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~----~vkL~DF 170 (414)
+...+|+||||+. ++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+||
T Consensus 86 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 86 --NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp --CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred --cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 4457999999997 69999999888899999999999999999999999999999999999999887 7999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
|+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 164 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 164 GLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp TTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred ccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 99986543321 245679999999999987 689999999999999999999999999988777666665433222
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+. .+..+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 238 ~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 238 DEE---------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CHH---------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred Chh---------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 221 124678999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=412.18 Aligned_cols=264 Identities=25% Similarity=0.363 Sum_probs=218.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||+||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++++. +.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----EC
Confidence 34689999999999999999999999999999999864210 0011224678999999999999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+|||||. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 67999999997 699998876 4699999999999999999999999999999999999999999999999999976533
Q ss_pred CCCccccccccccCccccccccccccC--CCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.. .......+||+.|+|||++.+.. ..|+.++|||||||++|+|++|++||.+.+..+....|.......
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 292 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------ 292 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc------
Confidence 22 11234678999999999987621 128899999999999999999999999988877777665311000
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (414)
. ......+|+.+.+||++||+.+|.+ |++++|+++||||+++
T Consensus 293 ------------------~---~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 293 ------------------T---FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ------------------C---CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ------------------c---CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0 0112468999999999999999988 9999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=403.35 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=212.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHH-HHhCCCCCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+ ++.++||||+++++++. +
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----T 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----C
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----e
Confidence 34689999999999999999999999999999999975432 22344566778777 57789999999999994 4
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 457999999998 5999999888889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....|....
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 255 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------- 255 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Confidence 3222 2356789999999999987 789999999999999999999999999888766665554310
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (414)
....+.+++.+.+||++||+.||.+||++ .++++||||+.+
T Consensus 256 ---------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 256 ---------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp ---------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ---------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 01124689999999999999999999986 699999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=411.78 Aligned_cols=291 Identities=34% Similarity=0.581 Sum_probs=214.8
Q ss_pred CCCeeE-eeeecccCceeEEEEEEC--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKI-LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i-~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.+.|++ .++||+|+||+||+|.++ .+++.||||++..... ...+.+|+.+|+.++||||+++++++... .
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~ 91 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH---A 91 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEET---T
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecC---C
Confidence 356877 568999999999999966 5788999999975422 23577899999999999999999998542 2
Q ss_pred CceEEEEEecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE----cCCCCe
Q 015019 99 FKDIYVVFELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKL 165 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl----~~~~~v 165 (414)
...+|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 3579999999999999988632 259999999999999999999999999999999999999 677899
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh---------
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--------- 236 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~--------- 236 (414)
||+|||+|+...............+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+...
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999998754332222233567899999999998763 4589999999999999999999999987654
Q ss_pred hhHHHHHHHhcCCCCHHHHHhhccH-HHHHHHHHhcCCCCCC------ccCCCCCCChHHHHHHHHhccCCCCCCCCHHH
Q 015019 237 VHQLDLITDLLGTPSPETIAVVRNE-KARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (414)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~ 309 (414)
.+++..|...+|.|....+...... ................ ........++.+.+||.+||++||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 4788999999999987655443221 1111111111110000 00111234788999999999999999999999
Q ss_pred HhcCCCCCccc
Q 015019 310 ALADPYFKGLA 320 (414)
Q Consensus 310 lL~hp~~~~~~ 320 (414)
+|+||||....
T Consensus 331 ~L~hp~f~~~~ 341 (405)
T 3rgf_A 331 AMQDPYFLEDP 341 (405)
T ss_dssp HHTSGGGTSSS
T ss_pred HhcChhhccCC
Confidence 99999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=414.49 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=211.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++. ..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence 368999999999999999999999999999999987432 12234456788999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+|||||. ++|.+++.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 7999999998 5999999888899999999999999999999998 9999999999999999999999999999975432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 302 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------- 366 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------- 366 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred CC---cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 22 12356789999999999977 7899999999999999999999999998887666555532110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.....+++.+.+||.+||+.||.+|| |++|+|+||||+++
T Consensus 367 ---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 367 ---------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 11246789999999999999999999 99999999999876
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=398.70 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=212.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||+||+|.++.+++.||||++.+.... ..+|+.++..+ +||||+++++++ .+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~-----~~~ 88 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVY-----DDG 88 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEE-----ECS
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEE-----EcC
Confidence 346899999999999999999999999999999999754322 34688888877 799999999999 445
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC----CCeEEeecCCcc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDFGLAR 174 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~----~~vkL~DFG~a~ 174 (414)
..+|+|||||. |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 67999999998 6999999988899999999999999999999999999999999999998543 359999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC---hhhHHHHHHHhcCCCC
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---VVHQLDLITDLLGTPS 251 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 251 (414)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.. ..+.+..+..
T Consensus 169 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~------ 237 (342)
T 2qr7_A 169 QLRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS------ 237 (342)
T ss_dssp ECBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH------
T ss_pred cCcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc------
Confidence 6543322 2245689999999999977 578999999999999999999999998642 2222222211
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
.........+..+++.+.+||++||..||.+|||+.++|+||||..+...
T Consensus 238 ---------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 238 ---------------------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp ---------------------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred ---------------------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence 11111122346789999999999999999999999999999999776443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=392.92 Aligned_cols=291 Identities=34% Similarity=0.590 Sum_probs=234.2
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~ 97 (414)
.++|++++.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.+ +||||+++++++......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999995 6789999999865332222223455677776665 899999999998643333
Q ss_pred CCceEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
....+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 456799999999999999998753 499999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+
T Consensus 170 ~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 170 YSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred ccCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 43221 2345679999999999987 67999999999999999999999999999999999999888888766543
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
........ .........+.....+.++..+.+||.+||+.||.+|||+.++|+||||+++...
T Consensus 244 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 244 PRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 21110000 0011122233344556789999999999999999999999999999999887543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=409.13 Aligned_cols=265 Identities=25% Similarity=0.356 Sum_probs=217.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|..++..++||||+++++++. +..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~ 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DEN 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCC
Confidence 4689999999999999999999999999999999864211 1112234778999999999999999999994 445
Q ss_pred eEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+|||||. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 7999999997 7999999874 4799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccccccccccCcccccccccccc-----CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
... ......+||+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+..+....|......
T Consensus 215 ~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---- 288 (412)
T 2vd5_A 215 DGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH---- 288 (412)
T ss_dssp TSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----
T ss_pred CCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----
Confidence 321 112356899999999998631 146899999999999999999999999998887777666531100
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCC---CCHHHHhcCCCCCccc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGLA 320 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R---pt~~~lL~hp~~~~~~ 320 (414)
. .+......+|+++.+||++||. +|.+| ++++++++||||+++.
T Consensus 289 ----------------~------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 289 ----------------L------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp ----------------C------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred ----------------c------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 0 0001124689999999999999 99998 5999999999998763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=390.02 Aligned_cols=260 Identities=24% Similarity=0.450 Sum_probs=208.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC------------------------hHHHHHHHHHHHHHH
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH------------------------ISDAIRILREVKLLR 77 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~E~~~l~ 77 (414)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999999999999999998653211 112346889999999
Q ss_pred hCCCCCccccceeecCCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 78 ~l~hpniv~l~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
.++||||+++++++... ....+|+||||+. ++|.+++ ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999998542 2357999999998 5776644 34579999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCC-CCCCcchhhhHhHHHHHHHhCCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~DiwSlG~il~~ll~g~~pf~~~~ 235 (414)
||++.++.+||+|||+++....... .....+||+.|+|||++.+... .++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999986543221 2345679999999999876311 14778999999999999999999998876
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
.......+.... .. ....+.+++.+.+||.+||+.||.+|||+.|+|+|||
T Consensus 245 ~~~~~~~~~~~~--------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKSQA--------------------------LE---FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHHCC--------------------------CC---CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhccc--------------------------CC---CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 544433332110 00 0112468999999999999999999999999999999
Q ss_pred CC
Q 015019 316 FK 317 (414)
Q Consensus 316 ~~ 317 (414)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 85
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=388.84 Aligned_cols=252 Identities=28% Similarity=0.337 Sum_probs=208.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||||++..............+|+..+..+ +||||+++++++ .+.+.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 579999999999999999999999999999999887666666666667777776655 899999999998 34567
Q ss_pred EEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||+++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999997654322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.. +...+
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~-------- 271 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPP-------- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCH--------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCc--------
Confidence 1 234569999999999865 689999999999999999999877765432211 110 11111
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.....+++.+.+||.+||+.||.+|||++++|+||||++
T Consensus 272 -------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 012467899999999999999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=411.61 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=218.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|.+++.||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence 4689999999999999999999999999999999864211 11224568899999999999999999999943 45
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||. ++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 7999999997 699999988889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 233 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF----------- 233 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-----------
T ss_pred c----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 2 23466899999999999872 2347899999999999999999999998876655555532110
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.....+++.+.+||++||+.||.+|||+.++++||||+..
T Consensus 234 --------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 --------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1123578999999999999999999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=396.80 Aligned_cols=264 Identities=25% Similarity=0.442 Sum_probs=193.5
Q ss_pred CCeeEe---eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCC
Q 015019 23 NRYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~---~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 98 (414)
++|++. +.||+|+||+||+|.++.+++.||||++.+ .....+.+|+.+++.+. ||||+++++++. +
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~ 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFH-----D 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----c
Confidence 457665 789999999999999999999999999864 23456778999999997 999999999994 4
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC---CeEEeecCCcc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLAR 174 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~---~vkL~DFG~a~ 174 (414)
...+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 467999999998 59999999988999999999999999999999999999999999999998765 79999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.....
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------- 218 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-------------- 218 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------------
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------------
Confidence 6433221 2345678999999999987 68999999999999999999999999875431100
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
......+..+...........+..+++++.+||.+||+.||.+|||+.++|+||||++...
T Consensus 219 ------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 219 ------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 0000111111111111111122468999999999999999999999999999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=394.41 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=202.3
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+|+.+|+.++||||+++++++. ...
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCC
Confidence 346799999999999999999999999999999998753 23456778999999999999999999994 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCCeEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~vkL~DFG~a~~~ 176 (414)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 7999999998 699999988888999999999999999999999999999999999999975 889999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh-HHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 255 (414)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+...
T Consensus 202 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~--------- 266 (349)
T 2w4o_A 202 EHQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC--------- 266 (349)
T ss_dssp ---------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT---------
T ss_pred Cccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC---------
Confidence 3321 1245679999999999987 689999999999999999999999997765433 22222211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
........+..++..+.+||++||+.||++|||+.++|+||||.+.
T Consensus 267 ------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 267 ------------------EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp ------------------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred ------------------CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 1111122345789999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=380.38 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=218.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
.....|++.+.||+|+||+||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.... ...
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 4456789999999999999999999999999999999866566667778999999999999999999999885432 345
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEc-CCCCeEEeecCCccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~-~~~~vkL~DFG~a~~ 175 (414)
..+|+||||+. ++|.+++.....+++..++.++.||+.||+|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 67999999997 599999988888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+................+
T Consensus 182 ~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 248 (290)
T 1t4h_A 182 KRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----- 248 (290)
T ss_dssp CCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----
T ss_pred ccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-----
Confidence 43321 234579999999998865 58999999999999999999999998755443332221110000
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.......++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 249 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 -----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0112356788999999999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=397.92 Aligned_cols=292 Identities=33% Similarity=0.569 Sum_probs=223.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC--CCCc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--REFK 100 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~~ 100 (414)
++|++.+.||+|+||+||+|.+..+++.||||++..... ...+..++++.++.++||||+++++++..... ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 689999999999999999999999999999999864322 22345577888888999999999999865432 2233
Q ss_pred eEEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCCEEEcC-CCCeEEeecCCc
Q 015019 101 DIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILANA-NCKLKVCDFGLA 173 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~al~~LH--s~givHrDlkp~NILl~~-~~~vkL~DFG~a 173 (414)
.+|+||||+.++|...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 588999999998776654 4568999999999999999999999 999999999999999997 899999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
+....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+..+
T Consensus 180 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 180 KKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp BCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 86543322 2456799999999998652 458999999999999999999999999999999999999999999887
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCcc----CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCC
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLF----QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (414)
.+.......... ........++. ......++.+.+||.+||+.||.+|||+.|+|+||||+++......
T Consensus 255 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 255 VLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp HHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred HHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 665432210000 00000111111 1122367889999999999999999999999999999988765443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=380.45 Aligned_cols=258 Identities=31% Similarity=0.470 Sum_probs=221.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++. +..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNT 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCC
Confidence 34689999999999999999999999999999999875433 23456889999999999999999999984 445
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE---cCCCCeEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl---~~~~~vkL~DFG~a~~~ 176 (414)
.+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 6999999998 5999999888889999999999999999999999999999999999999 77899999999999765
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......+....
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (277)
T 3f3z_A 160 KPGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-- 230 (277)
T ss_dssp CTTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH--
T ss_pred cCcc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh--
Confidence 4322 1245679999999999865 489999999999999999999999999887776666654333322221
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 231 -------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 231 -------------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -------------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 24678999999999999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=381.47 Aligned_cols=258 Identities=30% Similarity=0.458 Sum_probs=210.6
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|.+.+.||+|+||+||+|.+..++..||+|++..... ......+.+|+++|+.++||||+++++++. +.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHhee-----cC
Confidence 445789999999999999999999999999999999875432 233567889999999999999999999983 44
Q ss_pred ceEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE---cCCCCeEEeecC
Q 015019 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFG 171 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl---~~~~~vkL~DFG 171 (414)
..+|+||||+. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 57999999998 599988854 4689999999999999999999999999999999999999 456789999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
+++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 173 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 242 (285)
T 3is5_A 173 LAELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--- 242 (285)
T ss_dssp CCCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred cceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc---
Confidence 9976533221 245679999999999854 688999999999999999999999998776554433321110
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
........+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 243 -------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 -------------------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -------------------------CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -------------------------ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 111122357899999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=389.67 Aligned_cols=287 Identities=31% Similarity=0.575 Sum_probs=223.0
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 96 (414)
.++..++|++++.||+|+||+||+|.+..+++.||||++... ....+.+|+.+++.++ ||||+++++++...
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-- 103 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 103 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccC--
Confidence 445568999999999999999999999999999999998742 2356889999999997 99999999998543
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~a~ 174 (414)
.....++||||+. ++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 104 -~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 104 -VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp -TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 2356899999999 58888775 489999999999999999999999999999999999999776 89999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCC-CCCChhhHHHHHHHhcCCCCHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.+...
T Consensus 180 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 6543322 2456799999999998653 56899999999999999999999888 5566677777777666643321
Q ss_pred HHH-hhccHHHHHHHHHhcCCCCCCccC-----CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 254 TIA-VVRNEKARKYLTEMRKKPPVPLFQ-----KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 254 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
... .........+...........+.. ....+++.+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 111 000000000111111111111111 1123789999999999999999999999999999998764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=386.61 Aligned_cols=283 Identities=30% Similarity=0.509 Sum_probs=228.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEE-CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC------ccccceeecC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAID-THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRIMLP 93 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~ 93 (414)
..++|++++.||+|+||+||+|.+ ..+++.||||++... ......+.+|+.+++.++|++ ++++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~- 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE- 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-
Confidence 457999999999999999999998 568899999998742 344567788999998887654 899999883
Q ss_pred CCCCCCceEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC----------
Q 015019 94 PSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---------- 161 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---------- 161 (414)
..+.+|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 ----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 88 ----HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp ----ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ----cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 445799999999999999998765 6899999999999999999999999999999999999987
Q ss_pred ---------CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCC
Q 015019 162 ---------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (414)
Q Consensus 162 ---------~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~ 232 (414)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 668999999999764322 134579999999999987 689999999999999999999999999
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHhhccH--------------HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhcc
Q 015019 233 GKSVVHQLDLITDLLGTPSPETIAVVRNE--------------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298 (414)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 298 (414)
+.+..+.+..+....+.++...+...... ....+....... ...........++.+.+||.+||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHHHHHHHhC
Confidence 99999999999888888777655432211 111111111110 001111112345778999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCccc
Q 015019 299 FDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 299 ~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.||.+|||+.|+|+||||+.+.
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGGGG
T ss_pred cCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=385.93 Aligned_cols=281 Identities=25% Similarity=0.378 Sum_probs=208.0
Q ss_pred CCCCeeEe-eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCC
Q 015019 21 DANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++. +.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.+ +||||+++++++. +
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~ 82 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFE-----E 82 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----E
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----e
Confidence 34789995 789999999999999999999999999975422 3345788999999885 7999999999984 3
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC---eEEeecCCcc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLAR 174 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~---vkL~DFG~a~ 174 (414)
.+.+|+|||||. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 457999999998 699999988888999999999999999999999999999999999999998776 9999999997
Q ss_pred cccCCCC----ccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 175 VAFSDTP----MTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
....... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---- 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence 6432211 11112345799999999998641 135788999999999999999999999876532100000
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
+... ..........+...........+..+++.+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 239 ~~~~--------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 239 GEAC--------PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp --CC--------HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccc--------hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 0000 0000001111111111111112246889999999999999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=397.88 Aligned_cols=283 Identities=28% Similarity=0.417 Sum_probs=224.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC--------CCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--------HPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~~ 93 (414)
.++|++++.||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4799999999999999999999999999999999974 2345567889999999985 7889999999853
Q ss_pred CCCCCCceEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCC-------
Q 015019 94 PSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANC------- 163 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~------- 163 (414)
.. .....+|+||||++++|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 32 234579999999999988888764 5799999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------CeEEeecCCcccccCCCCccccccccccCccccccccc
Q 015019 164 ------------------------------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201 (414)
Q Consensus 164 ------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 201 (414)
.+||+|||+|+..... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865332 2455799999999999
Q ss_pred cccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC------hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhc----
Q 015019 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR---- 271 (414)
Q Consensus 202 ~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 271 (414)
.+ ..|+.++|||||||++|+|++|+.||.+.+ ..+.+..+....|.++...+....... .++....
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK--EFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG--GTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc--cccCCcccccc
Confidence 87 679999999999999999999999998755 566788888888888776543221110 0000000
Q ss_pred --CCCCCC-------ccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 272 --KKPPVP-------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 272 --~~~~~~-------~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
...+.. ........++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000000 00001123567889999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=396.20 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=213.5
Q ss_pred CCeeE--eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 23 NRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 23 ~~Y~i--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++. ..+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECC
Confidence 34555 67899999999999999999999999998752 3345667889999999999999999999984 445
Q ss_pred eEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE--cCCCCeEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA--NANCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl--~~~~~vkL~DFG~a~~~ 176 (414)
.+|+|||||. ++|.+.+... ..+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 7999999998 6998888654 479999999999999999999999999999999999999 56788999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~----- 308 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE----- 308 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-----
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----
Confidence 43322 234579999999999977 6899999999999999999999999999888777766654322111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 309 ----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 309 ----------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12235789999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=384.25 Aligned_cols=255 Identities=29% Similarity=0.520 Sum_probs=214.7
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.|...+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEE
Confidence 48889999999999999999999999999999865322 234567899999999999999999999843 35699
Q ss_pred EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
+||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 588887764 57999999999999999999999999999999999999999999999999999765433221
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-------------- 258 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-------------- 258 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC--------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 245679999999999977 6899999999999999999999999988776555444432110
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+.......+++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus 259 --------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 259 --------------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --------------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred --------------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0011123578999999999999999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=391.06 Aligned_cols=270 Identities=26% Similarity=0.399 Sum_probs=223.9
Q ss_pred cccccccCCCCCeeEe-eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCcccccee
Q 015019 13 KDFFTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRI 90 (414)
Q Consensus 13 ~~~~~~~~~~~~Y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~ 90 (414)
..|-..-...++|.+. +.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344444566789988 8999999999999999999999999999865444445667889999999995 6999999999
Q ss_pred ecCCCCCCCceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCC
Q 015019 91 MLPPSKREFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCK 164 (414)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~ 164 (414)
+. ....+|+|||||. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.
T Consensus 98 ~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YE-----NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EE-----CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCC
T ss_pred EE-----eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCc
Confidence 83 4456999999998 5899888543 67999999999999999999999999999999999999988 789
Q ss_pred eEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH
Q 015019 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 165 vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (414)
+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 173 ~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp EEECCGGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEeeCccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 99999999986543321 244679999999999987 689999999999999999999999999988776666554
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.....+. ...+..+++.+.+||.+||+.||.+|||++++|+||||+++.
T Consensus 247 ~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 247 QVNVDYS---------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HTCCCCC---------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hcccccC---------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 4322221 123457899999999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=388.79 Aligned_cols=273 Identities=24% Similarity=0.332 Sum_probs=219.0
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.....++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET- 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-
Confidence 33456899999999999999999999999999999999976433 3344567889999999999999999999985433
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
......|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 22235699999997 69999998888999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 239 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---- 239 (311)
T ss_dssp ----------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH----
T ss_pred ccccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc----
Confidence 5443222222345679999999999987 6899999999999999999999999998877665544433211111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
......+++.+.+||.+||+.||.+||++.++|.|+|++...
T Consensus 240 -----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 -----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -----------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -----------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 112356899999999999999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=423.46 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=221.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++++.||+|+||.||+|.++.+++.||||++.+... .......+.+|..+|..+ +||+|+.+++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 34689999999999999999999999999999999874311 112345677899999987 699999999998 44
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...+||||||+. |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 467999999998 6999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.....
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------- 559 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------- 559 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 3222 2356789999999999987 7899999999999999999999999999888777766643110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH-----HHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (414)
.....+++++.+||++||+.||.+||++ +++++||||+.+
T Consensus 560 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 560 ----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ----------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 1124689999999999999999999997 999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=379.88 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=215.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++. +...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 83 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 83 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCCE
Confidence 689999999999999999999999999999999864211 1112346789999999999999999999984 4457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+||||+. ++|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999999 6999999888889999999999999999999999999999999999999999999999999986543221
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 164 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 224 (279)
T 3fdn_A 164 -----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------ 224 (279)
T ss_dssp ---------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------
T ss_pred -----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC------------
Confidence 234579999999999987 6889999999999999999999999998876665555533111
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.....+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 225 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 -------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 11235788999999999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=392.86 Aligned_cols=280 Identities=33% Similarity=0.515 Sum_probs=225.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CC-----CccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP-----DIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--- 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--- 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---
Confidence 47999999999999999999999999999999999742 344556778888888885 55 4888888884
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCCEEEc--CCCCeEEee
Q 015019 96 KREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILAN--ANCKLKVCD 169 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LH--s~givHrDlkp~NILl~--~~~~vkL~D 169 (414)
..+.+|+||||++++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 127 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 --FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp --ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred --cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 34579999999999999999875 46999999999999999999999 57999999999999995 478899999
Q ss_pred cCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
||+|+..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+....|.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999865322 245679999999999988 68999999999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCC------CCCccC-CC---------------------CC-------CChHHHHHHH
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKP------PVPLFQ-KF---------------------PN-------VDPLALRLLQ 294 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~-~~---------------------~~-------~s~~~~dli~ 294 (414)
|+...+.... ....++..+.... ...... .. .+ .++.+.+||.
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 8877654322 2223322221100 000000 00 00 0137899999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 295 RLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 295 ~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
+||++||.+|||++|+|+||||+..
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=388.66 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=216.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 35799999999999999999999999999999999754332 3344678899999999999999999999843 35
Q ss_pred eEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+|||||.|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 7999999999999988854 568999999999999999999999999999999999999999999999999999764321
Q ss_pred CCccccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
...+||+.|+|||++.+ ....++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~----------- 269 (348)
T 1u5q_A 208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------- 269 (348)
T ss_dssp -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------
Confidence 34579999999999842 12578999999999999999999999998877655554443210
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.+ ......+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 270 ---------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 270 ---------------SP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------------CC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 00 0112467899999999999999999999999999999965
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=387.23 Aligned_cols=262 Identities=27% Similarity=0.347 Sum_probs=208.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC--CCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~ 98 (414)
..++|++++.||+|+||+||+|.+. +++.||||++............+.+|+.+|+.++| |||+++++++. .
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~ 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----e
Confidence 3568999999999999999999874 68899999997665566667788999999999986 99999999984 3
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...+|+|||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 45799999988899999999988999999999999999999999999999999999999997 67899999999986543
Q ss_pred CCCccccccccccCcccccccccccc---------CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh-hHHHHHHHhcC
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLG 248 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~ 248 (414)
... .......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--- 235 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--- 235 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---
Confidence 221 1122456799999999998531 146888999999999999999999999764321 11111110
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
... ........+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 236 -----------------------~~~---~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 236 -----------------------PNH---EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp -----------------------TTS---CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -----------------------CCc---ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 000 011123456789999999999999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=381.81 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=218.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++. +.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYE-----ST 78 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cC
Confidence 34468999999999999999999999999999999997532 223456789999999999999999999984 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE---cCCCCeEEeecCCccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl---~~~~~vkL~DFG~a~~ 175 (414)
..+|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 57999999998 6999999888889999999999999999999999999999999999999 7788999999999875
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 159 ~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----- 226 (304)
T 2jam_A 159 EQNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF----- 226 (304)
T ss_dssp CCCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC-----
T ss_pred cCCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 4321 1234579999999999987 689999999999999999999999998887666555554321110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
....+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 227 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 227 ----------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ----------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ----------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 112235689999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=392.38 Aligned_cols=267 Identities=28% Similarity=0.436 Sum_probs=215.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++++.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++. +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence 468999999999999999999999999999999986421 12345567889999999999999999999994 4
Q ss_pred CceEEEEEecCC-CCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 015019 99 FKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTREHHQFFLYQMLR 137 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~----------------------------------------~~~l~~~~~~~i~~qil~ 137 (414)
.+.+|+|||||. ++|.+++.. ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 457999999997 699998842 112467888999999999
Q ss_pred HHHHHHHCCcccCCCCCCCEEEcCCC--CeEEeecCCcccccCCCC-ccccccccccCccccccccccccCCCCCCcchh
Q 015019 138 ALKYMHTANVYHRDLKPKNILANANC--KLKVCDFGLARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (414)
Q Consensus 138 al~~LHs~givHrDlkp~NILl~~~~--~vkL~DFG~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 214 (414)
||+|||++||+||||||+|||++.++ .+||+|||+++....... ........+||+.|+|||++.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999986533221 111234567999999999986543678999999
Q ss_pred hhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHH
Q 015019 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294 (414)
Q Consensus 215 wSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 294 (414)
|||||++|+|++|+.||.+.+..+.+..+........ ...+..+++.+.+||.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE---------------------------NPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT---------------------------SGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC---------------------------CcccccCCHHHHHHHH
Confidence 9999999999999999999887766665543221111 1112357899999999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 295 RLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 295 ~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
+||+.||.+|||+.++|+||||+++.
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=399.23 Aligned_cols=260 Identities=33% Similarity=0.528 Sum_probs=204.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC------ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
.++|.+.+.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4689999999999999999999999999999999875321 11222347799999999999999999999732
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC---CeEEeecC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFG 171 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~---~vkL~DFG 171 (414)
..+|+|||||. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 34799999998 69999998888999999999999999999999999999999999999997654 59999999
Q ss_pred CcccccCCCCccccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHH-HHHHHhcCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT 249 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~ 249 (414)
+|+...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|.+||.+......+ ..+......
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 998754322 2345689999999999853 1256888999999999999999999999875543322 222211111
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.. ...+..+++.+.+||.+||+.||.+|||++++|+||||++
T Consensus 364 ~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 364 FI---------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CC---------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CC---------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 11 1123568999999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=377.06 Aligned_cols=261 Identities=29% Similarity=0.480 Sum_probs=219.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 57999999999999999999999999999999987532211 13567889999999999999999999984 3
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC----CeEEeecCCc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLA 173 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~----~vkL~DFG~a 173 (414)
....|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 456999999997 69999998888899999999999999999999999999999999999998877 7999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 233 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence 86533221 234579999999999977 689999999999999999999999999888766665554332222211
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.++.+++.+.+||.+||..||.+|||+.++|+||||+.+..
T Consensus 234 ---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 234 ---------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---------------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 12467899999999999999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=413.27 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=215.5
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eC
Confidence 34689999999999999999999999999999999864211 1122345789999999999999999999984 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..+|+|||||. |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 57999999997 69999998754 4999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----------- 399 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 399 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----------
Confidence 43221 245689999999999987 6899999999999999999999999987653211111111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.+..... .....+|+.+.+||++||+.||.+|| |++|+++||||+++
T Consensus 400 ---------~i~~~~~-------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 400 ---------LVKEVPE-------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ---------HHHHCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ---------Hhhcccc-------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 0011100 11246899999999999999999999 89999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=396.36 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=205.2
Q ss_pred CCCCCeeEe-eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHH-HhCCCCCccccceeecCCCCC
Q 015019 20 GDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 20 ~~~~~Y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~ 97 (414)
...++|.+. +.||+|+||+||+|.++.+++.||||++... ..+.+|+.++ +..+||||+++++++.... .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-A 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-c
Confidence 445678887 7899999999999999999999999998632 3456888887 4558999999999884321 2
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCCeEEeecC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFG 171 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~vkL~DFG 171 (414)
+...+|||||||. |+|.+++...+ .+++..++.|+.||+.||+|||+.||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 3457999999998 59999998753 5999999999999999999999999999999999999997 7889999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh----HHHHHHHhc
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH----QLDLITDLL 247 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~ 247 (414)
+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+... ....+..
T Consensus 210 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-- 281 (400)
T 1nxk_A 210 FAKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-- 281 (400)
T ss_dssp TCEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--
T ss_pred cccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--
Confidence 998653322 2346689999999999977 789999999999999999999999998765322 1111110
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
. ........+..+++++.+||++||+.||.+|||+.++|+||||.+..
T Consensus 282 ----------------------~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 282 ----------------------G---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ----------------------T---CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ----------------------C---cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0 00001123457899999999999999999999999999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=383.83 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=206.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC------
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK------ 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 96 (414)
++|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 57999999999999999999999999999999997542 33456778999999999999999999998854321
Q ss_pred ----------------------------------------------CCCceEEEEEecCC-CCHHHHHHhCC---CCCHH
Q 015019 97 ----------------------------------------------REFKDIYVVFELME-SDLHQVIKAND---DLTRE 126 (414)
Q Consensus 97 ----------------------------------------------~~~~~~~lV~E~~~-g~L~~~i~~~~---~l~~~ 126 (414)
.....+|+|||||. ++|.+++.... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11234899999998 59999998754 35666
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc---------cccccccccCccccc
Q 015019 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM---------TVFWTDYVATRWYRA 197 (414)
Q Consensus 127 ~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~---------~~~~~~~~gt~~y~a 197 (414)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 78999999999999999999999999999999999999999999999875443211 112245679999999
Q ss_pred cccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCC
Q 015019 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277 (414)
Q Consensus 198 PE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (414)
||++.+ ..++.++|||||||++|+|++|..|+.. ....+........+
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~------------------------- 292 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP------------------------- 292 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC-------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC-------------------------
Confidence 999987 6899999999999999999998766521 11111111111100
Q ss_pred ccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 278 LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 278 ~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..+...++.+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 293 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 293 --LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp --HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred --cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 0112356788999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=390.44 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=211.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh------HHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||+||+|+++.+++.||||++....... .....+.+|+.+|+.++||||+++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--- 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE--- 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 468999999999999999999999999999999987542211 12335668999999999999999999993
Q ss_pred CCCCceEEEEEecCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 96 KREFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
+.+.+|+||||+. | +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 --~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 100 --NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp --CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred --eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 4457999999986 5 99999998889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCC-CCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+....
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 86543322 245679999999999877 444 88999999999999999999999653211
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
... .......+++.+.+||.+||+.||.+|||++++|+||||++.
T Consensus 237 -----------------~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 -----------------VEA-----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----------------TTT-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -----------------Hhh-----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 001123578999999999999999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=386.05 Aligned_cols=259 Identities=28% Similarity=0.478 Sum_probs=218.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC------hHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH------ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 5799999999999999999999999999999998654321 11244677999999999 7999999999984
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.....|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 3457999999998 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCccccccccccCcccccccccccc----CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
....... ....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+....+..+......+
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6543321 2456899999999988531 1358899999999999999999999999887766665554422222
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
... .+..+++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 325 ~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 SSP---------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CHH---------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCc---------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 111 1246788999999999999999999999999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=378.44 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=198.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.+..+++.||+|++............+.++...++.++||||+++++++.. .+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence 368999999999999999999999999999999997643333333344555566888899999999999953 356
Q ss_pred EEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 102 IYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.|+||||++++|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 899999999988777653 56899999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCccccccccccCccccccccccc--cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~ 253 (414)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.... ....+..+...
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------- 229 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE------- 229 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-------
Confidence 43322 133469999999999631 11578999999999999999999999997633 22222222110
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..+ ......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 230 -------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 230 -------------------PSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -------------------CCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -------------------CCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 000 01123678999999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=405.83 Aligned_cols=255 Identities=18% Similarity=0.230 Sum_probs=203.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHH---HHHhCCCCCccccc-------ee
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVK---LLRLLRHPDIVEIK-------RI 90 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~---~l~~l~hpniv~l~-------~~ 90 (414)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+. +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999987432 23345677889995 55555799999998 44
Q ss_pred ecCCCC-------CCCc-----eEEEEEecCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcccCC
Q 015019 91 MLPPSK-------REFK-----DIYVVFELMESDLHQVIKANDDLTR-------EHHQFFLYQMLRALKYMHTANVYHRD 151 (414)
Q Consensus 91 ~~~~~~-------~~~~-----~~~lV~E~~~g~L~~~i~~~~~l~~-------~~~~~i~~qil~al~~LHs~givHrD 151 (414)
+..... .+.+ ..|+|||||+|+|.+++...+.+++ ..+..|+.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432211 0111 3799999999999999987555555 78888999999999999999999999
Q ss_pred CCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCC-----------CCCCcchhhhHhHH
Q 015019 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 220 (414)
Q Consensus 152 lkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----------~~~~~~DiwSlG~i 220 (414)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985322 2245678 99999999877 4 79999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCC
Q 015019 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (414)
Q Consensus 221 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 300 (414)
+|+|++|+.||.+.+.......+ ....+.+++.+.+||.+||+.|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWI-----------------------------------FRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSGGG-----------------------------------GSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchhhh-----------------------------------hhhccCCCHHHHHHHHHHcCCC
Confidence 99999999999765532211111 1123578999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCccc
Q 015019 301 PKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 301 p~~Rpt~~~lL~hp~~~~~~ 320 (414)
|.+|||+.++|+||||+++.
T Consensus 348 p~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHHH
T ss_pred chhCCCHHHHhhChHHHHHH
Confidence 99999999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=375.60 Aligned_cols=263 Identities=28% Similarity=0.422 Sum_probs=223.6
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE----- 85 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----
Confidence 345679999999999999999999999999999999987543 23455667889999999999999999999984
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..+.+|+||||+. ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 4457999999998 699999988888999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 230 (294)
T 2rku_A 166 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------- 230 (294)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------
Confidence 432221 244679999999999977 67899999999999999999999999887765544333210
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
. ......+++.+.+||.+||+.||.+|||++++|+||||.....+
T Consensus 231 ----------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 231 ----------------E-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ----------------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ----------------c-----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 0 01124678999999999999999999999999999999875443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=376.69 Aligned_cols=257 Identities=24% Similarity=0.410 Sum_probs=218.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++. +.+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 3689999999999999999999999999999999864211 1112356789999999999999999999984 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 168 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 228 (284)
T 2vgo_A 168 R-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD------------ 228 (284)
T ss_dssp C-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------
T ss_pred c-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc------------
Confidence 1 134579999999999987 678999999999999999999999998877655544443210
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
....+.++..+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 229 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 229 -------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0112457899999999999999999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=392.77 Aligned_cols=261 Identities=27% Similarity=0.350 Sum_probs=208.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~ 99 (414)
..+|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.++ ||||+++++++.. .
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~ 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----C
Confidence 3569999999999999999999865 899999999765555666778999999999996 5999999999843 3
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..+|+|||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 4699999977789999999988999999999999999999999999999999999999995 588999999999865432
Q ss_pred CCccccccccccCcccccccccccc---------CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh-hHHHHHHHhcCC
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGT 249 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~ 249 (414)
.. .......+||+.|+|||++.+. ...|+.++||||||||+|+|++|++||.+.... ..+..+..
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---- 282 (390)
T 2zmd_A 208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence 21 1123456899999999998541 136889999999999999999999999765321 22222211
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..... ......+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 283 ----------------------~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 ----------------------PNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ----------------------TTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------ccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 00000 1112347889999999999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=406.28 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=214.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCC
Confidence 3689999999999999999999999999999999964321 1122356789999999999999999999984 445
Q ss_pred eEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 101 DIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+|+|||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 7999999998 6999998763 3699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh----hHHHHHHHhcCCCC
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV----HQLDLITDLLGTPS 251 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~ 251 (414)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.. .....+..
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~------ 407 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE------ 407 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH------
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh------
Confidence 5433221 245689999999999987 68999999999999999999999999876421 11111111
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
... .....+++.+.+||++||+.||.+||+ ++++++||||+++
T Consensus 408 --------------------~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 408 --------------------QAV-----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp --------------------CCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred --------------------ccc-----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 000 112468999999999999999999995 5899999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=384.49 Aligned_cols=283 Identities=30% Similarity=0.511 Sum_probs=227.3
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCC-cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC------ccccceeecC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRIMLP 93 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~ 93 (414)
..++|++++.||+|+||+||+|.+..++ ..||+|++... ......+.+|+.+++.++|++ ++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-- 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-- 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE--
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee--
Confidence 4579999999999999999999998877 68999998742 344566788999999987665 78888877
Q ss_pred CCCCCCceEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE------------
Q 015019 94 PSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA------------ 159 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl------------ 159 (414)
...+.+|+||||++++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ---~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 ---NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ---EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred ---eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 3445799999999999999887653 79999999999999999999999999999999999999
Q ss_pred -------cCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCC
Q 015019 160 -------NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (414)
Q Consensus 160 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~ 232 (414)
+.++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999764322 134579999999999987 689999999999999999999999999
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHhhccHH--------------HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhcc
Q 015019 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEK--------------ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298 (414)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 298 (414)
+.+..+.+..+.+..+.++...+....... ...+........ ..........++.+.+||.+||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHHHHHHHHhc
Confidence 999999999999988888776554332110 111111111000 00001112235678999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCccc
Q 015019 299 FDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 299 ~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.||.+|||+.|+|+||||+++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCC
T ss_pred CChhhCcCHHHHhcChhhcCCC
Confidence 9999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=382.65 Aligned_cols=263 Identities=28% Similarity=0.417 Sum_probs=223.8
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
....++|.+++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE----- 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 345679999999999999999999999999999999987543 23455667889999999999999999999984
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.+.+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 4457999999999 699999988888999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....
T Consensus 192 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 257 (335)
T 2owb_A 192 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------- 257 (335)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred ccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------
Confidence 432221 245679999999999977 678999999999999999999999998877655444332210
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (414)
......+++.+.+||.+||+.||.+|||+.++|+||||.....+
T Consensus 258 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 258 ----------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 01123578999999999999999999999999999999875433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=376.95 Aligned_cols=267 Identities=20% Similarity=0.383 Sum_probs=218.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 4789999999999999999999999999999999874311 123456788999999999999999999998542 23
Q ss_pred ceEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
..+|+|||||.++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 56899999999888888876 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~---------- 229 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS---------- 229 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC----------
Confidence 32221 1224567999999999987632345779999999999999999999999877655544442210
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (414)
......+++.+.+||.+||+.||.+|||+.++++||||+......
T Consensus 230 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 230 ---------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 011246789999999999999999999999999999998765443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=374.50 Aligned_cols=264 Identities=28% Similarity=0.353 Sum_probs=213.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||.||+|.+..++..||+|++.... .......++.+|+.+++.++||||+++++++ ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence 4578999999999999999999999999999999986433 3445567789999999999999999999998 444
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+.+|+||||+. ++|.+++...+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 67999999998 59999999888999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 164 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------- 226 (294)
T 4eqm_A 164 TSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------- 226 (294)
T ss_dssp -------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS-------------
T ss_pred cccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-------------
Confidence 2211 1234679999999999987 6789999999999999999999999998876544333221
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...+.......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+
T Consensus 227 -------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 227 -------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp -------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred -------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 111111112235789999999999999999999977777777766544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=373.50 Aligned_cols=265 Identities=28% Similarity=0.427 Sum_probs=220.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC---C----hHHHHHHHHHHHHHHhCC-CCCccccceee
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---H----ISDAIRILREVKLLRLLR-HPDIVEIKRIM 91 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-hpniv~l~~~~ 91 (414)
+..++|++.+.||+|+||.||+|.++.+++.||||++..... . ......+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 455799999999999999999999999999999999864321 1 123456789999999995 99999999998
Q ss_pred cCCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeec
Q 015019 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DF 170 (414)
. ....+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 94 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 E-----TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp E-----CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred c-----cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 3 4467999999998 699999988888999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccc----cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (414)
|++........ ....+||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99986543221 245679999999998752 1246889999999999999999999999887766555544332
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.... ....+..++..+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 245 ~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 NYQF---------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCC---------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred Cccc---------------------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1111 0112246789999999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=372.39 Aligned_cols=251 Identities=23% Similarity=0.277 Sum_probs=208.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+..+..+ +||||+++++++. +.+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----EDDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ETTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 579999999999999999999999999999999987655556677888999999999 8999999999984 3457
Q ss_pred EEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC--------------
Q 015019 102 IYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-------------- 162 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-------------- 162 (414)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999997 5999999764 679999999999999999999999999999999999999844
Q ss_pred -----CCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh
Q 015019 163 -----CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237 (414)
Q Consensus 163 -----~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~ 237 (414)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+++......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999865432 233599999999998762 36678999999999999999999887554321
Q ss_pred hHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
..+.. . ........+++.+.+||.+||+.||.+|||+.++|+||||.
T Consensus 238 ---~~~~~---------------------------~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 ---HEIRQ---------------------------G---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp ---HHHHT---------------------------T---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred ---HHHHc---------------------------C---CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 11110 0 01112246889999999999999999999999999999998
Q ss_pred cc
Q 015019 318 GL 319 (414)
Q Consensus 318 ~~ 319 (414)
+.
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 63
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=372.31 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=214.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++. +.+..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 579999999999999999999999999999999864322 234567889999999999999999999984 44578
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999998 59999998878899999999999999999999999999999999999999999999999999976433221
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHH-HHHHHhcCCCCHHHHHhhcc
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 260 (414)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..... ..+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 223 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---------------
Confidence 1123456799999999998762 23477899999999999999999999876543221 11110
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
. ......+..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 224 ------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 224 ------------K--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ------------T--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------------c--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0 00111234678999999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=374.79 Aligned_cols=258 Identities=27% Similarity=0.476 Sum_probs=192.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++. +.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence 34689999999999999999999999999999999864211 1112356889999999999999999999984 34
Q ss_pred ceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
+.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 57999999997 5999999875 679999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.
T Consensus 164 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 225 (278)
T 3cok_A 164 MPHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------- 225 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------------
T ss_pred CCCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------------
Confidence 32211 134579999999999977 678999999999999999999999998765433221110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.........++..+.+||.+||+.||.+|||++++|+||||...
T Consensus 226 ------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 226 ------------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------------------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------------------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00011224578999999999999999999999999999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=378.68 Aligned_cols=282 Identities=22% Similarity=0.383 Sum_probs=213.9
Q ss_pred chhhhhhhcccccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CC
Q 015019 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RH 81 (414)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h 81 (414)
.++....+..-++-......++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+ +|
T Consensus 4 ~~~~~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h 80 (326)
T 2x7f_A 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHH 80 (326)
T ss_dssp ------------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCS
T ss_pred CCCCCCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCC
Confidence 33333444444444455677899999999999999999999999999999999864322 235677999999998 79
Q ss_pred CCccccceeecCCCC-CCCceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCE
Q 015019 82 PDIVEIKRIMLPPSK-REFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (414)
Q Consensus 82 pniv~l~~~~~~~~~-~~~~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NI 157 (414)
|||+++++++..... .....+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 81 ~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI 160 (326)
T 2x7f_A 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 160 (326)
T ss_dssp TTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred CCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHE
Confidence 999999999865422 12467999999998 4999999864 5799999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCcccccCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCC
Q 015019 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (414)
Q Consensus 158 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~ 234 (414)
|++.++.+||+|||++........ .....+||+.|+|||++... ...++.++|||||||++|+|++|..||.+.
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp EECTTCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEcCCCCEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999976533211 12345799999999998621 156899999999999999999999999887
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 015019 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (414)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp 314 (414)
+....+..+.... .+ ......+++.+.+||.+||..||.+|||+.++|+||
T Consensus 238 ~~~~~~~~~~~~~--------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 238 HPMRALFLIPRNP--------------------------AP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp CHHHHHHHHHHSC--------------------------CC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred cHHHHHHHhhcCc--------------------------cc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 7554443332100 00 011246789999999999999999999999999999
Q ss_pred CCCcc
Q 015019 315 YFKGL 319 (414)
Q Consensus 315 ~~~~~ 319 (414)
||+..
T Consensus 289 ~~~~~ 293 (326)
T 2x7f_A 289 FIRDQ 293 (326)
T ss_dssp HHHCC
T ss_pred HHhhC
Confidence 99763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=386.41 Aligned_cols=285 Identities=22% Similarity=0.333 Sum_probs=219.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.+..++..||+|++... ........+.+|+.+++.++||||+++++++. ..+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDG 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETT
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECC
Confidence 346899999999999999999999999999999998754 23455677899999999999999999999984 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+|||||. ++|.+++...+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 6999999998 59999999888899999999999999999999996 999999999999999999999999999975432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHh-cCCCCHHHHH-
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL-LGTPSPETIA- 256 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~- 256 (414)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... .+.+......
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234579999999999987 68999999999999999999999999887755433222111 1111100000
Q ss_pred -------------hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 257 -------------VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 257 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
..........+.......... .....++..+.+||.+||+.||.+|||++++|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000000111122222111111 11234789999999999999999999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=373.72 Aligned_cols=260 Identities=32% Similarity=0.542 Sum_probs=219.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++. ....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence 36899999999999999999999999999999999765444445667889999999999999999999984 3457
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CCeEEeecCCccccc
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAF 177 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~vkL~DFG~a~~~~ 177 (414)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999997 6999999887889999999999999999999999999999999999999764 469999999998654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 241 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------- 241 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 3321 234568999999999865 48999999999999999999999999887665555443311110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
....+..+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 242 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 242 --------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp --------------------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred --------------------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 0112356899999999999999999999999999999998653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=384.99 Aligned_cols=286 Identities=23% Similarity=0.361 Sum_probs=223.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-----------CCCcccccee
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKRI 90 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~ 90 (414)
.++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.+++.++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4799999999999999999999999999999999874 2344566788999998886 8999999999
Q ss_pred ecCCCCCCCceEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEc------C
Q 015019 91 MLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILAN------A 161 (414)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~------~ 161 (414)
+.... .....+++|||+++++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++ .
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 86432 233478999999988999999863 4699999999999999999999998 999999999999995 3
Q ss_pred CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC------
Q 015019 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------ 235 (414)
Q Consensus 162 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~------ 235 (414)
.+.+||+|||+|+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 447999999999765332 234579999999999987 679999999999999999999999998654
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhc---CCCCCCc----------cCCCCCCChHHHHHHHHhccCCCC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR---KKPPVPL----------FQKFPNVDPLALRLLQRLIAFDPK 302 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----------~~~~~~~s~~~~dli~~~L~~dp~ 302 (414)
..+.+..+...+|.++...+...... ..++.... ....... .......++.+.+||.+||+.||.
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 55677888888888877655432211 11100000 0000000 001123467889999999999999
Q ss_pred CCCCHHHHhcCCCCCcccc
Q 015019 303 DRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 303 ~Rpt~~~lL~hp~~~~~~~ 321 (414)
+|||++|+|+||||++...
T Consensus 324 ~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TCBCHHHHHTCGGGTTCTT
T ss_pred ccCCHHHHhhChhhhcccC
Confidence 9999999999999987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=374.15 Aligned_cols=265 Identities=22% Similarity=0.369 Sum_probs=213.0
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..+..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 87 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYH---- 87 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----
Confidence 345668999999999999999999999999999999998753 22345678899999999999999999999854
Q ss_pred CCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+.+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 88 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 88 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp -C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 346899999998 588888765 56799999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCccccccccccCccccccccccc---cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
..... ......+||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 239 (302)
T 2j7t_A 167 NLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---- 239 (302)
T ss_dssp HHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----
T ss_pred ccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC----
Confidence 32111 01134579999999998831 115789999999999999999999999988776554444332110
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
+.......++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 240 ------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 240 ------------------------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ------------------------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ------------------------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00111235788999999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=372.22 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=206.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||+||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++. ....
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----STTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCc
Confidence 36899999999999999999976 5889999999876556666778899999999999999999999994 3345
Q ss_pred EEEEEecCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 102 IYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
+|+|||||. ++|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 599999987653 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------ 257 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------ 257 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Confidence 433211 1245679999999999987 67899999999999999999999999887765544433211110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (414)
......+++.+.+||.+||+.||.+|||+.++++ +++++.
T Consensus 258 -----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 -----------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1123468999999999999999999999999987 455543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=369.10 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=207.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 3689999999999999999999999999999999864211 1122346789999999999999999999984 345
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 7999999997 699999988888999999999999999999999999999999999999999999999999999765332
Q ss_pred CCccccccccccCccccccccccccCCCC-CCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 227 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV----------- 227 (276)
T ss_dssp ----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred c----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Confidence 2 1234579999999999877 444 689999999999999999999998876554444332210
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
......++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus 228 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 --------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 01123578899999999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=389.06 Aligned_cols=269 Identities=17% Similarity=0.161 Sum_probs=195.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhC--CCCCccccc-------eeec
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL--RHPDIVEIK-------RIML 92 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l--~hpniv~l~-------~~~~ 92 (414)
..|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999986543 234455677785544444 699988755 3332
Q ss_pred CCCCC------------CCceEEEEEecCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHCCcccCCCC
Q 015019 93 PPSKR------------EFKDIYVVFELMESDLHQVIKAN-DDLTREHH------QFFLYQMLRALKYMHTANVYHRDLK 153 (414)
Q Consensus 93 ~~~~~------------~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~------~~i~~qil~al~~LHs~givHrDlk 153 (414)
..... ....+|+|||||+++|.+++... ..+++... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 22110 11458999999999999999863 23444444 5677999999999999999999999
Q ss_pred CCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCC
Q 015019 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (414)
Q Consensus 154 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~ 233 (414)
|+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+....|+.++|||||||++|+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865321 124457799999999865334789999999999999999999999987
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
....... ...... .............++.+++.+.+||.+||+.||++|||+.++|+|
T Consensus 296 ~~~~~~~-----~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIKG-----SWKRPS-----------------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCTT-----CCCBCC-----------------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCccccc-----chhhhh-----------------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6422100 000000 000000111122335789999999999999999999999999999
Q ss_pred CCCCcc
Q 015019 314 PYFKGL 319 (414)
Q Consensus 314 p~~~~~ 319 (414)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=377.51 Aligned_cols=260 Identities=34% Similarity=0.545 Sum_probs=209.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC------ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 3689999999999999999999999999999999875321 112234577999999999999999999998432
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC---eEEeecC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFG 171 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~---vkL~DFG 171 (414)
.+|+||||+. ++|.+.+..+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 3799999998 599999988889999999999999999999999999999999999999987664 9999999
Q ss_pred CcccccCCCCccccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHH-HHHHHhcCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT 249 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~ 249 (414)
+++...... .....+||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+......
T Consensus 163 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 998653221 1234579999999998742 1157899999999999999999999999765543222 222211111
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
..+ ..+..+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 239 ~~~---------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 239 FIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred cCc---------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 111 112467899999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=387.37 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=211.1
Q ss_pred CCeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|++++.||+|+||+||+|++. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---- 129 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 129 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe----
Confidence 68999999999999999999984 5899999999874321 112233466799999999 6999999999984
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
....+|+|||||. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 130 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 -TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 3456999999998 59999998888899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... .......+||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+...
T Consensus 209 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------- 277 (355)
T 1vzo_A 209 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--------- 277 (355)
T ss_dssp CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---------
T ss_pred cccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH---------
Confidence 43221 1122456899999999998753346889999999999999999999999765432222222110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.. .... .....++..+.+||.+||..||.+|| |++++++||||..+
T Consensus 278 ----------~~---~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 278 ----------IL---KSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ----------HH---HCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ----------Hh---ccCC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 00 0011 12246889999999999999999999 99999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=367.96 Aligned_cols=260 Identities=30% Similarity=0.437 Sum_probs=217.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4689999999999999999999999999999999976555556677889999999999999999999987532 2356
Q ss_pred EEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCCEEEcCCCCeEEeecC
Q 015019 102 IYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFG 171 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~al~~LHs~g-----ivHrDlkp~NILl~~~~~vkL~DFG 171 (414)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 899999998 5999998653 35999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--- 233 (279)
T 2w5a_A 162 LARILNHDTS---FAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--- 233 (279)
T ss_dssp HHHHC---CH---HHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred hheeeccccc---cccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---
Confidence 9976533221 1234579999999999977 6789999999999999999999999988776554444422100
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
......+++.+.+||.+||+.||.+|||+.++|+|+|+.+-
T Consensus 234 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 ---------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01123678999999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=371.81 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=210.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++||||+++++++.. .+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence 4578999999999999999999999999999999987532 23567899999999999999999999843 45
Q ss_pred eEEEEEecCCC-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELMES-DLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~-~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 68999999985 9999987 456899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 241 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP----------- 241 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------
Confidence 221 1245579999999999987 678999999999999999999999998776544433222110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.+.......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 242 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 242 -----------------PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp -----------------CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred -----------------CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00111123468899999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=375.06 Aligned_cols=284 Identities=20% Similarity=0.330 Sum_probs=209.8
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---C
Confidence 455789999999999999999999999999999999975322 223456779999999999999999999985432 3
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE----cCCCCeEEeecC
Q 015019 100 KDIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFG 171 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl----~~~~~vkL~DFG 171 (414)
..+|+|||||. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 46899999998 69999997643 39999999999999999999999999999999999998 777889999999
Q ss_pred CcccccCCCCccccccccccCcccccccccccc------CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh-HHHHHH
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLIT 244 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~-~~~~i~ 244 (414)
+|+....... ....+||+.|+|||++... ...++.++|||||||++|+|++|+.||....... ....+.
T Consensus 162 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9987544322 2456799999999987521 1578999999999999999999999996543221 111222
Q ss_pred Hhc-CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 245 DLL-GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
... +.|.. .+........ ..+. .....+ ........++..+.+||++||+.||.+|||++|+|+||=
T Consensus 238 ~~~~~~p~~-~~~~~~~~~~-~~~~-~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 238 KIITGKPSG-AISGVQKAEN-GPID-WSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHCCTT-CCEEEECSTT-CCEE-EESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHhcCCCcc-cchhhhcccC-Cccc-cCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 211 11111 0000000000 0000 000000 000111234567899999999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=372.73 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=210.6
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..++|++.+.||+|+||+||+|.+..++. .||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 120 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----- 120 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 45789999999999999999999986655 5999999754 23455667899999999999999999999983
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
+.+.+|+||||+. ++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 4456899999997 5999999754 5899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----- 273 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL----- 273 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-----
Confidence 6544333222334457888999999977 679999999999999999999 99999888776655554332111
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 274 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 -------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112468899999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=373.39 Aligned_cols=272 Identities=25% Similarity=0.372 Sum_probs=194.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.. .+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KD 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES-----SS
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cC
Confidence 35789999999999999999999999999999999864321 2344567899999999999999999999854 34
Q ss_pred eEEEEEecCC-CCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecC
Q 015019 101 DIYVVFELME-SDLHQVIKA--------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~--------~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG 171 (414)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 6899999997 699998863 4569999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCC--ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 172 LARVAFSDTP--MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 172 ~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
++........ ........+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9976433211 11112346799999999998652 36899999999999999999999999887665544332211100
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
... ...........+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 246 ~~~---------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 246 SLE---------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CTT---------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccc---------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 000 00011123456889999999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=366.56 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=216.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----D 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----C
Confidence 455789999999999999999999999999999999875422 2345678899999999999999999999843 3
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
..+|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 56999999998 489888864 5799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 234 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN------------ 234 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC------------
Confidence 221 1245679999999999987 67899999999999999999999999877654443333210
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.. ......++..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 235 ---------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 235 ---------------NP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ---------------CC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ---------------CC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 00 1122467899999999999999999999999999999965
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=371.49 Aligned_cols=267 Identities=22% Similarity=0.347 Sum_probs=197.3
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
-..++|++++.||+|+||+||+|.+..++. .||||++............+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 445789999999999999999999887765 89999997654455667789999999999999999999999865432
Q ss_pred C-CCceEEEEEecCC-CCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEe
Q 015019 97 R-EFKDIYVVFELME-SDLHQVIKAND------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 97 ~-~~~~~~lV~E~~~-g~L~~~i~~~~------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~ 168 (414)
. .....|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 1223599999998 59999986432 69999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhc
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 247 (414)
|||+|+......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 180 Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 180 DFGLSRKIYSGDYYR-QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred ecccccccccccccc-ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 999997653332111 1233457788999999987 679999999999999999999 999999887766555443211
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-------HHHHhcCCCCCcc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-------AEEALADPYFKGL 319 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-------~~~lL~hp~~~~~ 319 (414)
. ....+.+++.+.+||.+||+.||.+||| .+++++|||+...
T Consensus 257 ~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 R------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp C------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred C------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 1123568899999999999999999999 7888999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=374.45 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=209.1
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-------CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 93 (414)
.++|++++.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 368999999999999999999875 34567999999754 3345567789999999999 89999999999843
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
.+.+|+||||+. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 346899999998 59999998643 48999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
||++.++.+||+|||+|+........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865432211 11234567889999999977 689999999999999999999 999998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+....+.... .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 655444332210 011224678999999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=365.80 Aligned_cols=262 Identities=22% Similarity=0.331 Sum_probs=194.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++.. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CCc
Confidence 468999999999999999999999999999999997643333333334455566888899999999999843 457
Q ss_pred EEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+++.+..+... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999997666666544 56899999999999999999999996 9999999999999999999999999999765332
Q ss_pred CCccccccccccCccccccccccc---cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 255 (414)
.. .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.. ..+.+..+...
T Consensus 179 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 245 (318)
T 2dyl_A 179 KA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--------- 245 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS---------
T ss_pred cc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc---------
Confidence 21 234579999999999852 11568899999999999999999999997643 33333222210
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
. .+.......+++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus 246 -----------------~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 246 -----------------E--PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -----------------C--CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -----------------C--CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 0 011112246889999999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=378.63 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=210.3
Q ss_pred CCCeeEeeeecccCceeEEEEE-----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++++.||+|+||+||+|. +..++..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3689999999999999999999 5567889999998643 344556678899999999999999999999844
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC---Ce
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KL 165 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~---~v 165 (414)
....|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 345799999997 6999999764 3599999999999999999999999999999999999999655 49
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (414)
||+|||+|+........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999754222111 11234568999999999977 689999999999999999998 999999887766555543
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
.... ......+++.+.+||.+||+.||.+|||+.++++|.++-
T Consensus 301 ~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2111 011246788999999999999999999999999998763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=371.35 Aligned_cols=263 Identities=25% Similarity=0.428 Sum_probs=191.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHH-HHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++.. .+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence 478999999999999999999999999999999997543 2344455666666 6777899999999999843 35
Q ss_pred eEEEEEecCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 101 DIYVVFELMESDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~-----~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+|+||||+.++|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 6899999999998888863 56899999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCccccccccccCccccccccccc--cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
....... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+..... ..+...
T Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~------ 242 (327)
T 3aln_A 175 QLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQV------ 242 (327)
T ss_dssp C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC------
T ss_pred ecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHH------
Confidence 6533221 133479999999999832 11568999999999999999999999997643211 000000
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.....+.........+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 243 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 243 -----------------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp -----------------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00000111112234689999999999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=373.63 Aligned_cols=267 Identities=25% Similarity=0.397 Sum_probs=188.5
Q ss_pred ccccCCCCCeeEee-eecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHH-HHHHhCCCCCccccceeecC
Q 015019 16 FTEYGDANRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV-KLLRLLRHPDIVEIKRIMLP 93 (414)
Q Consensus 16 ~~~~~~~~~Y~i~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~ 93 (414)
.+.+...++|.+++ .||+|+||+||+|.++.+++.||||++... .. ..+|+ ..++.++||||+++++++..
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 45667778999965 699999999999999999999999998642 11 22233 33567799999999999854
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCCeEE
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKV 167 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~vkL 167 (414)
.. .....+|+|||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 94 ~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 94 MH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred cc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence 32 22456899999998 49999998754 6999999999999999999999999999999999999986 455999
Q ss_pred eecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
+|||+++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 173 ~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 243 (336)
T 3fhr_A 173 TDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-- 243 (336)
T ss_dssp CCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred eccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--
Confidence 9999997643221 234578999999999876 6789999999999999999999999976553322111100
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.............+..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 244 ---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 ---------------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ---------------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000000011123357899999999999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=360.84 Aligned_cols=258 Identities=27% Similarity=0.395 Sum_probs=205.2
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
+|.....||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++. ..+.+|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEE
Confidence 445556899999999999999999999999998753 2344567889999999999999999999984 345789
Q ss_pred EEEecCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-CCCeEEeecCCcccccC
Q 015019 104 VVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFS 178 (414)
Q Consensus 104 lV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-~~~vkL~DFG~a~~~~~ 178 (414)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999997 6999999765 25679999999999999999999999999999999999987 89999999999986543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+............
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------- 239 (295)
T 2clq_A 176 INP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG------------- 239 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-------------
T ss_pred CCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-------------
Confidence 221 1245679999999999866323488999999999999999999999975432221100000
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..... ......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 240 ----------~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 240 ----------MFKVH-----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ----------HHCCC-----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ----------ccccc-----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 00000 11234688999999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=373.74 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=209.2
Q ss_pred CCCeeEeeeecccCceeEEEEE-----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 4789999999999999999998 5667789999999753 3344556789999999999 799999999998543
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCC----------------------------------------------------
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDD---------------------------------------------------- 122 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~---------------------------------------------------- 122 (414)
...+|+|||||. |+|.+++.....
T Consensus 99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 234899999998 599999976543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccc
Q 015019 123 --------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (414)
Q Consensus 123 --------------l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 188 (414)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986543322 122345
Q ss_pred cccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHH
Q 015019 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (414)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (414)
..||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+........
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------------- 313 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT------------------- 313 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-------------------
Confidence 678999999999987 689999999999999999998 9999988764443322221100
Q ss_pred HHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 314 -----~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 314 -----R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----C-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0 01124578999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=360.66 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=210.4
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++. +...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCe
Confidence 4689999999999999999999999999999999864 34566678899999999999999999999984 3456
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999998 599999987 568999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcc-----------ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 180 TPMT-----------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 180 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------- 232 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------- 232 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------
Confidence 2111 01125679999999999987 789999999999999999999999987543211000
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.......... ...+.+++.+.+||.+||+.||.+|||+.++++ |++.+
T Consensus 233 -----------~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 233 -----------GLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp -----------SBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred -----------hhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 0000011110 112467889999999999999999999999987 55544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=359.67 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=202.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-------
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------- 95 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------- 95 (414)
++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 579999999999999999999999999999999864 2345567889999999999999999999885431
Q ss_pred -CCCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 96 -KREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 96 -~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
......+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 123467999999998 5999999864 3688999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----------ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHH
Q 015019 173 ARVAFSDTP-----------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQL 240 (414)
Q Consensus 173 a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~ 240 (414)
++....... ........+||+.|+|||++.+. ..++.++|||||||++|+|++ ||.... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 976532210 01122456799999999998762 468999999999999999998 554322 11122
Q ss_pred HHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
..+.. .............++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 239 ~~~~~---------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKLRS---------------------------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHS---------------------------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhccc---------------------------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 11111 1000011122456788999999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=363.00 Aligned_cols=263 Identities=27% Similarity=0.334 Sum_probs=207.5
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~ 97 (414)
...++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++ ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~---- 99 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT---- 99 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC----
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec----
Confidence 34467999999999999999999885 5889999999765555666778899999999997 5999999999843
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...+|+|||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+++...
T Consensus 100 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 100 -DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp -SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred -CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 456999999878899999999889999999999999999999999999999999999999964 899999999998654
Q ss_pred CCCCccccccccccCcccccccccccc---------CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh-hHHHHHHHhc
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLL 247 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~ 247 (414)
.... .......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus 178 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~--- 253 (313)
T 3cek_A 178 PDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 253 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---
T ss_pred Cccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---
Confidence 3221 1112345799999999998641 136888999999999999999999999765322 1111111
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..... .......+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 254 -----------------------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 254 -----------------------DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp -----------------------CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred -----------------------hcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00000 11123457889999999999999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=373.35 Aligned_cols=273 Identities=19% Similarity=0.311 Sum_probs=212.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh---------------HHHHHHHHHHHHHHhCCCCCccc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---------------SDAIRILREVKLLRLLRHPDIVE 86 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hpniv~ 86 (414)
.++|++++.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36999999999999999999998 89999999986421110 11267889999999999999999
Q ss_pred cceeecCCCCCCCceEEEEEecCCC-CHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCC
Q 015019 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQV------IKA--NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKN 156 (414)
Q Consensus 87 l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~------i~~--~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~N 156 (414)
+++++.. .+.+|+||||+.+ +|.++ +.. ...+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999843 4579999999985 99888 655 5689999999999999999999999 999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCC-cchhhhHhHHHHHHHhCCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~~ll~g~~pf~~~~ 235 (414)
|+++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865332 22456799999999998772 25666 9999999999999999999998876
Q ss_pred h-hhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 015019 236 V-VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (414)
Q Consensus 236 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp 314 (414)
. .+....+.......+... ... ...............+++.+.+||.+||+.||.+|||+.++|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDR-NHF-----------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSS-SSS-----------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccch-hhh-----------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 6 444443322111000000 000 000000000111256899999999999999999999999999999
Q ss_pred CCCcc
Q 015019 315 YFKGL 319 (414)
Q Consensus 315 ~~~~~ 319 (414)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=355.92 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=207.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++. +...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSS
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCc
Confidence 368999999999999999999987 5778999999754332 346889999999999999999999984 3456
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 899999998 5899999754 56999999999999999999999999999999999999999999999999999764322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 160 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------- 226 (269)
T 4hcu_A 160 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------- 226 (269)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred c--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------
Confidence 1 111234457888999999977 679999999999999999999 99999988766555544321110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......++.+.+||.+||+.||.+|||+.++++|
T Consensus 227 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ---------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1123568999999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=366.58 Aligned_cols=254 Identities=19% Similarity=0.206 Sum_probs=205.3
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CG 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ET
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cC
Confidence 45789999999999999999999999999999999864322 23477899999999 8999999999984 34
Q ss_pred ceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC-----eEEeecCCc
Q 015019 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLA 173 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~-----vkL~DFG~a 173 (414)
...|+||||++++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||+|
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 57899999998899999986 468999999999999999999999999999999999999998887 999999999
Q ss_pred ccccCCCCccc----cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhH---HHHHHHh
Q 015019 174 RVAFSDTPMTV----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ---LDLITDL 246 (414)
Q Consensus 174 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~---~~~i~~~ 246 (414)
+.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+. +..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 86543322110 1245689999999999988 6899999999999999999999999987543332 2222211
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
....... ......+ .+.+||..||+.||.+|||++++++
T Consensus 236 ~~~~~~~--------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 KRATPIE--------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHSCHH--------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCHH--------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1000000 0112234 8999999999999999999998876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=361.77 Aligned_cols=271 Identities=21% Similarity=0.351 Sum_probs=206.6
Q ss_pred CCCCeeEeeeecccCceeEEEEE----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..++|++++.||+|+||+||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH-
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 34689999999999999999998 667899999999975 34455677889999999999999999999985422
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
...+|+|||||. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 85 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp --HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred --CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 245899999997 69999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccc
Confidence 75443322222234567888999999987 68999999999999999999999998654321 111112111100
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.........+...... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 ------MIVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp ------HHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------hhHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011111222221111 123568899999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=358.21 Aligned_cols=255 Identities=18% Similarity=0.223 Sum_probs=207.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++++.||+|+||+||+|.+..+++.||||++.... ....+.+|+.+++.+ +|+|++++++++ ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEG 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EET
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCC
Confidence 4578999999999999999999999999999999986432 223467899999999 799999999988 344
Q ss_pred ceEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC-----eEEeecCCc
Q 015019 100 KDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLA 173 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~-----vkL~DFG~a 173 (414)
...|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 5789999999889999998754 6999999999999999999999999999999999999987776 999999999
Q ss_pred ccccCCCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh---hHHHHHHHh
Q 015019 174 RVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---HQLDLITDL 246 (414)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~---~~~~~i~~~ 246 (414)
+......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 8754432211 11245679999999999987 67999999999999999999999999875432 222222211
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
...+. .....+.+++.+.+||.+||+.||.+|||++++++
T Consensus 237 ~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTP--------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSC--------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCcc--------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 10011 11123468899999999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=369.05 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=210.2
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhCC--CCCccccceeecC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLR--HPDIVEIKRIMLP 93 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~ 93 (414)
...++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.++ ||||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 45679999999999999999999999999999999986532211 12234667999999996 599999999994
Q ss_pred CCCCCCceEEEEEecCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc-CCCCeEEeec
Q 015019 94 PSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDF 170 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~-~~~~vkL~DF 170 (414)
..+.+++|||++. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 4457999999997 69999998888999999999999999999999999999999999999999 7799999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (414)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +..
T Consensus 195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~----- 257 (320)
T 3a99_A 195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR----- 257 (320)
T ss_dssp TTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----
T ss_pred cccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc-----
Confidence 9998654322 2456799999999998762 3347889999999999999999999965321 100
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
... .....+++.+.+||.+||+.||.+|||++++++||||++.
T Consensus 258 ---------------------~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 258 ---------------------GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ---------------------CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---------------------ccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 000 1124688999999999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=362.10 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=210.6
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++.+.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 468999999999999999999983 45689999998753 344566778999999999999999999999843
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDD------------------------LTREHHQFFLYQMLRALKYMHTANVYHRD 151 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~------------------------l~~~~~~~i~~qil~al~~LHs~givHrD 151 (414)
.+.+|+||||+. ++|.+++..... +++..++.++.||+.||+|||++||+|||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 446899999998 699999986543 89999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCC
Q 015019 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (414)
Q Consensus 152 lkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~p 230 (414)
|||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999865433221 11234567889999999977 678999999999999999999 9999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
|.+.+.......+.... .......+++.+.+||.+||+.||.+|||+.++
T Consensus 253 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGH------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp STTCCGGGHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHhhcCC------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 98877655444332210 011234688999999999999999999999999
Q ss_pred hcC
Q 015019 311 LAD 313 (414)
Q Consensus 311 L~h 313 (414)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=384.35 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=194.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+|.+.+.||+|+||+|+. ....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++ .+...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTE-----KDRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCE
Confidence 4799999999999999764 3456899999999865322 1245799999999 799999999988 34457
Q ss_pred EEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-----CCCeEEeecCCccc
Q 015019 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-----NCKLKVCDFGLARV 175 (414)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-----~~~vkL~DFG~a~~ 175 (414)
+|+|||||+|+|.+++.... .+.+..+..++.||+.||+|||++||+||||||+|||++. ...+||+|||+|+.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 89999999999999998654 4666677899999999999999999999999999999953 23588999999987
Q ss_pred ccCCCCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
..............+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||...... ....+ .+...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~---~~~~~-- 246 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANIL---LGACS-- 246 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHH---TTCCC--
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHH---hccCC--
Confidence 54332222223557899999999998641 1567889999999999999999 88999654322 11111 11100
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
..........+..+.+||.+||+.||.+|||+.++|+||||..+
T Consensus 247 ----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 247 ----------------------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ----------------------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ----------------------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 00011112345668999999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=356.71 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=198.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 46899999999999999999998754 457999998753 334556678899999999999999999999732
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 34799999999 59999998654 7999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------- 235 (281)
T 1mp8_A 167 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------
T ss_pred Cccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-------
Confidence 432211 1133457789999999977 689999999999999999996 9999988776665554432110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
....+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 -----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11235689999999999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=354.32 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=207.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCc
Confidence 468999999999999999999776 5678999999754322 356789999999999999999999983 4456
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||++ ++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 899999997 68999997654 5999999999999999999999999999999999999999999999999999865433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 158 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (268)
T 3sxs_A 158 QYV--SSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--------- 224 (268)
T ss_dssp CEE--ECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred hhh--cccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence 221 1234457788999999977 678999999999999999999 99999887766555444321100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......++.+.+||.+||+.||.+|||+.++++|
T Consensus 225 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ---------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123468899999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=355.76 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=205.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++. +.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCC
Confidence 4478999999999999999999876 6778999999754322 356789999999999999999999984 445
Q ss_pred eEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 6899999997 699999976 46799999999999999999999999999999999999999999999999999976432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 173 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (283)
T 3gen_A 173 DE--YTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------- 240 (283)
T ss_dssp HH--HHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred cc--cccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence 21 111233457788999999987 679999999999999999998 99999988766655555332111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......++.+.+||.+||+.||.+|||+.++++|
T Consensus 241 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 ----------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1123568899999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=368.53 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=210.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC-------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 93 (414)
.++|++++.||+|+||+||+|.+..+ +..||+|++... ........+.+|+.+++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 36899999999999999999997543 357999999754 3445567889999999999 89999999999943
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
.+.+|+|||||. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 345899999998 59999998753 49999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 11234567889999999987 789999999999999999999 999998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+....+..... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 299 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6554444422110 11124688999999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=359.44 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=202.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..++|++.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.+++.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34689999999999999999998765 556899999986555666677899999999999999999999999765433
Q ss_pred CCceEEEEEecCC-CCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeec
Q 015019 98 EFKDIYVVFELME-SDLHQVIK------ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~------~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DF 170 (414)
.....|+||||+. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3446799999999 69999984 3357999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCC
Q 015019 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 171 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 267 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-
Confidence 999765332211 11233457889999999977 689999999999999999999 8999988776555444432110
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 -----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 -----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01124678999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=366.14 Aligned_cols=273 Identities=22% Similarity=0.224 Sum_probs=206.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||+||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCc
Confidence 3468999999999999999999765 789999998642 233445667999999999999999999986543 2245
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccCCCCCCCEEEcCCCCeEEee
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------NVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~----------givHrDlkp~NILl~~~~~vkL~D 169 (414)
.+|+|||||. |+|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 6899999998 5999999764 599999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 015019 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 170 FG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (414)
||+|+........ ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.............
T Consensus 175 Fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 175 FGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred CCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999765443221 122446799999999998652 124556889999999999999999999876543332222222
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCC-CCccCCC--CCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPP-VPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+.+....+. ........ ......+ ...++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 254 GQHPSLEDMQ-----------EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CSSCCHHHHH-----------HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCchhhhh-----------hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3333322211 11111111 1111111 122455899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.62 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=204.6
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHH-----HHHHHHHHHHHhCCCCCccccceeecCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-----IRILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
-..++|++.+.||+|+||+||+|.+..+++.||+|++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34579999999999999999999999999999999986543322221 5788999999999999999999998433
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCC-----e
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCK-----L 165 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~-----v 165 (414)
. ++||||+. ++|.+.+... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++. +
T Consensus 96 ~-------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 P-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp T-------EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred C-------eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 2 79999998 7998888654 47999999999999999999999999 999999999999988776 9
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhH--HHHH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ--LDLI 243 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~--~~~i 243 (414)
||+|||+++..... ....+||+.|+|||++......++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999753321 245679999999999854335688999999999999999999999976553322 1111
Q ss_pred HHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. .... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 243 ~~------------------------~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE------------------------EGLR-----PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH------------------------SCCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc------------------------cCCC-----CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 0000 1123467899999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=354.83 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=207.8
Q ss_pred CCCCeeEee-eecccCceeEEEEE--ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 21 DANRYKILE-VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 21 ~~~~Y~i~~-~lg~G~~g~V~~a~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..++|++.+ .||+|+||+||+|. +..+++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence 346899998 99999999999995 45678899999998654444556778999999999999999999999822
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...|+||||+. ++|.+++.....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 35899999998 699999999888999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------- 236 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------- 236 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---------
T ss_pred ccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence 443322222233456788999999977 678999999999999999999 99999887765444333211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 237 ------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 237 ------------------ER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 1122468899999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=363.77 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=209.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
..++|++++.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 3478999999999999999999987 35589999998754 234456678899999999999999999999843
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHR 150 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~qil~al~~LHs~givHr 150 (414)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 456899999998 5999999763 579999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCC
Q 015019 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (414)
Q Consensus 151 Dlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~ 229 (414)
||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999764322111 11234568899999999887 679999999999999999999 999
Q ss_pred CCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHH
Q 015019 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (414)
Q Consensus 230 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~ 309 (414)
||.+.+..+....+.... .......+++.+.+||.+||+.||.+|||+.+
T Consensus 276 p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGN------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhCCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 998877655444442210 01122467899999999999999999999999
Q ss_pred HhcC
Q 015019 310 ALAD 313 (414)
Q Consensus 310 lL~h 313 (414)
++++
T Consensus 326 ~~~~ 329 (343)
T 1luf_A 326 IHRI 329 (343)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=353.63 Aligned_cols=250 Identities=22% Similarity=0.416 Sum_probs=211.5
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++.+.||+|+||+||+|.+..++..||+|++... ......+.+|+.+++.++||||+++++++. ...
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence 346899999999999999999999999999999999743 345567889999999999999999999984 345
Q ss_pred eEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
.+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 6899999999 6999999864 459999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------- 230 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------- 230 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------
Confidence 3322 12244567889999999977 679999999999999999999 9999988776554444322110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 ----------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1122467899999999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=358.14 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=209.3
Q ss_pred CCCeeEeeeecccCceeEEEEEE-----CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++.+.||+|+||.||+|.+ ..++..||+|++... ........+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 36899999999999999999985 457789999999754 3345567788999999999 89999999999844
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
.+..|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 345899999998 59999998654 48999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999875443321 12234567889999999877 689999999999999999998 999998766
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.......+.... .. ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~-----------------------~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEG-----------------------FR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHT-----------------------CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccC-----------------------CC------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 443333222110 00 01124678999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=353.01 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=198.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
-..++|++.+.||+|+||+||+|.+. ..||+|+++...........+.+|+.+++.++||||++++++.. .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------A 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------C
Confidence 34568999999999999999999754 35999999876666677788999999999999999999999652 2
Q ss_pred ceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
..+++|||||. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 34799999998 699999864 4579999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+....+.+..+....
T Consensus 172 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------- 241 (289)
T 3og7_A 172 RWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG--------- 241 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT---------
T ss_pred cccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc---------
Confidence 2221 1123456799999999998621 1568889999999999999999999998866554443332211
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
............+++.+.+||.+||+.||.+|||+.++++
T Consensus 242 ----------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 242 ----------------SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ----------------SCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------ccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111222334578899999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=362.56 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=200.5
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcE----EEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..++|++++.||+|+||+||+|.+..+++. ||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 346899999999999999999999888775 477776532 1223446788999999999999999999998542
Q ss_pred CCCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
..++|+||+. |+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 90 ----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred ----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 3788999998 799999977 4679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----- 237 (327)
T 3poz_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----- 237 (327)
T ss_dssp HHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred EccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-----
Confidence 75433221 12234457889999999987 789999999999999999999 9999988776554433322110
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
....+..+..+.+|+.+||+.||.+|||+.+++++
T Consensus 238 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 -------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01124578899999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=356.81 Aligned_cols=255 Identities=27% Similarity=0.355 Sum_probs=200.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++. ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----ID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eC
Confidence 34789999999999999999999999999999999875432 3334567889999999999999999999984 34
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+.+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 57999999998 59999999888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 187 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------- 249 (309)
T 2h34_A 187 EKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ------------- 249 (309)
T ss_dssp ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-------------
T ss_pred ccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-------------
Confidence 221 11245679999999999987 6889999999999999999999999987654322211111
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-CHHHHhc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALA 312 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-t~~~lL~ 312 (414)
. ........+.+++.+.+||.+||+.||.+|| |++++++
T Consensus 250 --------------~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 --------------A-IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------------C-CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------------C-CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0 0111123457899999999999999999999 7887765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=357.86 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCC----cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
-...+|++.+.||+|+||+||+|.+..++ ..||||++... ........+.+|+.+++.++||||+++++++.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 116 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--- 116 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe---
Confidence 45678999999999999999999987654 35999999753 23455667889999999999999999999983
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
..+.+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 117 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 117 --KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp --SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 4456999999998 5999999764 67999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--- 269 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--- 269 (333)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---
T ss_pred hhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---
Confidence 875443222222233456888999999977 689999999999999999998 99999887765544444321100
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1124678999999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=368.79 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=197.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEEC---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK---- 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----
Confidence 3458999999999999999999877 46778999998753 234556678999999999999999999999843
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
...+|+|||||. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 118 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 118 -SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred -CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 356899999997 69999998754 799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~----- 269 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL----- 269 (373)
T ss_dssp -----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-----
T ss_pred cccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 5433222111122345778999999987 689999999999999999998 99999887765554444321110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 270 -------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 -------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 112357889999999999999999999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=371.22 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=207.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||.||+|.+..+++.||||++... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence 36899999999999999999999999999999998753 233445568899999999999999999999843 345
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999998 6999999764 36999999999999999999999999999999999999999999999999999764322
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ........++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 267 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------- 332 (377)
T 3cbl_A 267 VY-AASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----------- 332 (377)
T ss_dssp EE-ECCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-----------
T ss_pred ce-eecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 11 000112235678999999977 678999999999999999998 999999877655443332210
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 333 --------------~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 333 --------------RL-----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 112357889999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=362.37 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=202.2
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhC----CCCCccccceee
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLL----RHPDIVEIKRIM 91 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l----~hpniv~l~~~~ 91 (414)
...++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999999999999999987532211 2233456799999998 899999999998
Q ss_pred cCCCCCCCceEEEEEec-CC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc-CCCCeEEe
Q 015019 92 LPPSKREFKDIYVVFEL-ME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVC 168 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~-~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~-~~~~vkL~ 168 (414)
.. .+..|+|||+ +. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+
T Consensus 108 ~~-----~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ET-----QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred ec-----CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence 43 3568999999 55 69999999888899999999999999999999999999999999999999 88999999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
|||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +..
T Consensus 183 dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--- 247 (312)
T 2iwi_A 183 DFGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE--- 247 (312)
T ss_dssp CCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH---
T ss_pred EcchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh---
Confidence 999998754322 2456799999999998762 2335589999999999999999999975321 100
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.. ......+++.+.+||.+||+.||++|||++++|+||||+...
T Consensus 248 -----------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 248 -----------------------AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -----------------------TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -----------------------hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 00 011246789999999999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=363.43 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=206.0
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 468999999999999999999973 456789999997532 233456788999999999 89999999999844
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHHQFFLYQMLRALKYMHTANVYHRD 151 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~-----------------------~l~~~~~~~i~~qil~al~~LHs~givHrD 151 (414)
.+.+|+||||+. |+|.+++.... .+++..+..++.||+.||+|||++||+|||
T Consensus 121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 345899999998 69999997643 379999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCC
Q 015019 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (414)
Q Consensus 152 lkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~p 230 (414)
|||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999865443221 12244567889999999877 689999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
|.+......+..+... ... ......+++.+.+||.+||+.||.+|||+.++
T Consensus 275 ~~~~~~~~~~~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQN--------------------------GFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp STTCCCSHHHHHHHHT--------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCCcHHHHHHHHhc--------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 9877644333322210 000 01124578999999999999999999999999
Q ss_pred hcCC
Q 015019 311 LADP 314 (414)
Q Consensus 311 L~hp 314 (414)
++|.
T Consensus 326 ~~~l 329 (344)
T 1rjb_A 326 TSFL 329 (344)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=358.43 Aligned_cols=253 Identities=20% Similarity=0.368 Sum_probs=209.5
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 368999999999999999999876 46789999998753 334555678899999999999999999999843
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCe
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~v 165 (414)
....|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 346899999998 5999998652 457999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (414)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999765332211 11234467899999999987 679999999999999999999 899998877655444432
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
... .......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 210 011234688999999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.48 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=208.0
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-------CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 93 (414)
.++|++++.||+|+||+||+|.+. .++..||||++... ........+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 478999999999999999999976 45678999998754 3345567788999999999 89999999999843
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
.+.+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 456899999998 59999998653 38999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999865432211 11234457889999999877 678999999999999999999 999998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+....+..... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6554443322110 11224678999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=363.04 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=204.5
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcE----EEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
-..++|++++.||+|+||+||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--- 85 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--- 85 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---
Confidence 3457899999999999999999999888876 77777653211 122234668999999999999999999883
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
....|+||||+. |+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 86 ---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 86 ---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp ---BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred ---CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 235899999998 6999999764 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+........ .......||..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 235 (325)
T 3kex_A 163 DLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---- 235 (325)
T ss_dssp GGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----
T ss_pred cccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----
Confidence 875433221 22345678889999999987 679999999999999999999 9999988765544443322100
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......+++.+.+||.+||..||.+|||+.++++|
T Consensus 236 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 --------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp --------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred --------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123467788999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=350.10 Aligned_cols=257 Identities=20% Similarity=0.229 Sum_probs=206.5
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccC----CC
Confidence 3467999999999999999999999999999999998653322 347789999999999888777766532 33
Q ss_pred ceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE---cCCCCeEEeecCCccc
Q 015019 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl---~~~~~vkL~DFG~a~~ 175 (414)
...|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 56899999998899999974 5679999999999999999999999999999999999999 4788999999999987
Q ss_pred ccCCCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh---hhHHHHHHHhcC
Q 015019 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLG 248 (414)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 248 (414)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+. ...+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 54432211 11245679999999999987 6799999999999999999999999987432 222222221100
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+. .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STP--------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSC--------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCc--------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 000 00112468899999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=374.59 Aligned_cols=262 Identities=27% Similarity=0.350 Sum_probs=194.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 98 (414)
...+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++. +
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~ 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSET-----T 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----C
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----c
Confidence 34567888999999999999875 4567999999998642 234567899999876 8999999999983 4
Q ss_pred CceEEEEEecCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---------
Q 015019 99 FKDIYVVFELMESDLHQVIKANDDL-------TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--------- 162 (414)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l-------~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~--------- 162 (414)
...+|+|||||+|+|.+++...... ++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 4579999999999999999875433 233457799999999999999999999999999999754
Q ss_pred ----CCeEEeecCCcccccCCCCc-cccccccccCcccccccccccc-----CCCCCCcchhhhHhHHHHHHHh-CCCCC
Q 015019 163 ----CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLF 231 (414)
Q Consensus 163 ----~~vkL~DFG~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwSlG~il~~ll~-g~~pf 231 (414)
+.+||+|||+|+........ .......+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 47999999999875433211 1112356799999999998651 1468999999999999999999 99999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 015019 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (414)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL 311 (414)
.+..... ..+...... ... ........+++++.+||.+||+.||.+|||+.++|
T Consensus 241 ~~~~~~~--~~i~~~~~~-----------------------~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIFS-----------------------LDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp CSTTTHH--HHHHHTCCC-----------------------CCC-CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhH--HHHhcCCCC-----------------------ccc-ccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 7654322 111110000 000 00000123467899999999999999999999999
Q ss_pred cCCCCCc
Q 015019 312 ADPYFKG 318 (414)
Q Consensus 312 ~hp~~~~ 318 (414)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=347.26 Aligned_cols=249 Identities=15% Similarity=0.198 Sum_probs=207.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||+||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 468999999999999999999875 889999999876556666778999999999999999999999985432 256
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 59999998765 5899999999999999999999999 999999999999999999999999987542
Q ss_pred cCCCCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.. ...+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 164 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 229 (271)
T 3kmu_A 164 QS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR------ 229 (271)
T ss_dssp SC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC------
T ss_pred cc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC------
Confidence 21 234689999999998762 122334899999999999999999999887765554433221100
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123468999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=362.79 Aligned_cols=267 Identities=15% Similarity=0.146 Sum_probs=202.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEECC---CCcEEEEEEeCCccCChHH---------HHHHHHHHHHHHhCCCCCccccc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISD---------AIRILREVKLLRLLRHPDIVEIK 88 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~ 88 (414)
..++|++++.||+|+||+||+|.+.. ++..||||++......... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 7889999998754221111 12356788999999999999999
Q ss_pred eeecCCCCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC--CeE
Q 015019 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC--KLK 166 (414)
Q Consensus 89 ~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~--~vk 166 (414)
+++.... .....+|+|||||+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9986532 2356799999999779999998877899999999999999999999999999999999999999887 999
Q ss_pred EeecCCcccccCCCC----ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh--hhHH
Q 015019 167 VCDFGLARVAFSDTP----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQL 240 (414)
Q Consensus 167 L~DFG~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~--~~~~ 240 (414)
|+|||+|+....... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999976532211 1111245679999999999987 6799999999999999999999999965322 1111
Q ss_pred HHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..........+... ... .....+++.+.+||.+||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~-------------~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSV-------------LKW---------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHH-------------HHH---------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHH-------------Hhh---------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111111111110 000 001268899999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=364.85 Aligned_cols=269 Identities=16% Similarity=0.142 Sum_probs=204.5
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCC-----CcEEEEEEeCCccCChHHH---------HHHHHHHHHHHhCCCCCccc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDA---------IRILREVKLLRLLRHPDIVE 86 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~ 86 (414)
..++|++++.||+|+||+||+|.+..+ ++.||||++.......... .....|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998765 5789999986532111111 12345666778889999999
Q ss_pred cceeecCCCCCCCceEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc--CCC
Q 015019 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANC 163 (414)
Q Consensus 87 l~~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~--~~~ 163 (414)
+++++.... .....+|||||||+++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999986532 233568999999988999999876 6899999999999999999999999999999999999999 889
Q ss_pred CeEEeecCCcccccCCCCc----cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhH
Q 015019 164 KLKVCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239 (414)
Q Consensus 164 ~vkL~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~ 239 (414)
.+||+|||+|+........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 9999999999765332111 111234569999999999987 6799999999999999999999999986443322
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......... .......+..... ...+++.+.+||..||..||.+|||+.++++
T Consensus 270 ~~~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRY-----------RENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHH-----------HHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHh-----------hhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 222111000 0111111111110 1467899999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.23 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=191.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC---CC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS---KR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~---~~ 97 (414)
..+|++.+.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3589999999999999999999999999999999854 33455667889999999996 999999999985322 13
Q ss_pred CCceEEEEEecCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 98 EFKDIYVVFELMESDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~---~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
....+|+||||+.|+|.+++.. .+.+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 4456899999999999998865 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc---------ccccccccCccccccccccc-cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHH
Q 015019 173 ARVAFSDTPMT---------VFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (414)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~ 242 (414)
++......... ......+||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98754332211 01124569999999999831 115788999999999999999999999976543221110
Q ss_pred HHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 015019 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (414)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp 314 (414)
. .. .......+..+.+||.+||+.||.+|||+.++++|-
T Consensus 265 ~------------------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 265 K------------------------------YS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -------------------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred c------------------------------cc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0 00 011235677899999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.97 Aligned_cols=257 Identities=20% Similarity=0.229 Sum_probs=202.6
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||+||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecC----CC
Confidence 45689999999999999999999999999999999875432 22346789999999999888877776632 34
Q ss_pred ceEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE---cCCCCeEEeecCCccc
Q 015019 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl---~~~~~vkL~DFG~a~~ 175 (414)
...|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 56899999998899999985 5679999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh---HHHHHHHhcC
Q 015019 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH---QLDLITDLLG 248 (414)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~ 248 (414)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 54432211 11235679999999999987 679999999999999999999999998754322 2222211000
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. +.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ~~--------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 ST--------------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HS--------------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cc--------------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00 001112467899999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=359.85 Aligned_cols=271 Identities=21% Similarity=0.347 Sum_probs=213.2
Q ss_pred CCCCeeEeeeecccCceeEEEEE----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..++|++++.||+|+||.||+|. +..+++.||||++.. ........+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-- 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--
Confidence 34689999999999999999998 577899999999975 3445566789999999999999999999988643
Q ss_pred CCCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
+...+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 -GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp -SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred -CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 3456899999996 699999976 4569999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
................||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~--- 245 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCER--- 245 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC------
T ss_pred ecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hccccc---
Confidence 76444333223345678899999999977 67899999999999999999999999754322110 000000
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.................. ...+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 246 ----~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 ----DVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -----CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----ccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111111222222111 1235789999999999999999999999999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=357.71 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=201.0
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEE----EEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV----AIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..++|++++.||+|+||+||+|.+..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 4578999999999999999999998888765 666665322 223456788999999999999999999998543
Q ss_pred CCCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
..++|+|++. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 ----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 3788999988 699999976 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
........ .......||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 237 (327)
T 3lzb_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----- 237 (327)
T ss_dssp ---------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred EccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 65332221 12234457889999999987 789999999999999999999 9999988776554444322111
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
....+.++..+.+||.+||+.||.+|||+.++++
T Consensus 238 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 238 -------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112457889999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=354.22 Aligned_cols=245 Identities=17% Similarity=0.271 Sum_probs=201.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCC-------cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
.++|++.+.||+|+||+||+|.+..++ ..||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-
Confidence 468999999999999999999998877 47999998653 23445678899999999999999999999954
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC--------
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-------- 164 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~~-l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~-------- 164 (414)
.+..|+||||+. ++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 84 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 84 ----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ----TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred ----CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 345799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred eEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC-CCCCCCChhhHHHHH
Q 015019 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLI 243 (414)
Q Consensus 165 vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~-~pf~~~~~~~~~~~i 243 (414)
+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|. +||............
T Consensus 160 ~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999998654221 234588999999998653 46899999999999999999954 556554433322211
Q ss_pred HHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.. .. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~---------------------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 ED---------------------------RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HT---------------------------TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hc---------------------------cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 00 1123457789999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=359.54 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=206.5
Q ss_pred CCCCeeEeeeecccCceeEEEEE-----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 34689999999999999999998 5667889999998743 344556678899999999999999999999844
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC---CC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CK 164 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~---~~ 164 (414)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 105 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 ---SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ---CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 345799999996 6999999875 348999999999999999999999999999999999999844 46
Q ss_pred eEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHH
Q 015019 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243 (414)
Q Consensus 165 vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i 243 (414)
+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECccccccccccccccc-cCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9999999997543322111 1234568899999999977 679999999999999999998 99999887765544444
Q ss_pred HHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
..... ......+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 259 ~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCC------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22100 012246789999999999999999999999999998864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=350.43 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=209.9
Q ss_pred CCCeeEee-eecccCceeEEEEEEC--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILE-VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~-~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----
Confidence 36788887 9999999999999864 46788999999764 344566778999999999999999999999832
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 34899999998 5999998654 56999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..............||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--------- 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------- 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---------
T ss_pred ccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC---------
Confidence 433322222234457899999999977 678999999999999999998 99999887765544433221
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
. .....+.+++.+.+||.+||+.||.+|||+.++++|.+
T Consensus 230 ------------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 230 ------------------K---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------C---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------C---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0 01123578999999999999999999999999998743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=356.63 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=208.7
Q ss_pred CCCeeEeeeecccCceeEEEEEE-----CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||+||+|.+ ..+++.||||++... ........+.+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 47899999999999999999985 457789999999754 2344556788999999999 699999999998543
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEE
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDD----------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~----------------l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NIL 158 (414)
...+|+|||||. ++|.+++..... +++..+..++.||+.||+|||+.||+||||||+||+
T Consensus 104 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 235899999998 599999987543 899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChh
Q 015019 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (414)
Q Consensus 159 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~ 237 (414)
++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCCEEECCCccccccccCccc-eeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 999999999999999865433221 22245568899999999977 689999999999999999998 99999876543
Q ss_pred hHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+...... ... ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLKE--------------------------GTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHH--------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcc--------------------------Ccc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332222110 000 01124578999999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=347.07 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=194.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC--hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 468999999999999999999874 889999998653221 1224568899999999999999999999843 3
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCCEEEcC--------CCCeEE
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANA--------NCKLKV 167 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g---ivHrDlkp~NILl~~--------~~~vkL 167 (414)
...|+||||+. ++|.+++. ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 46899999998 58887775 568999999999999999999999999 899999999999986 678999
Q ss_pred eecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
+|||+++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 229 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN- 229 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-
Confidence 99999976533221 24579999999999977 67999999999999999999999999887755443333211
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
... ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 230 -------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 -------------------------KLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 000 11224678999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=348.77 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=204.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 3689999999999999999998654 3446999998754 234556778999999999999999999999843
Q ss_pred CceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
...|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 23599999999 6999999764 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||......+....+......
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------ 233 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------ 233 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC------
Confidence 432211 1234457889999999977 689999999999999999998 99999877665554444321110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1123578999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=345.95 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=207.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.. .+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCC
Confidence 468999999999999999999986 6778999999764332 3568899999999999999999999844 345
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 899999998 6999999875 56999999999999999999999999999999999999999999999999999764321
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
. ........+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 158 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~---------- 223 (267)
T 3t9t_A 158 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 223 (267)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred c--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------
Confidence 1 111234457888999999977 678999999999999999999 8999988776555444432100
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.......++.+.+||.+||+.||.+|||+.+++++
T Consensus 224 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 --------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123568899999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=353.33 Aligned_cols=270 Identities=22% Similarity=0.372 Sum_probs=209.3
Q ss_pred CCCeeEeeeecccCceeEEEEE----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
..+|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG-- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence 3579999999999999999998 67789999999997532 2233467889999999999999999999986432
Q ss_pred CCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
...+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 97 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 97 -GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 256899999998 599999954 56799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...............||..|+|||++.+ ..++.++|||||||++|+|++|..|+.... ..+....+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~- 247 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQM- 247 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGG-
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccccc-
Confidence 6544332233345678999999999977 678899999999999999999998874322 12222222222111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
........+...... ...+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 248 ------TVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp ------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ------CHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111222222222111 223578999999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=356.91 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=207.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCc-----EEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+++.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 4689999999999999999999987664 7999998753 2344566788999999999 89999999999843
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKA--------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~--------------~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
.+.+|+|||||. |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 346899999998 599999864 34689999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhH
Q 015019 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (414)
Q Consensus 161 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~ 239 (414)
.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999865433221 12234567889999999877 679999999999999999998 9999987664443
Q ss_pred HHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
+..+..... . .......++.+.+||.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~------------------------~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVKDGY------------------------Q-----MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHTC------------------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCC------------------------C-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 332221100 0 0112356889999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=359.00 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=207.3
Q ss_pred cccccccccCCCCCeeEeeeecccCceeEEEEEECCCCcEE--EEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCcccc
Q 015019 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEI 87 (414)
Q Consensus 11 ~~~~~~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l 87 (414)
.....|+..+ .++|++.+.||+|+||.||+|.+..++..+ |+|.+... ........+.+|+.+++.+ +||||+++
T Consensus 14 ~~~~~~p~~~-~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 91 (327)
T 1fvr_A 14 PDPTIYPVLD-WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINL 91 (327)
T ss_dssp --CCCSSBCC-GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred CCCccccccc-HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhh
Confidence 3444455443 368999999999999999999999888865 99988643 2233455688999999999 89999999
Q ss_pred ceeecCCCCCCCceEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 015019 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHR 150 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~al~~LHs~givHr 150 (414)
++++. ..+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||
T Consensus 92 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 166 (327)
T 1fvr_A 92 LGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 166 (327)
T ss_dssp EEEEE-----ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ceeee-----eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 99983 4457999999997 69999997654 79999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCC
Q 015019 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (414)
Q Consensus 151 Dlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~ 229 (414)
||||+|||++.++.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 167 dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~ 240 (327)
T 1fvr_A 167 DLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGT 240 (327)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCccceEEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCC
Confidence 999999999999999999999997432211 1133457889999999977 678999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHH
Q 015019 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (414)
Q Consensus 230 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~ 309 (414)
||.+.+..+....+.. ... ......+++.+.+||.+||..||.+|||+++
T Consensus 241 pf~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 241 PYCGMTCAELYEKLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp TTTTCCHHHHHHHGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCcHHHHHHHhhc---------------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9988775544333311 000 1122467899999999999999999999999
Q ss_pred HhcC
Q 015019 310 ALAD 313 (414)
Q Consensus 310 lL~h 313 (414)
+++|
T Consensus 291 ll~~ 294 (327)
T 1fvr_A 291 ILVS 294 (327)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=355.48 Aligned_cols=260 Identities=25% Similarity=0.320 Sum_probs=197.3
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh--CCCCCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++++.||+|+||+||+|.+ +++.||||++.. .......+|.+++.. ++||||+++++++.... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CC
Confidence 457899999999999999999977 689999999864 233455667777666 78999999999875432 33
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCCEEEcCCCCeEEee
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LH--------s~givHrDlkp~NILl~~~~~vkL~D 169 (414)
...+|+||||+. |+|.++++. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 456899999998 599999954 57999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccccCCCCcc-ccccccccCccccccccccccCC----CCCCcchhhhHhHHHHHHHhC----------CCCCCCC
Q 015019 170 FGLARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (414)
Q Consensus 170 FG~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~~ll~g----------~~pf~~~ 234 (414)
||+|+......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| ..||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654332221 11234579999999999876211 345789999999999999999 8888653
Q ss_pred Chh----hHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 235 SVV----HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 235 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
... ..+..+.... ......+........++.+.+||.+||+.||.+|||+.++
T Consensus 237 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVD-----------------------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp SCSSCCHHHHHHHHTTS-----------------------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCcchhhhhHHHhcc-----------------------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 211 1111111000 0000001000111245779999999999999999999999
Q ss_pred hc
Q 015019 311 LA 312 (414)
Q Consensus 311 L~ 312 (414)
++
T Consensus 294 ~~ 295 (301)
T 3q4u_A 294 KK 295 (301)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=349.19 Aligned_cols=260 Identities=26% Similarity=0.399 Sum_probs=198.7
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----- 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence 4457899999999999999999999999999999999753 2344566778899999999999999999999843
Q ss_pred CceEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 99 FKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
.+.+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 4569999999984 99988864 467999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChh--hHHHHHHHhcCCCC
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLITDLLGTPS 251 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~ 251 (414)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+.
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 251 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------- 251 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-------
Confidence 76533221 1234579999999999987 68899999999999999999999999764321 1111111
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.....+ .....+++.+.+||.+||+.||.+|||+.+++++ ++.+.
T Consensus 252 --------------------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~--l~~l~ 296 (310)
T 2wqm_A 252 --------------------QCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRMH 296 (310)
T ss_dssp --------------------TTCSCC--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred --------------------cccCCC--CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHH
Confidence 000000 1124678999999999999999999999999873 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=356.91 Aligned_cols=261 Identities=24% Similarity=0.399 Sum_probs=204.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 34789999999999999999999999999999999864 34456677889999999999999999999985322 2345
Q ss_pred eEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 7899999999 599998875 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcc------ccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhh-HHHHHHHhc
Q 015019 176 AFSDTPMT------VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLL 247 (414)
Q Consensus 176 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~ 247 (414)
........ .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||....... .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----
Confidence 42211100 011234679999999998652 1237899999999999999999999995321100 00000
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. ..... ....+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 260 -------------------~---~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 -------------------V---QNQLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -------------------H---HCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------h---hccCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0 00000 01124678999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.59 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=204.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
-+|.+.+.||+|+||+||+|.+..++. .||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 368889999999999999999765554 7999998753 34455677889999999999999999999985432
Q ss_pred ceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 23489999997 799999987 4578999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC-ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 178 SDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 178 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.... .........+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------ 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------ 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC------
Confidence 2211 1111234568899999999987 689999999999999999999 55666666554444433221111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 ------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112457889999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.88 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=204.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
..+|++.+.||+|+||+||+|.+..++ ..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence 357999999999999999999976443 36899998753 3445667789999999999999999999986432
Q ss_pred CceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
.+..|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 346799999998 599999976 456899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCc-cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 177 FSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 177 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-----
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-----
Confidence 332211 112244568889999999977 689999999999999999999 66888777665554444321110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 -------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112357889999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=374.34 Aligned_cols=249 Identities=22% Similarity=0.406 Sum_probs=209.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
..+|++.+.||+|+||.||+|.++.++..||||++..... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCc
Confidence 3579999999999999999999999999999999975422 34678899999999999999999999843 345
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999998 7999999863 4699999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 437 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------- 437 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 221 11233456788999999977 679999999999999999999 9999998776554443322100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 438 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ---------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0122468899999999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=360.93 Aligned_cols=260 Identities=14% Similarity=0.175 Sum_probs=201.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC--------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT--------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 93 (414)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999999874 889999998743 357789999999999999985433211
Q ss_pred CC-----------CCCCceEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc
Q 015019 94 PS-----------KREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (414)
Q Consensus 94 ~~-----------~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~ 160 (414)
.. ......+|+|||||+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 00 0124678999999988999999876 7899999999999999999999999999999999999999
Q ss_pred CCC--CeEEeecCCcccccCCCCc----cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCC
Q 015019 161 ANC--KLKVCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (414)
Q Consensus 161 ~~~--~vkL~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~ 234 (414)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999765332111 111244579999999999987 68999999999999999999999999865
Q ss_pred C-hhhHHHHH-HHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 235 S-VVHQLDLI-TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 235 ~-~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. ....+... ......+. ........+..+++.+.+||.+||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG----------------------PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC----------------------CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh----------------------hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 22221111 11100000 000001112367899999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=360.91 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=206.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++.+.||+|+||+||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CT
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CC
Confidence 45579999999999999999999864 6899999998753 2344567889999999999999999999984 34
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 100 KDIYVVFELME-SDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
+.+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 56899999998 69998886542 58999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....
T Consensus 188 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~------- 257 (321)
T 2qkw_B 188 KGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV------- 257 (321)
T ss_dssp ECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-------
T ss_pred cccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-------
Confidence 64332211 12244568999999999877 689999999999999999999999997654332111110000
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCc-cCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp 314 (414)
. ......+........ ....+..+..+.+|+.+||+.||++|||+.++++|.
T Consensus 258 ------~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 258 ------E--SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp ------H--HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------h--ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 000000000000000 011123456789999999999999999999999763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=352.82 Aligned_cols=270 Identities=22% Similarity=0.323 Sum_probs=207.5
Q ss_pred CCCCe-eEeeeecccCceeEEEEE----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 21 DANRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 21 ~~~~Y-~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
..++| ++++.||+|+||+||+|. +..+++.||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA- 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC-
Confidence 34566 999999999999998775 4457889999999754 3345567789999999999999999999998543
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
....+|+||||+. ++|.+++... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 106 --~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 --GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp --TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred --CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 2357899999998 5999998765 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
................||..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~ 255 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM 255 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch
Confidence 76544332222345568899999999987 67889999999999999999999999654321 111111111110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
........+..... ......+++.+.+||++||+.||.+|||+.++++
T Consensus 256 -------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 256 -------TVLRLTELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -------HHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------hHHHHHHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01111111111111 1223568899999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=381.22 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=204.1
Q ss_pred eeEe-eeecccCceeEEEEEE--CCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 25 YKIL-EVIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 25 Y~i~-~~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.+. +.||+|+||+||+|.+ +.+++.||||+++...........+.+|+.+|+.++||||+++++++.. ..
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CC
Confidence 4443 4899999999999954 4667899999998655555556789999999999999999999998832 24
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 799999998 6999999988899999999999999999999999999999999999999999999999999998754433
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
..........||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----------- 590 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------- 590 (635)
T ss_dssp -----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred cccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 22222234457889999999977 689999999999999999998 9999998887665554432111
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+++.+.+||.+||+.||++|||++++++
T Consensus 591 -------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 -------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0112468899999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=344.36 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=204.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++.. +.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 368999999999999999999875 567899999875322 24568899999999999999999998842 24
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 69999987543 699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------- 228 (279)
T 1qpc_A 162 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------- 228 (279)
T ss_dssp SCEE--CCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred cccc--cccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------
Confidence 2211 1234457889999999976 678999999999999999999 9999988776554444322100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 229 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ---------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112467899999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=344.57 Aligned_cols=248 Identities=28% Similarity=0.381 Sum_probs=205.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-------
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------- 95 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------- 95 (414)
++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999999999999999987532 24568999999999999999999874311
Q ss_pred ----CCCCceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEe
Q 015019 96 ----KREFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 96 ----~~~~~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~ 168 (414)
......+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 122456899999999 5999999754 579999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...
T Consensus 165 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~-------- 228 (284)
T 2a19_B 165 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS--KFF-------- 228 (284)
T ss_dssp CCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHH--------
T ss_pred cchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHH--------
Confidence 9999987543321 234579999999999987 678999999999999999999998874211 000
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
..+... .....+++.+.+||.+||+.||.+|||+.++++|++.-
T Consensus 229 -------------------~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 229 -------------------TDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -------------------HHHHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------HHhhcc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011110 01235788999999999999999999999999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=342.91 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=192.7
Q ss_pred cccCCCCCeeEe-eeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHH-HhCCCCCccccceeecCC
Q 015019 17 TEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 17 ~~~~~~~~Y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~ 94 (414)
......++|.++ +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 344555789888 7899999999999999999999999998641 3456788887 666899999999998532
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCCeEEe
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVC 168 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~vkL~ 168 (414)
. .....+|+|||||. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 84 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 84 Y-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp E-TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred c-CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 1 23457899999998 59999998754 6999999999999999999999999999999999999998 7889999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
|||++.... + ..|+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 163 Dfg~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~- 214 (299)
T 3m2w_A 163 DFGFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI- 214 (299)
T ss_dssp CCTTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS-
T ss_pred ccccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH-
Confidence 999885421 1 357889999999999999999999997655322110000000
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
...........+..+++.+.+||.+||+.||.+|||+.++|+||||.+...
T Consensus 215 ----------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 215 ----------------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp ----------------------CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ----------------------hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 000000000111468999999999999999999999999999999987544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=368.93 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=205.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.+|+.++||||+++++++. ...
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 368999999999999999999876 46789999997532 23567889999999999999999999984 234
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 799999998 6999999754 3689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ........+|..|+|||++.. ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 337 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 404 (454)
T 1qcf_A 337 NE--YTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------- 404 (454)
T ss_dssp HH--HHTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC--------
T ss_pred Cc--eeccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 11 111123446788999999977 679999999999999999999 99999988776655544321111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 405 ----------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 ----------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 112467899999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.84 Aligned_cols=243 Identities=25% Similarity=0.402 Sum_probs=203.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+|+.++||||+++++++... ...
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCc
Confidence 468999999999999999999775 7799999997532 345688999999999999999999997532 235
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+|||||. |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 899999998 69999998754 379999999999999999999999999999999999999999999999999985432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 342 ~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 404 (450)
T 1k9a_A 342 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------- 404 (450)
T ss_dssp -----------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---------
T ss_pred cc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 21 22357889999999977 689999999999999999998 9999988776555544432110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 405 ---------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0122468899999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=371.60 Aligned_cols=255 Identities=18% Similarity=0.206 Sum_probs=197.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCC-CCcccc---------ceee
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRH-PDIVEI---------KRIM 91 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~l---------~~~~ 91 (414)
..|++.+.||+|+||+||+|.+..+|+.||||++..... .....+.+.+|+.+++.++| +|...+ .++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 348899999999999999999999999999999873322 22235668899999999987 322111 1111
Q ss_pred cC------------CCCCCCceEEEEEecCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 015019 92 LP------------PSKREFKDIYVVFELMESDLHQVIKA-------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (414)
Q Consensus 92 ~~------------~~~~~~~~~~lV~E~~~g~L~~~i~~-------~~~l~~~~~~~i~~qil~al~~LHs~givHrDl 152 (414)
.. ........++++|+++.++|.+++.. ...+++..+..++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 01111345799999999999998841 335788899999999999999999999999999
Q ss_pred CCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccc--------cCCCCCCcchhhhHhHHHHHH
Q 015019 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEV 224 (414)
Q Consensus 153 kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~DiwSlG~il~~l 224 (414)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.. ....|+.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999998764322 345678 99999999831 115688899999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCC
Q 015019 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (414)
Q Consensus 225 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R 304 (414)
++|+.||.+.+.......+ ......+++.+.+||.+||+.||.+|
T Consensus 311 ltg~~Pf~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWI-----------------------------------FRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGG-----------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHHHH-----------------------------------HhhcccCCHHHHHHHHHHccCChhhC
Confidence 9999999876543221111 12234688999999999999999999
Q ss_pred CCHHHHhcCCCCCcc
Q 015019 305 PTAEEALADPYFKGL 319 (414)
Q Consensus 305 pt~~~lL~hp~~~~~ 319 (414)
||+.++|+||||+.+
T Consensus 356 pt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 356 LLPLQAMETPEYEQL 370 (413)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHHhCHHHHHH
Confidence 999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=347.62 Aligned_cols=257 Identities=22% Similarity=0.318 Sum_probs=200.4
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECC-CCc--EEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
.-..++|++++.||+|+||+||+|.+.. +++ .||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3445789999999999999999998643 333 699999875322 234566788999999999999999999998543
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
..++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 94 ------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 94 ------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp ------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence 2799999998 6999998764 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
++................+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--- 242 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--- 242 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---
T ss_pred cccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC---
Confidence 9876444332222234567889999999977 678999999999999999999 9999988776555444422110
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.......++..+.+||.+||..||.+|||+.++++
T Consensus 243 --------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 243 --------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01122468899999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=345.38 Aligned_cols=243 Identities=29% Similarity=0.429 Sum_probs=193.6
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||+||+|.+. ++.||+|++... .....+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN-------P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------C
Confidence 468999999999999999999764 788999998642 345678899999999999999999998742 2
Q ss_pred EEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCCCCEEEcCCCC-eEEeecCCc
Q 015019 102 IYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHT---ANVYHRDLKPKNILANANCK-LKVCDFGLA 173 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~al~~LHs---~givHrDlkp~NILl~~~~~-vkL~DFG~a 173 (414)
.|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 699999998 69999998654 47899999999999999999999 89999999999999998887 799999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 154 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--------- 216 (307)
T 2eva_A 154 CDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--------- 216 (307)
T ss_dssp -----------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH---------
T ss_pred cccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH---------
Confidence 754322 134469999999999987 689999999999999999999999997543221110000
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
...... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 217 ----------------~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 217 ----------------VHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ----------------HHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------HhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 000000 11235688999999999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=342.24 Aligned_cols=243 Identities=25% Similarity=0.396 Sum_probs=196.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|.+ +|+.||+|++... .....+.+|+.+++.++||||+++++++... .+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence 47899999999999999999976 4889999998753 2456788999999999999999999987432 245
Q ss_pred EEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~--~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+||||+.+ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999985 9999997654 389999999999999999999999999999999999999999999999999975433
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 170 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 230 (278)
T 1byg_A 170 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------- 230 (278)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred cc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------
Confidence 21 23357889999999977 688999999999999999998 99999877655444333210
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ----------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 ----------------Y---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------C---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0 01123468899999999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=365.76 Aligned_cols=280 Identities=21% Similarity=0.320 Sum_probs=205.8
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---C
Confidence 445789999999999999999999999999999999975321 223456779999999999999999999985432 3
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE----cCCCCeEEeecC
Q 015019 100 KDIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFG 171 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl----~~~~~vkL~DFG 171 (414)
..+|+|||||. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 46899999998 69999997543 39999999999999999999999999999999999998 777889999999
Q ss_pred CcccccCCCCccccccccccCcccccccccccc------CCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh----hhHHH
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV----VHQLD 241 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~----~~~~~ 241 (414)
+|+...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+... .+.+.
T Consensus 162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 998653322 22456799999999987531 03577899999999999999999999965332 22222
Q ss_pred HHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.+. .+.|... +........ ..+. .....+ ........++..+.+||.+||+.||++|||+.+++++
T Consensus 238 ~~~--~~~p~~~-~~~~~~~~~-~~~~-~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 238 KII--TGKPSGA-ISGVQKAEN-GPID-WSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHH--HSCCTTC-CEEEECSTT-CCEE-EESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHh--cCCCccc-chhheeccC-CCcc-cCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 222 1222211 000000000 0000 000000 0001112345678899999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=356.95 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=196.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
.+|++.+.||+|+||+||+|.+..++ ..||+|.+... ........+.+|+.+++.++||||+++++++... .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 46899999999999999999876433 46899998753 3345667889999999999999999999987432 2
Q ss_pred ceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
+..|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 45799999998 5999999864 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCc-cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-------- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--------
Confidence 32211 111234567889999999987 689999999999999999999 788998776554443332110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 314 -----------------~-----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 314 -----------------R-----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01124578999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=355.87 Aligned_cols=269 Identities=21% Similarity=0.295 Sum_probs=203.4
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++.+.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT-----P 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----S
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec-----C
Confidence 4457999999999999999999975 46889999998753211 122257899999999999999999999944 3
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCCEEEcCCCCeEEeecC
Q 015019 100 KDIYVVFELME-SDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDFG 171 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~qil~al~~LHs~---givHrDlkp~NILl~~~~~vkL~DFG 171 (414)
...|+|||||. ++|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 45799999998 59999997643 499999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-----hhhHHHHHHHh
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-----VVHQLDLITDL 246 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~ 246 (414)
+++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+...
T Consensus 180 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 180 LAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp SCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9986543322 12345679999999999977 678999999999999999999999996321 11111111000
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCc-cCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
....... ....... .......+..+.+|+.+||+.||.+|||+.++++|-.-.
T Consensus 256 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLE------------------ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCST------------------TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhh------------------hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 0000000 0000000 001112346789999999999999999999999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=363.38 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=203.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 3689999999999999999999875 46799999975432 24568899999999999999999999843 34
Q ss_pred EEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+|||||. |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999998 699999974 34699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 400 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 400 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2211 1123457788999999877 689999999999999999999 99999988766555444321100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (414)
...+.+++.+.+||.+||+.||++|||++++++ ..++..
T Consensus 401 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 112467899999999999999999999999987 345543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=385.17 Aligned_cols=285 Identities=25% Similarity=0.330 Sum_probs=211.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCC-CCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~~~ 100 (414)
.++|++++.||+|+||+||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++.... ....+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999999999999999998754 34455677899999999999999999999875422 12356
Q ss_pred eEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCC---eEEeecCCc
Q 015019 101 DIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLA 173 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~---vkL~DFG~a 173 (414)
..|+|||||. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 6899999997 69999998644 6999999999999999999999999999999999999997765 999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+... .......
T Consensus 172 ~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~ 242 (676)
T 3qa8_A 172 KELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNE 242 (676)
T ss_dssp CBTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC-----
T ss_pred cccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccch
Confidence 87543321 245679999999999987 78999999999999999999999999775432211000 0000000
Q ss_pred HHHhhccHHHHHHHHHhcCCCC-CCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 254 TIAVVRNEKARKYLTEMRKKPP-VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.+...... . ........ .........+++.+.+||.+||.+||.+|||+.++|+||||+.+..
T Consensus 243 ~~~~~~~l--~---g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 243 HIVVYDDL--T---GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp -CCSCCCC--S---SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhhhhh--c---cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 00000000 0 00000000 0011122346788999999999999999999999999999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=346.12 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=204.9
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
+....|...+.||+|+||+||+|.+ +++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 101 (307)
T 2nru_A 28 DERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD---- 101 (307)
T ss_dssp CCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred ccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec----
Confidence 3444567779999999999999975 68899999987532 233456678899999999999999999999843
Q ss_pred CCceEEEEEecCC-CCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~---~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
.+..|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 102 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 180 (307)
T 2nru_A 102 -GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180 (307)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred -CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccc
Confidence 346899999997 699999864 356999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (414)
+....... .......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.........
T Consensus 181 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 255 (307)
T 2nru_A 181 RASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK- 255 (307)
T ss_dssp EECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC-
T ss_pred cccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh-
Confidence 86543222 112245679999999999865 4789999999999999999999999876544333222221110000
Q ss_pred HHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
....+ +.. .........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 256 --------~~~~~---~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 --------TIEDY---IDK----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --------CHHHH---SCS----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------hhhhh---ccc----cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 000 0011112345678999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=347.27 Aligned_cols=271 Identities=21% Similarity=0.354 Sum_probs=209.0
Q ss_pred CCCCeeEeeeecccCceeEEEEE----ECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
..++|++++.||+|+||.||+|. +..+++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-
Confidence 34679999999999999999998 5678999999999753 3455667889999999999999999999985432
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred --CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 235899999998 5999999875 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+..+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchh
Confidence 76443322222234567888999999977 6789999999999999999999998864321 1111122211110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. ........+...... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 267 ~------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 M------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp H------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011111112111111 123568899999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.60 Aligned_cols=246 Identities=14% Similarity=0.163 Sum_probs=194.8
Q ss_pred CCCeeEeeeecccCceeEEEE-----EECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~ 93 (414)
.++|++.+.||+|+||+||+| .+..+++.||||++... ....+.+|+.+++.++ |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 468999999999999999999 46778999999999752 2335667888888776 9999999999843
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC------
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA------ 161 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~-----~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~------ 161 (414)
.+..|+|||||. |+|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 139 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 -----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp -----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred -----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 356899999998 799999973 567999999999999999999999999999999999999998
Q ss_pred -----CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCCh
Q 015019 162 -----NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (414)
Q Consensus 162 -----~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~ 236 (414)
++.+||+|||+|+....... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976432222 223356789999999999988 6799999999999999999999999964332
Q ss_pred hhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 015019 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (414)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~ 315 (414)
.... . ...+ .. ...++.+.+++..||+.+|.+|++..+.|.+.+
T Consensus 291 ~~~~-----------------------------~----~~~~-~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 291 GECK-----------------------------P----EGLF-RR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp TEEE-----------------------------E----CSCC-TT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred Ccee-----------------------------e----chhc-cc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 1000 0 0000 00 123567889999999999999976665555443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=359.93 Aligned_cols=259 Identities=19% Similarity=0.244 Sum_probs=203.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCC
Confidence 457999999999999999999999999999999987643222 24678999999998866555555442 2345
Q ss_pred eEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE---cCCCCeEEeecCCcccc
Q 015019 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl---~~~~~vkL~DFG~a~~~ 176 (414)
..||||||++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 6899999998899999985 5689999999999999999999999999999999999999 58899999999999875
Q ss_pred cCCCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
....... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.........+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----- 229 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----- 229 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH-----
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh-----
Confidence 4432211 11235689999999999988 689999999999999999999999998755433222221110
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.......+. .....++.++.+||..||+.||.+||++.++++
T Consensus 230 -------~~~~~~~~~-----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 230 -------EKKVATSIE-----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------HHHHHSCHH-----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------hccccccHH-----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000000000 111467899999999999999999999988765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=372.19 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=200.9
Q ss_pred CCeeEee-eecccCceeEEEEEECC--CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILE-VIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~-~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
++|.+.+ .||+|+||.||+|.++. ++..||||+++... .......+.+|+++|+.++||||+++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------
Confidence 4566666 89999999999998763 55679999997642 23345678899999999999999999999843
Q ss_pred ceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
..+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 34899999998 6999998754 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------- 556 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------- 556 (613)
T ss_dssp --------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC---------
T ss_pred CCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 32221111123345688999999977 689999999999999999998 999999887665554443211
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 557 ----------------~-----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 557 ----------------R-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------C-----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------C-----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 0122468899999999999999999999999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=351.79 Aligned_cols=280 Identities=20% Similarity=0.252 Sum_probs=197.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHH--HHHHHHhCCCCCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR--EVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++++.||+|+||+||+|.+ +++.||||++... ....... |+..+..++||||+++++.+.......
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 347899999999999999999965 6899999998642 2223333 444455689999999998665433345
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCCEEEcCCCCeEEe
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~---------givHrDlkp~NILl~~~~~vkL~ 168 (414)
...+|+|||||. |+|.+++... ..++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 567899999997 6999999765 458999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccCCCC-----ccccccccccCccccccccccccC-----CCCCCcchhhhHhHHHHHHHhCCCCC-CCCChh
Q 015019 169 DFGLARVAFSDTP-----MTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVV 237 (414)
Q Consensus 169 DFG~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwSlG~il~~ll~g~~pf-~~~~~~ 237 (414)
|||+|+....... ........+||+.|+|||++.+.. ..++.++|||||||++|+|++|..|| ++....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999986543211 111223567999999999986510 24567899999999999999996554 443322
Q ss_pred hHHHHHHH-hcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCC---CCCChHHHHHHHHhccCCCCCCCCHHHHhc-
Q 015019 238 HQLDLITD-LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF---PNVDPLALRLLQRLIAFDPKDRPTAEEALA- 312 (414)
Q Consensus 238 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~- 312 (414)
.....+.. ....+....+ ...... ......+...+ ...++.+.+||.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDM--------QVLVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHH--------HHHHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHH--------Hhhhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 21111111 1112221111 111110 11111111111 124557999999999999999999999954
Q ss_pred -----CCCCCc
Q 015019 313 -----DPYFKG 318 (414)
Q Consensus 313 -----hp~~~~ 318 (414)
++|-++
T Consensus 313 L~~ll~~~~~~ 323 (336)
T 3g2f_A 313 MAELMMIWERN 323 (336)
T ss_dssp HHHHHHCCCC-
T ss_pred HHHHHHHHHhc
Confidence 666654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=346.56 Aligned_cols=260 Identities=25% Similarity=0.329 Sum_probs=192.8
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC--CCCCccccceeecCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL--RHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~~~ 97 (414)
...++|++++.||+|+||.||+|.+. ++.||||++... ......+|..++..+ +||||+++++++.... .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-G 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-G
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-C
Confidence 34468999999999999999999875 899999998642 223445566665554 8999999999986543 2
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCCEEEcCCCCeEEe
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~--------givHrDlkp~NILl~~~~~vkL~ 168 (414)
....+|+|||||. |+|.++++.. .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 2367999999998 5999999765 699999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccCCCCc-cccccccccCccccccccccccCCCCCCc------chhhhHhHHHHHHHhC----------CCCC
Q 015019 169 DFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEVLTG----------KPLF 231 (414)
Q Consensus 169 DFG~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~------~DiwSlG~il~~ll~g----------~~pf 231 (414)
|||+|+........ .......+||+.|+|||++.+ ..++.. +|||||||++|+|++| ..||
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999765433221 111235679999999999876 444444 9999999999999999 6666
Q ss_pred CCCChh----hHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCH
Q 015019 232 PGKSVV----HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307 (414)
Q Consensus 232 ~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~ 307 (414)
...... .....+... .......+.......+++.+.+||.+||+.||.+|||+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCI-----------------------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTT-----------------------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred hhhcCCCCchhhhHHHHhh-----------------------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 443211 111111000 00000011000112356678999999999999999999
Q ss_pred HHHhcC
Q 015019 308 EEALAD 313 (414)
Q Consensus 308 ~~lL~h 313 (414)
.++++|
T Consensus 320 ~ell~~ 325 (337)
T 3mdy_A 320 LRVKKT 325 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.94 Aligned_cols=252 Identities=26% Similarity=0.370 Sum_probs=207.1
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 3689999999999999999999875 46799999975432 24568899999999999999999999843 34
Q ss_pred EEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|||||||. |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 799999998 599999974 24699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ........++..|+|||++.. ..++.++|||||||+||+|++ |+.||.+....+.+..+.....
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 482 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 482 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 11 011123456788999999877 689999999999999999999 9999998876655544432110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC--CCCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD--PYFK 317 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h--p~~~ 317 (414)
......++..+.+||.+||+.||++|||++++++. .+|.
T Consensus 483 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 01124678999999999999999999999999873 4444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=369.13 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=205.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++++.||+|+||+||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 36899999999999999999998654 457999998653 334455678999999999999999999999832
Q ss_pred CceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.+|+|||||. |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 34799999998 69999998654 7999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~------- 610 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------- 610 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 332211 1233457889999999977 689999999999999999997 9999998877665555432110
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
....+.+++.+.+||.+||..||.+|||+.++++
T Consensus 611 -----------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 -----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0122468899999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=344.39 Aligned_cols=254 Identities=20% Similarity=0.241 Sum_probs=199.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
..++|++.+.||+|+||.||+|.+.. .||+|++............+.+|+.+++.++||||+++++++.. ..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 34799999999999999999998754 49999987543333334456789999999999999999999854 34
Q ss_pred eEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++ ++.+||+|||+++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 6899999998 69999997654 799999999999999999999999999999999999998 67999999999875422
Q ss_pred CCC--ccccccccccCcccccccccccc-------CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 015019 179 DTP--MTVFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (414)
Q Consensus 179 ~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (414)
... .........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 259 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM-- 259 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC--
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC--
Confidence 111 11122345689999999998641 1357889999999999999999999998877554443332110
Q ss_pred CCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. ......++..+.+||.+||..||.+|||+.++++
T Consensus 260 -------------------------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 260 -------------------------KP--NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -------------------------CC--CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -------------------------CC--CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0111357889999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=359.28 Aligned_cols=254 Identities=17% Similarity=0.171 Sum_probs=189.8
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC------ChHHHHHHHHHHHHHHhCC---------CCCcc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLR---------HPDIV 85 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------hpniv 85 (414)
..++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346899999999999999999987 689999999975422 2223356778998888885 66666
Q ss_pred ccceeecCCC-------------------------CCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 015019 86 EIKRIMLPPS-------------------------KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139 (414)
Q Consensus 86 ~l~~~~~~~~-------------------------~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al 139 (414)
++.+++.... ......+|+|||||. |++.+.+.. ..+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 6655542110 012467999999997 556665543 5789999999999999999
Q ss_pred HHHH-HCCcccCCCCCCCEEEcCCC--------------------CeEEeecCCcccccCCCCccccccccccCcccccc
Q 015019 140 KYMH-TANVYHRDLKPKNILANANC--------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198 (414)
Q Consensus 140 ~~LH-s~givHrDlkp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aP 198 (414)
+||| ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCS
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccCh
Confidence 9999 99999999999999999887 8999999999865321 34799999999
Q ss_pred ccccccCCCCCCcchhhhHhHH-HHHHHhCCCCCCCCChhh-HHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCC
Q 015019 199 ELCGSFFSKYTPAIDIWSIGCI-FAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV 276 (414)
Q Consensus 199 E~~~~~~~~~~~~~DiwSlG~i-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (414)
|++.+ .. +.++||||||++ .+++++|..||.+..... ....+.. .. .....
T Consensus 247 E~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~-----------------------~~-~~~~~ 299 (336)
T 2vuw_A 247 DLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK-----------------------QM-TFKTK 299 (336)
T ss_dssp GGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH-----------------------TC-CCSSC
T ss_pred hhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh-----------------------hh-ccCcc
Confidence 99987 33 889999998776 788888999985421101 1111111 00 00011
Q ss_pred CccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh-cCCCCC
Q 015019 277 PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL-ADPYFK 317 (414)
Q Consensus 277 ~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL-~hp~~~ 317 (414)
.....++.+++++.+||++||+.| ||+|+| +||||+
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 111122357889999999999977 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=342.43 Aligned_cols=261 Identities=22% Similarity=0.254 Sum_probs=198.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh--CCCCCccccceeecCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~~~~ 98 (414)
..++|++.+.||+|+||.||+|.+ +++.||||++.. .....+.+|+.+++. ++||||+++++++.... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence 346899999999999999999987 589999999864 234567789999888 68999999999986543 22
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCCEEEcCCCCeEEee
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVCD 169 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LH--------s~givHrDlkp~NILl~~~~~vkL~D 169 (414)
...+|+||||+. ++|.+++... .+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 347999999999 5999999764 6999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccCCCCcc-ccccccccCccccccccccccCC----CCCCcchhhhHhHHHHHHHhC----------CCCCCCC
Q 015019 170 FGLARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (414)
Q Consensus 170 FG~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~~ll~g----------~~pf~~~ 234 (414)
||+++......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99997654432211 12245579999999999876211 233689999999999999999 6787654
Q ss_pred Chhh-HHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcC-CCCCCccCC--CCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 015019 235 SVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK-KPPVPLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (414)
Q Consensus 235 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~s~~~~dli~~~L~~dp~~Rpt~~~l 310 (414)
...+ ....+. ..... ......... ....+..+.+||.+||+.||.+|||+.++
T Consensus 271 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 271 VPSDPSVEEMR-----------------------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp SCSSCCHHHHH-----------------------HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CcCcccHHHHH-----------------------HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 3211 001110 00000 000000010 11234578999999999999999999999
Q ss_pred hcC
Q 015019 311 LAD 313 (414)
Q Consensus 311 L~h 313 (414)
++|
T Consensus 328 ~~~ 330 (342)
T 1b6c_B 328 KKT 330 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=327.46 Aligned_cols=227 Identities=17% Similarity=0.118 Sum_probs=184.9
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++. ..
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TR 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----EC
Confidence 457899999999999999999999999999999999765432 445577889999999999999999999984 34
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+..|+||||+. ++|.++++.+ ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 56999999998 5999998543 4667889999999999999999999999999999999999999998544
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHH-HhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT-DLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~ 257 (414)
|++ .++.++|||||||++|+|++|+.||.+.+....+.... ...+.+
T Consensus 175 ----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------- 222 (286)
T 3uqc_A 175 ----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP------- 222 (286)
T ss_dssp ----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCB-------
T ss_pred ----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCC-------
Confidence 232 36889999999999999999999998866432110000 000100
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.+.....+.+++.+.+||.+||+.||.+| |+.++++
T Consensus 223 ------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 223 ------------------IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ------------------CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ------------------CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 11112235789999999999999999999 9999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=368.26 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=200.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECC-CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|.+.. +++.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4799999999999999999999976 7899999998653 3344556788999999999999999999998654432223
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
..||||||+. ++|.+.+.. .+++..+..|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 3799999998 588877654 79999999999999999999999999999999999999986 8999999999865332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+...
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~------ 288 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDD------ 288 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTC------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------cccccc------
Confidence 34579999999999866 3488999999999999999999998753211 000000
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.....++.+.+||.+||+.||.+||++.+++.|+|+..+
T Consensus 289 ---------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 289 ---------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 001235778999999999999999999999999988543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=311.84 Aligned_cols=188 Identities=17% Similarity=0.123 Sum_probs=134.7
Q ss_pred eeecccCceeEEEEEECCCCcEEEEEEeCCccC--------ChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCCC
Q 015019 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--------HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 99 (414)
...+.|+.|.+..++....|+.||+|++.+... .....+.+.+|+++|+++ .|+||+++++++ ++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EEC
Confidence 346778888888888888999999999965321 123345688999999999 699999999999 566
Q ss_pred ceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+.+|||||||+| +|.++|...+++++. .|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 789999999995 999999998888875 4889999999999999999999999999999999999999999986543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p 230 (414)
... ..+..+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 322 2356789999999999876 467789999999999888766433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=259.19 Aligned_cols=189 Identities=20% Similarity=0.246 Sum_probs=141.6
Q ss_pred eEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-h-----HHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-I-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...+.||+|+||+||+| ...+..+|+|+....... . ...+++.+|+.+|+.++||||+++..+....
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----- 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----- 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence 44679999999999999 456788999986532211 1 1234578999999999999999544443221
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
...|||||||+ ++|.+++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 23599999998 699999875 5689999999999999999999999999999999 999999999987533
Q ss_pred CCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCC
Q 015019 179 DTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (414)
Q Consensus 179 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf 231 (414)
..... ......+||++|+|||++......|+..+|+||.++-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21110 012467899999999998764456888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=218.81 Aligned_cols=159 Identities=18% Similarity=0.181 Sum_probs=121.9
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----------------HHHHHHHHHHHHHHhCCCCCcccc
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----------------SDAIRILREVKLLRLLRHPDIVEI 87 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~hpniv~l 87 (414)
.|.+++.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 455669999999999999999 889999999986421110 13456889999999999 5 666
Q ss_pred ceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeE
Q 015019 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLK 166 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vk 166 (414)
.+++.. +..|+|||||+| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.+|
T Consensus 167 ~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 167 PKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp CCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred CeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence 666522 346999999985 8887 32 134567999999999999999999999999999999 99999
Q ss_pred EeecCCcccccCCCCccccccccccCccccccccccc--------cCCCCCCcchhhh
Q 015019 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWS 216 (414)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~DiwS 216 (414)
|+|||+|+. +..|+|||++.+ ....|+..+|+|.
T Consensus 233 l~DFG~a~~----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 233 IIDFPQSVE----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp ECCCTTCEE----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEECCCCeE----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999863 334788998743 0123555566664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=190.24 Aligned_cols=140 Identities=18% Similarity=0.153 Sum_probs=109.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcE--EEEEEeCCccCCh----------------------HHHHHHHHHHHHHHh
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHI----------------------SDAIRILREVKLLRL 78 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~----------------------~~~~~~~~E~~~l~~ 78 (414)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3488999999999999999998778999 9999875421110 112357899999999
Q ss_pred CCCCCcc--ccceeecCCCCCCCceEEEEEecCCC------CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCccc
Q 015019 79 LRHPDIV--EIKRIMLPPSKREFKDIYVVFELMES------DLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYH 149 (414)
Q Consensus 79 l~hpniv--~l~~~~~~~~~~~~~~~~lV~E~~~g------~L~~~i~~~~~l~~~~~~~i~~qil~al~~LH-s~givH 149 (414)
+.|+++. .++.. ...||||||+++ +|.+.... .++..+..++.||+.||.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 9888642 22221 235899999952 67665432 345678899999999999999 999999
Q ss_pred CCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 150 RDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 150 rDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=172.11 Aligned_cols=138 Identities=14% Similarity=0.143 Sum_probs=98.1
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC---------------ChHH---HH--HHHHHHHHHHhCCCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---------------HISD---AI--RILREVKLLRLLRHPD 83 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------------~~~~---~~--~~~~E~~~l~~l~hpn 83 (414)
-|.+++.||+|++|.||+|.+. +|+.||||+++.... .... .. ...+|...|..+.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999875 699999998752110 0000 11 1235677777775444
Q ss_pred ccccceeecCCCCCCCceEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC
Q 015019 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (414)
Q Consensus 84 iv~l~~~~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~ 162 (414)
+... ..+. ....+|||||++| .|..+. ....+..++.||+.+|.+||++|||||||||.|||++.+
T Consensus 175 v~vp-~p~~------~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVP-EPIA------QSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCC-CEEE------EETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCC-eeee------ccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 3211 1110 0112799999996 554322 223456789999999999999999999999999999887
Q ss_pred CC----------eEEeecCCccc
Q 015019 163 CK----------LKVCDFGLARV 175 (414)
Q Consensus 163 ~~----------vkL~DFG~a~~ 175 (414)
|. +.|+||+.+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 73 89999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=7.8e-13 Score=120.85 Aligned_cols=139 Identities=12% Similarity=0.129 Sum_probs=105.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.|++...++.|+.+.||++.. .+..+++|+...... .....+.+|+.+|+.+. +..+.+++++.. ..+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCc
Confidence 3589999999999999999964 367899999864221 11235778999999885 667778887763 3356
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 015019 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT------------------------------------ 144 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs------------------------------------ 144 (414)
.|+|||+++| +|.+.+. +......++.++..+|+.||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 8999999997 6665421 122345788999999999999
Q ss_pred -----------------------CCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 145 -----------------------ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 145 -----------------------~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998765567999997743
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.27 E-value=9.3e-12 Score=116.33 Aligned_cols=184 Identities=16% Similarity=0.247 Sum_probs=120.0
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCc--cccceeecCCCCCCCceEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDI--VEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~~~~~~~~~~l 104 (414)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+. +..+ .+++... .........|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 4569999999999982 5688998643 244567889999998884 3333 2332222 11112223589
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 015019 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------------------------------------- 144 (414)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs--------------------------------------- 144 (414)
||++++| .+..... ..++..+...++.|+...|+.||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 4543322 247888888899999999999996
Q ss_pred -------------------CCcccCCCCCCCEEEcC--CCCeEEeecCCcccccCCCCccccccccccCccc---ccccc
Q 015019 145 -------------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY---RAPEL 200 (414)
Q Consensus 145 -------------------~givHrDlkp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y---~aPE~ 200 (414)
..++|+|++|.||+++. ++.+.|+||+.+......... .....+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-------~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-------ISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-------HTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-------HHHHhhccccCHHH
Confidence 13699999999999998 456789999998764221111 111111 22322
Q ss_pred ccccCCCCC------------CcchhhhHhHHHHHHHhCCCCC
Q 015019 201 CGSFFSKYT------------PAIDIWSIGCIFAEVLTGKPLF 231 (414)
Q Consensus 201 ~~~~~~~~~------------~~~DiwSlG~il~~ll~g~~pf 231 (414)
.......|+ .-.+.|++|.+++.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111000111 1268999999999999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=8.8e-12 Score=113.35 Aligned_cols=134 Identities=16% Similarity=0.080 Sum_probs=94.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCCCCCc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFK 100 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~ 100 (414)
..|.+....+.|..+.||++. ..+|..+++|..... ....+.+|+.+++.+.+.+ +.+++.+... .+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SS
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CC
Confidence 356765554566679999995 356778999997642 1234668999998885444 4557766532 24
Q ss_pred eEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q 015019 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--------------------------------- 146 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g--------------------------------- 146 (414)
..|+|||+++| +| . .. ... ...++.++..+|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 58999999997 45 3 11 122 2356778888888888754
Q ss_pred -------------------------cccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 147 -------------------------VYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 147 -------------------------ivHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=5.7e-11 Score=113.65 Aligned_cols=145 Identities=16% Similarity=0.237 Sum_probs=104.3
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeC--CccCChHHHHHHHHHHHHHHhCC--CCCccccceeecCCCCCCCc
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~~ 100 (414)
...++.|+.|.++.||++... +..+++|+.. .. ........+.+|+.+++.+. +..+.+++.++.... ..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccC
Confidence 345788999999999999653 4678888765 21 11123446778999999997 445777777764331 224
Q ss_pred eEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 015019 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT----------------------------------- 144 (414)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs----------------------------------- 144 (414)
..|+|||+++| .+.+. ....++......++.++..+|+.||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57999999997 44221 12347888889999999999999997
Q ss_pred -----------------------CCcccCCCCCCCEEEcCCCC--eEEeecCCcccc
Q 015019 145 -----------------------ANVYHRDLKPKNILANANCK--LKVCDFGLARVA 176 (414)
Q Consensus 145 -----------------------~givHrDlkp~NILl~~~~~--vkL~DFG~a~~~ 176 (414)
.+++|+|++|.|||++.++. +.|+||+.|...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999998753 689999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=2.7e-07 Score=85.92 Aligned_cols=134 Identities=20% Similarity=0.235 Sum_probs=92.5
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCC---CccccceeecCCCCCCCceEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREFKDIYV 104 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~~~~~l 104 (414)
+..++.|....||++ +..+++|+... ......+.+|..+|+.+.+. .+.+.+.+.. ...+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence 556888998999998 56788888532 23456788999999999753 2344444432 12245689
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 015019 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-------------------------------------- 145 (414)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~-------------------------------------- 145 (414)
|||+++| .+....- ..++......+..|+...|+.||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4544221 1345566666666666666666653
Q ss_pred ----------------------CcccCCCCCCCEEEcC---CCCe-EEeecCCcccc
Q 015019 146 ----------------------NVYHRDLKPKNILANA---NCKL-KVCDFGLARVA 176 (414)
Q Consensus 146 ----------------------givHrDlkp~NILl~~---~~~v-kL~DFG~a~~~ 176 (414)
.++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3489999999999987 4554 89999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=6e-07 Score=81.78 Aligned_cols=132 Identities=16% Similarity=0.189 Sum_probs=92.1
Q ss_pred eecccCce-eEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCceEEEEEe
Q 015019 30 VIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFE 107 (414)
Q Consensus 30 ~lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~~lV~E 107 (414)
.+..|..| .||+......+..+++|+-.. .....+.+|...|+.+. +--+.+++.+.. +.+..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEE
Confidence 34455555 699988777778899998642 35567888999999885 323555666552 2346799999
Q ss_pred cCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 015019 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------------------------------------- 145 (414)
Q Consensus 108 ~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~----------------------------------------- 145 (414)
+++| ++.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 565554332 223345666677777777742
Q ss_pred -----------------CcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 146 -----------------NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 146 -----------------givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999877677999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.6e-06 Score=83.80 Aligned_cols=78 Identities=17% Similarity=0.083 Sum_probs=47.8
Q ss_pred EeeeecccCceeEEEEEECCCCcEEEEEEeCCccC--C---hHHHHHHHHHHHHHHhCCC--CC-ccccceeecCCCCCC
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H---ISDAIRILREVKLLRLLRH--PD-IVEIKRIMLPPSKRE 98 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--pn-iv~l~~~~~~~~~~~ 98 (414)
-++.||.|..+.||++....++..|++|....... . .....++.+|..+|+.+.. +. +.+++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~---- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T---- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence 46789999999999997666678899998653211 0 0112356778888887742 33 33444332 1
Q ss_pred CceEEEEEecCCC
Q 015019 99 FKDIYVVFELMES 111 (414)
Q Consensus 99 ~~~~~lV~E~~~g 111 (414)
...++|||+++|
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 124899999985
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=3.7e-06 Score=79.10 Aligned_cols=30 Identities=27% Similarity=0.348 Sum_probs=27.3
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=5.1e-06 Score=78.89 Aligned_cols=85 Identities=8% Similarity=0.139 Sum_probs=51.4
Q ss_pred eeEeeee-cccCceeEEEEEEC--C----CCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCC-C--CCccccceeecC
Q 015019 25 YKILEVI-GKGSYGVVCAAIDT--H----TGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-H--PDIVEIKRIMLP 93 (414)
Q Consensus 25 Y~i~~~l-g~G~~g~V~~a~~~--~----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~ 93 (414)
-...+.| +.|....+|++... . ++..+++|....... .......+.+|+.+|+.+. + -.+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 88889999988643 0 156788987643210 0001134567888888774 2 245666665533
Q ss_pred CCCCCCceEEEEEecCCC
Q 015019 94 PSKREFKDIYVVFELMES 111 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g 111 (414)
.. ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 12346899999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.92 E-value=0.00014 Score=63.00 Aligned_cols=97 Identities=18% Similarity=0.123 Sum_probs=66.0
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccccccc
Q 015019 112 DLHQVIKA-NDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (414)
Q Consensus 112 ~L~~~i~~-~~~l~~~~~~~i~~qil~al~~L-Hs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~ 189 (414)
+|.++++. +.+++|+++|.+++|.+.+|.-+ +.+.-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999986 56999999999999999998876 222222344457899999999988774 2111
Q ss_pred ccCccccccccccccCCCCCCcchhhhHhHHHHHHHhC
Q 015019 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (414)
Q Consensus 190 ~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g 227 (414)
.....+.|||... ...+.+.=|+|||+++|.-+--
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhc
Confidence 0122356888753 2456788999999999998853
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00014 Score=70.58 Aligned_cols=33 Identities=15% Similarity=0.269 Sum_probs=28.6
Q ss_pred HHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 143 Hs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+...++|+|++|.|||++.++ ++|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356799999999999999877 999999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00034 Score=64.49 Aligned_cols=68 Identities=15% Similarity=0.057 Sum_probs=41.2
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCCCCCceEEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~~~lV~ 106 (414)
++.|+.|....+|++ ..+++|+...... ......+|+.+++.+...++ .+++... . + .-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~---~--~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--P---A--TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T---T--TCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--C---C--CCEEEE
Confidence 788999999999999 4588888753211 11122457777777643233 3444432 1 1 126899
Q ss_pred ecC-CC
Q 015019 107 ELM-ES 111 (414)
Q Consensus 107 E~~-~g 111 (414)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00049 Score=63.87 Aligned_cols=74 Identities=18% Similarity=0.103 Sum_probs=53.5
Q ss_pred eEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC---CCCccccceeecCCCCCCCceE
Q 015019 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~~~ 102 (414)
.-++.|+.|....||++.. ++..+++|+... .....+.+|...|+.|. ...+.+++..... .+..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCce
Confidence 3467899999999999964 467888998653 23456778999888884 2456666665422 2468
Q ss_pred EEEEecCCC
Q 015019 103 YVVFELMES 111 (414)
Q Consensus 103 ~lV~E~~~g 111 (414)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999985
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00076 Score=62.62 Aligned_cols=149 Identities=13% Similarity=0.075 Sum_probs=78.7
Q ss_pred cCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCC-
Q 015019 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPS- 95 (414)
Q Consensus 19 ~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~- 95 (414)
++. +.-.-++.|+.|....||++... +| .+++|..... .....+..|+.+++.+...+ +.+++.......
T Consensus 19 ~~~-~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~ 91 (322)
T 2ppq_A 19 YDV-GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL 91 (322)
T ss_dssp BCC-CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred CCC-CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEE
Confidence 444 34445677888988999999643 33 6889987642 12234556777777764222 223322110000
Q ss_pred CCCCceEEEEEecCCCC-H-----H------HH---HHh-CCC--------CCHHHHHHH---------------HHHHH
Q 015019 96 KREFKDIYVVFELMESD-L-----H------QV---IKA-NDD--------LTREHHQFF---------------LYQML 136 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g~-L-----~------~~---i~~-~~~--------l~~~~~~~i---------------~~qil 136 (414)
....+..++||++++|. + . .. +.. ... ......... ...+.
T Consensus 92 ~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~ 171 (322)
T 2ppq_A 92 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR 171 (322)
T ss_dssp EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHH
Confidence 00124578999999862 1 0 01 111 001 111111110 01133
Q ss_pred HHHHHHHH-------CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 137 RALKYMHT-------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 137 ~al~~LHs-------~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
..++.+.+ .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 172 ~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 172 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 44555553 369999999999999987666899999774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0017 Score=59.39 Aligned_cols=76 Identities=12% Similarity=0.018 Sum_probs=50.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCC---CccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~ 99 (414)
.+..-+..+|.|..+.||++.. .+|+.|++|+...... .....+.+|...|+.|.-. -+.+++.+-
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 3456688999999999999964 5788999998653211 1122466899999888422 233333321
Q ss_pred ceEEEEEecCC
Q 015019 100 KDIYVVFELME 110 (414)
Q Consensus 100 ~~~~lV~E~~~ 110 (414)
.-++|||++.
T Consensus 84 -~~~lv~e~l~ 93 (288)
T 3f7w_A 84 -DRTLAMEWVD 93 (288)
T ss_dssp -TTEEEEECCC
T ss_pred -CceEEEEeec
Confidence 1278999987
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00067 Score=65.99 Aligned_cols=72 Identities=14% Similarity=0.151 Sum_probs=47.6
Q ss_pred EeeeecccCceeEEEEEECC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCCCC
Q 015019 27 ILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKRE 98 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~ 98 (414)
-++.|+.|....||++.... .+..|++|+.... . ....+.+|+.+++.+...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIF-----SG 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence 36678888889999997642 2578999987431 1 11344579999888853333 5556554 11
Q ss_pred CceEEEEEecCCC
Q 015019 99 FKDIYVVFELMES 111 (414)
Q Consensus 99 ~~~~~lV~E~~~g 111 (414)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 389999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00085 Score=62.72 Aligned_cols=31 Identities=29% Similarity=0.441 Sum_probs=27.2
Q ss_pred CCcccCCCCCCCEEEcCC----CCeEEeecCCccc
Q 015019 145 ANVYHRDLKPKNILANAN----CKLKVCDFGLARV 175 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~----~~vkL~DFG~a~~ 175 (414)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6799999998865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00082 Score=64.08 Aligned_cols=136 Identities=13% Similarity=0.147 Sum_probs=79.5
Q ss_pred eeeecccCceeEEEEEECC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCC
Q 015019 28 LEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 99 (414)
++.|..|-...+|++.... ++..|++|+.... ........+|..+++.+. +.-..++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-
Confidence 4567778888999997542 3578999985321 112345568999998885 32235555554 21
Q ss_pred ceEEEEEecCCC-CH-----------H---HHHH---hC-----CCC--CHHHHHHHHHHHHH-----------------
Q 015019 100 KDIYVVFELMES-DL-----------H---QVIK---AN-----DDL--TREHHQFFLYQMLR----------------- 137 (414)
Q Consensus 100 ~~~~lV~E~~~g-~L-----------~---~~i~---~~-----~~l--~~~~~~~i~~qil~----------------- 137 (414)
.+||||++| .| . +.+. .- ... -...+..+..|+-.
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 289999985 11 1 1111 11 111 23566666655432
Q ss_pred --HHHHHH----HC----CcccCCCCCCCEEEcCC----CCeEEeecCCccc
Q 015019 138 --ALKYMH----TA----NVYHRDLKPKNILANAN----CKLKVCDFGLARV 175 (414)
Q Consensus 138 --al~~LH----s~----givHrDlkp~NILl~~~----~~vkL~DFG~a~~ 175 (414)
.+..|. +. .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 22 48999999999999876 7899999997743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0019 Score=60.00 Aligned_cols=77 Identities=14% Similarity=0.072 Sum_probs=45.5
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC--ccccceeecCCCC--CCCceEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSK--REFKDIY 103 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~--~~~~~~~ 103 (414)
+..++ |....||++.. .+|+.+++|...... .....+..|..+++.+.... +.+++.. .+.. ...+..+
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYF 103 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEE
Confidence 34566 78889998843 346679999986321 12345667888888774222 3444332 1110 1134568
Q ss_pred EEEecCCC
Q 015019 104 VVFELMES 111 (414)
Q Consensus 104 lV~E~~~g 111 (414)
+||++++|
T Consensus 104 ~l~~~i~G 111 (328)
T 1zyl_A 104 AVFPSVGG 111 (328)
T ss_dssp EEEECCCC
T ss_pred EEEEecCC
Confidence 89999986
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0028 Score=59.52 Aligned_cols=31 Identities=16% Similarity=0.300 Sum_probs=27.7
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0012 Score=62.81 Aligned_cols=73 Identities=7% Similarity=0.005 Sum_probs=41.7
Q ss_pred EeeeecccCceeEEEEEECC--------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCC-ccccceeecCCCCC
Q 015019 27 ILEVIGKGSYGVVCAAIDTH--------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKR 97 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~ 97 (414)
-+..|+.|....||++.... .+..+++|+..... .......+|..+++.+...+ +.+++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~ 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C
Confidence 35678888888999997543 13678888765321 11112346888888775333 34555443 1
Q ss_pred CCceEEEEEecCCC
Q 015019 98 EFKDIYVVFELMES 111 (414)
Q Consensus 98 ~~~~~~lV~E~~~g 111 (414)
-++||||++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999986
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.023 Score=55.42 Aligned_cols=72 Identities=21% Similarity=0.242 Sum_probs=45.4
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCc-cccceeecCCCCCCCceEEEEE
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~~~lV~ 106 (414)
++.|+.|-...+|++.....+..|++|+........ ....+|..+++.|...++ .++++++ .. .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFF-----TN----GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEE
Confidence 567888888999999765445789999874321111 112478899988865444 4566655 11 2599
Q ss_pred ecCCC
Q 015019 107 ELMES 111 (414)
Q Consensus 107 E~~~g 111 (414)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.13 Score=49.53 Aligned_cols=73 Identities=10% Similarity=-0.012 Sum_probs=44.8
Q ss_pred EeeeecccCceeEEEEEECCC-------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCC
Q 015019 27 ILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 98 (414)
-++.|..|-...+|++..... +..|++++....... .....+|..+++.+. +.-..++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~-----~- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF-----P- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc-----C-
Confidence 356677788889999976521 578999886432111 112346888888774 32234455433 1
Q ss_pred CceEEEEEecCCC
Q 015019 99 FKDIYVVFELMES 111 (414)
Q Consensus 99 ~~~~~lV~E~~~g 111 (414)
-++||||++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 1789999986
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.14 E-value=0.03 Score=54.76 Aligned_cols=64 Identities=14% Similarity=0.085 Sum_probs=18.4
Q ss_pred eEeeeecccCceeEEEEEECCCCcEEEE------EEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeec
Q 015019 26 KILEVIGKGSYGVVCAAIDTHTGEKVAI------KKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIML 92 (414)
Q Consensus 26 ~i~~~lg~G~~g~V~~a~~~~~~~~vai------K~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 92 (414)
.+.+.|| ||.||++....+...||+ |..............+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4556676 999999987665568888 665532222333446778999999999999999988663
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.78 E-value=0.38 Score=45.84 Aligned_cols=29 Identities=31% Similarity=0.416 Sum_probs=24.8
Q ss_pred cccCCCCCCCEEE------cCCCCeEEeecCCccc
Q 015019 147 VYHRDLKPKNILA------NANCKLKVCDFGLARV 175 (414)
Q Consensus 147 ivHrDlkp~NILl------~~~~~vkL~DFG~a~~ 175 (414)
++|+|+.+.|||+ ++++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3457799999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 414 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-96 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-90 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-87 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-75 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-73 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-72 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-69 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-67 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-52 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 290 bits (743), Expect = 2e-96
Identities = 155/342 (45%), Positives = 215/342 (62%), Gaps = 5/342 (1%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY L IG+G+YG+VC+A D +VAIKKI FEH + R LRE+K+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ANV HRDLKP N+L N C LK+CDFGLARVA D T F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK + QL+ I +LG+PS E + + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
KAR YL + K VP + FPN D AL LL +++ F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (700), Expect = 5e-90
Identities = 141/346 (40%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLAR T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F + EP P + FE R + D+ + L Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (684), Expect = 1e-87
Identities = 134/346 (38%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQM
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+ L+Y+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+++++A+ Y+ + + N PLA+ LL++++ D + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F+ L E EP Q K + F+ T D+ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (617), Expect = 2e-77
Identities = 121/354 (34%), Positives = 190/354 (53%), Gaps = 23/354 (6%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
+ + RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 77 RLLRHPDIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +I+ + + P EF+D+Y+V ELM+++L QVI+ D E + LYQM
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LGTP PE +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKD 303
+ R Y+ K + + FP+ A LL +++ DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
R + ++AL PY + P + + + R T ++ +ELIY+E++
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 4e-77
Identities = 102/301 (33%), Positives = 155/301 (51%), Gaps = 7/301 (2%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ L IG+G++G V A TG+KVA+KK+ E I LRE+K+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQV-IKANDDLTREHHQFFLYQMLRA 138
++V + I + + IY+VF+ E DL + T + + +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRD+K N+L + LK+ DFGLAR + + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V N + + L ++ +K V K DP AL L+ +L+ DP R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 317 K 317
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 3e-75
Identities = 102/330 (30%), Positives = 168/330 (50%), Gaps = 19/330 (5%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRA 138
IV ++ +++ + + +V + + +++V +A L + + ++YQ+ R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ +++ P +F P P A+ L RL+ + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVF--RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDD 347
L + + F F + ++ +
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 6e-73
Identities = 100/307 (32%), Positives = 157/307 (51%), Gaps = 16/307 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-- 79
+Y+ + IG+G+YG V A D G VA+K++ + +REV +LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + +VFE ++ DL + + + E + ++Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYR
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYR 182
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 183 APEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + K P+ + ++D L LL + + F+P R +A AL+ PYF
Sbjct: 241 RDVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 317 KGLAKIE 323
+ L + +
Sbjct: 297 QDLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 7e-73
Identities = 108/312 (34%), Positives = 153/312 (49%), Gaps = 22/312 (7%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI---RILREVKLLRLLRHPD 83
L+ +G+G + V A D +T + VAIKKI + LRE+KLL+ L HP+
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + S I +VF+ ME+DL +IK N + H + ++ L+ L+Y+
Sbjct: 62 IIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP N+L + N LK+ DFGLA+ S +T V TRWYRAPEL
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL- 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E + +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
+ P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 233 DYVT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN---- 285
Query: 323 EREPSCQPISKL 334
P P +L
Sbjct: 286 --RPGPTPGCQL 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 6e-72
Identities = 65/311 (20%), Positives = 123/311 (39%), Gaps = 28/311 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ ++ + +G G+ GVV +G +A K IH + + +I+RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV +I + E M+ L QV+K + + +++ L Y
Sbjct: 65 YIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 142 MHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ + + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPER 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y+ DIWS+G E+ G+ P + + + ET R
Sbjct: 175 L--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN-------------VDPLALRLLQRLIAFDPKDRPTA 307
M +PP+ +F+ + + + +P +R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 308 EEALADPYFKG 318
++ + + K
Sbjct: 293 KQLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 5e-71
Identities = 107/300 (35%), Positives = 161/300 (53%), Gaps = 13/300 (4%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
++ +E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
IV++ ++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L +
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
Y K + P +D LL +++ +DP R +A+ ALA P+F+ + K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 218 bits (555), Expect = 4e-69
Identities = 104/295 (35%), Positives = 152/295 (51%), Gaps = 11/295 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y LE IG+G+YGVV A + + GE A+KKI E +RE+ +L+ L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV++ ++ + + + V L + + L + FL Q+L + Y
Sbjct: 61 NIVKLYDVI----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N +LK+ DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-68
Identities = 105/298 (35%), Positives = 148/298 (49%), Gaps = 11/298 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ LE IG+G+YG V A + T E VA+K++ + LRE+ LL+ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + K V + N DL E + FL+Q+L+ L +
Sbjct: 62 NIVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ NV HRDLKP+N+L N N +LK+ +FGLAR + V T WYR P++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLF 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ +ID+WS GCIFAE+ PLFPG V QL I LLGTP+ E +
Sbjct: 175 G-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT-- 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-68
Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV +++VV E + + + + L+AL+++
Sbjct: 78 NIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ V HRD+K NIL + +K+ DFG + + V T ++ APE+
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y P +DIWS+G + E++ G+P + ++ + L LI
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------------- 228
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P Q + + L R + D + R +A+E L + K
Sbjct: 229 ---------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 217 bits (553), Expect = 3e-68
Identities = 95/326 (29%), Positives = 164/326 (50%), Gaps = 27/326 (8%)
Query: 7 KKELKDKDFFT-EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD 65
+E D + E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--- 74
Query: 66 AIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDL 123
+I RE+K+L LR P+I+ + I+ P R +VFE + +D Q+ + L
Sbjct: 75 --KIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---L 126
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPM 182
T +F++Y++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLD 241
+ VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL
Sbjct: 186 ---YNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF------PNVDPLALRLLQR 295
I +LGT N + ++ + +++F V P AL L +
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAK 321
L+ +D + R TA EA+ PYF + K
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (548), Expect = 1e-67
Identities = 75/327 (22%), Positives = 137/327 (41%), Gaps = 43/327 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y +V+G G++ V A D T + VAIK I + E+ +L ++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + I +Y++ +L+ +L I T ++Q+L A+KY
Sbjct: 68 NIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+H + HRDLKP+N+L + + K+ + DFGL+++ + ++ T Y AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TACGTPGYVAP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y+ A+D WSIG I +L G P F ++ + I
Sbjct: 179 EVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--------------- 221
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
K + ++ A ++ L+ DP+ R T E+AL P+ G
Sbjct: 222 ------------LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTK 345
+++ +++ F + + +
Sbjct: 270 DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 6e-67
Identities = 74/344 (21%), Positives = 149/344 (43%), Gaps = 54/344 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
K+ + +Y I E +G+G +G+V ++T + + K + +D + + +E
Sbjct: 1 KELY------EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKE 51
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQF 130
+ +L + RH +I+ + +++ ++FE + D+ + I + +L
Sbjct: 52 ISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+++Q+ AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + +T
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT- 165
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y APE+ + A D+WS+G + +L+G F ++ ++ I +
Sbjct: 166 ---APEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T E F + A+ + RL+ + K R TA
Sbjct: 221 TFDEE---------------------------AFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
EAL P+ K KIER S + I L+ + K D+ ++
Sbjct: 254 EALQHPWLKQ--KIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 8e-67
Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 45/298 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LK+ DFG + A S T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ +D+WS+G + E L GKP F + I
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R + P V A L+ RL+ +P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-66
Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 37/296 (12%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++ +G+G+YG V A++ T E VA+K + D+ + I +E+ + ++L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLH-QVIKANDDLTREHHQFFLYQMLRALKY 141
++V+ + Y+ E I+ + + Q F +Q++ + Y
Sbjct: 64 NVVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRD+KP+N+L + LK+ DFGLA V F T Y APEL
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELL 177
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +D+WS G + +L G+ + S Q
Sbjct: 178 KR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------------ 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
K + +D L LL +++ +P R T + D ++
Sbjct: 219 ----------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 212 bits (540), Expect = 6e-66
Identities = 70/332 (21%), Positives = 131/332 (39%), Gaps = 45/332 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALK 140
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ + L
Sbjct: 84 TLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH N H DLKP+NI+ + +LK+ DFGL + V T + AP
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAP 194
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+WS+G + +L+G F G++ L +
Sbjct: 195 EVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------------- 237
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ F + +++L+ DP R T +AL P+
Sbjct: 238 ------------KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
R+ P S+ + + D E
Sbjct: 286 GNAPGRDSQI-PSSRYTKIRDSIKTKYDAWPE 316
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 211 bits (537), Expect = 2e-65
Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 44/300 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
++ + + ++ ++ E + +L I A D ++ ++ Q LK
Sbjct: 87 KLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH ++ H D+KP+NI+ +K+ DFGLA D + AT + AP
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAP 197
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+W+IG + +L+G F G+ + L +
Sbjct: 198 EIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------------- 240
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
++ F +V P A ++ L+ +P+ R T +AL P+ KG
Sbjct: 241 ------------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 208 bits (530), Expect = 2e-65
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 49/307 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-------RILREVKLL 76
Y+ E++G+G VV I T ++ A+K I A L+EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y APE+ Y +D+WS G I +L G P F + + L +I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
++ + L+ R + P+ R TAEEA
Sbjct: 228 --------------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 311 LADPYFK 317
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (531), Expect = 4e-65
Identities = 76/355 (21%), Positives = 134/355 (37%), Gaps = 50/355 (14%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D EL KD + + L IG GS+G V A D E VAIKK+ +
Sbjct: 1 DPDVAELFFKDDPEK-----LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 64 SDAI-RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND 121
++ I++EV+ L+ LRHP+ ++ + L ++V E S +
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK 110
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
+V T ++ APE + +Y +D+WS+G E+ KP + + L
Sbjct: 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
I + + P + + + +
Sbjct: 224 YHI--------------------------AQNESPAL---QSGHWSEYFRNFVDSCLQKI 254
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
P+DRPT+E L + +K + E + +++++++E
Sbjct: 255 PQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK-DAVRELDNLQYRKMKKILFQE 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 4e-64
Identities = 79/304 (25%), Positives = 117/304 (38%), Gaps = 48/304 (15%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A Y++L IG GSYG G+ + K++ ++ ++ EV LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----LTREHHQFFLYQML 136
P+IV ++ + +Y+V E E DL VI L E + Q+
Sbjct: 63 PNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 137 RALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
ALK H V HRDLKP N+ + +K+ DFGLAR+ DT +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F S I +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K +P ++ R++ RP+ EE L
Sbjct: 229 -------------------GKFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 312 ADPY 315
+P
Sbjct: 265 ENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-64
Identities = 63/320 (19%), Positives = 114/320 (35%), Gaps = 52/320 (16%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
+ ++L +DF ++I+ +G G++G V A + T A K I +
Sbjct: 2 EHVTRDLNPEDF---------WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSE 50
Query: 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KAND 121
+ + E+ +L HP+IV++ +++++ E + +
Sbjct: 51 EELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELER 105
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
LT Q Q L AL Y+H + HRDLK NIL + +K+ DFG++
Sbjct: 106 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238
++ T ++ APE+ SK Y D+WS+G E+ +P + +
Sbjct: 166 RR---DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
L I K P + L++ +
Sbjct: 223 VLLKIA----------------------------KSEPPTLAQPSRWSSNFKDFLKKCLE 254
Query: 299 FDPKDRPTAEEALADPYFKG 318
+ R T + L P+
Sbjct: 255 KNVDARWTTSQLLQHPFVTV 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-64
Identities = 83/351 (23%), Positives = 141/351 (40%), Gaps = 46/351 (13%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLR 80
+ YK+ +V+G G G V + T EK A+K + D + REV+ R +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 64 CPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ S +T T +
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPY 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ G KY + D+WS+G I +L G P F + +
Sbjct: 179 YVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------- 225
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
T +R ++ V L++ L+ +P R T E + P
Sbjct: 226 ------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLK 365
+ K+ + P L+ + ER K+++ + ++Y +K
Sbjct: 274 WIMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 323
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-62
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 41/301 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV K + K I +V ELM S L +K + + + + Q+L+ L
Sbjct: 67 HPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 140 KYMHTAN--VYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+++HT + HRDLK NI +K+ D GLA + + V + T +
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFM 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ + KY ++D+++ G E+ T + + Q+
Sbjct: 181 APEM---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------- 221
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ +T K P +++ I + +R + ++ L +F
Sbjct: 222 -------YRRVTSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
Query: 317 K 317
+
Sbjct: 270 Q 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-61
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 47/304 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
V++ K +Y + +L + I+ +F+ +++ AL+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N + +++ DFG A+V ++ +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ D+W++GCI +++ G P F + I
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA------LADPY 315
++ + P P A L+++L+ D R EE A P+
Sbjct: 223 --------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 316 FKGL 319
F+ +
Sbjct: 270 FESV 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-59
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 47/305 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLR 137
++HP+++ + + D+ ++ EL+ L + + LT E FL Q+L
Sbjct: 70 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 138 ALKYMHTANVYHRDLKPKNILAN----ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ ++K+ DFGLA + T
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTP 180
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE+ D+WSIG I +L+G F G + L ++ + E
Sbjct: 181 EFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
F N LA ++RL+ DPK R T +++L
Sbjct: 239 ---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 314 PYFKG 318
P+ K
Sbjct: 272 PWIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 191 bits (485), Expect = 8e-59
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 33/295 (11%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + D+ S +R RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV + + Y+V E ++ L ++ +T + + +AL
Sbjct: 66 HPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H + HRD+KP NI+ +A +KV DFG+AR + T Y +PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
D++S+GC+ EVLTG+P F G S V
Sbjct: 185 QARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--------------- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALAD 313
++ P+P + + ++ + +A +P++R TA E AD
Sbjct: 228 ------------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-57
Identities = 57/295 (19%), Positives = 104/295 (35%), Gaps = 38/295 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + + IG GS+G V VA+K ++ EV +LR R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +I+ + +V + E S L+ + + Q +
Sbjct: 63 HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+H ++ HRDLK NI + + +K+ DFGLA V + F + + AP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAP 175
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E + + Y+ D+++ G + E++TG+ + + Q+ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------- 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
R L + N RL+ + +RP + LA
Sbjct: 223 ------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-56
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLL-RLLR 80
+ + +++GKGS+G V A T + AIK + DV D + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP + + + ++++ V E + DL I++ F+ +++ L
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H+ + +RDLK NIL + + +K+ DFG+ + + T Y APE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ KY ++D WS G + E+L G+ F G+ I
Sbjct: 174 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------------- 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKG 318
P P ++ A LL +L +P+ R + P F+
Sbjct: 216 ----------RMDNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
Query: 319 L 319
+
Sbjct: 261 I 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-55
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 57/307 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLR 77
++Y++ ++G G +G V + I VAIK + + + + R+ EV LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 78 LLR--HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLY 133
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q+L A+++ H V HRD+K +NIL + N +LK+ DFG + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R Y PE + + + +WS+G + +++ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+R + V L++ +A P DRPT EE
Sbjct: 217 -----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 313 DPYFKGL 319
P+ + +
Sbjct: 255 HPWMQDV 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-55
Identities = 68/304 (22%), Positives = 127/304 (41%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
N + L+++GKG++G V + TG A+K + +V + + E ++L+ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALK 140
P + +K + + V E L + T E +F+ +++ AL+
Sbjct: 65 PFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE+
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEV 176
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 177 LED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----------------- 217
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPY 315
+ ++ P + P A LL L+ DPK R A+E + +
Sbjct: 218 ---------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 316 FKGL 319
F +
Sbjct: 264 FLSI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 180 bits (458), Expect = 9e-54
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 49/307 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
N + + +IG+G +G V TG+ A+K + + + + A+ + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
P IV + P K + + +LM DLH + + + +F+ +++
Sbjct: 64 GDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L++MH V +RDLKP NIL + + +++ D GLA P T Y A
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMA 173
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y + D +S+GC+ ++L G F +
Sbjct: 174 PEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------------- 215
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALA 312
E+ + + + P LL+ L+ D R A+E
Sbjct: 216 -----------EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 313 DPYFKGL 319
P+F+ L
Sbjct: 265 SPFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 175 bits (445), Expect = 3e-52
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 51/302 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++IL +G GS+G V H G A+K + ++ + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + ++ + I+++ + +E + +F+ ++ AL+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + N +K+ DFG A+ T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y +ID WS G + E+L G F + + + I
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFK 317
+ + P P + LL RLI D R E+ P+FK
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 318 GL 319
+
Sbjct: 262 EV 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 1e-50
Identities = 55/302 (18%), Positives = 111/302 (36%), Gaps = 49/302 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+++ ++ +G GS+G V +G A+K + + L E ++L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
P +V+++ K V+ + ++ ++ + H +F+ Q++ +Y
Sbjct: 101 PFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ ++ +RDLKP+N+L + ++V DFG A+ T APE+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEII 210
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S Y A+D W++G + E+ G P F + + I
Sbjct: 211 LS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------ 250
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ K P + LL+ L+ D R + +F
Sbjct: 251 --------VSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 317 KG 318
Sbjct: 298 AT 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-50
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 52/295 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 59 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + KV DFGL + A S + A
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTA 168
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G + E+ + G+ +P + + +
Sbjct: 169 PEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K P P +++ D RP+ +
Sbjct: 216 --------------GYKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 7e-50
Identities = 56/307 (18%), Positives = 100/307 (32%), Gaps = 44/307 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
NRY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQG 61
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ R E +V EL+ S + + + QM+ ++
Sbjct: 62 GVGIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 141 YMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAFSDTPMTVFW----TDYVATR 193
Y+H+ N HRD+KP N L + + DFGLA+ + T
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y + + + D+ S+G + G + G +
Sbjct: 178 RYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ------------ 223
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EA 310
KY KK P+ L + D+P +
Sbjct: 224 -----------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272
Query: 311 LADPYFK 317
+ + +
Sbjct: 273 FRNLFHR 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-49
Identities = 62/308 (20%), Positives = 126/308 (40%), Gaps = 44/308 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIH--DVFEHISDAIRILREVKLLR 77
+++L+V+G G+YG V TG+ A+K + + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 84 HIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+++H + +RD+K +NIL ++N + + DFGL++ F + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMA 198
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
+ G S + A+D WS+G + E+LTG F + I
Sbjct: 199 PDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------- 244
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEAL 311
++ +PP P + LA L+QRL+ DPK R A+E
Sbjct: 245 ---------SRRILKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 312 ADPYFKGL 319
+F+ +
Sbjct: 291 EHLFFQKI 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-49
Identities = 71/316 (22%), Positives = 111/316 (35%), Gaps = 55/316 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T VAIK + L+E ++++ LR
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLR 70
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLR 137
H +V++ ++ + IY+V E M + L Q+
Sbjct: 71 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ N HRDL+ NIL N KV DFGLAR+ + + A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE ++T D+WS G + E+ T G+ +PG LD + P P
Sbjct: 183 PEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---- 236
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
P L+ + +P++RPT E A +
Sbjct: 237 --------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 315 YFKGLAKIEREPSCQP 330
YF EP QP
Sbjct: 271 YFTST-----EPQYQP 281
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-49
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 45/297 (15%)
Query: 30 VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + VA+K + + + +L E +++ L +P IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
I E + +V E+ E L++ ++ N + ++ ++Q+ +KY+ +N
Sbjct: 74 IGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRDL +N+L K+ DFGL++ +D T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 207 KYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265
K++ D+WS G + E + G+ + G ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------------- 223
Query: 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALADPYFKGL 319
E ++ P L+ +D ++RP L + Y+ +
Sbjct: 224 ---EKGERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-49
Identities = 68/322 (21%), Positives = 121/322 (37%), Gaps = 35/322 (10%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A + E IGKG +G V GE+VA+K E + E+ +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRH 56
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
+I+ + + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 141 YMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVA 191
++H + HRDLK KNIL N + D GLA S T + + V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 192 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
T+ Y APE+ + + DI+++G +F E+ + G +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
PS E + RK + E + +P +P + + ++++ + R TA
Sbjct: 234 SDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 308 EEALADPYFKGLAKIEREPSCQ 329
L+++ ++ +
Sbjct: 286 LRIKKT-----LSQLSQQEGIK 302
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-48
Identities = 62/310 (20%), Positives = 119/310 (38%), Gaps = 48/310 (15%)
Query: 23 NRYKILEV-IGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ I ++ +G G++G V + ++ VAIK + E +D ++RE +++ L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQL 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLR 137
+P IV + + + + + +V E+ LH+ + +++ + L+Q+
Sbjct: 67 DNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+KY+ N HRDL +N+L K+ DFGL++ +D + + A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G E L+ G+ + + I
Sbjct: 181 PECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------- 225
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALAD 313
E K+ P P P L+ + +DRP +
Sbjct: 226 ------------EQGKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
Query: 314 PYFKGLAKIE 323
Y+ +K+E
Sbjct: 269 CYYSLASKVE 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (416), Expect = 2e-48
Identities = 71/321 (22%), Positives = 123/321 (38%), Gaps = 51/321 (15%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILRE 72
F + D + KI +VIG G +G VC+ G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT--D 188
L + +KY+ N HRDL +NIL N+N KV DFGL+R DT + +
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247
+ AP + K+T A D+WS G + EV++ G+ + + ++ I
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---- 246
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
E + P P + +L+ D RP
Sbjct: 247 ---------------------EQDYRLPPP-----MDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 308 EEALADPYFKGLAKIEREPSC 328
+ + L K+ R P+
Sbjct: 281 GQIVNT-----LDKMIRNPNS 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (413), Expect = 6e-48
Identities = 51/298 (17%), Positives = 95/298 (31%), Gaps = 43/298 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
+ + +E +V +L+ L ++ + + QML ++
Sbjct: 60 CTGIPN----VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YMHTANVYHRDLKPKNILANANC-----KLKVCDFGLARVAFSDTPMTVFW----TDYVA 191
+H ++ +RD+KP N L + V DFG+ + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---------- 223
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
KY KK PL + + + P +
Sbjct: 224 -------------KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-48
Identities = 61/303 (20%), Positives = 106/303 (34%), Gaps = 44/303 (14%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILR 71
T ++LE +G GS+GVV + VA+K + DV +R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQ 129
EV + L H +++ + ++ + +V EL S L ++ K
Sbjct: 61 EVNAMHSLDHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 114
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q+ + Y+ + HRDL +N+L +K+ DFGL R + V
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248
+ APE + ++ A D W G E+ T G+ + G + L I
Sbjct: 175 KVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----- 227
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ ++ P P + ++ + A P+DRPT
Sbjct: 228 -------------------DKEGERLPRP-----EDCPQDIYNVMVQCWAHKPEDRPTFV 263
Query: 309 EAL 311
Sbjct: 264 ALR 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-48
Identities = 61/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V + KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDL---HQVIKANDDLTREHHQFFLYQMLR 137
H +V + ++ + IY++ E ME+ + LT Q+
Sbjct: 67 HQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ + + A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE + +T D+WS G + E++T G+ +PG + + + P+
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--- 233
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
N +L++ P+DRPT + + +
Sbjct: 234 ---------------------------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 315 YF 316
+F
Sbjct: 267 FF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-47
Identities = 57/296 (19%), Positives = 102/296 (34%), Gaps = 46/296 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D L+ +G G +GVV VAIK I E + E K++ L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +V++ + + + I+++ E M L+ + + + + A
Sbjct: 58 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + HRDL +N L N +KV DFGL+R D + + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ SK++ DIW+ G + E+ + GK + + + I L P
Sbjct: 171 EVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---- 224
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ +RPT + L++
Sbjct: 225 --------------------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 1e-47
Identities = 62/335 (18%), Positives = 114/335 (34%), Gaps = 37/335 (11%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY ++ +G G + V A D VA+K + + E+KLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDA 69
Query: 83 DIVEIKRIMLP------------PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF 130
D + + + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQMLRALKYMHTA-NVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTD 188
Q+L L YMH + H D+KP+N+L + +A + + +T+
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTN 188
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV------VHQLDL 242
+ TR YR+PE+ + + DIWS C+ E++TG LF +
Sbjct: 189 SIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 243 ITDLLGTPSPETIAVVRNEK----ARKYLTEMRKKPPVPL-------FQKFPNVDPLALR 291
I +LLG + + + +R L + K PL ++ +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
L ++ DP+ R A + P+ K +E
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-47
Identities = 68/323 (21%), Positives = 119/323 (36%), Gaps = 69/323 (21%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
+ +V+G G++G V A + +VA+K + + + S+ ++ E+K+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKM 93
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
+ +L H +IV + IY++FE DL +++ +
Sbjct: 94 MTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 123 ------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT E F YQ+ + ++++ + HRDL +N+L +K+CDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
GLAR SD+ V + APE F YT D+WS G + E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGN-ARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
+PG V + + K P
Sbjct: 266 PYPGIPVDANFYKL------------------------IQNGFKMDQP-----FYATEEI 296
Query: 290 LRLLQRLIAFDPKDRPTAEEALA 312
++Q AFD + RP+ +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-46
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 46/294 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V +KVAIK I + D + E +++ L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED---FIEEAEVMMKLS 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFFLYQMLRA 138
HP +V++ + L + I +VFE ME L ++ L +
Sbjct: 59 HPKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+ A V HRDL +N L N +KV DFG+ R D T + +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ FS+Y+ D+WS G + EV + GK + +S ++ I+ P
Sbjct: 172 EVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---- 225
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+++ P+DRP L
Sbjct: 226 --------------------------LASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (395), Expect = 2e-45
Identities = 55/292 (18%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + + + L+E +++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIK 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
HP++V++ + ++ + + L + +++ + Q+ A++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ N HRDL +N L N +KV DFGL+R+ DT + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPES 187
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+K++ D+W+ G + E+ T G +PG + +L+ PE
Sbjct: 188 LAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE------ 239
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L++ ++P DRP+ E
Sbjct: 240 ------------------------GCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 5e-45
Identities = 61/339 (17%), Positives = 123/339 (36%), Gaps = 52/339 (15%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+K ++V+G G++G V + GE VAIK++ + ++ IL E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVD 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+P + + I L + + + L V + D++ ++ + Q+ + +
Sbjct: 70 NPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L +K+ DFGLA++ ++ + A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALES 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
YT D+WS G E++T G + G ++
Sbjct: 185 ILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------- 228
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
++ P P P ++ + D RP E + +
Sbjct: 229 -----------GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIE-----F 267
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
+K+ R+P L + + R YR +++
Sbjct: 268 SKMARDPQ----RYLVIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 68/314 (21%), Positives = 120/314 (38%), Gaps = 50/314 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE K+T A D+WS G + EV+T G+ + S + I D P+P
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP- 235
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ +L+ + + RP + ++
Sbjct: 236 -----------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
Query: 314 PYFKGLAKIEREPS 327
L K+ R P
Sbjct: 267 -----LDKLIRAPD 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-44
Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 47/299 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLR 77
R ++ IG+G +G V I VAIK + S + L+E +R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMR 63
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQM 135
HP IV++ ++ ++++ EL + L + YQ+
Sbjct: 64 QFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL Y+ + HRD+ +N+L ++N +K+ DFGL+R T + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKW 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE ++T A D+W G E+L G F G + I +
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------- 224
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ P+P PN P L+ + A+DP RP E A
Sbjct: 225 ----------------GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 1e-43
Identities = 57/320 (17%), Positives = 106/320 (33%), Gaps = 70/320 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + + IG+G++G V A + VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L+ Q+ + Y+ HRDL +N L N +K+ DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+R +S D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
G + + + D P N
Sbjct: 244 YGMAHEEVIYYVRD-------------------------GNILACP-----ENCPLELYN 273
Query: 292 LLQRLIAFDPKDRPTAEEAL 311
L++ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 65/317 (20%), Positives = 111/317 (35%), Gaps = 64/317 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
NR + +G G++G V A I + VA+K + H+++ ++ E+K+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
L L H +IV + V+ E DL ++ D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 123 -------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
L E F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+D+ V + +W + YT D+WS G E+ + G +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V + + + P + +++
Sbjct: 252 PVDSKFYKMIK------------------------EGFRMLSP-----EHAPAEMYDIMK 282
Query: 295 RLIAFDPKDRPTAEEAL 311
DP RPT ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 63/313 (20%), Positives = 110/313 (35%), Gaps = 63/313 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLL-R 77
D N K +VIG+G++G V A G + AIK++ + D E+++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCK 66
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
L HP+I+ + +Y+ E +L ++ +
Sbjct: 67 LGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ + F + R + Y+ HRDL +NIL N K+ DFGL+R
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239
T+ + A E S YT D+WS G + E+++ G + G +
Sbjct: 182 KKTMG----RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF 299
+ + + P N D L+++
Sbjct: 236 YEKLPQ-------------------------GYRLEKP-----LNCDDEVYDLMRQCWRE 265
Query: 300 DPKDRPTAEEALA 312
P +RP+ + L
Sbjct: 266 KPYERPSFAQILV 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-42
Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 44/291 (15%)
Query: 29 EVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EVIG+G +G V A+K ++ + I + + L E +++ HP+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ--FFLYQMLRALKYMH 143
+ I L VV M+ + N+ F Q+ + +K++
Sbjct: 92 SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYVATRWYRAPELCG 202
+ HRDL +N + + +KV DFGLAR + +V T + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ K+T D+WS G + E++T G P +P + +
Sbjct: 208 T--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------------- 249
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ P ++ + + RP+ E ++
Sbjct: 250 ---------GRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-41
Identities = 58/319 (18%), Positives = 114/319 (35%), Gaps = 65/319 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREV 73
+R + + +G+G++G V A + KVA+K + D ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEM 69
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK------------- 118
+++ + +H +I+ + + +YV+ E +L + ++
Sbjct: 70 EMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 119 ---ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ +W L YT D+WS G + E+ T G +PG
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V L+ + + P N +++
Sbjct: 242 PVEELFKLLKE-------------------------GHRMDKP-----SNCTNELYMMMR 271
Query: 295 RLIAFDPKDRPTAEEALAD 313
P RPT ++ + D
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-41
Identities = 53/320 (16%), Positives = 110/320 (34%), Gaps = 62/320 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + +G+GS+G+V + +VAIK +++ + I L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASV 76
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------LT 124
++ +V + ++ V+ ELM DL +++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
++ + Y++ HRDL +N + + +K+ DFG+ R +T
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR 190
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLI 243
+ + +PE +T D+WS G + E+ T + + G S L +
Sbjct: 191 KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ P N + L++ ++PK
Sbjct: 249 ME-------------------------GGLLDKP-----DNCPDMLFELMRMCWQYNPKM 278
Query: 304 RPTAEEALA------DPYFK 317
RP+ E ++ +P F+
Sbjct: 279 RPSFLEIISSIKEEMEPGFR 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-40
Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 59/314 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R K+ + +G+G++G V A T T VA+K + + H + L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-------------- 120
+ + H ++V + P + V+ E + +L +++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 121 --DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVV 237
D + +W + YT D+WS G + E+ + +PG +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
+ + + P P + +
Sbjct: 244 EEFCRR------------------------LKEGTRMRAP-----DYTTPEMYQTMLDCW 274
Query: 298 AFDPKDRPTAEEAL 311
+P RPT E +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 1e-21
Identities = 24/203 (11%), Positives = 60/203 (29%), Gaps = 27/203 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--------DVFEHISDAIRILREVKLL 76
I +++G+G V + +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATRWY 195
+ + + H DL N+L + + + DF + + + D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIG 218
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.78 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-66 Score=493.87 Aligned_cols=333 Identities=40% Similarity=0.749 Sum_probs=281.5
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.|.+.++|++++.||+|+||+||+|.++.+|+.||||++++........+.+.+|+++|+.++|||||+++++|.....
T Consensus 13 ~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 13 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 3567789999999999999999999999999999999998766666777889999999999999999999999976532
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
....++|+|||||+.+|..+++. +++++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 93 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 93 DDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 24456899999998888887765 57999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .+..+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.++.+.+.
T Consensus 172 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 172 DSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 332 2567899999999998663 567899999999999999999999999999999999999999999999988
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.........+...........+...++.+++.+.|||++||+.||.+||||+|+|+||||+.+...+++|..+ +++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~~ 321 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDD 321 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCCC
Confidence 8888888888888888777788888889999999999999999999999999999999999988777766544 3445
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCc
Q 015019 337 EFERRRVTKDDIRELIYREILEYHP 361 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (414)
.++....+.+++++++++|+++++|
T Consensus 322 ~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 322 SFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp C-----CCHHHHHHHHHHHHHTCCC
T ss_pred chhhhhcCHHHHHHHHHHHhhcCCC
Confidence 5666677889999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-65 Score=484.83 Aligned_cols=342 Identities=45% Similarity=0.803 Sum_probs=288.6
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.+....||++++.||+|+||+||+|.++.+|+.||||++.+. ......+++.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 356778999999999999999999999999999999999753 3455667889999999999999999999999776655
Q ss_pred CCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
....+|+++++++|+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 56678999988889999999765 69999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
............+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+....+.+.......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443333334667899999999998553 6789999999999999999999999999999999999999999999888777
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchhh
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (414)
...................++...++++|+.+.+||.+||+.||.+||||+|+|+||||+....+.+++..... ..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~ 317 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 317 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C---
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCC
Confidence 77777777777777777777777788999999999999999999999999999999999988776666554433 3345
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCcchh
Q 015019 338 FERRRVTKDDIRELIYREILEYHPQLL 364 (414)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e~~~~~~~~~ 364 (414)
.+....+.+++++++++|...++|+.+
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~~~ 344 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPGYR 344 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTTTC
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCCCC
Confidence 566778889999999999999998854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-64 Score=480.58 Aligned_cols=334 Identities=42% Similarity=0.794 Sum_probs=288.7
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 96 (414)
.+++++||++++.||+|+||+||+|+++.+|+.||||++++........+++.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred cccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 4566789999999999999999999999999999999998776677777889999999999999999999999975533
Q ss_pred CCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
++...+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|...
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 33455677777766899998864 57999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|.+..+.+..+...
T Consensus 172 ~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp TG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred Cc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 22 23456799999999987663 457899999999999999999999999999999999999999999998888
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCCCCCCccchh
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
.........+...........+...+.++++++.|||++||+.||.+||||+|+|+||||+++..+..++...+. +.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~~ 321 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQ 321 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---CC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---CC
Confidence 777777777777777766666666778899999999999999999999999999999999999888888776654 46
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCcc
Q 015019 337 EFERRRVTKDDIRELIYREILEYHPQ 362 (414)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~~ 362 (414)
.++......+++++.+++|+.++.|.
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~~~~~p~ 347 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEVISFVPP 347 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred cccchhcCHHHHHHHHHHHhhccCCC
Confidence 67788999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-64 Score=466.23 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=216.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++. +.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCce
Confidence 4679999999999999999999999999999999875322 223456889999999999999999999994 4467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|||||||. |+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998 5999999888899999999999999999999999999999999999999999999999999998754332
Q ss_pred CccccccccccCccccccccccccCCC-CCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ....+..+||+.|+|||++.+ .. ++.++|||||||++|+|++|++||.+.+............
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~------------ 222 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------ 222 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT------------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------
Confidence 2 222356789999999999877 44 4678999999999999999999998766543332221110
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
......+..+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 223 ----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 223 ----------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ----------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ----------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0111223568999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-64 Score=461.83 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=220.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|+++.+++.||+|++.+... .......+.+|+++|+.++||||+++++++. +.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 579999999999999999999999999999999864321 1123456789999999999999999999994 4467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999999 6999999988899999999999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+...
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------ 221 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------ 221 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 245689999999999988 7899999999999999999999999999887766655543110
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.....+|+++.+||.+||+.||.+|||++|+|+||||++
T Consensus 222 -------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 -------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 112358999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-63 Score=464.84 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=220.8
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
+..++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++. +.
T Consensus 17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~ 89 (293)
T d1yhwa1 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYL-----VG 89 (293)
T ss_dssp CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred CcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEE-----EC
Confidence 3456899999999999999999999999999999998754322 3456889999999999999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+.+|||||||. |+|.+++.. +.+++.+++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 57999999998 689888765 4799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... .+
T Consensus 169 ~~~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~-------- 234 (293)
T d1yhwa1 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP-------- 234 (293)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC--------
T ss_pred ccc---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC--------
Confidence 322 2356689999999999988 789999999999999999999999999888776665553211 00
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.......+|+.+++||.+||+.||.+|||++|+|+||||+.
T Consensus 235 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 -------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -------------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -------------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 01123468999999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-62 Score=452.19 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=217.6
Q ss_pred CCCe-eEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y-~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.+|| ++.++||+|+||+||+|+++.++..||+|++..........+.+.+|+++|+.++||||+++++++.... ....
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCC
Confidence 4566 7788999999999999999999999999999876556666778999999999999999999999986533 2346
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCCEEEc-CCCCeEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~g--ivHrDlkp~NILl~-~~~~vkL~DFG~a~~~ 176 (414)
.+|+|||||+ |+|.+++.....+++..++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 7999999998 699999998889999999999999999999999999 99999999999997 5789999999999764
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+..... .+.++.
T Consensus 166 ~~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~-~~~~~~---- 232 (270)
T d1t4ha_ 166 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPA---- 232 (270)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-TTCCCG----
T ss_pred cCC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH-cCCCCc----
Confidence 322 1245689999999999865 599999999999999999999999987655443322211 011110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (414)
......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 233 -----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 -----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11235788999999999999999999999999999995
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-62 Score=468.18 Aligned_cols=328 Identities=36% Similarity=0.660 Sum_probs=257.1
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CCC
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REF 99 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~ 99 (414)
..++|+++++||+|+||+||+|+++.+|+.||||++.+.........++.+|+.+|+.++||||++++++|..... +..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3478999999999999999999999999999999998776677777889999999999999999999999975533 356
Q ss_pred ceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 7899999999998888774 46999999999999999999999999999999999999999999999999998865433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
. ..+..+||+.|+|||++.+ ..+++++||||+||++|+|++|++||.+.+...+...+....+.+.++.+....
T Consensus 173 ~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp ------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2 2356689999999999988 789999999999999999999999999999999999999999999888776544
Q ss_pred cHHHHHHHHHhcCCCCCCccCCC------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCCCCCC
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKF------------PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~ 327 (414)
. ....+...............+ ...|+++.|||++||++||++||||+|+|+||||+...++.....
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~ 325 (355)
T d2b1pa1 247 P-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 325 (355)
T ss_dssp H-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTC
T ss_pred h-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccC
Confidence 3 333443333222222111111 124678999999999999999999999999999998654333322
Q ss_pred CCCCccchhhhhhccCCHHHHHHHHHHHHHH
Q 015019 328 CQPISKLEFEFERRRVTKDDIRELIYREILE 358 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 358 (414)
.++ ...+.+.+++..+.++|++++++|+++
T Consensus 326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 326 PPP-QIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp CCC--------CCCCCCHHHHHHHHHHHHHC
T ss_pred CCC-CCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 222 344556777888999999999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-63 Score=462.03 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=208.7
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
++.++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++||||+++++++. +.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~ 79 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYE-----SG 79 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 3456799999999999999999999999999999999754322 23356779999999999999999999994 44
Q ss_pred ceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc---CCCCeEEeecCCccc
Q 015019 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~---~~~~vkL~DFG~a~~ 175 (414)
+.+|||||||. |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+.
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 67999999998 69999999988999999999999999999999999999999999999995 478999999999986
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|.+....
T Consensus 160 ~~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~------ 227 (307)
T d1a06a_ 160 EDPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE------ 227 (307)
T ss_dssp -----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC------
T ss_pred ccCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC------
Confidence 53322 2245789999999999988 78999999999999999999999999998877666655432111
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.....++.+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 228 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 228 ---------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ---------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ---------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1112345789999999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-62 Score=456.89 Aligned_cols=266 Identities=28% Similarity=0.452 Sum_probs=228.0
Q ss_pred ccccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC----hHHHHHHHHHHHHHHhCCCCCccccceee
Q 015019 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (414)
Q Consensus 16 ~~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 91 (414)
|..-++.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++
T Consensus 3 ~~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp CBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34445667899999999999999999999999999999998653221 12356788999999999999999999999
Q ss_pred cCCCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC----CeE
Q 015019 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLK 166 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~----~vk 166 (414)
.+.+.+|||||||. |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 83 -----~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 83 -----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp -----ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred -----EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceE
Confidence 44567999999998 69999998888999999999999999999999999999999999999998776 499
Q ss_pred EeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 015019 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (414)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (414)
|+|||+|+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...
T Consensus 158 l~DfG~a~~~~~~~~----~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 158 IIDFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231 (293)
T ss_dssp ECCCTTCEECTTSCB----CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred ecchhhhhhcCCCcc----ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 999999987543322 245679999999999987 68999999999999999999999999999888777777553
Q ss_pred cCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
...+... .++.+|+.+.+||++||+.||.+|||++|+|+||||+..
T Consensus 232 ~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 232 NYEFEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCCCCHH---------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCCCch---------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3322221 125689999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-62 Score=453.29 Aligned_cols=257 Identities=30% Similarity=0.457 Sum_probs=211.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+++|+.++||||+++++++... ..+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 4679999999999999999999999999999999987655666677889999999999999999999998543 2346
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCCEEEcCCCCeEEeecC
Q 015019 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFG 171 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~al~~LHs~g-----ivHrDlkp~NILl~~~~~vkL~DFG 171 (414)
+|+|||||. |+|.+++.. +..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 699998853 568999999999999999999999976 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
+|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|....
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~---- 230 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---- 230 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----
Confidence 9987543322 2356789999999999987 789999999999999999999999999888766555553210
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
.......+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 231 --------------------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 --------------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 011224689999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-63 Score=460.58 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=218.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|.++.+|+.||||++.+... .......+.+|+++|+.++||||+++++++. +.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence 579999999999999999999999999999999864321 1223456889999999999999999999994 4467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999 6999999988999999999999999999999999999999999999999999999999999998754332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+...
T Consensus 163 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------------ 227 (288)
T d1uu3a_ 163 K-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY------------ 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC------------
T ss_pred c-ccccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 2 122356789999999999988 7899999999999999999999999999887766665542110
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHH------HhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~------lL~hp~~~~~ 319 (414)
.....+|+.+.+||++||+.||.+|||++| +++||||+++
T Consensus 228 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 228 -------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp -------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred -------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 112468999999999999999999999987 5889999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-63 Score=464.51 Aligned_cols=282 Identities=37% Similarity=0.571 Sum_probs=227.3
Q ss_pred EeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChH---HHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEE
Q 015019 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS---DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (414)
Q Consensus 27 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~ 103 (414)
.++.||+|+||+||+|+++.+|+.||||+++....... ....+.+|+.+|+.++|||||++++++. ..+++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence 57899999999999999999999999999875332211 2346889999999999999999999994 445689
Q ss_pred EEEecCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCc
Q 015019 104 VVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (414)
Q Consensus 104 lV~E~~~g~L~~~i-~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 182 (414)
||||||.+++...+ ..+..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 99999997555544 4456899999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHH
Q 015019 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (414)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (414)
.....+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 22456899999999998653 568999999999999999999999999999999999999999998876543221110
Q ss_pred HHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
.. .........++...++.+++++.|||++||+.||++||||+|+|+||||++..
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 233 DY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp TC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hh---hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 00 00111122233344567899999999999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-62 Score=462.87 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=223.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++ .+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence 579999999999999999999999999999999975321 122356688999999999999999999999 45567
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999 6999999998999999999999999999999999999999999999999999999999999998654332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~------------- 221 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------- 221 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-------------
Confidence 2 2356789999999999988 789999999999999999999999999988766655553211
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
. ..+..+|+++++||++||+.||.+|+ |++|+++||||+++
T Consensus 222 -------------~-----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 222 -------------I-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------C-----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 12246899999999999999999999 49999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-62 Score=457.12 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=219.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+.|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+++|+.++|||||++++++. +.+.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCe
Confidence 35799999999999999999999999999999999753 2344567889999999999999999999994 4457
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+|||||. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999998 699988765 567999999999999999999999999999999999999999999999999999754221
Q ss_pred CCccccccccccCcccccccccccc---CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
. ......+||+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 164 ~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-------- 232 (288)
T d2jfla1 164 I---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------- 232 (288)
T ss_dssp H---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--------
T ss_pred c---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 1 122457899999999998431 25689999999999999999999999999887776665543110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
+.......+|+++.+||++||+.||.+|||++|+|+||||+.
T Consensus 233 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 233 --------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 111223468999999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-63 Score=471.28 Aligned_cols=282 Identities=23% Similarity=0.361 Sum_probs=218.1
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|+++.+|+.||+|+++... ......++.+|+.+|+.++|||||+++++|. +..++
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 57999999999999999999999999999999997543 3344567889999999999999999999994 44579
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~-givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999999 59999998888999999999999999999999974 9999999999999999999999999999865322
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhH-HHHHHHhcCCCCHHHHHhh-
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTPSPETIAVV- 258 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~- 258 (414)
..+..+||++|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+.... ...+....|.+........
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred ----ccccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 1246789999999999988 7899999999999999999999999987664332 2222222232221110000
Q ss_pred -------------ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 259 -------------RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 259 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
................+... ....+|+++.|||.+||+.||.+||||+|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00001111222222221111 112468999999999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-62 Score=465.03 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=225.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.++||||+++++++. +.+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 46899999999999999999999999999999999753 3455677889999999999999999999994 4567
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC--CCCeEEeecCCccccc
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVAF 177 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~--~~~vkL~DFG~a~~~~ 177 (414)
+|||||||. |+|.+.+.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999998 699999854 567999999999999999999999999999999999999964 5889999999998754
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|......+..
T Consensus 178 ~~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----- 246 (350)
T d1koaa2 178 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----- 246 (350)
T ss_dssp TTS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----
T ss_pred ccc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 332 2245689999999999987 78999999999999999999999999999888777777543322221
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
..++.+|+.+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 247 ----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 247 ----------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp ----------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred ----------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 223568999999999999999999999999999999987543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-62 Score=457.20 Aligned_cols=288 Identities=37% Similarity=0.618 Sum_probs=234.5
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+++|++++||||+++++++. +..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 5899999999999999999999999999999999754333334567889999999999999999999994 44679
Q ss_pred EEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 103 YVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
|+|||||++++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887776644 4579999999999999999999999999999999999999999999999999998754332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....|.+....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23566899999999987663 4568899999999999999999999999999999999998888877654432211
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
. ..+................+.+|+++.|||++||+.||.+|||++|+|+||||+++.+
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0 0111111112222223345678999999999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-61 Score=462.83 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=226.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
...++|++++.||+|+||+||+|+++.+|+.||||+++.. .......+.+|+.+|+.++||||++++++|. +.
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~ 98 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DK 98 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CS
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 3446899999999999999999999999999999999763 3345567889999999999999999999994 45
Q ss_pred ceEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEc--CCCCeEEeecCCccc
Q 015019 100 KDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCKLKVCDFGLARV 175 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~--~~~~vkL~DFG~a~~ 175 (414)
+.+|||||||. |+|.+.+...+ ++++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence 67999999999 69998876644 799999999999999999999999999999999999998 578999999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++
T Consensus 179 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 248 (352)
T d1koba_ 179 LNPDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---- 248 (352)
T ss_dssp CCTTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----
T ss_pred cCCCC----ceeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Confidence 64332 2245679999999999988 7899999999999999999999999999988877777654322211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
...++.+|+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 249 -----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 249 -----------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -----------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 233467999999999999999999999999999999998643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-61 Score=455.97 Aligned_cols=290 Identities=34% Similarity=0.602 Sum_probs=236.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCC-CcEEEEEEeCCccCChHHHHHHHHHHHHHHhC---CCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~ 97 (414)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.+ +||||+++++++.....+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46999999999999999999999765 66799999875433333333455777776665 799999999998765445
Q ss_pred CCceEEEEEecCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~--~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
....+|++||||.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 567899999999976655443 345799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|....|.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 23356789999999999987 78999999999999999999999999999999999999999998877654
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
........ .........+.......+++.+.|||++||++||.+||||+|+|+||||+++..
T Consensus 240 ~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchh----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 32111100 011222333444456678999999999999999999999999999999998743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-62 Score=455.48 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=217.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.+|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+.+|+.++|||||++++++. +.+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCE
Confidence 4699999999999999999999999999999999764333 344567889999999999999999999994 3457
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||.+ +|..++..++++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999995 66666677789999999999999999999999999999999999999999999999999999764321
Q ss_pred CccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
...+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~------------ 230 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------ 230 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------------
Confidence 356799999999998642 2468999999999999999999999999887766665553211
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.+. .....+|+.+.+||.+||+.||.+|||++|+|+||||..
T Consensus 231 --------------~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 231 --------------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------------CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 000 112467999999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-61 Score=452.35 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=221.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++||||+++++++. +.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 469999999999999999999999999999999874321 1223467889999999999999999999994 4467
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~ 180 (414)
+|+|||||. |+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999998 589999999999999999999999999999999999999999999999999999999999999875332
Q ss_pred CccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|.....
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------ 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------ 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 245689999999999987 6899999999999999999999999999887776666543110
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
...+.+|+++.+||.+||+.||.+|+ |++++|+||||+++
T Consensus 219 -------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 219 -------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 11246899999999999999999996 99999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-61 Score=457.86 Aligned_cols=254 Identities=21% Similarity=0.384 Sum_probs=221.9
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+++|+.++||||+++++++ ....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 368999999999999999999999999999999986422 1123345688999999999999999999999 4456
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|+||||+. |+|...+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 7999999999 699999988889999999999999999999999999999999999999999999999999999875332
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|.....
T Consensus 195 ------~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------- 255 (350)
T d1rdqe_ 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------- 255 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred ------cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----------
Confidence 245689999999999988 7899999999999999999999999999887766666643111
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (414)
.....+|+++.+||++||+.||.+|+ |++++|+||||+++
T Consensus 256 --------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 256 --------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 11246899999999999999999995 99999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-60 Score=438.86 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=223.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC-------hHHHHHHHHHHHHHHhCC-CCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-------ISDAIRILREVKLLRLLR-HPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 93 (414)
.++|++.+.||+|+||+||+|+++.+|+.||||++++.... ......+.+|+.+|+.++ ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 46899999999999999999999999999999998754321 112345789999999997 99999999999
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
.+.+.+|||||||. |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ---ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 44567999999998 69999999888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccccccccCccccccccccc----cCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 015019 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (414)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (414)
|+...... ..+..+||+.|+|||++.+ ....|+.++||||+||++|+|++|+.||.+.+..+....+....-
T Consensus 157 a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 98754332 2256789999999998853 124578999999999999999999999999887776666643211
Q ss_pred CCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
. .....++++|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 233 ~---------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 233 Q---------------------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp C---------------------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred C---------------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1 1112235789999999999999999999999999999999853
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-60 Score=444.86 Aligned_cols=284 Identities=38% Similarity=0.640 Sum_probs=232.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+||++++.||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++++.. .+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence 69999999999999999999986 78999999997654433445678899999999999999999999944 4569
Q ss_pred EEEEecCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i-~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
|+|||++.+++...+ ...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997655555 5577899999999999999999999999999999999999999999999999999987543322
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccH
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (414)
.....+|++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.+....+.....
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 230 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh-
Confidence 12455799999999998763 5689999999999999999999999999999999999999999887655432211
Q ss_pred HHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
...+........+.+.....+.+++.+.|||++||++||++|||+.|+|+||||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp -STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11111112223333444556788999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-60 Score=446.95 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=223.4
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
.-+||++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+++|+.++||||+++++++ .+.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETT
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 347899999999999999999999999999999999753 23445678999999999999999999999 4456
Q ss_pred eEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC--CCeEEeecCCcccc
Q 015019 101 DIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~--~~vkL~DFG~a~~~ 176 (414)
.+|||||||. |+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 7999999999 59999998765 79999999999999999999999999999999999999854 57999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|.+....++..
T Consensus 155 ~~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 225 (321)
T d1tkia_ 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---
T ss_pred ccCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh---
Confidence 4322 2245679999999999987 689999999999999999999999999999888877776543333322
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
.++.+|+++.+||++||+.||.+|||++|+|+||||++
T Consensus 226 ------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 ------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 23578999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.7e-60 Score=452.19 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=214.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCcc----CChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+..+|+++++.++||||+++++++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~----- 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence 367999999999999999999999999999999986421 11122223345577788889999999999994
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
+.+.+|+|||||. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 4457999999999 699999998889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
.... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------- 224 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------
Confidence 4332 2456899999999998642 57899999999999999999999999876644333222111111
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCcc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (414)
....+..+|+++.+||.+||+.||.+||| |+|+++||||+++
T Consensus 225 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 225 ---------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp ---------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 11223468999999999999999999999 8999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-60 Score=451.06 Aligned_cols=286 Identities=34% Similarity=0.582 Sum_probs=233.4
Q ss_pred CeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC-CCCceE
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKDI 102 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~~~~ 102 (414)
+|+.+++||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++||||++++++|..... .+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 79999999999999999999999999999999975322 12379999999999999999999865432 345678
Q ss_pred EEEEecCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCCccccc
Q 015019 103 YVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (414)
Q Consensus 103 ~lV~E~~~g~L~~~i----~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~a~~~~ 177 (414)
|||||||++++...+ .....+++.+++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999997665554 3456899999999999999999999999999999999999999875 89999999998654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... .....+||+.|+|||++.+. ..|+.++||||+||++|||++|++||.+.+..+++..|.+.+|.+..+.+..
T Consensus 175 ~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGE----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTS----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCc----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 332 22456899999999987653 5799999999999999999999999999999999999999999998877654
Q ss_pred hccHHHHHHHHHhcCCCCCCc-cCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccccCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (414)
........ .+......++ ....+.+++++.|||.+||++||.+||||.|+|+||||+++..+.
T Consensus 250 ~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 250 MNPNYTEF---KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HCC---CC---CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hccchhhc---cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 33221100 0111111111 122356899999999999999999999999999999999876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-60 Score=448.62 Aligned_cols=300 Identities=33% Similarity=0.545 Sum_probs=233.5
Q ss_pred cccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 17 ~~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
+.++..+||++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp TTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 44566799999999999999999999999999999999987654444455678899999999999999999999865431
Q ss_pred ---CCCceEEEEEecCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 97 ---REFKDIYVVFELMESDLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 97 ---~~~~~~~lV~E~~~g~L~~~i~-~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
...+++|+|||||.+++...+. ....+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 2245799999999976665554 456899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 173 ARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 173 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
|+....... ........+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+....+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 976433221 11223456899999999998763 5799999999999999999999999999999999999999999888
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (414)
+..............+........ .....+ ...++.+.|||.+||++||++||||+|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhhccccchhhhhhhhcccccccc-cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 776554443332222221111100 000000 124788999999999999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=442.59 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=219.0
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHH-hCCCCCccccceeecCCCCCCCc
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLR-LLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
++|++++.||+|+||+||+|.++.+|+.||||++++... .......+.+|..++. .++||||+++++++. +.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence 579999999999999999999999999999999974311 1123345667777655 689999999999994 446
Q ss_pred eEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
.+|||||||. |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 7999999999 699999998889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhc
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (414)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|.. +.+
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~--------- 220 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNP--------- 220 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC---------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC---------
Confidence 22 2356789999999999988 7899999999999999999999999999887766655532 111
Q ss_pred cHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHH-HHhcCCCCCcc
Q 015019 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGL 319 (414)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~-~lL~hp~~~~~ 319 (414)
.....+|+.+.+||++||+.||.+|||+. ++++||||+++
T Consensus 221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 11246899999999999999999999995 89999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-59 Score=444.90 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=210.2
Q ss_pred CCCCCeeEee-eecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh-CCCCCccccceeecCCCCC
Q 015019 20 GDANRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 20 ~~~~~Y~i~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~ 97 (414)
...++|++++ .||+|+||+||+|+++.+++.||||++++. ..+.+|+.++.+ ++||||++++++|.+.. .
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-A 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-c
Confidence 3456899875 599999999999999999999999998642 356689998654 58999999999985422 2
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCCeEEeecC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFG 171 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~vkL~DFG 171 (414)
....+|||||||+ |+|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 3467999999998 6999999874 47999999999999999999999999999999999999985 4679999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
+|+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+......
T Consensus 160 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-- 231 (335)
T d2ozaa1 160 FAKETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-- 231 (335)
T ss_dssp TCEECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS--
T ss_pred eeeeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc--
Confidence 9987544322 245689999999999987 68999999999999999999999999877654443333221100
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
.........+..+|+++.+||++||+.||++|||+.|+|+||||..-
T Consensus 232 ---------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 232 ---------------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ---------------------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ---------------------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 00000001123579999999999999999999999999999999653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=430.35 Aligned_cols=288 Identities=36% Similarity=0.570 Sum_probs=236.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
+||++++.||+|+||+||+|+++.+++.||||+++..........++.+|+.+|+.++||||+++++++. +...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 6899999999999999999999999999999999766555667788999999999999999999999994 44578
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCC
Q 015019 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (414)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 181 (414)
++|+|++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 7777777788999999999999999999999999999999999999999999999999999987544322
Q ss_pred ccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHhhcc
Q 015019 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (414)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (414)
......++++|+|||++.+. ..++.++|||||||++|+|++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22445688999999998763 4579999999999999999999876 677778888888888888877654332211
Q ss_pred HHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcccc
Q 015019 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (414)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (414)
.. .+................+.+++.+.|||++||+.||.+||||+|+|+||||+++..
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 00 000000001112233445678999999999999999999999999999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=431.71 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=209.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhCC--CCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLR--HPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~ 95 (414)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....++.+|+.+|+.++ ||||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe---
Confidence 578999999999999999999999999999999986432111 12234668999999986 899999999994
Q ss_pred CCCCceEEEEEecCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCC-CCeEEeecCC
Q 015019 96 KREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGL 172 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~-~~vkL~DFG~ 172 (414)
+.+.+|+||||+. +++.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 4467999999997 4888899888899999999999999999999999999999999999999854 7999999999
Q ss_pred cccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 158 a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------- 218 (273)
T d1xwsa_ 158 GALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------- 218 (273)
T ss_dssp CEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-------
T ss_pred ceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-------
Confidence 9864332 23567899999999998762 3456789999999999999999999976421 111
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCcc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (414)
... .....+|+++.+||++||+.||.+|||++|+|+||||+++
T Consensus 219 -------------------~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 -------------------GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -------------------CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------------------ccc-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 000 1124689999999999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-58 Score=427.50 Aligned_cols=267 Identities=25% Similarity=0.357 Sum_probs=215.0
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
...++|++.+.||+|+||+||+|++..+|+.||||++++... ......++.+|+.+|+.++||||+++++++.... ..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CC
Confidence 346899999999999999999999999999999999986543 3455667899999999999999999999986543 23
Q ss_pred CceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
...+|||||||+ ++|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 346899999999 6999999888899999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
............+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~---------- 230 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED---------- 230 (277)
T ss_dssp ----------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----------
T ss_pred cccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC----------
Confidence 44333334466789999999999987 689999999999999999999999999888766655543311
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~ 316 (414)
+.+.....+.+|+.+.+||.+||+.||.+||+..+.|.|+|.
T Consensus 231 -----------------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 231 -----------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -----------------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -----------------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 112223346799999999999999999999954444456665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-58 Score=435.44 Aligned_cols=287 Identities=31% Similarity=0.562 Sum_probs=223.4
Q ss_pred ccCCCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCC
Q 015019 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (414)
Q Consensus 18 ~~~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 96 (414)
.++..++|++++.||+|+||+||+|+++.+|+.||||+++.. ...++.+|+.+|+.++ ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 466778999999999999999999999999999999998752 2456789999999995 99999999998543
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCC-CeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~-~vkL~DFG~a~ 174 (414)
....+|+|||||. ++|... .+.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 3356999999999 476554 34799999999999999999999999999999999999998655 69999999998
Q ss_pred cccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCC-CChhhHHHHHHHhcCCCCHH
Q 015019 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPE 253 (414)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~ 253 (414)
....... ....+||+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.. .+..++...+...+|.+...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 6543322 2566899999999998763 4689999999999999999999999864 45666777777777755433
Q ss_pred HHHhhccHH-HHHHHHHhcCCCCCCc-----cCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCCCCCccc
Q 015019 254 TIAVVRNEK-ARKYLTEMRKKPPVPL-----FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 254 ~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (414)
......... ...+............ ......+|+++.|||++||++||.+||||+|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 221111000 0000000000011000 112234789999999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-57 Score=415.05 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=207.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||+||+|... ..||||+++.........+.+.+|+.+|++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 468999999999999999999643 469999997665556677789999999999999999999998632 34
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999999 7999999754 57999999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccccccCcccccccccccc-CCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. ....+..+||+.|+|||++.+. ...|+.++|||||||++|||+||+.||.+.+....+..+.....
T Consensus 158 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---------- 226 (276)
T d1uwha_ 158 SG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY---------- 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS----------
T ss_pred CC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----------
Confidence 22 1223556899999999998642 24589999999999999999999999998776555443332111
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..........++++.+.+||.+||+.||++|||+.|+++|
T Consensus 227 ---------------~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 227 ---------------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1111223345789999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=416.93 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=205.6
Q ss_pred eeecccCceeEEEEEEC--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceEEEEE
Q 015019 29 EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 29 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
++||+|+||+||+|.+. .+++.||||+++.........+.+.+|+.+|++++||||+++++++.. ...||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 46999999999999864 456789999997654455556789999999999999999999999843 2479999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCCCCcccc
Q 015019 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (414)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (414)
|||+ |+|.+++.....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9998 699999999899999999999999999999999999999999999999999999999999999876544333333
Q ss_pred ccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhhccHHHH
Q 015019 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (414)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (414)
.....||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+.+..
T Consensus 167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~----------------- 227 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------- 227 (277)
T ss_dssp ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------
T ss_pred ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 345679999999999987 689999999999999999997 899999887665554443210
Q ss_pred HHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH---hcCCCCC
Q 015019 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA---LADPYFK 317 (414)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l---L~hp~~~ 317 (414)
. ......+|+++.+||.+||+.||.+|||++++ |+|+|++
T Consensus 228 --------~-----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 --------R-----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------C-----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------C-----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0 01224688999999999999999999999998 4566653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-56 Score=415.74 Aligned_cols=255 Identities=22% Similarity=0.402 Sum_probs=209.0
Q ss_pred ccccC-CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCC
Q 015019 16 FTEYG-DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (414)
Q Consensus 16 ~~~~~-~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 94 (414)
+..|. ..++|++.+.||+|+||+||+|+++.+++.||||+++.... ..+.+.+|+++|+.++|||||++++++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~-- 83 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCT-- 83 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEe--
Confidence 34443 33689999999999999999999999999999999875432 3456889999999999999999999994
Q ss_pred CCCCCceEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecC
Q 015019 95 SKREFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (414)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG 171 (414)
+.+.+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ---~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 84 ---REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred ---eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 3356899999999 7999998753 578999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCC
Q 015019 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTP 250 (414)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~ 250 (414)
+|+........ ......||+.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.......+..
T Consensus 161 ~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~----- 231 (287)
T d1opja_ 161 LSRLMTGDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----- 231 (287)
T ss_dssp CTTTCCSSSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----
T ss_pred ceeecCCCCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-----
Confidence 99875443222 2244568999999999987 7899999999999999999996655 455444333222211
Q ss_pred CHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
... ......+++.+.+||.+||+.||++|||++++++
T Consensus 232 ----------------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 232 ----------------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ----------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 000 1123468999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-56 Score=414.18 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=200.6
Q ss_pred CCCCCeeEeeeecccCceeEEEEEECCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
...++|++.+.||+|+||+||+|.++.+++ .||||++... ......+.+.+|+.+|+.++|||||++++++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--- 98 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--- 98 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee---
Confidence 345689999999999999999999987765 5899988653 334556679999999999999999999999943
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.+.+|+|||||. |+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 99 --~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 99 --STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred --CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 345899999999 6899988764 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccc--cccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCC
Q 015019 175 VAFSDTPMTV--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (414)
Q Consensus 175 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (414)
.......... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 252 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-- 252 (299)
T ss_dssp -------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 6543322111 1123468999999999987 789999999999999999998 89999988876665555321110
Q ss_pred HHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.....+++.+.+||.+||+.||++|||+.|++++
T Consensus 253 ----------------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 ----------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1124688999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=412.70 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=213.6
Q ss_pred CCeeEeee-ecccCceeEEEEEECCC--CcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEV-IGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~-lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
++|.+.+. ||+|+||+||+|.++.+ +..||||+++.. ......+++.+|+++|+.++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence 57888885 99999999999987644 457999999754 344566789999999999999999999999843
Q ss_pred ceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
+.+|+|||||+ |+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 24899999999 699998765 4679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
............+||+.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..|.+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--------- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---------
T ss_pred ccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 44333333345678999999999977 689999999999999999998 899999887665555443210
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHH---hcCCCCCc
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA---LADPYFKG 318 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~l---L~hp~~~~ 318 (414)
. ....+.+|+++.+||.+||+.||++|||+.++ |+|+|++-
T Consensus 230 ----------------~-----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 230 ----------------R-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ----------------C-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------------C-----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0 01235789999999999999999999999887 67888753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-56 Score=405.98 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=199.2
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
++++|++++.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+++++.++||||+++++++.. .+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QA 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceecc-----CC
Confidence 3568999999999999999999976 5678999999754332 3568899999999999999999999954 34
Q ss_pred eEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
.+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 5899999998 7999988754 5789999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
..... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+......
T Consensus 154 ~~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-------- 221 (263)
T d1sm2a_ 154 DQYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------- 221 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC--------
T ss_pred CCcee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence 32221 234579999999999987 689999999999999999999 56777777665555544331110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......++++.+||.+||+.||++|||++++|+|
T Consensus 222 ----------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ----------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123568899999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=419.58 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=207.2
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCc-----EEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|++++.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~---- 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT---- 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence 689999999999999999999876554 69999986532 233445788999999988 8999999999994
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN-----------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~-----------------------~~l~~~~~~~i~~qil~al~~LHs~givHrDl 152 (414)
+.+.+|+|||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3456899999998 7999999754 24899999999999999999999999999999
Q ss_pred CCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCC
Q 015019 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231 (414)
Q Consensus 153 kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf 231 (414)
||+|||++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999875443322 22345678999999999987 789999999999999999997 89999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 015019 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (414)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL 311 (414)
.+.+....+..+...-.. ......+|+++.+||.+||+.||++|||++|++
T Consensus 268 ~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFK-----------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp TTCCCSHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHhcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 887665554444321100 012246889999999999999999999999999
Q ss_pred cC
Q 015019 312 AD 313 (414)
Q Consensus 312 ~h 313 (414)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=410.62 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=208.4
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCceE
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~ 102 (414)
++|++++.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.. +.+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~ 82 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI 82 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCe
Confidence 68999999999999999999976 577899999975432 23568899999999999999999998743 247
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
|+|||||. |+|.+++... .++++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999 7898877543 36999999999999999999999999999999999999999999999999999875433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhC-CCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
.. .......||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||...+..+.+..+.....
T Consensus 163 ~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~---------- 228 (272)
T d1qpca_ 163 EY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------- 228 (272)
T ss_dssp CE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred cc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 21 12245679999999999977 6899999999999999999995 566776665555444432110
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCc
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (414)
. .....+++++.+||.+||+.||++|||++++++ |+||+.
T Consensus 229 ---------------~-----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 ---------------M-----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------C-----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0 112468899999999999999999999999998 788853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=401.52 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=211.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
++.|++++.||+|+||+||+|+++ ++..||||++++.... ...+.+|+.+++.++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEee-----CCc
Confidence 468999999999999999999985 7789999999864332 3468899999999999999999999943 356
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+|||||. |+|.+++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998 788888665 457999999999999999999999999999999999999999999999999999865433
Q ss_pred CCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHhh
Q 015019 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (414)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (414)
... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+.+....
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------- 220 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------- 220 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 222 2245679999999999987 689999999999999999998 89999998877666555432111
Q ss_pred ccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
......++.+.+||++||+.||++|||++++|+|
T Consensus 221 ---------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ---------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123578899999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=420.03 Aligned_cols=264 Identities=25% Similarity=0.411 Sum_probs=216.2
Q ss_pred CCeeEeeeecccCceeEEEEEE---CCCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhCCC-CCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~ 96 (414)
++|++++.||+|+||+||+|.+ +.+|+.||||++++... .....+.+.+|+.+|++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----- 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence 6799999999999999999997 44789999999875321 22234567799999999976 8999999998
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.+...+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 44467999999999 69999999988999999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
...... .......|++.|+|||.+.+....++.++|||||||+||+|++|+.||.+.+..+....+....
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------- 248 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 248 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence 533222 1234567999999999987643568889999999999999999999998877655544443211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCccc
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (414)
..... .....+|+++.+||++||+.||.+|| |++|+|+||||+++.
T Consensus 249 --------------~~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 249 --------------LKSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp --------------HHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred --------------ccCCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 00111 12246899999999999999999999 599999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=400.59 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=199.7
Q ss_pred CCeeEeeeecccCceeEEEEEECCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 99 (414)
++|++++.||+|+||+||+|++..++ ..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 58999999999999999999987554 46999988643 344556678999999999999999999999832
Q ss_pred ceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccccc
Q 015019 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (414)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~ 177 (414)
+.+|+|||||. |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 35799999999 688887765 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 015019 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (414)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (414)
..... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------- 227 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 32221 1244578999999999987 789999999999999999998 8999998887766655532110
Q ss_pred hhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
...++++|+.+.+||.+||+.||++|||+.|+++|
T Consensus 228 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12235789999999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=398.02 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=197.0
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCC----cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
++.|++.+.||+|+||+||+|..+.++ ..||||++... ........+.+|+.+|+.++|||||++++++..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~---- 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK---- 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec----
Confidence 457999999999999999999987654 47999999753 234455678899999999999999999999943
Q ss_pred CCceEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
...+|+|||||. +++.+.+... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 -~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 -YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred -CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 346899999999 5777777654 6799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC-CCCCCCChhhHHHHHHHhcCCCCHHH
Q 015019 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPET 254 (414)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (414)
...............||+.|+|||++.+ ..|+.++|||||||++|||++|. +||.+.+..+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-------
Confidence 5443332222345578999999999987 78999999999999999999965 5555555444433332110
Q ss_pred HHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.. .....+++.+.+||.+||+.||++|||+.++++
T Consensus 231 ------------------~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 231 ------------------RL-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------CC-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CC-----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01 112457899999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=397.34 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=205.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++.+.||+|+||+||+|+++.+ +.||||+++..... .+.+.+|+.+|+.++|||||++++++.. +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 46899999999999999999998755 57999999754332 3568899999999999999999998832 23
Q ss_pred EEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+|||||. |+|..++.. .+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 688887754 35799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhC-CCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+....+.+..+......
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------- 233 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 233 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence 2221 2244579999999999987 7899999999999999999995 5666666665555554321111
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc--CCCCCcc
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKGL 319 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~--hp~~~~~ 319 (414)
...+.+++++.+||.+||+.||++|||++++++ |+||...
T Consensus 234 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 123568999999999999999999999999998 8999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=402.23 Aligned_cols=251 Identities=21% Similarity=0.347 Sum_probs=201.6
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 98 (414)
.+|++++.||+|+||+||+|.+..+|+ .||+|+++... .....+.+.+|+.+|+.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 469999999999999999999988876 58888876432 223456789999999999999999999998543
Q ss_pred CceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccc
Q 015019 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~ 176 (414)
..++|+|+|. ++|.+.+.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 3577778777 789888766 458999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 015019 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (414)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (414)
..... ........||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+.+..
T Consensus 162 ~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 230 (317)
T d1xkka_ 162 GAEEK-EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------- 230 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC--------
T ss_pred ccccc-cccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 43322 222244568999999999987 689999999999999999998 789998877655544443211
Q ss_pred HhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.. ...+.+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 231 -----------------~~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 231 -----------------RL-----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------------CC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC-----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 00 1124688999999999999999999999999988
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=394.73 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=201.6
Q ss_pred CCCCCeeEeeeecccCceeEEEEEEC-CCC--cEEEEEEeCCccC-ChHHHHHHHHHHHHHHhCCCCCccccceeecCCC
Q 015019 20 GDANRYKILEVIGKGSYGVVCAAIDT-HTG--EKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (414)
Q Consensus 20 ~~~~~Y~i~~~lg~G~~g~V~~a~~~-~~~--~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 95 (414)
-..++|++++.||+|+||.||+|+.. .++ ..||||++.+... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 34567999999999999999999864 333 3789999875433 234456789999999999999999999999432
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCc
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a 173 (414)
.+|+|||||. |++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 -----~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 84 -----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -----chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 3699999998 688887655 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
+................|+..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~--- 233 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--- 233 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC---
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC---
Confidence 986554443334455678889999999988 789999999999999999998 89999998877766655431111
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
....+.+|+.+.+||.+||+.||++|||++++++
T Consensus 234 --------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 --------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123578899999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=396.40 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=198.1
Q ss_pred CCeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 96 (414)
++|++++.||+|+||.||+|.+.. +++.||||+++.. ........+.+|..++.++ +|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 589999999999999999999754 4568999998753 3334556677888887776 689999999987543
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEE
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl 159 (414)
...+|+|||||+ |+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 345899999999 7999999753 248999999999999999999999999999999999999
Q ss_pred cCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhC-CCCCCCCChhh
Q 015019 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVH 238 (414)
Q Consensus 160 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g-~~pf~~~~~~~ 238 (414)
+.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999865433222 22345689999999999987 7899999999999999999986 57888766544
Q ss_pred HHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
.+..+...-. . ......+++++.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~------------------------~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGT------------------------R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTC------------------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCC------------------------C-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333321100 0 01224688999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-52 Score=392.80 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=208.1
Q ss_pred CCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCC
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 97 (414)
++|++++.||+|+||+||+|+.+ .+++.||||+++.. ......+++.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~---- 87 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV---- 87 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeecc----
Confidence 57999999999999999999875 35678999998753 334456678999999999999999999999943
Q ss_pred CCceEEEEEecCC-CCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 015019 98 EFKDIYVVFELME-SDLHQVIKAND------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (414)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~------------------------~l~~~~~~~i~~qil~al~~LHs~givHrDl 152 (414)
...+++|||||. |+|.+++.... .+++..+..|+.||+.||+|||++||+||||
T Consensus 88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 356899999998 79999986432 4899999999999999999999999999999
Q ss_pred CCCCEEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC-CCC
Q 015019 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLF 231 (414)
Q Consensus 153 kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~-~pf 231 (414)
||+|||++.++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|. +||
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999986533222 112245678999999999987 78999999999999999999985 789
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 015019 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (414)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL 311 (414)
.+.+..+.+..+.+.. .......+++++.+||.+||+.||.+|||+.|++
T Consensus 244 ~~~~~~e~~~~v~~~~------------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGN------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp TTSCHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHcCC------------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 8887776665553211 0112346889999999999999999999999996
Q ss_pred c
Q 015019 312 A 312 (414)
Q Consensus 312 ~ 312 (414)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=385.68 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=198.5
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
.++|++++.||+|+||.||+|.. +|+.||||++++. ...+.+.+|+++|++++||||+++++++... .+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCc
Confidence 35799999999999999999987 4789999999753 3446788999999999999999999988542 234
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccC
Q 015019 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~ 178 (414)
+|+|||||. |+|.+++... ..+++..+..|+.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 799999998 6999998654 3589999999999999999999999999999999999999999999999999986433
Q ss_pred CCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHh
Q 015019 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
.. ....+|..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....|.+..
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---------- 217 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------- 217 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 22 33468899999999987 689999999999999999998 789998877666555442110
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
. ......+++.+.+||++||+.||.+|||+.+++++
T Consensus 218 ---------------~-----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ---------------K-----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------C-----CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 11234678999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=388.02 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=204.3
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCC-------cEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 93 (414)
.++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|...+.++ +||||+++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 479999999999999999999976554 379999997643 345566788899998888 79999999999943
Q ss_pred CCCCCCceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 94 PSKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
...+|+|||||. |+|.++|... ..+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 91 -----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp -----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 356899999999 7999999754 358999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
||++.++.+||+|||+++........ ......+||+.|+|||.+.+ ..|+.++|||||||++|+|++ |.+||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999876443322 12345679999999999987 789999999999999999998 789998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
.......+.... .. .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 243 ~~~~~~~i~~~~-------------------------~~-----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGH-------------------------RM-----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTC-------------------------CC-----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC-------------------------CC-----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 654444332210 00 122468899999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=391.28 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=204.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 98 (414)
.++|++.+.||+|+||+||+|.++.+|. .||||+++... .....+.+.+|+++|+.+ +||||+++++++. +
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~ 82 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 82 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----c
Confidence 3689999999999999999999998887 47788875432 223455788999999998 7999999999994 3
Q ss_pred CceEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC
Q 015019 99 FKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (414)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~ 161 (414)
.+.+|+|||||+ |+|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 456999999999 7999999643 57999999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCC-CCCCCCChhhHH
Q 015019 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQL 240 (414)
Q Consensus 162 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~-~pf~~~~~~~~~ 240 (414)
++.+||+|||+|+....... ....+||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+..
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp GGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCceEEcccccccccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999976433221 134568999999999987 78999999999999999999965 678877765554
Q ss_pred HHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+.+.. . ......+++++.+||.+||+.||++|||+.++++|
T Consensus 237 ~~i~~~~-------------------------~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 237 EKLPQGY-------------------------R-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHGGGTC-------------------------C-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcC-------------------------C-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4442210 0 11234688999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=387.46 Aligned_cols=252 Identities=20% Similarity=0.347 Sum_probs=210.7
Q ss_pred CCCeeEeeeecccCceeEEEEEECC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 96 (414)
.++|++++.||+|+||+||+|.+.. +++.||||+++.. ........+.+|++++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--- 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec---
Confidence 3799999999999999999998753 3578999999754 344556678999999999999999999999943
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCe
Q 015019 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (414)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~v 165 (414)
...+++|||||. |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 95 --~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 345899999998 7999988532 257899999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhC-CCCCCCCChhhHHHHHH
Q 015019 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLIT 244 (414)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g-~~pf~~~~~~~~~~~i~ 244 (414)
||+|||+|+....... .......+||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999986543322 222344578999999999987 7899999999999999999998 58898888776665554
Q ss_pred HhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
+... ......+++.+.+||.+||+.||++|||+.++++
T Consensus 250 ~~~~------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EGGL------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCC------------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3110 1122468899999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=384.54 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=209.8
Q ss_pred CCCeeEeeeecccCceeEEEEEEC-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhC-CCCCccccceeecCCC
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 95 (414)
.++|++++.||+|+||.||+|... .+++.||||+++.. ........+.+|+.+++.+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 379999999999999999999853 46679999999754 3455666789999999999 69999999999943
Q ss_pred CCCCceEEEEEecCC-CCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCC
Q 015019 96 KREFKDIYVVFELME-SDLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~N 156 (414)
...+|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 345899999998 69999987543 58999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHh-CCCCCCCCC
Q 015019 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (414)
Q Consensus 157 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~-g~~pf~~~~ 235 (414)
||++.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987644332 223355789999999999987 789999999999999999998 677787766
Q ss_pred hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
..+.+..+.+.-. .. .....+++.+.+||.+||+.||.+|||++++|+
T Consensus 253 ~~~~~~~~i~~~~------------------------~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGF------------------------RM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTC------------------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCC------------------------CC-----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6555444432100 00 112457899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-51 Score=385.32 Aligned_cols=265 Identities=20% Similarity=0.241 Sum_probs=204.7
Q ss_pred CCCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCc
Q 015019 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 21 ~~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 100 (414)
+++||++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|+|++..+..+. .+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEE----EETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEE----ecCC
Confidence 457999999999999999999999999999999998653222 34678999999998887666655543 2345
Q ss_pred eEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC---CCCeEEeecCCcccc
Q 015019 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVA 176 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~---~~~vkL~DFG~a~~~ 176 (414)
..++|||||++++.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+..
T Consensus 77 ~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 6899999999988887765 458999999999999999999999999999999999999764 457999999999876
Q ss_pred cCCCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 015019 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (414)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (414)
....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--- 231 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--- 231 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc---
Confidence 4332211 12245689999999999988 68999999999999999999999999876654433322211000
Q ss_pred HHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHH---HHhcCCCCCc
Q 015019 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EALADPYFKG 318 (414)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~---~lL~hp~~~~ 318 (414)
....+......++|+++.+||.+||+.||++|||++ ++|+|+|.+.
T Consensus 232 --------------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 232 --------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp --------------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000011112357899999999999999999999986 5577877643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.5e-50 Score=373.72 Aligned_cols=254 Identities=19% Similarity=0.225 Sum_probs=204.8
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCC-CCccccceeecCCCCCCCc
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSKREFK 100 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~ 100 (414)
+++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++| +|++.+++++ ....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCC
Confidence 5799999999999999999999999999999999864322 2346688899999975 8999999887 3446
Q ss_pred eEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcC-----CCCeEEeecCCcc
Q 015019 101 DIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-----NCKLKVCDFGLAR 174 (414)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~-----~~~vkL~DFG~a~ 174 (414)
..|+|||||+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 78999999999999999765 47999999999999999999999999999999999999974 5789999999998
Q ss_pred cccCCCCcc----ccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHH---HHHHhc
Q 015019 175 VAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD---LITDLL 247 (414)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~ 247 (414)
......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 754322111 12345689999999999988 789999999999999999999999998765433222 221110
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~ 312 (414)
-.+ +.....+++++++.+++..|+..+|++||+.+.+.+
T Consensus 233 ~~~--------------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 233 QST--------------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHS--------------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCC--------------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000 111223568899999999999999999999877644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-50 Score=385.41 Aligned_cols=282 Identities=24% Similarity=0.362 Sum_probs=211.3
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-----------CCCccccceee
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKRIM 91 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~ 91 (414)
+||+++++||+|+||+||+|+++.+|+.||||++++. ......+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5799999999999999999999999999999999753 334456778999888775 47899999887
Q ss_pred cCCCCCCCceEEEEEecCC--CCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCCEEEcCCCC--
Q 015019 92 LPPSKREFKDIYVVFELME--SDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCK-- 164 (414)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~--g~L~~~i~--~~~~l~~~~~~~i~~qil~al~~LHs-~givHrDlkp~NILl~~~~~-- 164 (414)
.... ....++|++++. ++...... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKG---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEE---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eecc---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 5422 234566666654 34333333 34689999999999999999999998 89999999999999987653
Q ss_pred ----eEEeecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-----
Q 015019 165 ----LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS----- 235 (414)
Q Consensus 165 ----vkL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~----- 235 (414)
+|++|||.|...... ....+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||.+..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeecccccccccc------cccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 999999999764322 245679999999999887 789999999999999999999999997543
Q ss_pred -hhhHHHHHHHhcCCCCHHHHHhhccHHHHHHHHHh---cCCCCC---C-------ccCCCCCCChHHHHHHHHhccCCC
Q 015019 236 -VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM---RKKPPV---P-------LFQKFPNVDPLALRLLQRLIAFDP 301 (414)
Q Consensus 236 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~-------~~~~~~~~s~~~~dli~~~L~~dp 301 (414)
..+.+..+...+|.++.......... ..++... ...... + ........++.+.|||.+||++||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 34566777788888877655332211 1110000 000000 0 001112356789999999999999
Q ss_pred CCCCCHHHHhcCCCCCccc
Q 015019 302 KDRPTAEEALADPYFKGLA 320 (414)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~ 320 (414)
.+||||+|+|+||||+...
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=374.21 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=199.8
Q ss_pred eeEeeeecccCceeEEEEEECCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
+.+.++||+|+||+||+|++..++ ..||||++++. .......++.+|+++|++++||||+++++++... .+.
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCc
Confidence 344688999999999999986543 36999999753 4556677899999999999999999999987432 246
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEeecCCcccccCC
Q 015019 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~ 179 (414)
+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 6888888754 46788899999999999999999999999999999999999999999999999875433
Q ss_pred CCc-cccccccccCccccccccccccCCCCCCcchhhhHhHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHHh
Q 015019 180 TPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAV 257 (414)
Q Consensus 180 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 257 (414)
... ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||.... ..+....+.. |
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g--------- 250 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--G--------- 250 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--T---------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--C---------
Confidence 221 122344678999999999887 689999999999999999999776665433 2222222211 0
Q ss_pred hccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
... .....+++.+.+||.+||+.||++|||+.|+++|
T Consensus 251 --------------~~~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 251 --------------RRL-----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCC-----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 000 1124678999999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=376.10 Aligned_cols=276 Identities=23% Similarity=0.232 Sum_probs=194.2
Q ss_pred CCCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCccccceeecCCCCCCCce
Q 015019 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 22 ~~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~ 101 (414)
..+|.+.+.||+|+||+||+|+. +|+.||||+++.. ........+|+..++.++||||+++++++.... .....
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceE
Confidence 46799999999999999999975 6899999998642 111122234555566789999999999986543 23346
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccCCCCCCCEEEcCCCCeEEeecCC
Q 015019 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------ANVYHRDLKPKNILANANCKLKVCDFGL 172 (414)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs--------~givHrDlkp~NILl~~~~~vkL~DFG~ 172 (414)
+|+|||||. |+|.+++++. .+++.....++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 899999998 6999999875 69999999999999999999997 5999999999999999999999999999
Q ss_pred cccccCCCCcc-ccccccccCccccccccccccCC----CCCCcchhhhHhHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 015019 173 ARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (414)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwSlG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (414)
++......... ......+||+.|+|||++.+... .++.++|||||||+||||+||.+||.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-~~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch-hhccc
Confidence 98764433221 12345789999999999865211 26778999999999999999998875432111000 00000
Q ss_pred CCCCHHHHHhhccHHHHHHHHHhcCCCCCCccCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 015019 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (414)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~Rpt~~~lL~h 313 (414)
..+.... .......-..++..+...........+.+|+.+||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~--------~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEE--------MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHH--------HHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHH--------HHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0111111 111100000001111000011223458899999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=2.1e-27 Score=205.82 Aligned_cols=171 Identities=16% Similarity=0.094 Sum_probs=122.0
Q ss_pred eeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCC----------------hHHHHHHHHHHHHHHhCCCCCccccc
Q 015019 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----------------ISDAIRILREVKLLRLLRHPDIVEIK 88 (414)
Q Consensus 25 Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~hpniv~l~ 88 (414)
|.++++||+|+||+||+|.+. +|+.||||+++..... ........+|+..+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578999999999999999885 6899999987531100 01123455789999999999998887
Q ss_pred eeecCCCCCCCceEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCCEEEcCCCCeEEe
Q 015019 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (414)
Q Consensus 89 ~~~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~givHrDlkp~NILl~~~~~vkL~ 168 (414)
+.. . -++||||+++... ..++...+..++.||+.||+|||++||+||||||+|||+++++ ++|+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEEC
T ss_pred Eec-----C----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEE
Confidence 654 1 2799999996322 1355666788999999999999999999999999999999765 9999
Q ss_pred ecCCcccccCCCCccccccccccCccccccccccccCCCCCCcchhhhHhHH
Q 015019 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (414)
Q Consensus 169 DFG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwSlG~i 220 (414)
|||+|+.......... ....+. .-.+.+ . ..|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~~-l~rd~~----~~~~~f-~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREI-LERDVR----NIITYF-S--RTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHH-HHHHHH----HHHHHH-H--HHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHH-HHHHHH----HHHHHH-c--CCCCCcccHHHHHHH
Confidence 9999976432221110 000000 001122 1 468899999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=2.2e-07 Score=82.04 Aligned_cols=139 Identities=12% Similarity=0.139 Sum_probs=87.9
Q ss_pred CCeeEeeeecccCceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCCCCCCce
Q 015019 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (414)
Q Consensus 23 ~~Y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~ 101 (414)
..|++++..+.++.+.||++. .++..+++|+....... ....+.+|...++.+. +--+.+++.+. ...+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 467777776666667899884 45667888987643221 2234567888887774 33345555554 23356
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------
Q 015019 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------------------------------- 145 (414)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~al~~LHs~----------------------------------- 145 (414)
.|+||++++| .+.+..... .....+..++...++.||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 7999999997 443332111 11222344444444445431
Q ss_pred ------------------------CcccCCCCCCCEEEcCCCCeEEeecCCccc
Q 015019 146 ------------------------NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (414)
Q Consensus 146 ------------------------givHrDlkp~NILl~~~~~vkL~DFG~a~~ 175 (414)
.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 258999999999999876667999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=6.8e-06 Score=76.90 Aligned_cols=77 Identities=19% Similarity=0.104 Sum_probs=46.4
Q ss_pred eeeecccCceeEEEEEECCCCcEEEEEEeCCcc----C-ChHHHHHHHHHHHHHHhCC-C-C-CccccceeecCCCCCCC
Q 015019 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----E-HISDAIRILREVKLLRLLR-H-P-DIVEIKRIMLPPSKREF 99 (414)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~-~~~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~~~~~~ 99 (414)
.+.||.|....||++.+..+++.|++|.-.... . ......+..+|...|+.+. + | .+.+++.+- .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~----- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C-----
Confidence 567999999999999888788899999643110 0 1112345667888887763 2 2 344444432 1
Q ss_pred ceEEEEEecCCC
Q 015019 100 KDIYVVFELMES 111 (414)
Q Consensus 100 ~~~~lV~E~~~g 111 (414)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 123789999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=2.1e-05 Score=68.53 Aligned_cols=71 Identities=10% Similarity=0.013 Sum_probs=44.0
Q ss_pred eecccCc-eeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCC--CccccceeecCCCCCCCceEEEEE
Q 015019 30 VIGKGSY-GVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVVF 106 (414)
Q Consensus 30 ~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~~~~~~lV~ 106 (414)
.+..|.. +.||++.. .++..+++|..... ....+.+|...|+.+... .+.+++.+.. +.+..++||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEE
Confidence 3445544 67898864 45667888876532 122356777877777432 2455565542 234579999
Q ss_pred ecCCC
Q 015019 107 ELMES 111 (414)
Q Consensus 107 E~~~g 111 (414)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.0011 Score=59.56 Aligned_cols=72 Identities=14% Similarity=0.014 Sum_probs=42.1
Q ss_pred ceeEEEEEECCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCCCCCcc--ccceeecCCCCCCCceEEEEEecCCC
Q 015019 36 YGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV--EIKRIMLPPSKREFKDIYVVFELMES 111 (414)
Q Consensus 36 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv--~l~~~~~~~~~~~~~~~~lV~E~~~g 111 (414)
--.||++.. .+|..|++|+.... ......+..|+..|..|...++. .....--..........+.++++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999964 46888999987532 22345577888888887533322 11111100111223457889999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.92 E-value=0.002 Score=59.53 Aligned_cols=74 Identities=15% Similarity=0.134 Sum_probs=48.5
Q ss_pred CeeEeeeecccCceeEEEEEECC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhCC-CCCccccceeecCCC
Q 015019 24 RYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (414)
Q Consensus 24 ~Y~i~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 95 (414)
..+ ++.|+.|-.-.+|++.... .++.|++++.... . ......+|..+++.+. +.-..++++++
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~---~~idr~~E~~i~~~ls~~gl~Pkll~~~---- 114 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E---TESHLVAESVIFTLLSERHLGPKLYGIF---- 114 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C---CHHHHHHHHHHHHHHHHTTSSSCEEEEE----
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c---hhhHHHHHHHHHHHHHhCCCCCeEEEEc----
Confidence 344 5678888888999997653 2456777776431 1 1234557999998885 43345667666
Q ss_pred CCCCceEEEEEecCCC
Q 015019 96 KREFKDIYVVFELMES 111 (414)
Q Consensus 96 ~~~~~~~~lV~E~~~g 111 (414)
.+ .+|+||+.|
T Consensus 115 -~~----g~I~efi~g 125 (395)
T d1nw1a_ 115 -SG----GRLEEYIPS 125 (395)
T ss_dssp -TT----EEEECCCCE
T ss_pred -CC----ceEEEEecc
Confidence 11 688999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.78 E-value=0.0014 Score=58.56 Aligned_cols=30 Identities=30% Similarity=0.282 Sum_probs=26.7
Q ss_pred CCcccCCCCCCCEEEcCCCCeEEeecCCcc
Q 015019 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (414)
Q Consensus 145 ~givHrDlkp~NILl~~~~~vkL~DFG~a~ 174 (414)
.|+||+|+.++||+++.+...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999874
|